30.12.2013 Views

Back Matter (PDF) - Clinical Chemistry

Back Matter (PDF) - Clinical Chemistry

Back Matter (PDF) - Clinical Chemistry

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

llifi1ll<br />

Si<br />

Journal of the American Association of <strong>Clinical</strong> <strong>Chemistry</strong><br />

Volume 35, 1989<br />

AUTHOR INDEX<br />

bbott,<br />

abe,<br />

Karen<br />

Akira;<br />

L See<br />

Yamashita,<br />

Sgoutas, Demetrios S.<br />

Swniko; Noina, Akio,<br />

552<br />

be, Kenji; Konaka, Ryusei, 1619<br />

be, Toshlo See Usui, Akihiko<br />

berus, C. See Fox, Martha; Millsap, Susan<br />

blin, Richard J., 507<br />

brahasn, Paul A. See Apple, Fred S.<br />

brahamsson, P.-A.; Andersson, C.; Bjork, T.;<br />

Ferniund, P.; Lilja, H.; Murne, A.; Weiber,<br />

H., 1497<br />

brams, Billy See Toffaletti, John<br />

bu-Farsakh, F. A.; Thajeel, A. H.; Itani, S. M.;<br />

Al-Khalily,<br />

bu-Farsakh,<br />

A. S.; Abu-Farsakh, N. A., 335<br />

N. A. See Abu-Farsakh, F. A.<br />

ckermann, H. See Blackwood, J.<br />

-; Staedter, M.; Blackwood, J.; Inbar, S.;<br />

Grenner, G., 1180<br />

damczyk, Maciej See Brashear, Jeff<br />

damson,<br />

delsteln,<br />

M.D. See Papadopoulos, N. M.<br />

Edward H. See Thornton, William<br />

H., Jr.<br />

.d1ercreutz, H.; Liewendahl, K., 1555<br />

dolphson, Janet L.; Albers, John J., 1074<br />

garwal, R. P. See McPherson, Richard A.<br />

.garwal, Veena R. See Gambhir, K. K.<br />

#.ggarwal, Suresh K. See Herold, David A.<br />

.gmon, J. See Rotenberg, Z.<br />

.gmon, Jacob See Rotenberg, Zvi; Weinberger,<br />

Itzhak<br />

Mimad, Suhail See Malik, Sohail<br />

Muardi, V. See Sadrzadeh, Sayed M. H.<br />

Mne, Risto See Panvonen, Jorma<br />

kanuma, Hiroshi See Yabuuchi, Masahiko<br />

kanuma, Yasuo See Ishibashi, Shun<br />

kers, L C. See Orsulak, P. J.<br />

-; Orsulak, P. J.; Crowley, G. T.; Arnold, L. L,<br />

1187<br />

takers, Linda C. See Orsulak, Paul J.<br />

skhavan, Hashem See Schaap, A. Paul<br />

khavan-Tafti, Hashem See Schaap, A. Paul<br />

kingbe, Olunude 0. See Koch, Thomas it<br />

-; Koch, Thomas R.; Alonsaxona, Gladys, 1107<br />

Maupovic, Petar See Graziani, Maria Stella<br />

Mbers, John J. See Adolphson, Janet L.; Lodge,<br />

Mark S.; Marcovina, Santica M., 1234<br />

-; Msrcovina, Santica M., 1357<br />

Mbertini,<br />

Mbertini,<br />

A. See Ferrari, it<br />

Alberto See Polesi, Claudio<br />

Mderaian, Frances R. See Gitehnan, Hillel J.<br />

Mexander, J. W. See Schroeder, Timothy J.<br />

Mexander, L See Peltyszyn, Stephanie;<br />

Winamer, Cathy<br />

Mexander, Nicholas M. See Roberts, Randall<br />

T.<br />

Mexander, Roy L.; Torloni, Sergio A., 1199<br />

Mexandrovich, S. See Mauck, Linda<br />

Meyasslne, H.; Duliot, M. P., 1116<br />

Ml, F. See El-Attar, Hanan M.<br />

Mi, Farouk M.; El-Attar, Hanan M., 1152<br />

M-Khalily, A. S. See Abu-Farsakh, F. A.<br />

Mlain, P. See Laine-Cessac, P.<br />

-; Turcant, A.; Premel-Cabic, A., 469<br />

Mien, L. C.; Kadijevic, Lilly; Romanschin, A. D.,<br />

2094<br />

Allin, Ronald E.; McBride, J. H.; 0th, M. K.;<br />

Rodgerson, D. 0., 1150<br />

Allison, T. See McConway, M. G.<br />

Monsazona, Gladys See Akingbe, Otumide 0.<br />

Mspector, F. See Wong, P. Y.<br />

Aitmiller, Dale H. See Parker, K. Michael<br />

-; Parker, K. Michael, 1153<br />

Altura, Burton M., 1055<br />

Alvarez, Francisco V. See Vents, Rafael<br />

Alves, Isabel Longo See Saraiva, Maria Joao<br />

Mascarenhas<br />

Alyea, K. See Witherspoon, L. It<br />

Amakawa, Tsutomu See Joukyuu, Ritsuko<br />

Ambrocio, E.; Bartlett, S.; Brady, A.;<br />

Buelteman, L.; Hammad, N., 1167<br />

Ambrose, R. See Rosano, Thomas<br />

Ainedee-Manesme, Olivier See Lambert, Willy<br />

Aniemiya, Norihiko See Kobaysshi, Isao<br />

Amino, Nobuyuki See Tamaki, Haruo<br />

Amrein, C. See Cosson, C.; Myara, I.<br />

Anand, I. See Ferrari, R.<br />

Andersen, TomE. See Rehak, Nadja N.<br />

Anderson, David J.; Rudy, Jack L., 2152<br />

Anderson, 0. See Patella, Lisa; Scott, Milda<br />

Anderson, Geoffrey; Scott, M., 1180<br />

Anderson-Mitchell, K. See Freeman, J.<br />

Andersson, C. See Abrahamsson, P.-A.<br />

Andob, Yukio See Nakashima, Koji<br />

Angback, K. See Wallinder, H.<br />

Angelova-Gateva, P.; Koev, D. J., 491<br />

Angstadt, D. S. See Witte, D. L.<br />

Anne, L See Hu, Mae<br />

Anne, Lakshmi; Kang, Sam; Forni, Theresa;<br />

Centofanti, Joan; Gottwald, Ken, 1167<br />

Annesley, Thomas M., 1337<br />

Annunziato, M. See Dakubu, S.<br />

Ansari, A.; Ghoneum, G.; Trevejo, R., 1155<br />

Anton, Soledad See Perez-Bendito, Dolores<br />

Antonarakis, Stylianos E., B4<br />

Apple, Fred S. See Eastep, Steven J.<br />

-; Benson, Peter; Abraham, Paul A.; Rosano.<br />

Thomas G.; Halstenson, Charles E., 312<br />

Applegarth, Derek A. See Harris, Heather M.<br />

Arsi, Tomiko See Imamura, Shigeyuki<br />

Aramaki, Shuichi See Hoffmann, Georg<br />

Arashima, Shin-ichiro See Yamaguchi, Akihiro<br />

Arcelloni, Cinzia See Paleari, Renata<br />

Arcuri, E. See Chiang, C. S.<br />

Arendt, Josephine See Skene, Debra J.<br />

Arevalo, Gaston, 475<br />

Arkin, Charles F. See Sughayer, Maher A.<br />

Armbruster, David A.; Green, Denise T., 323<br />

Armbruster, Franz Paul See Peters, Jorg<br />

Armbruster, MA.; Lewis, L. M., 1108<br />

Armour, C. See Napoli, K. L.<br />

Armstrong, 0. See Bronstein, I.; Voyta, J. C.<br />

Arnaud, Pierre See Speich, Michelle<br />

Arneodo, V. See Roche, D.<br />

Arnold, L L. See Akers, L. C.<br />

-; Haven, M. C.; Markin, R. S., 1197<br />

Arnold, Lyle J., Jr.; Hammond, Philip W.;<br />

Wiese, Wendy A.; Nelson, Norman C., 1588<br />

Arntsen, K. W. See Rosalki, Sidney B.<br />

Arter, T. See Detwiler, Richard; Leaky, Fred D.<br />

Arter, Thomas See Novros, Joel<br />

Artiss, J. D. See Bateson, J. E.<br />

-; Strandbergh, D. R.; Zak, B., 1159<br />

Artiss,<br />

Artur,<br />

Joseph D. See Bateson,<br />

Y. See Guemouri, Laila<br />

Joseph E.<br />

Artur, Yves See Schiele, Francoise<br />

Asai, Mario See Hirata, Rosario Dominguez<br />

Crespo<br />

Asano, Masao See Maruta, Kazuhiro<br />

Ascher, M. See Haden, B.<br />

Ash, K. 0. See Crockett, Harold; Pearson,<br />

Stephen D.; Swanson, Terry<br />

Ash, K. Owen See Pearson, Stephen D.<br />

Ashwood, E. it See Crockett, Harold<br />

Ashwood, Edward R. See Elliott, M. C.<br />

Askew, Gord; Krahn, John, 2019<br />

Aslam, M. See Moore, P.; Mundill, P.<br />

Astles, J. Rex See Tietz, Norbert W.<br />

Atger, V. See Duval, F.; Myara, I.<br />

Atherton, Nigel D., 975<br />

Attia, John; Tropak, Michael; Johnson, Paul W.;<br />

Newerly-Abranow, Wanda; Pawson, Tony;<br />

Roder, John C.; Dunn, Robert J., 717<br />

Au, J. Lai-Sim; Su, Muh-Hwan; Wientjes, M.<br />

Guillaume, 48<br />

Au, J.-X. See Yiu, Samuel C. K.<br />

Aubert, Jean-Pierre See Fontaine, Monique<br />

Aubry, Claude See Lespinas, Francis<br />

AuBuchon, J. P.; Wilkinson, J. S.; Kassapian, S.<br />

J.; Edwards, G. C., 1118<br />

Audino, Nancy See Haver, Virginia M.<br />

Auget, Jean-Louis See Speich, Michelle<br />

Aupetit, J. See Chadefaux, B.<br />

Austin, Garth E. See Morin, Leo G.<br />

Austin, Theresa M. See Horowitz, Gary L.<br />

Avenell, M. H. J. See Hahnel, R.<br />

Aversa, Catherine IL See Per, Steven R.<br />

Aw, T. C.; Koay, E. S. C.; Yuen, M., 1151<br />

Awdziej, T. See Farrenkopf, Bruce C.<br />

Awdziej, Tania N.; Blake, J.; Farrenkopf, B.;<br />

Kaufman, R. A., 1178<br />

Awni, Walid M.; Bakker, Leendert J., 2124<br />

Ayers, C. it See Boyd, James C.<br />

Aymard, Pierre See Feldmann, Delphine; Feaus,<br />

Paul D.; Moussa, Fathi<br />

Azuma, Yutaro See Maekawa, Masato<br />

-; Maekawa, Masato; Kuwabara, Yoshiko;<br />

Nakajima, Takeyuki; Taniguchi, Ken;<br />

Kanno, Takashi, 1399<br />

Baadenhuijsen, H.; Bayer, P.M.; Keller, H.;<br />

Knedel, M.; Montalbetti, N.; Brenna, S.;<br />

Prencipe, L.; Vassault, A.; Bailly, M.; Phung,<br />

H. T.; Bablok, W.; Poppe, W.; Stockmann,<br />

W., 1260<br />

Baar, Janet G. See Baker, Harold N.; Ford,<br />

Kent A.<br />

Babb, Joseph See Bernstein, Larry H.<br />

Babik, D. M. See Figard, Steve D.<br />

Bablok, W. See Baadenhuijsen, H.<br />

Bacchus, Robby A. See Frandsen, Erik K.<br />

Bachand, Steven S.; Gabor, Michael J.; Mattel,<br />

Patricia A.; O’Donnell, C. M., 1269<br />

Bachas, Leonidas G. See Barbarakis, Minas S.<br />

Bachorik, Paul S. See Cloey, Teresa; Cloey,<br />

Teresa A.; Kafonek, Stephanie<br />

-; Bradford, Reagan H.; Cole, Thomas; Frantz,<br />

Ivan; Gotto, Antonio M., Jr.; Roberta, Karen;<br />

Warnick, G. Russell; Williams, 0. Dale, 1734<br />

-; Cloey, Teresa A.. 2236<br />

<strong>Back</strong>er, Egbert T.; Harff, Gottfried A., 2190<br />

Bacon, Bonnie L; Pardue, Harry L., 360<br />

Badcock, N. R.; Leach, J. A., 889<br />

Badenoch, Jane See Baja, Renze<br />

Badenoch, Jane L; Bais, Renze, 645<br />

Baginski, P. See Khayam-Bashi, Hassan<br />

Bagneski, Kim; Koch, David D.; Haessig, Lorene<br />

K., 1129<br />

Baherji, M. See Wright, Reba K.<br />

Bailey, Kim See Painter, Pennell<br />

Bailey,<br />

Bailey,<br />

L. See Beierle, Floyd A.<br />

Mark See Donohue, Joseph<br />

Bailly, M. See Baadenhuijsen, H.<br />

Baird, F. See Witherspoon, L. R.<br />

Bais, Eenze See Badenoch, Jane L.; Branford,<br />

Susan<br />

-; Badenoch, Jane; Bayer, Peter M.; Foe, Ying;<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2343


Keller, Herbert; Roller, Peter U.; Leinberger,<br />

Robert; Weidemann, Gerhard;Rosalki,<br />

Sidney B., 317<br />

Baker, Harold N. See Ford, Kent A.<br />

-; Ford, Kent A.; Bear, Janet G.; Balay. Diane;<br />

Venetucci, Mary; Marlewaki, Debbie;<br />

Ogunro, Edward A., 1203<br />

Baker, R. See Madry, Norbert<br />

Bakke, Antony C. See Subbarao, Makam N.<br />

Bakker, Leendert J. See Awni, Walid M.<br />

Bakkeren, J. A. J. M. See Elving, L. D.<br />

Balay, Diane See Baker, Harold N.; Ford, Kent<br />

A.<br />

Baldet, L See Izembart, M.; Piechaczyk, M.<br />

Baldwin, James R.; Plesher, C. J.; Lenzo, A.,<br />

1174<br />

Bale, M. See Danielson, Susan J.; Mauck, Linda<br />

Bales, it M. See Duffy, T. H.<br />

Belle, W. See Soldin, Steven J.<br />

Ball, D. J.; Korchak, S., 1170<br />

Ball,<br />

Ball,<br />

G. DavId, 1062<br />

Michael K. See Halloran, Stephen P.<br />

Ball, Richard; Freedman, Danielle B.; Holmes,<br />

Julia C.;Midgley, John E. M.; Sheehan,<br />

Christopher P., 1891<br />

Bandi, Zoltan L; Sehoen, Irwin; Waters,<br />

Marilyn, 545<br />

-; Waters, Marilyn, 1138<br />

Bandivdekar, Atmaram H. See Tern, Tanuja H-<br />

Banerji, A. See Burrows, KeriLyn C.; Reddy.<br />

Padala V.; Shamberger, R. J.<br />

Banerji, M. See Reddy, Pedals V.<br />

Banfi, G. See Bonini, P. A.<br />

Banfl, Gluseppe; Casari, Erminia; Murone,<br />

Michelangelo; Bonini, Pier Angelo, 1545<br />

Banks. Tibor See Kapur, Bhushan M.<br />

Bankson, Daniel D. See Hghsmith, William E.<br />

-; Semroc, G.; Hofman, L F.; Silverman, L. M.,<br />

1123<br />

Bao, Constantlno 0. See Venta, Rafael<br />

Bara, J. M. Abbad See Budria, J. Ruiz<br />

Barak, Mira; Merzbach, David; Gruener,<br />

Nachman, 1467<br />

Barandica, Rob See Klonizchii, Walt<br />

Barbarakis, Minas S.; Daunert, Sylvia; Bachas,<br />

Leonidas G., 1201<br />

Barbierl, RObert L See Hankinson, Susan E.<br />

Barbour, Heather M. See Wenham, Philip R.<br />

Bardet, J. See Parvy, P.<br />

Bare, 0. See Uzan, Michel<br />

Barkey, D. See Shah, Vipin<br />

Barlow, Ellen See Felder, Robin A.<br />

Barlow, Ian M. See Harrison, Stephen P.<br />

Barnard, Geoff See Strssburger, Christian<br />

-; Kohen, Fortune; Mikola, Heikki; Lovgren,<br />

Timo, 555<br />

Barnhill, Matthew T., Jr. See Wells, David J.<br />

Barthe, Catherine; Carrere, Jacqueline;<br />

Figarella, Catherine; Guy-Crotte, Odette,<br />

1901<br />

Barthels, M. See Dati, F.<br />

Bartholomew, William K. See Katz, Paul H.<br />

Bartkowlak, Celeste D. See Carpenter, A. Betta<br />

Bartlett, S. See Ambrocio, E.<br />

Bartlett, S. M. See Reimers, T. J.<br />

Bartling, D.; Shieh, P.; Tanaka, S.; Binder, S.,<br />

1152<br />

Bartolome, Luls A. See Vents, Rafael<br />

Barton,<br />

Barton,<br />

E. See Sgoutas, D.<br />

Earl 0. See Sgoutaa, Demetrios S.<br />

Bartesch, B. See Lubec, 0.<br />

Bashani, Julie E.; Korchak, S., 1094<br />

-; Pike, S.; January, W.; Korchak, S., 1151<br />

Bastide, J.-M. See Piechaczyk, M.<br />

Basuyau, J. P.; Brunelle, Ph.; Leroy, M.; Vigier,<br />

M. P., 1194<br />

Bateson, J. E.; Artiss, J. D.; Zak, B., 1071<br />

Bateson, Joseph E.; Artisa, Joseph D.; Zak,<br />

Bennie, 1072<br />

Battaglia, Danlelle J. See Frings, Christopher<br />

S.<br />

Baudner, Siegfried See Burgi, Willy<br />

Bauler, G. See Felder, It A.<br />

Baum, John See Katz, Paul It<br />

Baum, D. See Chen, Alice<br />

Bayer, Monika F., 1144<br />

Bayer, P.M. See Baadenhuijsen, H.<br />

Bayer, Peter M. See Baja, Renze<br />

Bayhan, Aysel See Torun, Meral<br />

Baylink, D. See Hosoda, K.<br />

Baylls, Peter H. See Lewis, Helen M.<br />

Bayllss, Katherine; Kopinski, W. S.; Kueck, B.<br />

D., 1162<br />

Baynton, Robert D., 1056<br />

Bazan, Canoe, Ill See Schwartz, Joyce G.<br />

Beaman, Janine M.; Woodhead, J. Stuart. 828<br />

Bean, M. H. See Neisler, H. M.<br />

Beastall, G. H. See Linnet, Kristian; McConway,<br />

M. G.<br />

Beck, R.; Massad, A.; Liachinsky, S., 706<br />

Becker, K. K See Unni, L. K.<br />

Beckett, 0. J. See McConway, M. G.<br />

-; Foster, G. R.; Hussey, A. J.; Oliveira, D. B. G.;<br />

Donovan, J. W.; Prescott, L. F.; Proudfoot,<br />

A. T., 2186<br />

Beckett, Geoffrey J.; Hussey, Amanda J.;<br />

Laing, Ian; Howie, A. Forbes; Hayes, John<br />

D.; Strange, Richard C.; Faulder, Charles G.;<br />

Hume, Robert, 995<br />

Beck,, S. See Reason, C.<br />

Beever, K.; Bradbury, J.; Phillips, D.;<br />

McLachlan, S. M.; Pegg, C.; Goral, A.;<br />

Overbeck, W.; Feifel, G.; Smith, B. Rees,<br />

1949<br />

Baggs, Alan H. See Kunkel, Louis M.<br />

Beierle, P. See Berk, Lee; Webb, Gary<br />

Belerle, Floyd A.; Bailey, L., 1160<br />

Belchak, T. L See Fredrickson, R. A.<br />

Bell, Edward F. See Brans, Yves W.<br />

Bell, J. See Dominiczak, Marek<br />

Bell, M. See Steele, B.<br />

Bellet, N. See Freeman, J.<br />

Bellet, Neal See Hau, Po Choo;Leeder, Sydney;<br />

Rehkemper, Catherine<br />

Bellino, Linda See Demko, Paul R.<br />

Beng, C. 0. See Buttery, J. E.<br />

Bengtuon, Bengt-Ake See Nystrom, Ernst<br />

Bennett, H. J.; Gregory, B.; Kenny, M., 1129<br />

Benoit, Cheryl A. See Ricci, Mary Jo<br />

Benson, Peter See Apple, Fred S.<br />

Benson, Peter J. See Eastep, Steven J.<br />

Berg, M. See Klukas, C.; Leonard, H.<br />

Bergfeld, W. See Gupta, Manjula K.<br />

Bergman, Anders See Lindback, Bengt<br />

Bergqvist, Yngve See Eckerbom, Solveig<br />

-; Karlsson, Lisa, 1082<br />

-; Karlsson, Lisa Fohlin, tars, 2127<br />

Berk, L See Webb, Gary<br />

Berk, Lee; Beierle, F.; Webb, G.; Imperio, N.;<br />

Eby, W., 1100<br />

Bermes, Edward W. See Jandreski, Mark A.<br />

Bernadino, it See Mulberg, E.<br />

Bemnal, D. See Portoles, M.<br />

Bernard, A. M.; Lauwerya, R. It; Noel, A.;<br />

Vandeleene, B.; Lambert, A., 2141<br />

Bernard, Mark, Bonkoeki, E.; Liu, A., 1106<br />

Bernard, Serge See Orsonneau,Jean-Luc<br />

Bernstein, Larry; Rudolph, R.; Pinto, M., 1077<br />

Bernstein, Larry H.; Leukhardt-Fairfield, Carla<br />

J.; Pleban, Walter; Rudolph, Rosser, 271<br />

-; Good, I. J.; Holtzman, Golde I.; Deaton,<br />

Michael L.; Babb, Joseph, 444<br />

Berry, M. N.; Mazzachi,<br />

Peake, M. J., 817<br />

R. D.; Pejakovic, M.;<br />

Berti, Giovanni See Foesati, Piero<br />

Besemer, D. See Gibbons, I.<br />

Besemer, Diana See Urdea, Mickey S.<br />

Besse, Marie-Georges See Rogier, Herve<br />

Betebenner, Dave See Brashear, Jeff<br />

Bhalla,<br />

Bhalla,<br />

it See Chen, Yao-Tseng<br />

Ravi; Stankievic, R.; Schwartz, M. K.,<br />

1112<br />

Bhargava, A. K.; Han, Tin; Myers, M.;<br />

Fitzpatrick, J., 1079<br />

-; Myers, M. M.; Myers, L. S.; Fitzpatrick, J. E.,<br />

1102<br />

Bhargava, AK; Myers, M. M.; Petrelli, N.J.;<br />

Lele, S.; Bhattacharya, B.; Fitzpatrick, J.,<br />

1079<br />

Bhattacharya, B. See Bhargava, AK<br />

Bhayana, V.; Diamandis, E. P., 1077<br />

Blagini, A. V. See Lewis, L. M.; Vaughn, R.<br />

Blanca, Carol; Henke, J.; Hwang, D.; Meriadec,<br />

B., 1172<br />

Bidllngmaier, F. See Dablmann, N.<br />

Bled, Andree See Vernet, Michele<br />

Bielawski, C. See Muilins, Marvin<br />

Binder, S. See Bartlin, D.<br />

Bing, David H. See Williamson, Janice<br />

Biron, Marie-Philippe See Boitleux, Jean-<br />

Lou is<br />

Bissonnette, John See Swanson, J. Robert<br />

Blttlkofer, J. A.; Broenan, J. R.; Yanko, J., 1102<br />

Blxby, K See Konstantinides, Frank N.<br />

Bjork, T. See Abrahamsaon, P.-A.<br />

Black, David; Cook, Lisa, 1185<br />

Black, E.G. See Sheppard, Michael C.<br />

Black, W. See Clemens, John<br />

Black, William; Clemens, J.; Hojvat, S.;<br />

Martofano, A.; Cada, S., 1192<br />

Blackwell, Sherry See Leader, Sydney<br />

Blackwood, J. See Ackermann, H.; Padilla, A.;<br />

Staedter, M.<br />

-; Staedter, M.; Ackermann, H.; Chen, J.; Inbar,<br />

S.; Grenner, G., 1195<br />

Blackwood, J. J. See Grenner, G.<br />

Blake, D. See Rose, I. S.<br />

Blake, J. See Awdziej, Tania N.; Wilson, Job<br />

M.<br />

Blankenhomn, David H. See Graziani, Mars<br />

Stalls<br />

Blanton, J. See Lewis, L M.<br />

Blasco, Peter A. See Prior, Thomas W.<br />

Blaylock, it See Swanson, Terry<br />

Blelle, Dennis; Kamalakannan, Vedhachalai<br />

Moon, Patricia; Mak, Ken; Lohr, Steve; I<br />

Maria; Kalra, Krishan, 1148<br />

Blick, Kenneth E. See Dunn, Don J.; Parkei<br />

Michael; Passey, Richard B.<br />

-; Udwin, Michael, 1089<br />

-; Fry, Henry D.; Passey, Richard B.; Giflun<br />

Ronald L.; Parker, K. Michael, 1186<br />

Blijenberg, B. G.; Boerma, G. J. M.; Leijnae<br />

1089<br />

Blind., Eberhard See Bohler, Ulrich<br />

Bloodwomth, D. F. See Miceli, J. N.; Vroon, I<br />

H.<br />

Bloom, Jeffrey N. See Elm, Ronald J.<br />

Bluin-Hoffmann, Ellen See Hoffmann, (leo<br />

Blundell, 0. See McConway, M. G.<br />

Bodenmuller, H. See Klein, G.<br />

Bodlaender, P. See Sperling, Matthew<br />

Bodner, J. See Figard, Steve D.<br />

Bodor, Geza See Myrtle, James F.<br />

-; Wolf, Bryan A.; Hinds, Barbara; Nahm, !<br />

H.; Scott, Mitchell G., 1262<br />

Body, J. J.; Seraj, F.; Keymolen, V., 497<br />

Boehles, H. J. See Schoenau, E.<br />

Boehm, Corinne D., 1843<br />

Boerma, 0. J. M. See Blijenberg,<br />

Boeswald, W. See Schoenan, E..<br />

B. G.<br />

Boewing, B. See Schoenau, E.<br />

Bogema, Stuart C. See Ronald, Beverly A.<br />

Bohannon, J. See Wu, Yih-Shiong<br />

Bolder, Ulrich; Blind, Eberhard; Vogel, Gis<br />

Hitzler, Walter; Flentje. Dagmar; Schmb<br />

Gayk, Heinrich, 215<br />

Boitleux, Jean-Louis; Biron, Marie-Philipp<br />

Desmet, Gerard; Thomas, Daniel, 1026<br />

Bolann, Bjomn J.; Sandberg, Sverre; Digrarn<br />

Asbkorn, 1663<br />

Bollin, Ernest, Jr. See Lou, H. Philip<br />

Bonar, J. A. See McConway, M. G.<br />

Bonham, James it; Meeks, Andrew, 2253<br />

Bonini, P. A.; Pontfflo, M.; Murone, M.; Ban<br />

G., 1188<br />

Bonini, Pier Angelo See Banfi, Giuseppe<br />

Bonkoski,<br />

Bonnefont,<br />

B. See Bernard, Mark;<br />

Dominique; Legrand,<br />

Schneider,<br />

Main; Pe<br />

Jacqueline; Emerit, Jacques; Delattre,<br />

Jacques; Galli, Andre, 2054<br />

Bonnefont, J-P. See Parvy, P.<br />

Bonneton, Agnes See Pugeat, Michel<br />

Honors, Roberto See Panteghini, Mauro<br />

-; Pantehini, Mauro, 324<br />

-; Pagani, Franca; Panteghini, Mauro, 325<br />

Bonser, Jean C. See Dean, Harvey G.<br />

Bonte, H. A. See Veer, G. van der Sluijs; Vet<br />

Boone, D. Joe; Martin, M. Louise, 1087<br />

Booth, Frank See Tilzer, Lowell L.<br />

Boots, Larry See Shaw, Norman<br />

Borburgh, A. J. See Weykamp, C. W.<br />

Borden, Kim See Shaw, Norman<br />

Borden, Kimberlee See Dowel, Barry<br />

Borges, Marietta See Wortsman, Jacobo<br />

Bonmann, Priscilla See Eckfeldt, John H.<br />

Boruns, Peggy K. See Williamson, Jerry<br />

Bory, Claude; Boulieu, Roeelyne; Chantin,<br />

Christiane; Mathieu, Monique, 321<br />

Boskey, Adele L. See Bruns, David E.<br />

Bosonl, Tiziana See MeW d’Eril, Gian Vico<br />

Bottomley, Paul A.; Hardy, Christopher J.,<br />

Boulhlmez, K. See Crockett, R.<br />

Boulleu, Roselyne See Bo!y, Claude<br />

Boulter, Jim See Deneris, Even S.<br />

Bounaud, Jean-Yves See Perdrisot, Remy<br />

Bounaud, Marie-Paule See Perdrisot, Rem<br />

Bourdoux, Pierre P. See Delange, Francois<br />

Bouthillier, Daniel See Davignon, Jean<br />

Bowcock, A. See Smith, Douglas It<br />

Bowden, Don See Green, Philip<br />

Bowden, J. See Mifflin, Ted<br />

Bowden, James; Mifflin, T. E., 1076<br />

Bowen, Beta See Kessler, Jay<br />

Bowen, M. 5. See Grenner, G.<br />

Bowen, Thomas P. See Wiese, David A.<br />

Bowers, 0. N., Jr. See Krzymowski,<br />

Debra M.; Valcour, Andre<br />

G. A.; 11<br />

Bowers, George N,, Jr. See Okorodudu,<br />

Anthony 0.; Valcour, Andre A.<br />

Bowers, L. D. See Jessen, It H.<br />

2344 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


were, Larry 0., 1235, 1282<br />

wie, Lemuel J. See Dohnal, James C.<br />

Kirkpatrick, Peter P., 1355<br />

wman, C. See Patel, Niranjan<br />

yd, James C. See Felder, Robin A.<br />

Savory, M. G.; Hines, C.; Normansell, D. E.;<br />

Ayers, C. R., 1070<br />

ziniowski, D. See O’Neil, J.<br />

abham, Ewart A. See Mudarris, Ayad<br />

‘aconnier, Francois See Fesus, Paul D.<br />

‘adbury, J. See Beaver, K.<br />

‘adford, Reagan H. See Bachorik, Paul S.<br />

‘adley, Charles A.; Rogers, Michael M. .1084<br />

Dunn, Dale M.; Rogers, Michael M., 1123,<br />

1241<br />

‘adley, G. Mary See Eckfeldt, John H.<br />

‘adley, H. See Raymond, Anne<br />

‘adley, Linda See Shaw, Norman<br />

‘adstreet, K. See Demers, Laurence M.<br />

‘ady, A. See Ambrocio, E.; Freeman, J.<br />

‘ady, James A. See Spronk, Adrian M.<br />

aithwsite, Susan S.; Collins, Sonia; Prinz,<br />

Richard A.; Welch, Jami L; Winters, Gayle<br />

L., 2216<br />

undo,<br />

andt,<br />

B. See Zucchelli, G. C.<br />

B. See Schneider, L.; Sun, Lila; Villa,<br />

Barbara<br />

‘anford, Susan; Sobecki, Stan; Bais, Renze,<br />

1255<br />

us, Yves W.; Shaffer,<br />

Edward F.; Schwartz,<br />

Stanley G.; Bell,<br />

Connie A.; Martin,<br />

Lorene A., 1367<br />

antley, N. See Miceli, J. N.; Vroon, D. H.<br />

anum, Earl L See Gonchoroff, Daryl G.<br />

ashear, Jeff; Zeitvogel, Christine; Jackson,<br />

Jean; Flentge, Charles; Janulis, Lynn;<br />

Cantrell, Lois; Schmidt, Bob; Adamczyk,<br />

Maciej; Betebenner, Dave; Vaughan,<br />

Kenward, 355<br />

aunllng, 0. See Renz, M.<br />

ay, K. it See Werneke, Debra K.<br />

ay, Kurtla K.; Cerrito, M.; Broyles, D.; Hill,<br />

C.; Johnson, K.; Nunnelly, P.; Segal, A.; Van<br />

Tassel, K., 1078<br />

abant, Chantal See Pugeat, Michel<br />

eglio, Susan; Phillips, Vincent; Murthy, H.<br />

M.S., 1093<br />

Phillipe, Vincent; Murthy, H. M. S., 1093<br />

elnek, P. See Chromy, V.<br />

reitenfeld, Diane See Doumas, Basil T.<br />

anna, S. See Baadenhuijsen, H.<br />

ennan, George See Pilot, Robert L.;<br />

Zahradnik, Richard<br />

ennan, M. See Smith, Carol<br />

rent, 0. See Gault, M. H.<br />

ett, K. See Brocklehurst, D.<br />

rettfeld,<br />

Paul;<br />

Chris; Massoud, Neil; Munzenberger,<br />

Nigro, Michael; Sarnaik, Ashok;<br />

Gobrogge, Roger, 324<br />

ewater, Marge A.; Starrett, William, 1999<br />

len, Gerald See Jung, Klaus<br />

lnghurst, Cory See Wu, James T.<br />

ockas, A. J. See Crouch, CoHn<br />

ocklehurst, D.; Wilde, C. E.; Fmnbow, J. A. H.;<br />

Brett, It; Champion, A. E.; Dewhurst, D. G.,<br />

238<br />

rocks, D. G. See Schnorr, G.<br />

odeur, Garrett M., B38<br />

onstein, I. See Thorpe, G. H. G.; Voyta, J. C.<br />

Voyta, J. C.; Thorpe, G. H. G.; Kricka, L J.;<br />

Armstrong, G., 1441<br />

onstein, Irena; Voyta, John C., 1856<br />

rooks, Kiazina K; Smith, Norman B., 2100<br />

osnan, J. K. See Bittikofer, J. A.<br />

rotherton, Mary See Mahmood, Nishat<br />

own, A. See Corneliaon, L.<br />

own, K See McConway, M. G.<br />

own, Ellen D.; Rose, Alice; Craft, Neal;<br />

Seidel, Karen E.; Smith, J. C., Jr., 310<br />

own, J. M. See Cowley, D. M.; de Leacy, E. A.<br />

rown,K. See Gibbs, Judy<br />

own, Nigel N. See Do Leacy, Eric A.<br />

own, Patrice A. See Whitley, Chester B.<br />

own, Richard W. See Schwartz, Joyce G.<br />

own, Spencer A. See Patsch, Wolfgang<br />

own, W. See Butch, A.<br />

own, Warren P. See Rettmer, Rebecca L.<br />

own, Wayne S. See Butch, Anthony W.<br />

oyles, Celeste; Present, W.; Zhang, M.; Fang,<br />

X., 1187<br />

royles, D. See Bray, KUrtis It<br />

rudzlnski, A. See Lee, Sung C.<br />

runelle, Ph. See Basuyau, J. P.<br />

runs, David E. See Franquemont. Douglas W.;<br />

Mifflin, Theodore E.<br />

Boskey, Adele L.; Lieb, Wolfgang; Conway,<br />

Brian P.; Savory. John; Wills, Michael R.,<br />

183,705<br />

Bruzek, Debra See Chan, Daniel W.<br />

-; Drew, Helen; Regalado, Jacinto; Chan, Daniel<br />

W., 1188<br />

Budria, J. Ruiz; Bara, J. M. Abbad; Gonzalez, E.<br />

Fabre; Sanz, M. T. Higueras; Ostariz, J. L<br />

Serrano, 800<br />

Buelteman, L See Ambrocio, E.; Freeman, J.<br />

Buffone,<br />

Bulbley,<br />

Gregory<br />

Gregory<br />

J., 83<br />

Bartlett, 1051<br />

Bulley, M. See Remaley, A. T.<br />

Bunge, G. See Solano, Romeo<br />

Bunyagldj, C. See Wang, Tang Jang<br />

Burd, T. See Gibbons, I.<br />

Burdelski, M. See Oellerich, Michael<br />

Burgess-Cassler, Anthony; Johansen, Jon J.;<br />

Santek, David A.; Ide, Jonathan R.;<br />

Kendrick, Nancy C., 2297<br />

Burgi, Willy; Simonen, Sirkka; Baudner,<br />

Siegfried; Schmid, Karl, 1649<br />

Burke, M. Desmond, 1233<br />

Burlina, A. See Plebani, Mario<br />

Burnett, Robert W.; Itano, Masashi, 1779<br />

Burns, Washington See Lather, Barry P.<br />

Burn, Betty Jane; Kutnink, Mark A., 582<br />

Burns, Susan See Haver, Virginia M.<br />

Burrows, K. See Wright, Reba K.<br />

Burrows, KeriLyn C.; Lonardo, A.; Wright, It;<br />

Banerji, A., 1094<br />

Burtis, Carl A., 891<br />

Burton, Barbara See Shaw, Norman<br />

Burton, MB. See Kenney, J. T.<br />

Burton, Michael B. See Orsulak, Paul J.<br />

Bury, J. See Labeur, C.<br />

Busch, M. See Haden, B.<br />

Bush, 0. See Sibiia, R.<br />

Bush, Donna M. See Stevenson, Cathy C.<br />

-; Keren, David F., 1198<br />

Bush, P.; Rudy, J., 1111<br />

Butch, A.; Brown, W.; Koenig, J.; Hinds, B.;<br />

Kessler, G.; Scott, M., 1107<br />

Butch, Anthony; Shelton, M.; Matheke, M. L.;<br />

Valdes, It, Jr., 1109<br />

Butch, Anthony W.; Goodnow, Timothy T.;<br />

Brown, Wayne S.; McClellan, Adrain;<br />

Kessler, Gerald; Scott, Mitchell G., 2048<br />

Butler, Barbara A.; Taylor, W. Allen, 1102<br />

-; Taylor, W. Allen; Coper, Carol, 1103<br />

Butler, S. See Wu, Yih-Shiong<br />

Buttery, J. E.; Chamberlain, B. It; Beng, C. G.,<br />

2311<br />

Buttita, D. See Rosencrans, Robert<br />

Cada, S. See Black, William<br />

Caine., Patrick 8.; Cheung, R. M. C.; Draisey,<br />

T. F.; Yea, G. E., 1074<br />

Calamunci, K. See Woo, Charles<br />

Callis, James B., 1059<br />

Calore, James D. See DeMars, Daniel D.<br />

Calvin, J. See Monk, J.<br />

Calvo, S. See Pb, A.<br />

Cameron, J. D., 506<br />

Cameron, Oliver G. See Hariharan, M.<br />

Cami, J. See Segura, J.<br />

Camina,<br />

Camina,<br />

M. P. See Rodriguez-Segade, S.<br />

M. Felix See Rodriguez-Segade,<br />

Santiago<br />

Campbell, J. See Klukas, C.<br />

Campbell, M. See Steele, B.<br />

Campbell, W. B. See Lewis, L M.<br />

Candela, Ellen See Sadowaki, James<br />

Cannella, Giuseppe See Polesi, Claudio<br />

Cano, C.; Lykissa, E. D., 1170<br />

Cantrell, Lois See Brashear, Jeff<br />

Cao, G. See Present, Bill<br />

Caplan, Yale H.; Levine, Barry, 1794<br />

Carnyon, P. See Tercero, J. C.<br />

Cardno, Todd See Falutz, Julian<br />

Cardoni, D. See Sasse, E. A.<br />

Carey, Mary M. See Rettmer, Rebecca L.<br />

Carlaon, Ian H. See Lensmeyer, Gary L<br />

Carlson, J. See Raymond, Anne<br />

Canton, Esther See O’Connor, Daniel T.<br />

Carlyle, E. See McConway, M. G.<br />

Caro, Jose See Khazanie, Prabhaker<br />

Caroli, A. See Zucchelli, G. C.<br />

Canon, G. See Sheehan, M.<br />

Caron, Marc G. See Frielle, Thomas<br />

Carpenter, A. Betts; Bartkowiak, Celeste D.,<br />

484<br />

Carpenter, K. J.; Schelstraete, M., 2000<br />

Carreras,<br />

Carnere,<br />

L See Diaz, S.<br />

Jacqueline See Barthe, Catherine<br />

Carnico,<br />

Carrubba,<br />

Julie See Leader, Sydney<br />

J.; Doles, A.; Demeritt, S.; Levine, J.,<br />

1104<br />

Carry, Melissa See Tagari, Philip<br />

Carter, 0.; Mohr, M.; Pretty, P.; Janus, E. D.,<br />

1086<br />

Canter, G. 0. See McConway, M. G.<br />

Carter, J. See Lucas, F.<br />

Casares, Gerardo See Venta, Rafael<br />

Casari, Erminla See Banfi, Giuseppe<br />

Cassano, T. See Van Brunt, N.<br />

Cutellani, W. J. See Kazmierczak, S. C.;<br />

Khazanie, Prabhaker<br />

Castellani, William J.; Wheeler, W. S.;<br />

Kazmierczak, S.C.; Khazanie, P., 1158<br />

Caswell, A. Pd.; Russell, R. G. G., 326<br />

Catanzarlti, P. A. See Wiernik, M. D.<br />

-; Wiernik, M. D.; Swanson, B. N., 1069<br />

Cate, J. See Dyer, Deborah<br />

Catomeris, Peter; Monforte, J. R.; Thibert, It<br />

J.; Hood, I., 1176<br />

Caughlin, I See Peat, Michael A.<br />

Cavalie-Barthez, Ghlslalne See Rogier, Herve<br />

Cavalli-Sforza, IL. See Smith, Douglas R.<br />

Cavenee, Webster K., B48<br />

Cawood, A. H., 1832<br />

Cecil, M. See Wu, Yih-Shiong<br />

Ceconi, C. See Ferrari, R.<br />

Cekan, Sten Z. See Riesco, Oscar F.<br />

Cembrowski, George 8.; Lambrecht, Kristen<br />

K.; Kelly, Christine A.; Wang, Helen H., 1145<br />

Centofanti, J. See Hu, Mae; Mulberg, E.<br />

Centofanti, Joan See Anne, Lakshmi<br />

Cernosek, S. See Gage, S.<br />

Cenra, P. B. See Konstantinides, Frank N.<br />

CeiTItO, M. See Bray, Kurtis It<br />

Cervenka, Justine H. See O’Connor, Daniel T.<br />

Chadefaux, B.; Coude, M.; Hamet, M.; Aupetit,<br />

J.; Kamoun, P.. 2002<br />

Chafe, I See Gault, M. H.<br />

Cbkmkjian, Z. H. See Zachariah, N.Y.<br />

Chaleby, Kutaiba See El-Yazigi, Adnan<br />

Chalmers, A. H. See Cowley, D. M.; de Leacy, E.<br />

A.; Renouf, Judith A.<br />

Chain, B. K; Roeser, H. P.; Kamst, T. W., 2285<br />

Chamberlain, BR. See Buttery, J. E.<br />

Chambron, J. See Sapin, It<br />

Champion, A. B. See Brocklehurst, D.<br />

Chan, A. Y. W.; Swaminathan, It; Cockram, C.<br />

5., 315<br />

Chan, Daniel W. See Bruzek, Debra; Gerhardt,<br />

Gregory<br />

-; Bruzek, Debra; Rock, Robert, 1077<br />

Chan,<br />

Chan,<br />

K. See Hu, Mae<br />

Shirley See Fulton, Ann<br />

Chandler, C. See Crouch, CoHn<br />

Chandler, Wayne L. See Fine, James S.<br />

-; too, Swee-Chin; Nguyen, Son V.; Schmer,<br />

Gottfried;<br />

Chang, Agnes<br />

Stratton, John R., 787<br />

See Chou, Peter P.; Longhurst,<br />

Sharon<br />

Chang, J. See Kaseman, Deborah; Reilley,<br />

Therese<br />

Chang, L See Present, Bill<br />

Chantin, Chnistlane See Bory, Claude<br />

Chapelle, J, P. See El Allaf, Msgdeleine<br />

Chapelle, Jean-Paul; El Ailaf, M., 1120<br />

Chapman, Donna, 1068<br />

Chapman, J. F. See Levtzow, C. B.; Phillips, J.<br />

Chapman, itS. See Linnet, Kristian;<br />

McConway, M. G.<br />

Charleson, Stella See Tagari, Philip<br />

Charnas, I See Papadopoulos, N. M.<br />

Chasnoff, Ira J.; Lewis, Douglas E.; Griffith,<br />

Dan R.; Wiley, Steven, 1276<br />

Chaudhary, A. K. See Kalra, J.<br />

Chaumont, B. See Doria, Manuel, Jr.<br />

Cheek, J. H. See Zachariah, N. Y.<br />

Chen, Alice; Baum, D., 1130<br />

-;Goga,V.;Contis,L., 1162<br />

Chess, C. W. See Fu, J. C.<br />

Chen, Hso-Zhu See Geng, Jian-Guo<br />

Chen, Huel-Mei; Lifschitz, Carlo. H., 74<br />

Chen, Hul-Li See Wu, Alan H. B.<br />

Chen, I. See Sperling, Matthew<br />

Chen, J. See Blackwood, J.<br />

Chen, K. See Khayam-Bashi, Hasaan<br />

Chen, Katherine; Khayam-Bashi, H.; Gerard,<br />

S.; Hernandez, C.; tin, S. J., 1146<br />

Chen, Kwok-MIng See Crest, Michael H.<br />

Chen, I See Present, Bill<br />

Chen, Shu-Mal See Kuo, Cheng-Deng<br />

Chess, Y. M. See Sardesai, Sudha<br />

Chen, Yao-Tseng; Bhalla, It; Schwartz, M. K.,<br />

1117<br />

Cheng, A. J. See Fu, J. C.<br />

Cheng, C.; Farrenkopf, B.; Jerome, H.; Kaufman,<br />

R.A., 1178<br />

Cheng, C. Yan See Silvestrini, Bruno<br />

Cheng, K. Steve; fries, Julian J.; Girardot,<br />

Clemencia, 1144<br />

Cheng, M. See Rosenthal, Philip<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2345


Cheng. M. H. See Huang, W. T.<br />

Cheng, MI See Sarosi, David<br />

Cheng, Mary<br />

Teodosio.<br />

H.; Wong, H. T.; Hutchins, S. W.;<br />

F.; Restrepo, L.; Vu, T. H.; Huang,<br />

W. Y.; Lipsey, Allen I., 1109,1238<br />

Cheng, P. J. See Chin, Bruce G.<br />

Cheng, S. See Williams, Michael<br />

Chernow, Bart, 1054<br />

Chesler,<br />

Chesler,<br />

K. See Kroll, M. H.<br />

Ruth See KroU, Martin H.<br />

Cheung, C. K.; Cockram, C. S.; Yeung, V. T. F.;<br />

Swaminathan, R., 1672<br />

-; Lao, T.; Swaminathan, R., 1978<br />

Cheung, Kee; Hinds, John A.; Duffy, Patrick,<br />

295<br />

Cheung, Peter W., 1060<br />

Cheung, K. Pd. C. See Calnes, Patrick S.<br />

Chiang, Benjamin N. See Kuo, Cheng-Deng<br />

Chiang, Betty T. See Rehak, Nadja N.<br />

Chiang, C. S. See Cooper, M.; Tsunokawa, M.<br />

-; Grove, T.; Cooper, M.; Cuan, J.; Kowalski, A.;<br />

Parcells, K.; Tsunokawa M.; Rosenberg, M.;<br />

Arcuri, E.; Franklin, S.; mith, T.; Debouck,<br />

C.. 946<br />

Chlappetta, B. See Gates, Teresa; Melerski,<br />

JamesJ.<br />

Chiappetta, Enrico See Thacker, Susan<br />

Childers, David See Motika, Deborah<br />

Chin, Bruce G.; Cheng, P. J.; Cortes, G.; Globis,<br />

C.; Murza, B.; Kirchick, H. J., 1206<br />

Chisnall, W. N. See tim, Chew W.<br />

Cho, Hiroko; lijima, S.; Shiba, K.; Nakao, M.;<br />

Shiba, A.; Suzuki, K.; Toda, T.; Ohashi, M.,<br />

1083<br />

Chou, H. Dasgupta, See Amitava<br />

Chou, Peter P. See Longhurst, Sharon<br />

-; A.; King, Brenda; Chang, Toms, Rick Agnes;<br />

Longhurst, Sharon, 1099<br />

-; Toms, Rick A.; King, Brenda; Chang, Agnes;<br />

Longhurst, Sharon; Young, Maitland, 1099<br />

Chretien, J. See Thuan, N. T. Leuquang<br />

Chretien, P. B. See Huang, C. M.<br />

Christensen,<br />

Christensen,<br />

S. See Wu, James T.<br />

Stig Engkjaer See Engbaek,<br />

Frode<br />

Christenson, Robert H.; Toffaletti, John;<br />

Ohman, Magnus; Clemmenson, Peter M.;<br />

Wagner, Galen S.; Silverman, Lawrence M.,<br />

1124<br />

Ohman, Magnus; Clemmensen, Peter M.;<br />

Wagner, Galen S., 1125<br />

-; Ohman, E. Magnus; Clemmensen, Peter;<br />

Grande, Peer; Toffaletti, John; Silverman,<br />

Lawrence M.; Volimer, Robin T.; Wagner,<br />

Galen S., 2179<br />

Chnistofide., N. See Sheehan, C.<br />

Christy, P. See Paxton, Helene<br />

Chromy, V.; Breinek, P.; Sklepkova,<br />

Valendinova, M., 191<br />

A.;<br />

Chubb, S. A. P.; Hutchison, A., 326<br />

Chul, Shlu Ron; Wan, Koon Chin Lain,<br />

Christopher Was Kei; Lewis. W. H.P..<br />

Chung, B. See Houts, Robyn<br />

1770<br />

Chung, B. S. See Corneliaon, L<br />

Chung, Byung S. See Hsu, Po Choo<br />

Chung, Byung Book; Valdez, Johnny; Pease,<br />

John, 1166<br />

Church, W. See Howard, P.<br />

Churchill, Alison See Skene, Debra J.<br />

Chute, Christopher G. See Hankinson,<br />

Claniniboli, G. See Paci, Anna<br />

Susan E.<br />

Clanimboli, Giullano See Paci, Anna<br />

Cibull, Deanna See Stevenson, Cathy C.<br />

Ciucci, C. See Houts, Robyn<br />

Ciuti, K; Rinaldi, Graziella, 1562<br />

Clabe, A. See Crockett, R.<br />

Clague, Alan B. See De Leacy, Eric A.<br />

Clark, I See Sheehan, M.<br />

Clark,<br />

Clark,<br />

Larry<br />

Mary<br />

W.; Johnston, Sue, 1099<br />

M.; Sarosi, Elaine; Haden, Bill,<br />

1085<br />

Clark, P. See Lauderdale, V.<br />

Clark, It. See Sgoutas, D.<br />

Clark, Timothy See Hannan, Charles J., Jr.<br />

Clarke, Lorne A. See Harris, Heather M.<br />

Clarke, M. See Watson, I. D.<br />

Clayson, Kathleen J. See Fine, James S.<br />

Clemens, J. See Black, Wills<br />

Wesley<br />

,Schmidt,<br />

Clemens, John; Black, W.; Holmes, Earle W.;<br />

Hojvat, S., 1095<br />

Clement, Denial See Do Buyzere, Marc I<br />

Clemmensen, Peter See Christenson, Robert H.<br />

Clemmensen, Peter M. See Christenson, Robert<br />

H.<br />

Clemmenson, Peter Pd. See Christenson, Robert<br />

H.<br />

2346 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />

Clenc, C. See Ruelland, A.<br />

Clerico, A. See Paci, Anna; Zucchelli, G. C.<br />

Clerico, Aldo See Gianspietro, Ottavio; Paci,<br />

Anna<br />

Cline, Martin J., 1057<br />

Cloarec, I See Ruelland, A.<br />

Cloey, Teresa; Bachorik, Paul S.; Kwiterovich,<br />

P., 1069<br />

Cloey, Teresa A. See Bachorik, Paul S.<br />

-; Bachorik, Paul S., 1390<br />

Clyne, Jennifer See Urdea, Mickey S.<br />

Cobb, M. See Gibbons, I.<br />

Cocci, F. See Paci, Anna<br />

Cocci, Franca See Paci, Anna<br />

Cocker, J.; Wilson, H. K., 506<br />

Cockram, C. S. See Chan, A. Y. W.; Cheung, C.<br />

K.<br />

Coderre, James A. See Stock, John L.<br />

Cohen, Jacques, 1064<br />

Cole, K. See Prinsen, Johanna<br />

Cole, Thomas See Bachorik, Paul S.<br />

Coleman, Graham See Fulton, Ann<br />

Cohn, I See Hu, Mae<br />

Coilet-Cassart, D.; Limet, J. N.; Van Krieken,<br />

L.; Do Hertogh, R., 141<br />

Collie, Pd. J. See Santulli, M. J.<br />

Collins,<br />

Collins,<br />

K. Scott See Thompson, James D.<br />

S. See Elkhalifa, Mohained; Sloan, Chris<br />

Collins, Sonla See Braithwaite, Susan S.<br />

Colllnsworth, W. 1,1096<br />

CoIwell, Mark; Halsey, John F., 1252<br />

Comerci, C. See Klukaa, C.<br />

Comerford, A. See Gault, M. H.<br />

Comstock, George W. See Hsing, Ann W.<br />

Cone, Edward J.; Dickerson, Sandra, 1171<br />

Congest,<br />

Connelly,<br />

M. See Segura, J.<br />

I See Lasky, Fred D.<br />

Connolly, John See Deneris, Evan S.<br />

Contis, I See Chen, Alice<br />

Converse, Joan; Klee, G., 1160<br />

Conway, Brian P. See Bruns, David E.<br />

Cook, B. See Thomson, S.<br />

Cook, G. See Woo, Charles<br />

Cook, Lisa See Black, David<br />

Cooper, Carol See Butler, Barbara A.<br />

Cooper, Carol Pd. See Russell, John C.; Zibrat,<br />

Steven J.<br />

Cooper, G. K. See Moomman, Stacy; Myers, Gary<br />

L.<br />

Cooper, Katherine See Teas, Michael Y.<br />

Cooper, M. See Chiang C. S.<br />

-; Grove, T.; Chiang, C. S.; Rosenberg, M.;<br />

Franklin, S.; Debouck, C., 1191<br />

Copas, Pleas See Painter, Pennell<br />

Cope, June See Painter, Pennell<br />

Copeland, Kenneth; Yatscoff, It; Thliveris, J.;<br />

Honcharik, N., 1164<br />

Copeland, Kenneth K.; Yatacoff, Randall W.,<br />

1551<br />

Coppola, J. See Kubasik, N. P.<br />

Copur, Sitki; Kus, Sezal; Kars, Ayse; Renda,<br />

Nurten; Tekuzman, Gulten; Firat, Dincer,<br />

1968<br />

Corbin, Debra K.; Keenan, Edward J., 1148<br />

Condy, P.See Kubasik, N. P.; Thompson, F.<br />

Condy, P. A. See Kubasik, N. P.<br />

Conlna, 0.1 See Mills, G. A.<br />

Cornelison, I; Lam, X.; Brown, A.; Chung, B.<br />

S.; Tanimoto, L.; Valdez, J.; Wood, J., 1173<br />

Contes, 0. See Chin, Bruce G.<br />

Coson, C. See Myara, I.<br />

-; Myara, I.; Guillemain, It; Amrein, C.;<br />

Dreyfus, 0.; Moatti, N., 492<br />

Costa, B. See Joven, J.<br />

Costa, Pedro P. See Samaiva, Maria Joao<br />

Mascarenhas<br />

Costello, K. See Papadopoulos, N. M.;<br />

Papadopoulos, Nicholas M.<br />

Costello, K. Pd. See Shah, Vpin<br />

Costello, Rene See Pascali, Enzo<br />

-; Papadopoulos, Nick M., 186<br />

Coude, M. See Chadefaux, B.<br />

Coulam, Carolyn B. See Ng, Ronald H.<br />

Covault, H. P. See Schmidt, Wesley<br />

Cowley, 0. Pd. See de Leacy, E. A.<br />

-; McWhinney, B. C.; Brown, J. M.; Chalmers,<br />

A.H.,23<br />

Cox, N. H. See Dominiczak, Marek<br />

Cox, Timothy M. See Whitaker, Katrine B.<br />

Coyle, P.; Rofe, A. M.; Renfeng, F., 1806<br />

Craft, Neal See Brown, Ellen D.<br />

Crawford, A. See Wieringa, G. E.<br />

Creer, Michael H.; Lou, Brad W. C.; Jones,<br />

James D.; Chen, Kwok-Ming, 684<br />

Crisafulli, T. See Gates, Teresa<br />

Crissfulll, Terry See Thacker, Susan<br />

Crisan, D.; Diven, W. F.; Hartle, K.; Osborne, P.<br />

T.; Mason, L., 1854<br />

Cnisan, Domnita; Howrie, D. L.; Fricker, F. J.;<br />

Lower, D., 1163<br />

Cnitaer, John See Ng, Ronald H.<br />

Crockett, Harold; Knight, J. A.; Ashwood, E. F<br />

Ash, K. 0., 1069<br />

Crockett, K.; Boulhimez, K.; Velez, L.; Clabe, A<br />

La Moigne, F., 1132<br />

Crosby, Lisa E.; Krouwer, Jan 5., 1187<br />

Cnossin,<br />

Crouch,<br />

Kathryn 1,738<br />

Colin; Chandler, C.; Dent, A. H.;<br />

Glover, J.; Brockas, A. J., 1207<br />

Crowley, G. T. See Akers, IC.<br />

Cruschelll, Lorella See Gianspietro, Ottavio<br />

Crystal, Dali. See Fleisher, Martin<br />

Caako, G.; Zweig, M. H.; Glickman, J.; Ruddel,<br />

M.; Kestner, J., 1143<br />

Caako, Gyorgy; Zweig, Mark H.; Glickman,<br />

Janice; Kestner, Jane; Ruddel, Mark, 102<br />

-; Zweig, Mark H.; Glickman, Janice; Ruddel,<br />

Mark; Kestner, Jane, 1655<br />

Cuan, J. See Chiang, C. S.<br />

Cuccia, Claudlo See Panteghini, Mauro<br />

Culileron, Claude-Yve. See Pugeat, Michel<br />

Cummings, Steven T. See Fraser,<br />

Curran, S. See Perel, J. M.<br />

Callum 0.<br />

Curtis, George C. See Hartharan, M.<br />

Cvoniacec, D,; Stavljenic, A.; Vukelic, B., 2142<br />

Czaban, J. See Liffman, S.<br />

Czichos, A. See Rena, M.<br />

Dabe, Irwin See Hannan, Charles J., Jr.<br />

Daft, Michael C. See Wolf, Bryan A.<br />

Daggett, S. See Detwiler, Richard<br />

Dahlke, Lisa See Larsen, Sandra<br />

Dahlmann, N.; Bidlingnsaier, F., 2339<br />

Dahm, Pd. See Oster, 0.<br />

Dakubu, S.; Tovey, M.; Annunziato, M.;<br />

Whiteley, G.; Grenner, G., 1195<br />

Dalke, D. See Villa, Barbara<br />

Dallas, B. H. See Lim, Chew W.<br />

D’Amato, David See Kambli, Vijaykant B.<br />

Damodaran, K. See Khan, Shalsta; Narang,<br />

Rama<br />

Daneshvar, I<br />

Daniel, Molly<br />

See Smith, Douglas It<br />

See Wang, Hann-Ping<br />

Danielson, S. See Mauck, Linda<br />

Danielson, Susan J.; Mauck, L.; Hilborn, D.;<br />

Bale, M.; Engebrecht, R., 1200<br />

Dasgupta, Amltava See Malik, Sohail;<br />

Rosenzweig, I. Bruce<br />

-; Nakamura, Aurea; Doria, Lorna; Dennen,<br />

David, 323<br />

-; Chou, H.; Saldana, 5., 1144<br />

-; Dean, It; Dennen, D. A., 1176<br />

Dati, F.; Pelzer, H.; Barthels, M.; Egbring, It;<br />

Norfolk, D.; Tripodi, A.; Ten Cate, J. W.;<br />

Sturk,A., 1163<br />

Datl, Francesco; Lammers, M.; Metzmann, E.;<br />

Marcovina, S.; Redaelli, G., 1072<br />

Daufeldt, J. A. See Harrison, H. H.<br />

Daunert, Sylvia See Barbarakis, Mines S.<br />

Davidson, K See Rotenberg, Z.<br />

Davidson, Ehud See Rotenberg, Zvi;<br />

Weinberger, Itzhak<br />

Davidson, Kenneth See Sadowski, James<br />

Davignon, Jean; Fortin, Louis-Jacques;<br />

Tremblay, Michel; Bouthillier, Daniel;<br />

Nestruck, A. Christine, 495<br />

Davis, Holly A. See Rettmer, Rebecca L.<br />

Davis, K. See Smith, Douglas It<br />

Davitt, Christine See Gerhardt, Gregory<br />

Davouzadeh, Faegh See Wang, Hann-Ping<br />

Dawson-Hughes, Bess See Sokoll, tori J.<br />

Day, K. See Ishii, S.<br />

Day, Kevin K., 1178<br />

Deacon, Pd. C. See Rose, 1.S.<br />

Dean, Harvey G.; Bonaer, Jean C.; Gent, J. Pa<br />

1945<br />

Dean, K. See Dasgupta, Amitava<br />

Dear, P.R. F.; Henderson, M. J., 338<br />

Deaton, Michael 1 See Bernstein, Larry H.<br />

Dc Block, Jan See Dillen, Lieve<br />

DeBoen, 0. See Solano, Romeo<br />

Debouck, C. See Chiang, C. S.; Cooper, M.<br />

Do Bnoe, Marc E. See D’Haese, Patrick C.<br />

de Bruyne, Jan J.; Meijer, Gert W., 1263<br />

Dc Buyzere, Marc See Delange, Joris;<br />

Robbreeht, Johan<br />

Dc Buyzere, Marc I See Robbrecht, Johan H.<br />

-; Dc Scheerder, Ivan K.; Delanghe, Joris R.;<br />

Robbrecht, Johan H.; Clement, Denis L.;<br />

Wieme, Roger J., 246<br />

Dechaud, H.; Lejeune, H.; Garoscio-Cholet, M.;<br />

Mallein, It; Pugeat, M., 1609<br />

Dechaud, Henri See Pugeat, Michel<br />

Decker, Scott See Thompson, James D.<br />

de Costa,<br />

Defesche,<br />

Anna See Gaillard, M. Christine<br />

Charles 1 See Wortsman, Jacobo<br />

Defreese, James See Donohue, Joseph


gan, Paolo; Montagnoli, Giorgio; Wild,<br />

Christopher P., 2308<br />

egand, Pierre See Fontaine, Monigue<br />

a Bean, Karen E. C.; Woroniecka, Urszula D.,<br />

888<br />

ehennin, Louis, 532<br />

Hertogh, K. See Collet-Cassart, D.<br />

a Jong, J. G. N.; Wevers, It A.; Laarakkers, C.;<br />

Poorthuis, B. J. H. M., 1472<br />

a Rand, John; Dunlap, Larry; Hall, Terry D.,<br />

2110<br />

a Rat Angelino, C. Pd. See Elvin#{231}, L. D.<br />

elange, Francolse; Bourdoux, Pierre P., 710<br />

elange, Jonis; Do Slypere, Jean-Paul; Do<br />

Buyzere, Marc; Robbrecht, Johan; Wieme,<br />

Roger; Vermeulen, Alex, 1802<br />

elanghe, Jonis See Robbrecht, Johan<br />

elanghe, Jonls K. See Do Buyzere, Marc I;<br />

Robbrecht, Johan H.<br />

ala Tome, K, See Segura. J.<br />

elattre, Jacques See Bonnefont, Dominique<br />

elaurentis, M. See Hout, Robyn<br />

eLaurentis, Mark See Hsu, Po Choo;<br />

Rehkemper, Catherine<br />

el Carlo, F. See Doria, Manuel, Jr.<br />

elea, A. See Carrubba, J.; Ostrovaky, Irene<br />

elsa, A. C. See Garland, D. L.<br />

a Leacy, B. A.; Cowley, D. M., 1482<br />

-; Cowley, D. M.; Brown, J. M.; McWhinney, B.<br />

C.; Chalmers, A. H., 1541<br />

e Leacy, Eric A.; Brown, Nigel N.; Clague,<br />

Alan E., 1772<br />

e Leenheer, Andre P. See Lambert, Willy E.<br />

cLays, K. See Pollet, D. B.<br />

elgado, L See Enriquez, John L, Sr.<br />

elivonla-Papadopoulos, Maria, 1058<br />

elpuech, Patrick; Desch, Gerard; Fructus,<br />

Fabienne, 166<br />

el Rio, K. See Rodriguez-Segade, S.<br />

el Rio, Kamon See Rodriguez-Segade,<br />

Santiago<br />

eltour, G. See lzembart, M.<br />

elVeccbio, M. See Reilley, Therese<br />

elwlche,<br />

a Masker,<br />

J. P. See Galanti L. M.<br />

Gerhardus A. ee Franck, Paul F.<br />

H.<br />

emacker, Pierre N.M., 701<br />

eMsrco, Curtis See Mahmood, Nishat<br />

e Maria, K. See Zucchelli, G. C.<br />

eMars, Daniel D.; Katzmann, Jerry A.;<br />

Kimlinger, Terry K.; Calore, James D.;<br />

Tracy, Russell P., 766<br />

emenltt, 8. See Carrubba, J.<br />

emens, Laurence M.; Hicks, P.; Bradstreet, It,<br />

1120<br />

-; Hicks, Patti, 1196<br />

emko, Paul K.; Welch, Robin; Bellino, Linda;<br />

Griben, Denise; Young, C. C.; Winarte,<br />

Handani, 1091<br />

emshar,<br />

enaro,<br />

H. P. See Wang, Stephen T.<br />

Frank See Spector, Stephan A.<br />

enenis, Evan S.; Boulter, Jim; Connolly, John;<br />

Wads, Etsuko; Wads, Keiji; Goldman, Dan;<br />

Swanson, Larry W.; Patrick, Jim;<br />

Heinemann, Steve, 731<br />

cagIer, M. See Metzmann, E.<br />

eNicola, D. See Leaky, F. D.<br />

ennen, D. A. See Dasgupta, Aniitava<br />

ennen, David See Dasgupta, Amitava<br />

ennen, David A. See Kurschinski, Douglas T.<br />

e Nobel, B. See Elving, L. D.<br />

ason, D. D. See Haasan, F. Michael<br />

nt, A. See Sheehan, C.<br />

at, A. H. See Crouch, Cohn<br />

nton, KB. See Kazmierczak, S.C.<br />

Paulo, J. Raymond, Jr.; Simpson, Sylvia 0.;<br />

Folstein, Susan; Folstein, Marshal F., B28<br />

Potter, Werner See Dillen, Lieve<br />

‘Eril, Glanvico Melzl See Franciotta, Diego<br />

Michele<br />

e Roose, Joseph B. See Lambert, Willy E.<br />

esch, Genard See Dolpuech, Patrick<br />

s Scheerder, Ivan See Robbrecht, Johan<br />

e Scheerder, Ivan K. See Do Buyzere, Marc I<br />

e8hon, P. See Reason, C.<br />

-; Reason, C., 1094<br />

e Silva, LV. K.; Rotenberg, a, 2016<br />

esllva, Renuka See Schaap, A. Paul<br />

e Slypere, Jean-Paul Delange, See Joris<br />

esnaet, Gerard See Boitleux, Jean-Louis<br />

etweUer, G. See Howanitz, P. J.<br />

etwllen, Richard; Arter, T.; Daggett, S.;<br />

Pricker, It, 1098<br />

eutsch, Dale 6. See Duncan, Wayne P.<br />

ewhurst, D. G. See Brocklehurst, D.<br />

Zwaan, Chris See Giesen, Peter LA.<br />

‘Haese, Patrick C.; Lamberts, Ludwig V.; Do<br />

Broe, Marc E., 884<br />

Dhiranl, Nasreen See Molnar, Larry A.<br />

Diamandis, B. P. See Bhayana, V.; Khosravi, M.<br />

J.; Reichatein, E.; Shankaran, P.; Tan, A.,<br />

491<br />

-; Papanastasiou-Diamandi, A.; Lustig, V.;<br />

Khosravi,M.J.;Tan,A., 1117<br />

Diamandis, Elefthenlos P.; Papanastasiou-<br />

Diamandi, A.; Lustig, Viiam; Khosravi,<br />

Mohammad J.; Tan, Alan, 1915<br />

Diamond, Constance See Yeo, Kiang-Teck<br />

flax, K. See Khan, Shaista<br />

Dlaz, S.; Rose, H., 1066<br />

-; Hirsch, C.; Dubinsky, E.; Dudley, A. W., Jr.,<br />

1096<br />

Carreras, L., 1096<br />

-; Rose, H., 1096<br />

Dlaz, S. K. See Singh, Jagat<br />

Dlcamelll, K. F. See Sasse, E. A.<br />

Dicker, P. See Edwards, S.<br />

Dickerson, Sandra See Cone, Edward J.<br />

Dickey, D. See Graham, D.; Thompson, F.<br />

Didry, Jean Rene See Mousse, Fathi<br />

Dletzler, David N. See Landt, Yvonne<br />

Digranes, Asbjorn See Bolann, Bjorn J.<br />

Dllena,<br />

Difien,<br />

B. A.; White, G. H., 1543<br />

Lieve; Dc Block, Jan; Van Lear, Lutyart;<br />

Do Potter, Werner, 1934<br />

Dillon, K. See Gibbons,!.<br />

Di Mario, F. See Plebani, Mario<br />

Di Marlo Umberto See Sensi, Maurizio<br />

Dion, K, ee Lessard, F.<br />

Dlorio, Alfred F. See Shah, Vipin D.<br />

-;Haminer,P., 1117<br />

DlPaola, J. See Wimmer, Cathy<br />

-; Tyma, D.; Gharavi, A.; Mercer, W., 1207<br />

DlPaola, Joseph See Salinas, Roealia<br />

-; Salinas, Roealia; Mercer, Wayne, 1205<br />

Dives, W. F. See Crisan, D.<br />

Djulbegovic, Benjamin See Paaic, Resad<br />

Dnlstrlan, Ann M.; Greenberg, E. J.; Schwartz,<br />

D.; Smith, C.; Schwartz, M. K., 1080<br />

Doetsch, K. See Rifaj, Nader<br />

Dohnal, James C.; Bowie, Lemuel J., 1091<br />

Dolan, P. A.; Psnnington, C. D.; Yost, D. A., 1857<br />

Dolci, Alberto; Parlaveechia, Mariella; Mangili,<br />

Ruggero; Marcovina, Santica, 1209<br />

Doman, Joseef See Karadi, Istvan<br />

Domenici, Michael See Hsu, Po Choo<br />

Dominlczak, Marek; Bell, J.; Cox, N.H.;<br />

McCruden, D.; Jones, S. K.; Ong-Tone, L.;<br />

Finlay, A. Y.; Prier, B. M., 1137<br />

Donahoe, Mark; Hall, K.; Luxton, A., 1202<br />

Donis-Keller, H. See Smith, Douglas It<br />

Donis-Keller, Helen See Green, Philip<br />

Donnachie, KM.; Seccombe, D. W.; Urquhart,<br />

N. I.; Scudamore, C. H.; Shackleton, C. R.;<br />

Foreward, A. D.; Erb, 5., 899<br />

Donnelly, James G.; Soldin, S. J., 1167<br />

Donner, J. K See Tadepalli, Sarvamanagala<br />

Donohus, Joseph; Bailey, Mark; Gray, Robert;<br />

Holen, James; Huang, Tung-Ming; Keevan,<br />

James; Mattimiro, Chris; Putterman, Caryn;<br />

Stalder, Arnold; Dofreese, James, 1874<br />

Donovan, J. W. See Beckett, G. J.<br />

Doptis, P. See Van Brunt, N.<br />

D’Onazlo, Paul, 1232<br />

DorIa, LSee Doria, Manuel, Jr.<br />

Doria, Lomna See Dasgupta, Amitava<br />

Doria, M. J. See Harrison, H. H.<br />

Doria, Manuel,<br />

Schwemin,<br />

Jr.; Jove, M.; Molloy, S.;<br />

D.; Doria, L; Chawnont, B.; Del<br />

Carlo, F., 1085<br />

Donizzi, K,; Tagliaro, F., 1185<br />

Doss, K. See Marlewski, D.<br />

Dotchev, Dotcho C. See Svinarov, Dobrin A.<br />

Douet, Philippe See Orsonneau, Jean-Luc<br />

Douglas, J. See Marlewaki, D.<br />

Doumas, Basil T.; Hause, Lawrence L.;<br />

Simuncak, David M.; Breitenfeld, Diane,<br />

Dove, Janet 18cc Prior, Thomas W.<br />

151<br />

Dowdey, A.B.C. See Putnam, ItS.<br />

Dowel, Barry; Borden, Kimberlee; Shaw,<br />

Norm, 1192<br />

Dow.ett, M. See Pearce, S.<br />

Dralsey, T. F. See Caines, Patrick S.<br />

Draper, Karl A. See Whitley, Chester B.<br />

Drapem, Karl A. See Whitley, Chester B.<br />

Drew, Helen See Bruzek, Debra<br />

Dreyfus, 6. See Coeson, C.; Myara, L<br />

Dnueke, T. See Duval, F.<br />

D’Souza,, J. See Kubasik, N. P.<br />

D’Souza, J. P. See Kubasik, N. P.<br />

Dubin, Stuart B., 612<br />

Dublnsky, B. See Diaz, S.<br />

Dublnsky, Eli See Hirsch, Carl<br />

Dubler, Robert See Thacker, Susan<br />

Dubols, P. See Galanti, L M.<br />

DuCharme, L See Eble, K. S.<br />

Dudley, A. W., Jr. See Diaz, S.; Singh. J,; Singh,<br />

Jagat<br />

Duevel, J. See Oeilersch, Michael<br />

Dudley,<br />

Dudman,<br />

Alden<br />

N. P.<br />

W., Jr.<br />

B. See<br />

See Singh,<br />

Wang, X.<br />

J.<br />

L<br />

Duff, Henry J. See Sheldon, Robert S.<br />

Duffy, Patrick See Cheung, Kee<br />

Duffy, T. H.; Bales, R. M., 1079<br />

Dufour, D. Robert See Podiasek, Stanley J.<br />

Dufour, Lucienne See Moussa, Fathi<br />

Duggal, Rita N. See Newman, Edward S.<br />

Duggan, P. Flnbarr See O’Leary, Niall<br />

Dub, Show-Hong; Koch, Thomas It, 1182<br />

Duliot, M. P. See Aleyassine, H.<br />

Dummel, Robert See Zimmermann, Linda<br />

Dun, Huijun See Shoji, Shin’ichi<br />

Duncan, M. See Raymond, Anne<br />

Duncan, Marilyn; Prinsen, J.; Mitchell, G.;<br />

Trundle, D.; Hale, W., 1143<br />

Duncan, Wayne P.; Deutsch, Dale G., 1279<br />

Dunk., Louis, Jr. See Fan, Titan S.; Kish,<br />

Linda; Ku, Che-An; Sciotto-Brown, Susan;<br />

Zinimermann, Linda<br />

Dunlap, Larry See de Kanel, John<br />

Dunn, Dale M. See Bradley, Charles A.<br />

Dunn, Don J.; Bhick, Kenneth E.; Gillwn,<br />

Ronald 1, 1138<br />

Dunn, Robert J. See Attia, John<br />

Dupuy, Georges See Leapinas, Francis<br />

Dutton, Charyl M. See Whitley, Chester B.<br />

Duty, Gale See Passey, Richard B.<br />

Duval, F.; Frommherz, K.; Atger, V.; Drueke, T.;<br />

Lacour, B., 963<br />

Dyer, Deborah; Cate, J.; Skogen, W., 1184<br />

Dyer, K. See Shihabi, Z.<br />

Earl, LA. See Haven, M. C.<br />

-; Studts, D. J.; Markin, R. S., 1072<br />

-; Timko, D. M.; Markin, R. S., 1153<br />

Earl, Robert A. See Haven, Mary C.<br />

Earnhardt, Kimberly See Snouwaert, John N.<br />

Eastep, Steven J.; Benson, Peter J.; Presse,<br />

Lynne M.; Apple, Fred S., 333<br />

Eastman, Creswell J. See Novick, David M.<br />

Eble, K. 8.; Rynning, M.; Hutten, P.; Nelson, L.,<br />

1193<br />

-; DuChsrme, I; Stojak, J., 1193<br />

Eby, W. See Bark, Lee; Webb, Gary<br />

Echizen, Hirotoshi; Itoh, Roichi; Ishizaki,<br />

Takashi,64<br />

Eckehinan, W. C. See Jagoda, E.<br />

Eckenbom, Solveig; Bergqvist, Yngve, 2253<br />

Eckfeldt, John H.; Semi, Chris; Bormann,<br />

Priscilla; Bradley, 0. Mary, 1804<br />

Edo., Thomas K See Thornton, William H., Jr.<br />

Edinboro, Leslie B,; Hall, Karen V.; Pokhis,<br />

Alphonse, 1176<br />

Edwards, B. See Thorpe, G. H. G.<br />

Edwards, B. M. See Ostrow, D. H.<br />

Edwards, G. C. See AuBuchon, J. P.<br />

Edwards, Paul; Liu, Peter K. S.; Rose, G. Alan,<br />

241<br />

Edwards, K. See Koh, Tung Ruiz, Eliseo<br />

Edwards, S.; Moon, C.; Dicker, P.; Shepherd, H.,<br />

1080<br />

Edwards, W. See McConway, M. G.<br />

Egbents, J. See Wijnands, J. B. G.<br />

Egbnlng, K. See Dati, F.<br />

Egensperger, H. See Van Brunt, N.<br />

Eggertien, Robert See Lindstedt, Gorse<br />

Ehlen., 6. See Ferris, Robert J.<br />

Ehrenkranz, Joel K. I See Person, Nils B.<br />

Ehrmeyer, S. See Laessig, Ronald<br />

Elsenbeng, Paul K,; Shaw, David; Schsab,<br />

Colleen; Jaffe, Allan S., 440<br />

Ekin, Ronald J. See Kroll, Martin H.<br />

Eklndjian, 0.6.8cc Roche, D.; Thuan, N. T.<br />

Leuquang<br />

Ekina, Roger<br />

510<br />

Nelson, Jerald C.; Tomei, Ray T.,<br />

-; Tikanoja, Sari; Liewendahi, Kristian, 708<br />

El Allaf,<br />

El AIls!,<br />

Pd. See Chapelle, Jean-Paul<br />

Magdelelne; Chapelle, J. P., 1120<br />

El-Attar, Hanan M. See Ali, Farouk M.<br />

-;Shobokshi,O.;Ali,F., 1186<br />

Ella, Ronald J. See Hoeseini, Jeanette M.<br />

-; Hosseini, Jeanette M.; Ruddel, Mark, 1114<br />

-; Hosseini, Jeanette M.; Yang, Xiu Ying, 1115<br />

-; Hoeseini, Jeanette M.; Ruddel, Mark;<br />

Rubinow, David, 1115<br />

-; Bloom, Jeffrey N.; Herman, David C.; Shiva,<br />

Clara A.; Ruddel, Mark; Nussenblatt, Robert<br />

B.; Palestine, Alan G., 1159<br />

-;Ruddel,MarkE., 1182<br />

Elkhallfa, Mohamed; Collins, S.; Karcher, It;<br />

Epstein, E.; Kiechle, F. L., 1124<br />

Ellertz, Gina See Lindstedt, Gorse<br />

CLINICALCHEMISTRY. Vol. 35, No. 12, 1989 2347


Elliot, K.; Watson, I. D.; Stewart, M. J., 1352<br />

Elliot, R. L See Werneke, Debra K.<br />

Elliott, M. C.; Gordon, Wiffiam H.; Aahwood,<br />

EdwardR., 1120<br />

Elliott, K. L. See Konrath, J. G.<br />

Ellis, Graham; Holland, F. John; Makela,<br />

Sinikka K., 1150<br />

El Shanii, Said See Spiehier, Vine<br />

Bison, M. See Kusilek, Lesa D.<br />

Elving, L. D.; Bakkeren, J. A. J. M.; Jensen, M.<br />

J. H.; do Kat Angelino, C. M.; de Nobel, E.;<br />

van Munster, P. J. J., 308<br />

El-Yazigi, Adnan; Chaleby, Kutaiba; Martin,<br />

Cazemiro R., 848<br />

Emancipator, K.; Kroll, M. H., 1161<br />

Emerit, Jacques See Bonnefont, Dominique<br />

Endo, Takeahi See Kobayashi, Isao<br />

Endres, David B.; Villanueva, It; Sharp, C.;<br />

Singer, F., 1148<br />

Engbaek, Frode; Christensen, Stig Engkjaer;<br />

Jespersen, Bente, 93<br />

Engebrecht, K. See Danielson, Susan J.<br />

Engel, W. D. See Karl, Johann<br />

English, Trevor N. See Novick, David M.<br />

Enrlquez, John I., Sr.; Keniston, R.; Delgado. L,<br />

1136<br />

Epstein, K See Elkhalifa, Mohamed; Karcher,<br />

Raymond<br />

Epstein, Emanuel See Seharer, Katharine A.<br />

Erb, K, B. See Lewis, L M.<br />

Erb, S. See Donnachie, E. M.<br />

Erickson, Katherine See Kricka, Larry J.<br />

Eniksson, Lars See Hansson, Lena<br />

Esajas, M. See Wijnands, J. B. 0.<br />

Espina, Virginia See Faynor, Steven M.<br />

Esposito, Linda See Nicoison, Ruth E.<br />

Ethier, Diane See Tagari, Philip<br />

Evans, 0.0., 897<br />

Evans, I. See Prinsen, Johanna<br />

Evans, John See Painter, Pennell<br />

Fagglsn, D. See Plebani, Mario<br />

Fagin, A. See Miyada, D. S.<br />

Falkensson, Marianne; Jones, Wayne; Sorbo,<br />

Bo,918<br />

Falutz, Julian; Tsoukas, Chris; Cardno, Todd,<br />

704<br />

Pan, Der-Fong; Ke, Shu-Wen; Singh, Madhuri;<br />

Hartsock, Robert J., 1142<br />

Fan, Titan S.; Lentrichia, Brian B.; Solan,<br />

Vishnu; Sheiman, Mark I.; Dunka, Louis, Jr.,<br />

1171<br />

Fang, X. See Broyles, Celeste<br />

Fardin, E. See Marcovina, Santica<br />

Parley, John K,; Kyeyune-Nyombi, Eru;<br />

Tarbaux, Nanine M.; HaU, Susan L.; Strong,<br />

Donna D., 223<br />

Farmer, MG. See Zoha, Steven J.<br />

Farrance, I. See Rowbwy, D.<br />

Farrant, Robert K. See Philhpou, George<br />

Farrenkopf, B. See Awdziej, Tania N.; Cheng C.<br />

Farrenkopf, Bruce C.; Mylott, G.; Awdziej, T.;<br />

Kaufman, It A., 1178<br />

Farzami, B., 1557<br />

Fasullo, Frank J., Jr.; FrItsche, Herbert A., Jr.;<br />

Liu, Frank J.; Hamilton, Robert G., 364<br />

Faulder, Charles 0. See Beckett, Geoffrey J.<br />

Faynor, Steven M.; Eapina, Virginia, 1180<br />

Felfel, G. See Beever, K.<br />

Feild, Margaret See Thompson, James D.<br />

Fold, Ronald See Roberts, Pamela<br />

-; Roberta, Pamela, 1081<br />

Fold, Ronald D. See Nuwayhid, Naziha F.;<br />

Punzalan, Rubio It<br />

Feldbruegge, Donald See Tee, Martina<br />

Felder, K. A.; Holl, It W.; Martha, P., Jr.;<br />

Bauler, G.; Hellman, P.; Wills, M. It;<br />

Thorner, M. 0., 1423<br />

Felder, Robin A., 1051<br />

-; Roberts, Ruth; Barlow, Ellen; Boyd, James C.,<br />

1200<br />

Feldmann, Delphlne; Flandrois, Christine;<br />

Jardel, Alain; Phan, Tuyet-Minh; Aymard,<br />

Pierre, 864<br />

Fell, Anthony F. See Kirk, Elaine M.<br />

Fell, 0.8. See Fraser, W. D.<br />

Fehnayer, Gabriel Werner See Fucha, Dietmar<br />

Felmayer, Gabriele Werner See Fuchs,<br />

Dietmar<br />

Fenton, John See Motika, Deborah<br />

Ferber,!. See Lee, Sung C.<br />

Ferdeghini, M. See Pilo, A.<br />

Fernio, Isabella See Paleari, Renata<br />

Fernandez, P. See Vasdev, Sudesh<br />

Forniund, P. See Abrahamsson, P.-A.<br />

Ferran,M.E.;Lucas,F., 1111<br />

Ferrari, K.; Ceconi, C.; Signorini, C.; Anand, L;<br />

Harris, P.; Albertini, A., 331<br />

Ferrari, Roberto See Polesi, Claudio<br />

Femre, C. See Huuet, J.<br />

Ferreira, Victoria M.; Pastore, Denise, 1105<br />

Ferris, Robert J.; Ehlers, G., 1131<br />

Ferron, Liliane See Manca, Dino<br />

Fessas, Phedon See Giannoulaki, Elefteria E.<br />

Fesus, Paul D.; Preasac, Monique; Braconnier,<br />

Francois; Ayinard, Pierre, 481<br />

Feuillu, A. See Goujet, B.<br />

Field, Patricia H. See Stanton, Noel V.<br />

Fields, S. See Kaseman, Deborah; Reilley,<br />

Therese<br />

Figard, Steve D.; Bodner, J.; Babik, D. M.;<br />

Mlyniec, D.; Simpson, B.; Ogunro, E. A.,<br />

1147<br />

Figarella, Catherine See Barthe, Catherine<br />

Fiomena, Carol Ann, 1158,1795<br />

Finbow, J. A. H. See Brocklehurst, D.<br />

Finding, James W. See Raff, Hershel<br />

Fine, James S.; Chandler, Wayne L.; Clayson,<br />

Kathleen J., 2018<br />

Fine, Joan-Marina See Lefrere, Jean-Jacques<br />

Fink, Louis M. See Taylor, E. Howard<br />

Finlay, A. Y. See Dominiczak, Merck<br />

Flnlayson, J. See McConway, M. 0.<br />

Finn, Martha F. See Folan, John<br />

Finneran, J. See Staedter, M.<br />

Firat, Dincer See Copur, Sitki<br />

First, Pd. K, See Schroeder, Timothy J.<br />

Flschberg, B. See Kaseman, Deborah; Reilley,<br />

Therese<br />

Fischer, Johan; Verbruggen, Bert; Weasels,<br />

Hans; Haenen, Clemens, 483<br />

Fisher, Catherine See Rehkemper, Catherine<br />

Fisher, Delbert A. See Pandian, M. R.<br />

Fitzgerald, A. See Rowbury, D.<br />

Fitzgerald, D.; Richter, D.; Richards, J.;<br />

Hemker,<br />

Fitzpatrick,<br />

S.; Jawed, J.; Wegfahrt, P., 1140<br />

D. A.; Law, W. T.; Pasqua, J., 1133<br />

Fitzpatrick, J. See Bhargava, A. K.; Bhargava,<br />

AK<br />

Fitzpatrick, J. K See Bhargava, A. K.<br />

Flanagan, K. J.; Ruprah, M., 1342<br />

Flandrois, Christine See Feldinann,<br />

Flatow, B. See Fleisher, Martin<br />

Delphine<br />

Fleisher, Martin; Flatow, B.; Schwartz, M. K.,<br />

1128<br />

-; Gladstone, Michael; Crystal, Della; Schwartz,<br />

Morton K., 1532<br />

Flendnig, J. Guns See Gieaen, Peter L A.<br />

Flentge, Charles See Brashear, Jeff<br />

Ftentje, Dsgmar See Bohler, Ulrich<br />

Plom, Kenny J., 1087<br />

Floreani, A. See Plebani, Mario<br />

Floreani, M. See Kiang, W.<br />

Flye, M. Wayne See Wolf, Bryan<br />

Foglia, J. P. See Perel, J. M.<br />

A.<br />

-; Perel, J. M.; Lin, F. C.; Narayanan, S., 1185<br />

Fohlin, Lan See Bergqvist, Yngve<br />

Folan, John; Gosling, James P.; Finn,<br />

Fottrell, Patrick F., 569<br />

Martha F.;<br />

Folena-Wasserman, 0.5cc Tsunokawa,<br />

Foley, Thomas See Louderback, Allan<br />

M.<br />

Follett, Edward A. C. See Sinclair, David<br />

Folatein, Marshal F. See DoPaulo, J. Raymond,<br />

Jr.<br />

Folsteln, Susan See DoPaulo, J. Raymond, Jr.<br />

Folts, M. M. See Fredrickson, R A.<br />

Fontaine, Monique; Porchet, Nicole; Largffliere,<br />

Claude; Marrakchi, Slaheddine; Lhermitte,<br />

Michel; Aubert, Jean-Pierre; Degand, Pierre,<br />

2148<br />

Foo, A. Ylug See Rosalki, Sidney B.<br />

Foo, Ying See Bais, Renze<br />

Ford, Kent A. See Baker, Harold N.<br />

-; Baker, Harold N.; Bear, Janet G.; Belay,<br />

Diane; Marlewaki, Deborah; Venetucci,<br />

Mary; Ogunro. Edward A.. 2333<br />

Foneward, A. D. See Donnachie, E. M.<br />

Forman, Donald T. See Highamith. William E.<br />

Fomni, Theresa See Anne, Lakshmi<br />

Foranian, Rodney W. See Muffin, Theodore E.<br />

Fortin,<br />

Fossatl,<br />

Louis-Jacques<br />

Nero; Ponti,<br />

See Davignon, Jean<br />

Maurizi ,Principe,<br />

Lorenzo; Tarenghi, Giordano, 173<br />

-; Sirtoil, Melanie; Tarenghi, Giordano;<br />

Glachetti, Martino; Berti, Giovanni, 2212<br />

Foster, O.K. See Beckett, G. J.<br />

Fotiou, F.; Piper, M., 1073<br />

Fottrell, Patrick F. See Folan, John; Howard,<br />

Katrina; Power, Michael J.<br />

Fowlkes, Dana M. See Snouwaert, John N.<br />

Fox, J. Lawrence; Klasa, Michael, 1838<br />

Fox, M. See Thompson, F.; Vasilakis, Jeanne<br />

Fox, Martha; Vasilakie, J.; Thompson, F.; Pelch,<br />

D.; Haden, B.; Powers, M.; Aberin, C.; flano,<br />

V.; Noriyuki, I.; MiUsap, S., 1088<br />

Fraij, Bassam M., 658<br />

France, Laura A. See Whitley, Chester B.<br />

Franciotta, Diego Michele; D’Eril, Gianvico<br />

Melzi, 337<br />

Franck, Paul F. H.; de Meeker, Gerhardus A.;<br />

Moolenaar, Abraham J., 1995<br />

Frandsen, Erik K.; Bacchus, Bobby A.; Moaz,<br />

Ahmed A.; Sabagh, Tahir, 712<br />

Frandsen, Niels Jorgen; McNair, Peter, 1986<br />

Frank, Alison See Larsen, Sandra<br />

Frank, Kathy See Kress, Barry C.<br />

Franklin, S. See Chiang, C. S.; Cooper, M.<br />

Franquemont, Douglas W.; Sutphen, James I<br />

Herold, David A.; Bruns, David E., 1158<br />

-; Sutphen, James L.; Herold, David A.; Brum<br />

DavidE., 1760<br />

Frantz, Ivan See Bachorik, Paul S.<br />

Fraser, Callum G. See Stolarek, Iwona<br />

-; Cummings, Steven T.; Wilkinson, Stephen<br />

Neville, Ronald 0.; Knox, James D. E.; Ho<br />

Olga; MacWalter, Ronald S., 783<br />

-; Lott, John A., 1553<br />

Fraser, W. D.; Taggart, D. P.; Fell, G. S.; Lyon<br />

T. D. B.; Wheatley, D.; Garden, 0. J.;<br />

Shenkin, A., 2243<br />

Frazer, I. H. See Renouf, Judith A.<br />

Fredrickson, K. A.; Belchak, T. L; Foltz, M. I<br />

Loeschen, B. J.; Profitt, J. A.; Yoder, J. M.<br />

Morris, D. L,, 1140<br />

Freedman, Danielle B. See Ball, Richard<br />

Freeman, J.; Hsu, J.; Lopez, B.; Visor, J.;<br />

Messenger, H.; Wong, E.; Buelteman, L;<br />

Mills, A.; Brady. A.; Hu, M.; Anderson-<br />

Mitchell, K.; Bellet, N., 1180<br />

Freier, C. See Kan, Brenda<br />

Freier, Esther F. See Hanson, Naomi Quest<br />

Press, G.; Vignon, F.; Pau, B.; Paolucci, F.;<br />

Rochefort, H., 234<br />

Freiss, Gllles See Rogier, Herve<br />

Fricker, F. J. See Crisan, Domnita<br />

Fnicker,<br />

Fniddell,<br />

K. See Detwiler, Richard<br />

Colleen S. See Oldhem, Robert K.<br />

Fridrich, Leo; Szekeres, Thomas; Hartter,<br />

Engelbert; Sehweighofer, Franz; Gassner,<br />

Alfred; Laczkovic, Azel, 435<br />

Fniedberg, M. See Shihabi, Z.<br />

Friedman, K. J. See Prior, T. W.<br />

Friedmann, Kenneth J. See Prior, Thomas W<br />

Pride, Thomas; Caron, Marc G.; Lefkowitz,<br />

RobertJ., 721<br />

Frier, B. Pd. See Dominiczak, Marek<br />

Fries, P. See Keller, Charles H.<br />

Fninga, Christopher S.; Battaglia, Danielle J.;<br />

White, Robert M., 891<br />

Fritsche, E. T. See Holzberg, Roni A.<br />

Frltsche,<br />

Fritsche,<br />

B. A. See Shahangian, S.<br />

Herbert A., Jr. See Fasullo, Frank<br />

Jr.; Shahangian, Shahram<br />

Frommherz, K. See Duval, F.<br />

Fruchart, J. C. See Steinmetz, A.<br />

Fructus, Fabienne See Delpuech, Patrick<br />

Fry, Henry D. See Blick, Kenneth<br />

Fu, J. C. See Hong, X. Q.<br />

-; Cheng, A. J.; Chen, C. W.; Lu,<br />

E.<br />

W.; Lam, K.<br />

W., 1079<br />

Fu, Maria See Bleile, Dennis<br />

Pu, Paul; Zic, V.; Tanimoto, L.; Gorsky, J., 109<br />

Fuchs, Dietmar See Reibnegger, Gilbert<br />

-; Spire, Thomas J.; Heusen, Arno; Reibnegge<br />

Gilbert; Werner, Ernst It; Felmayer,<br />

Gabriele Werner; Wachter, Helmut, 1748<br />

-; Heusen, Arno; Reibnegger, Gilbert; Werner,<br />

Ernst R.; Felmayer, Gabriel Werner<br />

Wachter, Helmut, 2158<br />

-; Milstein, Sheldon; Kramer, Alexander;<br />

Reibnegger, Gilbert; Werner, Ernst It;<br />

Goedert, James J.; Kaufman, Seymor;<br />

Wachter, Helmut, 2305<br />

Fuchs, J. See Rotenberg, Z.<br />

Fuchg, Jacob See Rotenberg, Zvi; Weinberger,<br />

Itzhak<br />

Fuentes-Ardeniu See Juan-Pereira, L.<br />

Fuentes-Arderlu, X. See Huguet, J.<br />

-; Lott, John A., 1552<br />

Fujimoto, Takashi; Tsuda, Yoshiko; Tawa,<br />

Riichi; Hirose, Shingo. 867<br />

Fujita, Keisuke See Maruta, Kazuhiro<br />

Fukuda, Chisako; lijima, Kenji; Nakamura,<br />

Katsumi, 1897<br />

F’ukushi, Masaru See Yamaguchi, Akihiro<br />

Fukuyama, Yachiyo See Miure, Masakazu<br />

FUkUZUIni, Kieko See Terayame, Hiroahi<br />

Fulton, Ann; Chan, Shirley; Coleman, Graham<br />

641<br />

Fulton, T. K, See Smith, Douglas It<br />

Furuya, Shin See Kuroiwa, Ketsumaea<br />

Gabor, Michael J. See Bachand, Steven S.;<br />

King, David L.<br />

2348 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


thor, Mike; Martel, P.; O’Donnell, C. M., 1173<br />

Ige, Carole L See Schwartz, Joyce 0.<br />

ige, S.; Seymour, D.; Valenta, It; Cernosek, S.,<br />

1197<br />

ihi, W. A. See Papadopoulos, N. M.<br />

illlard, M. Christine; von Arb, Marianne; de<br />

Costs, Anna; Kilroe-Smith, Terence A., 1535<br />

danti, L M.; Delwiche, J. P.; Dubois, P.;<br />

Somville, M. A.; Pouthier, F.; Prignot, J., 496<br />

ilbraith, Linda V. See Leunj. Fred Y.<br />

Jablonsky,<br />

Henderson,<br />

George; Leung, Fred Y.;<br />

A. Ralph, 1116<br />

dlagher, S. K.; Johnson, L. K.; Milne, D. B.,<br />

369<br />

illi, Andre See Bonnefont, Dominique<br />

dliher, 0.See Sun, Lila<br />

dloway, Eric See Sinclair, David<br />

dteau, M. M. See Vincent-Viry, Monique<br />

unbhir, K, K.; Agarwal, Veena It, 1128<br />

lines, David E., 1055<br />

Innon, Allison; Teramoto, Y.; Knapp, S.;<br />

Tran, K.; Langton, B., 1079<br />

ircia, Marcel See Rogier, Herve<br />

ircia, Maria See Kurschinski, Douglas T.<br />

irden, 0. J. See Fraser, W. D.<br />

inland, D. L; Garland, T. E.; Delee, A. C., 1104<br />

inland, T. E. See Garland, D. L.<br />

iroscio-Cholet, Pd. See Dechaud, H.<br />

irrett, Patricia E. See Sullinger, Jana<br />

my, Philip J., 1061<br />

Irver, Fred A. See Moscoso, Hugo<br />

macon, Felix; Molina, Ernesto, 191<br />

m, T. See Leaky, F. D.<br />

laser, F. See Sapin, It<br />

masner, Alfred See Fridrich, Leo<br />

mat,Michael J. See Scott, Mitchell G.<br />

stes, Teresa See Thacker, Susan<br />

Crisafulli, T.; Chiappetta, E.; Jenkins, M.,<br />

1174<br />

itti, V. See Tamagno, B.<br />

ml, M. H. Chafe, L; Comerford, A.; Jenkins,<br />

M.; Hayden, K.; Vasdev, S.; Longerich, L.,<br />

1133<br />

Longerich, L.; Brent, D.; Johnson, D.;<br />

Johnson, E., 1150<br />

iwoski, J. Pd.; Walsh, D., 2140<br />

sijo, Sofia A. See Vents, Rafael<br />

slder, Frank B. See Shahangien, Shehram<br />

ing, Jian-Guo; Chen, Hso-Zhu; Yang, Yi-<br />

Feng; Qian, Zhong-Hao; Thong, Li-Ming, 96<br />

mi, J. Paul See Dean, Harvey G.<br />

mntzer, W. See Madry, Norbert<br />

sorge, P.M.; Sheet, J. M., 179<br />

sorge, William J. See Ricci, Mary Jo<br />

srard, S. See Chen, Katherine; Khayam-Bashi,<br />

Hasaan<br />

irasiniova, Natalija S.; Stekiova, Irma V.;<br />

Tuuminen, Tamara, 2112<br />

irber, M. See Klein, G.<br />

Ire, Jeffrey A. See Stevenson, Cathy C.<br />

mrhardt, Gregory; Davitt, Christine; Chan,<br />

Daniel W., 1554<br />

irmino, G. G. See Reeders, S. T.<br />

maravi, A. See DiPaola, J.<br />

moneum, G. See Ansari, A.<br />

acobiul, B. See Unni, L. K.<br />

senpietro,<br />

Lorelle;<br />

Ottavio; Clerico,<br />

Penno, Giuseppe;<br />

Aldo; Cruschelli,<br />

Nevalesi, Renzo,<br />

1560<br />

annouleki, Elefteria E. See Kalpexis,<br />

Dimitrios L.<br />

Kalpexis, Dimitrios L.; Tentas, Constantinos;<br />

Femsas, Phedon, 396<br />

bbons, L; Gorin, M.; Yassinzadeh, Z.;<br />

Peerson, P.; Besemer, D.; Dillon, K.; Burd,<br />

T.; Rillnian, R.; Smoluk, G.; Cobb, M., 1869<br />

bbs, Judy; Root, D.; Brown, K., 1190<br />

bbs, K. A. See McBride, L J.<br />

bIer, W, B. See Lewis, L. M.<br />

bean, S. See Murphy, Allan<br />

dwani, G. See Gupta, Manjula K.<br />

Lesen, Peter L A.; Peltenburg, Henny G.; de<br />

Zwaen, Chris; Janson, Piet C. W.; Flendrig,<br />

J. Guus; Hermens, Wim Th., 279<br />

ibent, S. See Witherspoon. L It<br />

Ilespie, David See Thompson, James D.<br />

llespie, G. A. J. See Reeders, S. T.<br />

llham, Sherni L See Schwartz, Joyce 0.<br />

Ilinor, K. See Okorodudu, A. 0.<br />

Ilum, Konald ISee Blick, Kenneth E.; Dunn,<br />

Don J.; Passey, Richard B.<br />

Llmore, B. See Myers, Gary L.<br />

Strap,<br />

nising,<br />

L See Putnam, It S.<br />

Peter; Nexo, Ebba, 1447<br />

ordano, Donna J., 1096<br />

rand, Yves See Tegari, Philip<br />

rardot, Clemencia See Cheng, K. Steve<br />

Gin, S. See Petersen, J. It<br />

Gitelnian, Hillel J.; Alderman, Frances R., 1517<br />

Glechetti, Martino See Fosseti, Piero<br />

Gladding, D. See Shah, Vipin<br />

Gladstone, Michael See Fleisher, Martin<br />

Glen, A. C. A. See McConway, M. 0.<br />

Glees, U. See Kruse-Jarres, J. D.<br />

Glick, M. See Rushkowski, Janet<br />

Glick, Melvin See Ryder, Kenneth<br />

-; Glick, Starla; Ryder, Kenneth W., 1108<br />

-; Glick, Sterla; Ryder, Kenneth W., 1160<br />

Gllck, Melvin K,; Ryder, Kenneth W.; Glick,<br />

Starle J.; Woods, John R., 837<br />

Glick, Starla See Glick, Melvin; Ryder. Kenneth<br />

Glick, Starla J. See Glick, Melvin R.<br />

Glickinan, J. See Cssko, G.<br />

Glickman, Janice See Csako, Gyorgy<br />

Globis, C. See Chin, Bruce G.<br />

Glover, J. See Crouch, Cohn<br />

Gobnogge, Koger See Brettfeld, Chris<br />

Goedert, James J. See Fucha, Dietmar<br />

Goga, V.5cc Chen, Alice<br />

Goldberg, N. See Prinsen, Johanna<br />

Goldenbeng, David M. See Hansen, Hans J.;<br />

Newman, Edward S.<br />

Goldensoph, C. K. See Tadepalli,<br />

Sarvacnanagala<br />

Goldman, Dan See Deneris, Even S.<br />

Goldsmith, Barbara M.; Troyanosky, Deborah;<br />

Hanges, Lisa, 1168<br />

Goldstein, P. J. See Manimekalai, S.; Sundarem,<br />

Shan G.<br />

Goldstein, Phiffip J.; Sundarem, G. S.;<br />

Manimekslai, S., 1157<br />

Golubjatnikov, Rjunik See Shaw, Norman<br />

Gomez-Hens. Agustina See Perez-Bendito,<br />

Dolores<br />

Gonchoroff, Daryl G.See Sehoenau, E.<br />

-; Branum, Earl L.; O’Brien, John F., 29<br />

Gonzalez, B. Fabre See Budria, J. Ruiz<br />

Good, I. J. See Bernstein, Larry H.<br />

Goodman, D. B. P. See Remeley, A. T.<br />

Goodman, H. See McCormick, C.<br />

Goodnow, Timothy T. See Butch, Anthony W.<br />

Goral, A. See Beever, K.<br />

Gordon, C. See Sadrzadeh, Sayed M. H.<br />

Gordon, Pd. See Smith, Carol<br />

Gordon, William<br />

Goren, Marshall<br />

H. See Elliott, M. C.<br />

P.; Li, Jacki T. L., 1110<br />

Gorin, M. See Gibbons,!.<br />

Gonman, E.G. See Newman, D. J.<br />

Gornet, Terrie G.See Wu, Alan H. B.<br />

Goraky, J. See Fu, Paul<br />

Gosling, James P. See Folan, John; Howard,<br />

Ketrina; Power, Michael J.<br />

Goth, Laszlo; Meszaros, Istvan; Scheller,<br />

Gyory, 1793<br />

Gotoh, Hiroshl; Hegihare, Masako; Nagatsu,<br />

Toehihsru; Iweta, Hisashi; Miura, Tskayuki,<br />

1016<br />

Gotto, Antonio M., Jr. See Bachorik, Paul S.;<br />

Patsch, Wolfgang<br />

Gottwald, K. See Hu, Mae<br />

Gottwald, Ken See Anne, Lakehmi<br />

Gouget, B.; Gourmelin, Y.; Feuillu, A.;<br />

Truchaud, A., 1133<br />

Gould, S. A. See Sehgal, Lakshman It<br />

Gourmehin, Y. See Gouget, B.<br />

Graham, B. See Mulberg, E.<br />

Graham, D.; Thompson, F.; Dickey, D., 1088<br />

Gram, Jorgen; Jespersen, Jorgen, 52<br />

Grande, Peer See Christenson, Robert H.<br />

Grandjean, Philippe,<br />

Gray, L See Winkles,<br />

1055<br />

J. W.<br />

Gray, Kichard W. See Lemann, Jacob, Jr.<br />

Gray, Kobert See Donohue, Joseph<br />

Gray, T. A. See Kennedy, R. Lee<br />

Grazia Do Roasi, Maria See Sensi, Maurizio<br />

Graziani, Maria Stella; Lippi, Ugo; Veasenelli,<br />

Corrado; Blankenhorn, David H.; Alsupovic,<br />

Peter, 1266<br />

Green, Denise T. See Armbruster, David A.<br />

Green, Eric D. See Scott, Mitchell G.<br />

Green, Judy L See Parker, K. Michael<br />

Green, Philip; Helms, Cynthia; Weiffenbach,<br />

Barbara; Stephens, Karen; Keith, Tim;<br />

Bowden, Don; Smith, Doug; Donis-Keller,<br />

Helen, B33<br />

Greenberg, B. J. See Dnistrian, Ann M.<br />

Greenberg, N. See Van Brunt, N.<br />

Gregg, K. E. See Huang, C. M.<br />

Gregory, B. See Bennett, H. J.<br />

Gregory,<br />

Grenner,<br />

Maudry See Ryan, Francis<br />

0. See Ackermann, H.; Bleckwood, J.;<br />

Dakubu, S.; Medry, Norbert; Padilla, A.;<br />

Staedter, M.<br />

-; Inbar, S.; Meneghmni, F. A.; Long, E. W.;<br />

Yamartino, E. J., Jr.; Bowen, M. S.;<br />

Blackwood, J. J.; Padille, A. J.; Mareteky, D.;<br />

Stsedter, M., 1865<br />

Grenot, Catherine See Pugeet, Michel<br />

Greuner, A. M. See Kropf, J.<br />

Grevel, J. See Napoli, K. L<br />

Grey, Joseph B. See Miles, Andrew<br />

Gniben, Denise See Domko, Paul It<br />

Griesser, H. W. See Kessler, Anne-Ch.<br />

Griffith, Dan K. See Chasnoff, Ire J.<br />

Griffiths, H. See Price, A.<br />

Griffiths, Huw See Kennedy, R. Lee; Price,<br />

Alun<br />

Grinatead, Gregory F., 1998<br />

Grinsted, J. See Wendrup, Jesper<br />

Gross, Susan F.; Hernandez, Carol; Weeks,<br />

Marilyn; Havranek, Lauren; Tono, Mary;<br />

Khayam-Bashi, H., 1183<br />

Grove, T. See Chiang, C. S.; Cooper, M.;<br />

Tsunokawe, M.<br />

Gruemer, Banns-Dieter See Prior, Thomas W.<br />

Gruemer, Hans-Dieter See Weiasbecker, Karen<br />

A.<br />

Gruener, Nachman See Barek, Mba<br />

Gruenent, D.C. See Smith, Douglas It<br />

Grutzmeier, Sven; von Schenck, Henning, 461<br />

Guadagno, Philip See Puleo, Peter K.<br />

Guadagno, Philip A. See Puleo, Peter R.<br />

Gusach, K, See Portoles, M.<br />

Gubata, Paul; Lefebvre, R. Craig, 1098<br />

Guemouni, Laila; Penn, R.; Artur, Y.; Mm, A.;<br />

Siest.G., 1126<br />

Guglielmotti, Angelo See Silvestrini, Bruno<br />

Guilbaud. Jean-Charles See Macart, Michel<br />

Guillemain, K, See Cosson, C.; Myare, L<br />

Gunter, Elaine W. See Myrick, James E.;<br />

Parsons, Patrick J.; Stanton, Noel V.<br />

-; Turner, Weyman E.; Huff, Dan L., 1601<br />

Gunzler, V. See Schnorr, G.<br />

Gupta, M. Pd. See Somani, B. L.<br />

Gupta, Manjula K.; Seifarth, K.; Redmond, G.<br />

P.; Gidwani, G.; Bergfeld, W., 1143<br />

Gutierrez, Alda; Rifai, N.; Holly, It, 1066<br />

Gutlerrez, M. Carmen See Perez-Bendito,<br />

Dolores<br />

Gutman, Steven!. See Katz, Paul R.<br />

Guy, Jennifer See Shew, Norman<br />

Guy-Crotte, Odette See Barthe, Catherine<br />

Haanen, Clemens See Fischer, Johan<br />

Hachmann, H. See Schnorr, G.; Schnorr, Gerd<br />

K.<br />

Hacisalihoglu, Ayse See Torun, Meral<br />

Haddow, James K See Knight, George J.<br />

Haden, B. See Fox, Martha; Mwrhead, C.;<br />

Thompson, F.; Vasilakis, Jeanne; Williams,<br />

Michael<br />

-; VenWinkle, M.; Scott, M.; Busch, M.; Ascher,<br />

M.; Thorstensson, It, 1204<br />

Haden, BW See Clark, Mary M.<br />

Haessig, Lorene K. See Bagneski, Kim<br />

Hafkenscheid, J. C. M.; van den Berg-Bosman,<br />

H. T. It; Hessels, M., 1790<br />

Hage, David S.; Taylor, Bob; Schryver, Pet; Keo,<br />

PamC., 1210<br />

Hagele, B. 0.; Kratzer, M.; Schaich, E.;<br />

Reuscher, E., 188<br />

Hagihara, Masako See Gotoh, Hiroehi<br />

Hagiwara, Kohjl See Konno, Norimichi<br />

Hahnel, B. See Hahnel, R.<br />

Hahnel, K.; Avenell, M. H. J.; Hahnel, E., 2226<br />

Hahnel, Koland See Masters, AM<br />

Haight, Pd. See Rosenthal, P.<br />

Haines, Dale See Thompson, James D.<br />

Hajnl-Mezghanl, Selma See Riesco, Oscar F.<br />

Halbert, Sheridan A., 1059<br />

Hale, W. See Duncan, Marilyn<br />

Hall, D. See Lee, Sung C.<br />

Hall, K. See Donehoe, Mark<br />

Hail,<br />

Hail,<br />

Karen V. See Edinboro,<br />

Pd. See Neisler, H. M.<br />

Leslie E.<br />

Hall, Margot See Panteghini, Mauro<br />

Hail, K, See Ishii, S.<br />

Hail, K, L See Rosenthal, Philip<br />

Hall, Susan L See Farley, John It<br />

Hail, Terry D. See de Kanel, John<br />

Halloran, Stephen P.; Bell, Michael K.; Watson,<br />

Anita, 1268<br />

Halonen, Tuija See Suonp#{227}A, Mikko<br />

Halsey, John F. See Colwell, Mark<br />

Halatead, K. See Van Brunt, N.<br />

Halstenson, Charles K See Apple, Fred S.<br />

Halveraon, Kevin See Melik, Soheil<br />

Hamet, M. See Chadefaux, B.<br />

Hamilton, Marilyn See Mifflin, Theodore E.<br />

Hamilton, RobertO. See Fasullo, Frank J., Jr.<br />

Hamilton, Robert W.; Hopkins, Marbry B., III;<br />

Shihabi, Z. K., 1713<br />

Hamilton-Smith, S. See Sarosi, David<br />

Hammad, N. See Ambrocio, E.<br />

CLINICALCHEMISTRY. Vol. 35, No. 12, 1989 2349


H.nunarstrom, M. See Sgoutes, D.<br />

Hammarstrom, Margareta See Sgoutas,<br />

Demetrios S.<br />

Hammer, M. K., 193<br />

Hammer, P. See Diorio, Alfred F.<br />

Hammer, Peggy A. See Shah, Vipin D.<br />

Hammond, Philip W. See Arnold, Lyle J., Jr.<br />

Han, Tin See Bhargeva, A. K.<br />

Hand, C. W. See Smith, K. F.<br />

Ranges, Usa See Goldsmith, Barbara M.<br />

Hsnfrhiaon, Susan E.; London, Stephanie J.;<br />

Chute, Christopher G.; Barbieri, Robert L;<br />

Jones, Level; Kaplan, Lawrence A.; Sacks,<br />

Frank M.; Stsmpfer, Meir J., 2313<br />

Hanks,<br />

JTannn,<br />

B. See Wells, David<br />

Charles J., Jr.; Kettler, Thomas;<br />

Debe, Irwin; Clark, Timothy, 1998<br />

Hannsnt, ME. See Unni, L K.<br />

Hannon, W. Harry See Jewel, Sandra E.;<br />

Myrick, James E.<br />

Hansen, Hans J. See Newman, Edward S.<br />

-; LaFontaine, George; Newman, Edward S.;<br />

Schwartz, Morton K.; Malkin, Aaron;<br />

Mojzisik, Kethy, Martin, Edward W.;<br />

Goldenberg, David M., 146<br />

Hansen, Joel B. See Lau, H. Philip<br />

Hansen, S. It; HoIm, J., 1721<br />

Hanson, Naomi Quast; Freier, Esther F., 1538<br />

Hanison, Lena; Petersson, Jean; Eriksson, Lees;<br />

Olin, Ake, 537<br />

Hardy, Christopher J. See Bottomley, Paul A.<br />

Hardy, Robert; Ng, R. H.; Sparks, K.; Statland,<br />

B. K.; Kent, S.; Valdes, K., Jr., 1102<br />

Harel, Danlela See Weinberger, Itahak<br />

Harell, D. See Rotenberg Z.<br />

Harff, Gottfnled A. See <strong>Back</strong>er, Egbert T.<br />

Harlharan, M.; VanNoord, Ted; Cameron,<br />

Oliver G.; Curtis, George C.; Ostrow, David<br />

G., 202<br />

-; VanNoord, T.; Singh, S.; Kindt, E.; Kronfol,<br />

Z., 1138<br />

Hanker, Carol C. See Wu, Alan H. B.<br />

Rarkness, Dianne; Whitlow, Karen; Schreiber,<br />

WillianiE., 2144<br />

Harper, J. D.; Mertel, P.; O’Donnell, C. M., 1087<br />

Harris, Heather Pd.; Applegarth, Derek A.;<br />

Clarke, Lorne A.; Wong, Jonathan, 703<br />

Harris, P. See Ferrari, R.<br />

Harrison, H. H.; Miller, K. L.; Powell, D.; Tang,<br />

C. L.; Daufeldt, J. A., 1083<br />

-; Doria, M. J.; Shaw, S. T., 1122<br />

Harrison, Stephen P.; Barlow, Ian M., 1980<br />

flarthus, H.P. See Schnorr, Gerd K.<br />

Hartle, K. See Crmsan, D.<br />

Hartley, T. F. See Nordin, B. E. C.<br />

Hartmann,<br />

Hartsock,<br />

A. B. See Myers, Gary L.<br />

Robert J. See Fan, Der-Fong<br />

Hartter, Engelbert See Fridrich, Leo<br />

Harvey, Sheryl See Lee, Theodore T.<br />

Hasegawa, K. See Hosoda, K.<br />

Hasegawa, T. See Matsuura, Tsuneski<br />

Hasegawa, Takaakl See Ohshima, Taeyuki<br />

Hashimoto, Takuma; Matsubara, Fujiteugu;<br />

Takeda, Ryoyu, 2153<br />

Haskins, C. See Woo, Jannie<br />

Hassan, F. Michael See Wermeling, Joseph K.<br />

-; Pesce, A. J.; Warner, A.; Denson, D. D., 1182<br />

Hasselberg, Stephen; Mauck, It.; Neslon, D.,<br />

1120<br />

Hasaemer, D. See Laeasig. Ronald<br />

Hassemer, David J.; Wiebe, Donald A.; Kramer,<br />

Tim, 1068<br />

-; Hill, Barbara M.; Wilber, Laura, 1068<br />

Hassett, J. See Leaky, Fred D.; Mauck, Linda<br />

Hauptiorenz, Susanne See Wencker, Marion<br />

Hause, Lawrence L See Doumas, Basil T.<br />

Hausen, Arno See Fuchs, Dietmar; Reibnegger,<br />

Gilbert<br />

Havelick, J. See Medry, Norbert<br />

Haven, MC.<br />

ItC.<br />

See Arnold, L. It.; Schiebout-Clark,<br />

-; Sobeski, It. M.; Earl, It A.; Markin, It S.,<br />

1183<br />

Haven, Mary C. See Orsulak, Paul J.<br />

-; Sobeski, Linda M.; Earl, Robert A.; Markin,<br />

Rodney S., 564<br />

Haver, Virginia M.; Audino, Nancy; Burns,<br />

Susan; Nelson, Margaret, 138<br />

Havranek,<br />

Hayashi,<br />

Lauren See Gross, Susan F.<br />

Tokishi See Tsuchiya, Hironori<br />

Hayden, C. See Present, Bill<br />

Hayden, K. See Gault, M. H.<br />

Hayes, John D. See Beckett, Geoffrey J.<br />

Hazzard, William K,, 1062<br />

Head, T. See Prinaen, Johanna<br />

Heard, Gregory S. See Weissbecker, Karen A.<br />

Heath, D. A. See Ratcliffe, W. A.<br />

Heerspink, W. See Zwart, Albert<br />

2350 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />

Heikklla, Jarmo See Hemniila, llkka<br />

Helm, C. See Renz, M.<br />

Helnemann, Steve See Deneris, Evan S.<br />

Helnzerling, K. H. See Kusilek, Less D.<br />

Helrd, Wiiliam C., 1237<br />

Helse, H. M. See Kruae.Jarres, J. D.<br />

Helss, 0. See Rifai, Nader<br />

Hejtmanclk, J. Fielding See Silverman,<br />

Lawrence M.<br />

Heilerstein, M. See Khayam-Bashi, Hasssn<br />

HelIman, P. See Felder, R. A.<br />

Helms, Cynthia See Green, Philip<br />

Hemans, Bert See Klotzsch, Sigrid<br />

Heminger, L See Sperling, Matthew<br />

Hemker, S. See Fitz#{231}erald, D.<br />

Hemmila, llkka; Heikkila, Jarmo; Leivo, Pekka,<br />

1206<br />

Henderson, A. K. See Smith, Deborah A.<br />

Henderson, A. Ralph See Galbraith, Linda V.;<br />

Leung,<br />

Henderson,<br />

Fred Y.; Smith, Deborah A.<br />

Pd. J. See Deer, P.R. F., 1043<br />

Henderson, K. W. See Rose, L S.<br />

Hendnlks, D.; Scharpe, S.; van Sande, M.;<br />

Lommaert, M. P., 177<br />

Henke, J. See Bianca, Carol<br />

Henny, Joseph; Tarailo, P.; Schiele, F.; Siest, 0.,<br />

1126<br />

Henocque, Genevieve See Macart, Michel<br />

Henry, Joseph F. See Hutchens, T. William<br />

Henton, D. See Rosenthal, P.; Rosenthal, Philip<br />

Herber, Shirley A. See Schwartz, Joyce G.<br />

Herberger, John See Lipset, Joel<br />

Herbertson, K. See McConwey, M. 0.<br />

Herman, David C. See Elm, Ronald J.<br />

Hermens, Wim Tb. See Giesen, Peter LA.<br />

Hernandez, C. See Chen, Katherine<br />

Hernandez, Carol See Gross, Susan F.<br />

Herold, David A. See Franquemont, Douglas W.<br />

Aggarwal, Suresh K.; Kinter, Michael; Wills,<br />

Michael R.; Savory, John, 1113<br />

Heron, Diane See Malik, Sohall<br />

Henshman, J. M. See Vowels, J. A.<br />

Herzog, K. H. See Schoensu, B.<br />

Hess, Allan D., 1235<br />

Heasels, Pd. See Hafkenscheid, J. C. M.<br />

Hess, Arpad See Karedi, Istvan<br />

Hewitt, C. D. See Winborne, K.<br />

-; Innes, D. J.; Savory, J.; Wills, M. R., 1777<br />

Heyndrlckz, L See Pollet, D. E.<br />

Hicks, J. Pd.See Ioeefsohn, Mariet<br />

Hicks, P. See Demers, Laurence M.<br />

Hicks, Patti See Demers, Laurence M.<br />

Higashi, Yasuko See Yoshioka, Shinichi<br />

Higgins, Trefor, 1801<br />

Hlghsmlth, W. K; Swift, M.; Perry, T.;<br />

Silverman, L. M.; Knowles, M., 1077<br />

Hlghsmlth, W. Edward, Jr.; Perry, Tenly R.;<br />

Prior, Thomas W.; Silverman, Lawrence M.,<br />

1260<br />

Hlghsmlth, William B.; Bankson, Daniel D.;<br />

Formen, Donald T., 1151<br />

Hilborn, D. See Danielson, Susan J.<br />

Hill, B. See Laessig, Ronald<br />

Hill, Barbara M. See Hassemer, David J.<br />

Hill, C. See Bray, Kurtis K.<br />

Hill, Roger J. See Sheldon, Robert S.<br />

Hlllman,<br />

HhlImi,,<br />

K. See Gibbons, I.<br />

Richard B. See Wyatt, David T.<br />

Hillock, K. See Webb, Gary<br />

Hlnberg, I. See Poon, K.<br />

Hinds, B. See Butch, A.<br />

Hinds, Barbara See Bodor, Geza; Myrtle, James<br />

F.<br />

Hinds, John A. See Cheung, Kee<br />

Hines, C. See Boyd, James C.<br />

Hlnz, V.S. See 83cc, G. G.<br />

Hirano, Tetsuo See Miura, Mesakazu<br />

Hirata, Mario Hiroyukl See Hirata, Roeenio<br />

Dominguez<br />

Hlrata, Roearlo<br />

Crespo<br />

Domlnguez Crespo; Hireta,<br />

Mario Hiroyuki; Stzufaldi, Bruno; Poesik,<br />

Rafael Abraao; Asai, Mario, 1385<br />

Hlrayama, Toshiakl See Imemura, Shigeyuki<br />

Hirokawa, Junichi See Konno, Noriniichi<br />

Hircee, Shingo See Fujimoto, Takashi<br />

Hirsch,<br />

Hirsch,<br />

C. See Diaz, S.<br />

Carl; Yu, Gordon; Dubiusky, Eli, 1100<br />

Hlsae, Nobuo See Mashige, Fumiko<br />

Hissami, Obuld, 1094<br />

Hltzler, Walter See Bohler, Ulrich<br />

Ho, Hsu-T.o See Wang, Henn-Ping<br />

Ho, Olta See Fraser, Callum G.<br />

Hoch, K. See Wilson, John M.<br />

Hoffman, Eric P. See Kunkel, Louis M.<br />

Hoffmann, Georg; Aramaki, Shuichi; Blum-<br />

Hoffmann, Ellen; Nyhan, William L;<br />

Sweetman, Lawrence, 587<br />

Hofman, J. A. See Meulenberg, P. M. M.<br />

Hofmsn, K. See Wong, P. Y.<br />

Hofmsn, L F. See Bankson,<br />

Hojvat, 8. See Black, With<br />

Daniel D.<br />

, Clemens, John;<br />

Schmidt, Wesley<br />

Holden, K. D.; Silverman, L. M., 1084<br />

Holen, James See Donohue, Joseph<br />

Boll, K, W. See Felder, It A.<br />

Hoiland, F. John See Ellis, Graham<br />

Hollander, Lorl See Inloes, Roger; Klonizchii,<br />

Walt<br />

-; Rinnie, Shernie; Worthy, Tom, 1141<br />

Holly, K, See Gutierrez, Aide<br />

Holm, J. See Hansen, S. I.<br />

Holmes, Earle W. See Clemens, John<br />

Holmes, Julia C. See Ball, Richard<br />

Bolt, David W. See Johnston, Atholl, 1236<br />

-; Johnston, Athoil, 1332<br />

Bolt, John A. See Russell, John C.; Zibrat,<br />

Steven J.<br />

Holtzman, Golde I. See Bernstein, Larry H.<br />

Holzberg, K. See Ponte, K.<br />

Holzberg, Koni A.; Sommer, M.; Moekaiski, %i<br />

B.; Fnitsche, E. T., 1104<br />

Honcharik, N. See Copeland, Kenneth<br />

Honda, T. See Matsuura, Tsuneaki<br />

Hong, X. Q.;Wong, M. M.; Pu, J. C., 1137<br />

Hood, I. See Cetomeris, Peter<br />

Hopkins, Marbry B., Ill See Hamilton, Robei<br />

W.<br />

Horenzy, M. J. See Peck, M.<br />

Hornick, Laurel J. See Lemann, Jacob, Jr.<br />

Horowits, Gary L See Yeo, Kiang-Teck; Yeo,<br />

Klang-Teck<br />

-; Austin, Theresa M.; Yeo, Kiang.Teck, 1128<br />

Hortin, G. L See Rosenblum, J. L<br />

Hortin, Glen L See Landt, Michael<br />

Hoshino, Yoshlyukl See Tsuchiya, Hironori<br />

Hosoda, K.; Kubota, T.; Hasegawa, R.;<br />

Wakabayashi, K., 1208<br />

-; Yamaji, ‘I’.; Baylink, D., 1208<br />

Hosseini, Jeanette M. See Elm, Ronald J.<br />

-; Yang, Xiu Ying; Elm, Ronald J., 1404<br />

Bouts, Robyn; Chung, B.; Ciucci, C.; Wood, J.;<br />

Delaurentis, M.; Valdez, J., 1167<br />

Howanltz, P. J.; Steindel, S. J.; Schifman, K. F<br />

Detweiler, G., 1160<br />

Howard, Katnina; Kane, Marian; Madden,<br />

Alden; Gosling, James P.; Fottrell, Patrick<br />

F., 2044<br />

Howard, P.; Jenny, R.; Church, W.; Tracy, R.,<br />

1161<br />

Howey, Jacqueline E. A. See Stolarek, Iwona<br />

Howie, A. Forbes See Beckett, Geoffrey J.<br />

Howrie, D. L See Crisan, Domnita<br />

Hsla, Karen See Spector, Stephen A.<br />

Hslao, Ray J. See O’Connor, Daniel T.<br />

Hsleh, C.-Y. See Pan, Jie<br />

Hslng, Ann W.; Comstock, George W.; Polk, B.<br />

Frank, 2145<br />

Hsu, J. See Freeman, J.<br />

Hsu, M. Y. See Sun, Lila<br />

Hsu, Po Choo; Domenici, Michael; Schulksnip,<br />

Kirk; Ballet, Neal; Chung, Bynng S.;<br />

DeLaurentis, Mark; Valdez, Johnny, 1141<br />

Han, S. See Keller, Charles H.<br />

Hen, Yu-Chu See Jeevenandem, Malayeppa<br />

Ba, M. See Freemen, J.<br />

Ru, Mae; Anne, L; Cohn, It.; Laungani, D.;<br />

Chan, K.; Gottwald, K.; Centofanti, J., 1164<br />

Huang, C. M.; Zweig, Mark, 125<br />

-; Kraft, H. G.; Gregg, It K., 1070<br />

-; Gregg. K. K., 1070, 1070<br />

-; Peck, G. L.; Chretien, P. B.; Ruddel, M.,.1OF<br />

Huang, H. M. See Wei, J. S.<br />

Huang, Tung-Ming See Donohue, Joseph<br />

Huang, W. T.; Cheng, M. H.; Wong, H. T.;<br />

Lipsey, A. I., 1183<br />

Huang, W. Y. See Cheng, Mary H.<br />

Hubbard, Elizabeth See Mifflin, Theodore E.<br />

Huchital, Michael See Kish, Linde; Sciotto-<br />

Brown, Susan; Zimmermann, Linde<br />

Hudson, C. See Weingand, Kurt<br />

Hudson, T. See Klukas, C.; Leonard, H.<br />

Huff, Dan L See Gunter, Elaine W.<br />

Huff, Daniel See Persona, Patrick J.<br />

Hughes, B. See Liffxnan, S.<br />

Hughes, J.; Weston, S.; Montague, D.; Summei<br />

M.; Shepherd, H.; Shepherd, B., 1149<br />

Hughes, J. I. See Shahangian, S.<br />

Hughes, John I. See Shehangian, Shahram<br />

Huguet, J.; Fuentes-Ardeniu, X.; Ferre, C., 1264<br />

Hulanicki, Adam See Lewandoweki, Ryszsrd<br />

Hnhm.rn., W. C. See Maceani, F.<br />

Huinbert, H. See Vernillet, L.<br />

Hume, Robert See Beckett, Geoffrey J.<br />

Hunkapiller, MW. See McBride, L J.<br />

Hunter,<br />

Hunrell,<br />

Thomas<br />

Yumlna;<br />

See Mabmood, Nishat<br />

Spiehler. Vine, 1175


sken, Brigitta C. P. See Leeuwenkamp.<br />

Oscar K.<br />

isey, A. J. See Beckett, G. J.<br />

isey, Amanda J. See Beckett, Geoffrey J.<br />

ehens, T. William; Henry, Joseph F.; Yip,<br />

Tei.Tung, 1928<br />

Lchlns, S. W. See Cheng, Mary H.<br />

Ichison, A. See Chubb, S. A. P.; McConway,<br />

M. G.<br />

ichison, James S. See Zabnadnik, Richard<br />

Lteu, P. See Eble, K. S.<br />

ang, D. See Bianca, Carol<br />

‘ang, N. See Phillips, E.<br />

e, J. K See toeefsohn, Mariet<br />

in, John E.; Soldin, S. J., 1167<br />

an, Jayson, 1083,1086<br />

nez, J. See Lucas, F.<br />

Jonathan K. See Burgess-Cassler, Anthony<br />

ku, Y. See Sorin, T.<br />

i,M. See Nekamure, Masekazu<br />

ma, Kenji See Fukuda, Chiseko<br />

ma, S. See Cho, Hiroko<br />

ama, K. See Mizuochi, E.<br />

ao,V. See Fox, Martha; Millsap, Susan<br />

y, P. See Reddy, Padala V.<br />

ii, Hirokazu See Wekui, Hideki<br />

emura, Shigeyukl; Hirayama, Toshieki; Arai,<br />

Tomiko; Tekso, Kyoji; Miseki, Hideo, 1126<br />

penio, N. See Bark, Lee<br />

ar, 8. See Ackermann, H.; Blackwood, J.;<br />

Grenner, G.; Padilla, A.; Steedter, M.<br />

lniksons, Andris; Schwartz, Joyce, G., 899<br />

ass, Koger; Hollander, Lori; Thut, Laurel;<br />

Picone, Teresa; Pflager, Ceroi, Zoccohi, Mike;<br />

Worthy, Tom, 1191<br />

tee, D. J. See Hewitt, C. D.<br />

nnou, Pinelopi C.; Konstentianos, Dimitrios<br />

G., 1492<br />

efsohn, Mariet; Rifai, N.; Hyde, J. E.; Soldin,<br />

S. J., 1156<br />

Soldin, S. J.; Hicks, J. M., 1168<br />

ce, H., Jr. See Ostrow, D. H.<br />

Hisami See Matsumoto, Kojiro<br />

as, Julian J. See Cheng, K. Steve<br />

ih, Glenn K. See Snyder, Andrew M.<br />

Madden, Thomas M.; Snyder, Thomas D.;<br />

Snyder. Andrew M., 1196<br />

ala, Kerttu See Koekinen, Pertti<br />

ksson, A. See Keller, Charles H.<br />

ibashi, Shun; Yemada, Nobuhiro; Shimeno,<br />

Hitoshi; Tekaku, Fumimaro; Akanuma,<br />

Yasuo; Munese, Toshio, 808<br />

Ida, Osamu; Kihire, Koji; Tsukamoto,<br />

Yusuke; Marumo, Fumiaki, 127<br />

ii, S.; Day, K.; Newton, M.; Hall, K., 1097<br />

imorl, Yoahio; Koyama, M.; Rokugewe, K.;<br />

Motoda, S.; Mateuda, H., 1204<br />

Izaki, Takashi See Echizen, Hirotosbi<br />

I, Akira See Nakashijna, Koji<br />

iii, S. M. See Abu-Fersakh, F. A.<br />

no, Masashi See Burnett, Robert W.<br />

h, Hideaki See Wakui, Hideki<br />

h, Roichi See Echizen, Hirotoshi<br />

kawa, Yoshinoni See Matsude, Akihiko<br />

e,W. Michael See Russell, John C.<br />

eta, Hisashi See Gotoh, Hiroshi<br />

eta, Jihel; Suga, Tetuya, 794<br />

mbart, M.; Sale, M.; Baldet, L;<br />

Schiuniberger, hi.; Deltour, G., 2137<br />

lonsky, George See Galbraith, Linda V.;<br />

Leung, Fred Y.<br />

k, Khona See Rettmer, Rebecca L<br />

*son,<br />

kson,<br />

J. See Shihabi, Z.<br />

J. S. See Kusilek, Lees D.<br />

kson, Jean See Brasheer, Jeff<br />

kson, Kathryn See Jenny, Richard W.<br />

kson, S. See Ryder, K.<br />

rfe, Allan S. See Eisenberg, Paul R.<br />

gods, E. See Reins, A.; Tsey, H.<br />

Tsay, H.; Mantha, S.; Ogan, M.; Stouffer, B.;<br />

Raise, A.; Turebi, N.; Tu, J.; Eckelman, W.<br />

C., 1189<br />

n, C. See Schinitz, J.<br />

n, Chandra See Navazi, Weleska<br />

ii, Narish See Spiehier, Vine<br />

kobi, Peter<br />

let, Pierre<br />

See Knivoy, Norberto<br />

See Perdrisot, Remy<br />

nani, Azim; Pudek, Morris; Schreiber,<br />

Wffliam K., 471<br />

nbou, Robert C. See Snouwaert,<br />

flies, S. K. See Phillipou, G.<br />

John N.<br />

nes, Steve K. See Phiffipou, George<br />

flatsch, G. See Knuse-Jarres, J. D.<br />

sdreski, Mark A.; Bermes, Edward W.;<br />

Leischner, Relph; Kahn, Stephen E., 1547<br />

netschek, Kobert J., 1089<br />

flsen, M. J. H. See Elving, L D.<br />

n, Piet C. W. See Giesen, Peter It. A.<br />

Jansson, Jan-Hakan; Norberg, Bo; Nilsson,<br />

Torbjorn K., 1544<br />

Janason, Svante See Lundberg, Per-Arne<br />

January, W. See Beshem, Julie E,<br />

Janulis, Lynn See Breshear, Jeff<br />

Janus, E. D. See Carter, G.<br />

Jarausch, J.; Lehmann, P.; Rietz, P., 1098<br />

Jardei, Main See Feldmann, Delphine<br />

Jauneau, Monique See Vernet, Michehe<br />

Jawad, J. See Fitzgerald, D.<br />

Jaynes, PatrIck, 1240<br />

Jeevansndsm, Malayappa; Hsu, Yu-Chu;<br />

Remiss, Lois; Schiller, William It, 2228<br />

Jeffcoate, S. L See Pearce, S.<br />

Jenkins, M. See Gates, Teresa; Gault, M. H.<br />

Jennings, T. See Van Brunt, N.<br />

Jenny, K. See Howard, P.<br />

Jenny, Richard W,; Jackson, Kathryn, 1184<br />

Jensen, Mogens Krogh See Rasmussen,<br />

Karsten<br />

Jerome, H. See Cheng, C.<br />

Jespersen, Bente See Engbaek, Frode<br />

Jespersen, Jorgen See Gram, Jorgen<br />

Jessen, K. H.; Killeen, A. A.; Bowers, L D., 1142<br />

Jeweil, Sandra B.; Slazyk, William J.; Smith, S.<br />

Jay; Hannon, W. Harry, 1701<br />

Jeyasinghem, M.D.; Pratt, 0. E.; Rooprai, H.<br />

K., 2129<br />

Johsnsen, Jon J. See Burgess-Cessler, Anthony<br />

Johanson, N. See Lee, Sung C.<br />

Johsnsson, Pie-Marie See Lindstedt, Goran<br />

Johno, Ikuo See Ohshima, Taeyuki<br />

Johnson, A. Myron See Ledue, Thomas B.<br />

Johnson, Andrew Myron; Ritchie, Robert F.;<br />

Ledue, Thomas B., 1268<br />

Johnson, Andrew W. See Rosslki, Sidney B.<br />

Johnson, Catherine See Skogerboe, Kristen J.<br />

Johnson, D. See Gault, M. H.<br />

Johnson, E. See Gault, M. H.<br />

Johnson, G. F. See Nuwayhid, N. F.<br />

Johnson, George F. See Nuweyhid, Naziha F.;<br />

Punzalan, Rubio It; Smith, Karen<br />

Johnson, J. See Morin, Leo G.<br />

Johnson, J. T. See Neisler, H. M.; Panteghini,<br />

Mauro<br />

Johnson, James K See Morn, Leo G.<br />

Johnson, K. See Bray, Kurtie It<br />

Johnson, L K. See Gallagher, S. K.<br />

Johnson, Pam M. See Perkins, Sherry L.<br />

Johnson, Paul W. See Attia, John<br />

Johnston, Atholl See Holt, David W.<br />

-; Marsden, Joanne T.; Holt, David W., 1309<br />

Johnston, D. See Lucas, F.<br />

Johnston, Dennis A. See Shahanjian. Shehram<br />

Johnston, Sue See Clark, Larry W.<br />

Jolley, Michael B., 1239<br />

Jones, A. W.; Jonsson, K-A; Jorfeldt, It., 400<br />

Jones, Carolee See Leeder, Sydney<br />

Jones, Christopher B.; Wians, Frank H., Jr.;<br />

Martinez, Luis A.; Merritt, Gerald J., 1394<br />

Jones, James D. See Creer, Michael H.<br />

Jones, Karen J., 1174<br />

Jones, Lovell See Hankinson, Susan E,<br />

Jones, S. K. See Dominiczak, Marek<br />

Jones, S. K. See Ratclffe, W. A.<br />

Jones, Wayne See Falkensson, Marianne<br />

Jonsson, K-A See Jones, A. W.<br />

Jonza, J. See Kubasik, N. P.; Thompson, F.<br />

Jordan, N.M. See Silver, M. K.<br />

Jordening, H. See Wandrup, Jesper<br />

Jorfeldt, L See Jones, A. W.<br />

Joseph, K. See Kropf, J.<br />

Joseph, R. See Phillips, E.; Sibilie, R.<br />

Joukyuu, Ritsuko; Mizuno, Shigeki; Amakawa,<br />

Tsutomu; Tsukeds, Toshihiko; Nishima,<br />

Toshihir Kitemura, Motoshi, 687<br />

Joustra, M.; Nilsson, Ingegerd, 1109<br />

Jove, M. See Doria, Manuel, Jr.<br />

Joven, J.; Vilelle, E.; Costa, B.; Turner,<br />

Richart, C.; Mesana, L., 813<br />

P.R.;<br />

Juan-Pereira, L; Fuentes-Ardeniu, 1544<br />

Jung,<br />

-; Pergande,<br />

Klaus; Nickel,<br />

Monika;<br />

Erika, 336<br />

Klotzek, Silke, 1955<br />

-; Bnien, Gerald; Kirschner, Peter; Schroder,<br />

Kersten; Schmiedel, Thomas, 2000<br />

Juste, Patrick See Klotzsch, Signid<br />

Kadijevic, Lilly See Allen, It. C.<br />

Kafonek, Stephanie; Bechorik, Paul S.;<br />

Kwiterovich, Peter 0., Jr., 380<br />

Kahsn, J. See Wellinder, H.<br />

Kahn, Sidney N., 508<br />

Kahn, Stephen E. See Jandreski, Mark A.<br />

Kahhan, Satish C. See Shoup, Vernon A.<br />

KaHn. Marcia F. See Novick, David M.<br />

Kallner,<br />

Kalpazis,<br />

Anders, 1803<br />

Dimitnios L See Giannoulaki,<br />

Elefteria E.<br />

-; Giennoulaki, Elefteria E., 844<br />

Kaira, J.; Chaudhary, A. K.; Massey, K. L.;<br />

Prasad,K., 1137<br />

Kaira, Krishan<br />

Kzm.tak*nnzn,<br />

See BIde, Dennis<br />

Vedhachalam See Bleile,<br />

Dennis<br />

Kambli, Vijaykant B.; D’Amato, David;<br />

Reynoso, Gustavo, 1156<br />

Kammerer, K. C. See Lopez, C.<br />

Kamoun, P. See Chadefaux, B.; Parvy, P.<br />

-; Rabier, D., 1267<br />

Kampa, logo 5., 1165<br />

Kamst, T. W. See Cham, B. E.<br />

Ran, Brenda See Rigault, Marie Y.<br />

-; Freier, C., 1082<br />

Kanba, Shigenobu See Matsumoto, Kojiro<br />

Kane, Marlan See Howard, Katrine<br />

Kaneda, N. See Watszu, V.<br />

Rang, Sam See Anne, Lakshmi<br />

Kanno, Takashi See Azuma, Yutaro; Maekawa,<br />

Maseto<br />

Kao, Pal See Klee, George<br />

Kao, Pal C. See Hage, David S.<br />

Kapadia, P. See Petersen, J. It<br />

Kaplan, J. C. See Orsuisk, P. J.<br />

Kaplan, Lawrence A. See Hankinson, Susan E.;<br />

Russell, John C.; Stain, Even A.<br />

Miller, Judith A.; Stampfer, Meir; Romieu,<br />

Isebelle; Stein, Evan A.. 1114<br />

Kaplan, M. See Kusilek, Less D.<br />

Kapmeyer, W. See Metzmann, E.<br />

Kapmeyer, Wolfgang H.; Metzmann, Erwin,<br />

1092, 1092<br />

Kapsalls, A. See Scheffel, J.<br />

Kapur, Bhushan M.; Banks, Tibor, 1185<br />

Kapyaho, Kirsti See Svens, Elvor<br />

Karadi, Iatvan; Romics, Laszlo; Pals, Gabor;<br />

Doman, Jozsef; Kaszss, lions; Hesz, Arpad;<br />

Kostner, Gerhard hi., 2121<br />

Karasawa, Kouji See Shoji, Shin’ichi<br />

Karcher, K. See Elkhalife, Mohamed; Sloan,<br />

Chris<br />

Karcher, Raymond; Scharer, K.; Epstein, E.;<br />

Kiechle, F. L., 1124<br />

Karcher, Raymond B. See Scharer, Katharine<br />

A.<br />

Range, W. H.; Weiner, E. J.; Rogers, E. J.;<br />

Nicolosi, It J., 1790<br />

Karl, Johann; Kerscher, It.; Engel, W. D.;<br />

Ziegenhorn, J., 1067<br />

Karisson, Lisa See Bergqvist. Yngve<br />

Karmen, Arthur See Murthy, Vadiraja V.<br />

Kars, Ay.e See Copur, Sitki<br />

Karuza, Jurgis See Katz, Paul It<br />

Kasemsn, Deborah; Stamy, K.; Fields, S.;<br />

Usategui-Gomez, M.; Reilley, T.; Kaufman,<br />

R.A.,1121<br />

Chang, J.; Wenk-Salamone, K.; Fischberg, E.;<br />

Usatagui-Gomez, M.; Kaufman, It A., 1121<br />

Kassapian, S. J. See AuBuchon, J. P.<br />

Kaszas, Hona See Karadi, Istvan<br />

Kataoka, Mikiko See Matsuda, Akihiko<br />

Ratayama, Katsuhiro See Kuroiwa,<br />

Kate, Kanefusa See Usui, Akihiko<br />

Katsumasa<br />

Katoh, Kazuo See Yabuuchi, Masehiko<br />

Katz, Paul K.; Gutman, Steven I.; Richmen,<br />

Gary Karuza, Jurgis; Bartholomew, William<br />

R.; Baum, John, 466<br />

Katz, Paula See Zoccol, Michael A.<br />

Katzn,znn, Jerry A. See DeMars, Daniel D.<br />

Kaufman, J. See Villa, Barbara<br />

Kaufman, K. A. See Awdziej, Tame N.; Cheng,<br />

C.; Ferrenkopf, Bruce C.; Ksseman,<br />

Deborah; Keihley, Therese; Rosenfield,<br />

Henry- Zaunczkoswki, Denise<br />

Kaufman, Seymor See Fuchs, Dietmar<br />

Kawajiri, Yoshiko See Yoshioka, Shinichi<br />

Kawamura, Kenya<br />

Kazmlerczak, S.C.<br />

See Mon. Mikio<br />

See Castellani, William J.;<br />

Van Lente, F.<br />

-; Castellani, W. J.; Denton, E. E., 1106<br />

Kazmierczak, Steven C. See Rosalki, Sidney B.<br />

Van Lente, Frederick, 251<br />

Ke, Shu-Wen See Fan, Der-Fon<br />

Keefe, M. It See Rosenthal, Phihp<br />

Keenan, Edward J. See Corbin, Debra K.<br />

Keevan, James See Donohue, Joseph<br />

Keir, Geoffrey See Luxton, Richard W.<br />

Keith, Tim See Green, Philip<br />

Kelier, Charles H.; Fries, P.; Kline, E.; Kucera,<br />

K.; Hsu, S.; Isaksson, A.; Neider, K., 1142<br />

Keller, H. See Baadenhuijsen, H.<br />

Keller, H.P. See Vernillet, L<br />

Keller, Herbert See Bais, Renze<br />

Kelly, A. See McIntosh, S. J.<br />

Kelly, Christine A. See Cembrowski, George S.<br />

Kelner, Michael J. See Roberts, Randall T.<br />

Kendrick, Nancy C. See Burgess-Cessler,<br />

Anthony<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2351


Keniston, IL See Enriquez, John I., Sr.<br />

Kennedy, Annette See Prabhaksran, Victor M.<br />

Kennedy, K. Lee; Grifliths, Huw; Gray, T. A.,<br />

1882<br />

Kenney, J. T.; Orsulek, P. J.; Kolodner, K. M.;<br />

Burton, M. E., 2134<br />

Kenny, M. See Bennett, H. J.<br />

Kenny. Margaret, 1241<br />

Kenny, Margaret A. See Malik, Sohail<br />

Kenny, Terry See Swenson, J. Robert<br />

Kent, S. See Hardy, Robert<br />

Keren, David F. See Bush, Donna M.; Register,<br />

Loretts J.<br />

Kerscher, L. See Karl, Johann<br />

Kessler, Anne-Ch.; Griesser, H. W.; Willnow, P.;<br />

Kueppers,R., 1141<br />

Kessler, G. See Butch, A.<br />

Kessler, Gerald See Butch, Anthony W.<br />

Kessler, Jay; Warlck-Yates, Kathy; Bowen,<br />

Bets, 1097<br />

Kessner, Art See Navazi, Waleske<br />

Keatner, J. See Cseko, G.<br />

Kestner, Jane See Csako, Gyorgy<br />

Ketchum, Catherine H. See Russell, John C.<br />

Kettler, Thomas See Hennan, Charles J., Jr.<br />

Keymolen, V. See Body, J. J.<br />

Key.er, H. See Petersen, J. It<br />

Khadempour, M. Hassan; Ofulue, A. Felix;<br />

Thurlbeck, William M., 1150<br />

Khan, S. See Petersen, J. K.<br />

Khsn, Shaista; Damoderan, K.; Diaz, It,<br />

Khsakhntan, N. K. See Krause, J. S.<br />

1198<br />

Khanna, Pyare See Klonizcbii, Walt; Zoccoli,<br />

Michael A.<br />

Khayam-Bashl, H. See Chen, Katherine; Gross,<br />

Susan F.<br />

Khayani-Bashl, Hsssan; Gerard, S.; Bagineki,<br />

P.; Hellerstein, M.; Chen, K., 1136<br />

Khazanle,<br />

lCh.v.-ie,<br />

P. See Castellani, William J.<br />

Prabhsker; Sinhe, Madhur; Caro,<br />

Jose; Silverman, Jan F.; Castellani, W. J.,<br />

1146<br />

Khosravl, M. J. See Diamandis, E. P.; Tan, A.<br />

-; Diemandis, E. P., 181<br />

-; Diamandis, E. P., 1138<br />

-; Sudsbuzy, It, 2251<br />

Khosravl, Mohammad J. See Diamandis,<br />

Eleftherios P.<br />

Khurl, Shuknl F. See Lum, Gifford<br />

Klsng, W.; Mimme, L.; Swenson, S.; Floreani,<br />

M., 1090<br />

Kiechle, F. L See Elkhalife, Mohamed; Karcher,<br />

Raymond; Sloan, Chris<br />

Kiechle, Frederick L See Scharer, Katharine<br />

A.<br />

Kiefer, Charles K. See Moecoso, Hugo<br />

Kihira, Koji See Ishida, Osamu<br />

Kilbeeney, J. See Wang, TanJang<br />

Khhleen, A. A. See Jessen, B. H.<br />

-;Orr,H.T., 1075<br />

Kllroe-Smith, Terence A. See Geillard, M.<br />

Christine<br />

Kim, Sook-Chia See Nandedksr, Arvind K. N.<br />

Kimlinger, Terry K. See Dehiars, Daniel D.<br />

Kimura, Mieko See Mateude, Akihiko<br />

Kimura, Motoko See Tameki, Haruo<br />

Kindt, E. See Heriharen, hi.<br />

King, Brenda See Chou, Peter P.; Longhurst,<br />

Sharon<br />

King, David L; Gabor, Michael J.; Martel,<br />

Patricia A.; O’Donnell, C. Michael, 163<br />

King, J. S., 198, 344, 517, 715,905, 1271, 1565,<br />

1812, 2023, 2161, 2259, 2340<br />

Klnter, Michael See Herold, David A.<br />

Kir, Sedef See Torun, Meral<br />

Kirchick, H. J. See Chin, Bruce G.<br />

Kirk, Elaine<br />

Kirkpatrick,<br />

M.; Fell, Anthony F., 1288<br />

Peter P. See Bowie, Lemuel J.<br />

Kirschner, Peter See Jung, Klaus<br />

Kish, Linda; Lin, Yuh-Nan; Huchitel, Michael;<br />

Solan, Vishnu; Sheiman, Mark; Dunks,<br />

Louis, Jr., 1172<br />

Kissinger, Peter T., 1240<br />

Kitamura, Motoshi See Joukyuu, Riteuko<br />

Kitszawa, Shikifumi See Ohahima, Taeyuki<br />

Kiasa, Michael See Fox, J. Lawrence<br />

Klaus, Eric M.; McComb, Robert B., 2158<br />

KIss, G. See Converse, Joan<br />

Kiss, G. G.; Preissner, C. M.; Hinz, V.S., 1147<br />

Kiss, George; Preiesner, Carol; Schryver,<br />

Patricia; Taylor, Robert; Kao, Psi, 1147<br />

Klee, George G.; Post, Gregory, 1362<br />

Klein, G. See Rizzotti, P.<br />

Bodenmuiler, H.; Gerber, M., 1089<br />

Kline, B. See Keller, Charles H.<br />

Kline, Michael<br />

Kloepter, Hans<br />

J. See Muffin, Theodore<br />

See Warnick, G. Russell<br />

E.<br />

2352 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />

Kionizchil, Walt; Barendice, Rob; Hollander,<br />

Lori; Worthy, Tom, 1141<br />

-; Khenna, Pyare, 1171<br />

Klotzek, Silke See Jung, Klaus<br />

Klotmch, S. See Levy, S.<br />

Klotzsch, Sigrid; Hemams, Bert; Juste, Patrick,<br />

1105<br />

Klukas, C. See Leonard, H.<br />

-; Comerci, C.; Campbell, J.; Hudson, T.;<br />

Williems, M.; Berg, M.; Kozel, P., 1194<br />

Knapp, S. See Gammon, Allison<br />

Knedel, M. See Beadenhuijeen, H.<br />

Knepil, Janusz; McPhillips, Mary, 181<br />

Knight, George J.; Palomaki, Glenn E.; Lee,<br />

Dale H.; Haddow, James E., 1036<br />

Knight,<br />

Knight,<br />

J. A. See Crockett, Harold<br />

William See Wang, Hamm-Ping<br />

Knowles, M. See Highamith, W. E.<br />

Knox, James D. E. See Fraser, Callum G.<br />

Koay, E. S.C. See Aw, T. C.<br />

Kobayeshi, lsao; Amemiya, Norihiko; Endo,<br />

Takeshi; Okuyama, Kohji; Tamura, Kohji;<br />

Kume, Shoji, 1644<br />

Kobayashi, Kunlo; Ogasehara, Naomi;<br />

Sskoguchi, Takafumi; Taniuchi, Koji;<br />

Metsuoka, Akira, 177<br />

Kobayashi, Ryoji See Wakui, Hideki<br />

Koch, D. D. See Pauley, Scott D.<br />

Koch, David D. See Begneski, Kim; Larsen,<br />

Sandra; Tee, Martina<br />

Koch, Thomas IL See Akimgbe, Olumide 0.;<br />

Duh, Show-Hong<br />

-; Akimgbe, Olumide 0.; Neelkantan, N. V.;<br />

Vickery, D. K.; Naccarato, W. F., 1145<br />

-; Platoff, Gennady E., 1182<br />

Koch, W. See Kus, Debra hi.<br />

Koda, Naoya See Yamegucbi, Shuichi<br />

Koenig, J. See Butch, A.<br />

Koenig, John W. See Wolf, Bryan A.<br />

Koepf, S. M. See McBride, L. J.<br />

Koev, D. J. See Angelova-Gateve, P.<br />

Koffl, Agnes See Macart, Michel<br />

Koh, T. See Ruiz, Eliseo<br />

Koh, Tung; Ruiz, E.; Edwards, K., 1084<br />

Kohen, Fortune See Bernard, Geoff;<br />

Strasburger, Christien<br />

Kohl, HH; Tsai, LL; Uhn, J; Miller, DL, 1077<br />

Kohno, H. See Sorin, T.<br />

Koivisto, Velkko See Suhonen, Lauri<br />

Kolberg, Janice See Urdea, Mickey S.<br />

Koiler, D. E. See Zarembka, F. It<br />

Koller, P. U.. 186<br />

Roller, Peter U. See Baja, Renze<br />

Kolodner, K. M. See Kenney, J. T.<br />

Komachi, Y. See Nekemura, Masakazu<br />

Komiyania, Atsuahi See Shoji, Shin’ichi<br />

Konaka, Kyusei See Abe, Kenji<br />

Konings, C. H. See van Heeften, T. W.<br />

Konishi, M. See Nakamura, Masakezu<br />

Konno, Nonimichi; Hirokawe, Jumichi; Tsuji,<br />

Mesehiro; Hegiwara, Kohji; Taguchi, Hideo;<br />

Murakami, Shigeki; Teguchi, Shizuko, 159<br />

Konrath, J. G.; Manderino, G. L.; Przywara, L.<br />

W.; Elliott, K. L., 1078<br />

Konstantisnos, Dimitnios G. See Ioannou,<br />

Pinelopi C.<br />

Konstantinides, Frank N.; Mitchell, D. It;<br />

Bixby, B..; Singh, It K.; Li, J. C.; Cerra, F. B.,<br />

178<br />

Koottathep,<br />

Kopinaki,<br />

S. See Singksmani, It<br />

W. S. See Bayliss, Katherine<br />

Konchak, S. See Ball, D. J.; Bashem, Julie E.<br />

Korley, Victoria See Tagari, Philip<br />

Koskinen, Pertti; lrjala. Kerttu, 327<br />

Kost, Gerald J. See Wiese. David A., 1232<br />

Kostner, Gerhard M. See Karadi, Ietvan<br />

Kothari, Kanchan; Sivaprased, N.; Mani, It S.,<br />

701<br />

Kowaiski, A. See Cbiamg, C. S.<br />

Kowarski, Avinosm See Strasburger, Christian<br />

Koyama, M. See Ishimori, Yoshio<br />

Kozel, P. See Klukas, C.; Leonard, H.<br />

Kraft, H. G. See Huang, C. M.<br />

Krahn, John See Askew, Gord; Prosser, Connie<br />

Kramer, Alexander See Fuchs, Dietmar<br />

Kramer, Fred Russell See Lomeli, Hilda<br />

Kramer, Tim See Hassemer, David J.<br />

Kramp, W. J.; Nevill, J. It.; McCusker, L. M.;<br />

Larsen, F. It., 1194<br />

Kratzer, M. See 1-Isgele, E. 0.<br />

Krause, J. S.; Khankhamian, N. K., 494<br />

Krauza, C. See Leaky, Fred D.<br />

Kress, Barry C.; Frank, Kathy; Leverett,<br />

Lenore; Norton, Kurt; Sweet, Michael, 1197<br />

Krlcka, L J. See Bronstein, I.; Thorpe, G. H. G.;<br />

Voyta, J. C.<br />

Krlcka, Larry J.; Erickson, Katherine; Wilding,<br />

Peter, 1065<br />

-; Erickson, Katherine; Mullen, James; Wildini<br />

Peter, 1112, 1239<br />

Krivoy, Norberto; Jakobi, Peter; Weissman,<br />

Amir; Zimmer, Eten Z., 192<br />

-; Jakobi, Peter, 895<br />

Kroil, M. H. See Emancipator, K.<br />

-; Chesler, K., 1066<br />

Kroll, Martin H.; Chesler, Ruth; Ekin, Ronald<br />

J., 1523<br />

Kronfol, Z. See Hariharan, M.<br />

Kronlck, MN. See McBride, It. J.<br />

Kropf, J.; Gressner, A. M.; Joseph, K., 1540<br />

Marx, A. hi.; Gressner, A. M., 2144<br />

Krouwer, Jan S. See Crosby, Lisa E.; Schlain,<br />

Brian, 901<br />

Kruse-Jarnes, J. D.; Janatach, G.; Glees, U.;<br />

Msrbsch, It; Heise, H. M., 1854<br />

Krystal, Gerald; Lam, Vivian; Schreiber,<br />

William E., 860<br />

Krzymow.ki, GA.; Valcour, A. A.; Onoroski,<br />

M.; McComb, It M.; Bowers, G. N., Jr., 111<br />

Ku, Che-An; Lentrichia, Brian B.; Solan,<br />

Vishnu; Sheiman, Mark I.; Dunks, Louis, Ji<br />

1171<br />

Kubasik, N. See Peck, M.; Thompson, F.<br />

Kubasik, N. P.; Cordy, P. A.; Murray, C.; Maye<br />

T. K.; D’Souza, J. P., 1107<br />

-; Cordy, P.; Jonza, J.; Mayer, T.; D’Souze, J.,<br />

1108<br />

-; Xander, S. A.; Coppola, J.; Mayer, T. K.;<br />

D’Souza, J. P., 1125<br />

-; Cordy, P. A.; Meyer, T. K.; D’Souza, J. P.,<br />

1125<br />

Kubo, Hiroeki See Matsumoto, Kojiro<br />

Kubota, T. See Hosoda, K.<br />

Kucera, K. See Keller, Charles H.<br />

Kueck, B. D. See Bayliss, Katherine<br />

Kueppers, K. See Kessler, Anne-Ch.<br />

Kuhlman, J. See Vasiliades, John<br />

Kulig, K. See Sinh, J.; Singh, Jagat<br />

Kulig, Kim See Smgh, J.<br />

Kuine, Shoji See Kobeyashi, Isao<br />

Kunkel, Louis M.; Beggs, Alan H.; Hoffman,<br />

Eric P., B21<br />

Kuo, Cheng-Deng; Wu, Wen-Guey; Wang, Jia-<br />

Horng; Chen, Shu-Mai; Chiemg, Benjamin<br />

N., 667<br />

Kupferschmidt, Reinhard See Schmid, Raine<br />

-; Schmid, Rainer W., 1313<br />

Kurata, K. See Mizuochi, E.<br />

Kunoiwa, Katsumasa; Katayame, Kateuhiro;<br />

Miura, Toshihide; Nagasawa, Takeshi;<br />

Ohsawa, Susumu; Yoshida, Toshihiko;<br />

Furuya, Shin, 1117<br />

-; Neketsuyama. Shuichi; Kateyame, Keteuhii<br />

Nagasewa, Tekeahi, 2169<br />

Kurschinski, Douglas T.; Dennen, David A.;<br />

Garcia, Merle, Scamu, Angelo M., 2156<br />

Kurtz, K. See Smith, Carol<br />

Kus, Debra M.; Miller, B..; Bowers, G. N., Jr.;<br />

Koch,W., 1130<br />

Kus, Sezal See Copur, Sitki<br />

Kusilek, Lesa D.; Jackson, J. S.; Kaplan, hi.;<br />

Elson, M.; Heinzerling, K. H., 1191<br />

Kutnink, Mark A. See Burn, Betty Jane<br />

Kuwabara, Yoshiko See Azuma, Yutaro<br />

Kuwana, Tomomi; Sugita, Osamu; Yakata,<br />

Minoru, 179<br />

Kwant, G.; Oeseburg, B.; Zijlstra, W. G., 773<br />

Kwant, Gerard See Oeseburj, Berend<br />

Kwiterovich, P. See Cloey, Teresa<br />

Kwlterovich, Peter 0., Jr. See Kafonek,<br />

Stephanie<br />

Kyeyune-Nyombi, Era See Farley, John R.<br />

Kyler, Mary Kay See Lott, John A.<br />

Laarakkers, C. See de Jong, J. G. N.<br />

Labbe, Robert F. See Rettmer, Rebecca L.;<br />

Skogerboe, Kristen J.<br />

Labeur, C.; Michiels, G.; Bury, J.; Usher, D. C.;<br />

Kosseneu, hi., 1380<br />

Lacher, D. A., 330<br />

Lachman, Mary F.; Romeo, K.; hicComb, K. il<br />

499<br />

Lacour, B. See Duval, F.<br />

Laczkovlc, Axel See Fridrich, Leo<br />

Ladd, Don See Leeder, Sydney<br />

Ladenson, J. H. See Silva, D. P., Jr.<br />

Ladenaon, Jack H. See Lendt, Yvonne; Olesen<br />

Hennik; Scott, Mitchell G., 904<br />

Ladouceur, P. See Muirhead, C.<br />

Ledouceur, Pete See Roberts, Pamela<br />

Leessig, Konald; Ehrmeyer, S.; Lanphesr, B.;<br />

Hill, B.; Hassemer, D., 1088<br />

LaFontaine, George See Hansen, Hans J.<br />

Lame, Seppo See Peavonen, Jorma<br />

Laine-Cessec, P.; Turcant, A.; Allain, P., 77<br />

Laing, Ian See Beckett, Geoffrey J.<br />

Lake, Mitcheil S.; Ruby, Stephen G., 1067


alouel, Jean-Marc See Wu, Lily L.<br />

alouel, J.-M. See Wu, Lily L.<br />

am, Christopher Wai Kel See Chui, Shiu Hon<br />

em,K. W. See Fu, J. C.<br />

am, Vivian See Krystal, Gerald<br />

am, X. See Cornelison, L<br />

amb, S. V. See Reimers, T. J.<br />

ambert, A. See Bernard, A. M.<br />

ambert, Willy B.; Yousef, Mohammed A.; Van<br />

Liedekerke, Beatrijs M.; De Rooee, Joseph<br />

Be Leenheer, Andre P., 298<br />

-; Vanneste, Lutgert; De Leenheer, Andre P.;<br />

Amedee-Menesme, Ohvier, 671<br />

imberts, Ludwig V. See D’Haese, Patrick C.<br />

ambin, Patrick See Lefrere, Jean-Jacques<br />

ambrecht, Kristen K. See Cembrowski,<br />

George S.<br />

siemens, M. See Deti, Frenceeco<br />

mndicho, Del See MaUl, Soheil<br />

andmark, Knud See Urdel, Petter<br />

sndt, M. See Roeenblum, J. L.<br />

sndt, Michael; Hortin, Glen L; Smith, Carl H.,<br />

889<br />

sndt, Y. See Sllva, D. P., Jr.<br />

sndt, Yvonne; Valdys, Hemant C.; Porter,<br />

Sharon E.; Dietzler, David N.; Ledenson,<br />

Jack H., 985<br />

engan, C. E. See Watson, I. D.<br />

ington, B. See Gannon, Allison<br />

lngton, Simon K. See O’Leary, Thomas Denis<br />

snphear, B. See Lsessig, Ronald<br />

so, T. See Cheung, C. K.<br />

argilliere, Claude See Fontaine, Monique<br />

ersen,<br />

men,<br />

F. L See Kramp, W. J.<br />

Sandra; Frank, Alison; Dehike, Lisa;<br />

Koch, David D., 1100<br />

Lease See Nelson, Nine, Ohman, Stan<br />

ash, J. M. See Ward, Kory M.<br />

asky, F. D.; Zapoticznyj, W.; Gaas, T.;<br />

DeNicola, D., 1134<br />

esky, Fred D.; Arter, T.; Connelly, L; Hassett,<br />

J.; Kreuza, C.; Warren, K.; Wrenberg, A.,<br />

1132<br />

atner, Barry P.; Sksle, Jeffery S.; Burns,<br />

Weshing#{231}on, 1965<br />

Cu, Brad W. C. See Creer, Michael H.<br />

su, H.P. See Neelkantan, N. V.; Zohe, Steven<br />

J.<br />

su, H. Philip; Miller, Warren K.; Hansen, JosI<br />

B.; Bollin, Ernest, Jr., 1860<br />

euderdele, V.; Clark, P.; Roszak, D.; Wong, B.,<br />

1075<br />

eungani, D. See Hu, Mae<br />

iutz, H. U. See Oellerich, Michael<br />

euwerya, iLK. See Bernard, A. hi.<br />

ew, W. T. See Fitzpatrick, D. A.; Silver, M. It<br />

Iwson, G. J. See Quigley, hi. It<br />

lyte, K. See Moore, P.<br />

ea, Dale H. See Knight, George J.<br />

each, J. A. See Badcock, N. It<br />

eal-Khouri, Susana See Lum, Gifford<br />

eavltt, Lynda F. See Ledue, Thomas<br />

Bigot, J. F. See Vernillet, L.<br />

B.<br />

,due, Thomas B. See Johnson, Andrew Myron<br />

Poulin, Sue B..;Lesvitt, Lynda F.; Johnson, A.<br />

Myron, 2001<br />

C. See Zecbaniah, N. Y.<br />

ie, C. K. See Vaughn, R.<br />

C. K, See Rosenthal, Philip<br />

C.-Y. G. See Pan, Jie<br />

J. See Lee, Sung C.<br />

e, Martha See Wyatt, David T.<br />

Sung C., 900<br />

Johanson, N.; Lee. J.; Brudzinski, A.; Hall, D.;<br />

Mess, L; Ferber, I.; Orf, J., 1164<br />

ie, Theodore T.; Sullivan, Susan; Harvey,<br />

Sheryl, 1198<br />

eder, Sydney; Blackwell, Sherry; Ladd, Don;<br />

Yein, Fred; Carrion,<br />

Bellet, Neal, 1166<br />

Julie; Jones, Carolee;<br />

euwenkamp, Oscar K.; van der VijLh, Willem<br />

J. F.; Husken, Brigitte C. P.; Lips, Paul;<br />

Netelenbos, J. Coen, 1911<br />

febvre, K. Craig See Gubata, Paul<br />

,fkowitz, Robert J. See Frielle, Thomas<br />

,frere, Jean-Jacques; Fine, Jean-Menus;<br />

Marneux, Micheine; Lambin, Patrick;<br />

Salmon, Charles, 338<br />

gene, S. See Prinsen, Johanne<br />

grand, Alain See Bonnefont, Dominique;<br />

Peynet, Jacqueline<br />

gras, B. See Ruelland, A.<br />

hmenn, P. See Jarausch, J.<br />

,brer, Michael, 1180<br />

htinen, Matti See Paavonen, Jorme<br />

hto, Math See Peavonen, Jorme<br />

ijnse, B. See Blijenberg, B. G.<br />

Inberger. K. See Wielinger, H.<br />

Leinberger, Robert See Bale, Renze<br />

L.eischner, Ralph See Jandreski, Mark A.<br />

Leivo, Pekks See Hemmila, llkka<br />

Lejeune, H. See Dechaud, H.<br />

Lejeune, Henve See Pugeat, Michel<br />

Lele, S. See Bhergava, AK<br />

Leleux, J. See Sentulli, M. J.<br />

Leloux, Mirjam S.; Mees, R. A. A., 1183<br />

Lernann, Jacob, Jr.; Hornick, Laurel J.; Pleuss,<br />

Joan A.; Grey, Richard W., 2107<br />

La Moigne, F. See Crockett, It<br />

Lensmeyer, Gary L; Wiebe, Donald A.; Carlson,<br />

Ian H., 59<br />

Lentrichia, Brian B. See Fan, ‘l’itan S.; Ku,<br />

Che-An<br />

Lenzo, A. See Baldwin, James It<br />

Leonard, Deborah K.; Li, Philip K., 1128<br />

Leonard, H.; Klukes, C.; Williams, M.; Berg, M.;<br />

Kozel, P.; Hudson, T., 1194<br />

Leong, Denis A., 1053<br />

Lequang, N. T. See Roche, D.<br />

Leroy, M. See Basuyau, J. P.<br />

Lertora, Juan J. L See Kicci, Mary J0<br />

Leshner, Robert T. See Prior, Thomas W.<br />

Lesi, Carlo See Melzi d’Eril, Gian Vico<br />

Leslie, P. See Tibi, L.<br />

Lespinas, Francis; Dupuy, Georges; Revol,<br />

Francoise; Aubry, Claude, 654<br />

Lessard,F.;Dion,R., 2116<br />

Leukhardt-Falrfleld, Carla J. See Bernstein,<br />

Larry H.<br />

Leung, Fred Y. See Galbreith, Linde V.<br />

-; Galbraith, Linde V.; Jablonsky, George;<br />

Henderson, A. Ralph, 1435<br />

Leveno, K. See Putnam, R. S.<br />

Leverett, Lenore See Kress, Benny C.<br />

Levine,<br />

Levine,<br />

Berry See Caplsm, Yale H.<br />

J. See Carrubba, J.; Levy, S.<br />

Levine, R. See Levy, S.<br />

Levunson, Stanley S. See Smith, Michael P.<br />

Levtzow, C. B.; Chapman, J. F.; Parker, N. C.;<br />

McDade, M., 1086<br />

Levy, 0. A. See Yiu, Samuel C. K.<br />

Levy, S.; Levine, J.; Levine, R.; Klotzsch, S., 1130<br />

Lewendowski, Ryszard; Sokalski, Tomesz;<br />

Hulanicki, Adam, 2146<br />

Lewis, Douglas It See Chssnoff, Ira J.<br />

Omori, Erin; Nishio, Junko; Schnoll, Sidney<br />

H., 1186<br />

Lewis, Helen M.; Ratcliffe, Wendy A.; Stott,<br />

Richard A. W.; Wilkins, Martin R.; Baylis,<br />

Peter H., 953<br />

Lewis, L M. See Armbruster, M. A.; Vaughn, It<br />

-; Gibler, W. B.; Erb, It E.; Vaughn, R.; Biagini,<br />

A. V.; Campbell, W. B.; Blanton, J., 1125<br />

Lewis, W. H. P. See Chin, Shiu Hon<br />

Lewko, Walter M. See Oldham, Robert K.<br />

Lhermltte, Michel See Fontaine, Monique<br />

LI, J. C. See Konstantinides, Frank N.<br />

LI, Jacki T. L See Goren, Marshall P.<br />

LI, Mingen G.; Madappelly, hiathew hi., 2330<br />

LI, Philip K. See Leonard, Deborah It; Nagy,<br />

Mary P.<br />

Li, Z. M. See O’Grady, hi.<br />

Liaw, Yun-Fan See Yeh, Chau-Ti<br />

Lieb, Wolfgang See Brums, David -<br />

Liewendahl, K. See Adlercneutz, H.<br />

Liewendshl, Kristlan See Ekins, Roger<br />

Liffnian, S.; Pizza, T.; Qureshi, H.; Czaben, J.;<br />

Hughes, E.; Schwartz, D., 1112<br />

Llfechitz, Carlo. H. See Chen, Huei-Mei<br />

Lilja, H. See Abrahameson, P.-A.<br />

LIe, Chew W.; Dallas, B. H.; Chisnall, W. N.,<br />

1085<br />

Llmet, J. N. See Collet-Cssssnt, D.<br />

LIn, F. C. See Foglia, J. P.; Perel, J. hi.<br />

Lin, S. J. See Chen, Katherine<br />

Lie, Yuh-Nan See Kish, Linda; Sciotto-Brown,<br />

Susan; Zimmermann, Linde<br />

LInareHl, Louis 0. See Nelson, Jereld C.<br />

Llndhack, Bengt; Bergman, Anders, 835<br />

Lindsay, G. See Watson, I. D.<br />

Lindsay, W. See Wilson, John hi.<br />

Llndstedt, Goren See Lundberg, Per-Anne;<br />

Nystrom, Ernst<br />

-; Lundberg, Per-Arne; Johamsson, Pie-Marie;<br />

Eggerteen. Robert; Ellertz, Gina; Nystrom,<br />

Ernst, 1557<br />

Lhnnet, KristIan, 284, 1416<br />

-; hicConway, hi. G.; Chapman, R. S.; Beastall,<br />

G.H., 1805<br />

Lippi, Ugo See Graziani, Marie Stalls<br />

Lips, Paul See Leeuwenkamp, Oscar B..<br />

Upset, Joel; Mansbach, Lillian; Herberger,<br />

John, 1201<br />

Lipsey, A. I. See Huang, W. T.<br />

Lipsey, Allen I. See Cheng, Many H.<br />

Lischinsky, S. See Beck, R.<br />

LIu, A. See Bernard, Mark; Schneider, L.<br />

LIu, Frank J. See Fasullo, Frank J., Jr.<br />

Uu, Peter K. S. See Edwards, Paul<br />

Lizardi, Paul M. See Lomei, Hilda<br />

Lloyd, Cynthia; Travis, James, 1971<br />

Lochmulier, Charles H., 1052<br />

Lockitch, GIllian, 1241<br />

Lodato, D. See Relyee, Noel hi.<br />

Lodge, Mark S.; Albere, John J., 1073<br />

Loeschen, B. J. See Fredrickson, It A.<br />

Loeschen, Barbara J. See Sommer, Ronald G.<br />

Lohff, M. See Sibilia, It<br />

Lohr, Steve See Bleile, Dennis<br />

Lojo, S. See Rodriguez-Segade, S.<br />

Lojo, Santiago See Rodriguez.Segade, Santiago<br />

Lomeli, Hilda; Tyagi, Sanjay; Pritchard, Cynthia<br />

G.; Lizardi, Paul M.; Kramer, Fred Russell,<br />

1826<br />

Lommaert, M. P. See Hendriks, D.<br />

Lonardo, A. See Burrows, KeriLyn C.; Reddy,<br />

Pedals V.<br />

London, Stephanie J. See Hankinson, Susan E.<br />

Long, E. W. See Grenner, G.<br />

Longerich, L See Gault, M. H.<br />

Longhuret, Sharon See Chou, Peter P.<br />

-; Chou, Peter P.; Toms, Rick A.; King, Brenda;<br />

Chang, Agnes, 1099<br />

Leo, Swee-Chun See Chandler, Wayne L<br />

Lopez, B. See Freeman, J.<br />

Lopez, C.; Lykissa, E. D.; Kammerer, R. C., 1169<br />

Lopez-Otln, Carlo. See Vents, Rafael<br />

Lou, John A. See Fraser, Callum G.; Fuentes-<br />

Arderiu, X.; Lu, Carrie J.; Warren, Patricia,<br />

201<br />

-; Manning, Neal It; Kyler, Mary Kay, 347<br />

Warren, Patricia, 1766<br />

Lotti, Gaetano See Musso, Netale It<br />

Louderback, Allan; Foley, Thomas, 1086<br />

Louderback, Allen L.; Palmer, John J., 1087<br />

Love, James B., Jr., 1067<br />

Lovell, Mark A., B43<br />

-; hiifflin, Theodore B.., 1816<br />

Lovell, Mark Alan See Silverman, Lawrence<br />

Lovgren, Timo See Barnard, Geoff<br />

hi.<br />

Lower, D. See Crisan, Domnita<br />

Lu, Carrie J.; Lott, John A., 1090<br />

Lu, W. See Fu, J. C.<br />

Lubec, G.; Sehmid, It; Bantosch, B.; Sensi, M.,<br />

2254<br />

Lucas, F. See Fernan, hi. E.; Steele, B.<br />

-; Johnston, D.; Sewell, R.; Shukia, R.; Carter,<br />

J.; Ibanez, J., 1156<br />

Lucco, L See Singh, J.<br />

Lum, Gifford; Leel-Khouri, Susana, 639<br />

-; Marquardt, Carolyn; Khuri, Shukni F., 664<br />

Lundberg, Per-Anne See Lindetedt, Goran<br />

-; Lindstedt, Goran; Jansson, Svante; Tisell,<br />

Lars-Erik, 340<br />

Lundqulst, Per; Sorbo, Bo, 617<br />

Lunec, J. See Winkles,<br />

Lustenbergor, Patrick<br />

J. W.<br />

See Orsonnesu, Jean-<br />

Luc<br />

Lustgarten, J. See Sundaram, Sham G.<br />

Lustgarten, J. A.; Wenk, It B..; Noel, S., 1067<br />

Lustig, V. See Diamendis, B.. P.<br />

Lustig, Villain See Diamandis, Eleftherios P.<br />

Luxton, A. See Donahoe, Mark<br />

Luxton, Richard W.; Petal, Prague; Keir,<br />

Geoffrey; Thompson, Edward J., 1731<br />

Lykls.a, B. D. See Cano, C.; Lopez, C.<br />

Lykissa, Ernest D., 1169<br />

Lynch, Braden See Zoccoli, Michael A.<br />

Lynch, Michael J., 1188<br />

Lyon, T. D. B. See Fraser, W. D.<br />

Mass, L See Lee, Sung C.<br />

Mabbett, S.; McIntyre, A.; Thomp.on, W.;<br />

hiontaue, D., 1149<br />

Macart, Michel; Koffi, Agnes; Henocque,<br />

Genevieve; Mathieu, Jean-Francois;<br />

Guilbaud, Jean-Charles, 211<br />

Maccan, F.; Hulsmann, W. C., 711<br />

Maclejko, James J. See Smith, Michael P.<br />

Macloazek, J. See Ostrow, D. H.<br />

MacKenzie, A. See Wong, T.<br />

MacWalter, Ronald S. See Fraser, Celluin G.<br />

Madappally, Mathew M. See Li, Mingen G.<br />

Madden, Alden See Howard, Ketrina<br />

Madden, Thomas M. See Irish, Glenn R.<br />

Madry, Norbert; Senftner, H. J.; Gentzer, W.;<br />

Palermo, M.; Pothier, S.; Baker, K.;<br />

Havelick, J.; Grenner, G., 1195<br />

Meeda, M. See Uji, Y.<br />

Meekawa, Masato See Azuma, Yutaro<br />

-; Sugiura, Koseku; Azums, Yutaro; Kanno,<br />

Takashi, 897<br />

Mae., K. A. A. See Leloux, Mirjam S.<br />

Magglo, Vincent L See Mynick, James E.<br />

Magglore, Jack See O’Connor, Brian<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2353


Magnotti, Ralph A., Jr.; Stephens, Gregory W.;<br />

Rogers, Rick K.; Peace, Amadeo J., 1371<br />

Mahaffey, K. See Sibilia, R.<br />

Mahan, J. D. See Ward, Kory M.<br />

Mahan, John D. See Wailer, Kathy V.<br />

Mahinood, Nishat; Srebro, Sonia; McCarthy,<br />

M; Brotherton, Mary; Hunter, Thomas;<br />

DeMarco, Curtis, 1095<br />

Mahoney, John See Van Kessel, Antonius L.<br />

Mahuzier, 0. See Thuen, N. T. Leuquang<br />

Maler, K. S. See Pauley, Scott D.<br />

Mak, Ken See Bleile, Dennis<br />

Makela, Sinikka K. See Ellis, Graham<br />

Maklnen, Malja-Lilsa; Pettersson, Kim;<br />

Suonpaa, Mikko, 1205<br />

Malecker, James K. See Oldhem, Robert K.<br />

Malik, Sohail; Kenny, Margaret A.; Landicho,<br />

Del; Heron, Diane; Helverson, Kevin;<br />

Dasgupta, Amitava; Ahmad, Suhsil, 1157<br />

Malkin, Aaron See Hansen, Hans J.<br />

Mallein, K. See Dechaud, H.<br />

Malloy, D. See Pexton, Helene<br />

Maluf, Karen See Passey, Richard B.<br />

Manca, Dm0; Ferron, Liliene; Weber, Jean-<br />

Philippe, 601<br />

Manderino, G. L See Konrath, J. G.<br />

Manganello, Jeanne See O’Connor, Brian<br />

Mangil, Ruggeno See Dolci, Alberto<br />

Manguni, B. W., 503<br />

Mani, H. S. See Kotheni, Kanchan<br />

Manimekalai, S. See Goldstein, Philip J.;<br />

Sundaram, Sham G.<br />

-; Unni, S.; Sundarem, G. S.; Goldstein, P. J.,<br />

1140<br />

Manning, J. See Murphy, Allan<br />

Manning, Neal K. See Lott, John A.<br />

Manning, Wayne See Zoccoli, Michael A.<br />

Mansbach, Lillian<br />

Mantero, Giovanni<br />

See Lipeet, Joel<br />

See Polesi, Claudio<br />

Mantha, S. See Jagoda, E.; Raise, A.; Tsay, H.<br />

-; Tsay, H.; Tu, J., 1190<br />

Marbach, K. See Kruse-Jarres, J. D.<br />

Marcovina, S. See Dati, Francesco<br />

Marcovina, Santica See Dolci, Alberto<br />

-; Zoppo, A.; Parlavecchie, M.; Fardin, E., 1163<br />

Marcovina, Santlca M. See Albers, John J.<br />

-; Albers, John J., 2009<br />

Maretsky, D. See Grenner, G.; Padilla, A.;<br />

Staedter, hi.<br />

Markin, R. S. See Arnold, L. L.; Earl, R. A.;<br />

Haven, hi. C.; Schiebout-Clerk, K. C.<br />

Markin, Rodney S. See Haven, Mary C.<br />

Marlewski, D.; Douglas, J.; Sacha, P.; Ogunro,<br />

E.;Doss,R., 1146<br />

Marlewski,<br />

Marlewski,<br />

Debbie See Baker, Harold N.<br />

Deborah See Ford, Kent A.<br />

Marneux, Micheline See Lefrere, Jean-Jacques<br />

Marquardt, Carolyn See Lum, Gifford<br />

Marrakchi, Slaheddine See Fontaine, Monique<br />

Marsden, Joanne T. See Johnston, Athoil<br />

Marsh, K. See Woo, Jannie<br />

Marshall, Thomas See Williams, John<br />

Martel, P. See Gabor, Mike; Harper, J. D.<br />

Martel, Patricia A. See Bechand, Steven S.;<br />

King, David L.<br />

Martha, P., Jr. See Felder, R. A.<br />

Martin, Cazemiro R. See El-Yazigi, Adnen<br />

Martin, Edward W. See Hansen, Hans J.<br />

Martin, J. K. See Moore, P.<br />

Martin,<br />

Martin,<br />

Lorene A. See Brans, Yves W.<br />

M. LouIse See Boone, D. Joe<br />

Martinez, Luis A. See Jones, Christopher E.<br />

Martofano, A. See Black, William<br />

Marumo, Funiiaki See Ishida, Osamu<br />

Maruta, Kazuhiro; Teradaira, Ryo; Watsnabe,<br />

Noriyuki; Nagetsu, Toshiharu; Asano,<br />

Maeao; Yamamoto, Katsunobu; Matsumoto,<br />

Takatoshi; Shionoya, Yoshihiko; Fujita,<br />

Kelsuke, 1694<br />

Marx, A. M. See Kropf, J.<br />

Masana, L. See Joven, J.<br />

Mashige, Fumiko; Hisae, Nobuo; Toyota,<br />

Sechiko; Yoshinoya, Sadeyoshi; Ohkubo,<br />

Akiyuki, 2322<br />

Masiero, M. See Plebeni, Mario<br />

Masini, S. See Zucchelli, G. C.<br />

Mason, L See Crisan, D.<br />

Masover, B. See Mulberg, E.<br />

Messed, A. See Beck, R.<br />

Massey, K. L See Kalra, J.<br />

Massoubre, Catherine See Orsonneau, Jean-<br />

Luc<br />

Massoud, Nell See Brettfeld, Chris<br />

Masters, AM; Hahnel, Roland, 979<br />

Masude, Minoru See Yebuuchi, Mesehiko<br />

Masulli, I. S. See Zoha, Steven J.<br />

Matamoros, H. A. See Reimers, T. J.<br />

Matheke, M. L See Butch, Anthony<br />

Matheke, Mary Lou See Reason, Craig<br />

Mathias, Dietgen See Peters, Jorg<br />

Mathieu, Jean-Francols See Macart, Michel<br />

Mathleu, Monique See Bony, Claude<br />

Mathisen, Mary L; Vessella, Robert L., 1092<br />

Matsubara, Fujitsugu See Hashimoto, Takuma<br />

Matsuda, Akihiko; Kimure, Mieko; Kateoke,<br />

Mikiko; Ohkuma, Shin-ichi; Sato, Makoto;<br />

Itokawa, Yoshinori, 1939<br />

Matsuda, H. See Ishimori, Yoshio<br />

Matsumoto, Kojiro; Kanbe, Shigenobu; Kuhn,<br />

Hiroaki; Yegi, Gohei; In, Hiseini; Yuki,<br />

Hideteke, 453<br />

Matsumoto, Takatoshi See Maruta, Kazuhino<br />

Matsuoka, Akira See Kobayeshi, Kunio<br />

Metsuura, Tsuneaki; Hasegewa, T.; Tanaka, K.;<br />

Shibeta, H.; Honda, T., 1082<br />

Matsuzaki, Hiroko See Miura, Masakezu<br />

Mattimiro, Chris See Donohue, Joseph<br />

Maturen, Andrew See Nice, Allen; O’Connor,<br />

Brian<br />

Meuck, L. See Danielson, Susan J.; Hasselberg,<br />

Stephen<br />

Mauck, Linda; Alexandrovich, S.; Bale, M.;<br />

Danielson, S.; Hassett, J.; Sundberg, hi.;<br />

Widener, J., 1200<br />

Meugh, K. Se. Sperling, Matthew<br />

Mexon, H. See Sperling, Matthew<br />

Mayer, T. See Kubasik, N. P.<br />

Mayer, T. K. See Kubasik, N. P.<br />

Mayfield, C. See Singh, Jagat<br />

Mayrand, P. E. See McBride, L J.<br />

Mazzachi, K. D. See Berry, hi. N.<br />

McBlain, William A. See Molnar, Larry A.<br />

McBride, J. H. See Aim, Ronald B..; Schotters,<br />

S. B.<br />

McBride, James H.; Rodgerson, Denis 0., 1356<br />

-; Rodgerson, Denis 0.; Park, Sue S.; Reyes, Ana<br />

F., 1726<br />

McBride, L J.; Koepf, S. M.; Gibbs, R. A.;<br />

Salser, W.; Mayrend, P. E.; Hunkapiller, M.<br />

W.; Kronick, hi. N., 2196<br />

McCallum, Theresa See Picone, Teresa<br />

McCarthy,<br />

McClellan,<br />

M. See Mahmood, Nishat<br />

Adrain See Butch, Anthony W.<br />

McClure, K. Dale See Watkins, Michael<br />

McComb, H. B. See Lachmen, Mary F.; Valcour,<br />

Andre<br />

McComb, K. M. See Knzymowski, G. A.<br />

McComb, Robert B. See Klaus, Eric M.;<br />

Okorodudu, Anthony 0.; Valcour, Andre A.<br />

McConwey, M. G. See Linnet, Kristian<br />

-; Chapman, It S.; Beastall, G. H.; Brown, E.;<br />

Tilhnan, J.; Bonar, J. A.; Hutchison, A.;<br />

Allison, T.; Finlayson, J.; Weston, B.;<br />

Beckett. G. J.; Canter. G. D.; Carlyle, B..;<br />

Henbenteon, B..; Blundell, G.; Edwards, W.;<br />

Glen, A. C. A.; Reid, A., 289<br />

McCord, Joe M., 1050<br />

McCormick, C.; Shihabi, Z., 1122<br />

-; Shihabi, Z ; Goodman, H., 1137<br />

McCormick, Michael I See Sun, Yi<br />

McCruden, D. See Dominiczek, Marek<br />

McCusker, L M. See Kramp, W. J.<br />

McDade, M. See Levtzow, C. B. -<br />

McDowell, Ian F. W.; Wisdom, G. Brian;<br />

Trimble, Elisabeth K., 2070<br />

McGinley, M. H. See Schottens, S. B.<br />

McGinnis, S. See Silver, hi. It<br />

McIntosh, S. J.; Watson, I. D.; Kelly, A.;<br />

Stewart, hi. J., 1353<br />

McIntyre, A. See Mabbett, S.<br />

McKenzie, Sheila See Sinclair, David<br />

McLachlan, R., 478<br />

McLachlan, S. M. See Beaver, K.<br />

McLaughlin, Kathleen See Skogerboe, Kristen<br />

J.<br />

McMahan, C. Alex See Schwartz, Joyce G.<br />

McMurray, H. 0. See Rifai, Nader<br />

McNair, Peter See Frandsen, Niels Jorgen<br />

McNally, A. J. See Siemon, Peggy<br />

McNainara, Judith K., 1234<br />

McPherson, Richard A. See Podiesek, Stanley<br />

J.; Podlesek, Stanley J.<br />

-; Aganwal, K. P.; Scott, Joan R.; Podlasek,<br />

Stanley J., 1076<br />

McPhillip., Mary See Knepil, Janusz<br />

McWhinney, B.C. See Cowley, D. M.; de Leacy,<br />

E. A.<br />

Medcalf, E. See Newman, D. J.<br />

Me., A. V. See Wang, P. Y.<br />

Meeks,<br />

Meijer,<br />

Andrew See Bonham, James R.<br />

Gert W. See de Bruyne, Jan J.<br />

Meleraki, James J.; Chiappetta, B..; Spells, M.;<br />

Ramsey,J., 1174<br />

Mellbning, Goran See Nilsson, Torbjorn K.<br />

Melzi d’Bnil, Glen Vico; Bosoni, Tiziana; Lesi,<br />

Carlo, 2142<br />

Meneghini, F. A. See Grenner, G.<br />

Meng, Xianzhong See Pippenger, C. F.<br />

Meola, John K. See Persons, Patrick J.<br />

Mercer, W. See DiPeola, J.; Peltyszyn,<br />

Stephanie; Wimimer, Cathy<br />

Mercer, Wayne See DiPaola, Joseph; Salinas,<br />

Rosalie<br />

Meriadec, B. See Bianca, Carol<br />

Merritt, Gerald J. See Jones, Christopher E.<br />

Merritt, Russell J., 1060,1238<br />

Merzbach, David See Barak, Mire<br />

Messenger, H. See Freemin, J.<br />

Messing, Bernard See Peynet, Jacqueline<br />

Meszaros, Istvan See Goth, Laszlo<br />

Metzler, M.; Pierre, K., 1071<br />

Metzmann, B. See Dati, Francesco<br />

-; Schmidt, B.; Dengler, M.; Kapmeyer, W.,<br />

1091<br />

Metzmann, Erwin See Kepmeyer, Wolfgang H.<br />

Meulenberg, P.M. M.; Hofmen, J. A., 168<br />

Miceli, J. N. See Vroon, D. H.<br />

-; Vroon, D. H.; Bloodworth, D. F.; Brantley, N.<br />

Tackett, E. B.; Wellington, Pat, 1165<br />

Miceli, Joseph N., 1240<br />

Michalski, 1, 1112<br />

Michiels, G. See Labeur, C.<br />

Mldgley, J. See Sheehan, C.<br />

Midgley, John B. M. See Ball, Richard<br />

Mlfflin, T. E. See Bowden, James<br />

Mifflin, Ted; Bowden, J.; Walton, 5., 1076<br />

Mifflin, Theodore E. See Lovell, Mark A.<br />

-; Hamilton, Marilyn; Hubbard, Elizabeth;<br />

Kline, Michael J.; Bruns, David E., 110<br />

-; Foremen, Rodney W.; Bruns, David F., 1651,<br />

1819<br />

Migueres, ML See Thuan, N. T. Leuqueng<br />

Mikola, Heikkl See Barnard, Geoff<br />

Miles, Andrew; Philbrick, David B.. S.; Grey,<br />

JosephE., 514<br />

Miller, Barbara B.; Turner, Wayman E., 1756<br />

Mliler, Dayton T. See Mynick, James E.<br />

Miller, DL See Kohl, HH<br />

Miller, JudIth A. See Kaplan, Lawrence A.<br />

Miller, K. L. See Harrison, H. H.<br />

Miller, R. See Kus, Debra hi.<br />

Mifier, R. C. See Pauley, Scott D.<br />

Miller, W. Greg See Tetrault, Gregory A.;<br />

Weiesbecker, Karen A.<br />

Miller, Warren K. See Lau, H. Philip<br />

Miller, Wayne See Shew, Norman<br />

Mills, A. See Freeman, J.<br />

Mills, A. J. See Prabhakaran, Victor hi.<br />

Mills, 0. A.; Walker, V.; Coma, D. L, 673<br />

Mills, Graham A. See Walker, Vaierie<br />

MIllsap, S. See Fox, Martha<br />

Millsep, Susan; Powers,<br />

V.; Abenin, C., 1103<br />

hi.; Noriyuki, I.; llama,<br />

Milne, D. B. See Gallagher, S. K.<br />

Milstein, Sheldon See Fuchs, Dietmar<br />

Mimes, I See Kieng, W.<br />

Mien, A. See Guemouri, Leila<br />

Mlsaki, Hldeo See Imamuna, Shigeyuki<br />

Mitchell, D. R. See Konstantinides, Frank N.<br />

Mitchell, 0. See Duncan, Marilyn<br />

Mitsunioto, H. See Solano, Romeo<br />

Miura, Akira B. See Wakui, Hideki<br />

Miura, Masakszu; Fukuyama, Yechiyo; Hirano,<br />

Tetsuo; Matsuzaki, Hiroko, 1995<br />

Miura, Takayuki See Gotoh, Hiroehi<br />

Miura, Toshihide See Kuroiwa, Katsumesa<br />

Miya, Terry See Wu, James T.<br />

Miyada, D. S.; Fegin, A.; Ocaniz, J.; Vezini, N. D.,<br />

1134<br />

-; Fagin, A.; Pinkie, H.; Ocaniz, J.; Vazini, N. D.,<br />

2325<br />

Miyagi, Kouichi See Shoji, Shin’ichi<br />

Mlyai, KIyoshi See Tamaki, Henuo<br />

Mlzokemi, M. See Sorin, T.<br />

Mlzuno, Shigeki See Joukyuu, Riteuko<br />

Mizuochl, E.; Yamaneshi, H.; Obata, K.; Takai,<br />

M.; Iinuma,K.;Kureta,K., 1192<br />

Mizushima, Yoshikiyo See Yamaguchi, Akihiro<br />

Mlyniec, D. See Figand, StaveD.<br />

Moatti, N. See Cosaon, C.; Myers, L<br />

Moawad, Atef H. See Zibret, Steven J.<br />

Moaz, Aheed A. See Fnandsen, Erik K.<br />

Moelby, Lam See Rasmussen, Kersten<br />

Mohr, M. See Center, G.<br />

Mojzislk, Kathy See Hansen, Hens J.<br />

Molina, Ernesto See Gascon, Felix<br />

Moll, Willi See Wencker, Marion<br />

Molloy, S. See Doria, Manuel, Jr.<br />

Molnar, Larry A.; Dhirani, Nasreen; Tram, Kim:<br />

McBlain, William A., 824<br />

Molyneux, Angus See Rowbotham, Lynn<br />

Monforte, J. H. See Cetomeris, Peter<br />

Monk, J.; Calvin, J.; Price, C. P.; Wreghitt, T. G.<br />

431<br />

2354 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


lontagnoli, Giorglo See Degan, Paolo<br />

lontague, D. See Hughes, J.; Mabbett, S.<br />

lontalbettl, N. See Baedenhuijsen, H.<br />

lontero, A. See Singh, J.<br />

loolenaar, Abraham J. See Franck, Paul F. H.<br />

loon, C. See Edwards, S.; Mumdill, P.<br />

loon, Patricia See Bleile, Denmis<br />

loom, F.M. I; Simpson, D., 1782<br />

bore, Gordon P., 1849<br />

loom, K. See Putnam, K. S.<br />

bore, P.; Layte, K.; Aslem, M.; Martin, J. K.,<br />

1149<br />

loom, K. B. See Okorodudu, A. 0.<br />

loorman, Stacy; Winn, C. I; Myers, G. I;<br />

Cooper, 0. R., 1073<br />

lorales, A. See Soldin, Steven J.; Stone, Judy<br />

lorales, Antonio See Rifai, Nader<br />

lorano, Susanne See Senei, Meurizio<br />

bomno, Kuben F. See Tilzer, Lowell I<br />

borgan, Craig See Pandian, M. H.<br />

Ion, Mlkio; Kawamura, Kenye, 1127<br />

brim, Leo 0.; Austin, Garth E.; Rodey, Glenn<br />

E.; Johnson, James E., 1039<br />

-; Austin, Garth E.; Rodey, G.; Johnson, J., 1154<br />

lornis, Brian See Rowbotham, Lynn<br />

bornis, Brian W. See Price, Mum<br />

bornis, D. I See Fredrickson, K. A.<br />

lonris, David L See Somnier, Ronald G.<br />

bornlsett, Joel D. See Petech, Wolfgang<br />

bortler, Eric See Robbrecht, Johan<br />

bosca, Andrea See Paleari, Renete<br />

boscoso, Hugo; Shyamala, M.; Kiefer, Charles<br />

B..; Garver, Fred A., 2066<br />

loses,<br />

loses,<br />

G. C. See Smith, Deborah A.<br />

Godfrey C. See Smith, Deborah A.<br />

lo.k.khl, W. B. See Holzberg, Roni A.<br />

loskie, Laura A. See Newman, Edward S.<br />

loss, Donald W. See Whitaker, Katrine B.<br />

-; Whitaker, Katrine B.; hiunno, Alastair J., 896<br />

loss, 0.5. See Sehgal, Lakshman K.<br />

lotika, Deborah; Childers, David; Fenton,<br />

John, 1068<br />

lotin, Jean See Pugeat, Michel<br />

lotoda, S. See Ishiinori, Yoehio<br />

louisa, Fathi; Dufour, Lucienne; Didry, Jean<br />

Rene; Aymard, Pierre, 874<br />

boyer, Thomas P., 1815<br />

ludarris, Ayad; Brabhem, Ewart A., 1164<br />

lueggler, Paul See Subbarso, hiakam N.<br />

luirhead, C.; Ladouceur, P.; Pierre, K.; Heden,<br />

B.; Seislove, J.; Purcell, 0., 1110<br />

luirhead, C. L See Vasilakis, Jeanne<br />

lukharjee, A. See Zacherieh, N.Y.<br />

lulbeng, E.; Masover, B.; Graham, B.;<br />

Bernedino, H.; Silva, K.; Centofanti, J., 1173<br />

Lullen, James See Kricke, Larry J.<br />

bullies, Marvin; Spanien, M.; Bielawski, C.,<br />

1095<br />

lundlll, P.; Moon, C.; Aslam, M., 1149<br />

lunro, Alastair J. See Moss, Donald W.<br />

lunzenberger, Paul See Brettfeld, Chris<br />

lurakami, Shigeki See Konmo, Norimichi<br />

lures., Mituya See Usui, Akihiko<br />

lures., Toshlo See Ishibeshi, Shun<br />

lure., A. See Abrahamsson, P.-A.<br />

lurone, M. See Bonini, P. A.<br />

lurone, Michelangelo See Banfi, Giuseppe<br />

lurphy, Allan; Manning, J.; Gibson, S., 1091<br />

Furray, C. See Kubasik, N. P.<br />

Furthy, H. MS. See Breglio, Susan; Staples,<br />

Mark; Watkins, Michael; Zen, Geraldine Tun<br />

Lurthy, Vadiraja V.; Kermen, Arthur, 1115<br />

-; Kaninen, Arthur, 1190<br />

Lurza, B. See Chin, Bruce G.<br />

[mao, Natal. K.; Vergassola, Claudio; Pende,<br />

Aldo; Lotti, Gaetano, 1975<br />

[yarn, I. See Coeson, C.<br />

-; Atger, V.; Coeson, C.; Guillemain, K.; Amnein,<br />

C.; Dryfus, G.; Moatti,<br />

(yer,, 0.1 See Moorman,<br />

N., 1258<br />

Stacy<br />

[yen, Gary I; Schap, F. D.; Smith, S. J.;<br />

Cooper, 0. K.; Hantmann, A. E.; Gilmore, B.;<br />

Ray, D. H., 1073<br />

yen, IS. See Bhargeve, A. K.<br />

[yen, M. See Bhergeve, A. K.<br />

Lyers,M. M. See Bhargava, A. K.; Bhargava,<br />

[ylott, G. See Ferrenkopf, Bruce C.<br />

lyre, S. A. See Schroeder, Timothy J.<br />

[yrick, James E.; Gunter, Elaine W.; Maggio,<br />

Vincent L; Miller, Dayton T.; Hannon, W.<br />

Harry, 37<br />

yrti,, James F.; Bodor, Geza; Wolf, Bryan A.;<br />

Hinds, Barbara; Nahm, Moon H.; Scott,<br />

Mitchell 0., 2154<br />

accarato, W. F. See Koch, Thomas K.<br />

agasawa, Takeshi See Kuroiwa, Katsumasa<br />

Nagatsu, Toshiharu See Gotoh, Hinoshi;<br />

Maruta, Kazuhiro<br />

Nagy, Mary P.; Li, Philip K., 1168<br />

Nahm, Moon H. See Bodor, Geza; Myrtle, James<br />

F.<br />

Nail, Bharat See O’Connor, Brian<br />

Naka, Keilchl See Shimojo, Nobuo<br />

Nakajlina, Chiaki See Shimojo, Nobuo<br />

Nakajinia, Takeyukl See Azume, Yutaro<br />

Nakamoto, Yasushi See Wakui, Hideki<br />

Nakainura, Aurea See Dasgupte, Amitava<br />

Nakamura, Katsumi See Fukuda, Chisako<br />

Nakamura, M. See Sonin, T.<br />

Nakaniura, Muakazu; Seth, S.; Konishi, M.;<br />

lide, M.; Komachi, Y., 1065<br />

Nakamura, Masao See Shoji, Shin’ichI<br />

Nakamura,<br />

Nakamura,<br />

Robert<br />

Tsun.o<br />

M., 1239<br />

See Yebuucbi, Mesahiko<br />

Nakao, M. See Cho, Hiroko<br />

Nakashima, Koji; Nishizaki, Osamu; Andoh,<br />

Yukio; Takei, Hitoshi; Itei, Akira; Yoshida,<br />

Yukio, 958<br />

Nakatsuyama, Shuichi See Kuroiwa,<br />

Ketsumasa<br />

Nance, Walter B. See Weissbecker, Karen A.<br />

Nandedkar, Arvind K. N.; Kim, Sook-Chie,<br />

1135<br />

Napoil, K. I; Grevel, J.; Armour, C., 1186<br />

Narang, Emma; Damodaran, K.; Rao, J., 1200<br />

Narayanan, S. See Foglia, J. P.; Perel, J. M.<br />

Nargessl, H. D.; Sverlow, K.; Schneider, D.;<br />

Ralston, S., 1198<br />

Naudin, Claude See Vernet, Michele<br />

Nevalesi, Kenzo See Giampietro, Ottevio<br />

Navazl, Waleska; Keasner, Art; Jam, Chandre,<br />

1106<br />

Nealon, D. See Hasselberg, Stephen<br />

Neary, K. H., 2336<br />

Need, A. 0. See Nordin, B. E. C.<br />

Neelkantan, N. V. See Koch, Thomas K.; Zohe,<br />

Steven J.<br />

-; Weston, S.; Lou, H. P., 1202<br />

Neely, H. See Witherspoon, I K.<br />

Neglia, Joseph P. See Whitley, Chester B.<br />

Neider,<br />

Neisler,<br />

K. See Keller, Charles H.<br />

H. M.; Bean, M. H.; Thompson, W. R.;<br />

Johnson, J. T.; Hall, M.; Pittington, J.;<br />

Smith, J. L., 1136<br />

Nelsl,r, Mike See Panteghini, Meuro<br />

Nelson, Jerald C. See Ekins, Roger; Pandian,<br />

M. K.<br />

-; Tomei, Ray T., 541<br />

-; Linerelli, Louis G.; Pandian, M. K., 1257<br />

Nelson, I See Eble, K. S.<br />

Nelson, Margaret See Hever, Virginia M.<br />

Nelson, Nine; Ohman, Stan; Lareson, Lease, 486<br />

Nelson, Norman C. See Arnold, Lyle J., Jr.<br />

Nestruck, A. Christine See Devignon, Jean<br />

Netelenbos, J. Coon See Leeuwenkamp, Oscar<br />

K.<br />

Neuenhofer, S. See Schnomr, Gerd K.<br />

Nevill,<br />

Neville,<br />

J. I See Kramp, W. J.<br />

Ronald G. See Fraser, Callum 0.<br />

Newerly-Abranow, Wanda See Attia, John<br />

Newman, D. J., hiedcalf, E.; Gorinan, E.G.;<br />

Price, C. P., 1205<br />

Newman, Edward S. See Hansen, Hans J.<br />

-; Moskie, Laura A.; Duggal, Rita N.;<br />

Goldenberg, David M.; Hansen, Hens J.,<br />

1743<br />

Newman, Howard A. I., 1234<br />

Newton, M. See Iehii, S.<br />

Newton, M. K. See Rosenthal, Philip<br />

Nexo, Ebbs See Gimsing, Peter<br />

Ng, H.-T. See Pan, Jie<br />

Ng, K. H. See Hardy, Robert<br />

Ng, Ronald H.; Sparks, Katherine; Statland,<br />

BernardE., 1106<br />

-; Coulam, Carolyn B.; Trout, Neil; Cnitser,<br />

John; Stetland, Bernard E., 1144<br />

-; Sparks, Katherine; Statland, Bernard B., 1159<br />

Nguyen, Son V. See Chandler, Wayne L<br />

Nguyen, Thuy; Wernick, 0. Russell, 1086<br />

Nice, Allen; Meturen, Andrew, 1542<br />

Nicholson, J. See Winborne, K.<br />

Nicholson, James H.P.; Savory, M. Geraldine;<br />

Savory, John; Wills, Michael K., 488<br />

Nicholson, John F., 1238<br />

Nickel, Erika See Jung, Klaus<br />

Nicoloal,<br />

Nicolson,<br />

K. J. See Karge, W. H.<br />

Ruth B.; Reilly, Christopher P.;<br />

Pannall, Peter K.; Esposito, Linde, Wellby,<br />

Maurice I, 931<br />

Nigro, Michael See Brettfeld, Chris<br />

Nilsson, Ingegerd See Joustra, M.<br />

Nilsson, Torbjorn K. See Jansson, Jan.Hakan<br />

-; hiellbring, Goran, 1999<br />

Nlshlna, Toshihlro See Joukynu, Ritauko<br />

Nlshlo, Junko See Lewis, Douglas #{163}<br />

Nishizaki, Oseinu See Nakaahiina, Koji<br />

Noedel, M. See Peat, Michael A.<br />

Noel, A. See Bernard, A. M.<br />

Noel, S. See Lustgarten, J. A.<br />

Noller, Hans G., 1209, 1209<br />

Noma, A. See Uji, Y.<br />

Noma, Aklo See Abe, Akina<br />

Nomoto, Shozo See Shoji, Shin’ichi<br />

Norb.rg, Be See Janseon, Jan-Hakan<br />

Nondin, B. B. C.; Need, A. 0.; Hartley, T. F.;<br />

Philcox, J. C.; Wilcox, hi.; Thomas, D. W., 14<br />

Norfolk, D. See Deti, F.<br />

Noriyukl, I. See Fox, Martha; Millsap, Susan<br />

Nonmansell, D. B. See Boyd, James C.<br />

Norton, Carol See Kej, Robert<br />

Norton, Gary See Novros, Joel<br />

Norton, Kurt See Knees, Berry C.<br />

Noun, N. See Peltyszyn, Stephanie; Wimmer,<br />

Cathy<br />

Novick, David M.; Poretsky, Leonid; Kalin,<br />

Marcia F.; English, Trevor N.; Ruxton,<br />

David; Eastman, Creswell J., 1807<br />

Novros, Joel; Norton, Gary; Arter, Thomas;<br />

Shenklin, Nora, 1101<br />

Nunneily, P. See Bray, Kurtis K.<br />

Nuss.nblatt, Robert B. See Elm, Ronald J.<br />

Nustad, Kjeil See Peus, Elisabeth<br />

Nuwayhid, N. F.; Johnson, G. F., 1179<br />

Nuwayhid, Naziha F.; Johnson, George F.; Feld,<br />

Ronald D., 1526<br />

Nyberg, S. See Phillips, E.<br />

Nyhan, William I See Hoffmenm, Georg<br />

Nystrom, Ernst See Lindstedt, Conan<br />

-; Lindstedt, Goran; Rudenstam, Carl-Magnus;<br />

Bengtsaon, Bengt-Ake; Tisell, Lars-Erik,<br />

1019<br />

Obata, K. See Mizuochi, F.<br />

Ob.nley, Larry W. See Sun, Yi<br />

O’Brien, John F. See Gonchoroff, Daryl 0.;<br />

Schosnau, B..<br />

O’Brien, Maureen See Sedowski, James<br />

Obst, Joachlm, 1208<br />

Ocanlz,J. See Miyade, D. S.<br />

O’Conneil, Kathleen M., 1233<br />

O’Connor, Brian; Manganello, Jeanne;<br />

Pacholski, Janet; Roth, Diethuld; Maggiore,<br />

Jack; Quale, Marguerite; Naik, Bharet;<br />

Maturen, Andrew, 2250<br />

O’Connor, Daniel T.; Pandian, M. K.; Canlton,<br />

Father; Cervenke, Justine H.; Hsiao, Ray J.,<br />

1631<br />

Od,il, William D. See Zahradnik, Richard<br />

O’Donnell, C. M. See Bachend, Steven S.;<br />

Gabor, Mike; Harper, J. D.<br />

O’Donnell, C. Michael See King, Devid L.<br />

0.1, T. See Ryder, K.<br />

0.lert, B. See Oster, 0.<br />

0.llerich, Michael; Burdelski, M.; Louts, H. U.;<br />

Rodeck, B.; Duevel, J., 1135<br />

Oeseburg, B. See Kwant, 0.<br />

Oeseburg, Berend; Kwant, Gerard, 515<br />

Ofulue, A. Felix See Khadempoun, M. Hassan<br />

Ogan, M. See Jagoda, E.<br />

Ogasahara, Naomi See Kobeyashi, Kunio<br />

O’Grady, MS.. Peck, hi.<br />

-;Li,Z.M., 1069<br />

Ogunro, B. See Marlewski, D.<br />

Ogunro, B. A. See Figard, Steve D.<br />

Ogunro, Edward A. See Baker, Harold N.; Ford,<br />

Kent A.<br />

Ohasbi, M. See Cho, Hiroko<br />

Obkubo, Aklyukl See Mashige, Fumiko<br />

Ohkuma, Shin-ichi See Matsuda, Akihiko<br />

Ohean, B. Magnus See Christenson, Robert H.<br />

Ohman, Magnus See Christenson, Robert H.<br />

Ohmin, Stan; Lersson, Lease, 900<br />

Obese, Stan See Nelson, Nina<br />

Ohsewa,<br />

Ohshlma,<br />

Susumu See Kuroiwa,<br />

Ta.yukl; Hasegewa,<br />

Katsumese<br />

Takaeki; Johno,<br />

Ikuo; Kitazawa, Shikifumi, 1722<br />

Ohtani, Shigeru See Tsuchiya, Hinonori<br />

Ohyanagi, Kazuhiko See Yamaguchi, Akihiro<br />

Okab.,<br />

Okada,<br />

H. See Uji, Y.<br />

Kunlo See Shimojo, Nobuo<br />

Okaniwa, K. See Yamaseli, Mesehiko<br />

Okorodudu, A. 0.; Gillmor, H.; Onoroski, hi.;<br />

Parker, L.; Moore, K. F., 1555<br />

Okorodudu, Anthony 0.; Pelletier, Peter R.;<br />

Valcour, Andre A.; Bowers, George N., Jr.;<br />

McComb, Robert B., 153<br />

Okuda, Klyoshl See Shimojo Nobuo<br />

Okuyama, Kohjl See Kobayashi, Isao<br />

Oldham, Robert K.; Maleckar, James K.;<br />

Friddell, Colleen S.; Lewko, Walter hi.;<br />

West, William H.; Yennelli, John K., 1576<br />

O’Leary, Niall; Pembroke, Anthony; Duggan, P.<br />

Finbarr, 510<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2355


O’Leary, Thomas Denis; Langton, Simon R.,<br />

1697<br />

Olesen, Henrik; Ladenson, Jack H., 189<br />

Olin, Ake See Hansson, Lena<br />

Oliveira, D. B. G. See Beckett, G. J.<br />

Olivier, Frencoise See Vernet, Michele<br />

Olley, A. See Rosencrens, Robert<br />

Olson, II. M. See Sun, Lilla; Walters, S.<br />

Omorl, Erie See Lewis, Douglas E.<br />

O’Neil, J.; Bozimowski, D., 1125<br />

Ong-Tone, I See Dominiczak, Marek<br />

Onica, D. See Wallinder, H.<br />

Onoroski, M. See Krzymowski, G. A.;<br />

Okorodudu, A. 0.<br />

Opheini, K. E. See Sadrzadeh, Sayed hi. H.<br />

Oppenheimer, J. See Woo, Jennie<br />

Oppermann, M. See Patal, Ninanjan<br />

Orf, J. See Lee, Sung C.<br />

Orf, J. W. See Tadepalli, Servamanagala<br />

Origenes, Maurice I, Jr. See Rettmer,<br />

Rebecca L<br />

Orr, H. T. See Killeen, A. A.<br />

Orsonneau, Jean-Luc; Douet, Philippe;<br />

Massoubre, Catherine; Lustenberger,<br />

Patrick; Bernard, Serge, 2233<br />

Orsulak, P. J. See Akers, L. C.; Kenney, J. T.;<br />

Schiebout-Clark, K. C.<br />

-; Akere, I C.; Kaplan, J. C., 1184<br />

Orsulak, Paul J.; Haven, Mary C.; Burton,<br />

Michael E.; Akers, Linda C., 1318<br />

Osawa, Hisao; Yoshino, Fumio; Yamada,<br />

Akefumi, 1133<br />

Osborne, James W. See Sun, Yi<br />

Osborne, P. T. See Crisan, D.<br />

Osonio, R. Vex; Vilaninho, 1,2338<br />

Ostariz, J. I Serrano See Budnia, J. Ruiz<br />

(later, 0.; Dabm, hi.; Oelert, H.; Pnellwitz, W.,<br />

851<br />

Ostrovsky, Irene; Delea, A.; Stesiw, K.;<br />

Santiago, I., 1104<br />

Ostrow, D. H.; Trace, H., Jr.; Macioszek, J.;<br />

Swanson, S. M.; Edwards, B. M., 1193<br />

Ostrow, David G.See Hariharan, hi.<br />

Ota, M. K. See Allin, Ronald F.<br />

Ou, Ching-Nan See Rognerud, Cheryl;<br />

Rognerud, Cheryl L.<br />

-;Rognerud,CherylL, 1164<br />

Overbeck, W. See Beever, K.<br />

Peavonen, Jorma; Lehtinen, Matti; Lehto,<br />

Maili; Lame, Seppo; Aine, Risto; Rasanen,<br />

Liise; Stanman, Ulf-Hekan, 869<br />

Pacholski. Janet See O’Connor, Brian<br />

Paci, Anna; Cocci, F.; Piras, F.; Ciariinboli, G.;<br />

Clenico, A., 1140<br />

-; Cocci, Fnanca; Piras, Francesca; Cianimboh,<br />

Giuliano; Clerico. Aldo, 2093<br />

Padilla, A.; Maretsky, D.; Blackwood, J.; Inbar,<br />

S.; Grenner, G., 1196<br />

Padilla, A. J. See Grenner, G.<br />

Pagan!, Franca See Bonora, Roberto;<br />

Panteghini, Mauro<br />

Painter, Pennell; Evens, John; Cope, June;<br />

Bailey, Kim; Smith, Jane; Whaley, Tammy,<br />

1136<br />

Evans, John; Copas, Pleas; Smith, Jane; Cope,<br />

June, 1143<br />

Paleani, Renata; Arcelloni, Cinzia; Paroni, Kite;<br />

Fermo, Isabella; hiosca, Andrea, 425<br />

Palermo,<br />

Palestine,<br />

M. See Madry, Norbert<br />

Alan 0. See Elm, Ronald J.<br />

Palmer, Adele, 1154<br />

Palmer, J. See Peck, hi.<br />

Palmer, John J. See Louderback, Allan I<br />

Palomaki, Glenn E. See Knight, George J.<br />

Palo., Gebor See Karadi, Istvan<br />

Pen, Jie; Ng, H.-T.; Heieh, C.-Y.; Lee, C.-Y. 0.,<br />

1081<br />

Pandian, M. IL See Nelson, Jerald C.; O’Connor,<br />

Daniel T.; Tercero, J. C.<br />

-; Morgan, Craig; Nelson, Jerald C.; Fisher,<br />

Delbert A., 1150<br />

Pang, E. See Singh, Jagat<br />

Pannall, Peter R. See Nicolson, Ruth F.<br />

Panteghini, Mauro See Bonora, Roberto<br />

-; Pagani, Franca, 180<br />

-; Pagani, Franca, 417<br />

-; Bonore, Roberto; Pagani, Franca; Hall,<br />

hiargot; Neisler, Mike; Johnson, J. T., 901<br />

-; Pagani, Franca; Cuccia, Claudia, 909<br />

-; Pagani, Franca, 1116<br />

-; Pagani, Franca, 1264<br />

Peolucci, F. See Freiss, G.<br />

Peolucci, Francis See Rogier, Herve<br />

Papedimitriou, Dimitri C. See Wortsman,<br />

Jacobo<br />

Papadopoulos, N. M.; Costello, R.; Charnas, L.;<br />

Adamson, hi. D.; Gahl, W. A., 2231<br />

2356 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989<br />

Papadopoulos, Nicholas M.; Costello, R., 1085<br />

Papedopoulos, Nick M. See Costello, Rene;<br />

Pascal!, Enzo<br />

Pepanastasiou-Diamandi, A. See Diamandis, E.<br />

P.; Diamandis, Eleftherios P.<br />

Pappas, Alex A. See Taylor, F. Howard<br />

Patuet, K, J. See Santulli, M. J.<br />

-; Santulli, hi.; Penson, J., 1105<br />

Parcells, K. See Chiang, C. S.<br />

Pardue, Harry I See Bacon, Bonnie L.<br />

Park, Sue S. See McBride, James H.<br />

Parker, K, Michael See Aitmiller, Dale H.;<br />

Blick, Kenneth F.<br />

-; Green, Judi L.; Aitmiller, Dale H.; Blick,<br />

Kenneth E., 1184,1238<br />

Parker. I See Okorodudu, A. 0.<br />

Parker, N. C. See Levtzow, C. B.<br />

Pankkinen, Jaakko, 1638<br />

Parlavecchla, M. See Marcovina, Santica<br />

Parlavecchla, Manlella See Dolci, Alberto<br />

Paroni, Rita See Peleari, Renata<br />

Parra, H. J. See Steinmetz, A.<br />

Parsons, Patrick J. See Stanton, Noel V.<br />

-; Stanton, Noel V.; Gunter, Elaine W.; Huff,<br />

Daniel; Meola, John R.; Reilly, Andrew A.,<br />

2059<br />

Parvy, P.; Bardet, J.; Rabier, D.; Bonnefont, J-<br />

P.; Kamoun, P., 178<br />

Pascal!, Enzo; Pezzoli, Antonio; Costello, Rene;<br />

Papadopoulos, Nick M., 1550<br />

Pasic, limed; Djulbegovic, Benjamin; Wittliff,<br />

JamesL., 2317<br />

Pasqua, J. See Fitzpatrick, D. A.<br />

Pusey, Richard B. See Blick, Kenneth E.<br />

-; Maluf, Karen; Smith, James; Gillum, Ronald<br />

L., 1099<br />

-; Duty, Gale; Blick, Kenneth E.; Gillum,<br />

Ronald L., 1157<br />

Pastore, Denise See Ferreira, Victoria M.<br />

Petal, Niranjan; Opperniann, hi.; Bowman, C.,<br />

1199<br />

Petal, Pragna See Luzton, Richard W.<br />

Patella, Lisa; Anderson, 0,, 1102<br />

Patrick, A. W. See Tibi, L.<br />

Patrick, Jim See Deneris, Even S.<br />

Patsch, Josef K. See Patech, Wolfgang<br />

Patscb, Wolfgang; Brown, Spencer A.;<br />

Morrisett, Joel D.; Gotto, Antonio hi., Jr.;<br />

Patech, Josef K., 265<br />

Patton, Phillip E., 1063<br />

Pen, B. See Freiss, G.; Piechaczyk, M.<br />

Pan, Bernard See Rogier, Herve<br />

Pauley, Carol See Werner, Mario<br />

Pauley, Scott D.; Miller, K. C.; Maier, K. S.;<br />

Roes, S. J.; Koch, D. D., 1142<br />

Paus, Elisabeth; Nusted, Kjell. 2034<br />

Pavlls-Jenklns, Lynn See Spronk, Adrian hi.<br />

Pawson, Tony See Attia, John<br />

Paxton, Helene; Christy, P.; hialloy, D., 1201<br />

Paz, J. M. See Rodriguez-Segade, S.<br />

Paz, J. Manuel See Rodniguez-Segade, Santiago<br />

Peake, M. J. See Berry, M N.<br />

Pearce, S.; Dowsett, M.; Jeffcoate, S. L, 632<br />

Pearson, Stephen D.; Ash, K. Owen; Urry,<br />

Francis hi., 636<br />

-; Wu, J. T., 1082<br />

-; Ash, K. 0.; Urry, F.M., 1163<br />

-; Wu, James T., 1997<br />

Pease, John See Chuog, Byung Soak<br />

Peat, J. J. See Peat, Michael A.<br />

Peat, Michael A.; Pino, J. A.; Caughlin, L.;<br />

Noedel, hi.; Peat, J. J., 1185<br />

Peck, 0.1 See Huang, C. M.<br />

Peck, M.; O’Gredy, M.; Sanghvi, A.; Horenzy, M.<br />

J.; Kubasik, N.; Palmer, J., 1101<br />

Peck, William A., 1053<br />

Pedd.cord, K. Michael, 691<br />

Pesters, D. See Pallet, D. E.<br />

Pegg, C. See Beever, K.<br />

Pejakovic, M. See Berry, hi. N.<br />

Pekary, A. B. See Vowels, J. A.<br />

Pelcb, D. See Fox, Martha<br />

Peiletier, Peter ft. See Okorodudu, Anthony 0.<br />

Peltenburg, Henny G. See Giesen, Peter LA.<br />

Peltyszyn, Stephanie; Alexander, L.; Mercer,<br />

W.; Noun!, N.; Wimmer, C., 1111<br />

-; Alexander, L.; Noun, N.; Mercer, W.;<br />

Wimmer, C., 1207<br />

Pelzer, H. See Dati, F.<br />

Pembroke, Anthony See O’Leary, Niall<br />

Pende, Aldo See Musso, Natale K.<br />

Penders, T. J. See Weykamp, C. W.<br />

Pennington, C. D. See Dolan, P. A.<br />

Penno, Giuseppe See Giampietro, Ottavio<br />

Penson, J. See Paquet,<br />

Penta, K. See Steedter,<br />

R. J.<br />

M.<br />

Per, Steven H.; Averse, Catherine K.; Situ,<br />

Alexander F., 1859<br />

Perdnisot, Remy; Bounaud, Manie-Paule;<br />

Bounaud, Jean-Yves; Jellet,<br />

Perel, J. M. See Foglia, J. P.<br />

Pierre, 115<br />

-; Foglia, J. P.; Curran, S.; Lin, F. C.;<br />

Narayenan, 5., 1175<br />

-; Stiller, K. L; Cunran, S.; Lin, F. C.;<br />

Narayanen, S., 1179<br />

Perez-Bendito, Dolores; Gomez-Hens.<br />

Agustina; Gutierrez, M. Carmen; Anton,<br />

Soledad, 230<br />

Pergande, Monika See Jung, Klaus<br />

Perkins, Sherry 1; Johnson, Pam M., 1508<br />

Perrin,<br />

Perrot,<br />

K. See Guemouni, Laila<br />

Daniel See Pugeat, hiichei<br />

Perry,<br />

Perry,<br />

T. See Highamith, W. E.<br />

Tenly R. See Highamith, W. Edward, Jr,<br />

Perryman, M. B. See Puleo, Peter K.<br />

Perryman, M. Benjamin See Puleo, Peter K.<br />

Person, Nil. B.; Ehrenknanz, Joel ILL, 1181<br />

Pesce, A. J. See Hassan, F. Michael; Schroeder,<br />

Timothy J.; Wermeling, J. K.<br />

Pesce, Amadeo J. See hiagnotti, Ralph A., Jr.;<br />

Wermeling, Joseph R.<br />

Peace, Michael<br />

Pete, Philomena<br />

A., 1232<br />

M. See Sgoutes, Demetrios S.<br />

Peter, James B. See Sevall, J. Sanders; Young,<br />

Karen K. Y.<br />

Peters, Barbara See Peters, Jorg<br />

Peters, Jeffrey I See Wu, James T.<br />

Peters, Jorg; Schmidt-Gayk, Heinnich; Peters,<br />

Barbara; Armbruster, Franz Paul;<br />

Quentmeier, Armin; Mathias, Dietger, 573<br />

Peters, P. See Sgoutes, D.<br />

Petersen, J. R.; Kapadie, P., 1197<br />

-;Gini,S.,1201<br />

-; Khan, S.; Keyser, H., 1203<br />

Peterson, P. See Gibbons, L<br />

Peterson, Timothy B. See Sun, Vi<br />

Petersson, Jean See Hausson, Lens<br />

Petrelli, N.J. See Bhargava, AK<br />

Pettersson, Kim See Makinen, Maije-Liisa;<br />

Suonpal, Mikko<br />

Pevet, Paul See Skene, Debra J.<br />

Peynet, Jacqueline See Bonnefont, Dominique<br />

-; Legrand, Alsin; Messing, Bernard; Thuillier,<br />

Francois; Rousselet, Francois, 674<br />

Pezzoll, Antonio See Pascali, Enzo<br />

Pflager, Carol See Inloes, Roger; Picone, Teres<br />

Pham, Q.See Rifai, Nader<br />

Pham, Quynbchl; Rifai, N.; Soldin, S. J., 1066<br />

Phan, Tuyet-Mlnh See Feldmann, Delphine<br />

Philbrick, David H. S. See Miles, Andrew<br />

Philcox, J. C. See Nordin, B. B.. C.<br />

Phillipou, G.; James, S. K.; Seeborn, C. J.;<br />

Phillips, P. J., 456<br />

Phillipou, George; Farnant. Robert K.; Phiffips<br />

Patrick J., 2017<br />

-; James, Steve K.; Seaborn, Chris J.; Phillips,<br />

Patrick J., 2019<br />

Phillips, D. See Bsever, K.<br />

Phillips, E.; Hwang, N.; Joseph, K.; Nyberg, S.,<br />

1131<br />

Phillips, J. C.; Chapman, J. F., 1072<br />

Phillips, M. J. See Yiu, Samuel C. K.<br />

Phillips, P. J. See Phillipou, G.<br />

Phillips, Patrick J. See Phillipou, George<br />

Phillips, Vincent See Breglio, Susan<br />

Phung, H. T. See Baadenhuijsen, H.<br />

Picone, Teresa See Inloes, Roger<br />

-; McCallwn, Theresa; Pflager, Carol; Zoccoli,<br />

Michael A., 1171<br />

Piechaczyk, M.; Baldet, L; Peu, B.; Bastide, J.<br />

M., 422<br />

Pleper, Robert K. See Wu, James T.<br />

Pierre, K. See Metzler, M.; Muirheed, C.<br />

Pike, S. See Basham, Julie F.<br />

Pb, A. See Zucchelli, G. C.<br />

-; Zucchelli, 0. C.; Calvo, S.; Ferdeghini, M.,<br />

1209<br />

Pilot, Robert 1; Brennan, George; Zehrednik,<br />

Richard, 1206<br />

Pino, J. A. See Peat, Michael A.<br />

Pinto, M. See Bernstein, Larry<br />

Piper, M. See Fotiou, F.<br />

Plppenger, C. See Solano, Romeo<br />

Pipp.nger, C. E.; hieng, Xienzhong; Van Lamt<br />

Frederick; Rothnen, A. David, 1173, 1348<br />

Piras, F. See Pad, Anna<br />

Pinas, Francesca See Paci, Anna<br />

PinkIe, H. See Miyada, D. S.<br />

Plea, M. See Schottare, S. B.<br />

Pittington, J. See Neisler, H. M.<br />

Pizza, T. See Liffman, S.<br />

Platoff, Gennady E. See Koch, Thomas R.<br />

Plaut, David; Steed, Linda, 1110<br />

Pleban, Walter See Bernstein, Larry H.<br />

Plebani, Mario; Faggian, D.; Masiero, hi.; Di<br />

Mario, F.; Burlns, A., 1126


-; Faggian, D.; Floreani, A.; Masiero, hi.;<br />

Bunlina, A., 1134<br />

lesher, C. J. See Baldwin, James K.<br />

leuse, Joan A. See Lemann, Jacob, Jr.<br />

lotke, B. D. See Zarembka, F. K.<br />

odlesek, Stanley J.; Dufour, D. Robert;<br />

McPherson, Richard A., 1763<br />

odlasek, Stanley J. See McPherson, Richard<br />

A.<br />

-; McPherson, Richard A., 69<br />

-; McPherson, Richard A., 1119<br />

oklis, Alphonse See Edinboro, Leslie F.<br />

olaniec, Julie See Reason, Craig<br />

olesi, Claudlo; Rodella, Anna; Mantero,<br />

Giovanni; Cannella, Giuaeppe; Ferrari,<br />

Roberto; Albertini, Alberto, 1431<br />

olk, B. Frank See Hsing, Ann W.<br />

ollet, D. B..; Pesters, D.; Warmenbol, H.;<br />

Vastmans, I; Saman, B.; Heyndrickx, I; Do<br />

Lays, K.; Vsnderborght, B.; Wauters, C.; Van<br />

Heuverswyn, H., 1204<br />

onte, K.; Holzberg, K., 1130<br />

onti, Maunlzlo See Foesati, Piero<br />

ontllio, M. See Bonini, P. A.<br />

Oon, Mm Kwong See Wang, Shih Yung<br />

oon, H.; Hinberg, I., 1108<br />

-; Hinberg, I., 1161<br />

oorthuls, B. J. H. M. See de Jong, J. 0. N.<br />

oppe, W. See Baadenhuijsen, H.<br />

orchet, Nicole See Fontaine, Monique<br />

oretsky, Leonid See Novick, David hi.<br />

orter, S. K. See Silva, D. P., Jr.<br />

orter, Sharon E. See Landt, Yvonne<br />

orioles, M.; Bernal, D.; Guasch, R., 1117<br />

oslilico, James T. See Stock, John I<br />

ossik, Rafael Abraao See Hirata, Rosanio<br />

Dominguez Crespo<br />

ost, Gregory See Klee, George G.<br />

othier, S. See Madry, Norbert<br />

ottathil, H. See Siemon, Peggy<br />

oulin, Sue B. See Ledue, Thomas B.<br />

outhier, F. See Galanti, L. hi.<br />

owell, D. See Harrison, H. H.<br />

‘ower, Michael J.; Gosling, James P.; Fottrell,<br />

Patrick F., 1408<br />

-; Fottrell, Patrick F., 2087<br />

owers, M. See Fox, Martha; Milleep, Susan<br />

rabhakaran, V. M. See Vasdev, Sudesh<br />

rabhakaran, Victor M.; Whelan, Vern C.;<br />

Mills, A. J.; Kennedy, Annette, 1075<br />

rasad, K. See Kaira, J.<br />

ratt, O.K. See Jeyasingham, M.D.<br />

‘reese, Lynne M. See Eastep, Steven J.<br />

‘reissner,<br />

reissner,<br />

C. M. See Klee, G. 0.<br />

Carol See Klee, George<br />

‘rellwitz, W. See (later, 0.<br />

remel-Cabic, A. See Allain, P.<br />

‘rencipe, I See Baedenhuijsen, H.<br />

‘rescott, I F. See Beckett, G. J.<br />

‘resent, Bifi; Hayden, C.; Chang, L.; Chen, L.;<br />

Ceo, 0., 1204<br />

‘resent, W. See Broyles, Celeate<br />

ress, Richard D.; Wilding, Peter, 2219<br />

ressac, Monique See Fesus, Paul D.<br />

retty, P. See Canter, 0.<br />

ribor, Hugo C., 1233<br />

‘ricci, Flavie See Sensi, Meunizio<br />

‘rice, A.; Griffaths, H., 2017<br />

rice, Alun; Gniffiths, Huw; Morris, Brian W.,<br />

275<br />

rice, C. P. See Monk, J.; Newman, D. J.<br />

‘rignot, J. See Gelanti, I M.<br />

‘rihoda, Thomas J. See Schwartz, Joyce 0.<br />

‘rmncipe, Lorenzo See Fossati, Piero<br />

rninsen,<br />

[Anne<br />

J. See Duncan, Marilyn; Raymond,<br />

rlnsen, Johanna; Evans, I.; Heed, T.; Cole, K.;<br />

Legere, S.; Rushkowski, J.; Trundle, D.;<br />

Goldberg, N., 1135<br />

rrinz,<br />

‘nor,<br />

Richard A. See Braithwaite, Susan S.<br />

T. W.; Friedman, K. J.; Silverman, I M.,<br />

1075<br />

‘nor, Thomas W. See Highsmith, W. Edward,<br />

Jr.<br />

F-;Blasco, Peter A.; Dove, Janet L.; Leshner,<br />

Robert T.; Gruemer, Hanns-Dietar, 679<br />

-; Fniedmenn, Kenneth J.; Silverman, Lawrence<br />

hi., 1256<br />

nitchard, Cynthia G. See Lomeli, Hilda<br />

rrofitt, J. A. See Fredrickson, K. A.<br />

trosser, Connie; Krehn, John, 2336<br />

‘roudfoot, A. T. See Beckett, 0. J.<br />

truemer, J. M. See Wermeling, J. K.<br />

truemer,<br />

rzywara,<br />

Jane M. See Wermeling, Joseph<br />

LW. See Konrath, J. G.<br />

K.<br />

!uckett, ID. See Tadepalli, Sarvamanagala<br />

udek. Morris See Jainani, Azim<br />

Pugeat, M. See Dechaud, H.<br />

Pugeat, Michel; Bonneton, Agnes; Perrot,<br />

Daniel; Rocle-Nicolas, Brigitte; Lejeune,<br />

Herve; Grenot, Cetherine; Decheud, Henri;<br />

Brebent, Chantal; hiotin, Jean; Cuilleron,<br />

Claude-Yves, 1675<br />

Puleo, Peter ft.; Guedagno, Phili , Scheel, M.;<br />

Roberts, R.; Perryman, hi. B., 1119<br />

-; Guadagno, Philip A.; Roberts, Robert;<br />

Perryman, hi. Benjamin, 1452<br />

Punter,<br />

Pun,.alai,<br />

J. See Schnorr, G.<br />

Rubio ft.; Johnson, George F.; Feld,<br />

RoneldD., 1112<br />

Purcell, G. See Muinhead, C.<br />

Puschendorf, Bernd See Wencker, Marion<br />

Putnam, R. S.; Dowdey, A. B. C.; Van Dreal, P.;<br />

Moore, K.; Gilstrap, L.; Leveno, K., 1136<br />

Puttermen, Caryn See Donahue, Joseph<br />

Qian, Zhong-Hao See Geng, Jian-Guo<br />

Quale, Marguerite See O’Connor, Brian<br />

Quentmeler, Aninin See Peters, Jorg<br />

Quigley, M. K.; Lawson, 0. J., 507<br />

Quinn, K. See Tadepalli, Sarvamanagala<br />

Quinton, Paul M., 726<br />

Qureshi, H. See Liffman, S.<br />

Ream, Shanthi; Vrebel, Done M., 339<br />

Rabler, D. See Kamoun, P.; Pervy, P.<br />

Raff, Hershel; Finding, James W., 596<br />

Rainey, Petrie M., 1165<br />

Relay., Vidmantaa A. See Rohner, Charles;<br />

Rosenzweig, I. Bruce<br />

Ralston, S. See Nargeasi, K. D.<br />

Ramias, Lois See Jeevanandam, Malayappa<br />

Ramsey, J. See Melerski, James J.<br />

Rao, J. See Narang, Rema<br />

Raaanen, Lila. See Paavonen, Jorms<br />

Rasmussen, Karsten, 260,2271<br />

-; Moelby, Lane; Jensen, hiogens Krogh, 2277<br />

Ratdliffe, W. A.; Heath, D. A.; Ryan, hi.; Jones,<br />

S.R., 1957<br />

Ratcllffe, Wendy A. See Lewis, Helen M.<br />

Rauscher, B. See Hagele, E. 0.<br />

Ray, D. H. See hiyers, Gary L.<br />

Ray, K. See Williams, Michael<br />

Raymond, Anne; Bradley, H.; Sinipkins, F.;<br />

Trundle, D., 1105<br />

-; Duncan, hi.; Carlson, J.; Pnineen, J.; Trundle,<br />

D., 1139<br />

Raynaud, Florence See Skene, Debra J.<br />

Ream, Linda See Wu, James T.<br />

Reason, C. See DeShon, P.<br />

-; DeShon, P.; Becks, 5., 1094<br />

Reason, Craig; Polaniec, Julie; Matheke, Mary<br />

Lou, 1118<br />

Recio, Carmen See Recio, Fernando<br />

Redo, Fernando; Redo, Carmen, 1127<br />

Redaelli, G. See Dati, Francesco<br />

Reddy, Padala V.; fley, P.; Banerji, A.; Lonardo,<br />

A., 1170<br />

-; hey, P.; Benerji, hi.; Banerji, A.; Lonardo, A.,<br />

1170<br />

Redmond, G. P. See Gupta, Manjula K.<br />

Reeders, S. T.; Germino, G. G.; Gillespie, G. A.<br />

J., B13<br />

Regalado, Jacinto See Bruzek, Debra<br />

Register, Loretta J.; Keren, David F., 2016<br />

Rehak, Nadja N.; Chiang, Betty T., 1031<br />

-; Andersen, Tom F., 1538<br />

Rehkemper, Catherine; Fisher, Catherine;<br />

DeLaurentis, Mark; Ballet, Neal, 1141<br />

Roibnegger, Gilbert See Fuchs, Dietmar<br />

-; Fuchs, Dietmar; Hausen, Ama; Werner, Ernst<br />

K.; Werner-Felmayer, Gabniele; Wachter,<br />

Helmut, 990<br />

-; Fuchs, Dietmar; Hausen, Arno; Werner, Ernst<br />

R.; Wemner-Felmayer, Gebriele; Wechter,<br />

Helmut, 2157<br />

Reich.teln, B. See Shankaran, P.<br />

-; Diamandis, E. P., 1139<br />

Reid, A. See McConwey, M. G.<br />

Reid, S. See Shackleton, C. H. L.<br />

Reilley, T. See Kaseman, Deborah<br />

Reffley, Therese; Fields, S.; Stamy, K.;<br />

Del Vecchio, M.; Chang, J.; Fischberg, E.;<br />

Kaufman, K. A., 1122<br />

Reilly, Andrew A. See Parsons, Patrick J.<br />

Reffly, Christopher P. See Nicolson, Ruth B..<br />

Reimer, Keith A., 1049<br />

Relniers, T. J.; Matamoros, K. A.; Bartlett, S.<br />

hi.; Lamb, S. V., 1133<br />

Roles, A. See Jagoda, F.; Tsay, H.<br />

-; Stouffer, B.; Tesy, H.; Jagoda, E.; Mantha, S.;<br />

Tunebi, N.; Tu, J., 1189<br />

Rej, Robert; Norton, Carol, 1069<br />

Relyea, Noel M., 1169<br />

-; Lodato, D., 1169<br />

Remaley, A. T.; Builey, hi.; Senior, hi. B.;<br />

Goodman, D. B. P., 1259<br />

Remaley, Alan T.; Wilding, Peter, 2261<br />

Renda, Nurten See Copur, Sitki<br />

Renfeng, F. See Coyle, P.<br />

Renouf, Judith A.; Wood, Amends; Frazer, I.<br />

H.; Thong, Y. H.; Chalmers, A. H., 1478<br />

Renz, M.; Helm, C.; Breunlmg, 0.; Czichos, A.;<br />

Wieland, C.; Seelig, H. P., 1861<br />

Resnick, Lowrence M., 1054<br />

Restrepo, L. See Cheng, Mary H.<br />

Retsum, Helga; Ueland, Per Magne; Svardel,<br />

Aebjorn Martin, 1921<br />

Rettmer, Rebecca I; Davis, Holly A.; Carey,<br />

Mary hi.; Jack, Rhona Labbe, Robert F.,<br />

1113<br />

-; Origenes, Maurice I, Jr.; Brown, Warren P.;<br />

Labbe, Robert F., 1114<br />

Revenant, Marie-Claude See Vernet, Michele<br />

Revol, Francoise See Lespinas, Francis<br />

Hayes, Ana F. See McBride, James H.<br />

Reynoso, Gustavo See Kambli, Vijeykant B.<br />

Rhode., M. See Wells, David<br />

Ricci, Mary Jo; Benoit, Cheryl A.; Lertora, Juan<br />

J. I; George, William J., 1809<br />

Rice, D. See Shihabi, Z.<br />

Richards, J. See Fitzgerald, D.<br />

Richardson, Douglas K. See Russell, John C.<br />

Richant, C. See Joven, J.<br />

Riche, I. See Vincent-Viry, Monique<br />

Rlchman, Gary See Katz, Paul K.<br />

Richter,<br />

Ridnoun,<br />

D. See Fitzgerald, D.<br />

Michelle D. See Whitley, Chester B.<br />

Riesco, Oscar F.; Hejri-Mezghani, Selma;<br />

Cekan, Stem Z., 1680<br />

Rletz, P. See Jarausch, J.<br />

Rifal, N. See Gutierrez, Aide; Iosefsohn, Mariet<br />

Pham, Quynhchi<br />

Rifal, Nader; Heiss, 0.; Doetech, K., 1065<br />

-; Pham, Q.; hicMurnay, K. G., 1066<br />

-; Morales, Antonio, 1189<br />

-; Morales, Antonio, 1996<br />

Rigault, Marie Y.; Ken, Brenda, 1092<br />

Rinaldi, Grazieila See Ciuti, R<br />

Rinker, Alan D.; Tietz, Norbert W., 1799<br />

Rinnie, Sherrie See Hollander, Loni<br />

Ritchie, Robert F. See Johnson, Andrew Myron<br />

Rizzotti, P.; Rozza, F.; Klein, G., 1090<br />

Robbrecht, Joban See Delange, Joris<br />

-; Do Buyzere, Marc; Dolanghe, Joris; Do<br />

Scheerder, Ivan; Mortier, Eric;<br />

Vanderschueren, Serge, 898<br />

Robbrecht, Johan H. See Do Buyzere, Marc L.<br />

-; Do Buyzere, Marc I; Dolanghe, Joris K., 1540<br />

Roberts, K., 1093<br />

Roberts, Karen See Bachorik, Paul S.<br />

Roberts, Pamela See Felci, Ronald<br />

-; Feld, Ronald; Ladouceur, Pete, 1128<br />

Roberts, Pamela I See Smith, Karen<br />

Roberta, R. See Puleo, Peter K.<br />

Roberts, Randall T.; Kelner, Michael<br />

Alexander, Nicholas M., 1124<br />

J.;<br />

Roberts, Robert See Puleo, Peter K., 1050<br />

Roberts, Ruth See Felder, Robin A.<br />

Robinson, P. See Ryder, K.<br />

Roche, D. See Thuan, N. T. Leuquang<br />

-; Arneodo, V.; Lequeng, N. T.; Skindjien, 0.0.,<br />

Rochefort, H. See Freiss, 0.<br />

Rochefort, Henri See Rojier, Herve<br />

Rock, Robert See Chan, Daniel W.<br />

Rocle-Nicolas, Brigitte See Pugeet, Michel<br />

Rodeck, B. See Oellerich, Michael<br />

Rodella, Anna See Polesi, Claudio<br />

Roder, John C. See Attla, John<br />

Rodey, 0. See Morin, Leo G.<br />

Rodey, Glenn B. See hiorin, Leo G.<br />

Rodgerson, D. 0. See Aim, Ronald E.;<br />

Schotters, S. B.<br />

Rodgerson, DenI. 0. See McBride, James H.<br />

Rodriguex-Segade, S.; Lojo, S.; Camina, hi. F.;<br />

Paz, J. hi.; Del Rio, K., 1556<br />

Rodnlguez-Segade, Santiago; Lojo, Santiago;<br />

Camina, hi. Felix; Paz, J. Manuel; Del Rio,<br />

Remon, 134<br />

Roeser, H. P. See Chain, B. E.<br />

Rote, A. M. See Coyle, P.<br />

Rogers, E. J. See Karge, W. H.<br />

Rogers, K. See Sibilia, K.<br />

Rogers, I See Schmidt, Wesley<br />

Rogers, Linda C.; Smith, F. A., 1103<br />

Rogers, Michael M. See Bradley, Charles A.<br />

Rogers, Rick K. See Ma#{231}aotti,Ralph A., Jr.<br />

Rogler, Herve; Freise, Gillee; Bases, Marie-<br />

Georges; Cavslie-Barthez, Ghislaine; Garcia,<br />

Marcel; Pau, Bernard; Rochefort, Henri;<br />

Peolucci, Francis, 81<br />

Rognerud, Cheryl; Ou, Ching-Nan, 1164<br />

Rognerud, Cheryl I See Ou, Ching-Nan<br />

-; Ou, Ching-Nan, 857<br />

CLINICALCHEMISTRY, Vol.35, No. 12, 1989 2357


Rohdewald, Peter See Schaefer, Hans Guenter<br />

Rohner, Charles; Raisys, Vidmantas A., 1177<br />

Rome, Risto See Tunpeinen, Ursula<br />

Rokahr, B. See Woo, Jannie<br />

Rokugawa, K. See Ishimori, Yoshio<br />

Romano, Louis J. See Schaap, A. Paul<br />

Romanschln, A. D. See Allen, L. C.<br />

Romeo, K. See Lschman, Mary F.<br />

Romics, Laazlo See Karadi, Istvan<br />

Romleu, Isabeile See Kaplan, Lawrence A.<br />

Ronald, Beverly A.; Bogeme, Stuart C., 1177<br />

Roopral, H. K. See Jeyasingham, M. D.<br />

Root, D. See Gibbs, Judy<br />

Ro.alkl, Sidney B. See Baja, Renze<br />

-; Kazmierczak, Steven C.; Van Lente,<br />

Frederick, 187<br />

-; Foo, A. Ying, 513<br />

-; Foo, A. Ying; Amnteen, K. W., 702<br />

-; Foo, A. Ying; Johnson. Andrew W., 707<br />

Rosano, Thomas; Yadegari, P.; Swift, T.; Wu, A.;<br />

Ambrose, K., 1132<br />

Rosano, Thomas 0. See Apple, Fred S.<br />

Rose, Alice See Brown, Ellen D.<br />

Rose, 0. Alan See Edwards, Paul<br />

Rose, H. See Dlaz, S.<br />

Roes, I. S.; Young, G. P.; St. John, D. J. B.;<br />

Deacon, M. C.; Blake, D.; Henderson, K. W.,<br />

2290<br />

Rosen, A. I See Sehgal, Lakshmen K.<br />

Rosenberg, Jonathan 8., 1571<br />

Rosenberg, M. See Chiang, C. S.; Cooper, hi.;<br />

Tsunokawe, hi.<br />

Rosenblum, J. I; Stahlschmidt, G. E.; Landt,<br />

M.; Hortin, G. L; Vaidys, H. C.; SOya, D. P.,<br />

Jr.;Smith,C.H., 1123<br />

Rosencrans, Robert; Buttita, D.; Olley, A.;<br />

Semna, F., 1090<br />

Rosenfeld, Louis, 521<br />

Rosenfleld, H. See Zeunczkoswki, Denise<br />

Rosenfleld, Henry; Kaufman, K. A., 1129<br />

Rosenthal, P.; Height, M.; Henton, D., 1151<br />

Rosenthal, Philip; Keefe, M. I.; Henton, D.;<br />

Cheng, hi.; Lee, C. K.; Hall, K. L.; Newton,<br />

hi. K., 1095<br />

Rosenzweig, I. Bruce; Dasgupte, Amitave;<br />

Turgeon, Jeanne; Raisys, Vidmantas A., 1177<br />

Ross, S. J. See Pauley, Scott D.<br />

Rosseneu, M. See Labeun, C.<br />

Roszak, D. See Lauderdale, V.<br />

Rotenberg, Z. See De Silve, L. V. K.<br />

-; Weinberger, I.; Davidson, F.; Fucha, J.;<br />

Harell, D.; Agmon, J., 871<br />

Rotenberg, Zvi See Weinberger, htzhak<br />

-; Weinberger, Itzhak; Sagie, Alex; Fucha, Jacob;<br />

Davidson, Ehud; Sperling, Oded; Agmon,<br />

Jacob, 301<br />

Roth, Diethild See O’Connor, Brian<br />

Rothner, A. David See Pippenger, C. E.<br />

Roussel, G. See Thuan, N. T. Leuqueng<br />

Rousselet, Francols See Peynet, Jacqueline<br />

Rowbotham, Lynn; Molyneux, Angus; Morris,<br />

Brian, 513<br />

Rowbury, D.; Fanrence, h.; Fitzgerald, A., 1552<br />

Rozza, F. See Rizzotti, P.<br />

Rubinow, David See Elm, Ronald J.<br />

Ruby, Stephen G. See Lake, Mitchell S.<br />

Ruddel, M. See Csako, G.; Huang, C. M.<br />

Ruddel, Mark See Csako, Gyorgy; FIn, Ronald<br />

J.<br />

Ruddel, Mark K. See Elm, Ronald J.<br />

Rudenstam, Carl-Magnus See Nystrom, Ernst<br />

Rudolph, K. See Bernstein, Larry<br />

Rudolph, Raiser See Bernstein, Lenny H.<br />

Rudy, J. See Bush, P.<br />

Rudy, Jack K..See Anderson, David J., 509<br />

Ruelland, A.; Clerc, C.; Legras, B.; Cloerec, I,<br />

2155<br />

Rulz, K See Koh, Tun&<br />

Hula, Eliseo; Koh, T.; Edwards, K., 1084<br />

Rulz, Jean-Charles See Vernet, hiichele<br />

Running, Joyce A. See Urdes, Mickey S.<br />

Ruprah, M. See Flanagan, K. J.<br />

Ru.hkowski, J. See Prinsen, Johanna<br />

Rushkowski, Janet; Trundle, D.; Glick, hi.,<br />

1098<br />

Russell, John C. See Zibrat, Steven J.<br />

-; Cooper, Carol hi.; Ketchum, Catherine H.;<br />

Torday, John S.; Richardson, Douglas K.;<br />

Halt, John A.; Kaplan, Lawrence A.;<br />

Swanson, J. Robert; Lyle, W. Michael, 1005<br />

-; Cooper, Carol hi.; Ketchum, Catherine H.;<br />

Torday, John S.; Richardson, Douglas<br />

Holt, John A.; Kaplan, Lawrence A.;<br />

K.;<br />

Swenson, J. Robert; lyle, W. Michael, 1075<br />

Russell, K. 0. G. See Caswell, A. hi.<br />

Rutten, WimP. F. See van Rijn, Jan L. hi. L.<br />

Rutterford, Mary See Smith, K. F.<br />

Ruxton, David See Novick, David hi.<br />

Ryan, Diane F. See Zibrat, Steven J.<br />

Ryan, Francis; Scott, Deborah; Gregory,<br />

Maudry; Turner, Marshall, 1123<br />

Ryan, M. See Ratcliffe, W. A.<br />

Ryder, K.; Oei, T.; Robinson, P.; Jackson, S.;<br />

Taylor, D.; Whang, K., 1130<br />

Ryder, Kenneth; Glick, Starla; Glick, Melvin,<br />

1155<br />

Ryder, Kenneth W. See Glick, Melvin; Glick,<br />

Melvin K.<br />

Rynning, M. See Eble, K. S.<br />

Sabagh, Taliir See Frandsen, Erik K.<br />

Sacha, P. See hiarlewski, D.<br />

Sacks, Frank M. See Hankinson, Susan F.<br />

Sadowskl, James; Davidson, Kenneth; O’Brien,<br />

Maureen; Candela, Ellen, 1162<br />

Sadrzadeh, Sayed M. H.; Ainardi, V.; Gordon,<br />

C.; Tartaglione, T.; Opheim, K. E., 1181<br />

Sagie, Alex See Rotenberg, Zvi<br />

Salle, H. See Steinmetz, A.<br />

Sakai, Y. See Uji, Y.<br />

Sakoguchi, Takafumi See Kobayashi, Kunio<br />

Sala, M. See Izembart, hi.<br />

Saldana, S. See Dasgupta, Amiteva<br />

Salinas, H. See Wimmer, Cathy<br />

Salinas, Rosalla See DiPaola, Joseph<br />

DiPaola, Joseph; Mercer, Wayne, 1205<br />

Salmon, Charles See Lefrere, Jean-Jacques<br />

Salser, W. See McBride, L. J.<br />

Semen, E. See Pallet, D. E.<br />

Sampson, C. See Vasdev, Sudesh<br />

Sanchez, Agustin C. See Venta, Rafael<br />

Sanchez-Pescador, Ray See Urdea, Mickey S.<br />

Sandberg, Sverre See Bolann, Bjorn J.<br />

Sanghvi,<br />

Santek,<br />

A. See Peck, hi.<br />

David A. See Burgese-Caealer, Anthony<br />

Santiago, L See Ostrovsky, Irene<br />

Santulli, M. See Paquet, K. J.<br />

Santulli, M. J.; Paquet, K. J.; Collie, M. J.;<br />

Leleux, J., 1104<br />

Sans, M. T. Higuenas See Budria, J. Ruiz<br />

Sapin, K.; Gasser, F.; Chambron, J., 888<br />

Saraiva, Maria Joao Mascanenhas; Alves,<br />

Isabel Longo; Costa, Pedro P., 1033<br />

Sardesai, Sudha; Chen, Y. hi.; Vaughn, C. B.,<br />

1081<br />

Sarnaik, Ashok See Brettfeld, Chris<br />

Sarosi, David; Hamilton-Smith, S.; Cheng, hi.<br />

L., 1101<br />

Sarosi, Elaine See Clark, Many hi.<br />

Sasaki, Masabide, 1052<br />

Saso, Luciano See Silvestrini, Bruno<br />

Sasse, B. A.; Cardoni, D.; Dicamelli, K. F., 2140<br />

Sate, K. See Sorin, T.<br />

Sato, Makoto See Matsuda, Akihiko<br />

Sato, S. See Nakamura, Maeakazu<br />

Savory, J. See Hewitt, C. D.; Winbomne, K.<br />

Savory, John See Brune, David<br />

David A.; Nicholson, James<br />

E.; Herold,<br />

K. P.<br />

Savory, M. G. See Boyd, James C.; Winbomne, K.<br />

Savory, M. Geraldine See Nicholson, James K.<br />

P.<br />

Scanu, Angelo M. See Kunechinski, Douglas T.<br />

Scano, J. See Shihabi, Z.<br />

Schaab, Coileen See Eisenberg, Paul K.<br />

Schaap, A. Paul; Akhavan-Tafti, Hashem;<br />

Desilva, Renuka, 1201<br />

-; Akhavan, Hashem; Romano, Louis J., 1863<br />

Schaefer, Hans Guenter; Rohdewald, Peter,<br />

821<br />

Schaich, K. See Hagele, E. 0.<br />

Schap, F. D. See Myers, Gary L.<br />

Scharer, K. See Karcher, Raymond<br />

Scharer, Katharine A.; Karcher, Raymond F.;<br />

Epstein, Emanuel; Kiechle, Frederick L.,<br />

2250<br />

Scharpe, S. See Hendriks, D.<br />

Scheel, M. See Puleo, Peter K.<br />

Scheffel, J.; Wiesner, D.; Kapsalis, A.; Traylor,<br />

D.; Susrez, A., 1210<br />

Scheller, Gyorgy See Goth, Laszlo<br />

Schel.traete, M. See Carpenter,<br />

Schiebout-Clark, B.C.; Haven,<br />

K. J.<br />

hi. C.; Orsulak,<br />

P. J.; Markin, K. S., 1146<br />

Schiele, F. See Henny, Joseph<br />

Schiele, Francolse; Antur, Yves; Varasteh,<br />

Abdolreza; Weilman, Maria; Siest, Gerard,<br />

926<br />

Schifman, K. B. See Howanitz, P. J.<br />

Schiller, William H. See Jeevanandam,<br />

Malayeppe<br />

Schlain, Brian; Knouwer, Jan S., 2118<br />

Schlumberger, M. See Izembert, hi.<br />

Schmer, Gottfried See Chandler, Wayne L.<br />

Schmid, Karl See Bungi, Willy<br />

Schmid, K. See Lubec, G.<br />

Schmid, Rainer; Kupferschmidt, Reinhand, 1352<br />

Schmld, Rainer W. See Kupferschmidt,<br />

Reinherd<br />

Schmidt, B. See Metzmann, F.<br />

Schmidt, Bob See Brashear, Jeff<br />

Schmidt, Linda S. See Spronk, Adrian hi.<br />

Schmidt, N. A. See Weykamp, C. W.<br />

Schmidt, Nico A. See van Rijn, Jan L hi. L<br />

Schmidt, Wesley; Clemens, J.; Rogers, L.;<br />

Covault, H.P.; Hojvet, S., 1152<br />

Schmldt-Gayk, Heinnich See Bohler, Ulrich;<br />

Peters, Jorg<br />

Schmledel, Thomas See Jung, Klaus<br />

Schmltz,J.;Jain,C.;Stockert,L., 1131<br />

Schneider, D. See Nargessi, R. D.<br />

Schneider, I; Liu, A.; Bonkoski, F.; Brendt, B.<br />

1181<br />

Schnoil, Sidney H. See Lewis, Douglas F.<br />

Schnorr, G.; Brocks, D. G.; Gunzler, V.;<br />

Hachmann, H.; Punter, J., 1188<br />

Schnorr, Gerd K.; Hachmann, H.; Harthus, H.<br />

P.; Neuenhofer, S.; Walter, 0., 1188<br />

Schoen, Irwin See Bandi, Zolten L.<br />

Schoenau, K; Boeswald, W.; Wanner, K.;<br />

Herzog, K. H.; Boewing, B.; Boehies, H. J.;<br />

Stahr, K., 1888<br />

-; Herzog, K. H.; Gonchoroff, Daryl 0.; O’Brie:<br />

John F., 2255<br />

Schotters, S. B.; McBride, J. H.; Rodgerson, D<br />

0.; McGinley, hi. H.; Pisa, hi., 1109<br />

Schrelber, William K. See Harkness, Dianne;<br />

Jamani, Azini; Knystel, Gerald<br />

Schroder, Karaten See Jun, Klaus<br />

Schroeder, Timothy J.; Weiskittel, P.; Pesce,<br />

J.; Myre, S. A.; Alexander, J. W.; First, Ml<br />

1176<br />

Schryver, Pat See Hage, David S.<br />

Schryver, Patricia See Klee, George<br />

Schulkamp, Kirk See Heu, Pa Choo<br />

Schwartz, Connie A. See Brens, Yves W.<br />

Schwartz, D. See Dnietnian, Ann hi.; Liffman,<br />

S.; Smith, Carol<br />

Schwartz, Joyce, G. See Indriksons, Andris<br />

-; Brown, Richard W.; hicMahan, C. Alex; Gai<br />

Carole L; Herber, Shirley A., 130<br />

-; Bazan, Cabs, Ill; Gage, Carole L; Prihoda,<br />

Thomas J.; Gillhani, Sherni L, 651<br />

Schwartz, M. K. See Bhalla, Ravi; Chen, Yao-<br />

Tseng Dnistrian, Ann M.; Fleisher, Mantis<br />

Smith, Carol<br />

Schwartz, Morton K. See Fleisher, Martin;<br />

Hansen, Hans J.<br />

Schweighofer, Franz See Fridnich,<br />

Schweitzer, J. K. See Witte, D. L<br />

Leo<br />

Schwenzin, D. See Doris, Manuel, Jr.<br />

Sciotto-Brown, Susan; Lin, Yuh-Nan; Huchit<br />

Michael; Sheiinan, Mark; Dunks, Louis, Jr<br />

1172<br />

Scott, Deborah See Ryan, Francis<br />

Scott,<br />

Scott,<br />

Joan H. See McPherson, Richard A.<br />

M. See Anderson, Geoffrey Butch, A.;<br />

Haden, B.<br />

Scott, Milda; Anderson, G., 1103<br />

Scott, Mitchell G. See Bodor, Geza; Butch,<br />

Anthony W.; Myrtle, James F.; Wolf, Bryai<br />

A.<br />

-; Ladenean, Jack H.; Green, Eric D.; Gast,<br />

Michael J., 620<br />

Scriven, Anthony J.; Tapley, Elizabeth hi., 15<br />

Scudamore, C. H. See Donnachie, E. hi.<br />

Seaborn, C. J. See Phillipou, G.<br />

Seaborn, Chris J. See Phillqou, George<br />

Seamonds, Bette; Strasser, B. L.; Tuhy, P. M.,<br />

1202<br />

Seccombe, D. W. See Donnachie, E. hi.<br />

Seelig, H. P. See Rena, M.<br />

Sefraoui, M. See Stainmetz, A.<br />

Segal, A. See Bray, Kurtis R.<br />

Segers, M. F. G. See Thomas, C. hi. G.<br />

Segura, J.; de Ia Torre, K.; Congost, hi.; Cami,<br />

879<br />

Sehgal, H. L See Sehgal, Lakshmen K.<br />

Sehgal, Lakshman 1K.;Sehgal, H. L.; Rosen, A<br />

L.; Gould, S. A.; Moss, G.S., 1155<br />

Seldel, Karen E. See Brown, Ellen D.<br />

Seifarth, K. See Gupta, Manjula K.<br />

Seislove, J. See Muinhead, C.<br />

Selzlnger, Bernd K., B25<br />

Semroc, G. See Bankeon, Daniel D.<br />

Senftner, H. J. See Madry, Norbert<br />

Senior, M. B. See Remaley, A. T.<br />

Senn, Chris See Eckfeldt, John H.<br />

Seoul,<br />

Sensi,<br />

M. See Lubec, 0.<br />

Maurlzio; Pricci, Flavia; Grazis De Roe<br />

Maria, Moreno, Susanne; Di MarIo,<br />

Umberto, 384<br />

Sephel, Gregory C. See Smith, Mary Carole<br />

Saraj, F. See Body, J. J.<br />

Serna, F. See Rosencrane, Robert<br />

2358 CLINICALCHEMISTRY, Vol.35, No. 12, 1989


,ta, F. See Tamagno, B.<br />

‘vaIl, J. Sanders; Peter, James B., 1076<br />

,verson, Suzanne L See Whitley, Chester<br />

,well, K. See Lucas, F.<br />

B.<br />

,ymour, D. See Gage, S.<br />

routes, D.; Clank, R.; Sgoutas, S., 1145<br />

Barton, E.; Hammarstrom, hi.; Peters, P.;<br />

Sgoutas,S., 1145<br />

routes, Demetrioe<br />

Hammarstrom,<br />

S.; Barton, Earl G.;<br />

Margareta; Pete, Philomena<br />

hi.; Sgoutas, Sandra A., 1785<br />

Abbott, Karen L, 2251<br />

routes, S. See Sgoutas, D.<br />

loutas, Sandra A. See Sgoutas, Demetris<br />

teckleton, C. H. L.; Reid, S., 1906<br />

S.<br />

tackleton, C. K. See Donnachie, E. M.<br />

tee, M. See Staedter, hi.<br />

teffer, Stanley G. See Brans, Yvee W.<br />

teb, V. See Yen, Sg.Erh<br />

teh, Vipin; Gladding, D.; Costello, K. M.;<br />

Barkey, D., 1162<br />

teh, Vipin D.; Yen, Shing-Erh; Diorio, Alfred<br />

F.; Hammer, Peggy A., 493, 1801,2157,2337<br />

tekanglan, S.; Fritache, H. A.; Hughes, J. I.,<br />

1080<br />

tehangian, Shahnam; Friteche, Herbert A.,<br />

Jr.; Hughes, John I.; Gelder, Frank B., 405<br />

Friteche, Herbert A., Jr.; Hughes, John I.;<br />

Johnston, Dennis A., 972<br />

teler, Robert C., 1058<br />

iamberger, K. J.; Banerji,<br />

Benerji, A., 1118<br />

A., 1113<br />

hankanan, P.; Reichatein, F.; Diamandie, F. P.,<br />

1153<br />

hanklin, Nora See Novms, Joel<br />

liapino, Sander 8., 1063<br />

harp, C. See Endres, David B.<br />

mw, David See Eisenberg, Paul R.<br />

law, Leslie M., 5,1235,1299<br />

law, Norm See Dowell, Barry<br />

law, Norman; Guy, Jennifer; Borden, Kim;<br />

Golubjetnikov, Rjunik; Bradley, Linda;<br />

Boots, Larry; Burton, Barbara; Miller,<br />

Wayne, 1192<br />

law, S. T. See Harrison, H. H.<br />

heat, J. M. See George, P.M.<br />

heehan, C.; Chnistofides, N.; Dent, A.; Midgley,<br />

J., 1148<br />

heehan, Christopher P. See Ball, Richard<br />

heehan, M.; Caron, 0.; Clark, L, 1103<br />

heiman, Mark See Kish, Linde; Sciotto-Brown,<br />

Susan; Zimmermenn, Linde<br />

heiman, Mark I. See Fan, Titan S.; Ku, Che.<br />

An<br />

heldon, Robert S.; Hill, Roger J.; Duff, Henry<br />

J., 748<br />

helton, M. See Butch, Anthony<br />

henkin, A. See Fraser, W. D.<br />

hepherd, B. See Hughes, J.<br />

hepherd, H. See Edwards, S.; Hughes, J.<br />

heppard, Michael C.; Black, F. G., 1142<br />

herman, W. M. See Ward, Kory M.<br />

heth, Anil K. See Tern, Tanuja K.<br />

heth, Nandini A. See Teni, Tenuja K.<br />

bibs, A. See Cho, Hinako<br />

hiba, K. See Cho, Hinoko<br />

hibata, H. See Matsuura, Tsuneaki; Yshikawa,<br />

Kazuaki<br />

hieh, P. See Bartling, D.<br />

bleak, Shu-Chu See Ting, Stanford W.<br />

Ting, W. K., 1111<br />

hihabi, Z. See McCormick, C.<br />

-; Rice, D.; Dyer, K., 1122<br />

-; Scero, J.; Jackson, J.; Friedberg, hi., 1203<br />

hihabi, 7.. K. See Hamilton, Robert W.<br />

himano, Hitoehi See Ishibeshi, Shun<br />

bimizu, Noriko See Terayama, Hiroshi<br />

bijuixu, K. See Yen, Shing-Erh<br />

himizu, Yoehlo See Yamauchi, Akihiro<br />

Itimojo, Nobuo; Naka, Keiichi; Nakajima,<br />

Chiaki; Yoshikawa, Chikao; Okuda, Kiyshi;<br />

Okada, Kunio, 1992<br />

hionoya, Yoehlhlko See Marute, Kazuhino<br />

hirahase, Y. See Watazu, Y.<br />

hobokshi, 0. See FI-Attar, Hanan M.<br />

boil, Shin’ichl; Komiyama, Atsushi;<br />

Nakamure, Maseo; Nomoto, Shozo, 1264<br />

-; Karasawa, Kouji; hiiyagi, Kouichi; Dun,<br />

Huijun, 2254<br />

bort, 6. See Uzan, Michel<br />

hoop,<br />

huey,<br />

Vernon<br />

Denise<br />

A.; Kalhan,<br />

F. See Tietz,<br />

Satish C., 495<br />

Norbert W.<br />

hukla, K. See Lucas, F.<br />

huler, S.F. See Witherspoon, L. R.<br />

hyaniala, M. See Moscoso, Hugo<br />

hyu, W. C. See Wei, J. S.<br />

ihiha, H.; Lohff, M.; Bush, D.; Rogers, K.;<br />

Joseph, R., 1106<br />

-; Lohff, M.; Bush, D.; Maheffey, K.; Joseph, R,<br />

1158<br />

Slemon, Peggy; Pottathil, K.; Usategui, M.;<br />

McNally, A. J., 1195<br />

Sleet, G. See Guemouni, Laila; Henny, Joseph;<br />

Vincent.Viry, Mornque<br />

Siest, Gerard See Schiele, Francoise<br />

Sigmund,<br />

Signorini,<br />

D. See Wermeling,<br />

C. See Ferrari, R.<br />

J. K.<br />

Silva, D. P., Jr. See Roeenblum, J. L.<br />

-; Landt, Y.; Porter, S.F.; Ladenson, J. H., 1203<br />

Silva, K. See Mulberg, F.<br />

Silver, M. K.; McGinnis, S.; Jordan, N.M.; Law,<br />

W.T., 1074<br />

Silverman, Jan F. See Khazanie, Prabhaker<br />

Silverman, L M. See Bankson, Daniel D.;<br />

Highemith, W. F.; Holden, K. D.; Prior, T.<br />

W.<br />

Silverman, Lawrence M. See Christenson,<br />

Robert H.; Highamith, W. Edward, Jr.; Prior,<br />

Thomas W.<br />

-; Hejtmancik, J. Fielding; Thibodeeu, Stephen<br />

N.; Lovell, Mark Alan, B53<br />

Silvestnini, Bruno; Guglielmotti, Angelo; Saso,<br />

Luciano; Cheng, C. Yen, 2207<br />

Slmbeye, A. G. A., 1081<br />

Simmons, M. See Wu, Yih-Shiong<br />

Slmonen, Sirkka See Bungi, Willy<br />

Slmpklna, F. See Raymond, Anne<br />

Simpson, B. See Figard, Steve D.<br />

Simpson, D. See Moore, F. M. L.<br />

Simpson, Sylvia G. See DePaulo, J. Raymond,<br />

Jr.<br />

Simsek, Bolkan See Torun, Meral<br />

Simuncak, David M. See Doumas, Basil T.<br />

Sinclair, David; Galloway, Eric; McKenzie,<br />

Sheila; Follett, Edward A. C.; Wallace,<br />

Leeley, 1669<br />

Sine, H. K See Wu, Yih.Shio<br />

Singer, F. See Endres, David<br />

Sl,igh, J.; Dudley, Alden W., Jr.; Montaro, A.;<br />

Kulig,K., 1073<br />

-; Kulig, Kim; Dudley, A. W., Jr.; Lucco, L.,<br />

1115<br />

Slngh, Jagat; Dudley, A. W., Jr.; Pang, E.; Kulig,<br />

K.; Mayfield, C., 1145<br />

-; Dudley, A. W., Jr.; Diaz, S. K.; Kulig, K., 1154<br />

Slngh, Madhuni See Fan, Der.Fong<br />

Slngh, K. K. See Konstantinides, Frank N.<br />

Slngh, S. See Haniharan, hi.<br />

Singkamani, R.; Koottethep, S.; Supapang, A.;<br />

Thurnham, D. I., 513<br />

Sinba, Madhur See Khazanie, Prabhaker<br />

Sinha, K. See Somani, B. L.<br />

Sinnecker, Gernot, 1253<br />

Sirtoll, Melanie See Foseati, Piero<br />

Site, Alexander F. See Per, Steven K.<br />

Sivaprasad, N. See Kothani, Kanchan<br />

Shale, Jeftery S. See Latner, Benny P.<br />

Skene, Debra J.; Churchill, Alison; Raynaud,<br />

Florence; Pevet, Paul; Arendt, Josephine,<br />

1749<br />

Sklepkova, A. See Chromy, V.<br />

Skogen, W. See Dyer, Deborah<br />

Skogerboe, Kristen J.; McLaughlin, Kathleen;<br />

Labbe, Robert F., 1114<br />

-; Johnson, Catherine; Labbe, Robert F., 1157<br />

Skonier, John K See Snouwaert, John N.<br />

Slaby, K. See Wright, Robs K.<br />

Slazyk, William J. See Jewel, Sandra E.<br />

Sliva, Clara A. See Elm, Ronald J.<br />

Sloan, Chris; Collins, S.; Karcher, K.; Kiechle, F.<br />

L., 1159<br />

Smith, A. F. See Tibi, L.<br />

Smith, B. Re.. See Beaver, K.<br />

Smith, C. See Dnistrien, Ann M.<br />

Smith, C. H. See Rosenblum, J. L.<br />

Smith, Carl H. See Landt, Michael<br />

Smith, Carol; Schwartz, D.; Kurtz, R.; Brennan,<br />

hi.; Gordon, M.; Schwartz, hi. K., 1078<br />

Smith, Deborah A.; Henderson, A. Ralph, 509<br />

-; Moses, 0. C.; Henderson, A. K., 1116<br />

-; Henderson, A. Ralph, 1127<br />

-; Moses, Godfrey C.; Henderson, A. Ralph,<br />

1774<br />

Smith, Doug See Green, Philip<br />

Smith, Douglas K.; Fulton, T. K.; Swain, P.;<br />

Bowcock, A.; Daneshvar, L; Traver, C.;<br />

Gruenert, D.C.; Davis, R.; Cavelli-Sforza, L.<br />

L.; Donis-Keller, H., B17<br />

Smith, K See Wilson, John M.<br />

Smith, F. A. See Rogers, Linda C.<br />

Smith, J. C., Jr. See Brown, Ellen D.<br />

Smith, J. L. See Neisler, H. hi.<br />

Smith, James See Passey, Richard B.<br />

Smith, Jane See Painter, Pennell<br />

Smith, Joyce K.; Woo, Jannie, 1179<br />

Smith, Karen; Roberts, Pamela L; Johnson,<br />

George F., 1083<br />

Smith, Mary Carole; Sephel, Gregory C., 1156<br />

Smith, Michael P.; Levinson, Stanley S.;<br />

Maciejko, James J., 1074<br />

Smith, Norman B. See Brooks, Klezina E.<br />

Smith, K. F.; Rutterford, Mary; Hand, C. W.,<br />

1175<br />

Smith, S. J. See Myers, Gary L.<br />

Smith, S. Jay See Jewel, Sandra E.<br />

Smith, T. See Chiang, C. S.<br />

Smith, Wendell C. See Sportsman, J. Richard<br />

Smoluk,<br />

Sneath,<br />

G. See Gibbons, I.<br />

Tom See Spiehler, Vms<br />

Sninsky, John J., 1058<br />

Snouwaert, John N.; Jambou, Robert C.;<br />

Skonier, John E.; Earnhardt, Kimberly;<br />

Stebbina, John K.; Fowlkes, Dana M., B7<br />

Snyder, Andrew M. See Irish, Glenn K.<br />

Irish, Glenn K.; Snyder, Thomas D., 1197<br />

Snyder, Thomas D. See Irish, Glenn K.; Snyder,<br />

Andrew M.<br />

Sobecki, Stan See Branford, Susan<br />

Sobeski, L M. See Haven, hi. C.<br />

Sobeski, Linda M. See Haven, Mary C.<br />

Sokalski, Tomasz See Lewandowski, Ryszard<br />

Sokoll, Lon J.; Dawson.Hughes, Bess, 328<br />

Solan, Vishnu See Fan, Titan S.; Kish, Linde;<br />

Ku, Che-An<br />

Solano, Romeo; Pippenger, C.; Bunge, G.;<br />

Miteumoto, H.; DeBoer, 0., 1173<br />

Soldin, S. J. See Donnelly, James 0.; Hyde, John<br />

E.; Iosefsohn, Mariet; Pham, Quynhchi;<br />

Stone, Judy<br />

Soldin, Steven J. See Stone, Judith A.<br />

-; Morales, A.; Velasquez, hi. T.; Belfe, W., 1136<br />

Solomon, Judy See Wynn, Annette<br />

Somani, B. L; Sinha, K.; Gupta, M. M., 497<br />

Sommer, M. See Holzberg, Roni A.<br />

Sommer, Ronald G.; Loeschen, Barbara J.;<br />

Morris, David L., 1166<br />

Somville, M. A. See Galanti, L. M.<br />

Soonemaker, K. See Witherspoon, L. R.<br />

Sorbo, Be See Falkenseon, Marianne; Lundquist,<br />

Per<br />

Sorin, T.; Ifuku, Y.; Sato, K.; Kohno, H.;<br />

Mizokemi, hi.; Tokude, H.; Nekamure, hi.;<br />

Yamamoto, hi., 1206<br />

Spain, Mark See Wamnick, G. Russell<br />

Spanier, M. See hiullins, Marvin<br />

Sparks, K. See Hardy, Robert<br />

Sparks, Katherine See Ng, Ronald H.<br />

Spaven, F. F. See Zoha, Steven J.<br />

Spector, Deborah H. See Spector, Stephen A.<br />

Spector, Stephen A.; Hale, Karen; Denaro,<br />

Frank; Spector, Deborah H., 1581<br />

Spelcb, Michelle; Auget, Jean-Louis; Arnaud,<br />

Pierre, 833<br />

Spells, M. See Melerski, James J.<br />

Sperllng, Matthew; Chen, L; Heminger, L;<br />

Maxon, H.; Maugh, K.; Bodlaender, P., 1160<br />

Sperling, Oded See Rotenberg, Zvi<br />

Spichiger, Ursula E.; Vonderschmitt, Dieter J.,<br />

448<br />

Splehler, Vine See Hurrell, Yumina<br />

-; Wilson, Howard; El Shami, Said; Snesth,<br />

Tom; Jam, Narish, 1175<br />

Spiekerman, Michael, 1147<br />

Spire, Thomas J. See Fuchs, Dietmar<br />

Sportsman, J. Richard; Smith, Wendell C.;<br />

Wisely, Carl L., 1623<br />

Spronk, Adrian M.; Pavlis-Jenkins, Lynn;<br />

Schmidt, Linda S.; Taskar, Suhas; Brady,<br />

James A., 1193<br />

Srebro, Some See Mehznood, Nishat<br />

Staedter, M. See Ackermann, H.; Blackwood, J.;<br />

Grenner, G.<br />

-; Maretaky, D.; Finneren, J.; Penta, K.; Shee,<br />

M.; Inbar, S.; Blackwood, J.; Grenner, G.,<br />

1196<br />

Stahlschmidt, G. K. See Roeenbluxn, J. L.<br />

Stalder, Arnold See Donahue, Joseph<br />

Stampfer, Mein See Kaplan, Lawrence A.<br />

Stampfer, Meir J. See Hankineon, Susan F.<br />

Stamy, K. See Kasemen, Deborah; Reilley,<br />

Therese<br />

Stankievic, K. See Rhalle, Ravi<br />

Stanton, Noel V. See Parsons, Patrick J.<br />

-; Gunter, Elaine W.; Parsons, Patrick J.; Field,<br />

Patricia H., 2104<br />

Staples, Mark See Zen, Geraldine Tun<br />

-; Zen, Geraldine Tun; Munthy, H. hi. S., 1190<br />

Starrett, William See Brewster, Mange A.<br />

Stasiw, K. See Ostrovsky, Irene<br />

Statland, B. E. See Hardy, Robert<br />

Statland, Bernard E. See Ng, Ronald H.<br />

Stavljenlc, A. See Cvoriscec, D.<br />

Stebbins, John K. See Snouwsert, John N.<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2359


Steed, Linda See Plaut, David<br />

Steele, B.; Bell, M.; Campbell, hi.; Lucas, F.,<br />

1123<br />

Steffes, Michael W., 1237<br />

Stehr, K. See Schoenau, F.<br />

Stein, Kvau A. See Kaplan, Lawrence A.<br />

-; Wilson, Pamela; Kaplan, Lawrence A., 1203<br />

Steinberg, William M. See Werner, Mario<br />

Steindel, S. J. See Howanitz, P. J.<br />

Steinmetz, A.; Salle, K.; Sefraoui, M.; Parre, H.<br />

J.; Fruchart,<br />

Stekiova, Irma<br />

J. C., 671<br />

v.a.. Gerasimova, Netalija S.<br />

Stenman, Ulf-Hakan See Paevonen, Jorma;<br />

Suhonen, Lauri; Turpeinen, Ursula<br />

Stephens, Gregory W. See Magnotti, Ralph A.,<br />

Jr.<br />

Stephens, Karen See Green, Philip<br />

Stevenson, Cathy C.; Cibull, Deanna; Gere,<br />

Jeffrey A.; Bush, Donna M., 1179<br />

Stewart, M. J. See Elliot, K.; McIntosh, S. J.;<br />

Watson, I. D.<br />

Stiller, K. L See Perel, J. hi.<br />

St. John, D. J. B. See Roe., I.S.<br />

Stock, John L; Coderre, James A.; Posillico,<br />

JamesT., 18<br />

Stockert, L See Schmitz, J.<br />

Stockmann, W. See Baadenhuijsen, H.<br />

Stojak, J. See Eble, K. S.<br />

Stolarek, Iwona; Hawey, Jacqueline E. A.;<br />

Fraser, Callum G., 560<br />

Stone, Judith A.; Soldin, Steven J., 1326<br />

Stone, Judy; Morales, A.; Soldin, S. J., 1168<br />

Stott, Richard A. W. See Lewis, Helen hi.<br />

Stouffer, B. See Jagode, F.; Reise, A.; Tsay, H.<br />

Strandbergh, D. K. See Arties, J. D.<br />

Strange. Richard C. See Beckett, Geoffrey J.<br />

Strasberg, Paula, 1512<br />

Strasburger, Christian; Barnard, Geoff; Toldo,<br />

Lure; Zarmi, Bstya; Zadik, Zvi; Kowarski,<br />

Avinoam; Kohen, Fortune, 913<br />

Strasser, B. L See Seamonde, Bette<br />

Stratton, John K. See Chandler, Wayne L<br />

Streeter, B. See Wu, Lily L.<br />

Strong, Donna D. See Farley, John K.<br />

Strong, Wllliam B., 1061<br />

Strufaldi, Bruno See Hinata, Rosaria<br />

Dominguez Crespo<br />

Studts, U. J. See Earl, R. A.<br />

Stork, A. See Dati, F.<br />

Su, Muh-Hwan See Au, J. Lai-Sim<br />

Suarez, A. See Scheffel, J.<br />

Subbarao, Makam N.; Bakke, Antony C., 1153<br />

-; hiueggler, Paul, 1181<br />

Sudsbury, K. See Khosravi, hi. J.<br />

Suga, Tetuya See Iwate, Jihel<br />

Sughayer, Maher A.; Arkin,<br />

Sugita, Osamu See Kuwana,<br />

Charles F.. 1794<br />

Tomomi<br />

Sugiura, Ko.aku See Maekawe, Masato<br />

Suhonen, Lauri; Stanman, Ulf-Hakan; Koivisto,<br />

Veikko; Teramo, Karl, 922<br />

Suit, Paula See Van Lente, Frederick<br />

Sullinger, Jane; Garrett, Patricia F., 2223<br />

Sullivan, Susan See Lee, Theodore T.<br />

Summers, M. See Hughes, J.<br />

Sun, C. See Wong, P. Y.<br />

Sun, Lila; Galliher, G.; Tueak, R.; Brandt,<br />

Hsu, hi. Y.; Olson, H. hi., 1071<br />

B.;<br />

Sun, Yi; Peterson, Timothy E.; McCormick,<br />

Michael L.; Oberley, Larry W.; Osborne,<br />

James W., 1265<br />

Sundarain, G. S. See hienimekalni, S.<br />

Sundaram, Shan G.; Lustgartan, J.; Wenk, R.<br />

F.;Manimekalai, S.; Thilakavathi, S.;<br />

Goldstein, P. J., 1118<br />

Sundarem, G.S. See Goldstein, Phillip J.<br />

Sundberg, M. See Mauck, Linda<br />

Suonpaa, Mikko See hiakinen, Maija-Liisa<br />

-; Halonen, Tuija; Pettareson, Kim, 1205<br />

Supapang, A. See Singkamani, R.<br />

Sutphen, James L. See Franquemont, Douglas<br />

Suzuki, K. See Cho, Hiroko<br />

Svardal, Asbjorn Martin See Retsum, Helga<br />

Svens, Elvor; Kapyaho, Kirsti; Tanner, Pirjo;<br />

Weber, T. H., 662<br />

Sverlow, K. See Nargessi, R. D.<br />

Svlnarov, Dobrin A.; Dotchev, Dotcho<br />

Swain, P. See Smith, Douglas R.<br />

C., 1615<br />

Swaminathan, R. See Chan, A. Y. W.; Cheung,<br />

C. K.<br />

Swanson, B. N. See Catanzariti, P. A.; Wiernik,<br />

M.D.<br />

Swanson, J. Robert See Russell, John C.<br />

Kenny, Terry; Bissonnetta, John, 1193<br />

Swanson, Larry W. See Deneris, Even S.<br />

Swanson, S. See Kieng, W.<br />

Swanson, S. M. See Oetrow, D. H.<br />

Swanson, Terry; Blaylock, R.; Ash, K. 0., 1100<br />

Sweet, Michael See Kress, Barry C.<br />

Sweetman, Lawrence See Hoffmann, Georg<br />

Swift, M. See Highamith, W. F.<br />

Swift, T. See Roseno, Thomas<br />

Szekeres, Thomas See Fridrich, Leo<br />

Tackett, K. B. See Miceli, J. N.; Vroon, D. H.<br />

Tadepalli, Sarvamanagala; Quinn, R.; Puckett,<br />

L. D.; Onf, J. W.; Goldensoph, C. R.; Donner,<br />

J.E., 1187<br />

Tagari, Philip; Ethier, Diane; Carry, Melissa;<br />

Korley, Victoria; Chanleson, Stalla; Girard,<br />

Yves; Zamboni, Robert, 388<br />

Taggart, D. P. See Fraser, W. D.<br />

Tagliaro, F. See Donizzi, R.<br />

Taguchi, Hideo See Kanno, Norimichi<br />

Taguchi, Shizuko See Komno, Norimichi<br />

Takagi, Nobubiko See Tsuchiya, Hironori<br />

Takai, M. See hiizuochi, E.<br />

Takaku, Fumim.ro See Ishibashi, Shun<br />

Takao, Kyoji See Imamura, Shigeyuki<br />

Takasugi, Nobuo See Yamaguchi, Akihiro<br />

Takeda, Ryoyu See Hashinioto, Takuma<br />

Takei, Hitoshi See Nakashima, Koji<br />

Takeuchi, Fiji See Usui, Akihiko<br />

Talwar, D. See Watson, I. D.<br />

Tamagno, B.; Gatti, V.; Sets, F., 1539<br />

Tamaki, Haruo; Amino, Nobuyuki; Kixnura,<br />

Motoko; Miyal, Kiyoshi, 1252<br />

Tamura, Kohji See Kabeyashi, Isao<br />

Tan, A. See Diamandis, F. P.<br />

-; Khosravi, M. J.; Diamendis, E. P., 1139<br />

Tan, Alan See Diamandis, Eleftherios P.<br />

Tanaka, K. See Matsuura, Tsuneaki; Yoshikawa,<br />

Kazuaki<br />

Tanaka, Minoru See Usui, Akihiko<br />

Tanaka, S. See Bantling, D.<br />

Tang, C. L See Harrison, H. H.<br />

Taniguchi, Ken See Azuma, Yutaro<br />

Tanimoto, L See Cornelison, L.; Fu, Paul<br />

Tanluchi, Koji See Kobayashi, Kunio<br />

Tanner, Pirjo See Svens, Elvor<br />

Tapley, Elizabeth M. See Scriven, Anthony J.<br />

Tarailo, P. See Henny, Joseph<br />

Tarbaux, Nanine M. See Farley, John R.<br />

Tareoghi, Giordano See Fossati, Piero<br />

Tartaglione, T. See Sadrzsdeh, Sayed M. H.<br />

Tas, Sinan, 256<br />

Taskar, Subas See Spronk, Adrian M.<br />

Tataumi, Mikio See Teuchiya, Hironori<br />

Tawa, Rilchi See Fujimoto, Takashi<br />

Taylor. Bob See Hage, David S.<br />

Taylor, D. See Ryder, K.<br />

Taylor, E. Howard; Fink, Louis M.; Pappas,<br />

Alex A., 710<br />

Taylor, G. See Wang, P. Y.<br />

Taylor,<br />

Taylor,<br />

Robert See Klee, George<br />

W. Allen See Butler, Barbara A.<br />

Tekuzman, Gulten See Copur, Sitki<br />

Ten Cate, J. W. See Dati, F.<br />

Tern, Tanuja K.; Banclivdekar, Atmaram H.;<br />

Sheth, Anil R.; Sheth, Nandini A., 1376<br />

Tentas, Constentinos See Giannoulaki,<br />

Elefteria F.<br />

Teodosio, F. See Cheng, Mary H.<br />

Teredaira, Ryo See Maruta, Kazuhiro<br />

Teramo, Karl See Suhonem, Lauri<br />

Teramoto, Y. See Gannon, Allison<br />

Terayama, Hhroshi; Shimizu,<br />

Fukuzumi, Rieko, 2202<br />

Noriko;<br />

Tercero, J. C.; Pandian, hi. K.; Cerayon, P.,<br />

1208<br />

Tetrault, Gregory A.; Miller, W. Greg, 1065<br />

Thacker, Susan; Dubler, Robert; Wang, Neil;<br />

Walling, John; Chiappetta, Enrico; Gates,<br />

Teresa; Crisafulli, Terry, 1176<br />

Thajeel, A. H. See Abu-Fareakh, F. A.<br />

Them, Sock Ying See Wang, Shih Yung<br />

Thibert, K. J. See Catomeris, Peter<br />

Thibodeau, Stephen N. See Silverman,<br />

Lawrence M., 1057<br />

Thilakavatbi, S. See Sundaram, Shan G.<br />

Thliveris, J. See Copeland, Kenneth<br />

Thomas, C. M. G.; Segers, hi. F. G., 1791<br />

Thomas,<br />

Thomas,<br />

U. W. See Nordim, B. F. C.<br />

Daniel See Boitleux, Jean-Louis<br />

Thomas, Stanley M. See Tilzer, Lowell L.<br />

Thompson,<br />

Thompson,<br />

Edward J. See Luxton, Richard W.<br />

F. See Fox, Martha; Graham, D.<br />

-; Fox, hi.; Heden, B.; Vasilakis, J.; Dickey, D.;<br />

Cordy, P.; Jonza, J.; Kubasik, N., 1088<br />

Thompson, James D.; Decker, Scott; Haimes,<br />

Dale; Collins, R. Scott; Feild, Margaret;<br />

Gillespie, David, 1878<br />

Thompson, W. See Mebbett, S.<br />

Thompson, W. H. See Neisler, H. M.<br />

Thomson, S.; Wallace, A. hi.; Cook, B., 1706<br />

Thong, Y. H. See Renouf, Judith A.<br />

Thorner, MO. See Felder, K. A.<br />

Thornton, William H., Jr.; Adelstein, Edward<br />

H.; Roes, Thomas E., 459<br />

Thorpe, 0. H. 0. See Bronstein, I.; Voyte, J. C.<br />

-; Bronstein, I.; Knicka, L. J.; Edwards, B.;<br />

Voyta, J. C., 2319<br />

Thorstensson, K. See Haden, B.<br />

Thuan, N. T. Leuquang; hiigueres, M. L.;<br />

Roche, D.; Rouseel, 0.; hiahuzier, G.;<br />

Chretien, J.; Ekindjian, 0. G., 1456<br />

Thuillier, Francois See Peynet, Jacqueline<br />

Thurlbeck. William M. See Khadempour, M.<br />

Hassan<br />

Thunnham, U. I. See Singkamanm, K.<br />

Thut, Laurel See mb.., Roger<br />

Tibi, L; Patrick, A. W.; Leslie, P.; Taft, A. D.;<br />

Smith, A. F., 1427<br />

Tietz, Norbert W. See Rinker, Alan D.<br />

-; Astles, J. Rex; Shuey, Denise F., 1688<br />

Tikanoja, Sari See Ekins, Roger<br />

Tillman, J. See hicConway, hi. 0.<br />

Tilzer, Lowell L; Moreno, Ruben F.; Booth,<br />

Frank; Wilbur, Stephen; Thomas, Stanley<br />

hi.,2147<br />

Tiniko, U. M. See Earl, K. A.<br />

Ting, Stanford W.; Shiesh, Shu-Chu; Yang, Ch<br />

Fang, 1155<br />

Ting, W. K. See Shiesh, Shu-Chu<br />

Tlsell, Lars-Erik See Lundberg, Per-Anne;<br />

Nystrom, Ernst<br />

Tizio,<br />

Toda,<br />

T. See Wimmer, Cathy<br />

T. See Cho, Hiroko<br />

Toffaletti, John See Christenson, Robert H.<br />

-; Abrams, Billy, 935<br />

-; Abrams, Billy, 1131<br />

Toft, A. D. See Tibi, L.<br />

Tokuda, H. See Sorin, T.<br />

Toldo, Luce See Straeburger, Christian<br />

Tom, K. See Watkins, Michael<br />

Tomasik, J. See Walters, S.<br />

Tomei, Ray T. See Ekine, Roger; Nelson, Jerald<br />

C.<br />

Toms, Kick A. See Chou, Peter P.; Longhunst,<br />

Sharon<br />

Tono, Mary See Gross, Susan F.<br />

Torday, John S. See Russell, John C.<br />

Torloni, Sergio A. See Alexander, Roy L.<br />

Torun, Meral; Hacisalihoglu, Ayse; Kin, Sedef;<br />

Simsek, Bolkan, 1263<br />

-; Bayhan, Aysel; Yentur, Gulderen, 1792<br />

Tovey, M. See Dakubu, S.<br />

Toyota, Sachiko See Mashige, Fumiko<br />

Tracy, R. See Howard, P.<br />

Tracy, Russell P. See Dehiars, Daniel D.<br />

Tran,<br />

Tran,<br />

K. See Gennon, Allison<br />

Kini See hiolnar, Larry A.<br />

Trever, C. See Smith, Douglas K.<br />

Traverse, William See Yea, KIeng-Teck<br />

Travis, James See Lloyd, Cynthia<br />

Traylor, D. See Scheffel, J.<br />

Tremblay, Michel See Davignan, Jean<br />

Trevejo, K. See Aneani, A.<br />

Trimble, Elisabeth K. See McDowell, Ian F. W<br />

Tripodi,<br />

Tropak,<br />

A. See Dati, F.<br />

Michael See Attia, John<br />

Trout, Neil See Ng, Ronald H.<br />

Troyanosky, Deborah See Goldsmith, Barbara<br />

M.<br />

Truchaud, A. See Gouget, B.<br />

Trujillo, G. See Woo, Charles<br />

Trundle, U. See Duncan, Marilyn; Prinsen,<br />

Johanna; Raymond, Anne; Rushkowski,<br />

Janet<br />

Trundle, Diana S., 1237<br />

Tsai, LL See Kohl, HH<br />

Tsai, Michael Y.; Cooper, Katherine, 1989<br />

Tsay, H. See Jagoda, F.; Mantha, S.; Reiss, A.<br />

-; Reise, A.; Stouffer, B.; Mantha, S.; Turabi, S<br />

Jegoda, F.; Tu, J., 1189<br />

Tse, Mertlna; Feldbruegge, Donald; Wiebe,<br />

Donald; Koch, David D., 1068<br />

Tsoukas,<br />

Tsuchiya,<br />

Chris See Falutz, Julian<br />

Hiz’onorl; Hayeshi, Tokishi; Tatsum<br />

Mikio; Hoshino, Yoshiyuki; Ohtani, Shigert<br />

Takagi, Nobuhiko, 43<br />

Tsuda, Yoshiko See Fujimoto, Takeshi<br />

Tsuji, A. See Uji, Y.<br />

Tsuji, Masahiro See Konno, Norimichi<br />

Tsukada, Toshihiko See Joukyuu, Ritsuko<br />

Tsukeda, Yuteka See Yoshioka, Shinichi<br />

Tsukenioto, Yusuke See Ishida, Osamu<br />

Tsunokawa, M. See Chiang, C. S.<br />

-; Chiang, C. S.; Grove, T.; Folena-Wasserman,<br />

0.; Rosenberg, M., 1191<br />

Tu, J. See Jagoda, F.; hientha, S.; Reiss, A.;<br />

Tsay, H.<br />

Tuhy, P. M. See Seamonds, Bette; Zoha, Steven<br />

J.<br />

Turabi, N. See Jagoda, F.; Reiss, A.; Tsay, H.<br />

2360 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


1’urcant, A. See Allain, P.; Laine-Cessec, P.<br />

Turgeon, Jeanne See Rosenzweig, I. Bruce<br />

Turk, John W. See Wolf, Bryan A.<br />

Turner, Marshall See Ryan, Francis<br />

Turner, P. K. See Joven, J.<br />

Turner, Wayman K. See Gunter, Elaine W.;<br />

Miller, Barbara B.<br />

I’urpelnen, Ursula; Stenman, Ulf-Hekan;<br />

Rome, Risto, 33<br />

Tusak, K. See Sun, Lila<br />

Tuumlnen, Tamara See Gerasimova, Natslija S.<br />

Tvede, K. See Wendrup, Jesper<br />

Tyagi, Sanjay See Lomeli, Hilda<br />

Tyma, D. See DiPaole, J.<br />

Uchimaru, U. See Won, P. Y.<br />

Udwin, Michael See Bhck, Kenneth E.<br />

Ueland, Per Magne See Retsum, Helga<br />

Uemura, M. See Yemasaki, Mesehiko<br />

Uji, Y.; Okebe, H.; Sakai, Y.; Noma, A.; Meede,<br />

hi.; Tsuji, A., 325<br />

Ullman, Edwin F., 1239<br />

Ulm, J See Kohl, RH<br />

Unni, L K.; Hannant, hi. F.; Becker, R. E.;<br />

Giecobini, F., 292<br />

Unni, S. See Manimekalai, S.<br />

Urdal,<br />

Urdea,<br />

Petter; Landmark, Knud, 1559<br />

Mickey S.; Kolberg, Janice; Clyne,<br />

Jennifer; Running, Joyce A.; Besemer,<br />

Diana; Warner, Brian; Senchez-Pescedor,<br />

Ray, 1571<br />

Urquhart, N. L See Donnachie, E. M.<br />

Urry, F.M. See Pearson, Stephen D.<br />

Urry, Francis M. See Pearson, Stephen D.<br />

Usatagul-Gomez, M. See Kasemen, Deborah<br />

Usategui, M. See Siemon, Peggy<br />

Usategul-Gomez, M. See Kaseman, Deborah<br />

Usher, D.C. See Labeur, C.<br />

Usui, Akihiko; Kato, Kanefusa; Abe, Toshio;<br />

Murase, Mituya; Tanaka, Minoru; Takeuchi,<br />

Eij, 1942<br />

Uzan, Mlchel; Short, 0.; Bare, 0., 1092<br />

Valdya, H. C. See Rosenblum, J. L<br />

Valcour, A. A. See Krzymowski, G. A.<br />

Valcour, Andre; Bowers, 0. N., Jr.; McComb, K.<br />

B., 1119<br />

Valcour, Andre A. See Okorodudu, Anthony 0.<br />

-; Bowers, George N., Jr.; hicComb, Robert B.,<br />

939<br />

Valdes, R., Jr. See Butch, Anthony; Hardy,<br />

Robert<br />

Valdez, J. See Cornelison, L; Haute, Robyn<br />

Valdez, Johnny See Chung, Byung Sook; Hsu,<br />

Po Choo<br />

Valdya, Hemant C. See Lsndt, Yvonne<br />

Valendinova, M. See Chromy, V.<br />

Valenta, K. See Gage, S.<br />

Van Brunt, N.; Egensperger, H.; Greenberg, N.;<br />

Halstead, K.; Cassano, T.; Doptis, P.;<br />

Jennings, T., 1101<br />

van do Galseyde, J. F. See Weykemp, C. W.<br />

Vandeleene, B. See Bernard, A. hi.<br />

van den Berg-Bosnian, H. T. K. See<br />

Hafkenscheid, J. C. hi.<br />

Vanderborght, B. See Pallet, D. F.<br />

Vanderschueren, Serge See Robbrecht, Jahan<br />

van der Sluljs Veer, G. See Vermes, I.<br />

van der Vljgh, Willem J. F. See Leeuwenkamp,<br />

Oscar R.<br />

Van Dreal, P. See Putnam, K. S.<br />

van Haeften, T. W.; Konings, C. H., 1024<br />

Van Heuverswyn, H. See Pallet, D. F.<br />

Van Kesel, Antonius L; Mahoney, John, 1131<br />

Van Krleken, L. See Collet-Cassant, D.<br />

Van Lear, Lutyart See Dillen, Lieve<br />

Van Lente, F.; Kazmierczak, S.C., 1542<br />

Van Lente, Frederick See Kazmierczak, Steven<br />

C.; Pippenger, C. F.; Rosalki, Sidney B., 1233<br />

-; Suit, Paula, 2326<br />

Van Liedekerke, Beatrijs M. See Lambert,<br />

Willy E.<br />

van Munstor, P. J. J. See Elving, L. D.<br />

Vanneste, Lutgart See Lambert, Willy F.<br />

VanNoord, T. See Heriharan, M.<br />

VanNoord, Ted See Harihanan, M.<br />

van Ru, Andre M. See Wade, Chris K.<br />

van Rijn, Jan L M. L; Schmidt, Nico A.;<br />

Rutten, WimP. F., 840<br />

van Sande, M. See Hendniks, D.<br />

Van Tassel, K. See Bray, Kurtis K.<br />

Van Winkle, M. See Haden, B.<br />

van Zanten, A. P. See Weber, J. A.<br />

Varastoh, Abdolreza See Schiele, Francoise<br />

Vasdev, S. See Gault, M. H.<br />

Vasdev, Sudesh; Fernandez, P.; Prabhakaran, V.<br />

hi.; Sampson, C., 1138<br />

Vasilakis, J. See Fox, Martha; Thompson, F.<br />

Vasilakis, Jeanne; Muirhead, C. L.; Fox, M.;<br />

Haden,B., 1126<br />

Vasiliedes, John; Kuhlman, J., 1168<br />

Vassaneili, Corrado See Graziani, Maria Stalls<br />

Vassault, A. See Baedenhuijsen, H.<br />

Vastmans, L See Pallet, D. F.<br />

Vaughan, Kenward See Brashear, Jeff<br />

Vaughn, C. B. See Serdesai, Sudha<br />

Vaughn, K. See Lewis, L. M.<br />

-; Lewis, L hi.; Biagini, A. V.; Lee, C. K., 1108<br />

-;Lewis,L.hi., 1159<br />

Vaziri, N. D. See Miyade, D. S.<br />

Veer, G. van der Sluijs; Vermes, I.; Bonta, H.<br />

A., 493<br />

Velasquez, MT. See Soldin, Steven J.<br />

Velez, L See Crockett, R.<br />

Venetucci, Mary See Baker, Harold N.; Ford,<br />

Kent A.<br />

Vente, Rafael; Geijo, Sofia A.; Sanchez, Agustin<br />

C.; Bao, Constentino G.; Bartolame, Luis A.;<br />

Casanes, Gerardo; Lopez-Otin, Carlos;<br />

Alvarez, Frencisco V., 2003<br />

Verbruggen, Bert See Fischer, Johan<br />

Vergassola, Cleudio See Musso, Natale R.<br />

Vermes, I. See Veer, G. van der Sluijs<br />

-; van den Sluijs Veer, G.; Bonta, H. A., 1139<br />

Vermeulen, Alex<br />

Vernet, Michele;<br />

See Delange, Joris<br />

Revenant, Marie-Claude;<br />

Bird, Andree; Naudin, Claude; Jauneau,<br />

Monique; Olivier, Frencoise; Ruiz, Jean-<br />

Charles, 672<br />

Vernillet, L; Keller, H. P.; Le Bigot, J. F.;<br />

Huinbert, H., 608<br />

Vessella, Robert I See Mathisen, Mary L.<br />

Vickery, D. K. See Koch, Thomas R.<br />

Vigier, M. P. See Basuyau, J. P.<br />

Vignon, F. See Freiss, G.<br />

Vllarinho, I See Osorio, K. Vex<br />

Vilelle, E. See Joven, J.<br />

Villa,<br />

Villa,<br />

B. See Williams, Michael<br />

Barbara; Brandt, B.; Dalke, D.; Kaufman,<br />

J., 1109<br />

Villanueva, K. See F,ndres, David B.<br />

Vincent-Viry, Monique; Riche, L; Siest, 0.;<br />

Galteau, hi. M., 1184<br />

Visor, J. See Freeman, J.<br />

Vogel, Gisela See Bobber, Ulnich<br />

Vogt, B. W.; Ziegsnhorn,<br />

Volke, Teresa McMlllen<br />

J., 1110<br />

See Warnick, G.<br />

Russell<br />

Volimer, Robin T. See Christenson, Robert H.<br />

von Arb, Marianne See Gaillard, hi. Christine<br />

Vonderschmitt, Dieter J. See Spichiger, Ursula<br />

F.<br />

von Schenck, Henning See Grutzmeier, Sven<br />

Vowels, J. A.; Pekary, A. F.; Hershman, J. hi.,<br />

1147<br />

Voyte, J. C. See Bronstein, I.; Thorpe, G. H. G.<br />

-; Bronstein, I.; Thorpe, G. H. G.; Kricka, L. J.;<br />

Armstrong, G., 1190<br />

Voyta, John C. See Bronstein, Irena<br />

Vrabel, Dene M. See Raam, Shanthi<br />

Vroon, U. H. See Miceli, J. N.<br />

-; Miceli, J. N.; Bloodworth, D. F.; Brantley, N.;<br />

Tackett, F. B.; Wellington, P., 1165<br />

Vu, T. H. See Cheng, Mary H.<br />

Vukelic, B. See Cvoriscec, D.<br />

Wachter, Helmut See Fuchs, Dietmar;<br />

Reibnegger, Gilbert<br />

Wade, Etsuko See Deneris, EvanS.<br />

Wade, Keiji See Deneris, Even S.<br />

Wade, Chris K.; van Rij, Andre hi., 336<br />

Wagner, Galen S. See Christenson, Robert H.<br />

Wakabayashi, K. See Hosoda, K.<br />

Wakui, Hideki; Kobayashi, Ryoji; Itoh, Hideaki;<br />

Imsi, Hirokazu; Nakemoto, Yasushi; Miura,<br />

Akira B., 577<br />

Waldenlind, L. See Wallinder,<br />

Walker, V. See Mills, G. A.<br />

H.<br />

Walker, Valerie; Mills, Gnaham A., 1460<br />

Wallace,<br />

Wallece,<br />

A. M. See Thomson, S.<br />

Lesley See Sinclair, David<br />

Wailer, Kathy V.; Ward, Kary M.; Mahan, John<br />

D.; Wismatt, Dorothy K., 755<br />

Wallinder, H.; Angback, K.; Kshan, J.; Onica,<br />

D.; Waldenlind, L, 328<br />

Walling,<br />

Walloch,<br />

John<br />

Jami<br />

See Thacker, Susan<br />

I See Braithwaite, Susan S.<br />

Walsh, D. See Gawoski, J. M.<br />

Walter, G. See Schnorn, Gerd K.<br />

Walters, S.; Tomasik, J.; Olson, H. M., 1071<br />

Walton, S. See Mifflin, Ted<br />

Wan, Koon Ching See Chui, Shiu Hon<br />

Wandrup, J., 2027<br />

Wandrup, Jesper; Tvede, K.; Grinsted, J.;<br />

Jordening,H.,<br />

Wang, Henn-Ping;<br />

1740<br />

Ho, Hsu-Tso; Davouzadeb,<br />

Feegh; Wang, Huie, 1189<br />

-; Daniel, hiolly; Williams, Barbara; Knight,<br />

William, 1192<br />

Wang, Helen H. See Cembrowski, George S.<br />

Wang, Huie See Wang, Hann-Ping<br />

Wang, J. See Wang, X. L.<br />

Wang, Jia-Horng See Kuo, Cheng-Deng<br />

Wang, Neil See Thacker, Susan<br />

Wang, Shib Yung; Them, Sock Ying; Poon, Mm<br />

Kwong, 329<br />

Wang, Stephen T.; Demshar, H. P., 1152<br />

Wang, Tang Jang; Kilheeney, J.; Weaver, R.;<br />

Bunyagidj, C., 1198<br />

Wang, X. I; Dudman, N. P. B.; Wilcken, D. F.<br />

L., 1000<br />

-; Dudman, N. P. B.; Wang, J.; Wilcken, D. E.<br />

L., 2082<br />

Wang, Yue Hue See Wu, Lai Wen<br />

Wanner, K. See Schoenau, F.<br />

Ward, Kory M. See Wailer, Kathy V.<br />

-; Mahan, J. D.; Sherman, W. M.; Lash, J. hi.,<br />

1135<br />

Warlick-Yates, Kathy See Kessler, Jay<br />

Warmenbol, H. See Pallet, D. F.<br />

Warner, A. See Hassen, F. Michael<br />

Warner, Ann See Wermeling, Joseph R., 648<br />

Warner, Brian See Urdea, Mickey S.<br />

Warnick, 0. Russell See Bachonik, Paul S.;<br />

Nguyen, Thuy; Wu, Lily L.<br />

-; Spain, Mark; Kloepfer, Hens; Volke, Teresa<br />

Mchiillan, 409, 1235<br />

Warnik, K. See Wu, Lily L.<br />

Warren, K. See Lasky, Fred D.<br />

Warren, Patricia See Lott, John A.<br />

-; Lott, John A., 1090<br />

Watanebe, Norlyuki See Maruta, Kazuhiro<br />

Watazu,Y.;Shinahase,Y.; Keneda, N., 1127<br />

Waters, Marilyn See Bandi, Zoltan L.<br />

Watkins, Michael; Munthy, H. M. S.; McClure,<br />

K. Dale; Tom, K., 1140<br />

Watman, N. See Woo, Jannie<br />

Watson, Anita See Halloran, Stephen P.<br />

Watson, I. D. See Elliot, K.; Mcintosh, S. J.<br />

-; Langen, C. F.; Stewart, hi. J., 1353<br />

-; Clarke, M.; Stewart, hi. J.; Lindsay, G.;<br />

Talwar,D., 1354<br />

Watts, Nelson B., 1236<br />

Wauters, C. See Pallet, D. F.<br />

Weaver, K. See Wang, Tang Jang<br />

Webb,<br />

Webb,<br />

G. See Berk, Lee<br />

Gary; Beierle, F.; Berk, L.; Hillock, K.;<br />

Eby, W., 1097<br />

Weber, J. A.; van Zanten, A. P., 2143<br />

Weber, Jean-Philippe See Menca, Dma<br />

Weber, T. H. See Svens, Elvor<br />

Weeks, Marilyn See Gross, Susan F.<br />

Wegfahrt, P. See Fitzgerald, D.<br />

Wei, J. S.; Huang, H. M.; Shyu, W. C.; Wu, C. S.,<br />

2247<br />

Wei, Jeng S. See Yeh, Chau-Ting<br />

Weiber, H. See Abrahamsson, P.-A.<br />

Weldemenn, Gerhard See Baja, Rsnze<br />

Weiffenbach, Barbara See Green, Philip<br />

Weinberger, I. See Rotenberg, Z.<br />

Weinberger, Itzhak See Rotenberg, Zvi<br />

-; Fucha, Jacob; Rotenberg, Zvi; Davidson,<br />

Ehud; Hard, Daniels; Agmon, Jacob, 414<br />

Weiner, E. J. See Karge, W. H.<br />

Weingand,<br />

Weiskittel,<br />

Kurt; Hudson, C., 1134<br />

P. See Schroeder, Timothy J.<br />

Weissbecker, Karen A.; Gruemer, Hans-Dieter;<br />

Heard, Gregory S.; Miller, W. Gregory;<br />

Nance,<br />

Welssman,<br />

Walter F.; Wolf, Barry, 831<br />

Amir See Krivoy, Norberto<br />

Welch, Robin See Demka, Paul R.<br />

WelIby, Maurice I See Nicolson, Ruth F.<br />

Wellington, P. See Vroon, D. H.<br />

Wellington, Pat See Miceli, J. N.<br />

Wellmen, Maria See Schiele, Frencaise<br />

Wells, David; Ranks, B.; Rhodes, M., 1165<br />

Wells, David J.; Barnhill, Matthew T., Jr., 2241<br />

Wenoker, Marion; Hauptiorenz. Susanne;<br />

Willi; Puschendorf, Bernd, 1519<br />

Moll,<br />

Wenhain, Philip K.; Barboun, Heather M., 895<br />

Wenk, K. K. See Lustgarten, J. A.; Sundaram,<br />

ShanG.<br />

Wenk-Salamone, K. See Kaseman, Deborah<br />

Wermeling, J. it; Pruemer, J. hi.; Sigmund, D.;<br />

Peace, A. J., 1182<br />

Wermeling, Joseph K.; Pruemer, Jane hi.;<br />

Hassan, F. Michael; Warner, Ann; Peace,<br />

AmadeoJ., 1011<br />

Werneke, Debra K.; Elliot, K. L.; Bray, K. R.,<br />

1078<br />

Werner, Ernst K. See Fucha, Dietmar;<br />

Reibnegger, Gilbert<br />

Werner, Mario; Steinberg, William M.; Pauley,<br />

Carol, 967<br />

Werner-Felmayer, Gabriele See Reibnegger,<br />

Gilbert<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2361


Weasels, Hans See Fischer, Johan<br />

West, William H. See Oldham, Robert K.<br />

Weston, R See McConway, M. G.<br />

Weston, S. See Hughes, J.; Neelkanten, N. V.<br />

Wevers, K. A. See de Jong, J. G. N.<br />

Weykamp, C. W.; Pendera, T. J.; Schmidt, N. A.;<br />

Borburgh, A. J.; van de Galseyde, J. F.;<br />

Wolthers, B. J., 2281<br />

Whaley, Tammy See Painter, Pennell<br />

Wheng, F. See Ryder, K.<br />

Wheatley, U. See Fraser, W. D.<br />

Wheeler, W. S. See Castalleni, William J.<br />

Whelan, Vern C. See Prabhakaran, Victor M.<br />

Whitaker, Katrine B. See Moss, Donald W.<br />

-; Cox, Timothy hi.; Moss, Donald W., 86<br />

White, G. H. See Dilena, B. A.<br />

White, Paul F., 1056<br />

White, Robert M. See Fringe, Christopher S.<br />

White, Y. See Wu, Yih-Shiong<br />

Whiteley, 0. See Dekubu, S.<br />

Whitley, Chester B.; Ridnour, Michelle D.;<br />

Draper, Karl A.; Dutton, Cheryl M.; Neglia,<br />

Joseph P., 374<br />

-; Draper, Karl A.; Dutton, Cheryl hi.; Brown,<br />

Patrice A.; Severson, Suzanne L.; France,<br />

Laura A., 2074<br />

Whltlow, Karen See Harkness, Dianne<br />

Wiana, Frank H., Jr. See Jones, Christopher E.<br />

Widener, J. See Mauck, Linda<br />

Wiebe, Donald See Tee, Martins<br />

Wiebe, Donald A. See Hassemer, David J.;<br />

Lensmeyer, Gary L.<br />

Wieland, C. See Renz, hi.<br />

Wielinger, H.; Leinberger, K.; Zimmermann, 0.,<br />

1161<br />

Wleme, Roger See Delange, Joris<br />

Wieme, Roger J. See De Buyzere, Marc L.<br />

Wientjes, M. Guillaume See Au, J. Lai-Sim<br />

Wieringa, G. K.; Crawford, A., 2146<br />

Wiernik, M.D. See Catanzariti, P. A.<br />

-; Catanzaniti, P. A.; Swanson, B. N., 1119<br />

Wiese, David A.; Bowen, Thomas P.; Kost,<br />

Gerald J., 1098<br />

Wiese, Wendy A. See Arnold, Lyle J., Jr.<br />

Wiesner, D. See Scheffel, J.<br />

Wijnends, J. B. 0.; Esajas, hi.; Egberts, J., 706<br />

Wijono, Mercy, 1177<br />

Wilber, Laura See Hassemer, David J.<br />

Wilbur, Stephen See Tilzer, Lowell L.<br />

Wilcken, U.K. I See Wang, X. L.<br />

Wilcox, M. See Nordin, B. E. C.<br />

Wild, Christopher P. See Degan, Peolo<br />

Wilde, C. K. See Brocklehurst, D.<br />

Wilding, Peter See Kricka, Larry J.; Press,<br />

Richard D.; Remaley, Alan T.<br />

Wilkins, Martin It. See Lewis, Helen M.<br />

Wilkinson, J. 8. See Auliuchan, J. P.<br />

Wilkinson, Stephen P. See Fraser, Cailum G.<br />

Willey, Steven See Chasnoff, Ira J.<br />

Williams, Barbara See Wang, Hann-Ping<br />

Williams,<br />

Williams,<br />

Bernadine K. See Yeo, Kiang-Teck<br />

John; Williams, Katherine hi.;<br />

Marshall, Thomas, 206<br />

Williams, Katherine M. See Williams, John<br />

Williams, M. See Klukaa, C.; Leonard, H.<br />

Williams, Michael; Villa, B.; Ray, F.; Cheng, S.;<br />

Haden,B., 1132<br />

Williams, 0. Dale See Bachorik, Paul S.<br />

Williams, K. K. See Wu, Lily L.<br />

Williams, Roger K. See Wu, Lily L.<br />

Williamson, Janice; Bing, David H., 1208<br />

Williamson, Jerry; Borum, Peggy R., 1161<br />

Williamson, Robert, 2165<br />

Wifinow, P. See Kessler, Anne-Ch.<br />

Wills, MR. See Felder, K. A.; Hewitt, C. D.;<br />

Winborne, K.<br />

Wills, Michael R. See Bruns, David E.; Herold,<br />

David A.; Nicholson, James K. P.<br />

Wilson, H. K. See Cocker, J.<br />

Wilson, Howard See Spiehier, Vine<br />

Wilson, John M.; Hoch, K.; Blake, J.; Lindsay,<br />

W.; Smith, F., 1178<br />

Wilson, I See Wu, James T.<br />

Wilson, Pamela See Stain, Even A.<br />

Wimmer,<br />

Wimmer,<br />

C. See Peltyszyn, Stephanie<br />

Cathy; Alexander, L.; Mercer, W.;<br />

Noun, N.; Tizia, T., 1207<br />

-; DiPaola, J.; hiercer, W.; Noun, N.; Salinas,<br />

R., 1207<br />

Winarte, Handeni See Demko, Paul R.<br />

Winborne, K.; Nicholson, J.; Savory, M. G.;<br />

Hewitt, C. D.; Wills, hi. K.; Savory, J., 1114<br />

Windy, Carl L. See Sportsman, J. Richard<br />

Winkel, Per, 1595<br />

Winkles, J. W.; Lunec, J.; Gray, L., 303<br />

Winn, C. I See Moorman, Stacy<br />

Winters, Geyle I See Braithwaite, Susan S.<br />

Winters, Robert K. See Young, Karen K. V.<br />

Wisdom, G. Brian See McDowell, Ian F. W.<br />

Wlsmett, Dorothy K. See Weller, Kathy V.<br />

Witherapoon, lit; Shuler, S. E.; Neely, H.;<br />

Soonemaker, R.; Alyea, K.; Gilbert, S.; Baird,<br />

F., 1191<br />

Witte, U. I; Angstadt, D. S.; Schweitzer, J. K.,<br />

1148<br />

Wittliff, James L. See Pasic, Resad<br />

Wolf, Barry See Weissbecker, Karen A.<br />

Wolf, Bryan A. See Bodor, Geze; Myrtle, James<br />

F.<br />

-; Daft, Michael C.; Koenig, John W.; Flye, hi.<br />

Wayne; Turk, John W.; Scott, Mitchell G.,<br />

120<br />

Wolthers, B. J. See Weykamp, C. W.<br />

Wang, B. See Lauderdale, V.<br />

Wang, K. See Freeman, J.<br />

Wong, H. T. See Cheng, Mary H.; Huang, W. T.<br />

Wang, Jonathan See Harris, Heather M.<br />

Wong, M. M. See Hong, X. Q.<br />

Wang, P. Y.; Mee, A. V.; Sun, C.; Hofman, K.;<br />

Taylor, G.; Uchimaru, D.; Alspector, F., 1195<br />

Wong, Steven H. Y., 1240, 1293<br />

Wang, T.; MacKenzie, A., 1110<br />

Wong, William H., 1115<br />

Woo, Charles; Trujillo, G.; Cook, G.; Calaniunci,<br />

K.,1172<br />

Woo, Jannie See Smith, Joyce E.<br />

-; Haskins, C.; Oppenheimer, J.; Watman, N.;<br />

Rokahr, B.; Marsh, K., 1122<br />

Wood, Amanda See Renouf, Judith A.<br />

Wood, J. See Cornelison, L.; Houts, Robyn<br />

Woodheed, J. Stuart See Beaman, Janine hi.<br />

Woods, John K. See Glick, Melvin R.<br />

Woroniecka, Ursznle D. See de Haen, Karen E.<br />

C.<br />

Worthy, Tom See Hollander, Lan; Inloes, Roger;<br />

Klonizchii, Walt<br />

Worton, Ronald G., 519<br />

Wortsman, Jacobo; Papadimitriou, Dimitri C.;<br />

Barges, Marietta; Defesche, Charles L., 90<br />

Wreghitt, T. G. See Monk, J.<br />

Wrenberg, A. See Leaky, Fred D.<br />

Wright, K. See Burrows, KeriLyn C.<br />

Wright, Reba K.; Burrows, K.; Baherji, hi.;<br />

Slaby,R., 1170<br />

Wu, A. See Rosano, Thomas<br />

Wu, Alan H. B., 7<br />

-;Gornet,TerrieG., 1121<br />

-; Gornet, Ternie G.; Marker, Carol C.; Chen,<br />

Hui-Li, 1752<br />

Wu, C. S. See Wei, J. S.<br />

Wu, J. T. See Pearson, Stephen D.<br />

Wu, James T. See Pearson, Stephen D.; Wu, Lily<br />

L.<br />

-; Pieper, Robert K.; Wu, Lily H.; Peters,<br />

Jeffrey L., 778<br />

-; Ream, Linda; Miya, Terry, 1100<br />

-; Wilson, L.; Christensen, S., 1152<br />

-; Bringhurst, Cony, 1196<br />

Wu, Lai Wen; Wang, Yue Hue.<br />

Wu, Lily H. See Wu, James T.<br />

1355<br />

Wu, Lily I; Streeter, B.; Williams, R. R.;<br />

Lalouel, J.-M.; Wernik, K., 1071<br />

-; Wannick, G. Russell;Wu, James T.; Williams,<br />

Roger R.; Lalouel, Jean-Marc, 1486<br />

Wu, T..W. See Yiu, Samuel C. K.<br />

Wu, Wen-Guey See Kuo, Cheng-Deng<br />

Wu, Yih-Shiong; Bohannon, J.; White, V.; Cecil,<br />

hi.; Butler, S.; Simmons, M.; Sine, H. E.,<br />

1119<br />

-; Cecil, hi.; Bohannon, J.; Simmons, hi.; Sine,<br />

H.E., 1154<br />

Wyatt, David T.; Lee, Martha; Hillman, Richard<br />

E., 2173<br />

Wynn, Annette; Solomon, Judy, 1088<br />

Xander, S. A. See Kubasik, N. P.<br />

Yabuuchi, Masahiko; Masuda, Minoru; Katoh,<br />

Kazuo; Nakamura, Tsuneo; Akanunia,<br />

Hiroshi, 2039<br />

Yadegari, P. See Ensano, Thomas<br />

Yogi, Gohei See Matsumoto, Kojiro<br />

Yakata, Minoru See Kuwana, Tomomi<br />

Yamada, Akefumi See Osawa, Hisao<br />

Yameda, Nobuhiro See Ishibashi, Shun<br />

Yamaguchi, Akihiro; Fukushi, hiasaru;<br />

Mizushime, Yoshikiyo; Shimizu, Yoshia;<br />

Takasugi, Nobuo; Arashima, Shin-ichiro;<br />

Ohyanagi, Kazuhiko, 1962<br />

Yamaguchi, Shuichi; Koda, Naoya; Yamamoto,<br />

Hideaki, 1806<br />

Yamaji, T. See Hosoda, K.<br />

Yameinoto, Hideaki See Yamaguchi, Shuichi<br />

Yamemoto, Katsunobu See Maruta, Kazuhiro<br />

Yamamoto, M. See Sonin, T.<br />

Yanianashi, H. See Mizuochi, E.<br />

Yamartino, E. J., Jr. See Grenner, G.<br />

Yamasaki, Masabiko; Uemura, M.; Okaniwa,<br />

K., 1187<br />

Yamashita, Sumiko See Abe, Akira<br />

Yang, Chi-Faug See Ting, Stanford W.<br />

Yang, Xiu Ying See Elm, Ronald J.; Hoeseini,<br />

Jeanette hi.<br />

Yang, Yi-Peng See Geng, Jian-Guo<br />

Yanko, J. See Bittikofer, J. A.<br />

Yannelli, John K. See Oldham, Robert K.<br />

Yassinzadeh, Z. See Gibbons, I.<br />

Yatscoff, K. See Copeland, Kenneth<br />

Yatscoff Randall W. See Copeland, Kenneth K.<br />

Yea, G. K. See Caines, Patrick S.<br />

Yeb, Chau-Ting; Wei, Jeng S.; Liaw, Yun-Fan,<br />

1684<br />

Yein, Fred See Leeder, Sydney<br />

Yen, Shing-Erh See Shah, Vipin D.<br />

-; Shimizu, K.; Shah, V., 1121<br />

Yentur, Gulderen See Town, Meral<br />

Yea, Kiang-Teck See Horowitz, Gary L.<br />

-; Diamond, Constance; Williams, Bernadine E.;<br />

Horowitz, Gary L., 1093<br />

Yea, Klang-Teck; Traverse, Willi ,Horowitz,<br />

GaryL., 1504<br />

Yeung, V. T. F. See Cheung, C. K.<br />

Yip, Tal-Tung See Hutchens, T. William<br />

Ylu, Samuel C. K.; Wu, T.-W.; Levy, 0. A.; Au,<br />

J.-X.; Phillips, hi. J., 1137<br />

Yoder, J. M. See Fredrickson, K. A.<br />

Yoshida, Toshihiko See Kunoiwa, Ketsumasa<br />

Yoshida, Yuklo See Naksahima, Kaji<br />

Yoshlkawa, Chikao See Shimojo, Nobuo<br />

Yoshikawa, Kezuaki; Tanaka, K.; Shibate, H.,<br />

1082<br />

Yoshino, Funno See Osewa, Hisao<br />

Yosbinoya,<br />

Yoshloka,<br />

Sadayoshi See Mashige, Fumiko<br />

Shinichi; Kawajini, Yoshiko; Higashi,<br />

Yasuko; Tsukada, Yutaka, 1175<br />

Yost, D. A. See Dolan, P. A.<br />

Young, C. C. See Demko, Paul K.<br />

Young, G. P. See Rose, L S.<br />

Young, Karen K. Y.; Winters, Robert F.; Peter,<br />

James B., 1076<br />

Young, Keith See Zoccoli, Michael A.<br />

Young,<br />

Yousef,<br />

Maitland See Chou, Peter P.<br />

Mohammed A. See Lambert, Willy F.<br />

Yu, Gordon See Hirsch, Carl<br />

Yuen, M. See Aw, T. C.<br />

Yuki, Hidetake See Matsumoto, Kajiro<br />

Zecharieli, N.Y.; Lee, C.; Cheek, J. H.;<br />

Chakmskjian, Z. H.; Mukharjee, A., 1080<br />

Zadik, Zvi See Stnasbunger, Christian<br />

Zahradnik, Richard See Pilot, Robert L.<br />

-; Brennan, George; Hutchison, James S.; Odd,<br />

William D., 804<br />

Zak, B. See Artiss, J. D.; Batason, J. F.<br />

Zak, Bennie See Bateson, Joseph F.<br />

ZaIIIbOnI, Robert See Tagari, Philip<br />

Zen, Geraldine Tue See Staples, Mark<br />

-; Staples, Mark; hiurthy, H. hi. 5., 1093<br />

Zapoticznyj, W. See Lasky, F. D.<br />

Zarembka, F. F.; Koller, D. F.; Plotka, E. D., 143<br />

Zarnil, Batya See Strasburger, Christian<br />

Zaunczkoswki, Denise; Rosenfield, H.;<br />

Kaufman, K. A., 1129<br />

Zeltvogel, Christine See Brashear, Jeff<br />

Zheng, M. See Broyles, Celeste<br />

Zhichu, Cui, 630<br />

Thong, Li-Ming See Geng, Jien-Guo<br />

Zibrat, Steven J.; Halt, John A.; Ryan, Diane F.;<br />

Russell, John C.; Cooper, Carol hi.; Moewad,<br />

Atef H., 1107<br />

Zic, V. See Fu, Paul<br />

Ziegenhorn, J. See Karl, Johann; yogI, 5. W.<br />

Zijlstra, W. G. See Kwent, G.<br />

Ziinmer, Etan L See Knivoy, Norberto<br />

Zimmermann,<br />

Zimmermann,<br />

G. See Wielinger, H.<br />

Linda; Lin, Yuh-Nen; Dummel,<br />

Robert; Huchital, Michael; Sheiman, Mark;<br />

Dunka, Louis, Jr., 1172<br />

Zoccoli, Michael A. See Picone, Teresa<br />

-; Young, Keith; Katz, Paula; Lynch, Braden;<br />

Manning, Wayne; Kbanne, Pyare, 1095<br />

Zoccoli, Mike See Inloes, Roger<br />

Zoha, Steven J.; Neelkantan, N. V.; Lau, H. P.;<br />

Masulli, I. S.; Spaven, F. F.; Tuhy, P.M.;<br />

Fanner, M. G., 1202<br />

Zoppo, A. See Marcovina, Santica<br />

Zuccbelli, G. C. See Pilo, A.<br />

-; Clenico, A.; Dc Mania, K.; Pilo, A.; Masini, S.;<br />

Caroli, A.; Brando, B., 1155<br />

Zwart, Albert; Heerspink, W., 1163<br />

Zweig, M. H. See Csako, G.<br />

Zweig, Mark See Huang, C. hi.<br />

Zweig, Mark H. See Cseko, Gyorgy<br />

2362 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


Volume 35, 1989<br />

SUBJECT INDEX<br />

A, abstractof meetingpaper<br />

CR,casereport<br />

CC,caseconference<br />

E, editorial<br />

H, history<br />

KEY TOABBREVIATiONS<br />

L, letter<br />

0, opinion<br />

obit, obituary<br />

A, review<br />

S,symposiumpaper<br />

SN,scientificnote<br />

SR,special report<br />

TB, technical brief<br />

AACC<br />

See also History<br />

AACC award winners, 1989,1565<br />

41st natL mtg., abstracts of papers, 1065<br />

41st netL mtg., industry-sponsored workshops,<br />

1242<br />

41st natL mtg., plenary session, 1048<br />

41st natl. mtg., roundtables, 1225<br />

41st natl. mtg., scientific program, 1045<br />

41st natl. mtg., selected topics, 1232<br />

41st natl. mtg., symposia abstracts, 1049<br />

41st natL mtg., workshops, 1211<br />

Abused drugs<br />

activation energies detd. for drugs of<br />

abuse-their use in projecting product shelflife<br />

(A), 1180<br />

adaptation of drugs of abuse testing to<br />

Synchron CX#{149}4 and CX’5 cm. analyzers<br />

(A), 1178<br />

adaptatian of Syva assays for drugs of abuse on<br />

the Olympus Reply lab, analyzer (A), 1174<br />

adaption of Syva EMIT d.a.u.n assays to the<br />

570 Alliance cm. chem. analyzer (A), 1170<br />

edulterants intended to cause false negatives in<br />

urine screens for marijuana or cocaine use<br />

(A), 1175<br />

amphetamine, methamphetamime quant.<br />

confirmation procedure by GCIMS (A), 1169<br />

anal. of cocaine metabolitas in urine:<br />

comparison of TDx FPIA cocaine metebolite<br />

assay with GCIMS (A), 1186<br />

benzodiazepines identified by capillary gas<br />

chrometog.-msss spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs., 1394<br />

calibrators containing 11-nor-9-THC-9-<br />

canboxylic acid for use with Syva EMIl’<br />

cannabinoid assays (A), 1173<br />

cocaine end pregnancy chin. end toxicoL<br />

implications fan the neonate(S), 1276<br />

cost-effective<br />

performed<br />

EMrr method for qual. d.e.u.<br />

on Cobas Mire (A), 1168<br />

delte-9-THC and delta-9-THC-canboxylic in<br />

serum by quant. GC/MS (A), 1170<br />

detection limit of the TDx fluorescence<br />

polarization immunoassay extended far<br />

benzoylecgonine in urine (SN), 2110<br />

detn. of cocaine metabolite, ecgonine methyl<br />

ester in urine, by gas chromatog. with N-<br />

selective detector (A), 1168<br />

development of EMil’ drugs of abuse assay for<br />

amphetamine/methamphetamine in urine on<br />

the ETS’5 system (A), 1180<br />

drug testing in sports-the 1988 Olympics end<br />

beyond (A), 1056<br />

emetine identified in urine by HPLC, with<br />

fluorescence and ultrevialet/diode array<br />

detection, in a patient with candiomyopethy<br />

(CR), 499<br />

EMIT convenient twa-reagent system for drug<br />

of abuse testing on most common chem.<br />

analyzers (A), 1167<br />

evain. of Abbott AD,” analyzer in traditional<br />

and nontraditional markets (A), 1174<br />

evaln. of Abbott MTD,’ drug anal, system (A),<br />

1185<br />

evaln. of Abbott TD, for drugs of abuse<br />

testing in a field environment (A), 1179<br />

evaln. of Boehninger Mannheim/Hitachi 717<br />

for routine drug of abuse testing (A), 1165<br />

eveln. of combined cocaine/opiate screening<br />

procedure on Abbott labs. TDx (A), 1165<br />

evaln. of screening method bias for five drugs<br />

of abuse classes (A), 1102<br />

evaln. of Syva EMIl’ d.a.u. appins. on 550<br />

Express (A), 1170<br />

evaln. of the TDx and ADx methadone<br />

immunoassays (TB), 1794<br />

evaln. of TLC technique for detection of<br />

opiates in urine (A), 1173<br />

evaln. of urine temp. measurement methods to<br />

screen urine specimens for drug testing (A),<br />

1181<br />

evaln. of vitreous fluid as a specimen for drug<br />

abuse testing (A), 1181<br />

five cannabinoid immunoassay systems<br />

compared at the screening threshold of 100<br />

ig/L (SN), 2241<br />

high-volume Syva EMIT drug testing on<br />

multiple Epoe analyzers interfaced to a<br />

central computer system (A), 1166<br />

improved GC/MS drug detection with chem.<br />

ionization mass spectrametry and ion trap<br />

detection (A), 1180<br />

intercornelations between direct and total<br />

plasma pyridoxal 5’ phosphate and social<br />

and therapeutic drug use, and health status<br />

(A), 1138<br />

interference of common household chemicals in<br />

immunoassays for drugs of abuse (SN), 648<br />

measurements of clonazepam and lorazepam<br />

by HPLC using solid-phase extn. (A), 1183<br />

mechanism of false-negative urine cannabinoid<br />

immunoassay screens by Visine’5 eyednaps<br />

(SN), 636<br />

(A), 1163<br />

melanin and other indole compds. do not cause<br />

false-positive cannabinoid assay results (L),<br />

1809<br />

methadone and thynoid-function tests (L),<br />

1807<br />

multiple drugs of abuse detection by FPIA<br />

using TDx reagent mixture (A), 1164<br />

performance characteristics of automated<br />

random-access analyzer Cobas Mira5 for<br />

measurement of drugs of abuse (A), 1097<br />

proficiency testing on drugs of abuse: one<br />

year’s experience in Spain (SN), 879<br />

rhabdamyolysis in a case of free-base cocaine<br />

(“crack”) overdose (CR), 1547<br />

status of drugs-of-abuse blind testing in urine:<br />

an AACC study (SR), 891<br />

use of GC/IRIMS for high-confidence identifn.<br />

of drugs (S), 1279<br />

use of Sentry’5 drug control in evaluating<br />

performance of TDx drugs of abuse<br />

screening near NIDA cutoff concns, (A), 1103<br />

Aceteminophen<br />

acetaminophen as substrate for peroxidase (A),<br />

1122<br />

enzymatic sahicylata and acetaminophen anal.<br />

on Monarch 2000 (A), 1185<br />

evaln. of serum acetaminophen and tricycic<br />

antidepressants assays on the Abbott AD,”<br />

drug detection system (A), 1102<br />

Acetoacetate<br />

kinetic mess, of ketone bodies (L), 1263<br />

multipoint kinetic simultaneous mess, of<br />

combined concns, of acetoecetate--<br />

hydnoxybutyrata and lactate-pyruvata (SN),<br />

1526<br />

Acetylated hemoglobin<br />

liq.-chnomatog. detn. of acetylated Hb, 33<br />

Acetylator phenotype<br />

simplified, rapid test for scetylator<br />

phenatyping by use of the peak height ratio<br />

of two urinary caffeine metabohites (SN), 848<br />

Acetylcholine<br />

immunoenzymometnic assay for antibody<br />

against human acetylchohine receptor using<br />

precoated microtitar plate and receptor<br />

isolated from normal leg muscle (A), 1196<br />

Acetylprocalnamide<br />

TDM assays by fluorescence polarization on<br />

Cobas Fare IF”: detn. of serum N-<br />

acetylprocainamide, theophylline, and<br />

phenytoin (A), 1178<br />

Acidosis<br />

assessing metabolic acidosis (L), 338<br />

calculated HCO3- or total C02?, 1697<br />

effects of in viva and in vitro production of<br />

lactic acid on ionized, protein-bound, and<br />

complex-bound Ca in blood, 935<br />

“stat” measurements of L-lectate in whole<br />

blood and CSF assessed (SN), 1740<br />

Acid phosphatase<br />

characterization of 2,6-dichloro.4-nitrophenyl<br />

phosphate as a substrata for acid<br />

phosphatase (A), 1119<br />

detn. of acid phosphatase in serum with 2,6-<br />

dichloro-4-acetylphenyl phosphate substrata<br />

(A), 1117<br />

distribution of proetatic acid phoephatase in<br />

benign end malignant diseases determined<br />

by Magiwel’5 enzyme immunoassay (A), 1079<br />

evaln. of kinetic method for prostatic acid<br />

phosphatase with use of self-indicating<br />

substrate, 2,6-dichloro-4-nitrophenyl<br />

phosphate, 939<br />

factors affecting a cyanogen bromide-based<br />

assay of thiamin, 2173<br />

immunoessey of band 5 (“tantrate-resistent”)<br />

acid phosphatase involving use of antiporcine<br />

utarofernin antibodies, 86<br />

PAP and PSA as markers of proetatic<br />

carcinoma (A), 1191<br />

ref. intervals far two bone-derived enzyme<br />

activities in serum: bone isoenzyme of elk.<br />

phosphatase and tartrate-resistant acid<br />

phosphatase (TB), 180<br />

stabilizer effect on cancn. of serum pnostatic<br />

acid phosphatase (A), 1118<br />

Acquired immune deficiency syndrome<br />

See also HIV<br />

depressed activities of punine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

development of a confirmatory enzyme-linked<br />

iinmunosorbent assay for HIV-1 antibodies,<br />

946<br />

follow-up of monoclonal gammopathies in<br />

asymptomatic HI V-infected subjects (L), 338<br />

molecular probes used to detect<br />

cytomegalovinus and human<br />

immunodeflciency virus (5), 1581<br />

neoptarin mess. in serum, tissue culture<br />

supernatas by competitive enzyme-linked<br />

iinmunosorbant assay, 1467<br />

ohigoclonal bending detected by urinary<br />

protein electrophoresis and immunofixation<br />

in two patients with AIDS end proteinunia<br />

(CR), 1795<br />

ohigoclanal immunoglobulins in HIV infection,<br />

1669<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2363


quant. EIA for detn. of tumor necrosis factoralpha<br />

(A), 1187<br />

serum prealbumin levels in normal individuals<br />

of various age; and in patients with AIDS (A),<br />

1115<br />

serum Zn in homosexual men (L), 704<br />

specific routine detn. of 3’-azido-3’.<br />

deoxythymidine in plasma by<br />

semieutomated liq. chnamatog. (5), 1313<br />

urinary neopterin concns. vs total neopterins<br />

for chin, utility (SN), 2305<br />

Acromegaly<br />

somatotrapin as mess. by a twa-site timeresolved<br />

immunofluorometric assay, 913<br />

ACTH<br />

See Corticotropin<br />

Acute abdominal disease<br />

pancreatic amylase in serum for differential<br />

diagnosis of acute pancreatitis, acute<br />

abdominal diseases (TB), 2142<br />

Acute-phase proteins<br />

changes in serum acute-phase proteins in<br />

patients with dermatologic diseases (A), 1084<br />

Adamantyl 1,2-dioxetane phosphate<br />

chemiluminescent assay of alk. phosphatase<br />

applied in an ultrasensitive enzyme<br />

immunoassay of thyrotropin (A), 1190<br />

1441<br />

chemilumineacent enzyme immunoassay of a-<br />

fetoprotein with edamantyl dioxetane<br />

phenyl phosphate as substrate (SN), 2319<br />

Adenoelne<br />

adenosine and dopamine simultaneously deed.<br />

in urine by reversed-phase HPLC, with online<br />

meas. of uv ebsorbance end electrochem.<br />

detection, 64<br />

Adenosine deaminase<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

Adenosine kinase<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

Adhesion molecules<br />

cell and substrata adhesion molecules in<br />

embryonic end neural development (S), 738<br />

Adrenal disorders<br />

direct detn. of 4 sulfates and 7 glucunonides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” hiq. chromatog., 794<br />

Adrenergic receptors<br />

properties of the th- and 2-adrenergic receptor<br />

subtypes revealed by molec. cloning (5), 721<br />

Advanced analytical concepts<br />

See Oak Ridge Conference<br />

Affinity blotting<br />

monoclonal immunoghobuhins: affinity<br />

for law concne. in serum (SN), 478<br />

blatting<br />

Aflatoxins<br />

time-resolved fluoroimmunoassay of aflatoxins<br />

(SN), 2308<br />

Age-related effects<br />

See Sex- and age-related effects<br />

AIDS<br />

See Acquired immune deficiency syndrome,<br />

HIV<br />

Alanine aminotransferase<br />

ALT reagent with thionicotinamide adenine<br />

dinucleotide (S), 1857<br />

evaln. of the IFCC Ref. Method for alanine<br />

aminotransferase: spurious blank ALT acty.<br />

due to contamination of D-alanine with L-<br />

alanine; recommendations for a correction<br />

(SN), 153<br />

high alanine aminotransferase activities in<br />

plasma, hearts in patients with acute<br />

myocardial infarction, 279<br />

high.M, (“biiary”) isoenzyme of elk.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

mess. of glutathione S-transferase B1 in plasma<br />

after birth asphyxia: early indication of<br />

hepatoceilular damage, 995<br />

plasma glutathione S-transfersse and F protein<br />

are mare sensitive than alanine<br />

aminotransferase as markers of<br />

acetaminophen-induced liver damage, 2186<br />

ratio of serum aspartate to alanine<br />

aminotransferase as a prognostic index in<br />

pediatric liver disease (A), 1151<br />

system to standardize ALT cutoff actys. (A),<br />

1118<br />

Albumin<br />

accuracy of total protein and albumin system<br />

specific values for SMA, SMAC-3, RA-1000,<br />

Assist, and Demand compared with the ref.<br />

method far T. protein and a comparative<br />

method for albumin (A), 1104<br />

direct, indirect techniques for free thyraxin<br />

compared in patients with nonthyroidal<br />

illness. II. effect of prealbumin, albumin,<br />

tbyroxin-binding globulin, 1655<br />

effect of albumin on results for free-thyraxin<br />

index as estd. by total T4tF3 uptake ratio<br />

(L),706<br />

effect of serum albumin on displacement of<br />

phenytoin by ceftriaxone end nafcuilin (A),<br />

1176<br />

evaln. of immunochem. methods for detg. low<br />

cancns. of albumin in urine (A), 1209<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns. (CR), 333<br />

interaction between pyridine nucleotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme.linked enzymes (SN), 2129<br />

longitudinal study of thyroid function in<br />

pregnancy, 275<br />

law-normal cancns. of free thyraxin in serum in<br />

late pregnancy: physiol. fact, not tech.<br />

artefact,<br />

microplate<br />

1891<br />

mess, of urinary albumin,<br />

creatinine, 1371<br />

monoclonal antibodies evald. far use in<br />

screening far conjugates of human serum alb.<br />

and pyridoxal 5’-P04 (SN), 1756<br />

more on albumin end thyroid hormones (L),<br />

2017<br />

nonprotein components of urine interfere with<br />

colorimetry of urinary albumin with<br />

bromphenol blue (L), 336<br />

usefulness of data on albumin and prealbumin<br />

concns. in detg. effectiveness of nutrit., 271<br />

Albuminurie<br />

albuminunia and progression of diabetic<br />

nephropathy (A), 1237<br />

automated measurement of microalbuminunis<br />

with a microcentrifugal analyzer (A), 1084<br />

calorimetric screening method for<br />

microalbuminuria: intra-individual<br />

variability for untimed day specimens (L),<br />

2019<br />

high incidence of false-positive albuminurla<br />

results with the Micro-Bumintest’5 (TB),<br />

1252<br />

microelbuminuria in dlabetes mellitus: mare on<br />

urine storage and accuracy of calorimetry<br />

(L), 1560<br />

micnoalbuminuria in rats and humans (A),<br />

1137<br />

rapid assays far microalbuminunia on two<br />

analyzers (A), 1196<br />

screening for microalbuminuria in patients<br />

with diabetes: frozen storage of urine<br />

samples decreases their albumin content<br />

(SN), 308<br />

screening for microalbuniinuria with a rapid,<br />

low-cost calorimetric assay (SN), 456<br />

Albuterol<br />

albuterol: transdermal absorption and<br />

f’mgerprick blood-sample contamination<br />

from nebulizers (TB), 889<br />

Alcaptonurla<br />

homogentisic acid deed. in biol. fluids by<br />

}IPLC (SN), 321<br />

Alcohol<br />

See also Alcoholism, Ethanol<br />

alcohol detection by microdiffusion (L), 1269<br />

bedside diagnosis of alcohol intoxn. with a<br />

pocket-size breath-alcohol device: sampling<br />

from unconscious subjects and specificity for<br />

ethanol, 918<br />

differences between capillary and venous<br />

blood-alcohol concns. as a function of time<br />

after drinking, with emphasis on sampling<br />

variations in left vs right arm, 400<br />

serum mitochondrial aspartate<br />

aminotransferase acty.: not useful as marker<br />

of excessive alcohol consumption in an<br />

unselected population, 926<br />

Alcoholism<br />

liq.-chromstog. detn. of acetylated Hb, 33<br />

measurement of carbohydrate-deficient<br />

transferrin, biochem. marker for alcohol<br />

disease (A), 1109<br />

signif. of low serum urea N concns. (SN), 639<br />

Alkaline phosphetase<br />

elk. phosphatase acty. from osteosarcoma cell<br />

line SaOS-2: isoenzyme std. for quantifying<br />

skeletal elk. phosphatase acty. in serum, 223<br />

elk. phosphetese isoenzyme mystery (L), 707<br />

elk. phosphatase isoenzymes in plasma in<br />

hyperthyroidism, 1427<br />

alk. phosphatase isoenzymes of liver and bone<br />

origin are incompletely resolved by wheatgerm-lectin<br />

affinity chromatog., 29<br />

elk. phosphatase of possible renal origin<br />

identified in plasma after colchicine overdose<br />

(L),702<br />

biliary elk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-cellulose:<br />

appin. to detection of hepetobilisny diseases,<br />

1684<br />

chemiluminescent assay af elk. phosphatase<br />

applied in an ultrasensitive enzyme<br />

immunoassay of thyrotropin (A), 1190<br />

chemiluminescent substrates far elk.<br />

phosphatase: application to ultrasensitive<br />

enzyme-linked immunoassays and DNA<br />

probes (A), 1201<br />

(S), 1863<br />

conflicting results of liq.-chromatog. detns. of<br />

elk. phosphatase isoenzymes (L), 2255<br />

differences between alk. phosphatase activities<br />

in serum end lyophilized controls in AMP<br />

buffer explained (L), 510<br />

effect of Triton X-100 an pptn. of biiary<br />

phoephatase by wheat-germ lectin (L), 513<br />

evaln. of a photometric assay for detn. of<br />

human bone elk. phosphatase (A), 1089<br />

high-M, (“biiery”) isoenzyme of elk.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

hypomagnesemia and low elk. phosphatase<br />

acty. in patients’ serum after cardiac surgery<br />

(SN), 664<br />

identn, of Salmonella app. with an alkaline<br />

phosphatase-labeled oligonucleotide probe:<br />

comparison with standard biochem. identn.<br />

techniques<br />

measurement<br />

(A), 1075<br />

of elk. phosphatase acty. by<br />

Kodak Ektachem 700 XR analyzer compared<br />

with other routine anal, methods (TB), 328<br />

ref. intervals for two bone-derived enzyme<br />

activities in serum: bone isoenzyme of alk.<br />

phosphatase and tartrate-resistent acid<br />

phosphatase (TB), 180<br />

short- and long-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

siahidase from different sources compared for<br />

electrophoretically sepg. serum elk.<br />

phosphatase fractions from liver end bone<br />

(SN), 1955<br />

Stratus automated creatine kinase-MB essay<br />

evald.: identn. and eliinn. of falsely increased<br />

results assocd. with a high-M, form of elk.<br />

phosphatase, 2048<br />

sugar-chain anal, of elk. phosphatese by lectin<br />

affinity chromatog. in serum from a patient<br />

with oeteosancoma (TB), 179<br />

Alkaptonuris<br />

anal. far homogentisic acid by NMR<br />

spectrometry<br />

(L), 1806<br />

on diagnosis of alkaptonunie<br />

Allergy<br />

mess, of urinary leukatnienes by reversedphase<br />

hiq. chromatog. and RIA, 388<br />

response of allergic and normal persons to<br />

sulfiting agents in wine: detn. of urinary<br />

thiosulfeta excretion (TB), 1792<br />

Aluminoxamine<br />

indirect mess, of deaferniaxamine<br />

chelated cmps. aluminoxamine<br />

and its<br />

and<br />

fernioxamine by Zeeman at. absorp.<br />

spectrom. (SN), 884<br />

Aluminum<br />

critical appraisal of methods for Al-monitoring<br />

program (A), 1114<br />

electrothermal at. absorp. spectrom. detn, of<br />

Al: serum matrix effects eliminated (SN),<br />

1517<br />

micro-quantity tissue digestion for metal<br />

measurements by use of a microwave aciddigestion<br />

bomb (SN), 488<br />

Alxheimer’s disease<br />

detn. of physostigmine in plasma and CSFby<br />

hiq. chnamatog. with electrochem. detection<br />

(SN), 292<br />

American Board of <strong>Clinical</strong> <strong>Chemistry</strong><br />

See ABCC<br />

Amidolytic activity<br />

functional, immunolog. of a2-<br />

cancns.<br />

macroglobulin compared in plasma of<br />

subjects without ai-protease inhibitor<br />

defIciency<br />

Amikacin<br />

(SN), 1535<br />

TDM assays by fluorescence polarization on<br />

Cobas Fare II” analyzer; detn, of serum<br />

amikacin, gentamicin, and tobramycm (A),<br />

1178<br />

2364 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


Amino acids<br />

amino acid anal, for nutritional assessment by<br />

Pica-Tag HPLC: precision studies, ref.<br />

ranges, and correlations with ion-exchange<br />

method (A), 1113<br />

detn. of branched-chain amino acids and<br />

tynosine in serum in various hepatic diseases,<br />

and its chin, usefulness, 1399<br />

fully automated fluorescence assay far detg.<br />

total homocystaine in plasma, 1921<br />

new pitfall in plasma amino acid analysis (TB),<br />

178<br />

proton NMR studies of plasma to determine<br />

metab. status of patients with adult resp.<br />

distress syndrome (SN), 667<br />

therapeutic agents affecting amino acid<br />

chrometograms (TB), 1999<br />

Aminolevulinic acid<br />

i-aminalevulinic acid in plasma by free amino<br />

acid anal. (TB), 1998<br />

Anilnotransferases<br />

See also specific enzymes<br />

modified IFCC reagents for ALT and AST<br />

tasting on Ciba Corning 550 Express (A),<br />

1118<br />

serum apo-aminotransferases reassociate<br />

equally well with pyridoxal 5’-P04 in water<br />

or buffer (TB), 1790<br />

Amiodarone<br />

amiodarone and the thyroid function (R), 1882<br />

Ammonia<br />

evaln, of Abbott hiq. NH3 assay (A), 1103<br />

Amniotic fluid<br />

amniotic fluid lameilan bodies characterized by<br />

resistive-pulse counting: relation to measures<br />

of fetal lung maturity, 612<br />

eveln. of PG-Numeric’S test for semiautomated<br />

anal, of phosphatidylglycerol in<br />

amniotic fluid (A), 1072<br />

improved staining of thin-layer chnomatognams<br />

of amniotic fluid phosphohipids (TB), 1539<br />

IMx’5 AFP, automated microparticle<br />

immunoassay far AFP: performance<br />

characteristics and chin, studies (A), 1192<br />

multicenter evaln. of TDx test far assessing<br />

fetal hung maturity, 1005<br />

phospholipid surface tension: diagnostic utility<br />

of amniotic fluid and its lipid extract, an<br />

anal, of the value of pptn. with cold acetone,<br />

800<br />

tumor markers in seminal plasma and amniotic<br />

fluid (A), 1079<br />

Amperometry<br />

See also Ehectrochemical detection<br />

“stat” measurements of L-lactata in whole<br />

blood and CSF assessed (SN), 1740<br />

Amphetamine<br />

AD,.” amphetamine class assay (A), 1174<br />

amphetamine, methamphetamine quant.<br />

confirmation procedure by GC/MS (A), 1169<br />

development of drugs of abuse assay for<br />

amphetaniine/methamphetamine in urine on<br />

the El’S”' system (A), 1180<br />

false-positive urine amphetamine screen with<br />

ritodnine (TB), 1542<br />

ranitidine and high concns. of<br />

phenyh,pnapanolamine cross react in the EMIT<br />

manaclonal<br />

amphetamine/methamphetamine assay<br />

(TB), 1998<br />

relative operating characteristic curves used to<br />

compare drug screening immunoasseys<br />

amphetamine and methamphetamine<br />

for<br />

(A),<br />

1175<br />

Amylase<br />

a-amylase detn. with the Reflotron reagent<br />

carrier system: use of whole blood, plasma,<br />

and serum, and effect of isoenzymes (SN),<br />

317<br />

anal, of a.amylase isoenzymes by automated<br />

isoelectric focusing (SN), 2116<br />

diagnostic value of measuring pancreatic hipase<br />

and the P3 isoform of pancreatic amylase<br />

isoenzyme in serum of hospitalized<br />

hyperamylasemic patients, 417<br />

effect of forced diuresis on urinary excretion of<br />

pancreatic amylase (A), 1127<br />

hyperamylasemia and a-amylase isoenzymes in<br />

acute liver congestion due to cardiac<br />

circulatory failure (TB), 1793<br />

immobilized anti-salivary amylase antibody<br />

interacts with macroamylases: implications<br />

for use in a pancreatic amylase assay to<br />

distinguish niacroamylasemia from acute<br />

pancreatitis, 1651<br />

immunocatahytic assay af pancreatic a-amylase<br />

in serum and urine with a specific<br />

monoclonal antibody (SN), 662<br />

immunolog.-derived pancreatic amylase,<br />

pancreatic hpase, and total amylase<br />

compared as predictors of pancreatic<br />

inflammation (TB), 1542<br />

measuring canboxypeptidase A acty. with a<br />

centnif. analyzer: anal, and chin.<br />

considerations, 251<br />

mechanism of action of pancreatic end salivary<br />

a-amylase on 4,6-ethyhidene-a-4-<br />

nitraphenylmaltoheptaoside substrate (L),<br />

methodoL and din. multicenter evaln, of<br />

specific pancreatic a.amylase assay based on<br />

a double monoclonal antibody technique (A),<br />

1090<br />

methods compared for detg. total ecty. and<br />

isoenzymes of amylase in serum (SN), 645<br />

pancreatic amylase in serum for differential<br />

diagnosis of acute pancreatitis, acute<br />

abdominal diseases (TB), 2142<br />

pancreatic amyhase mess, in serum by use of a<br />

monoclonal antibody immunochem.<br />

immobilized to a solid phase, 110<br />

pancreatic isoamyhase: direct assay based on<br />

efficient capture by a monoclonal antibody<br />

(A), 1123<br />

performance of Reflotron amylase and<br />

biirubin test methods in two physicians<br />

office labs. (A), 1093<br />

Reflotron amylase: eveln. of new dry-chem. test<br />

for the Reflotron (A), 1096<br />

serum P.amylase detn. using monoclonal<br />

antibody (A), 1127<br />

staining method for use in electrophoretic<br />

detn, of amylase isoenzymes in serum (SN),<br />

2322<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

time-resolved immunofluorometric assay of<br />

human pancreatic amylase in serum (A),<br />

1117<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamylase in serum, with use of<br />

two monoclonel antibodies, 1915<br />

urine appln. far Abbott Spectrum and VP<br />

using Abbott hiq. amylase reagent (A), 1102<br />

Amyloid A<br />

confusion of apolipoprotain E phenotyping by<br />

serum amyhoid A (TB), 671<br />

Anaesthesia<br />

morphine monitoring for an anaesthesia pain<br />

service (A), 1182<br />

Analgesic drugs<br />

newer approaches in management of acute pain<br />

(A), 1056<br />

Analytical error<br />

See also Variation, source of<br />

acceptable anal. error: different opinion (L),<br />

1553<br />

alpha-fetoprotein assay and abnormal values<br />

(A), 1157<br />

characterization of sulfasalazine’s interference<br />

in mess. of conj. bihirubin with the Ektachem<br />

slide (SN), 1760<br />

choosing qual.-control systems to detect max.<br />

chin, allowable anal, errors, 284<br />

circulating antibodies to mouse monoclonal<br />

immunoglobulins caused false-positive<br />

results in two-site assay for alphafetoprotein<br />

(L), 2339<br />

citrate interference in assays of total Ca in<br />

serum (TB), 2140<br />

CK-MM interference with an<br />

immunoenzymometric method for quantn. of<br />

CK-MB in serum (L), 901<br />

CK-unrelatad serum component identified<br />

CK isoenzyme anal, using Helena Rep<br />

in<br />

system (A), 1117<br />

chin, important<br />

measurement<br />

interference of sulfasalazine<br />

of conjugated bilirubin by<br />

in<br />

Ektachem slide method (A), 1158<br />

counting errors: effect on immunoassay<br />

precision, 1362<br />

differences between elk. phosphatase activities<br />

in serum and lyophilized controls in AMP<br />

buffer explained (L), 510<br />

differences between values for plasma and<br />

serum in tests performed in the Ektachem<br />

700 XR analyzer, and evaln. of “plasma<br />

separator tubes (PST)” (SN), 151<br />

differentiating between sensitivity and limit of<br />

detection (L), 509<br />

disturbance of the detn, of Hb concn. in<br />

patients with high leukocyte counts (L), 515<br />

effect of measurement wavelength on<br />

fructosamine results (L), 1552<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerlex cortisol, Biodata testosterone (SN),<br />

641<br />

effect on results of temp. at which Reflotron#{149}<br />

strips are stored (L), 186<br />

effects of various serum proteins on quantn. of<br />

fructosamine (SN), 134<br />

estimation of true values in RhAs, 1680<br />

evaln, of Gilford <strong>Chemistry</strong> Control<br />

interference with the chloride method in the<br />

Beckman Synchron CX3 analyzer:<br />

cumulative effect of Br an Cl- results (TB),<br />

1538<br />

factitiously high Na activities in the<br />

Ektachem 400 awing to interferences by high<br />

gamma-globulin condos. (CR), 333<br />

falsely elevated hgG indices in CSF of<br />

plasmapheresed patients (A), 1158<br />

falsely hih values for serum testosterone by<br />

“direct’ assay (A), 1142<br />

false-positive urine amphetamine screen with<br />

ritodrine (TB), 1542<br />

hazard of commercial antiserum crossreactivity<br />

in monoclonel gammopathy eveln,<br />

(L),2016<br />

Indocyanine Green interference in the Kodak<br />

Ektachem detn, of total bihirubin (L), 899<br />

indole compounds do not cause false positives<br />

with the TDx cannabinoid assay (TB), 323<br />

interference of common household chemicals in<br />

immunoassays far drugs of abuse (SN), 648<br />

interference of coumarin therapy with the<br />

“Heptast” owing to declining prothrombin<br />

concns. (SN), 483<br />

interference of plasma expanders in detn. of<br />

total protein (TB), 2143<br />

interferences of human anti-mouse antibodies<br />

in mouse monoclonal antibody-based<br />

immunoassays (A), 1188<br />

interference with mess, of intact parathynin in<br />

serum from renal dialysis patients (TB),<br />

1543<br />

interlab. study of blood-gas anal.: dependence<br />

of Poi end pcce results on atmospheric<br />

pressure (SN), 1779<br />

investigation of protoporphyrin IX std.<br />

materials used in ecid-exth, methods;<br />

proposed correction for the millimolar<br />

absorptivity of protoporphyrin IX, 1601<br />

labile enzyme in fresh serum interferes with<br />

assay of carboxypeptidase N (TB), 177<br />

mechanism of false-negative urine cannabinoid<br />

immunoaasay screens by Visine”' eyedrops<br />

(SN), 636<br />

(A), 1163<br />

more on “hook effects” in immunometric<br />

assays for prostate-specific antigen (L), 1262<br />

multi-factor designs. II. design for identifying<br />

instruments with sample-to-sample<br />

carryover end drift (SN), 2118<br />

murine monoclonel antibody adsorbed onto<br />

vinylidene j’luanide floccules used to<br />

eliminate antibody interference in<br />

“sandwich”-type immunoassays (SN), 1743<br />

nitromethane interferes in assay for creatinine<br />

by Jaff#{233} reaction (SN), 1772<br />

nonprotein components of urine interfere with<br />

calorimetry of urinary albumin with<br />

bromphenol blue (L), 336<br />

oxalate is overestd. in elk. unines collected<br />

during administration of HC032 with no<br />

specimen pH adjustment (SN), 2107<br />

quantn. of x-and X-containing<br />

immunoglobulins by rate nephelametry’.<br />

comparison of two comm. reagent antisera<br />

(A), 1198<br />

ranitidine and high concns. of<br />

phenylpropanolamine cross react in the EMIl’<br />

monoclonal<br />

amphetamine/methamphetamine assay<br />

(TB), 1998<br />

relative potency of commercial calibrators far<br />

fructosamine, and their effect on mess, of<br />

fructosamine in serum (L), 712<br />

reliable mess. of circulating immune complex<br />

depends on stable, accurate ref. material (L),<br />

1555<br />

serum Mg as effected by drugs (L), 506<br />

standard deviation errors in spreadsheet<br />

statistics (A), 1087<br />

standn. of a commercial (Boehniner<br />

Mannheim Diagnostics) enzymic method for<br />

cholesterol, 409<br />

technique-induced errors in two popular blood<br />

glucose reagent strips (A), 1156<br />

therapeutic agents affecting amino acid<br />

chromatognams (TB), 1999<br />

CLINICALCHEMISTRY, Vol.35, No. 12, 1989 2365


Anaphylaxis<br />

mess, of urinary leukotrienes by reversedphase<br />

liq. chromatog. and RIA, 388<br />

Androgens<br />

measurement of free testosterone and free<br />

androgen index by use of sex-hormonebinding<br />

globulin concns,<br />

(fluoroimmunoassay) in hirsutism (A), 1143<br />

plasma conjugated endrogens as digitalis-like<br />

factors ins dialysis-dependent male (A),<br />

1150<br />

Androstenedione<br />

1251RhA for androstenedione in serum end in<br />

blood-spot-samples from neonates, 1706<br />

Anemia<br />

reliability of detn, of whole-blood 02 affinity<br />

with blood-gas enalyzers and multiwavelength<br />

oximetars, 773<br />

Anglotensin-converting enzyme<br />

specific enzyme immunoassey for measuring<br />

new angiotensin-converting enzyme<br />

inhibitor, SQ 29,852, in plasma; comparison<br />

with SQ 29,852 RIA (A), 1190<br />

Animal models of disease<br />

See Veterinary chemistry<br />

Anion gap<br />

improved method for calcg. Ce fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

Antlarrhythmlc drugs<br />

amiodarone and the thyroid function (R), 1882<br />

entiarrhythmic drugs and the cardiac Na<br />

channel: current models (5), 748<br />

concurrent mess. of flecainide acetate and<br />

propranolol by normal-phase liq. chromatog.<br />

(SN), 857<br />

relevance of pharmecokinetics to monitoring<br />

new antiarrhythmics (S), 1332<br />

simultaneous deth. of lidocaine and its<br />

metabohite (MEGX), mexiletine,<br />

disopynimide, and quinidine in serum by<br />

HPLC (A), 1355<br />

Antibiotics<br />

See also specific antibiotic of interest<br />

estn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

Anticoagulants<br />

correction of instrument- and reagent-based<br />

differences in detn. of the int. normalized<br />

ratio fat monitoring anticoagulant therapy<br />

(SN), 840<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

simultaneous “sandwich” enzyme<br />

immunoassay for protein C using monoclonal<br />

antibodies (A), 1208<br />

specific RIA for measuring new thromboxane<br />

antagonist, SQ 30,741, in plasma (A), 1189<br />

Anticonvulsant<br />

antiepileptic<br />

drugs<br />

drug monitoring by FPIA and gas<br />

chromatography (A), 1208<br />

automated HPLC of anticonvulsants: cost<br />

assessment (A), 1353<br />

implications of near-patient testing at an<br />

anticonvulsant clinic (A), 1352<br />

simult, liq.-chnomatog. detn, of some<br />

bronchodilators, anticonvulsants,<br />

chioramphenicol, and hypnotic agents, with<br />

Chromosorb P columns used for sample<br />

prepn., 1615<br />

Antidepressants<br />

See also Tricyclic antidepressants<br />

issues in methodology and applns. for ther.<br />

monitoring of entidepressants (S), 1318<br />

new method for monitoring fluvoxamine in<br />

human plasma by HPLC with uv detection<br />

(A), 1185<br />

Antiepileptic drugs<br />

See Anticonvulsant drugs<br />

Antipyrine -<br />

antipyrine interferes with chem, detn. of Br m<br />

simultaneous estn. of total body H20 and<br />

extracellular H20, 1367<br />

Antlthrombin<br />

increased concns. of heparmn cofactar II in<br />

diabetic patients, and possible effects on<br />

thrombin inhibition assay of antithrombin<br />

111,52<br />

Antitrypsin -<br />

screening far deficiency of a,-proteinase<br />

inhibitor (SN), 1971<br />

Apolipoproteins<br />

adaptation of serum apolipoproteins A-h and B<br />

immunoturbidimetric assays<br />

737 Autoanelyzer (A), 1069<br />

on the Hitachi<br />

alpha slow-moving HDL subfraction in serum<br />

of a patient with radiation enteritis and<br />

peritoneal carcinosis (CR), 674<br />

apolipoprotein<br />

characterizing<br />

E isofarm anal. in<br />

atherogenic risk (A), 1235<br />

apolipoprotein E isoforms in patients with<br />

hypertrophic candiomyapathy (A), 1070<br />

epolipoprotein E phenotype deed. by agarose<br />

gel electrofocusing, immunoblotting, 2070<br />

candidate Ref. Method for measurement of<br />

apolipoprotein B-100 evaln. of a<br />

monoclonal-antibody-based enzyme-linked<br />

immunosorbent assay (A), 1073<br />

calorimetric detn. of non-enzymaticaily<br />

glyceted spolipoprotein B (A), 1074<br />

comparative measurements of apohipoprotein<br />

B by immunonephelometry and radial<br />

immunodiffusion (A), 1069<br />

comparison of serum apolipoprotain<br />

measurements end serum hpid parameters<br />

(A), 1067<br />

concns. of lipids, apolipoproteins in patients<br />

with chin, well-controlled insulin-dependent<br />

and non-insulin-dependent diabetes, 813<br />

confusion of apolipoprotein E phenotyping by<br />

serum amyloid A (TB), 671<br />

designing a reliable calibrator for<br />

nephelometnic apo A-hand B assays (A),<br />

1073<br />

development of a receptor assay for measuring<br />

serum “active” epolipoprotein B-100 concn,<br />

(A), 1066<br />

effect of glycation of low-density hipoprotein on<br />

immunolog. deth. of apolipoprotein B (SN),<br />

2219<br />

enzyme-linked immunosorbent assay of<br />

apolipopratein B in blood spotted onto filter<br />

paper, suitable for neonatal screening, 1000<br />

eveln, of assays far apolipoprotein A-I and B<br />

on TurbiTimer (A), 1072<br />

evaln, of matrix effects of lyophilized pools on<br />

apolipoprotein B immunoasseys (A), 1074<br />

extrapolation of lipoprotein ref. limits to<br />

epolipoprotein measurements (A), 1070<br />

HUP-lipid program: apohipoprotein A-hand B<br />

and the spa B/apo A-I ratio (A), 1065<br />

immunoturbidimetric detn. of apolipoprotemn<br />

A-h and B on Hitachi analyzers (A), 1067<br />

implications for mess, of pre- high-density<br />

lipoprotein (free apo A-I) by ultracentrifn.<br />

(L),2336<br />

influence of end-stage renal failure on concns.<br />

of free apolipoprotein A-i in serum, 963<br />

mess, of apolipoprotein B in plasma from<br />

hyperhipidemic subjects treated with<br />

chohestyramine or placebo: differential<br />

effects of storage at -70 #{176}C, 380<br />

measurements of apolipoprotein A-I and B in<br />

normal individuals end in survivors of<br />

myocardial infarction (A), 1073<br />

mechanisms responsible for increasing<br />

immunoreactivity of apolipoprotein A.I with<br />

storage: role of oxidn., 2082<br />

rate immunonephelometry, radial<br />

immunodiffusion compared for<br />

apolipoproteins Al and B assay (SN), 2236<br />

serum lipid and epolipoprotein changes in<br />

normal pregnancy (A), 1066<br />

standn. of epohipoprotein Band A-h mess. (R),<br />

1357<br />

stendn. of immunochem. detn, of<br />

apolipoproteins A-I and B: report on IFCC<br />

meeting on standn. of apolipoprotein A-I and<br />

B measurements (basis for future<br />

consensus), Vienna, Austria, April 18-19,<br />

1989 (SE), 2009<br />

strong ssaocn, of a single nucheotide<br />

substitution in the 3’-untranslated region of<br />

the apolipoprotain-CIU gene with common<br />

hypertrighyceridemia in Arabs, 256<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

Arachidonic acid<br />

mess, of urinary leukotrienes by reversedphase<br />

liq. chramatog. and RIA, 388<br />

Argimne<br />

arginine pharmacokinetics assessed with an<br />

enzymatic assay adapted to a centrif.<br />

analyzer (SN), 1024<br />

Argininosuccinate synthetase<br />

HPLC for argininosuccinate synthetase (A),<br />

1117<br />

Arteriosclerosis<br />

atherosclerosis and the cholesterol connection:<br />

evolution of a cm. appln. (R), 521<br />

distribn, of thiobarbitunic acid-reactive<br />

substances in lipoprotains, proteins in serum,<br />

2054<br />

lipoprotein(a): enetic marker for<br />

atherosclerosis (A), 1234<br />

lipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monoclonel<br />

antibodies, 1380<br />

plasma lipoprotein(a) and the Friedewald<br />

formula (L), 2156<br />

role of Mg in etiology of cardiovascular disease<br />

(A), 1055<br />

serum lipoproteins and coronarographic<br />

features (L), 1266<br />

Artificial intelligence<br />

artificial intelligence program for<br />

interpretation of raw data from automated<br />

hemotol. instruments (A), 1089<br />

Aspartate aminotransferase<br />

effect of therapeutic coronary reperfusion on<br />

serum aspartete aminotransferase<br />

isoenzymes<br />

myocardial<br />

in patients with acute<br />

infarction (A), 1116<br />

effects of therapeutic coronary reperfusion on<br />

aspartate aminotransferase isoenzynies in<br />

sera of patients with acute myocardial<br />

infarct, 909<br />

high-M, (“biliary”) isoenzyme of alt.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

increases in aspartate aminotransferase,<br />

creatine kinase in hemorrhagic shock and<br />

encephalopathy syndrome (L), 2253<br />

ratio of serum aspartate to alanine<br />

aminotransferase as a prognostic index in<br />

pediatric liver disease (A), 1151<br />

selective proteoiytic measurement of serum m-<br />

AS’l’ (A), 1127<br />

serum mitochondrial aspartate<br />

aminotransferase acty.: not useful as marker<br />

of excessive alcohol consumption in en<br />

unselected population, 926<br />

Aspirin<br />

See Selicylate<br />

Atherogenesla<br />

effect of glycation of how-density lipoprotein on<br />

immunohog. deth. of apolipoprotein B (SN),<br />

2219<br />

Atherosclerosis<br />

See Arteriosclerosis<br />

Atomic absorption spectrometry<br />

See also Atomic absorption spectroscopy,<br />

Atomic absorption spectrophotometry<br />

at. absorption spectrom. detn. of Se in blood<br />

components, 537<br />

concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />

heart tissue in coronary heart disease (SN),<br />

851<br />

electrothermal at. abeorp. spectrom. detn. of<br />

Al: serum matrix effects eliminated (SN),<br />

1517<br />

improved detn, of Vain biol. fluids by<br />

electrotherm. at. absorption spectrom. (SN),<br />

127<br />

indirect mess, of desfernioxamine<br />

chelated cmps. aluminoxamine<br />

end its<br />

and<br />

fernioxamine by Zeeman at. absorp.<br />

spectram. (SN), 884<br />

micro-quantity tissue digestion for metal<br />

measurements by use of a microwave aciddigestion<br />

bomb (SN), 488<br />

quantn. of Sr in plasma and urine with<br />

flameless at. abeorp. spectrom., 1911<br />

Atomic absorption .pectrophotometry<br />

enzymatic assay of Mg through glucokinase<br />

actn. (SN), 2212<br />

evaln, of urine metals control using at.<br />

absorption spectrophotom. (A), 1177<br />

fast, stable method for harvesting leukocytes<br />

far measuring intracellular Mg (SN), 1986<br />

quantn. Mn in lymphocytes to assess Mn<br />

nutrit. status,<br />

sensitive, direct<br />

1939<br />

calorimetry of Cu in serum,<br />

552<br />

ATP<br />

platelet-derived ATP may contribute to<br />

measured concn, of inorg. pyrophosphate in<br />

serum (TB), 326<br />

Atrial natriuretic peptide<br />

development and validn. of a two-site<br />

immunoradiometric assay for atrial<br />

natriuretic factor in unextracted plasma, 953<br />

heart disorders and concentrations of directly<br />

measured atrial natriuretic peptide in<br />

plasma, 435<br />

improved RIA of atrial natriuretic peptide in<br />

plasma, 1431<br />

influence of blood pressure, heart rate, age, and<br />

sex on concns, of atrial natriuretic factor end<br />

cyclic GMP (SN), 1519<br />

Autoantibodies<br />

autoantibodies to lactate dehydnogenase in<br />

serum identified by use of immobilized<br />

Protein G and immobilized jacalin, a<br />

jackfruit lectin, 2190<br />

highly sensitive assays of autoantibodies to<br />

2366 CLINICALCHEMISTRY,Vol.35, No. 12, 1989


thyroglobulin, thyroid peroxidase, 1949<br />

meas, of autoimmune response against collagen<br />

types 1,111, and N by enzyme-linked<br />

immunosorbent assay, and appln. in<br />

infective endocarditis, 246<br />

sensitive radiobinding assay for measuring<br />

autoantibodies to thynoperoxidase in human<br />

serum (A), 1208<br />

streptokinase binds to lactate dehydrogenase<br />

subunit.M, which shares en epitope with<br />

plasminagen, 69<br />

Autoimmune disease<br />

amiodarone and the thyroid function (R), 1882<br />

changes in concanavalin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

cobalamin-binding capacity of haptocorrin and<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

ELISA method to measure antibodies to<br />

cardiolipin and phosphatidylserine (A), 1207<br />

expression of the major human<br />

ribonucleoprotein (RNP) autoantigens in E.<br />

coli end their use in an EIA for screening<br />

sera from patients with autoimmune diseases<br />

(S), 1861<br />

mess, of autoimmune response against collagen<br />

types 1,111, and N by enzyme-linked<br />

immunoeorbent assay, and appln. in<br />

infective endocarditis, 246<br />

Automated analyzers<br />

See Continuous-flow analysis, Discrete<br />

analysis, etc.<br />

Autoradiography<br />

evaln. of biotinylated (Blugene’)<br />

labeled cDNA probes of $-<br />

vs<br />

glucocerebrosidase: rd. sensitivities in<br />

genamic and other systems (SN), 1512<br />

Avidin-biotin interaction<br />

biotin-avidin-based<br />

immunosorbent<br />

solid-phase enzyme-linked<br />

assay for human serum IgE<br />

(A), 1192<br />

biotin-specific binders to probe charge effects<br />

in enzyme immunoassays (A), 1201<br />

immunoradiometry of carcinoembryomc<br />

antigen with use of avidin-biotin labeling,<br />

573<br />

immunoradiometry of corticotropin with use of<br />

avidin-biotin sepn., 804<br />

quanta. of biotin in serum by competition with<br />

solid-phase biotin for binding to<br />

peroxidase-avidin conjugate (SN), 1721<br />

Awards<br />

See AACC<br />

Azidodeoxythymidine<br />

adaptation of ZDV-Trac’ for simultaneous<br />

monitoring of AZT and G-AZT (A), 1187<br />

sensitive and rapid HPLC procedure for<br />

measuring zidovudine (AZT) in serum (A),<br />

1181<br />

specific routine detn. of 3’-azido-3’-<br />

deoxythymidine in plasma by<br />

semiautomated liq. chromatog. (S), 1313<br />

Bacteria<br />

identn. of Salmonella spp. with an alkaline<br />

phosphatase-labeled oligonucheotide probe:<br />

comparison with standard biochem. identn.<br />

techniques (A), 1075<br />

Barbiturates<br />

See also specific barbiturate of interest<br />

BASO-DALT<br />

See Electrophoresis, twa-dimensional<br />

Beckman Conference<br />

introduction (S), B3<br />

panel discussion (5), B53<br />

Bence Jones protein<br />

Bence Jones proteins in urine of patients with<br />

multiple sclerosis (L), 1550<br />

Benzodiazepines<br />

assay for benzodiazepines on the ADS”<br />

analyzer (A), 1174<br />

measurement of benzodiazepines in urine by<br />

double-antibody RIA (A), 1175<br />

measurements of clonazepam end lorazepam<br />

by HPLC using solid-phase extn, (A), 1183<br />

Benzophenones<br />

benzodiazepines identified by capillary gas<br />

chnamatog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs., 1394<br />

Benzoylecgonine<br />

cocaine and pregnancy: chin. and toxicol.<br />

implications for the neonate (5), 1276<br />

detection limit of the TDx fluorescence<br />

polarization immunoassay extended for<br />

benzoylecgonine in urine (SN), 2110<br />

Bicarbonate<br />

calculated HCO or total C02?, 1697<br />

development of dry powder bicarbonate<br />

reagent on Boehringer Mannheim/Hitachi<br />

analyzers (A), 1154<br />

improved method for celcg. Ca fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

kinetic evaln. of HCO assay system (A), 1112<br />

Bichromatic analysis<br />

adaption of Syva EMIT d.a,u.’ assays to the<br />

570 Alliance chin. chem, analyzer (A), 1170<br />

appln. of three turbidimetric immunoglobulin<br />

assays, IgG, IgA, and 1gM, to the Express 550<br />

analyzer (A), 1095<br />

bichromatic sample-blank methodologies for<br />

Dacos, Dacos XL (A), 1156<br />

bichromatics for total protein detn. (A), 1159<br />

cardiac enzyme measurement with Eur.<br />

reagents using Ciba Corning 550 Express’”<br />

(A), 1118<br />

evaln. of a Hg-free Cl reagent on Technicon<br />

Assist’” and RA-100’” systems (A), 1105<br />

evaln. of the 570 alliance cm. chem. analyzer<br />

and Ciba Corning Diagnostics reagents (A),<br />

1094<br />

Fe detn. using CIBA Corning 550 Express<br />

analyzer (A), 1113<br />

modified IFCC reagents for ALT and AST<br />

tasting on Ciba Corning 550 Express (A),<br />

1118<br />

performance characteristics of Ciba Corning<br />

Diagnostic single liq. Mg reagent on the<br />

Express 550(A), 1094<br />

Bile acids<br />

bile acid-binding activity of diethylaminoethyl<br />

dextran in healthy subjects and in primary<br />

biliary cirrhosis (A), 1134<br />

enzymic mess. of total bile acids adapted to the<br />

Cobss Fara centrif. analyzer (TB), 1538<br />

Bihirubin<br />

biliary elk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-cellulose:<br />

appln. to detection of hepatobihiary diseases,<br />

1684<br />

characterization of sulfasalazine’s interference<br />

in mess, of conj. bilirubin with the Ektschem<br />

slide (SN), 1760<br />

chin, important interference of sulfasalazine in<br />

measurement of conjugated bilirubin by<br />

Ektachem slide method (A), 1158<br />

delta and conjugated bilirubins as predictors of<br />

early liver allograft rejection are unaffected<br />

by cytomegalovirus infection (A), 1137<br />

detn. of biirubin in neonatal serum with<br />

Abbott A-Gent5 neonatal bilirubin reagent<br />

(A), 1151<br />

detn. of total bihirubin in serum using an<br />

improved liq. total bilirubin reagent (A),<br />

1094<br />

effect of hemoglobinemia on biirubin assays<br />

on Kodak Ektachem 700 and<br />

Bihirubinometar (A), 1157<br />

evaln. of total and direct bilirubin assays on<br />

the Beckman Astra and Synchron CX5 and<br />

Kodak Ektachem systems in comparison<br />

with HPLC bihirubin measurements (A),<br />

1095<br />

Indocyanine Green interference in the Kodak<br />

Ektachem detn. of total bihirubin (L), 899<br />

Monoject Amber Samplett.e free of bihirubin<br />

photolysis (TB), 889<br />

one-step protocol for assays of total and direct<br />

bihirubin with stable combined reagents<br />

(SN), 173<br />

performance of Reflotron amylase and<br />

bilirubin test methods in two physicians<br />

office labs. (A), 1093<br />

three direct spectrophotometric methods for<br />

detn. of total bilirubin in neonatal and adult<br />

serum, adapted to the Technicon RA-1000<br />

analyzer (SN), 1980<br />

total bihirubin bias: is accuracy more important<br />

than consistency? (A), 1128<br />

total digoxin-like immunoreactive<br />

total biirubin concn., and birth<br />

factor(s),<br />

wt. in<br />

neonates (L), 192<br />

unreliable visual estn. of incidence and amount<br />

of turbidity, hemolysis, and icterus in serum<br />

from hospitalized patients (SN), 837<br />

Bioassay<br />

ultrasensitive bioassay of thyrotropin (TB),<br />

1252<br />

Bioengineered proteins<br />

deveL of a vector system for expression of<br />

bioengineered proteins (S), B7<br />

Biological variation<br />

See Variation,<br />

Bioluminescence<br />

source of<br />

assay<br />

chemi- and bioluminescent immunoassays (A),<br />

1239<br />

Biometry<br />

See Statistics<br />

Biotin<br />

See Avidin-biotin<br />

Biotinidase<br />

automated procedure for mess, of biotinidase<br />

acty. in serum (SN), 831<br />

kinetic detn. of serum biotinidase using a<br />

unique chromogenic substrate (A), 1151<br />

Bipolar affective disorder<br />

genetics of bipolar affective disorder: chin.<br />

implications (5), B28<br />

Birth asphyxia<br />

mess, of glutathione S-transferase B, in plasma<br />

after birth asphyxia: early indication of<br />

hepatocellular damage, 995<br />

Birth defects<br />

See Heritable disorders, Genetics<br />

Blood gases<br />

calculated HCO3- or total C02?, 1697<br />

evaln, of Biotrol bicarbonate reagent on Abbott<br />

Spectrum (A), 1091<br />

evaln. of Biotrol bicarbonate reagent on Roche<br />

Cobas Mira (A), 1092<br />

evaln, of GEM-6 in-line blood gas analyzer (A),<br />

1108<br />

influence of blood 02 tension on dipstick<br />

glucose detns. (L), 1268<br />

interinstrument comparison in P02 between<br />

tonometared whole blood and<br />

perfluorocarbon (A), 1131<br />

interinstrument differences in P02<br />

measurement on four recent blood gas<br />

analyzers (A), 1133<br />

intarlab. study of blood.gss anal.: dependence<br />

of P02 and pco2 results on atmospheric<br />

pressure (SN), 1779<br />

organic acids and drug interference in<br />

measurement of CO2 concn. by Kodak<br />

Ektachem 700(A), 1156<br />

performance evaln, of Corning 288 and Nova<br />

Stat Profile 1 blood gas systems (A), 1093<br />

recent developments in blood ss and<br />

electrolyte measurements with electrochem.<br />

sensors<br />

reliability<br />

(A), 1232<br />

of detn, of whole-blood 02 affinity<br />

with blood-gas analyzers and multiwavelength<br />

oximeters, 773<br />

reliability of temp. correction algorithms for<br />

assessing blood gas parameters at


Separation of Individual Compound Classes,<br />

2258<br />

Measurement of Oxygen by Membrane-<br />

Covered Probes, 194<br />

Medical Decision Making, 2020<br />

Medical Toxicology-Diagnosis and Treatment<br />

of Human Poisoning, 195<br />

Molecular Luminescence Spectroscopy:<br />

Methods and Applications: Part 2, 342<br />

Nonisotopic Immunoessay, 2160<br />

Otto FaIn. America’s First <strong>Clinical</strong><br />

Biochemist, 1810<br />

Peptide Hormones as Prohormones:<br />

Processing, Biological Activity,<br />

Pharmacology, 2258<br />

Recent Advances in Thin-Layer<br />

Chromatography, 342<br />

A Software Program far Immunoassay Data<br />

Handling, 1564<br />

Brain<br />

estn. of brain lesion size based on quantifying<br />

CK-BB in serum (L), 2018<br />

HPLC anal. of brain and plasma for octanoic,<br />

decanoic acids, 1945<br />

rapid, reliable in vivo assays of phosphate<br />

metabolites by NMR, 392<br />

serum creatine kinase isoenzyme BB: poor<br />

index to size of various brain lesions (SN),<br />

651<br />

Breast<br />

comparison of CA- 15 and steroid receptors in<br />

cancerous and adjacent noncancerous tissue<br />

of the breast (A), 1080<br />

immunahistochem. studies utilizing<br />

monoclonel and polyclonel antibodies to c-<br />

erbB-2 protein (A), 1079<br />

IMx’” BCM, automated microparticle enzyme<br />

immunoassay for breast cancer mucin (A),<br />

1078<br />

incidence of elevation of tumor markers CA-<br />

549, CA-15.3, end CEA in sera of breast<br />

cancer patients (A), 1078<br />

measurement of estrogen and progesterone<br />

receptors in breast tumors using steroidbinding<br />

assays and monoclonal enzyme<br />

immunoassays (A), 1138<br />

use of CEA, CA 15-3, and sialic acid in<br />

evaluating din, course of breast cancer<br />

patients (A), 1080<br />

Breast milk<br />

detn. of protein concn, in human breast milk<br />

using Coomassie Brilliant Blue on the Cobas<br />

Fare centrifugal analyzer (A), 1082<br />

total protein detd. in breast milk by use of<br />

Coomassie Brilliant Blue and centrif, anal,<br />

(SN), 2127<br />

Breath analysis<br />

confirmatory<br />

Brodifacouni<br />

breath ethanol testing (A), 1184<br />

brodifacoum (super warfarmn) poisoning: lab,<br />

methods for assessment of vit. K antagonism<br />

(A), 1162<br />

Bromide<br />

entipyrine interferes with chem. detn. of Br- in<br />

simultaneous estn. of total body H20 and<br />

extracellular H20, 1367<br />

effect of Br- on ion-specific electrodes in the<br />

Hitachi 736 (A), 1161<br />

evaln. of Gilford <strong>Chemistry</strong> Control<br />

interference with the chloride method in the<br />

Beckman Synchran CX3 analyzer:<br />

cumulative effect of Br an Cl results (TB),<br />

1538<br />

Bronchodilators<br />

simult. liq.-chromatog. detn, of some<br />

bronchodilators, anticonvulsants,<br />

chloraniphenicol, and hypnotic agents, with<br />

Chromosorb P columns used for sample<br />

prepn., 1615<br />

Cachectin<br />

See Tumor necrosis factor<br />

Caffeine<br />

caffeine interference eliminated in HPLC detn,<br />

of urinary nicotine and cotinine, 1456<br />

direct HPLC detn. of theophyiline,<br />

theophylline analogs, and caffeine in plasma<br />

with an ISRP (Pinkerton) column (A). 1185<br />

simplified, rapid test for acetylator<br />

phenotyping by use of the peak height ratio<br />

of two urinary caffeine metabolites (SN), 848<br />

Calciferin<br />

calciferin and cathepsmn D-like acid protease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

Calcinosis<br />

tumoral cslcinosi& seasonal biochem. studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

Calcitonin<br />

osteoporosis 1989 (A), 1053<br />

Calcium<br />

elk. phosphatase isoenzymes in plasma in<br />

hyperthyroidism, 1427<br />

Ca content of healthy erythrocytes (L), 1264<br />

Cs metab. in hypertension (A), 1054<br />

citrate interference in assays of total Ca in<br />

serum (TB), 2140<br />

critical anal, and din, aspects of ionized Cain<br />

neonates (R), 2027<br />

effect of citrate on urinary excretion of Ca and<br />

oxalata: relevance to Ca oxalate<br />

nephrohithiasis, 23<br />

effect of hematocrit and added heparin on Ca2<br />

in capillary blood from neonates (SN), 486<br />

effect of oral citrate on Ca absorption after oral<br />

load of Ca phosphate (TB), 1541<br />

effects of in vivo and in vitro production of<br />

lactic acid an ionized, protein-bound, and<br />

complex-bound Cain blood, 935<br />

effects on ionized Ca by different heparin<br />

preparations measured in ICA 2 analyzer<br />

(A), 1128<br />

improved method for calcg. Ca fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

increased Ca uptake in vascular tissue by<br />

plasma of salt-induced hypertensive DahI<br />

rats (A), 1138<br />

modern trends in image analysis (A), 1053<br />

NCCLS evaln. protocols EP-5 (precision), EP-<br />

6 (linearity), end EP-lO (preliminary<br />

evaluation) tested with en unsuitable Ca<br />

method (AAS) (A), 1099<br />

new liquid Ca reagent for Abbott Spectrum5<br />

(A), 1094<br />

new method for detg. bound and ionized Cain<br />

serum (TB), 491<br />

no relation between colorectal cancer and<br />

concns. of Cain serum (L), 1263<br />

quantn. of Sr in plasma and urine with<br />

flameless at. absorp. spectrom., 1911<br />

relation between plasma cholesterol and total<br />

and ionized Ca concns. in serum from<br />

poetmenopausal women (TB), 328<br />

statis, interpretn. of concns. of Mg, Zn, Ca, K,<br />

choleatarols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

tumorel calcinosis: seasonal biochem, studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

urine Ca anal, using Beckman Synchron CX3<br />

and Synchron CX5 din, systems (A), 1132<br />

Calcium-binding protein<br />

RIA of oateocalcin with polyclonal and<br />

monoclonal antibodies, 1408<br />

solid-phase enzymaimmunoassay for<br />

osteocalcin<br />

monoclonal<br />

in serum or plasma, with use of a<br />

antibody, 2087<br />

Calculous disease<br />

determinants of carbonate apatite in renal<br />

calculi (A), 1133<br />

effect of citrate on urinary excretion of Ca and<br />

oxalate: relevance to Ca oxalate<br />

nephrolithiasis, 23<br />

electrophoresis gel model for Ca oxalate<br />

crystallization (A), 1130<br />

enzymatic detn. of urinary axalate (SN), 2330<br />

enzymatic method for oxalate automated with<br />

the Cobas Fare centrif. analyzer (SN), 2094<br />

excretion of urinary enzymes after<br />

extracorporeal shock-wave lithotripsy (TB),<br />

2000<br />

oxalate is overestd, in elk. urines collected<br />

during administration of HCO3-2 with no<br />

specimen pH adjustment (SN), 2107<br />

sepn., identn. of urinary proteins and atonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate-polyacrylamide gel electrophoresis<br />

(SN), 658<br />

Calibration materials<br />

See Control materials, Quality control<br />

Cancer<br />

elk. phosphatase acty. from osteosarcoma cell<br />

line SaOS-2: isoenzyme std, for quantifying<br />

skeletal elk. phosphatase acty. in serum, 223<br />

alpha slow-moving HDL subfraction in serum<br />

of a patient with radiation enteritis end<br />

peritoneal carcinosis (CR), 674<br />

anal. sensitivity of prostate-specific antigen<br />

Tandem#{149}-E enzyme immunometric assay<br />

(A), 1078<br />

assay of “intact” parathyrin in the immediate<br />

and long-term postoperative follow-up of<br />

patients treated for hyperparathyraidism or<br />

thyroid tumor (L), 340<br />

benign transient hyperphosphatasemia in an<br />

adult with malignant lymphoma (L), 897<br />

biliary elk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-cellulose:<br />

appln. to detection of hepatobiliary diseases,<br />

1684<br />

calciferin and cathepsin D-like acid protease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

CA195, marker for colorectal cancer (A), 1077<br />

chemiluminescent enzyme immunoassay of a-<br />

fetoprotein with adamantyl diaxetane<br />

phenyl phosphate as substrate (SN), 2319<br />

cm, signif. of genetic rearrangements in<br />

neuroblastomas (S), B38<br />

cobalamin-binding capacity of haptocorrin and<br />

transcobelamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

Coloscreen VPI teat kit evald, for detection of<br />

fecal occult blood, 156<br />

comparison of CA-15 and steroid receptors in<br />

cancerous and adjacent noncanceraus tissue<br />

of the breast (A), 1080<br />

concns, of tumor-associated trypsin inhibitor<br />

and C-reactive protein in serum in acute<br />

pelvic inflammatory disease (SN), 869<br />

creatine kinase and lactate dehydrogenase<br />

isoenzymes in serum and tissues of patients<br />

with stomach adenocarcinoma, 1385<br />

decreased dehydroepiandrosterane sulfate in<br />

pigmented nodular adrenal dysplasia (SN),<br />

2216<br />

detn, of a2-macroglobulin-trypsin complex<br />

with a new synthetic substrate, 2169<br />

detn, of the allyl lysophospholipid derivative<br />

ET-18-OCH3, a new antineophastic drug, in<br />

plasma, 821<br />

direct detn. of 4 sulfates and 7 glucuronides<br />

17-ozystaroids in urine by fluorescence<br />

of<br />

“high-performance” liq. chromatog., 794<br />

discordant hCG measurements ins patient<br />

with carcinoma (TB), 1259<br />

distribution of prostatid acid phosphatase in<br />

benign and malignant diseases determined<br />

by Magiwel’” enzyme immunoassay (A), 1079<br />

DNA binding differences of active and inactive<br />

platinum anticancer drugs shown by agarose<br />

electrophoresis of restriction endonuchease<br />

fragments of drug-treated DNA (A), 1077<br />

estrogen end progesterone receptor assays,<br />

the EIA method (Abbott), of low-speed<br />

by<br />

supernates of breast-cancer homogenates<br />

(SN), 2226<br />

evaln, of human-serum-based tumor marker<br />

control by comm. available RIA and EIA test<br />

kits (A), 1068<br />

extn. of intracellular nucleosides and<br />

nucleotides with acetonitrile, 48<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN),<br />

fundamental mechanisms<br />

166 -<br />

of tumorigenesis in<br />

the nervous system: isoln. and charactern. of<br />

genes assocd. with hered. farms of cancer (S),<br />

B25<br />

grand round at Sahlgren’s Hospital:<br />

hypercelcemia ins patient with mammary<br />

carcinoma; metastases or primary<br />

hyperparathyroidism? (CC), 1019<br />

fl-hCG vs intact hCG assays in detection of<br />

trophoblastic disease (CR), 1799<br />

high serum ferritin level and its significance in<br />

cancer (A), 1081<br />

immunoassay for estrogen receptor does not<br />

detect inactivated receptor (SN), 824<br />

immunoassey of band 5 (“tartrate-resistant”)<br />

acid phosphatase involving use of antiporcine<br />

utaroferrmn antibodies, 86<br />

immunohistochem, studies utilizing<br />

monoclonal and polyclonal antibodies to c-<br />

erbB-2 protein (A), 1079<br />

immunoradiometry of a’y- and y’y-enohase<br />

(neuron-specific enolase), with use of<br />

monochonal antibodies and magnetizable<br />

polymer particles, 2034<br />

IMx’” BCM, automated micropartiche enzyme<br />

immunoessay for breast cancer mucin (A),<br />

1078<br />

incidence of elevation of tumor markers CA-<br />

549, CA-15.3, and CEA in sara of breast<br />

cancer patients (A), 1078<br />

influence of O.C.T. embedding compd. on<br />

detns, of estrogen and pragestin receptors in<br />

breast cancer (SN), 2317<br />

lactate dehydrogenase isoenzyme pattern in<br />

sara in malignant diseases, 396<br />

lactate dehydrogenase isoenzyme patterns m<br />

serum in metastatic liver disease (SN), 871<br />

loss of heterozygosity in stages of malignancy<br />

(S), B48<br />

2368 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


measurement of estrogen and progesterone<br />

receptors in breast tumors using steroidbinding<br />

assays and monoclonel enzyme<br />

immunoassays (A), 1138<br />

measuring decision values for prostate-specific<br />

antigen in serum (A), 1077<br />

measuring tissue factor (Factor HI) acty. in<br />

plasma, 1897<br />

methods for detg. “reference chenes” from<br />

serial measurements: plasma lipid-bound<br />

sialic acid, 972<br />

2-microglobulin and immune activation (L),<br />

2158<br />

molecular genetics of leukemia and lymphoma<br />

(S),B43<br />

neopterin meas. in serum, tissue culture<br />

supernates by competitive enzyme-linked<br />

immunosorbant assay, 1467<br />

no relation between colorectal cancer and<br />

concns. of Ca in serum (L), 1263<br />

pancreatic oncofetal antigen and carbohydrate<br />

antigen 19-9 in sera of patients with<br />

pancreatic cancer, 405<br />

PAP end PSA as markers of prostatic<br />

carcinoma (A), 1191<br />

partial charectern, of an abnormal lactate<br />

dehydrogenase isoenzyme, LDH-lex, in<br />

serum from a patient with hepatocellular<br />

carcinoma (SN), 844<br />

prelim, chin. evaln. of an ovarian cancer<br />

marker-CA 215 (A), 1081<br />

preliminary appraisal of a PR-EIA kit for<br />

quantifying progesterone receptors in breastcancer<br />

tissue (L), 339<br />

prostatic inhibin-hike peptide in urine of<br />

prostatic cancer patients, meas, by enzymelinked<br />

immunosorbent assay, 1376<br />

proto-oncogene abnormalities in human cancer<br />

(A), 1057<br />

relative importance of estrogen and<br />

progesterone receptor assays as prognostic<br />

indicators in primary breast cancer: shortterm<br />

study, 238<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasla, and assessment of<br />

effects of organ failure, 1631<br />

RIA of -microseminaprotein, a prostaticsecreted<br />

protein in acre of men and women,<br />

1497<br />

serum creatine kinase isoenzyme BB: poor<br />

index to size of various brain lesions (SN),<br />

651<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoassays<br />

of carcinoembryonic antigen (SN), 146<br />

sugar-chain anal, of elk. phosphatase by lectin<br />

affinity chromatog. in serum from a patient<br />

with osteosarcoma (TB), 179<br />

tumor-derived activated cells: prehim. lab, and<br />

din, results (5), 1576<br />

two-site immunoenzymometric assay of 52-kDa<br />

pro-cathepsin D; use in breast diseases, 234<br />

two-site immunoenzymometry of 52-kDa<br />

cathepsin D in cytosols of breast-cancer<br />

tissues, 81<br />

two-site IRMA far detn, of urinary<br />

cytakeratin-18; apphicn. to management of<br />

bladder cancer (A), 1198<br />

use of CEA, CA 15-3, and sialic acid in<br />

evaluating cm, course of breast cancer<br />

patients (A), 1080<br />

Cannablnoids<br />

calibrators containing 11-nor--THC-9-<br />

carboxylic acid far use with Syva EMIT#{176}<br />

cannabinoid assays (A), 1173<br />

comparison of Abbott TDx FPIA for<br />

cannabinoids with GC/MS (A), 1185<br />

delta-9-THC and delta-9-THC-carboxylic in<br />

serum by quant. GC/MS (A), 1170<br />

five cannabinoid immunoessey systems<br />

compared at the screening threshold of 100<br />

ig/L (SN), 2241<br />

indole compounds do not cause false_positives<br />

with the TDx cannabinoid assay (TB), 323<br />

mechanism of false-negative urine cannabinoid<br />

immunoassay screens by Visin&M eyedrops<br />

(SN), 636<br />

(A), 1163<br />

melanin and other indole compds. do not cause<br />

false-positive cannabinoid assay results (L),<br />

1809<br />

sample preparation for thin-layer chromatog.<br />

anal, for 11-nor-9-tatrahydrocannabinoh-9-<br />

carboxylic acid in urine (SN), 163<br />

Carbamazepine<br />

differing results far carbamazepine between<br />

ace and TDx (A), 1182<br />

EMIT mess, of carbamazepine, phenobarbital,<br />

and theophyllline in the “Monarch” centrif.<br />

analyzer (L), 895<br />

latex-based immunoassay for detn. of<br />

carbamazepine with IL Monarch” chem.<br />

system (A), 1171<br />

Syva EMITS convenience pack assays for<br />

carbamazepine and tobramycin on the Cobas<br />

Mira analyzer (A), 1173<br />

Carbon dioxide<br />

calculated HC0 or total C02?, 1697<br />

Carbon monoxide<br />

reliability of detn. of whole-blood 02 affinity<br />

with blood-gas analyzers and multiwavelength<br />

oximeters, 773<br />

Carboxyhemoglobin<br />

spectrophotometric stat detn. of HbCO in<br />

microsamples (A), 1163<br />

Carboxypeptidase<br />

labile enzyme in fresh serum interferes with<br />

assay of carboxypeptidase N (TB), 177<br />

measuring carboxypeptidsse A acty. with a<br />

centrif. analyzer anal, and din.<br />

considerations, 251<br />

Carcinoembryonic<br />

immunometric<br />

antigen<br />

assay for carcinoembryonic<br />

antigen based on enhanced luminescence<br />

(A), 1080<br />

immunoradiometry of carcinoembryonic<br />

antigen with use of avidin-biotin labeling,<br />

573<br />

incidence of elevation of tumor markers CA-<br />

549, CA-15.3, and CEA in acre of breast<br />

cancer patients (A), 1078<br />

solid-phase time-resolved immunofluorometric<br />

assay for carcinoembryonic antigen (A), 1077<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoassays<br />

of carcinoembryonic antigen (SN), 146<br />

use of CEA, CA 15-3, and sialic acid in<br />

evaluating din, course of breast cancer<br />

patients (A), 1080<br />

Carcinoma<br />

measurement of sialic acid in squamous cell<br />

carcinoma patients (anal canal and cervix)<br />

by an automated Cobas-Mira procedure (A),<br />

1079<br />

Cardiac disease<br />

See Heart disease<br />

Cardiac glycosides<br />

detection of poisoning by plant-origin cardiac<br />

glycoside with the Abbott TDx analyzer<br />

(SN), 295<br />

Cardiolipin<br />

ELISA method to measure antibodies to<br />

cardiohipin and phosphatidylserine (A), 1207<br />

Carnitine<br />

(acyl)carnitine<br />

erythrocytes,<br />

distribution between plasma,<br />

and leukocytes in blood (L),<br />

711<br />

ref. values for creatine, creatinine, and<br />

carnitine are lower in vegetarians (L), 1802<br />

Carotenoids<br />

butylated hydroxytoluene in the mobile phase<br />

increases sensitivity in carotenoids<br />

chromatog. (L), 513<br />

concns, of carotanoids, retinol, and tocopherol<br />

in plasma aftera meal (SN), 310<br />

transport conditions and stability<br />

markers in blood (SN), 2313<br />

of biochem.<br />

Catecholamines<br />

comparison of HPLC and radioenzymatic assay<br />

for plasma catecholamines (A), 1100<br />

Cathepsin<br />

twa-site immunoenzymometry of 52-kDe<br />

cathepsin D in cytosols of breast-cancer<br />

tissues, 81<br />

Cathepsin-llke acid protease<br />

calciferin and cathepsin D-like acid protease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

CEDIA<br />

cloned enzyme donor immunoassay of serum<br />

digoxin (A), 1190<br />

performance of CEDIA’ ‘1’4MAb and T-uptake<br />

assays on Technicon RA-1000’ (A), 1191<br />

Cell surface modulation<br />

cell and substrate adhesion molecules in<br />

embryonic and neural development (5), 738<br />

Centrifugal<br />

analyzer<br />

arginine pharmacokinetics assessed with an<br />

enzymatic assay adapted to a centrif,<br />

analyzer (SN), 1024<br />

assays for immunoglobulins on the Cobas Mire<br />

analyzer (A), 1197<br />

automated enhanced<br />

rheumatoid factors<br />

latex agglutn, assay for<br />

in serum (SN), 303<br />

automated measurement of microalbuminuria<br />

with a microcentrifugal analyzer (A), 1084<br />

automated methods far din, assay of<br />

superoxide dismutase and glutathione<br />

peroxidase in human plasma and<br />

erythrocytes using a Cobas Bio centrifugal<br />

analyser (A), 1126<br />

automated micromethod for measuring free<br />

fatty acids in plasma/serum (SN), 2228<br />

din, performance of the EMIT vancomycin<br />

assay (SN), 1504<br />

cost-effective assays for use in monitoring<br />

carbamazepine, phenobarbital, and<br />

phenytoinin serum (SN) 1782<br />

detn, of protein concn. in human breast milk<br />

using Coomassie Brilliant Blue on the Cobas<br />

Fara centrifugal analyzer (A), 1082<br />

development of apphicn. protocols for EMIT<br />

vancomycin assay on the Syva Autolab’”<br />

instrument system and for Cobss Mira<br />

analyzer (A), 1167<br />

development of automated latex agglutination<br />

immunoassay for proceinainide for IL<br />

Monarch’ chem. system (A), 1171<br />

development of latex-based tobramycin<br />

immunoassay for the IL Monarch” chem.<br />

system (A), 1172<br />

dimethylniethylene blue-based spectrophotom,<br />

of glycoeaminoglycans in untreated urine:<br />

rapid screening for mucopolysaccharidos,<br />

1472<br />

EMIT ethanol assays for use on Cobas Mira<br />

and Cobas Bio analyzers (A), 1166<br />

EMIT mess, of carbamazepine, phenobarbitaj,<br />

and theophyliline in the “Monarch” centrif,<br />

analyzer (L), 895<br />

EMIT’” serum thyroid hormone uptake assay<br />

for use on Cobas Mire and Cobas Bjo<br />

analyzers (A), 1141<br />

enzymatic assay of Mg through glucokinase<br />

actn. (SN), 2212<br />

enzymatic<br />

enzymatic<br />

detn. of K in serum, 817<br />

method for lactate in whole blood<br />

adapted to the Cobas Bio (TB), 324<br />

enzymatic method for oxalata automated with<br />

the Cobas Fara centrif. analyzer (SN), 2094<br />

enzymatic theophyllmne assay an Cobas-Mira<br />

(A), 1102<br />

enzymic assay of sahicylate adapted to the<br />

Monarch centrifugal<br />

enzymic mess, of total<br />

analyzer (TB), 326<br />

bile acids adapted to the<br />

Cobas Fare centrif, analyzer (TB), 1538<br />

evaln. of Biotrol bicarbonate reagent on Roche<br />

Cobas Mira (A), 1092<br />

evaln. of PG-Numeric’” test for semiautomated<br />

anal, of phosphatidylglycerol in<br />

amniotic fluid (A), 1072<br />

evaln. of theophylline rotor for DuPont Analyst<br />

(A), 1108<br />

four fluorescence polarization immunoassays<br />

for therapeutic drug monitoring evald., 138<br />

immunometric assay for digoxin adapted to<br />

Roche Cobas Fara centrifugal analyzer (A),<br />

1166<br />

immunoturbidimetry of prealbumin<br />

(transthyretin) in a microcentrifugal<br />

analyzer (TB), 178<br />

improved pyrogallol red-Mo method for detg.<br />

total urinary protein (SN), 2233<br />

improved urinary oxalate method for a centrif.<br />

analyzer (L), 1806<br />

kinetic mess, of ketone bodies (L), 1263<br />

latex agglutination inhibition immunoassay for<br />

gentamicmn on the IL Monarch’” chem,<br />

system (A), 1172<br />

latex agglutination inhibition immunoassay for<br />

quinidine on the IL Monarch’” chem. system<br />

(A), 1172<br />

latex-based immunoassay for detn. of<br />

carbamazepine with IL Monarch’” chem.<br />

system (A), 1171<br />

measurement of fructoaamine using nitroblue<br />

tetrazohium on IL Multistat end comparison<br />

with Hb A1 in diabetic patients (A), 1146<br />

measurement of sialic acid in squamous cell<br />

carcinoma patients (anal canal and cervix)<br />

by an automated<br />

1079<br />

Cobas-Mira procedure (A),<br />

measuring carboxypeptidase A acty. with a<br />

centrif. analyzer anal, and chin.<br />

considerations, 251<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2369


modified EMITS thyroxin assay for use on<br />

Cobas Mire and Cobss Bio analyzers (A),<br />

1141<br />

modifn. and automation of whole-blood CN<br />

assay (A), 1177<br />

multipoint kinetic simultaneous mess. of<br />

combined concns. of acetoacetate--<br />

hydroxybutyrata and lactate-pyruvate (SN),<br />

1526<br />

neonatal phenyhalanine screening using the<br />

Encore centrifugal analyzer (A), 1153<br />

pancreatic amylase in serum for differential<br />

diagnosis of acute pancreatitis, acute<br />

abdominal diseases (TB), 2142<br />

pyruvate mess, in whole blood with the Cobss<br />

Bio analyzer (TB), 325<br />

safe, easy removal of Cobas Bio sample cups<br />

(L), 2156<br />

serum valproic acid detn, on Cobas<br />

centrifugal analyzer (A), 1178<br />

BioFP<br />

single-channel glycerol-blanked triglyceride<br />

method adapted to the Cobas Fara (A), 1067<br />

Syva EMITS digoxin assay utilizing on-line pretreatment,<br />

for use on Cobss Mira analyzer<br />

(A), 1167<br />

total protein detd. in breast milk by use of<br />

Coomassie Brilliant Blue and centrif. anal.<br />

(SN), 2127<br />

Centrifugal ultrafiltration<br />

three methods compared for estg. testosterone<br />

and estradiol not bound to sex-hormonebinding<br />

lobulin (SN), 632<br />

Centrifugation, two-dimensional<br />

creatine kinase and lactate dehydrogenase in<br />

whole blood, plasma, and serum determined<br />

with Abbott’s Vision system (A), 1125<br />

creatine kinase assay by Abbott Vision system<br />

(A), 1125<br />

Cerebrospinal fluid<br />

appln. of a silver-binding assay to detn, of<br />

protein in CSF (SN), 860<br />

Biotrol urine proteins reagent using pyrogallol<br />

red-Mo complex (A), 1082<br />

chin. applns. for quent. a and X light chain<br />

detns.<br />

cystatin<br />

(A), 1084<br />

C quantn. in CSF (TB), 179<br />

detn. of physostigmine in plasma and CSF by<br />

hiq. chromatog with electrochem. detection<br />

(SN), 292<br />

estn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

eveln. and performance characteristics of<br />

Paramax anal, system for detg. spinal fluid<br />

and urine protein with hiq. Coomassie Blue<br />

user-defined chem. (A), 1112<br />

evaln. of Kodak<br />

(A), 1090<br />

slides for CSF protein assays<br />

falsely elevated IgG indices in CSF of<br />

plasmapheresed patients (A), 1158<br />

micro-method for total protein in CSF, using<br />

benzethonium chloride in microtitar plate<br />

wells (SN), 1731<br />

more on ohigoclonal bands and diagnosis of<br />

multiple sclerosis (L), 337<br />

performance characteristics of CSF protein on<br />

Paramax (A), 1084<br />

sensitive and specific procedure for detecting<br />

ohigoclonal bending in CSF by agarose gel<br />

electrophoresis (A), 1082<br />

(TB), 1997<br />

simplified screening of populations at risk for<br />

tranathyretin Metwsssocd. familial<br />

amyloidatic polyneuropathy (SN), 1033<br />

“stat” measurements of L-hactate in whole<br />

blood and CSF assessed (SN), 1740<br />

three methods for demonstration of oligoclanal<br />

bands of IgG in CSF compared (A), 1085<br />

Ceruloplasmin<br />

measurement of human ceruloplasmin by its<br />

oxidase acty. using 4,4’-<br />

bis(dimethylamino)diphenylamine (A), 1082<br />

short- and long-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

CF antigen<br />

isolation of “cystic fibrosis protein” from<br />

serum, 1901<br />

Chemical-sensitive field effect transistors<br />

update on CHEMFET sensors for patient<br />

monitoring (A), 1060<br />

Cheinllunainescence<br />

appin. of a rapid non-radioisotopic nucleic acid<br />

anal. system to the detection of sexually<br />

transmitted disease-causing organisms end<br />

assocd. antimicrobial resistances (5), 1571<br />

assay formats involving acridinium-esterlabeled<br />

DNA probes (5), 1588<br />

chemilumescence receptor assay for vit. B12<br />

(A), 1194<br />

chemiluminescence receptor assay for folete<br />

(A), 1194<br />

chemiluminescent assay of elk. phosphatase<br />

applied in an ultrssensitive enzyme<br />

immunoassay of thyrotrapin (A), 1190<br />

chemiluminescent detection of herpes simplex<br />

virus I DNA in blot and in-situ hybridization<br />

assays (S), 1856<br />

chemiluminescent detn. of nonesterified fatty<br />

acids in serum (TB), 325<br />

chemiluminescent substrates for elk.<br />

phosphatase: application to ultrasensitive<br />

enzyme-linked immunoassays and DNA<br />

probes (A), 1201<br />

(5), 1863<br />

comparison of sample preparation techniques<br />

for measurement of total N in stool and food<br />

samples by chemiluminescence (A), 1114<br />

enhanced luminescence competitive<br />

immunoassay for anti-HIV (A), 1207<br />

role of rapid immunoassays for urgent detns, of<br />

creatine kinase isoenzyme MB (SN), 1752<br />

Chemlluminescence enzyme lmmunoassay<br />

chemiluminescent enzyme immunoassay of a-<br />

fetoprotein with adamantyl dioxetane<br />

phenyl phosphate as substrata (SN), 2319<br />

Chemllumlnescence immunoasaay<br />

chemi- and bioluminescent immunoassays (A),<br />

1239<br />

chemiluminescent assay for total serum IgE<br />

(A), 1194<br />

chemiluminescent assay of elk. phosphatase<br />

applied in an ultrasensitive enzyme<br />

immunoassay of thyrotropin, 1441<br />

diagnostic efficacy of Magic Lite intact<br />

parathyrin assay (A), 1187<br />

evaln. of chemiluminescent immunoassay for<br />

deth. of serum peptide hormones (A), 1206<br />

evaln. of ultrasensitive chemiluminescent<br />

thyrotropin assay (A), 1139<br />

measurement of thyrotrapin and T4 by new<br />

luminescence immunoassay LIA-MAT (A),<br />

1209<br />

measuring creatine kinase MB isoenzyme ins<br />

maintenance hemodialysis popn,:<br />

chemiluminometric immunoassay end<br />

electrophoresis compared (SN), 1965<br />

monoclonal chemiluminesceut digoxui assay<br />

(A), 1194<br />

quantn, of progesterone in human serum using<br />

the Amerhita system (A), 1205<br />

two-point calibration of immunoassays in the<br />

Ciba Coming Magic Lita system (A), 1188<br />

use of affinity chromatog. in developing<br />

chemiluminescent-labeled antibodies for a<br />

parathyrin immunometric assay (A), 1210<br />

Chimerlc antibodies<br />

genetically engineered antibodies (S), 1849<br />

Chloride<br />

enzymatic Cl method far the EMDS Easy ST<br />

analyzer (A), 1133<br />

evaln. of a Hg-free Cl reagent on Technicon<br />

Assist’” and RA-100’” systems (A), 1105<br />

evaln, of Gilford <strong>Chemistry</strong> Control<br />

interference with the chloride method in the<br />

Beckman Synchron CX3 analyzer:<br />

cumulative effect of Br-an C1 results (TB),<br />

1538<br />

influence of aspirin on in vitro direct<br />

potantiometry of Cl in serum (TB), 2146<br />

nonniercurimetric spectrophotometric assay<br />

for Chin blood serum (A), 1129<br />

rapid detn. of C1 in serum using a cyclic<br />

voltammetric method (A), 1133<br />

Chlorophenoxy herbicides<br />

HPLC mess, of chlorophenozy herbicides,<br />

bromoxynil, and ioxynil, in bioL specimens<br />

to aid diagnosis of acute poisoning(S), 1342<br />

Cholesterol<br />

accuracy, precision of anal, for total cholesterol<br />

as measured with the Reflotron cholesterol<br />

method (SN), 1734<br />

accurate cholesterol results by modn. of Roche<br />

enzymatic method parameters (A), 1068<br />

atherosclerosis and the cholesterol connection:<br />

evolution of a chin. apphn. (R), 521<br />

CAP-CDC cholesterol ref. materials study (A),<br />

1073<br />

cholesterol measurement in grossly hipemic<br />

specimens (A), 1072<br />

cholesterol standardization for 13 years by<br />

CDC and Japanese cholesterol levels (A),<br />

1065<br />

comparison of Technicon Chem-1 HDL<br />

cholesterol method with ppth, and<br />

ultracentrifugetion methods (A), 1066<br />

comparison testing of lot-to-lot variance in<br />

Reflotron dry reagent strip method of<br />

cholesterol measurement (A), 1098<br />

concns. of lipids, apolipoproteins in patients<br />

with chin, well-controlled insulin-dependent<br />

and non-insulin-dependent diabetes, 813<br />

cyclosporine does not interfere in total and<br />

high-density lipoprotain cholesterol mess.<br />

with use of enzymatic cholesterol assays<br />

(TB), 2251<br />

development of enzymic ref. equiv. method for<br />

total cholesterol (A), 1071<br />

diagnosis of recessive X-linked ichthyosis:<br />

quantitative HPLC/mass spect. anal. of<br />

plasma for cholesterol sulfate, 1906<br />

dual-pptn. method evald, for mess, of<br />

cholesterol in high-density hipoprotein<br />

subfractions HDL2 and HDL3 in plasma, 265<br />

effect of lyophiln. on results of five enzymic<br />

methods for cbolestarol (SN), 1523<br />

enzymatic deth. of total cholesterol in<br />

gallstones (SN), 2247<br />

evaln, of Beckman cholesterol reagents by a<br />

nath. cholesterol ref. method lab. (A), 1068<br />

evaln. of cholesterol mess, with the Beckman<br />

System 700 Analyzer in the Centers for<br />

Disease Control-NatL Heart, Lung and<br />

Blood Institute Lipid Standn, Program<br />

(TB), 1790<br />

evain. of the Kodak Ektachem HDL<br />

cholesterol kit on the Kodak Ektachem 700<br />

analyzer (A), 1069<br />

external assessment of lab, cholesterol<br />

measurements using patients specimens (A),<br />

1069<br />

improved accuracy of cholesterol values<br />

obtained by Synchron AS#{149} calibrator setpoint<br />

modn. as evidenced in patient<br />

correlation to Abell-Kendell ref. method (A),<br />

1071<br />

influence of end-stage renal failure on concns.<br />

of free apolipoprotain A-i in serum, 963<br />

interhospital lab. comparison of total and highdensity<br />

hipoprotain cholesterol assays (A),<br />

1075<br />

Lp(a) hipoprotein concn. in serum of patients<br />

with heavy proteinuria of different origin<br />

(SN), 2121<br />

performance evaln, of Ciba Corning<br />

Diagnostics HDL cholesterol reagent on the<br />

Impact 400E (A), 1094<br />

polyacryhamide gel electrophoresis used in a<br />

critical study of ppth. reagents for<br />

quantifying MDL cholesterol (TB), 1254<br />

rapid micro-scale proced. for detn, of total lipid<br />

profile, 1486<br />

regional interlab. standn. of serum cholesterol,<br />

HDL cholesterol, and triglycerides (A), 1065<br />

relation between plasma cholesterol and total<br />

and ionized Ca concns. in serum from<br />

postmenopausal women (TB), 328<br />

screening of serum cholesterol end HDL<br />

cholesterol using the E.M. Diagnostic<br />

Systems EASY ST analyzer (A), 1074<br />

standn, of a commercial (Boehringer<br />

Mannheim Diagnostics) enzymic method for<br />

cholesterol, 409<br />

statis. interpretn. of concns, of Mg, Zn, Ca, K,<br />

cholesterols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

study of lyophilization effect on enzymatic<br />

methods for cholesterol (A), 1066<br />

Synchron CX’” 4/5 system meets cholesterol<br />

accuracy goals of nath. cholesterol education<br />

program (A), 1071<br />

transport conditions and stability of biochem,<br />

markers in blood (SN), 2313<br />

twa-center evaln, of physician’s office chem.<br />

analyzer (Clinistat) for cholesterol anal. (A),<br />

1102<br />

whole-blood quality-control materiel for<br />

Reflatron#{149} assays of cholesterol (TB), 1255<br />

Wisconsin cholesterol study-assessment of<br />

lab, performance (A), 1068<br />

workshop to improve total cholesterol anal.<br />

(A), 1067<br />

Cholesteryl ester transfer protein<br />

alpha slow-moving MDL subfraction in serum<br />

of a patient with radiation enteritis<br />

peritoneal carcinosis (CR), 674<br />

and<br />

Cholinesterase<br />

adaptation of six DGKC enzymes and<br />

cholinestarase to Synchran CX’5 at 30#{176}C<br />

and 37#{176}C (A), 1126<br />

2370 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


automated detn, of cholinestarase acty. in<br />

plasma and erythrocytes by flow-injection<br />

anal,, and eppln. to identify subjects<br />

sensitive to succinylchohine, 77<br />

detn. of physostigmine in plasma and CSF by<br />

liq. chromatog. with electrochem. detection<br />

(SN), 292<br />

devehpment of Kodak Ektachem thin-film<br />

assay for serum chohinesterase (A), 1120<br />

Hitachi 717 procedure for dibucaine inhibition<br />

phenotyping of chohinestarase variants (A),<br />

1120<br />

Chorlocarcinoina<br />

fl-hCG vs intact hCG assays in detection of<br />

trophoblastic<br />

Choriogonadotropin<br />

disease (CR), 1799<br />

algorithm for testing and reportin serum<br />

choriagonadotropin at chin, signif. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

assay for human choriogonadotropin using<br />

higand and enti-ligand system (A), 1093<br />

chariogonadotrapin discriminatory zone and<br />

ultrasonograpliy (L), 2019<br />

chin, significant decision levels of hCG (L),<br />

1801<br />

comparison of intact and beta-subunit hCG<br />

levels in maternal serum with normal end<br />

aborting prenancy (A), 1136<br />

comparison of intact and beta subunit hCG<br />

levels in paired serum end urine samples (A),<br />

1143<br />

confusion about the discriminatory zone and<br />

choriogonadotropin stds, (L), 2336<br />

discordant hCG measurements in a patient<br />

with carcinoma (TB), 1259<br />

evaln. of Baxter Dade Stratus as a stat method.<br />

for human choriogonadotropin, digoxin, and<br />

digitoxin (A), 1111<br />

evaln. of human choriogonadotropin on Abbott<br />

IMx automated immunoassay systems (A),<br />

1099<br />

fl-hCG vs intact hCG assays in detection of<br />

trophoblastic disease (CR), 1799<br />

quant. hCG for the stat lab. (A), 1100<br />

quantn. of choriogonadotropin: differential<br />

cross-reactivities of free hCG fl-subunit with<br />

eight different monoclonal antibody-based<br />

hCG and (hCG + fi) “sandwich”-type assays<br />

(TB), 1791<br />

quanth. of free and whole molecule fl-hCG in<br />

an automated fluorescence immunoassay<br />

(A), 1147<br />

quanth. of hCG and its fl-subunit in the<br />

Amerlite system (A), 1205<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

solid-phase immunochemiluminometric assay<br />

for human choriogonadotropin (A), 1147<br />

three nonisotopic methods for human<br />

choriogonadotropin evald. (TB), 1545<br />

Chromaffin granules<br />

enzyme-linked immunoeorbent assay for<br />

chromogranin A, 1934<br />

Chromatofocusing<br />

chromatofocusing and isoelectric focusing in<br />

immobilized pH gradients compared<br />

characterization of Hb variants, 425<br />

far<br />

Chromatography, affinity<br />

adenosine end dopamine simultaneously deed.<br />

in urine by reversed-phase HPLC, with online<br />

meas, of uv absorbance end electrochem.<br />

detection, 64<br />

elk. phoephatase isoenzymes of liver and bone<br />

origin are incompletely resolved by wheatgerm-lectin<br />

affinity chromatog., 29<br />

liq.-chromatog. deth. of acetylatad Mb, 33<br />

precision of mess, of glycated Hb by affinity<br />

chromatog. on regenerated columns (L), 191<br />

ref. range of glycated Hb in nandiabetic<br />

persons possessing Mb S by affinity<br />

chromatog.<br />

sugar-chain<br />

(A), 1162<br />

anal, of elk. phosphatase by hectin<br />

affinity chromatog. in serum from a patient<br />

with osteosarcoma (TB), 179<br />

use of affinity chromatog. in developing<br />

chemiluminescent-lebeled<br />

parathyrin immunometric<br />

antibodies for a<br />

assay (A), 1210<br />

Chromatography, capifiary gas<br />

fluoxetine and narfluoxetine detn. in serum by<br />

capillary GC-ECD with solid-phase extn.<br />

(A), 1169<br />

long-chain aliphatic fatty acids end phytanic<br />

acid simultaneously measured by dualcolumn<br />

capillary chromatog. (SN), 1989<br />

phytanic acid, pristanic acid, and very-longchain<br />

fatty acid methyl esters mess.<br />

simultaneously by capillary gas chromatog.<br />

(L),703<br />

steroid profile for urine: ref. values, 2281<br />

system far toxicoL screening by capillary gas<br />

chrometog. with use of a drug retention<br />

index based on Ni-containing ref. cmpds.,<br />

601<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

Chromatography, cation-exchange<br />

fully automated fluorescence assay for detg.<br />

total homocysteine in plasma, 1921<br />

interlab, evaln. of isocratic HPLC method for<br />

creatinine in serum (A), 1132<br />

liq.-chromatog, detn, of acetylated Mb, 33<br />

stability of hemoglobins A, F, 5, and C in dried<br />

neonatal whole-blood samples when<br />

analyzed by cation-exchange HPLC (A),<br />

1152<br />

Chromatography, column<br />

therapeutic agents effecting amino acid<br />

chromatograms (TB), 1999<br />

Chromatography, gas<br />

quantn. of halothane by headspsce gas<br />

chrometog.<br />

Chromatography,<br />

(A), 1173<br />

gas-liquid<br />

detn. of cocaine metabohita, ecgonine methyl<br />

ester in urine, by gas chromatog. with N-<br />

selective detector (A), 1168<br />

simple enzymatic method for detg. 1,5-<br />

anhydro-D-glucitol in plasma for diagnosis of<br />

Chromatography, ion-exchange<br />

simple enzymatic method for detg. 1,5-<br />

anhydro-D-glucitol in plasma for diagnosis of<br />

diabetes, 2039<br />

simplified anal, for glycated Hb by ionexchange<br />

chromatog. (L), 2253<br />

Chromatography, liquid<br />

anal, of supplemented vit, K1 (20) in serum<br />

microsamples by solid-phase extrn. end<br />

narrow-bore HPLC with multichannel uv<br />

detection (S), 1288<br />

anal. performance of AACC Creatinine Study<br />

Group HPLC method (A), 1104<br />

assessment of renal function by inulin<br />

clearance: comparison with creatinine<br />

clearance as deed, enzymatically (SN), 312<br />

automated detn, of drugs in serum by columnswitching<br />

tetracycic<br />

HPLC. IV. sepn. of tricycic<br />

antidepressants end their<br />

and<br />

metabolitas (SN), 453<br />

automated fluoroimmunoassay of theophylline<br />

and vaiproic acid by flow-injection anal, with<br />

use of HPLC (SN), 469<br />

automated HPLC of anticonvulsents: cost<br />

assessment (A), 1353<br />

biliary elk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-ceilulose:<br />

appln. to detection of hepatobihiary diseases,<br />

1684<br />

butylatad hydroxytoluene in the mobile phase<br />

increases sensitivity in carotenoids<br />

chromatog. (L), 513<br />

caffeine interference eliminated in HPLC detn,<br />

of urinary nicotine and cotinine, 1456<br />

concurrent mess, of flecainide acetate and<br />

prapranolol by normal-phase liq. chromatog,<br />

(SN), 857<br />

conflicting results of hiq.-chromatog. detns. of<br />

elk. phosphatase isoenzymes (L), 2255<br />

creatine kinase isoforms in ischemic heart<br />

disease (R), 7<br />

cyclosporin A mess, in plasma in various<br />

transplant types by HPLC and RIA (A),<br />

1356<br />

cyclosporine measured in plasma from patients<br />

with various transplants: HPLC and RIA<br />

with a specific monoclonal antibody<br />

compared (SN), 1726<br />

detn, of physostigmine in plasma and CSF by<br />

hiq. chromatog. with electrochem. detection<br />

(SN), 292<br />

deth. of serum desipramine and 2-<br />

hydroxydesipramine for pharmacokinetic<br />

applns, by HPLC with uv detection (SN),<br />

2134<br />

diagnosis of recessive X-linked ichthyosis:<br />

quantitative HPLC/mass sped, anal, of<br />

plasma for cholesterol sulfate, 1906<br />

direct detn. of 4 sulfates and 7 glucuronides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” liq. chromatog., 794<br />

distribn, of cyclosporin A metabolites among<br />

plasma and cells in whole blood: effect of<br />

temp., hematocrit, and metabolite concn,, 59<br />

emetine identified in urine by HPLC, with<br />

fluorescence and ultraviolet/diode array<br />

detection, in a patient with cardiomyopathy<br />

(CR), 499<br />

estimation of true values in RIAs, 1680<br />

fluorescence polarn. immunoassay of urinary 5-<br />

hydroxy-3-indoleacetic acid, 355<br />

free 3-methoxy-4-hydroxyphenylghycol deed, in<br />

plasma by liq. chromatog. with coulometric<br />

detection, 202<br />

high-M, (“biliary”) isoenzyme of elk.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

HPLC anal, for serotonin and tryptamine<br />

excreted in urine after oral loading with L-<br />

tryptophan, 43<br />

HPLC anal, of brain end plasma for octanaic,<br />

decanoic acids, 1945<br />

HPLC detn. of hemoglobin A1, in the presence<br />

of the fast hemoglobin I-Philadelphia (TB),<br />

494<br />

HPLC deth. of L-tryptophan in serum end<br />

urine (A), 1115<br />

HPLC/mass spectrom.: state of the art for the<br />

drug anal, lab. (S), 1282<br />

HPLC meas. of chlorophenoxy herbicides,<br />

bromoxynil, end ioxynil, in bioL specimens<br />

to aid diagnosis of acute poisoning(S), 1342<br />

HPLC meas. of phenylalanme by direct<br />

injection of plasma onto en internal-surface<br />

reversed-phase silica support, 975<br />

HPLC using diode array detection (A), 1240<br />

hiq. chromato. assay for free and<br />

transthyretin-bound retinal-binding protein<br />

in serum, 582<br />

liq.-chromatog. assay of urinary<br />

porphobilinogen (SN), 471<br />

hiq.-chromatog. detn, of acetylated Mb, 33<br />

liquid chromatog./electrochem.: in uivo deths.<br />

with microdialysis sampling probes (A), 1240<br />

liquid-chromatog. method for indomethacin<br />

and other inflammatory drugs (A), 1164<br />

loss of porphyrins from soln, during anal.:<br />

effect of sample pH and matrix on porphyrin<br />

qusntn, in urine by HPLC (SN), 1508<br />

measurements of clonazepam and lorazepam<br />

by HPLC using solid-phase extn, (A), 1183<br />

new method for monitoring fluvoxamine in<br />

human plasma by I-IPLC with uv detection<br />

(A), 1185<br />

new pitfall in plasma amino acid analysis (TB),<br />

178<br />

polyamines assayed by HPLC with<br />

electrochem. detection after post-column<br />

reaction with immobilized polyamine<br />

oxidase, 1694<br />

prepn. of fecal samples for assay of volatile<br />

fatty acids by gas-hiq. chromatog. and<br />

HPLC, 74<br />

quantn. of urinary porphyrins by liq.<br />

chromatog. after oxidn, of porphyrinogens,<br />

1619<br />

resolution of issues in HPLC anal, of urinary<br />

porphyrmns (A), 1157<br />

sensitive and rapid HPLC procedure for<br />

measuring zidovudine (AZT) in serum (A),<br />

1181<br />

simple hiq.-chromatog. method for vit. B6 cmps.<br />

in plasma, 241<br />

simultaneous detn. of lidocaine and its<br />

metabolite (MEGX), mexiletine,<br />

disopyrimide, and quinidine in serum by<br />

HPLC (A), 1355<br />

simultaneous deth. of pentoxifylline and three<br />

metabohites in bioL fluids by liq. chromatog.<br />

(SN), 298<br />

simultaneous liq.-chromatog, detn. of vit. K1,<br />

vit, E in serum, 2285<br />

simult. hiq.-chromatog. detn. of same<br />

bronchodilators, enticonvulsants,<br />

chloramphenicol, and hypnotic agents, with<br />

Chromoeorb P columns used for sample<br />

prepn., 1615<br />

specific routine detn. of 3’-azido-3’-<br />

deoxythymidine in plasma by<br />

semiautomated hiq. chromatog. (5), 1313<br />

supercritical fluid end microbore liquid<br />

chromatog. for din, anal, (A), 1240<br />

supercritical fluid chrometog. and microbore<br />

hiq. chromatog. for drug anal. (S), 1293<br />

two-site immunochemiluminametric assay of<br />

intact parathyrin with use of a tracer peptide<br />

purified by reversed-phase hg. chromatog.,<br />

215<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2371


urinary 5-hydroxyindoleacetic acid by HPLC<br />

with electrochem. detection (L), 507<br />

urine free cortisol in depressed patients<br />

assayed by HPLC (A), 1138<br />

whole-blood cyclosporin A: comparison of<br />

monoclonal antibody RIA with HPLC (A),<br />

1100<br />

Chromatography, reversed-phase<br />

See also Chromatography, liquid<br />

adenosine and dopamine simultaneously deed.<br />

in urine by reversed-phase HPLC, with online<br />

mess, of uv absorbance and electrochem,<br />

detection, 64<br />

amino acid anal. for nutritional assessment by<br />

Pico-Tag HPLC: precision studies, ref.<br />

ranges, and correlations with ian-exchange<br />

method (A), 1113<br />

i-eminolevulinic acid in plasma by free amino<br />

acid anal. (TB), 1998<br />

anal. of mexiletine stereoisomers in serum by<br />

HPLC with a chiral column (A), 1178<br />

anal. of urinary metanephrines of patients<br />

treated with antihypertensive a-methyldopa<br />

(Ahdomet) (A), 1138<br />

antipyrmne, indocyanine green, and lorazepam<br />

deed, in plasma by HPLC (SN), 2124<br />

detn. of cyclosporine in plasma: specific RIA<br />

with a monoclonal antibody and liq.<br />

chromatog. compared, 608<br />

deth. of trans-phylloquinone in children’s<br />

serum (SN), 874<br />

detn, of tyramine in plasma by ian-pair extn.<br />

and reversed-phase liquid chromatog. with<br />

electrochem. detection (A), 1152<br />

direct deth. of 4 sulfates and 7 glucuronides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” liq. chromatog., 794<br />

direct HPLC detn, of theophylline,<br />

theophyhline analogs, and caffeine in plasma<br />

with en ISRP (Pinkerton) column (A), 1185<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes end porphyrins, 2290<br />

encainide and metabohite anal, in serum or<br />

plasma using reversed-phase HPLC (A),<br />

1177<br />

exth. of intracellular nucleosides and<br />

nucheotides with acetonitrile, 48<br />

HPLC for argininosuccinate synthetese (A),<br />

1117<br />

liq. chromato. assay for free and -<br />

transthyretin-bound retinal-binding protein<br />

in serum, 582<br />

hiq.-chromatog. monitoring of cytosine<br />

arabinoside<br />

arabinoside,<br />

and its metabolite,<br />

in serum, 1011<br />

uracil<br />

meas, of urinary leukotrienes by reversedphase<br />

hiq. chromatog. end RIA, 388<br />

polyamines assayed by HPLC with<br />

ehectrochem. detection after post-column<br />

reaction with immobilized polyamine<br />

oxidase, 1694<br />

quantn. of urinary porphyrins by liq.<br />

chromatog. after oxidn, of porphyrinogens,<br />

1619<br />

reversed-phase HPLC sepn. of plasma<br />

norepinephrine, epinephrine, and dopamine,<br />

with 3-electrode coulometric detection (SN),<br />

1975<br />

simultaneous detn, of pentoxifylline and three<br />

metabohites in biol. fluids by liq. chromatog.<br />

(SN), 298<br />

Chromatography, size-exclusion<br />

hiq. chromato. assay for free and<br />

transthyretm-bound retinal-binding protein<br />

in serum, 582<br />

Chromatography, supercritical fluid<br />

hybrid chrometog. methodologies for drug<br />

anal.-GC-MS,<br />

supercritical<br />

LC-MS, MS-MS. and<br />

fluid chromatography-MS (A),<br />

1055<br />

supercritical fluid chromatog. and microbore<br />

liq. chromatog. for drug anal. (5), 1293<br />

Chromatography, thin-layer<br />

detn. of the allyl lysophospholipid derivative<br />

ET-18-OCH3, a new antineoplastic drug, in<br />

plasma, 821<br />

evaln. of TLC technique for detection of<br />

opiates in urine (A), 1173<br />

improved staining of thin-layer chromatograms<br />

of amniotic fluid phosphohipids (TB), 1539<br />

phospholipid surface tension: diagnostic utility<br />

of amniotic fluid and its lipid extract, an<br />

anal, of the value of pptn. with cold acetone,<br />

800<br />

rapid thin-layer chromatog. semiquantification<br />

of morphine in urine via dabsylation:<br />

comparison with EMIT and thin-layer<br />

chromatog.-iodoplatinate methods (TB), 329<br />

sample preparation for thin-layer chromatog.<br />

anal. for 11-nor-9-tetrahydrocannabinol-9-<br />

carboxylic acid in urine (SN), 163<br />

thin-layer chromatog. of free porphyrins for<br />

diagnosis of porphyria (SN), 1043<br />

Chromatography, two-dimensional<br />

encainide by HPLC-simplified 2-D<br />

chromatog.<br />

1177<br />

to eliminate interferences (A),<br />

Cbromogranin<br />

enzyme-linked<br />

A<br />

immunosorbent assay for<br />

chromogrenin A, 1934<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

Chylomicrons<br />

strong assocn. of a single nucleotide<br />

substitution in the 3’-untranslated region of<br />

the apolipoprotein-Clil gene with common<br />

hypertriglyceridemia in Arabs, 256<br />

Chymotrypein<br />

fecal chymotrypsin: suitable test for diagnosing<br />

pancreatic insufficiency (A), 1090<br />

Circadlan<br />

rhythm<br />

circadien variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

Clrcannual rhythms<br />

tumoral calcinosis: seasonal biochem, studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

Cirrhosis<br />

bile acid-binding activity of diethylaminoethyl<br />

dextran in healthy subjects and in primary<br />

biliary cirrhosis (A), 1134<br />

buliary elk. phospbatase measured by minicolumn<br />

chromatog. on DEAE-cellulose:<br />

appln. to detection of hepatobiliary diseases,<br />

1684<br />

calciferin and cathepsin D-ike acid pratease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

Citrate<br />

citrate interference in assays of total Ca in<br />

serum (TB), 2140<br />

effect of citrate on urinary excretion of Ca end<br />

oxalate: relevance to Ca oxalate<br />

nephrolithiasis, 23<br />

effect of oral citrate on Ca absorption after oral<br />

load of Ca phosphate (TB), 1541<br />

Clearance, renal<br />

See also Creatinine<br />

<strong>Clinical</strong> Chemist, The<br />

198,344,517,715,905, 1271, 1565, 1812,2023,<br />

2161, 2259,2340<br />

<strong>Clinical</strong><br />

chemistry<br />

appln. of expert systems in the cm. lab. (R),<br />

1595<br />

bial. variability of 26 cm. chem. analytes in the<br />

elderly, 783<br />

mal. genetics end the transformation of cm.<br />

chem, (5), 2165<br />

regulatory<br />

evaln, (SR), 691<br />

Clotting<br />

See Coagulation<br />

Coagulation<br />

anal, of supplemented<br />

model for chin, labs.: an empirical<br />

vit, K1 (20) in serum<br />

microsamphes by solid-phase extrn, and<br />

narrow-bore HPLC with multichanneh uv<br />

detection (S), 1288<br />

brodifacoum (super warfarin) poisoning lab.<br />

methods for assessment of vit. K antagonism<br />

(A), 1162<br />

correction of instrument- and reagent-based<br />

differences in deth. of the int, normalized<br />

ratio for monitoring anticoagulant therapy<br />

(SN), 840<br />

development of human factor VII ELISA:<br />

preliminary studies (A), 1161<br />

enzyme immunoassay for quantn. of<br />

thrombin-antithrombin III<br />

complex-multicenter evsln. (A), 1163<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

increased concns. of heparin cofactor II in<br />

diabetic patients, and possible effects on<br />

thrombin inhibition assay of antithrombin<br />

111,52<br />

measuring tissue factor (Factor III) acty. in<br />

plasma, 1897<br />

monitoring lysis of fully cross-linked fibrin<br />

clots with comm. D-dimer test (A), 1161<br />

new chromogenic substrate for detn, of<br />

prothrombin time with the Reflotron5 (A),<br />

1161<br />

optimized microturbidimetric assay for<br />

fibrinogen, 211<br />

standn, of methods for meas. plasminogen<br />

activator inhibitor acty. in plasma, 787<br />

Cobalamin<br />

cobalamin-binding capacity of haptocarrin and<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

high prevalence of atrophic gastritis in the<br />

elderly: implications for health-associated<br />

ref. limits for cobalamin in serum (L), 1557<br />

methyimalanic acid. I. concns. in serum and<br />

urinary excretion in normal subjects after<br />

feeding and during fasting, and after loading<br />

with protein, fat, sugar, isoleucine, valine,<br />

2271<br />

methylmalonic acid. II. relation between<br />

concns, in serum and urinary excretion, and<br />

the correln. between serum cobalamin and<br />

accumulation of methylmalonic acid, 2277<br />

solid-phase sample extn. for rapid detn. of<br />

methyimalonic acid in serum, urine by stable<br />

isotope dilution, 260<br />

Cobalamin-binding proteins<br />

cobalamin-binding capacity of haptocorrin and<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

Cocaine<br />

anal, of cocaine metabohites in urine:<br />

comparison of TDx FPIA cocaine metabolite<br />

assay with GCIMS (A), 1186<br />

cocaine and pregnancr cm. and toxicol.<br />

implications for the neonate (5), 1276<br />

detn, of cocaine metabohite, ecgonine methyl<br />

ester in urine, by gas chromatog. with N-<br />

selective detector (A), 1168<br />

urine screening for cocaine use with ELISA and<br />

confirmation with GC/MS (A), 1171<br />

Codeine<br />

simultaneous quantn. of morphine, codeine,<br />

and 06-monoacetyl morphine by gas<br />

chromatog. mass spectrom. (A), 1355<br />

Collagen<br />

collagen-linked fluorescence in skin biopsy<br />

specimens from young insulin-dependent<br />

diabetic patients (A), 1137<br />

mess, of autoimmune response against collagen<br />

types 1,111, and IV by enzyme-linked<br />

immunosorbent assay, and appln. in<br />

infective endocarditis, 246<br />

Colorinietry<br />

See also Spectrophotometry<br />

antipyrine interferes with chem, detn. of Br<br />

simultaneous estn. of total body H20 end<br />

in<br />

extracellular H20, 1367<br />

assessment of renal function by inuhin<br />

clearance: comparison with creatinine<br />

clearance as deed. enzymatically (SN), 312<br />

Biotrol urine proteins<br />

red-Mo complex (A), 1082<br />

colorimetric detn. of non-enzymatically<br />

glycated apohipoprotein B (A), 1074<br />

calorimetric screening method for<br />

reagent using pyrogallol<br />

microalbuminuria: intra-individual<br />

variability for untimed day specimens (L),<br />

2019<br />

detn. of a2-macroglobulin-trypsin<br />

with a new synthetic substrate,<br />

complex<br />

2169<br />

enzymic urea asseT. new cohorimetric method<br />

based on H202 mess. (SN), 654<br />

fluorescence polarn. immunoassay of urinary 5-<br />

hydroxy-3-indoleacetic acid, 355<br />

improved colorimetric fructosamine assay (A),<br />

1110<br />

measurement of human cerulophasmin by its<br />

oxidase acty. using 4,4’-<br />

bis(dimethylamina)diphenylamine (A), 1082<br />

microalbuminuria in diabetes mellitus: more on<br />

urine storage and accuracy of colarimetry<br />

(L), 1560<br />

new liquid Ca reagent for Abbott Spectrums<br />

(A), 1094<br />

one-step protocol for assays of total and direct<br />

bihirubin with stable combined reagents<br />

(SN), 173<br />

performance characteristics of a Mg procedure<br />

for the Olympus AU5000 series of chem,<br />

analyzers (A), 1089<br />

performance of Technicon cohorimetric K<br />

method on the RA-100 system (A), 1130<br />

quant. measurement of urinary cystine by<br />

nitroprusside reaction (A), 1152<br />

rapid detn. of toxic CN- concns, in blood, 617<br />

2372 CLINICAL CHEMISTRY,Vol. 35, No. 12, 1989


screening for microalbuminuria with a rapid,<br />

low-cost calorimetric assay (SN), 456<br />

sensitive, direct calorimetry of Cu in serum,<br />

552<br />

Wako UV colorimetric pancreatic lipase assay<br />

with 1,2-dihinoleoylglycerol as substrate<br />

evald. (TB), 1540<br />

Complement<br />

complement activation in plasma donors (A),<br />

1155<br />

complement C4 sUbtypes and psoriasis (TB),<br />

2142<br />

immunochem. detn. of C4b-binding protein in<br />

human plasma (A), 1163<br />

serum proteins, immunoglobuhin, and<br />

complement (C3 & C4) levels in Down’s<br />

syndrome in Kuwait sample (A), 1081<br />

Computers<br />

appln. of Quality Management System<br />

microcomputer qual.-control program in the<br />

RIA/endocrine lab. (A), 1086<br />

automation end interpretation of quentn.<br />

antibodies to therapeutic proteins,<br />

of<br />

illustrated with somatotrapin, 1623<br />

chin, evaln. of Beckman “Interlinkn Systems<br />

Director” interfacing the Syncbron CX 5 and<br />

Synchron AS analyzers (A), 1088<br />

computerized interpretation of Toxi-Lab<br />

chromatograms (A), 1087<br />

computerized model for automating collection<br />

of field data (A), 1088<br />

computerized quant. anal, of Coomassie-Bluestained<br />

serum proteins sepd. by twodimensional<br />

electrophoresia, 2297<br />

evaln, of Beckman Interhink’s custom<br />

formatting far reporting glucose tolerance<br />

test results (A), 1088<br />

evaln. of Beckman Interlinkn Systems<br />

Director-software version 3.0 interfacing one<br />

Synchron CX3 and one Synchron CX 5<br />

(A), 1088<br />

high-volume Syva EMIl’ drug testing on<br />

multiple Rpos analyzers interfaced to a<br />

central computer system (A), 1166<br />

integrated computer-controlled lab. anal. and<br />

reporting system incorporating the Olympus<br />

AU5031 (A). 1086<br />

knowledge-based systems in a comm. lab.<br />

setting (A), 1233<br />

Concanavalin<br />

changes in concanavahin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

Congenital adrenal hyperplasia<br />

assessment of screening program for congenital<br />

adrenal hyperplasia in Portugal based on<br />

antibody-coated tube RIA for 17a-OH<br />

progesterone (L), 2338<br />

1-RIA for endrostenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

Congenital disorders<br />

See Heritable disorders<br />

Continuous-flow analysis<br />

accuracy of total protein and albumin system<br />

specific values for SMA, SMAC-3, RA-1000,<br />

Assist, and Demand compared with the ref.<br />

method forT, protein and a comparative<br />

method for albumin (A), 1104<br />

automated deth. of urinary Nat, K, Cl,<br />

urea, and creatinine without sample diln.<br />

with the “RAT-XT” (SN), 481<br />

automated procedure for meas, of biotinidsse<br />

acty. in serum (SN), 831<br />

Control materials<br />

activation energies deed. for drugs of<br />

abuse-their use in projecting product shelflife<br />

(A), 1180<br />

evaln, of human-serum-based tumor marker<br />

control by comm. available<br />

kits (A), 1068<br />

RIA and EIA test<br />

evaln. of hiq. quality-control<br />

of fructosamine in human<br />

material for detn.<br />

serum (A), 1106<br />

evain. of liquid immunology control using the<br />

Beckman Array (A), 1154<br />

evaln. of urine metals control using at.<br />

absorption spectrophotom. (A), 1177<br />

interinstrument comparison in poe between<br />

tonometared whole blood and<br />

perfluorocarbon (A), 1131<br />

interlab. comparison of control materials for<br />

use with hematofluorameters, 2059<br />

reflectometric evaln. of Quantimetrix urine<br />

dipstick controls (A), 1108<br />

serum-based quality control fluids and<br />

calibrators: lyophihization vs vacuum-drying?<br />

(A), 1101<br />

use of Sentry<br />

performance<br />

drug control in evaluating<br />

of TDx drugs of abuse<br />

screening near NIDA cutoff concns. (A), 1103<br />

Copper<br />

changes in Fe, Zn, Cu concns. in serum and in<br />

their binding to transport proteins after<br />

cholecystectomy, cardiac surgery (SN), 2243<br />

interactions of Cu with some analytes in serum<br />

(L),335<br />

sensitive, direct calorimetry of Cu in serum,<br />

552<br />

Coproporphyrin<br />

quantn. of urinary porphyrins by hiq.<br />

chramatog. after oxidn. of porphyrmnagens,<br />

1619<br />

rapid detn. of uroporphyrin and<br />

coproporphyrmns in urine using secondderivative<br />

spectroscopy (A), 1132<br />

Coronary angioplasty<br />

creetine kinase isoforms in ischemic heart<br />

disease (R), 7<br />

Corrections<br />

670, 2257<br />

Corticosterold-binding globulin<br />

decreased immunoreecty. and binding acty. of<br />

corticosteroid-binding globulin in serum in<br />

septic shock, 1675<br />

Corticotrophn -<br />

evaln. of high sensitivity corticatropin<br />

immunorediometric assay (A), 1146<br />

immunoradiometry of corticatrapin with use of<br />

avidin-biotin sepn., 804<br />

new immunoradiometric assay for<br />

corticotropin evald, in normal subjects and<br />

patients with Cushing’s syndrome, 596<br />

parallel assays of -endorphin end ACTH in<br />

Cushing’s patients undergoing petrosal<br />

studies (A), 1145<br />

Cortisol<br />

decreased immunareacty. and binding acty. of<br />

corticostaroid-binding globulin in serum in<br />

septic shock, 1675<br />

detn, of FSH, LH, and cortisoh with automated<br />

enzyme immunoassays (A), 1141<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerhex cortisol, Biodata testosterone (SN),<br />

641<br />

evaln. of an RIA of urinary cortisol without<br />

extrn. (SN), 125<br />

reservations regarding assessment of data<br />

obtained with commercialiy available<br />

cortisol RIA kite (L), 2153<br />

solid-phase non-isotopic immunassay for<br />

quantn. of cortisol in serum (A), 1201<br />

urine free cortisol in depressed patients<br />

assayed by HPLC (A), 1138<br />

Cotinine<br />

caffeine interference eliminated in HPLC detn,<br />

of urinary nicotine end cotinine, 1456<br />

exposure to environmental tobacco smoke<br />

measured by cotinine I-RIA (SN), 1036<br />

Coulometry<br />

detn. of trans-phylloquinone in children’s<br />

serum (SN), 874<br />

free 3-methoxy-4-hydroxyphenylglycol deed. in<br />

plasma by liq. chromatog. with coulometric<br />

detection, 202<br />

reversed-phase HPLC sepn. of plasma<br />

norepinephrine, epinephrine, and dapamine,<br />

with 3-electrode coulametric detection (SN),<br />

1975<br />

Counterimmunoelectrophoresis<br />

See Immunoelectrophoresis<br />

Coupled-enzyme method -<br />

Hb peroxidase arty. for coupled enzymatic<br />

reactions (A), 1122<br />

C-peptide<br />

improved RIA of C-peptide and its appln. ins<br />

multiyear study, 37<br />

C-reactive protein<br />

See also Acute-phase proteins<br />

concns, of tumor-associated trypsin inhibitor<br />

and C-reactive protein in serum in acute<br />

pelvic inflammatory disease (SN), 869<br />

decreased immunareacty. and binding acty. of<br />

corticosteroid-binding globulin in serum in<br />

septic shock, 1675<br />

erythrocyte sedimentation rate and C-reactive<br />

protein compared in the elderly (SN), 466<br />

evaln, of a particle-enhanced immunoassay for<br />

quantifyingC-reactive protein (TB), 2001<br />

evaln. of the Tina-quant immunoturbiditnetric<br />

method for C-reactive protein on the Hitachi<br />

705 (A), 1081<br />

four immunochem, methods compared for<br />

mess. C-reactive protein in plasma (SN), 461<br />

method comparison for C-reactive protein<br />

comparing the Array’ protein system from<br />

Beckman to the Behring BNA (A), 1085<br />

nephelometric detn. of C-reactive protein (A),<br />

1197<br />

sensitive turbidimetric<br />

of C-reactive protein<br />

immunoassay for detn.<br />

in serum (A), 1082<br />

simultaneous detn. of serum neopterin and C-<br />

reactive protein as markers of infection in<br />

heart-transplant recipients (TB), 1258<br />

Creatine<br />

ref. values for creatine, creatinine, and<br />

carnitine are lower in vegetarians (L), 1802<br />

Creatine kinase<br />

appin. of Magic’ Lite<br />

immunochemiluminometric method for<br />

measurement of creatine kinase-MB in blood<br />

spots (A), 1123<br />

cardiac isoenzyme (CK-MM isoform) assays for<br />

early detection of acute myocardial<br />

infarction: comparison of immunometric and<br />

ehectrophoretic systems (A), 1117<br />

changes in creatine kinase acty. in acute<br />

myocerdial infarction, 414<br />

changes in isoform patterns end stability of<br />

CK-MB during storage (A), 1120<br />

characteristics of creatine kinase-MB and MB<br />

isoforms in serum after reperfusion in acute<br />

myocard. infarct, 2179<br />

CK-MM interference with en<br />

imenunoenzymometric method far quanta. of<br />

CK-MB in serum (L), 901<br />

CK-unrelated serum component identified in<br />

CK isoenzyme anal. using Helena Rep<br />

system (A), 1117<br />

cm. and anal. evaln. of different methods for<br />

mess, of creatine kinase isoenzyme MB (SN),<br />

130<br />

cm. comparison of Helena REP vs Kodak<br />

Ektachem creatine kinase MB slide in<br />

patients with suspected acute myocardial<br />

infarction (A), 1125<br />

comparison of automated vs manual<br />

ehectraphoresis system far creatine kinase<br />

isoenzymes (A), 1106<br />

comparison of Kodak CK-MB assay with CK<br />

isoenzyme electropharesis (A), 1123<br />

comparison of Stratus and Roche methods for<br />

CK-MB deth. (A), 1124<br />

concordance of creatine kinase-MB arty. and<br />

mass, 440<br />

creatine kinase and lactate dehydrogenase in<br />

whole blood, plasma, and serum determined<br />

with Abbott’s Vision system (A), 1125<br />

creatine kinase and lactate dehydrogenase<br />

isoenzymes in serum and tissues of patients<br />

with stomach adenocarcinoma, 1385<br />

creatine kinase and lactate dehydrogenase<br />

isoenzyme utilization: cut-off values for<br />

fractionation based on total CK activity, and<br />

monitoring of ordering patterns in 334<br />

intensive-care-unit patients (A), 1122<br />

creetine kinsse assay by Abbott Vision’ system<br />

(A), 1125<br />

creatine kinase isoforms in ischemic heart<br />

disease (R), 7<br />

creatine kinase MB isoenzyme in<br />

rhabdomyosarcoma (L), 896<br />

detection of serum CK-MB iaoforms by RIA<br />

(A), 1121<br />

development of a second-generation Isomune<br />

CK’assay(A), 1121<br />

diagnosis of acute myocardial infarction from<br />

two measurements of creatine kinase<br />

isoenzyme MB with use of nonparametric<br />

probability estn., 444<br />

diagnosis of acute myacardial infarct, when<br />

skel. muscle damage is present: a caveat<br />

regarding use of creatine kinase isoenzymes<br />

(L),705<br />

diagnostic performances of CK-MB assays by<br />

Du Pont and by Ciba-Corning compared (A),<br />

1122<br />

diagnostic utility of serum total creatine kinase<br />

and creatine kinase-2 in myocardiel<br />

infarction re-evaluated, 1435<br />

elevated CK-MB in a patient with pelvic<br />

sarcoma (A), 1124<br />

EMDS test pack CK-MB immunoassay<br />

immunoinhibition with anti-CK-M antibody<br />

(A), 1115<br />

estn. of brain lesion size based on quantifying<br />

CK-BB in serum (L), 2018<br />

evaln, of automated CK-MB mass assay (A),<br />

1107<br />

evaln, of Dade Stratus<br />

1090<br />

for detn. of CK-MB (A),<br />

eveln. of immunoenzymatic assay for CK-MB<br />

using the Icon format (A), 1121<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2373


evolution of serum CK-MB isoforms after<br />

acute myocardial infarction (A), 1120<br />

four assays for creatine kinase MB compared<br />

(A), 1124<br />

heterogeneity of serum creatine<br />

isoenzyme MM in myocardiel<br />

kinase<br />

infarction:<br />

din, significance and poet-synthetic<br />

conversion of “abnormal” sub-bands, 206<br />

high incidence of appearance end/or<br />

diaapperance of macro CK type in hosp.<br />

population<br />

IgA-CK-BB<br />

(A), 1123<br />

complex with CK-MB<br />

ehectrophoretic mobility can lead to<br />

erroneous diagnosis of acute myocard.<br />

infarct. (CR), 2003<br />

immunoaffinity purifn. of creatine kinase-MB<br />

from human, dog, end rabbit heart with use<br />

of monoclonal antibody specific for CK-MB,<br />

985<br />

immunochemical vs electrophoretic CK-MB<br />

deths. in early detection of acute myocardial<br />

infarction (A), 1125<br />

immunochem. test for CK-MB isoforms (L),<br />

2157<br />

increases in aspartete aminotransferase,<br />

creatine kinase in hemorrhagic shock and<br />

encepbalopathy syndrome (L), 2253<br />

interference of macro-creatine kinase in detn.<br />

of CK-MB in serum with the Kodak<br />

Ektachem (L), 2155<br />

is electrophoresis a ref. method for CK-MB in<br />

comparison with an immunoenzymometric<br />

method? (L), 900<br />

isoenzymes and isoforms of CK: what is the<br />

score? (E), 201<br />

measurement of creatine kinase MB by the<br />

Baxter Stratus fluorometric analyzer (A),<br />

1123<br />

measuring creatine kinase MB isoenzyme in a<br />

maintenance hemodialysis popn.:<br />

chemiluminometric immunoassay and<br />

electrophoresis<br />

more on methods<br />

compared (SN), 1965<br />

for CK-MB (L), 899<br />

rapid purifn. of creatine kinase MB isoenzyme<br />

on preparative polyacrylamide slabs, 96<br />

rapid, quant. immunoassay for creatine kinase-<br />

MB using Tandem Icon’ QSR technology<br />

(A), 1197<br />

rapid, specific method for CK-MB using<br />

Tandem Icon OSR CK-MB reagents (A),<br />

1120<br />

rate of release of CK isoforms into serum of<br />

patients with myocardial infarction treated<br />

with thrombolysis (L), 1264<br />

reproducibility of creatine kinase isoenzyme<br />

electrophoresis (L), 710<br />

role of CK subforms in thrombolytic therapy<br />

early diagnosis and assessment of efficacy<br />

(A), 1050<br />

role of rapid immunoassays for urgent detns. of<br />

creatine kinase isoenzyene MB (SN), 1752<br />

S-lOOa,, protein in blood and urine during<br />

open-heart surgery, 1942<br />

scheme for detecting elevated CK-MB in<br />

children (A), 1109<br />

sensitive, rapid assay of subforms of crestine<br />

kinase MB in plasma, 1452<br />

sepn. of the CK-MM isoforms by the Paragon’<br />

agarose gel electrophoreais system (A), 1101<br />

serum creatine kinase in primary hypothermia<br />

(L),2254<br />

serum creatine kinase isoenzyme BB: poor<br />

index to size of various brain lesions (SN),<br />

651<br />

single-vial screening assay for creatine kinase-<br />

MB (A), 1122<br />

statis, interpreth. of concns. of Mg, Zn, Ca, K,<br />

cholesterols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

Stratus automated creatine kinase-MB assay<br />

evald.: identn. and emmn. of falsely increased<br />

results assocd. with a high-M, farm of elk.<br />

phosphatase, 2048<br />

two kits for CK-MM isoforms evald. for early<br />

recognition of acute myocardial infarction<br />

(TB), 493<br />

use of creatine kinase MB isoforms for<br />

predicting myocardial reperfusion (A), 1125<br />

variation in decision thresholds for CK and<br />

CK-2 in myocardial infarction (A), 1116<br />

Creatinine<br />

anal, performance of AACC Creatinine Study<br />

Group HPLC method (A), 1104<br />

assessment of renal function by inulin<br />

clearance: comparison with creatinine<br />

clearance as deed. enzymatically (SN), 312<br />

automated detn. of urinary Na, K, Cl, P,,<br />

urea, and creatinine without sample diln.<br />

with the “RAT-XT” (SN), 481<br />

interlab. evaln. of isocratic HPLC method for<br />

creatinine in serum (A), 1132<br />

kinetic study of the Jaffe reaction for<br />

crsatinine in serum: 2. evaln. of buffered<br />

reagent and comparison of different dataprocessing<br />

options, 360<br />

micraplate mess, of urinary albumin,<br />

creatinine, 1371<br />

modifn. of Kodak Ektachem<br />

creatinine to substantially<br />

smde far<br />

reduce<br />

interference from lidocaine metabolite (A),<br />

1098<br />

new commercial method for enzymatic detn. of<br />

creatinine in serum and urine eveld:<br />

camper son with a kinetic Jaff#{233} method and<br />

- isotope diln.-mass spectrometry (SN), 835<br />

nitromethane interferes in assay for creatinine<br />

by Jaff#{233} reaction (SN), 1772<br />

ref. values for creetine, creatimne, and<br />

carnitine are lower in vegetarians (L), 1802<br />

renal function assessed by serum creatinine<br />

and creatinine clearance: ghomerular<br />

filtration rate estd. by four procedures (SN),<br />

2326<br />

Creatinine clearance<br />

renal function assessed by serum creatinine<br />

and creatinine clearance: glamerular<br />

filtration rate esed. by four procedures (SN),<br />

2326<br />

Cross reactivity<br />

See antigen-antibody system of interest<br />

Cryolnununoglobulins<br />

148 cryoimniunoglobulins characterized by<br />

cryocrit, immunoelectraphoresis, and<br />

immunonephelometry (A), 1083<br />

Cushing’. syndrome<br />

decreased dehydroepiandrosterone sulfate in<br />

pigmented nodular adrenal dysplasia (SN),<br />

2216<br />

Cutoff value<br />

chin, significant decision levels of hCG (L),<br />

1801<br />

creatine kinase and lactate dehydrogenase<br />

isoenzyme utilization: cut-off values far<br />

fractionation based on total CK activity, and<br />

monitoring of ordering patterns in 334<br />

intensive-care-unit patients (A), 1122<br />

detection limit of the Tl)x fluorescence<br />

polarization immunoassay extended for<br />

benzoylecgonine in urine (SN), 2110<br />

empirically deed. Pb-poisoning screening cutoff<br />

for the Protofluor-Z hematofluorometer<br />

(SN), 2104<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN), 166<br />

measuring carboxypeptidase A arty. with a<br />

centrif. analyzer: anal, end chin.<br />

considerations, 251<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

system to standardize ALT cutoff sctys. (A),<br />

1118<br />

Cyanide<br />

modifn. and automation of whale-blood CN<br />

assay (A), 1177<br />

rapid detn. of toxic CN- concns. in blood, 617<br />

Cyanocobalamin<br />

See Vitamin B12<br />

Cyclic GMP<br />

influence of blood pressure, heart rate, age, end<br />

sex on concns. of atrial natriuretic factor and<br />

cyclic GMP (SN), 1519<br />

Cycho.porine<br />

adv. in cyclosporine pharmacol., measurement,<br />

and ther. monitoring (S), 1299<br />

automated assay specific for #{231}yclosporine<br />

whole blood, with use of a Cr02 particle<br />

column (5), 1860<br />

calibration of 1I immunoassay measuring<br />

cyclosporin A (TB), 181<br />

calibration problems with the<br />

immunoassay for cyclosporin A (L), 1551<br />

comparison of assay methods far a new<br />

strategy for cyclosporine monitoring (A),<br />

1186<br />

comparison of cyclosporine assays in pediatric<br />

patients receiving organ transplants (A),<br />

1168<br />

comparison<br />

methods:<br />

of cyclosporine immunoassay<br />

examination of rejection and<br />

nephrotoxic episodes in liver transplantation<br />

(A), 1183<br />

comparison of four methods for measurement<br />

of cyclosporin (A), 1186<br />

concn, dependence and mechanism of the<br />

immunosuppressive activity of cyclosporine<br />

(A), 1235<br />

continuing need for qual. assessment of<br />

cyclosporine measurement (5), 1309<br />

cyclosporin A meas. in plasma in various<br />

transplant types by HPLC and RIA (A),<br />

1356<br />

cyclosporine concns, in blood after liver<br />

transplanth.: correlation<br />

results with chin, events,<br />

of immunoasaay<br />

564<br />

cyclosporine does not interfere in total and<br />

high-density lipoprotein cholesterol meas,<br />

with use of enzymatic cholesterol assays<br />

(TB), 2251<br />

cyclosporine measured in plasma from patients<br />

with various transplants: HPLC and RIA<br />

with a specific monoclonsi antibody<br />

compared (SN), 1726<br />

cyclosporine metabolism impeded/blocked by<br />

co-administration of phenobarbital (A), 1160<br />

cyclosporine monitoring (E), 5<br />

cyclosporine pharmacokinetics with<br />

concomitant ketoconazole therapy (A), 1176<br />

deth, of cyclosporine in plasma specific RIA<br />

with a monoclonal antibody and mq.<br />

chromatog. compared, 608<br />

distribn, of cyclosporin A metabolites among<br />

plasma and cells in whale blood: effect of<br />

temp., hematocrit, and metabolite concn., 59<br />

impact of meal timing on bioavailability of<br />

cycloeporine in CsA-treated renal allograft<br />

recipients post-transplantation (A), 1179<br />

isolation, characterization, and pharmacoL<br />

arty. of cyclosporine metabolites (A), 1235<br />

mess, of cycloeporine concns, in whole blood:<br />

HPLC and 83A with a specific monoclonal<br />

antibody end 8H- or iesIlabeled ligand<br />

compared (SN), 120<br />

new directions in cyclosporine monitoring (A),<br />

1235<br />

nonselective measurements of cyclosporin A in<br />

transplant patient specimens by RIA a<br />

monoclonal antibody and 1251tracer (A),<br />

1164<br />

pharmacokinetics and biotransformation of<br />

cyclosporine metabolite, M-17 (A), 1164<br />

qual. assurance of cyclosporine measurements:<br />

comparison of current methods (A), 1236<br />

receptor assay for cyclosporine acty. in whole<br />

blood (A), 1167<br />

sensitivity of CYCLO-Trac SP (specific<br />

monoclonal immunoassay for cyclosporin A)<br />

(L),900<br />

whole-blood cyclosporin A: comparison of<br />

monoclonsl<br />

1100<br />

antibody RIA with HPLC (A),<br />

Cystatin<br />

cystatin C quantn. in CSF (TB), 179<br />

Cystic fibrosis<br />

defective epitheliel ion transport in cystic<br />

fibrosis (5), 726<br />

genetic heterogeneity at the cystic fibrosis<br />

locus (A), 1077<br />

high-Mr (“biliary”) isoenzyme of elk.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

isolation of “cystic fibrosis protein” from<br />

serum, 1901<br />

update on cystic fibrosis: a molecular approach<br />

(A), 1057<br />

use of the polymerase chain reaction for<br />

simultaneous anal, of two Pst I<br />

polymorphisms linked to cystic fibrosis<br />

(TB), 1260<br />

Cystine<br />

quant. measurement of urinary cystine by<br />

nitroprusside reaction (A), 1152<br />

Cytochrome c<br />

interaction between pyridine nucleotide<br />

coenxymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

Cytokeratin-18<br />

two-site IRMA for deth, of urinary<br />

cytokeratin-18; applicn. to management of<br />

bladder cancer (A), 1198<br />

Cytomegalovirus<br />

molecular probes used to detect<br />

cytomegelovirus and human<br />

iminunodeficiency virus (5), 1581<br />

Cytosine arabino.ide<br />

documentation of cytosine arabinoside<br />

using drug monitoring (A), 1182<br />

toxicity<br />

2374 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


liq.-chromatog. monitoring a! cytosine<br />

arabinoside and its metabohite, uracil<br />

arabinoside, in serum, 1011<br />

Data handling<br />

algorithmic-driven lab, testing in a primary<br />

care setting (A), 1233<br />

automation and interpretation of quantn. of<br />

antibodies to therapeutic proteins,<br />

illustrated with somatotropin, 1623<br />

biol. variation of urinary N-acetyl-fl-Dglucoseminidase:<br />

practical and chin.<br />

implications, 560<br />

comparison of ref. standard and standard curve<br />

data-reduction methods for NMI’ low-end<br />

sensitive TSH IRMA (A), 1187<br />

CV at the detection limit (L), 901<br />

determining “ref. changes” for serial<br />

measurements of plasma lipid-bound sialic<br />

acid (A), 1080<br />

detn, of the lower limit of detection (L), 2152<br />

generalized likelihood ratio concept and<br />

logistic regression anal, for multiple<br />

diagnostic categories, 990<br />

methods for detg. “reference changes” from<br />

serial measurements: plasma lipid-bound<br />

sielic acid, 972<br />

reservations regarding assessment of data<br />

obtained with commercially available<br />

cortisol RIA kits (L), 2153<br />

sampling distribn, of skewness and kurtosis<br />

(TB), 330<br />

use of algorithms to achieve cost containment<br />

in a chin, lab. (A), 1233<br />

Data processing<br />

artificial intelligence program for<br />

interpretation of raw data from automated<br />

hemotoL instruments (A), 1089<br />

kinetic study of the Jaff#{233} reaction for<br />

creatinine in serum: 2. evahn. of buffered<br />

reagent and comparison of different dataprocessing<br />

options, 360<br />

Decanoic acid<br />

HPLC anal, of brain and plasma for octenoic,<br />

decanoic acids, 1945<br />

Dehydroepiandrosterone sulfate<br />

decreased dehydroepiandrosterone sulfate in<br />

pigmented nodular adrenal dysplasia (SN),<br />

2216<br />

solid-phase enzyme immunoassay of serum<br />

DHEA-S (A), 1197<br />

Densitometry<br />

See also Reflection densitometry<br />

detection of Duchenne/Becker muscular<br />

dystrophy carriers by densitometric scanning<br />

(TB), 1256<br />

deth. of the allyl lysophospholipid derivative<br />

ET-18-0CH, a new antineophastic drug, in<br />

plasma, 821<br />

Depression<br />

free 3-methoxy-4-hydroxyphenylghycoh deed, in<br />

plasma by liq. chromatog. with coulometric<br />

detection, 202<br />

urine free cortisol in depressed patients<br />

assayed by HPLC (A), 1138<br />

Desferrioxamine<br />

indirect mess, of desferrioxamine and its<br />

chelated cmpa. aluminoxamine and<br />

ferrioxamine by Zeeman at. absorp.<br />

spectrom. (SN), 884<br />

Dextran<br />

interference of plasma expanders in detn. of<br />

total protein (TB), 2143<br />

Diabetes<br />

albuminuria and progression of diabetic<br />

nephropathy (A), 1237<br />

assessin metabolic acidosis (L), 338<br />

biol, variation of urinary N-acetyl-$-Dglucosaminidase:<br />

practical and din.<br />

implications, 560<br />

chin. evaln, of fructosainine assay for screening<br />

for diabetes mellitus (A), 1096<br />

collagen-linked fluorescence in skin biopsy<br />

specimens from young insulin-dependent<br />

diabetic patients (A), 1137<br />

composition of very-low-density lipoproteins in<br />

nan-insulin-dependent diabetes, 808<br />

concns. of lipids, apohipoprotains in patients<br />

with din, well-controlled insulin-dependent<br />

and non-insulin-dependent diabetes, 813<br />

correin, of HbAic, glycated serum proteins and<br />

albumin, and fructosamine with 24-h glucose<br />

profile of insulin-dependent pregnant<br />

diabetics, 922<br />

detn. of usefulness of fructosamine assay for<br />

diagnosis of diabetes (A), 1145<br />

diabetes mellitus: diagnosis and screening (A),<br />

1236<br />

D-lysine effectively decreases non-enzymic<br />

glycation of proteins in vitro, 384<br />

effect of din, apparent recent change in<br />

glycemic control on serum fructosamine (A),<br />

1136<br />

effect of exercise training on glycemic control,<br />

kidney function, and renal ultrastructure in<br />

obese (diabetic) Zucker rats (A), 1135<br />

effect of glycation of low-density lipoprotain on<br />

immunohog. detn. of apolipoprotein B (SN),<br />

2219<br />

effects of various serum proteins on quantn. of<br />

fructosamine (SN), 134<br />

enzyme immunoassay of Hb Ak: anal.<br />

characteristics and din, performance in<br />

diabetes mellitus, with and without uremia,<br />

93<br />

fructosamine and IgA: no correln. in nondiabetics<br />

(L), 1558<br />

fructosamine as routine parameter in diabetes<br />

diagnosis (A), 1098<br />

glycatad Hb and fructosamine measurements<br />

in assessing glycemic control (A), 1236<br />

glycatad Hb in fractionated erythrocytes, 958<br />

increased concns. of heparin cofactor II in<br />

diabetic patients, and possible effects on<br />

thrombin inhibition assay of antithrombin<br />

III, 52<br />

measurement of fructosamine using nitroblue<br />

tatrazolium on IL Multistat and comparison<br />

with Hb A1, in diabetic patients (A), 1146<br />

microalbuminuria in diabetes mellitus: more on<br />

urine storage and accuracy of calorimetry<br />

(L), 1560<br />

microalbuminuria in rats and humans (A),<br />

1137<br />

microphata mess. of urinary albumin,<br />

creatinine, 1371<br />

nonenzymic glycation of human<br />

immunoglobulins does not impair their<br />

immunoreactivity (A), 1154<br />

oral glucose tolerance test does not provide a<br />

uniform stimulus to pancreatic islets in<br />

pregnancy, 1482<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

screenin for microalbuminuria in patients<br />

with diabetes: frozen storage of urine<br />

samples decreases their albumin content<br />

(SN), 308<br />

screening for microalbuiniiiuria with a rapid,<br />

how-cost calorimetric assay (SN), 456<br />

simple enzymatic method for detg. 1,5-<br />

anhydro-D-glucitol in plasma for diagnosis of<br />

diabetes, 2039<br />

transferrin in urine of non-insulin-dependent<br />

diabetics: marker for early complications?,<br />

1672<br />

variables involved in evaluating maternal<br />

serum alpha.fetoprotein: albumin, total<br />

protein and fructosamine (A), 1159<br />

Dialysis patients<br />

See also Hemodialysis<br />

plasma conjugated androgens as digitalis-like<br />

factors in a dialysis-dependent male (A),<br />

1150<br />

Dibucaine<br />

Hitachi 717 procedure for dibucaine inhibition<br />

phenotyping of cholinestarase variants (A),<br />

1120<br />

Diet-related effects<br />

effect of ingestion of hemoprotains on fecal<br />

excretion of hemes and porphyrmns, 2290<br />

methyhmalonic acid. I. concns. in serum and<br />

urinary excretion in normal subjects after<br />

feeding and during fasting, and after loading<br />

with protein, fat, sugar, isoleucine, valine,<br />

2271<br />

Digitalis<br />

plasma conjugated androgens as digitalis-like<br />

factors in a dialysis-dependent male (A),<br />

1150<br />

radioreceptor assay for endogenous digitalislike<br />

substances using microsomal fractions<br />

from human placenta (A), 1140<br />

specific binding of cardiac glycoside drugs and<br />

endogenous digitalis-like substances to<br />

particulate membrane fractions from<br />

placenta, 2093<br />

Digitoxin<br />

evaln. of Baxter Dade Stratus as a stat method.<br />

for human choriogonadotropin, digoxin, and<br />

diitoxin (A), 1111<br />

Digoxin<br />

apphn. of Microgenics CEDIAIN digoxin assay to<br />

the EN! Gemstar’” (A), 1171<br />

cloned enzyme donor immunoassay of serum<br />

digoxin (A), 1190<br />

comparison of free digoxin and total dioxin:<br />

extant of interference from digoxin-like<br />

immunoreactive substances in a fluorescence<br />

polarn, assay (TB), 323<br />

digoxin anal, using Abbott’s digoxin NXT<br />

system (A), 1164<br />

digoxin drug-drug interactions investigated<br />

with a human myocardial NaIK-ATPase<br />

radioreceptor assay (A), 1168<br />

digoxin immune Feb (Digibind’) markedly<br />

affects results of immunoassays for digoxin<br />

(A), 1165<br />

digoxin-like immunoreactive substances in<br />

post-liver transplantation patients with<br />

positive fluid balance (A), 1144<br />

digoxin-like immunoreectivity in neonates and<br />

infants minimized by centrifugal<br />

ultrafiltration and FPIA (A), 1163<br />

dry-strip immunametric assay for digoxin on<br />

the AmesiN seralyzer’ (A), 1168<br />

elimination of total digoxin from a patient in<br />

chronic renal failure post-Fab fragment<br />

(Digibind) therapy (A), 1179<br />

endogenous digoxin measured by receptor<br />

assay in normotensive and hypertensive<br />

subjects (A), 1135<br />

evaln. of a dry reagent digoxin immunometric<br />

assay on a physician’s office analyzer (A),<br />

1109<br />

evaln. of Baxter Dade Stratus as a stat method.<br />

for human choriogonadotropin, digoxin, and<br />

digitoxin (A), 1111<br />

evaln. of Becton<br />

immunoassay<br />

Dickinson Affinity’<br />

system (A), 1107<br />

immunometric assay for digoxin adapted to<br />

Roche Cobas Fare centrifugal analyzer (A),<br />

1166<br />

kinetic behavior of digoxin-hike -<br />

immunoreactive substances during<br />

ultrafiltration studies (A), 1157<br />

measurement of serum digoxin using CEDIA<br />

reagents and the RA-1000 (A), 1183<br />

monoclonal chemiluminescent digoxin assay<br />

(A), 1194<br />

performance of CEDIA Digoxin R assay on<br />

Technicon RA-1000’ chem. analyzer (Al,<br />

1171<br />

physician office eveln. of Chinimate’ digoxin<br />

and theophylhine systems (A), 1099<br />

sequential changes in cross reactivity of antidigaxin<br />

antibodies during immunization (A),<br />

1186<br />

storage temp. and concns. of digozin-hike<br />

immunoreactive factor(s) in plasma (L), 895<br />

Syva EMIT digoxin assay utilizing on-line pretreatment,<br />

for use on Cobas Mire analyzer<br />

(A), 1167<br />

thin-film immunochem. measurement of<br />

digoxin in human serum (A), 1200<br />

total digoxin-hike immunoreactive factor(s),<br />

total bilirubin concn., and birth wt. in<br />

neonates (L), 192<br />

update on digoxin (S), 1326<br />

Dthydroneopterin<br />

urinary neopterin concns. vs total neopterins<br />

for chin, utility (SN), 2305<br />

Dimethyl sulfoxide - -<br />

detection of dimethyl sulfoxide in urine using a<br />

modified Toxilab’ procedure (A), 1165<br />

Diode array spectrometry<br />

HPLC using diode array detection (A), 1240<br />

Dipeptidyl peptidase<br />

activities of dipeptidyl peptidase II and<br />

dipeptidyl peptidase IV in synovial fluid<br />

from patients with rheumatoid and<br />

ostaoarthritis, 1016<br />

evaln. of leukocyte-associated dipeptidyl<br />

peptidase IV enzyme in normal and<br />

immunodeficient conditions (A), 1153<br />

Dipsticks<br />

See also Test stripe<br />

implications of probability anal, for<br />

interpreting results of leukocyte esterase and<br />

nitrite test stips, 1663<br />

underestn. of urinary glucose by an automated<br />

dipstick analyzer based on glucose oxidase<br />

with I as indicator chromogen (L), 1804<br />

Discrete analysis -<br />

See also analyte of interest, Instrumentation,<br />

Random-access analysis, etc.<br />

assay of glucose-6-phosphate dehydrogensse<br />

acty. in blood on the Hitachi 737, with<br />

simultaneous detn. of Hb (A), 1119 -<br />

automated assay specific for cyclosporine m<br />

whole blood, with use of a Cr02 particle<br />

column (S), 1860<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2375


estn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

evaln. of Boehringer Mannheim/Hitachi 717<br />

for routine drug of abuse testing (A), 1165<br />

evain, of Boehringer MannheimfHitachi 717<br />

for routine TDM (A), 1165<br />

evaln. of Hitachi 736 chem. analyzer (A), 1109<br />

evaln, of single-reagent Mg procedure on the<br />

Hitachi 737 (A), 1128<br />

measurement of methotrexate on Du Pont ace<br />

discrete din, analyzer (A), 1169<br />

measurement of vancomycin on the Du Pont<br />

ace’ discrete chin, analyzer (A), 1169<br />

stat TDEF capability on Dacos’ XL (A), 1111<br />

Diurnal variation<br />

circadien variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

I-RIA for androstanedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

DNA<br />

automated DNA sequencing methods involving<br />

polymerase chain reaction, 2196<br />

detection of HIV proviral DNA in peripheral<br />

blood mononuclear cells by polymerase chain<br />

reaction (A), 1076<br />

DNA binding differences of active and inactive<br />

platinum anticancer drugs shown by agarose<br />

electrophoresis of restriction endonuclease<br />

fragments of drug-treated DNA (A), 1077<br />

purifn., characterization of intact hactoferrin<br />

found in the urine of human milk.fed<br />

preterm infants, 1928<br />

quanth. of residual DNA in biol. products (S),<br />

1859<br />

DNA fingerprinting<br />

DNA fingerprinting (S), 1832<br />

DNA fingerprinting procedure in the chin, lab.<br />

(A), 1076<br />

DNA fingerprinting with nonradioactive gene<br />

probes (TB), 2147<br />

identn. of locus-specific VNTR sequences in<br />

forensic samples (A), 1058<br />

DNA probes<br />

assay formats involving acridinium-esterlabeled<br />

DNA probes (S), 1588<br />

carrier detection and characterization of gene<br />

deletions in Duchenne and Becker muscular<br />

dystrophy utilizing dystrophin cDNA probes<br />

(A), 1075<br />

chemihuminescent substrates for elk.<br />

phosphatase: application to ultrasensitive<br />

enzyme-linked immunoassays and DNA<br />

probes (A), 1201<br />

(S), 1863<br />

din, lab, use of a semi-automated DNA probe<br />

system (A), 1076<br />

DNA probes for carrier identn.<br />

muscular dystrophy (E), 519<br />

in Duchenne<br />

DNA probes used in detecting carriers of<br />

Duchenne muscular dystrophy: selected case<br />

studies (CR), 679<br />

evaln. of biotinylated (Blugene”) vs<br />

labeled cDNA probes of -<br />

glucocerebrosidase: rel, sensitivities in<br />

genomic and other systems (SN), 1512<br />

genetic heterogeneity at the cystic fibrosis<br />

locus (A), 1077<br />

identh. of Saimonella<br />

phosphstase-labeled<br />

app. with an alkaline<br />

oligonucleotide probe:<br />

comparison with standard biochem. identh.<br />

techniques (A), 1075<br />

use and apphns. of nucleic acid probes in the<br />

chin, lab. (S), 1819<br />

use of DNA probes and complement<br />

phenotyping for diagnosis and carrier<br />

detection in families with steroid 21-<br />

hydroxylase deficiency (A), 1075<br />

Dopainine<br />

adenosine and dopamine simultaneously deed.<br />

in urine by reversed-phase HPLC, with online<br />

meas, of uv absorbance and electrochem.<br />

detection, 64<br />

reversed-phase HPLC sepn. of plasma<br />

norepinephrine, epinephrine, and dopamine,<br />

with 3-electrode coulometric detection (SN),<br />

1975<br />

Down’s<br />

syndrome<br />

chemiluminescent enzyme ‘immunoassay of a-<br />

fetoprotein with adamantyl dioxetane<br />

phenyl phosphate as substrate (SN), 2319<br />

evaln, of Abbott IMx immunoassay analyzer<br />

for maternal serum alpha-fetoprotein<br />

screening of open neural tube defect and<br />

Down syndrome (A), 1195<br />

maternal serum estriol in screening for Down’s<br />

syndrome: significance of high SD for the<br />

population (A), 1193<br />

serum proteins, immunoglobulin, and<br />

complement (C3 & C4) levels in Down’s<br />

syndrome in Kuwait sample (A), 1081<br />

Drug assay<br />

See also rpecific drug of interest, Abused<br />

drugs, Toxicology<br />

adaptation of ZDV-Trac”' for simultaneous<br />

monitoring of AZT and G-AZT (A), 1187<br />

adaption of Syva EMIT’ TDM assays to the 550<br />

Express (A), 1170<br />

appln. of the Syva EMIT quant. therapeutic<br />

drug assays to Roche Cobas Mire”' analyzer<br />

(A), 1184<br />

chin, lab. evaln. of Clinimata’” digoxin,<br />

theophyhine, phenytoin, phenobarbital, and<br />

carbamazepine systems (A), 1103<br />

computerized interpretation of Taxi-Lab<br />

chromatograms (A), 1087<br />

cost-effective essays for use in monitoring<br />

csrbamazepine, phenobarbital, and<br />

phenytoin in serum (SN), 1782<br />

detn. of serum desipramine and 2-<br />

hydroxydesipramine for pharmacokinetic<br />

applns. by HPLC with uv detection (SN),<br />

2134<br />

effect of gel separator tubes on specimens for<br />

therapeutic drug anal, (A), 1182<br />

effect of serum albumin on displacement of<br />

phenytoin by ceftriaxone and nafcillin (A),<br />

1176<br />

evaln. of Boehringer Mannheim/Hitachi 717<br />

for routine TDM (A), 1165<br />

evaln. of Syva ETS and Abbott AD, urine drug<br />

screening immunoassay analyzers (A), 1176<br />

evaln. of TDM available on the DuPont<br />

Dimension (A), 1096<br />

GC-NPD and GC.MS anal. of comm. available<br />

Taxi-Disc’<br />

HPLC/mass<br />

drugs (A), 1184<br />

spectrom.: state of the art for the<br />

drug anal. lab. (S), 1282<br />

hybrid chromatog. methodologies for drug<br />

anal.-GC-MS, LC-MS, MS-MS, and<br />

supercritical fluid chromatography-MS (A),<br />

1055<br />

identn, of some typical a-blockers (bisoprolol,<br />

betaxolol) and propefenone in biol.<br />

specimens: applicn. to doping anal. (A), 1183<br />

hiq.-chromatog. monitoring of cytosine<br />

arabinoeide and its metabolita, uracil<br />

arabinoside, in serum, 1011<br />

liquid-chromatog. method for indomethacin<br />

and other inflammatory drugs (A), 1164<br />

patient-side immunoasssy system with a<br />

singhe-use cartridge for measuring analytes<br />

in blood(S), 1869<br />

performance of theophylline, gentamicin,<br />

tobramycin, phenytoin, and digoxin reagents<br />

on the Beckman Synchron CXn4 (A), 1181<br />

ranitidine and high concns. of<br />

phenylpropanolamine<br />

monoclonal<br />

cross react in the EMIT<br />

amphetamine/methamphetaniine assay<br />

(TB), 1998<br />

simult. liq.-chromatog. detn. of some<br />

bronchodilators, anticanvulsants,<br />

chloramphenicol, and hypnotic agents, with<br />

Chromosorb P columns used for sample<br />

prepn,, 1615<br />

specific RIA for measuring prsvastatin in<br />

human serum (A), 1189<br />

specific RIA for measuring SQ 31,765 in human<br />

serum (A), 1189<br />

strategies for sample prepn. with use of solidphase<br />

extrn. in TDM of basic drugs (A), 1352<br />

supercritical fluid cbromatog. and microbore<br />

liq. chromatog. for drug anal. (S), 1293<br />

system for toxicoL screening by capillary gas<br />

chromatog. with use of a drug retention<br />

index based on Ni-containing ref. cmpds.,<br />

601<br />

use of GC/IR/MS for high-confidence identifn.<br />

of drugs (S), 1279<br />

variations in protein binding of drugs in<br />

plasma, serum (SN), 1722<br />

versatile, efficient system for extracting drugs<br />

from urine for gas chromatog./mass<br />

spectrom. anal. (SN), 2100<br />

Drug dependence<br />

See Abused drugs, Drug assay, Toxicology<br />

Drug metabolism<br />

antiarrhythmic drugs and the cardiac Na<br />

channel: current models (S), 748<br />

oxidation phenotype, comparison between<br />

debrisoquine and dextromethorphan tests<br />

(A), 1184<br />

Drug<br />

monitoring<br />

cydlosporine monitoring (E), 5<br />

fluorescence polarn. iminunoaaaay of<br />

gentamicin or netilmicin in bhood spotted on<br />

filter paper (SN), 867<br />

four fluorescence polarization immunoassays<br />

for therapeutic drug monitoring evald., 138<br />

Drugs of abuse<br />

See Abused drugs<br />

Duchenne muscular dystrophy<br />

DNA probes for carrier identn. in Duchenne<br />

muscular dystrophy (E), 519<br />

DNA probes used in detecting carriers of<br />

Duchenne muscular dystroph selected case<br />

studies (CR), 679<br />

Dumping syndrome<br />

oral glucose tolerance test does not provide a<br />

uniform stimulus to pancreatic islets in<br />

pregnancy, 1482<br />

Dwarfism<br />

somatotropin as mess. by a twa-site timeresolved<br />

immunofluorometric assay, 913<br />

Dye-binding procedures<br />

micro-method for total protein in CSF, using<br />

benzethonium chloride in microtiter plate<br />

wells (SN), 1731<br />

new highly sensitive dye-forming system for<br />

immunostaining (A), 1187<br />

nonprotein components of urine interfere with<br />

colorimetry of urinary albumin with<br />

bromphenol blue (L), 336<br />

total protein deed. ‘inbreast milk by use of<br />

Coomassie Brilliant Blue and centrif. anal.<br />

(SN), 2127<br />

Dysfibrogenemias<br />

optimized microturbidimetric assay for<br />

fibrinogen,<br />

Dystrophln<br />

211<br />

carrier detection and characterization of gene<br />

deletions in Duchenne and Becker muscular<br />

dystrophy utilizing dystrophin cDNA probes<br />

(A), 1075<br />

Economics of laboratory operation<br />

binding of labeled thyroxin analog to serum<br />

proteins evald. after RIA of free thyroxin<br />

(SN), 475<br />

calculation of charges for erroneous results<br />

caused by interfering substances in an outpatient<br />

chem. lab. (A), 1155<br />

concurrent mess. of flecainide acetate and<br />

propranolol by normal-phase liq. chromatog.<br />

(SN), 857<br />

two-point calibration of immunoassays in the<br />

Ciba Corning Magic Lita system (A), 1188<br />

use of algorithms to achieve cost containment<br />

in a chin, lab. (A), 1233<br />

Ectopic pregnancy<br />

algorithm for tasting and reportinq serum<br />

choriogonadotropin at din, signif. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

Effects of Disease on <strong>Clinical</strong> Laboratory<br />

Tests, 2nd. edn.<br />

2161<br />

Ektachem<br />

See Multilayer film analysis<br />

Ehectrochemical detection<br />

bedside diagnosis of alcohol intoxn, with a<br />

pocket-size breath-alcohol device: saxniling<br />

from unconscious subjects and specificity for<br />

ethanol, 918<br />

detn. of physostigmine in plasma and CSF by<br />

liq. chromatog. with electrochem. detection<br />

(SN), 292<br />

detn. of tyrainine in plasma by ion-pair extn.<br />

and reversed-phase liquid chromatog. with<br />

electrochem. detection (A), 1152<br />

recent developments in blood as and<br />

electrolyte measurements with electrochem.<br />

sensors (A), 1232<br />

Electrochemical<br />

See Ion-selective<br />

techniques<br />

electrodes, Electrochemistry,<br />

Potantiometry<br />

Electrodes<br />

See Ion-selective electrodes<br />

Electrofocusing<br />

apolipoprotein E phenotype deed. by agarose<br />

gel electrofocusing, immunoblotting, 2070<br />

Electroimmunoassay<br />

four immunochem, methods compared for<br />

mess. C-reactive protein in plasma (SN), 461<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

Electrolyte, transport<br />

defective epithehial ion transport in cystic<br />

fibrosis (S), 726<br />

Electrolytes<br />

See also specific electrolyte of interest<br />

antiarrhythmic drugs and the cardiac Na<br />

channel: current models (S), 748<br />

automated detn. of urinary Nsf, K, Cl, P.<br />

urea, and creatinine without samphe diln.<br />

with the “RAT-XT” (SN), 481<br />

2376 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


detn. of Mg2 in granulocytes, 1404<br />

enzymatic assay of Mg through glucokinase<br />

actn. (SN), 2212<br />

enzymatic detn, of K in serum, 817<br />

evaln. of Nova 12: whole-blood and serum<br />

electrolyte, glucose, and BUN analyzer (A),<br />

1128<br />

fast, stable method for harvesting leukocytes<br />

for measuring intracellular M (SN), 1986<br />

fluorometry of Mg2 in serum with 2-hydroxy-<br />

1-naphthaldehyde salicyloylhydrazone, 1492<br />

improvement in Synchron CX’-3 electrolyte<br />

performance by use of an enzymatic cleaner<br />

(A), 1097<br />

performance characteristics of Na, K, and Chin<br />

urine on the Paramax analytical system’ (A),<br />

1131<br />

performance evaln, of Corning 288 and Nova<br />

Stat Profile 1 blood gas systems (A), 1093<br />

recent developments in blood gas and<br />

electrolyte measurements with electrochem,<br />

sensors (A), 1232<br />

simultaneous deth. of urea, glucose, Na, K, Cl,<br />

and total CO2 in undlluted human serum<br />

using an electrode-based automated analyzer<br />

(A), 1091<br />

transient increase of sweat electrolyte concns.<br />

associated with environmental deprivation<br />

(A), 1153<br />

Ehectrophoresls<br />

is electrophoresis a ref. method for CK-MB in<br />

comparison with an immunoenzymometric<br />

method? (L), 900<br />

Electrophoreels, agarose<br />

reproducibility of creatine kinase isoenzyme<br />

electrophoresis (L), 710<br />

Electrophoresls, agarose gel<br />

agarose gel ehectrophoresis, and a chaotropic<br />

method compared for lactate dehydrogenase<br />

isoenzyme-1 (TB), 2250<br />

comparison of automated vs manual<br />

ehectrophoreais system for creetine kinase<br />

isoenzymes (A), 1106<br />

ehectrophoresis gel model far Ca oxalate<br />

crystallization (A), 1130<br />

electrophoretic examin. of proteinuria in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

evaln, of Paragon high-resolution<br />

electropboresis system (A), 1088<br />

field evaln. of Paramax’ Plus anaL system with<br />

Closed Container Sampling”' (A), 1106<br />

IgA-CK-BB complex with CK-MB<br />

ehectrophoretic mobility can lead to<br />

erroneous diagnosis of acute myocard.<br />

infarct. (CR), 2003<br />

lactate dehydrogenase isoenzyme pattern in<br />

sera in malignant diseases, 396<br />

measuring creatine kinase MB isoenzyme in a<br />

maintenance hemodialysis popn.:<br />

chemiluminometric immunoassay and<br />

electrophoresis compared (SN), 1965<br />

sensitive and specific procedure for detecting<br />

oligochonal banding in CSF by agarose gel<br />

electrophoresis (A), 1082<br />

(TB), 1997<br />

sepn. of the CK-MM isoforms by the Paragon’<br />

agarose gel electrophoresis system (A), 1101<br />

serum glycated -lipoprotein deed, by agarose<br />

gel electrophoresis with nitroblue<br />

tetrazolium<br />

Ehectrophoreals,<br />

coloration<br />

cellulose<br />

(TB), 177<br />

acetate<br />

diagnostic value of measuring pancreatic lipase<br />

and the P3 isoform of pancreatic amyhase<br />

isoenzyme in serum of hospitalized<br />

hyperamyhasemic patients, 417<br />

intra-individual variation of electrophoretic<br />

serum protein fractions (TB), 1544<br />

sialidase from different sources compared for<br />

electrophoretically sepg. serum alk.<br />

phosphatase fractions from liver and bone<br />

(SN), 1955<br />

staining method far use in ehectrophoretic<br />

detn. of amylase isoenzymes in serum (SN),<br />

2322<br />

Electrophoresis, gel<br />

lactate dehydrogenase isoenzyme campn. of<br />

platelets (SN), 2325<br />

quantn. of glycated Rb by alkaline gel<br />

electrophoresis: the Paragon system (A),<br />

1162<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd. familial<br />

amyhoidotic pohyneuropathy (SN), 1033<br />

Electrophoresis, high-voltage<br />

creatine kinase isoforms in ischemic heart<br />

disease<br />

sensitive,<br />

(R), 7<br />

rpid assay of subforms of creatine<br />

kinase MB in plasma, 1452<br />

Ehectrophoresis, hectin affinity<br />

alk. phosphatase isoenzymes of liver and bone<br />

origin are incompletely resolved by wheatgerm-hectin<br />

affinity chromatog., 29<br />

Electrophoreals, pohyacryhanjide gel<br />

See also Electrophoresis, two-dimensional<br />

anal. of a-amyhase isoenzymes by automated<br />

isoelectric focusing (SN), 2116<br />

partial charactern. of an abnormal lactate<br />

dehydrogenase lsoenzyme, LDH-lex, in<br />

serum from a patient with hepetocellular<br />

carcinoma (SN), 844<br />

pohyacryhamide gel ehectrophoresis used in a<br />

critical study of pptn. reagents for<br />

quantifying HDL cholesterol (TB), 1254<br />

rapid purifn. of creatine kinase MB isoenzyme<br />

on preparative polyacrylamide slabs, 96<br />

sepn., identn. of urinary proteins and stonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate.-pohyacrylamide gel electrophoresis<br />

(SN), 658<br />

Electrophoreels, two-dimensional<br />

chin. applns, of high-resolution 2-D<br />

ehectropboresis of proteins: comparative<br />

anal, by 2DE of proteins in high-resolution<br />

agarose ehectrophoresis bands and current<br />

med. indications for 2DE anal, of serum<br />

proteins (A), 1083<br />

computerized quant. anal, of Coomassie-Bluestained<br />

serum proteins sepd. by twodimensional<br />

electrophoresis, 2297<br />

Electrophysiohogy<br />

antiarrhythmic drugs and the cardiac Na<br />

channel: current models (S), 748<br />

Embryonic development<br />

cell and substrata adhesion molecules in<br />

embryonic and neural development (S), 738<br />

Emergency procedure<br />

bedside diagnosis of alcohol intoxn. with a<br />

pocket-size breath-alcohol device: sampling<br />

from unconscious subjects and specificity for<br />

ethanol, 918<br />

diagnostic value of measuring pancreatic hipase<br />

and the P3 isoform of pancreatic emyhase<br />

isoenzyme in serum of hospitalized<br />

hyperamyhasemic patients, 417<br />

methods compared for detg. total acty. and<br />

isoenzymes of amylase in serum (SN), 645<br />

role of rapid immunoassays for urgent detns, of<br />

creatine kinase isoenzyme ME (SN), 1752<br />

“stat” measurements of L-lactate in whole<br />

blood and CSF assessed (SN), 1740<br />

Emetine<br />

emetine identified in urine by HPLC, with<br />

fluorescence and ultraviolet/diode array<br />

detection, in a patient with cerdiomyopathy<br />

(CR), 499<br />

EMIT<br />

See Enzyme immunoassay<br />

Emphysema<br />

functional, immunohog. concns, of a2-<br />

macroglobulin compared in plasma of<br />

subjects without a1-protease inhibitor<br />

deficiency (SN), 1535<br />

screening for deficiency of at-proteinase<br />

inhibitor (SN), 1971<br />

Encalnide<br />

encainide and metabohita anal, in serum or<br />

plasma using reversed-phase HPLC (A),<br />

1177<br />

encainide by HPLC-simphified 2-D<br />

chromatog. to eliminate interferences (A),<br />

1177<br />

Encephalopathy syndrome<br />

increases in aspartata aminotransferase,<br />

creatine kinase<br />

encephalopathy<br />

in hemorrhagic shock and<br />

syndrome (L), 2253<br />

Endocarditis<br />

meas. of autoimmune response against collagen<br />

types I, IH, and IV by enzyme-linked<br />

immunosorbent assay, and apphn. in<br />

infective endocarditis, 246<br />

Endorphin<br />

parallel assays of -endorphin and ACTH in<br />

Cushing’s patients undergoing petrosal<br />

studies (A), 1145<br />

Enolase<br />

immunoradiometry of a-y-and -enohase<br />

(neuron-specific enolase), with use of<br />

monoclonal antibodies and magnetizable<br />

polymer particles, 2034<br />

Environmental hazards<br />

new approach to etiohogic diagnosis in<br />

environmental<br />

Enzyme activity<br />

chem. poisoning (A), 1055<br />

activities of dipeptidyl peptidase II and<br />

dipeptidyl peptidase IV in synovial fluid<br />

from patients with rheumatoid and<br />

ostaoarthritis, 1016<br />

adaptation of six DGKC enzymes and<br />

chahinesterase to Synchron CX’5 at 30#{176}C<br />

and 37#{176}C (A), 1126<br />

choice of substrate concn, in the search for<br />

abnormal enzyme acty. in tissues (L), 1267<br />

concordance of creatine kinase-MB acty. and<br />

mass, 440<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

effects of therapeutic coronary reperfusion on<br />

aspartata aminotransferase isoenzymes in<br />

sara of patients with acute myocardial<br />

infarct,, 909<br />

evaln. of kinetic method far prostatic acid<br />

phosphatase with use of self-indicating<br />

substrate, 2,6-dichhoro-4-nitrophenyh<br />

phosphate, 939<br />

interaction between pyridine nucheotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-hinked enzymes (SN), 2129<br />

macroenzymes: biochem. characterization, chin.<br />

signif., and lab, detection (R), 2261<br />

methods compared for detg. total acty. and<br />

isoenzymes of amyhase in serum (SN), 645<br />

partial charactern. of an abnormal lactate<br />

dehydrogenase isoenzyme, LDH-lex, in<br />

serum from a patient with hepatoceiluhar<br />

carcinoma (SN), 844<br />

serum mitochondrial aspartate<br />

aminotransferase acty.: not useful as marker<br />

of excessive alcohol consumption in an<br />

unselected population, 926<br />

two-site immunoenzymometry of 52-kDa<br />

cathepsin D in cytosois of breast-cancer<br />

tissues, 81<br />

valproate therapy depresses GSH-PX and<br />

SOD enzyme acty.: possible mechanism for<br />

VPA-induced idiosyncratic drug toxicity (A),<br />

1173<br />

Enzyme electrodes<br />

enzyme electrode far glucose measurement in<br />

whale blood a critical care profiling<br />

instrument (A), 1098<br />

evaln. of Nova-12 urea electrode (A), 1100<br />

use of enzyme electrodes in whole-blood<br />

measurements (A), 1233<br />

Enzyme immunoassay<br />

adaptation of drugs of abuse testing to<br />

Synchron CX’4 and CX’S din, analyzers<br />

(A), 1178<br />

adaptation of Syva assays for drugs of abuse on<br />

the Olympus Reply lab, analyzer (A), 1174<br />

adaption of Syva EMI’r’ d.a.u,”' assays to the<br />

570 Alliance chin. chem, analyzer (A), 1170<br />

adaption of Syva EMIT’ TDM assays to the 550<br />

Express (A), 1170<br />

advances in enzyme-amplified immunoassay<br />

methods (A), 1239<br />

anal. sensitivity of prostate-specific antigen<br />

Tandem’-E enzyme immunometric assay<br />

(A), 1078<br />

appln. of Microgenics CEDIAn digoxin assay to<br />

the ENI Gemstar”' (A), 1171<br />

appin. of the Syva EMIT’ quant. therapeutic<br />

drug assays to Roche Cobas Mira”' analyzer<br />

(A), 1184<br />

automated enzyme immunoessay for detecting<br />

1gM antibody to hepatitis B core antigen (A),<br />

1193<br />

automated enzyme immunoassay for detecting<br />

1gM antibody to hepatitis A virus (A), 1193<br />

automated enzyme immunoasaay for lutropin<br />

(Abbott IMx’ analyzer) (SN), 2333<br />

benzodiazepines identified by capillary gas<br />

chromatog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs., 1394<br />

biotin-avidin-based solid-phase enzyme-linked<br />

iinmunosorbent assay for human serum IgE<br />

(A), 1192<br />

biotin-specific binders to probe charge effects<br />

in enzyme immunoassays (A), 1201<br />

calibrator design considerations for Du Pont<br />

Vista”' immunoassay system (A), 1202<br />

calibrators containing 11-nor-9-THC-9-<br />

carboxyhic acid far use with Syva EMIT’<br />

cannabinoid assays (A), 1173<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2377


candidate Ref. Method for measurement of<br />

apohipoprotein B-100: evaln. of a<br />

monochonal-antibody-based enzyme-linked<br />

immunosorbent assay (A), 1073<br />

CEDIA”' total T3. a rapid homogeneous enzyme<br />

immunoassay for serum total T3 (A), 1095<br />

chemihuminescent assay of alk. phosphatase<br />

applied in an uhtrasensitive enzyme<br />

immunoassay of thyrotropin, 1441<br />

chemihuminescent substrates for alk.<br />

phosphatase: application to ultrasensitive<br />

enzyme-linked immunoassays and DNA<br />

probes (A), 1201<br />

(S), 1863<br />

circulating antibodies to mouse monoclonal<br />

iinniunoglobulins caused false-positive<br />

results in two-site assay for alphafetoprotein<br />

(L), 2339<br />

chin, performance of the EMIT vancomycin<br />

assay (SN), 1504<br />

comparison of two comm. available<br />

immunological occult blood tests and a<br />

guaiac slide test (A), 1162<br />

cost-effective assays far use in monitoring<br />

carbamazepine, phenobarbital, and<br />

phenytoin in serum (SN), 1782<br />

cost-effective EMIT method for qual. d.a.u.<br />

performed an Cobas Mire (A), 1168<br />

detection of antibody to hepatitis B core<br />

antigen using automated micropartichebased<br />

EIA (A), 1193<br />

detection of hepatitis B infection in a randomly<br />

selected pediatric hospital population using<br />

an automated enzyme immunoassay far<br />

HBsAg (A), 1152<br />

detn. of FSH, LH, and cortisoh with automated<br />

enzyme immunoassays (A), 1141<br />

development of applicn. protocols for EMIT’<br />

vancomycin assay on the Syva’ Autolab”'<br />

instrument system and for Cobas Mire<br />

analyzer (A), 1167<br />

development of EMIT’ drugs of abuse assay for<br />

amphetamine/methamphetamine in urine on<br />

the ETh”' system (A), 1180<br />

development of fully automated immunoassay<br />

for hLH on the Abbott IMx’ automated<br />

immunoassay system (A), 1203<br />

development of human factor VII ELISA:<br />

preliminary studies (A), 1161<br />

direct solid-phase enzymoimmunoassay of<br />

testosterone in saliva, 2044<br />

discordant hCG measurements in a patient<br />

with carcinoma (TB),<br />

distribution of prostatic<br />

1259<br />

acid phosphatase in<br />

benign and malignant diseases determined<br />

by Magiwel”' enzyme immunoassay (A), 1079<br />

EIA for detection of RTLV-1 antibodies using<br />

a mixture of synthetic peptide and viral<br />

hysate (A), 1204<br />

ELISA method to measure antibodies to<br />

cardiolipin and phosphatidylserine (A), 1207<br />

EMIT’ convenient two-reagent system for drug<br />

of abuse tasting on most common chem.<br />

analyzers (A), 1167<br />

EMIT”' serum thyroid hormone uptake assay<br />

for use on Cobas Mire and Cobas Bio<br />

analyzers (A), 1141<br />

enhanced luminescence competitive<br />

immunoassay for anti-HIV (A), 120’?<br />

enzyme immunoassay for quantn. of IgG<br />

antibody to rubella virus in serum (A), 1092<br />

enzyme immunoassay for quantn. of<br />

thrombin-antithrombin III<br />

complex-multicentar evaln, (A), 1163<br />

enzyme immunoassay measurement of serum<br />

interheukin-2 receptor in heart-transplanted<br />

patients (A), 1155<br />

enzyme immunaassay of Hb A1,,:anal.<br />

characteristics and chin. performance in<br />

diabetes mellitus, with and without uremia,<br />

93<br />

evahn. of Abbott Commander enzyme<br />

immunoassay system for hepatitis B surface<br />

antigen and B core antibody (A), 1207<br />

evaln. of Abbott IMx immunoassay analyzer<br />

for maternal serum ahpha-fetoprotein<br />

screening of open neural tube defect and<br />

Down syndrome (A), 1195<br />

evaln, of Abbott IMx T3 assay (A), 1202<br />

evain. of a dry reagent digoxin ixnmunometric<br />

assay on a physician’s office analyzer (A),<br />

1109<br />

evahn, of automated CK-MB mass assay (A),<br />

1107<br />

evaln. of chemiluminescent immunoassay for<br />

deth. of serum peptide hormones (A), 1206<br />

evaln. of EIA for detn. of haloperidol, a<br />

neuroheptic drug, in serum (A), 1175<br />

evaln. of enzyme immunoassay kits for<br />

hepatitis B surface antigen, B surface<br />

antibody, and B core antibody (A), 1207<br />

evaln, of ferritin on Abbott IMx’ automated<br />

immunoassay systems (A), 1099<br />

evaln. of high-sensitivity TSH enzyme<br />

immunoassay reagents far use with Photon<br />

ERA (A), 1196<br />

evsln, of human choriogonadotropin on Abbott<br />

IMx’ automated immunoassay systems (A),<br />

1099<br />

evaln, of new consumer test for lutropin (A),<br />

1146<br />

evaln. of new recombinant ELISA immunoassay<br />

for detection of antibodies to HIV vs DuPont<br />

Western blot (A), 1204<br />

evaln. of Syva EMIT’ d.a,u, apphns. on 550<br />

Express (A), 1170<br />

evaln, of the Olympus P1(310 automated<br />

enzyme immunoassay system (TB), 1995<br />

evaln, of thyroid-stimulating hormone<br />

immunoassay on the IMx (A), 119’?<br />

evaln. of total T3 on Abbott IMx’ automated<br />

immunoassay systems (A), 1099<br />

expression of the major human<br />

ribonucleoprotein (RNP) autoantigens in E.<br />

coil and their use in an EIA for screening<br />

sara from patients with autoimmune diseases<br />

(S), 1861<br />

fluorometric enzyme immunoassay for<br />

measurement of free T4 using Magnisep”'<br />

Cr02 particles (A), 1202<br />

fluorometric enzyme immunoassay for<br />

measurement of total thyroxin using a<br />

reagent delivery module”' (RDM) (A), 1140<br />

fluorometric enzyme immunoassay far<br />

measurement of total T3 using Magnisep”'<br />

Cr02 particles (A), 1202<br />

functional acty. of protein S detd. with use of<br />

protein C activated by venom activator, 1644<br />

high-volume Syva EMrr’ drug tasting on<br />

multiple Epos analyzers interfaced to a<br />

central computer system (A), 1166<br />

immunoassay system for panel testing enzyme<br />

(5), 1874<br />

immunometric total thyroxin assay for use with<br />

dry reagent stripe and a reflectance<br />

photometer (A), 1140<br />

improved test for confirming antibodies to HJV<br />

using six recombinant peptides, including<br />

the intact gag gene-product, p24 (A), 1191<br />

IMi”' APP, automated micropartiche<br />

immunoassay for AFP: performance<br />

characteristics and chin, studies (A), 1192<br />

IMx”' BCM, automated micraparticle enzyme<br />

immunoassay for breast cancer mucin (A),<br />

1078<br />

IMx’ 2-microghobuhin, fully automated<br />

microparticle enzyme immunoassay (A),<br />

1192<br />

how-cost high-sensitivity diagnostic tool (A),<br />

1209<br />

Magiwel”' enzyme immunoassay for dog<br />

heartworm (Dirofiiaria immitis) infections<br />

(A), 1137<br />

measurement of antibodies to soluble CD4 by<br />

ELISA using recombinant CD4 (A), 1191<br />

measurement of estrogen and progesterone<br />

receptors in breast tumors using steroidbinding<br />

assays and monoclonal enzyme<br />

immunoassays (A), 1138<br />

measurement of methotrexate on Du Pant aca<br />

discrete cm. analyzer (A), 1169<br />

measurement of serum digoxin using CEDIA”'<br />

reagents and the RA-l000 (A), 1183<br />

measurement of vancamycin on the Du Pont<br />

ada discrete chin, analyzer (A), 1169<br />

microparticle enzyme immunoassay for<br />

measuring antibodies to hepatitis B surface<br />

antigen, IMx anti-HBs (A), 1193<br />

modified EMIT’ thyroxin assay for use on<br />

Cobas Mire and Cobas<br />

1141<br />

Bio analyzers (A),<br />

monochonal antibodies evald, for use in<br />

screening for conigstes of human serum alb.<br />

and pyridaxal 5’-P04 (SN). 1756<br />

monochonal antibody toy chain of fetal Rb<br />

used to develop an enzyme immunoassay,<br />

2066<br />

novel nonisotopic immunoassay for grkb3-<br />

microghobulin (A), 1205<br />

one-step enzyme immunoassay for free<br />

thyroxin: results with dysalbuminemic sara<br />

and one serum containing autoantibodiea to<br />

thyroxin (TB), 888<br />

overview of enzyme immunoassays (A), 1239<br />

performance characteristics and chin. eveln. of<br />

the Abbott IMx’ APP (A), 1092<br />

performance of CEDIA Digaxin R assay on<br />

Technicon RA-1000”' chem. analyzer (A),<br />

1171<br />

performance of CEDIA”' T4 MAb homogeneous<br />

enzyme immunoessay on the Olympus AU-<br />

5000 din, analyzer (A), 1141<br />

performance of Microgenics CEDIA”' thyroxin<br />

and T-uptake assays on the Ciba-Corning<br />

550 Express”' analyzer (A), 1141<br />

photometric microtitar strip technique for<br />

doctor’s office lab (A), 1209<br />

prospective study of Abbott AFP-EIA as an aid<br />

in detection of fetal neural tube defect (A),<br />

1192<br />

quant. ELA for detn. of tumor necrosis factoralpha<br />

(A), 1187<br />

quant. hCG for the stat lab. (A), 1100<br />

ranitidine and high concns. of<br />

phenyhprapanohamine cross react in the EMIT<br />

monoclonal<br />

amphetamine/methamphetamine assay<br />

(TB), 1998<br />

rapid automated detection of human 1gM<br />

antibody to hepatitis B core antigen (A),<br />

1206<br />

rapid enzyme immunoassay for visual,<br />

semiquant. detn. of hutropin in urine for<br />

ovulation prediction (A), 1148<br />

rapid self-contained immunoassay far hepatitis<br />

B surface antigen (A), 1195<br />

rapid self-contained immunoassay for human<br />

thyrotropin (A), 1195<br />

rapid, specific method for CK-MB using<br />

Tandem Icon OSR CK-MB reagents (A),<br />

1120<br />

rapid thin-layer chromatog. semiquantification<br />

of morphine in urine via dabsylation:<br />

comparison with EMIT and thin-layer<br />

chromatog.-iodoplatinate methods (TB), 329<br />

screening utility of a rapid, automated<br />

fluorescent enzyme immunosssay for HBsAg<br />

in an S.T.D. clinic (A), 1192<br />

simultaneous “sandwich” enzyme<br />

immunoassay for measuring human<br />

osteocalcin using antibodies against<br />

synthetic peptides (A), 1208<br />

simultaneous “sandwich” enzyme<br />

immunoassay for protein C using monoclonal<br />

antibodies (A), 1208<br />

solid-phase enzyme immunoassay of serum<br />

DHEA-S (A), 1197<br />

solid-phase enzyme immunoassay of serum<br />

ferritin (A), 1203<br />

solid-phase enzymoimmunoassay for<br />

osteocahcin in serum or plasma, with use of a<br />

monochonal antibody, 2087<br />

solid-phase enzymaimmunoassay of estrone in<br />

saliva, 569<br />

solid-phase non-isotopic immunassay for<br />

quantn. of cortisol in serum (A), 1201<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoassays<br />

of carcinoembryonic antigen (SN), 146<br />

specific enzyme immunoassay far measuring<br />

new angiotensin-converting enzyme<br />

inhibitor, SQ 29,852, in plasma comparison<br />

with SQ 29,852 RIA (A), 1190<br />

surface characterization of polystyrene (A),<br />

1190<br />

Syva EMIT’ convenience pack assays for<br />

carbamazepine and tobramycin on the Cobas<br />

Mira analyzer (A), 1173<br />

Syve EMIT’ digoxin assay utilizing on-line pretreatment,<br />

for use on Cobas Mire analyzer<br />

(A), 1167<br />

thin-film enzyme immunoassay for<br />

measurement of serum or plasma T4 (A),<br />

1200<br />

thin-film immunochem. measurement of<br />

digoxin in human serum (A), 1200<br />

urine screening for cocaine use with ELISA and<br />

confirmation with GC/MS<br />

Enzyme inhibition assay<br />

(A), 1171<br />

evaln. of a photometric assay for detn. of<br />

human bone alk. phosphatase (A), 1089<br />

Enzyme inhibition lmmunoassay<br />

development of a second-generation Isomune<br />

CK#{149} assay (A), 1121<br />

EMDS test pack CK-MB immunaassay<br />

immunoinhibition with anti-CK-M antibody<br />

(A), 1115<br />

2378 CLINICALCHEMISTRY, Vol. 35, No. 12, 1989


lactate dehydrogenase-1 assay using an<br />

subunit-specific, immobilized monochonal<br />

antibody (A), 1121<br />

methods compared for detg. total acty. and<br />

isoenzymes of amylase in serum (SN), 645<br />

serum P-amylase deth. using monoclonal<br />

antibody (A), 1127<br />

single-vial screening assay for creatine kinase-<br />

MB (A), 1122<br />

Enzyme-linked lnununoasaay<br />

five cannabinoid immunoaasay systems<br />

compared at the screening threshold of 100<br />

ig/L (SN), 2241<br />

immunoradiometry of carcinoembryanic<br />

antigen with use of avidin-biotin labeling,<br />

573<br />

time-resolved fluoroimmunoassay of aflatoxins<br />

(SN), 2308<br />

Enzyme-linked hnmunosorbent assay<br />

See also Enzyme immunoassay<br />

algorithm for testing and reporting serum<br />

choriogonadotropin at chin. signif. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

development of a confirmatory enzyme-linked<br />

immunosorbent assay far HIV-1 antibodies,<br />

946<br />

enzyme-linked immunoeorbent assay for<br />

chromogranin A, 1934<br />

enzyme-linked immunoaorbent assay for free<br />

thyroxin in serum (SN), 1770<br />

enzyme-linked immunosorbent assay of<br />

apolipoprotein B in blood spotted onto filter<br />

paper, suitable for neonatal screening, 1000<br />

hipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

mesa, of autoimmune response against collagen<br />

types I, III, and IV by enzyme-linked<br />

immunosorbent assay, and appln. in<br />

infective endacarditls, 246<br />

microplate meas. of urinary albumin,<br />

creatinine, 1371<br />

neopterin mess, in serum, tissue culture<br />

supernates by competitive enzyme-linked<br />

immunosorbant assay, 1467<br />

prostatic inhibin-like peptide in urine of<br />

prostatic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

rheumatoid factors deed, by fluorescence<br />

immunoassay comparison with qual. and<br />

quant. methods (SN), 464<br />

standn. of apolipoprotein B and A-I mess. (R),<br />

1357<br />

Enzyme-linked ligand sorbent assay<br />

quantn. of biotin in serum by competition with<br />

solid-phase biotin for binding to<br />

peroxidaae-avidin conjugate (SN), 1721<br />

Enzyme-multiplied lmmunoassay<br />

See Enzyme immunoassay<br />

Enzymes<br />

circadian variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

excretion of urinary enzymes after<br />

extracorporeal shock-wave hithotripsy (TB),<br />

2000<br />

urinary excretion of some proteins and<br />

enzymes during normal pregnancy (SN),<br />

1978<br />

Enzymlc methods<br />

accurate cholesterol results by modn. of Roche<br />

enzymatic method parameters (A), 1068<br />

arginine pharmacokinetics assessed with an<br />

enzymatic assay adapted to a centrif,<br />

analyzer<br />

automated<br />

(SN), 1024<br />

micromethod for measuring free<br />

fatty acids in plasma/serum (SN), 2228<br />

chemihuminescent deth. of nonestarified fatty<br />

acids in serum (TB), 325<br />

cyclosporine does not interfere in total and<br />

high-density lipoprotein cholesterol mess.<br />

with use of enzymatic cholesterol assays<br />

(TB), 2251<br />

deth. of branched-chain amino acids and<br />

tyrosine in serum in various hepatic diseases,<br />

and its chin, usefulness, 1399<br />

detn. of glucose using glucose oxidase in a<br />

fixed-time reaction (A), 1105<br />

development of enzymic ref. equiv. method for<br />

total chohesterol (A), 10’71<br />

development of liq. triglycerides-GPO reagent<br />

utilizing response-surface ca-optimization<br />

(A), 1071<br />

effect of lyophiln. on results of five enzymic<br />

methods for cholesterol (SN). 1523<br />

enzymatic assay of Mg through glucokinase<br />

actn. (SN), 2212<br />

enzymatic Cl method for the EMDS Easy ST<br />

analyzer (A), 1133<br />

enzymatic detn. of K in serum, 817<br />

enzymatic detn. of total cholesterol in<br />

gallstones (SN), 2247<br />

enzymatic deth. of urinary oxalate (SN), 2330<br />

enzymatic method for lactate in whale blood<br />

adapted to the Cobas Bio (TB), 324<br />

enzymatic method for oxalate automated with<br />

the Cobas Fare centrif, analyzer (SN), 2094<br />

enzymatic method using 1,2-diglyceride for<br />

pancreatic lipase test in serum (A), 1126<br />

enzymatic salicylate and acetaminophen anal.<br />

on Monarch 2000 (A), 1185<br />

enzymatic theophylline assay on Cobas-Mira<br />

(A), 1102<br />

enzymic assay of salicylate adapted to the<br />

Monarch centrifugal analyzer (TB), 326<br />

enzymic mess. of total bile acids adapted to the<br />

Cobas Fare centrif. analyzer (TB), 1538<br />

enzymic urea assay new colorimetric method<br />

based on H202 mess, (SN), 654<br />

evaln. of Abbott hiq. NH3 assay (A), 1103<br />

evaln. of APEC glucose analyzer method (A),<br />

1112<br />

factors affecting a cyanogen bromide-based<br />

assay of thiamin, 2173<br />

glycerol-blanked triglyceride measurement an<br />

the Hitachi 705 chem. analyzer (A), 1072<br />

increase of hypoxanthine during cardiac<br />

surgery, as measured by an indirect<br />

automated enzymatic assay (L), 898<br />

modified enzymatic approach to measure blood<br />

urea Nan the Technicon RA.1000’ (A), 1104<br />

multipoint kinetic simultaneous mess, of<br />

combined concns, of acetoacetate-l9-<br />

hydroxybutyrate and lactate-pyruvate (SN),<br />

1526<br />

new commercial method for enzymatic deth. of<br />

creatinine in serum and urine evald:<br />

comparison witha kinetic Jaff#{233} method and<br />

isotope dihn.-mass spectrometry (SN), 835<br />

pohyamines assayed by HPLC with<br />

ehectrochem. detection after poet-column<br />

reaction with immobilized pohyamine<br />

oxidase, 1694<br />

rapid micro-scale proced. for detn. of total lipid<br />

profile, 1486<br />

screening for deficiency of ai-protainase<br />

inhibitor (SN), 1971<br />

selective proteohytic measurement of serum m-<br />

AST (A), 1127<br />

simple enzymatic method for detg. 1,5-<br />

anhydro-D-glucitol in plasma for diagnosis of<br />

diabetes, 2039<br />

simultaneous detn, of urea, glucose, Na, K, Cl,<br />

and total CO2 in undiluted human serum<br />

using an electrode-based automated analyzer<br />

(A), 1091<br />

standn. of a commercial (Boehrin?er<br />

Mannheim Diagnostics) enzymac method for<br />

cholesterol, 409<br />

study of hyophilization effect on enzymatic<br />

methods for cholesterol (A), 1066<br />

test-strip method far lactate in whole blood<br />

(SN), 1992<br />

two-center evaln. of physician’s office chem.<br />

analyzer (Clinistat’) for cholesterol anal. (A),<br />

1102<br />

Enxymoimmunoassay<br />

See Enzyme immunoassay<br />

Epidemiology<br />

cholesterol standardization for 13 years by<br />

CDC and Japanese cholesterol levels (A),<br />

1065<br />

Lp(a) phenotype frequency in a normal North<br />

Am. population (A), 1070<br />

Epilepsy<br />

See also Anticonvulsant drugs<br />

HPLC anal, of brain and plasma for octanoic,<br />

decanoic<br />

Epinephrlne<br />

acids, 1945<br />

reversed-phase HPLC sepn. of plasma<br />

norepinephrine, epinephrine, and dopamine,<br />

with 3-electrode coulometric detection (SN),<br />

1975<br />

Equilibrium dialysis<br />

direct and indirect techniques for free thyroxin<br />

compared in nonthyroidal illness I. effect of<br />

free fatty acids, 102<br />

direct, indirect techniques for free thyroxin<br />

compared in patients with nonthyroidal<br />

illness. II. effect of prealbumin, albumin,<br />

thyroxin-binding globulin, 1655<br />

Errata<br />

See Corrections<br />

Erythrocytes<br />

(acyh)carnitine distribution between plasma,<br />

erythrocytes, and leukocytes in blood (L),<br />

711<br />

automated detn. of chohinesterase acty. In<br />

plasma and erythrocytes by flow-injection<br />

anal., and apphn. to identify subjects<br />

sensitive to succinyhcholine, 77<br />

automated methods for chin, assay of<br />

superoxide dlsmutase and glutathione<br />

peroxidase in human plasma and<br />

erythrocytes using a Cobas Bio centrifugal<br />

analyser (A), 1126<br />

Ca content of healthy erythrocytes (L), 1264<br />

effect of substrate concn, on erythrocyte<br />

transketolase assay (L), 1557<br />

erythrocyte ferritin assay to fmd patients with<br />

homozygous hemochromatosls (A). 1083<br />

glycated Hb in fractionated erythrocytes, 958<br />

interaction between pyridine nucleotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

simple method to deth. human red cell viability<br />

(A), 1128<br />

stability of red cell folate after hemohysis with<br />

ascorbic acid sob. (A), 1160<br />

Erythrocyte sedimentation rate<br />

erythrocyte sedimentation rate and C-reactive<br />

protein compared in the elderly (SN), 466<br />

Erythropoletln<br />

RIA for measurement of natural and Rh<br />

erythropoietin in patient sara (A), 1191<br />

Estradlol<br />

enhanced luminescence immunoassay for<br />

estradiol (A), 1149<br />

estradiol-17 deed, in plasma by gas<br />

chromatog,-mass spectrom. with selected ion<br />

monitoring of mixed silyl<br />

ether-pertluoroacyl ester deravs. and use of<br />

various stable-isotope-labeled internal stds,,<br />

532<br />

evaln. of six direct 17$-estradioh RIA kits and<br />

comparison with an in-house extn, RIA (A),<br />

1150<br />

investigation of sex-hormone-binding globulin<br />

interference in direct RIM for testosterone<br />

and estradioh, 979<br />

one-step estradiol RIA with use of pre-reacted<br />

double-antibody system (A), 1198<br />

three methods compared for estg. testosterone<br />

and estradiol not bound to sex-hormonebinding<br />

globulin (SN), 632<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

Estriol<br />

maternal serum estriol in screeninjfor Down’s<br />

syndrome: significance of high SD for the<br />

population (A), 1193<br />

Estrogen receptors<br />

effect of ether or ketamine anesthesia on rat<br />

uterine estrogen, progesterone receptors<br />

(SN), 143<br />

estrogen and progesterone receptor assays, by<br />

the EIA method (Abbott), of low-speed<br />

supernates of breast-cancer homogenates<br />

(SN), 2226<br />

immunaassay for estrogen receptor does nat<br />

detect inactivated receptor (SN), 824<br />

measurement of estrogen and progesterone<br />

receptors in breast tumors using steroidbinding<br />

assays and monochonal enzyme<br />

immunoassays (A), 1138<br />

relative importance of estrogen and<br />

progesterone receptor assays as prognostic<br />

indicators in primary breast cancer shortterm<br />

study, 238<br />

Estrogens<br />

See also specific estrogen of interest<br />

effects of estrogen on mineral metab. in<br />

poetmenopausal women as evald. by multiple<br />

assays measuring parathyrin bloacty., 18<br />

estradiah-17$ deed, in plasma by gas<br />

chromatog.-mass spectrom. with selected ion<br />

monitoring of mixed silyl<br />

ether-perfluoroacyl ester derive, and use of<br />

various stable-isotope-labeled internal sods.,<br />

532<br />

hormonal evaln, of female infertility,<br />

reproductive disorders (CC), 620<br />

influence of OCT. embedding compd. on<br />

detns. of estrogen and progestin receptors in<br />

breast cancer (SN), 2317<br />

mess, of estrone-3-glucuronide in urine by<br />

rapid, homogeneous timeresolved<br />

fluoroimmunoassay, 665<br />

solid-phase enzymoimmunaassay of estrone in<br />

saliva, 569<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2379


Estrone<br />

mess. of estrone-3-ghucuronide in urine by<br />

rapid, homogeneous time-resolved<br />

fluoroimmunoasssy, 555<br />

sohid-phase enzymoimmunoassay of estrone in<br />

saliva, 569<br />

Ethanol<br />

See also Alcohol<br />

confirmatory breath ethanol tasting (A), 1184<br />

EMIT’ ethanol assays for use on Cobas Mira<br />

and Cobas Bio analyzers (A), 1166<br />

evaln. of Abbott AD,” analyzer in traditional<br />

and nontraditional markets (A), 1174<br />

ET-18-OCH3<br />

detn. of the allyl lysophosphohipid derivative<br />

ET-18-OCH3, a new antineophastic drug, in<br />

phasma, 821<br />

Exercise, effects of<br />

alteration of lymphocyte subsets and endocrine<br />

response during 80 days of competitive swim<br />

training (A), 1136<br />

effect of exercise training on glycemic control,<br />

kidney function, and renal ultrastructure in<br />

obese (diabetic) Zucker rats (A), 1135<br />

effects of in vivo and in vitro production of<br />

hectic acid on ionized, protein-bound, and<br />

complex-bound Cain blood, 935<br />

heterogeneity of serum creatine<br />

isoenzyme MM in myocardial<br />

kinase<br />

infarction:<br />

chin, significance and post-synthetic<br />

conversion of “abnormal” sub-bands, 206<br />

lactate dehydrogenase in serum of patients<br />

performing an exercise test (L), 2016<br />

patterns of lactate dehydrogenase isoenzymes<br />

and 2 in serum on exercise (SN), 301<br />

I<br />

pyruvata mess, in whole blood with the Cobas<br />

Bio analyzer (TB), 325<br />

test-strip method for lactate in whole blood<br />

(SN), 1992<br />

Expert systems<br />

appln. of expert systems in the din, lab. (R),<br />

1595<br />

Exponential amplification<br />

quant. essays based on use of replicetable<br />

hybridization probes (S). 1826<br />

Extraceiluhar water<br />

antipyrine interferes with chem. detn. of Br in<br />

simultaneous estn, of total body H20 and<br />

extracellular H2O, 1367<br />

Factor III<br />

measuring tissue factor (Factor III) acty. in<br />

plasma, 1897<br />

Familial aniyloidotic polyneuropathy<br />

simplified screening of populations at risk far<br />

transthyretin Met30-asaocd. familial<br />

amyloidotic pohyneuropethy (SN), 1033<br />

Familial dy.albuniinemic hyperthyroxinemia<br />

evaln. of Amerliten VF4 method in patients<br />

with FDH and nonthyroidal illness (A), 1142<br />

Fanconi syndrome<br />

ehectrophoretic examin. of protainuria in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

Fatty acids<br />

See also Lipids, Triglycerides<br />

automated micromethod for measuring free<br />

fatty acids in plasma/serum (SN), 2228<br />

chemiluminescent detn. of nonesterified fatty<br />

acids in serum (TB), 325<br />

direct and indirect techniques for free thyroz.in<br />

compared in nonthyroidal illness I. effect of<br />

free fatty acids, 102<br />

do nonesterified fatty acids displace thyroxin<br />

from its plasma binding sites in severe<br />

nonthyroidal illnesses? (A), 931<br />

effect of thyroid hormone-binding proteins and<br />

fatty acids on modified analog assays of F’1’4<br />

and FF3 in serum (L), 708<br />

hang-chain aliphatic fatty acids and phytanic<br />

acid simultaneously measured by dualcolumn<br />

capillary chromatog. (SN), 1989<br />

low-normal concns. of free thyroxin in serum in<br />

hate pregnancy- physial. fact, not tech.<br />

artefact, 1891<br />

phytanic acid, pristanic acid, and very-langchain<br />

fatty acid methyl esters mess.<br />

simultaneously by capillary gas chromatog.<br />

(L),703<br />

prepn. of fecal samples for assay of volatile<br />

fatty acids by gas-hiq. chromatog. and<br />

HPLC, 74<br />

Feces<br />

chin, effective screening of asymptomatic<br />

patients for fecal occult blood loss requires<br />

lab, assistance (L), 2337<br />

comparison of sample preparation techniques<br />

for measurement of total N in stool and food<br />

samples by chemihuminescence (A), 1114<br />

effect of ingestion of hemoprotains on fecal<br />

excretion of hemes and porphyrins, 2290<br />

fecal chymotrypsin: suitable test for diagnosing<br />

pancreatic insufficiency (A), 1090<br />

“Fecatwin Sensitive” test for fecal occult blood<br />

not intended for use without testing positives<br />

with the FECA-ELA assay (L), 1555<br />

prepn, of fecal samples for assay of volatile<br />

fatty acids by gas-hiq. chromatog. and<br />

HPLC, 74<br />

thin-layer chromatog. of free porphyrins for<br />

diagnosis of porphyria (SN), 5043<br />

Ferrioxamine<br />

indirect mess, of desferrioxamine and its<br />

chelated cmps. aluminoxamine and<br />

ferrioxamine by Zeeman at. absorp.<br />

spectrom. (SN), 884<br />

Ferritin<br />

commercially available dissociation-enhanced<br />

hanthanide t’luoroimmunoassay kit evald. for<br />

quantifying ferritin in serum (TB), 327<br />

concns, of Se, Zn, Cu, Fe, Mg, K in blood and<br />

heart tissue in coronary heart disease (SN),<br />

851<br />

erythrocyte ferritin assay to find patients with<br />

homozygous hemochromatosis (A), 1083<br />

evaln. of ferritin on Abbott LMx’ automated<br />

immunoassay systems (A), 1099<br />

high serum ferritin level and its significance in<br />

cancer (A), 1081<br />

rapid det. of ferritin in serum by the<br />

“Stratus” fluoroenzymoinimunometric assay<br />

(TB), 672<br />

short- and lang-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

solid-phase enzyme immunoassay of serum<br />

ferritin (A), 1203<br />

solid-phase immunofluorometric assay for<br />

human serum ferritin (A), 1189<br />

Fertility<br />

high concns. of Zna2-glycoprotein and lack of<br />

a2HS-ghycoprotein in ejaculates, 1649<br />

RIA of $-microseminopratein, a prostaticsecreted<br />

protein in sara of men and women,<br />

1497<br />

Fertility studies<br />

See also Infertility<br />

embryo cryopreservation (A), 1064<br />

hormonal evaln. of female infertility,<br />

reproductive disorders (CC), 620<br />

IVF-GIFT: enhanced reproductive technol.<br />

(A), 1063<br />

meas. of estrone-3-ghucuronide in urine by<br />

rapid, homogeneous time-resolved<br />

fluoroimmunoassay, 555<br />

ovarian stimulation monitoring (A), 1063<br />

solid-phase enzymoimmunoassay of estrone in<br />

saliva, 669<br />

Fetal status<br />

See also Amniotic fluid,<br />

Lecithin/sphingomyein ratio, etc.<br />

amniotic fluid lameilar bodies characterized by<br />

resistive-pulse counting: relation to measures<br />

of fetal lung maturity, 612<br />

automated rapid assessment of surfactant and<br />

fetal lung maturity by altered fluorescence<br />

polarization of a dye (PC16) (A), 1107<br />

comparison of tests used to assess fetal<br />

maturity (A), 1069<br />

lab. role in predicting fetal lung maturity (A),<br />

1241<br />

maternal serum estriol in screening for Down’s<br />

syndrome: significance of high SD for the<br />

population (A), 1193<br />

multicenter evaln. of TDx’ fetal hung maturity<br />

(A), 1075<br />

multicenter eveln. of TDx teat for assessing<br />

fetal lung maturity, 1005 - -<br />

phosphohipid surface tension: diagnostic utility<br />

of amniotic fluid and its lipid extract, an<br />

anal. of the value of pptn. with cold acetone,<br />

800<br />

Fetoprotein<br />

AFP quantn. compared using a semiautomated<br />

monoclonal and a -<br />

polyclonal-monoclonal immunoenzymatic<br />

assay (A), 1200<br />

alpha-fetoprotein assay and abnormal values<br />

(A), 1157<br />

biiary all, phosphatase measured by minicolumn<br />

chromatog. on DEAR-cellulose:<br />

appln. to detection of hepatobihiary diseases,<br />

1684<br />

chemiluminescent enzyme immunoassay of a-<br />

fetoprotein with adamantyl dioxetane<br />

phenyh phosphate as substrate (SN), 2319<br />

circulating antibodies to mouse monochonal<br />

immunoglobulins caused false-positive<br />

results in two-site assay for alphafetoprotein<br />

(L), 2339<br />

dissocn. of immunocomplexes by ionic shock<br />

for development of immunosensors: appln. to<br />

meas. of ai-fetoprotain (SN), 1026<br />

eveln. of Abbott IMx immunoassay analyzer<br />

for maternal serum alpha-fetoprotein<br />

screening of open neural tube defect and<br />

Down syndrome (A), 1195<br />

IMx” AFP, automated micropartiche<br />

immunoassay for AFP: performance<br />

characteristics and chin, studies (A), 1192<br />

performance characteristics and din, evaln. of<br />

the Abbott IMx AFP (A), 1092<br />

prospective study of Abbott AFP-EIA as an aid<br />

in detection of fetal neural tube defect (A),<br />

1192<br />

racial and other differences of maternal serum<br />

a-fetoprotein in a large obstetrical<br />

population (A), 1136<br />

variables involved in evaluating maternal<br />

serum alpha-fetoprotein: albumin, total<br />

protein and fructosamine (A), 1159<br />

Fiber Optic sensors<br />

intravascular monitoring techniques, risks and<br />

problems (A), 1059<br />

Fibrin<br />

monitoring hysis of fully cross-linked fibrin<br />

clots with comm. D-dimer teat (A), 1161<br />

Fibrinogen<br />

optimized microturbidimetric assay for<br />

fibrinogen.<br />

Fibronectin<br />

211<br />

See also Prealbumin<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusiona (SN), 166<br />

Flame photometry<br />

enzymatic detn. of K in serum, 817<br />

Flecainide<br />

fhecainide: comparison of fluorescence<br />

polarization with HPLC (A), 1097<br />

Flow-injection analysis<br />

automated fluoroimmunoassay of theophyiline<br />

and vaiproic acid by flaw-injection anal. with<br />

use of HPLC (SN), 469<br />

Fluorescein<br />

interference by intravenous fluorescein with<br />

lab. tests (A), 1159<br />

Fluorescence immunoassay<br />

See Fhuoroimmunoassay, Immunoassay<br />

Fluorescence polarization<br />

automated rapid assessment of surfactant and<br />

fetal lung maturity by altered fluorescence<br />

polarization of a dye (PC 16) (A), 1107<br />

comparison of free digoxin and total dioxin:<br />

extent of interference from digoxin-hike<br />

immunoreactive substances in a fluorescence<br />

polarn. assay (TB), 323<br />

cost-effective assays for use in monitoring<br />

carbamazepine, phenobarbital, and<br />

phenytoin in serum (SN), 1782<br />

flecainide: comparison of fluorescence<br />

polarization with HPLC (A), 1097<br />

multicenter evaln. of TDx fetal lung maturity<br />

(A), 1075<br />

multicenter evaln. of TDx test for assessing<br />

fetal hung maturity, 1005<br />

TDM assays by fluorescence polarization on<br />

Cobas Fara IITNanalyzer; detn. of serum<br />

amikacin, gentamicin, and tobramycin (A),<br />

1178<br />

TDM assays by fluorescence polarization on<br />

Cobas Fare IITN:detn, of serum N-<br />

acetyhprocainamide, theophylline, and<br />

phenytoin (A), 1178<br />

Fluorescence polarization immunoassay<br />

AD” amphetamine class assay (A), 1174<br />

antiepieptic drug monitoring by FPIA and gas<br />

chromatography (A), 1208<br />

assay for benzodiazepines on the AD,’<br />

analyzer (A), 1174<br />

cm. performance of the EMIT vancomycin<br />

assay (SN), 1504<br />

comparison of Abbott TDx FPIA for<br />

cannabinoids with GC/MS (A), 1185<br />

cyclosporine concns. in blood after liver<br />

transplantn.: correlation of immunoassay<br />

results with chin. events, 564<br />

detection limit of the TDx fluorescence<br />

polarization immunoassay extended for<br />

benzoylecgonine in urine (SN), 2110<br />

development of TD./ADn fluorescence<br />

polarization immunoassay for detection of<br />

methadone in human urine (A), 1176<br />

digoxin-hike immunoreactivity in neonates and<br />

infants minimized by centrifugal<br />

ultrafiltration and FPIA (A), 1163<br />

2380 CLINICALCHEMISTRY, Vol. 35, No. 12, 1989


evaln. of Abbott AD,. analyzer in traditional<br />

and nontraditional markets (A), 1174<br />

evaln. of Abbott MTDX’ drug anal. system (A),<br />

1185<br />

evaln, of Abbott TD for drugs of abuse<br />

testing ins field environment (A), 1179<br />

evaln. of combined cocaine/op!ate screening<br />

procedure on Abbott labs. TDx (A), 1165<br />

evaln. of the Ames Seralyzer for therapeutic<br />

drug monitoring of phenobarbital, phenytoin<br />

(TB), 324<br />

evaln. of the Tl)x and ADx methadone<br />

immunoassays (TB), 1794<br />

five cannabinoid immunoasaay systems<br />

compared at the screening threshold of 100<br />

,&g/L (SN), 2241<br />

fluorescence polarn. immunoassay of<br />

gentainicin or netilmicin in blood spotted on<br />

filter paper (SN), 867<br />

fluorescence poharn. immunoasaay of urinary 5-<br />

hydroxy-3-indoleacetic acid, 355<br />

four fluorescence polarization immunoassays<br />

for therapeutic drug monitoring evald,, 138<br />

multiple drugs of abuse detection by FPIA<br />

using TDx reagent mixture (A), 1164<br />

prognostic value of MEGX liver-function test<br />

in transplant candidates (A), 1135<br />

serum valproic acid detn. on Cobas B1oFP<br />

centrifugal analyzer (A), 1178<br />

rluoroenzymoimmunometric assay<br />

rapid detn. of ferritin in serum by the<br />

“Stratus” fluoroenzymoimmunametric assay<br />

(TB), 672<br />

!luorobnmunoassay<br />

automated fluoroimmunoassay of theophylhine<br />

and valproic acid by flow-injection anal, with<br />

use of HPLC (SN), 469<br />

commercially available dissociation-enhanced<br />

lanthanide fluoroimmunoassay kit evald. far<br />

quantifying ferritin in serum (TB), 327<br />

development of monoclonal antibodies<br />

human myoglobin and their use in<br />

to<br />

fluorescence immunoassay (A), 1203<br />

dry-chem. multilayer element for thyroid<br />

hormone uptake assay (A), 1195<br />

dry-chem. multilayer immunoassay for total<br />

thyroxin (A), 1180<br />

dry-chem. multilayer inlmunaassay test far<br />

theophylline (A), 1196<br />

dry-chem. multihayer immunoaasay tests for<br />

phenytoin and phenabarbital (A), 1196<br />

evaln, of automated CK-MB mass assay (A),<br />

1107<br />

evaln. of automated fluorescent immunoassay<br />

far detection of HBsAg (A), 1095<br />

fluorescence immunoassays (A), 1239<br />

mess, of estrone-3-glucuronide in urine by<br />

rapid, homogeneous time-resolved<br />

fluoroimmunoassay, 555<br />

measurement of free testosterone and free<br />

androgen index by use of sex-hormonebinding<br />

globulin concns.<br />

(fluoroimmunoassay) in hirsutism (A), 1143<br />

multilayer fluorescence immunoassay<br />

technique(S), 1865<br />

quantn. of free and whole molecule -hCG in<br />

an automated fluorescence immunoassay<br />

(A), 1147<br />

rheumatoid factors detd, by fluorescence<br />

immunoassay comparison with qual. and<br />

quant. methods (SN), 464<br />

stable liposomes for microcapeule<br />

immunoassay in human sara (A), 1204<br />

time-resolved fluorescence immunoassay<br />

system especially suited for res. applications<br />

(TB), 491<br />

time-resolved fluoroimmunoassay for<br />

measuring thyroxin-binding globulin (A),<br />

1205<br />

time-resolved fluoraimniunoassay of aflatoxins<br />

(SN),2308<br />

rluoromoiry<br />

antipyrine<br />

simultaneous<br />

interferes<br />

estn.<br />

with chem. detn. of Br<br />

of total body H20 and<br />

in<br />

extracellular H20, 1367<br />

automated DNA sequencing methods involving<br />

polymerase chain reaction, 2196<br />

calibrator design considerations for Du Pont<br />

Vista’ immunoassay system (A), 1202<br />

collagen-linked fluorescence in skin biopsy<br />

specimens from young insulin-dependent<br />

diabetic patients (A), 1137<br />

detn. of trons-phyiloquinone in children’s<br />

serum (SN), 874<br />

direct detn. of 4 sulfates and 7 glucuronides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” hiq. chromatog., 794<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyrins, 2290<br />

effect of light on reactions between N’-<br />

methylnicotinamide and methyl ketones<br />

(TB), 2000<br />

evaln, of Abbott IMx T3 assay (A), 1202<br />

evaln, of thyroid-stimulating hormone<br />

immunoassay on the IMx (A), 1197<br />

fluorometric enzyme immunoassay for<br />

measurement of free T4 using Magnisep’<br />

Cr02 particles (A), 1202<br />

fluorometric enzyme immunoassay for<br />

measurement of total thyroxin using a<br />

reagent delivery module’ (RDM) (A), 1140<br />

fluorometric enzyme immunoassay for<br />

measurement of total T3 using Magnisep’<br />

Cr02 particles (A), 1202<br />

fluorometric method for phenylalanine<br />

microplate assay adapted for<br />

phenylketonuria screening (SN), 2112<br />

fluorometry of Mg2+ in serum with 2-hydroxy-<br />

1-naphthahdehyde salicyloyhhydrszone, 1492<br />

fully automated fluorescence assay for detg.<br />

total homocysteine in plasma, 1921<br />

immunoassays for rubella antibodies (IgG and<br />

1gM) in serum using time-resolved<br />

fluorescence (A), 1153<br />

hiq. chromatog. assay for free and<br />

transthyretin.bound retinol-binding protein<br />

in serum, 582<br />

how-cost high-sensitivity diagnostic tool (A),<br />

1209<br />

measurement of creatine kinase MB by the<br />

Baxter Stratus fluorometric analyzer (A),<br />

1123<br />

microassay for screening newborns for<br />

galactosemia with use of a fluorometric<br />

microplata reader (SN), 1962<br />

modern trends in image analysis (A), 1053<br />

nonenzymatic stopped-flaw fluorimetry for<br />

direct detn. of uric acid in serum and urine,<br />

230<br />

novel nonisotopic immunoassay for grkb2-<br />

microglobulin (A), 1205<br />

quantn. of urinary porphyrins by hiq.<br />

chromatog. after oxidn, of porphyrinogens,<br />

1619<br />

rapid self-contained immunoassay for human<br />

thyrotropin (A), 1195<br />

screening utility of a rapid, automated<br />

fluorescent enzyme immunoassay for HBsAg<br />

in an S.T.D. clinic (A), 1192<br />

simultaneous liq.-chramatog. detn. of vit. K1,<br />

vit. E in serum, 2285<br />

two-site IRMA for detn, of urinary<br />

cytokeratin-18; epplicn. to management of<br />

bladder cancer (A), 1198<br />

Fluorouracil<br />

extn, of intracellular nucleoeides and<br />

nucheotides with acetonitrile, 48<br />

Fluoxetine<br />

fluoxetine and norfluoxetine detn. in serum by<br />

capillary GC-ECD with solid-phase extn.<br />

(A), 1169<br />

fluozetine inhibition of imipramine<br />

metabolism (A), 1180<br />

Fluvoxamine<br />

new method for monitoring fluvoxamine in<br />

human plasma by RPLC with uv detection<br />

(A), 1185<br />

Folate<br />

See also specific fohate of interest<br />

chemilumineacence receptor assay for fohate<br />

(A), 1194<br />

stability of red cell fohate after hemohysis with<br />

ascorbic<br />

Fohic acid<br />

acid sohn. (A), 1160<br />

See Fohate<br />

Follitropin<br />

assay far human follitropin using higand and<br />

anti-higand system (A), 1190<br />

detn. of FSH, LH, and cortisol with automated<br />

enzyme immunoassays (A), 1141<br />

development of solid-phase FSH IRMA (A),<br />

1201<br />

fully automated essay for human folliclestimulating<br />

hormone on the Abbott IMx’<br />

automated immunoassay system (A), 1142<br />

time-resolved immunofluorometry of<br />

fohhitropin in serum (TB), 181<br />

(A), 1138<br />

Forensic medicine<br />

benzodiazepines identified by capillary gas<br />

chromatog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs,, 1394<br />

confirmatory breath ethanol testing (A), 1184<br />

degree of lipid peroxidation in postmortem<br />

blood of tire victims (A), 1176<br />

DNA fingerprinting(S), 1832<br />

evaln, of vitreous fluid as a specimen for drug<br />

abuse testing (A), 1181<br />

five cannabinoid immunoassay systems<br />

compared at the screening threshold of 100<br />

g/L (SN), 2241<br />

identn, of locus-specific VNTR sequences in<br />

forensic samples (A), 1058<br />

F protein<br />

plasma glutathione S-transferase and F protein<br />

are mare sensitive than alanine<br />

aminotransferase as markers of<br />

acetaminophen-induced liver damage, 2186<br />

Fructosamine<br />

din, evaln. of fructosamine assay for screening<br />

for diabetes mellitus (A), 1096<br />

correln, of 14bAi, glycated serum proteins and<br />

albumin, and fructosamine with 24-h glucose<br />

profile of insulin-dependent pregnant<br />

diabetics, 922<br />

detergent enhances interference of urete in<br />

detns, of fructosamine (L), 1803<br />

detn, of usefulness of fructosamine assay far<br />

diagnosis of diabetes (A). 1145<br />

effect of chin. apparent recent change in<br />

glycemic control on serum fructosamine (A),<br />

1136<br />

effect of measurement wavelength<br />

fructosamine results (L), 1582<br />

on<br />

effects of various serum proteins on quantn. of<br />

fructosamine (SN), 134<br />

evaln. of liq. quality-control material for detn.<br />

of fructosaniine in human serum (A), 1106<br />

fructosamine and IgA: no correln, in nondiabetics<br />

(L), 1556<br />

fructoeamine as routine parameter in diabetes<br />

diagnosis (A), 1098<br />

fructosamine assay modified far estn. of<br />

glycated Rb (TB), 497<br />

fructosamine: matrix problems with stds. based<br />

on protein matrices (L), 191<br />

glycated Hb and fructosamine measurements<br />

in assessing glycemic control (A), 1236<br />

glycated Hb in fractionated erythrocytes, 958<br />

improved colorimetric fructosamine assay (A),<br />

1110<br />

D-hysine effectively decreases nan-enzymic<br />

glycation of proteins in vitro, 384<br />

measurement of fructosamine using nitroblue<br />

tetrazohum on IL Multistat and comparison<br />

with Hb A1 in diabetic patients (A), 1146<br />

relative potency of commercial calibrators for<br />

fructosamine, and their effect on mess. of<br />

fructosamine in serum (L), 712<br />

Galactosemia<br />

microassay for screening newborns for<br />

galactosemia with use of a fluorometric<br />

microphate reader (SN), 1962<br />

Gallstones<br />

enzymatic detn. of total cholesterol in<br />

gallstones (SN), 2247<br />

Gammopathie.<br />

See also Monoclonal gammopathies<br />

Gas<br />

See Blood gases, Breath analysis<br />

Gas chromatography<br />

cost-effective assays for use in monitoring<br />

carbamazepine, phenobarbital, and<br />

phenytoin in serum (SN), 1782<br />

use of GC/IR/MS for high-confidence identifn.<br />

of drugs(S), 1279<br />

Gas chromatography, capillary<br />

benzodiszepines identified by capillary gas<br />

chromatog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs., 1394<br />

Gas chromatography/mass ipectrometry<br />

amphetamine, methamphetamine quant.<br />

confirmation procedure by GCIMS (A), 1169<br />

biochem, contribution to diagnosis and study<br />

of a new case of D-glyceric acidemia/aciduria<br />

(CR), 2148<br />

din, steroid profiles by GC/MS (A), 1142<br />

comparison of Abbott TDx FPIA for<br />

cannabinoids with GC/MS (A), 1185<br />

delta-9-THC and delta-9-THC-carboxyhic in<br />

serum by quant. GC/MS (A), 1170<br />

estrsdiol-17$ detd. in plasma by gas<br />

chromatog.-mass spectrom. with selected ion<br />

monitoring of mixed sihyl<br />

ether-perfluoroscyl ester derive, and use of<br />

various stable-isotope-labeled internal sods.,<br />

532<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2381


GC-NPD and GC-MS anal, of comm. available<br />

Toxi-Disc drugs (A), 1184<br />

identn, of some typical -bhockers (bisoprohol,<br />

betaxolol) and prapafenone in bioL<br />

specimens: applicn. to doping anal. (A), 1183<br />

improved GCIMS drug detection with chem.<br />

ionization mass spectrometry and ion trap<br />

detection (A), 1180<br />

isotope diln, GC-MS of metals at trace levels in<br />

biol. samples (A), 1113<br />

quant anal. for org. acids in biol, samples:<br />

batch isolation followed by gas<br />

chromatog.-mass spectrom. anal., 587<br />

simultaneous qusntn. of morphine, codeine,<br />

and 06-monoacetyl morphine by gas<br />

chromatog. mass spectrom. (A), 1355<br />

urinary org. acid excretion by premature<br />

babies,<br />

versatile,<br />

1460<br />

efficient system for extracting drugs<br />

from urine for gas chromatog./mass<br />

spectrom. anal. (SN), 2100<br />

Gastrltls<br />

high prevalence of atrophic gastritis in the<br />

elderly: implications for health-associated<br />

ref. limits for cobalamin in serum (L), 1557<br />

Gastroduodenal ulcers<br />

pepsin and pepsinogen group I levels in human<br />

gastroduodenal biopsies (A), 1126<br />

Gaucher’. disease<br />

immunoassay of band 5 (“tartrate-resistant”)<br />

acid phosphatase involving use of antiporcine<br />

uteroferrin antibodies, 86<br />

GELLAB<br />

See Ehectrophoresis, twa-dimensional<br />

Gene probes<br />

DNA fingerprinting with nonradioactive gene<br />

probes (TB), 2147<br />

Gene synthesis<br />

genetically engineered antibodies (5), 1849<br />

Genetic engineering<br />

genetically engineered antibodies (S), 1849<br />

Genetics<br />

See also Heritable disorders<br />

carrier detection and characterization of gene<br />

deletions in Duchenne and Becker muscular<br />

dystrophy utilizing dystrophin cDNA probes<br />

(A), 1075<br />

cm. signif. of genetic rearrangements in<br />

neuroblastomas (5), B38<br />

construction of a linkage map of the human<br />

gename, and its apphn. to mapping genetic<br />

diseases (5), 833<br />

cystic fibrosis: diagnostic testing and the<br />

search for the gene (5), B17<br />

DNA flngerprintmg (5), 1832<br />

erythrocyte ferritin assay to find patients with<br />

homozygous hemochromatosis (A), 1083<br />

fundamental mechanisms of tumorigenesis in<br />

the nervous system: isoln, and charactern, of<br />

genes assocd, with hered. forms of cancer (S),<br />

825<br />

genes encoding neuronal nicotinic<br />

acetylchohine receptors (S), 731<br />

genetic heterogeneity at the cystic fibrosis<br />

locus (A), 1077<br />

genetics of bipolar affective disorder: chin.<br />

implications (5), B28<br />

lipoprotain(a): genetic marker for<br />

atherosclerosis (A), 1234<br />

loss of heterozygosity in stages of malignancy<br />

(S). B48<br />

Lp(a) phenotype frequency in a normal North<br />

Am: population (A), 1070<br />

mapping the locus of autosomal dominant<br />

polycystic kidney disease: diagnostic eppln.<br />

mole, genetics of Duchenne and Becker<br />

muscular dystrophy emphasis on improved<br />

diagnosis (S), B21<br />

molecular genetics of leukemia and lymphoma<br />

(S),B43<br />

moL genetics and the transformation of cm.<br />

chem, (S), 2165<br />

oxidation phenotype, comparison between<br />

debrisoquine and dextromethorphan tests<br />

(A), 1184<br />

recombinant DNA technoL in diagnosis of<br />

genetic disorders(S), 84<br />

strong assocn, of a single nucheotide<br />

substitution in the 3’-untranslated region of<br />

the apohipoprotein.CIII gene with common<br />

hypertrighyceridemia in Arabs, 256<br />

use of DNA probes and complement<br />

phenotyping for diagnosis and carrier<br />

detection in families with steroid 21-<br />

hydroxylase deficiency (A), 1075<br />

Gentamicin<br />

fluorescence poharn. immunoassay of<br />

gentamicin or netilmicin in blood spotted on<br />

filter paper (SN), 867<br />

latex agglutination inhibition immunoassay for<br />

gentamicin on the IL Monarch’ chem.<br />

system (A), 1172<br />

quality assurance study of gentamicin usage<br />

and monitoring ins children’s hospital (A),<br />

1167<br />

TDM assays by fluorescence polarization on<br />

Cobas Fare 1P5 analyzer; detn. of serum<br />

amikacin, gentamicin, and tobramycin (A),<br />

1178<br />

Technicon tobramycin and gentamicin: secondgeneration,<br />

improved methods on the RA-<br />

1000 system (A), 1172<br />

Geriatric chemistry<br />

bioL variability of 26 din. chem. analytes in the<br />

elderly, 783<br />

chin. chem. ref,-intervals for healthy elderly<br />

(A), 1061<br />

erythrocyte sedimentation rate and C-reactive<br />

protein compared in the elderly (SN), 466<br />

geriatric ther, drug monitoring: special<br />

considerations(S), 1337<br />

Gigantism<br />

somatotropin as mess. by a two-site timeresolved<br />

immunofluorometric assay, 913<br />

Globulins<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns,<br />

Glomerular filtration rate<br />

(CR), 333<br />

renal function assessed by serum creatinine<br />

and creatinine clearance: glomerular<br />

filtration rate estd. by four procedures (SN),<br />

2326<br />

Glucitol<br />

simple enzymatic method for detg. 1,5-<br />

anhydro-D-ghucitol in plasma for diagnosis of<br />

diabetes, 2039<br />

Glucocerebrosldsse<br />

evaln. of biotinylated (Blugene’) vs 32p<br />

labeled cDNA probes of -<br />

glucocerebrosidase: rel. sensitivities in<br />

genomic and other systems (SN), 1512<br />

Glucosaminidase<br />

bioL variation of urinary N.acetyh--Dglucosaminidase:<br />

practical and din.<br />

implications, 560<br />

intra-individual biol. variation in the N-acetyl-<br />

$-glucosaminidsse/creatininium ratio for<br />

first morning urine (TB), 1256<br />

Glucose<br />

accuracy, precision, and chin, reliability of three<br />

capillary blood glucose monitors (A), 1135<br />

aqueous-based glucose control solos. for use<br />

with glucose reagent-strips and meters (L),<br />

2017<br />

deth, of glucose using glucose oxidase<br />

fixed-time reaction (A), 1105<br />

in a<br />

effectiveness of NsF as a preservative of blood<br />

glucose (SN), 315<br />

effects of glucose on spectraphotometric detn,<br />

of blood D-xylose (A), 1156<br />

enzyme electrode for glucose measurement<br />

whole blood with a critical care profiling<br />

in<br />

instrument (A), 1098<br />

evaln. of APEC glucose analyzer method (A),<br />

1112<br />

evaln, of Beckman Interhink’s custom<br />

formatting for reporting glucose tolerance<br />

test results (A), 1088<br />

evaln. of Litescan “One Touch” glucometer far<br />

a hoep. bedside glucose monitoring program<br />

(A), 1107<br />

evaln. of Nova 12: whale-blood and serum<br />

electrolyte, glucose, and BUN analyzer (A),<br />

1128<br />

individual home glucose meters evalusted by<br />

routine chin. lab, methods (A), 1142<br />

influence of blood 02 tension on dipstick<br />

glucose detns. (L), 1268<br />

qua!. control of glucose monitors outside the<br />

chin, lab.: use of commercial nonhuman<br />

erythrocyte prepns. supplemented with<br />

glucose (L), 509<br />

quality-control program for evaluating and<br />

monitoring multiple-site reflectance glucose<br />

analyses (A), 1160<br />

reagenthess detn, of glucose and other<br />

constituents in blood by ATR-FT-IRspectroscapy<br />

(5), 1854<br />

relationship between plasma and whole-blood<br />

glucose during the glucose tolerance test (A),<br />

1127<br />

reliable bedside glucose tasting ins hospital<br />

(A), 1237<br />

simultansous detn, of urea, glucose, Na, K, Cl,<br />

and total CO2 in undiluted human serum<br />

using an electrode-based automated analyzer<br />

(A), 1091<br />

technique-induced errors in two popular blood<br />

glucose reagent strips (A), 1156<br />

underestn. of urinary glucose by an automated<br />

dipstick analyzer based on glucose oxidase<br />

with has indicator chromogen (L), 1804<br />

Glucose-6-phosphate dehydrogensse<br />

assay of glucose-S-phosphate dehydrngenase<br />

acty. in blood on the Hitachi 737, with<br />

simultaneous detn. of Hb (A), 1119<br />

Glucose tolerance test<br />

oral glucose tolerance test does not provide a<br />

uniform stimulus to pancreatic islets in<br />

pregnancy, 1482<br />

relationship between plasma and whole-blood<br />

glucose during the glucose tolerance test (A),<br />

1127<br />

Glutsmyhtransfersse<br />

high-M, (“biliary”) isoenzyme of alk,<br />

phosphataae and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

Ghutathioue peroxidsse<br />

automated methods for chin, assay of<br />

superoxide dismutase and ghutethione<br />

peroxidase in human plasma and<br />

erythrocytes using a Cobas Bia centrifugal<br />

analyser (A), 1126<br />

Glutathione synthetase deficiency<br />

pyroghutamic acidemia in an adult (CR), 684<br />

Glutathione S-transferase<br />

mess, of glutathione S-transferase B1 in plasma<br />

after birth asphyxia: early indication of<br />

hepatocellular damage, 995<br />

plasma glutathione S-transferaae and F protein<br />

are more sensitive than alanine<br />

aminotransferase as markers of<br />

acetaminophen-induced liver damage, 2186<br />

Glycated albumin<br />

correhn. of HbAic, glycated serum proteins and<br />

albumin, and fructosamine with 24-h glucose<br />

profile of insulin-dependent pregnant<br />

diabetics, 922<br />

Ghycated hemoglobin<br />

enzyme immunoassay of Hb Air: anal.<br />

characteristics and chin, performance in<br />

diabetes mellitus, with and without uremia,<br />

93<br />

fructosamine assay modified for estn. of<br />

glycated Rb (TB), 497<br />

glycated Hb and fructosamine measurements<br />

in assesaing glycemic control (A), 1236<br />

glycated Rb in fractionated erythrocytes, 958<br />

HPLC detn. of hemoglobin A1,,in the presence<br />

of the fast hemoglobin I-Philadelphia (TB),<br />

494<br />

liq.-chromatog. detn. of acetylated Rb, 33<br />

precision of mess. of glycated Rb by affinity<br />

chromatog. on regenerated columns (L), 191<br />

quantn. of glycated Hb by alkaline gel<br />

ehectrophoresis: the Paragon system (A),<br />

1162<br />

ref. range of glycated Hb in nondiabetic<br />

persons possessing Rb S by affmity<br />

chromatog. (A), 1162<br />

simplified anal, for glycated Hb by ionexchange<br />

chromatog. (L), 2253<br />

Glycated<br />

lipoprotein<br />

effect of ghycation of law-density lipoprotein on<br />

immunolog. detn. of apohipoprotein B (SN),<br />

2219<br />

serum glycated $-lipoprotein detd. by agarose<br />

gel ehectrophoresis with nitroblue<br />

tatrazohium coloration (TB), 177<br />

Glycated lysine<br />

does the effective diminution of nonenzymatic<br />

glycation by D-lysine really highlight its<br />

potential use in viva? (L), 2254<br />

Glycated proteins<br />

colorimetric detn. of non-enzymatically<br />

glycated apolipoprotein B (A), 1074<br />

correln, of HbAic, glycated serum proteins and<br />

albumin, and fructosamine with 24-h glucose<br />

profile of insulin-dependent pregnant<br />

diabetics, 922<br />

l).hysine effectively decreases non-enzymic<br />

glycation of proteins in vitro, 384<br />

nonenzymic glycation of immunoghobulins does<br />

not impair their immunoreactivity (SN),<br />

1039<br />

Glyceric acldemia<br />

biochem. contribution to diagnosis and study<br />

of a new case of D-ghyceric acidemia/aciduria<br />

(CR), 2148<br />

2382 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


Glycohemoghobin<br />

See Glycated hemoglobin<br />

Glycoprotems<br />

apphn. of a silver-binding assay to detn. of<br />

protein in CSF (SN), 860<br />

changes in concanavalin A-reactive proteins in<br />

mflammatory disorders, 2207<br />

decreased immunoreacty. and binding acty. of<br />

corticosteroid.binding globulin in serum in<br />

septic shock, 1675<br />

detecting serum acidic range glycoproteins<br />

using isoehectric focusing on cellulose acetate<br />

mambranes<br />

high condos,<br />

(A), 1083<br />

of Zna2-glycoprotein and lack of<br />

a2HS-ghycopratein in ejaculates, 1649<br />

high-yield purifn. of the complex-farming<br />

glycoprotein in urine, 577<br />

two-site immunoenzymometry of 52.kDa<br />

cathepsin Din cytosols of breast-cancer<br />

tissues, 81<br />

Ihycosaminoghycans<br />

diagnostic test for mucopolysaccharidosis I.<br />

direct method for quantg. excessive urinary<br />

glycosaininoglycan excretion, 374<br />

diagnostic test for mucopolysaccharidosis. II.<br />

rapid quantn. of ghycosaminoghycan in urine<br />

samples one paper matrix, 2074<br />

dimethylmethylene blue-based spectrophotom.<br />

of glycosaminoghycana in untreated urine:<br />

rapid screening for mucopolysaccharidoses,<br />

1472<br />

lyoxa1<br />

glyoxal: an artefact from metronidazohe and<br />

glyoxylic acid in urinary org. acid anal. (TB),<br />

673<br />

Ryoxylic acid<br />

glyoxal: an artefact from metronidazohe and<br />

glyoxylic acid in urinary org. acid anal. (TB),<br />

673<br />

onadotroplns<br />

RIA of -microseminoprotein, a prostatic.<br />

secreted protein in sera of men and women,<br />

1497<br />

3ranuhocyte.<br />

detn. of Mg2+ in granulocytes, 1404<br />

rowth hormone<br />

changes of growth-related hormones and<br />

growth factors following pneumanectomy’ I.<br />

growth hormone (A), 1150<br />

aloperidoh<br />

evain. of EIA for detn, of hahoperidoh, a<br />

neuroheptic drug, in serum (A), 1175<br />

how-dose monitoring of haloperidol (A), 1179<br />

alothane<br />

quantn. of halothane by headspace gsa<br />

chromatog. (A), 1173<br />

hlaptocorrin<br />

cobalamin-binding capacity of haptocorrin and<br />

transcobalsmin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

lieart disease<br />

See also Myocardial infarction<br />

antiarrhythniic drugs and the cardiac Na<br />

channel: current models(S), 748<br />

apolipoprotein E isoform anal, in<br />

characterizin[atherogenic risk (A), 1235<br />

epolipoprotein E isoforms in patients with<br />

hypertrophic cerdiomyopethy (A), 1070<br />

concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />

heart tissue in coronary heart disease (SN),<br />

851<br />

creatine kinase isoforms in ischemic heart<br />

disease (R), 7<br />

diagnostic utility of serum total creatine kinase<br />

and creatine kinase-2 in myocardial<br />

infarction re-evaluated, 1435<br />

duah-pptn. method evald. for mess, of<br />

cholesterol in high-density lipoprotein<br />

subfractions HDL2 and HDL3 in plasma, 265<br />

emetine identified in urine by HPLC, with<br />

fluorescence and ultraviolet/diode array<br />

detection, in a patient with cerdiomyopathy<br />

(CR), 499<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN), 166<br />

heterogeneity of serum creatine kinase<br />

isoenzyme MM in myocardial infarction:<br />

chin. significance and post-synthetic<br />

conversion of “abnormal” sub-bands, 206<br />

high alanine aminotransferase activities in<br />

plasma, hearts in patients with acute<br />

nyocardial infarction, 279<br />

HUP-lipid program: apolipoprotain A-I and B<br />

and the apo B/apo A-I ratio (A), 1065<br />

hypomagnesemia and how alk. phosphatase<br />

acty. in patients’<br />

(SN), 664<br />

serum after cardiac surgery<br />

immunochem. test for CK-MB isoforms (L),<br />

2157<br />

increase of hypoxanthine during cardiac<br />

surgery, as measured by an indirect<br />

automated enzymatic assay (L), 898<br />

LDL heterogeneity relationships between<br />

particle size and coronary disease (A), 1234<br />

lipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monoclonal<br />

antibodies, 1380<br />

mess, of autoimmune response against collagen<br />

types I, Ill, and IV by enzyme-linked<br />

immunosorbent assay, and appln. in<br />

infective endocarditia, 246<br />

mess, of urinary heukotrienes by reversedphase<br />

liq. chromatog. and RIA, 388<br />

optimized microturbidimetric assay for<br />

fibrinogen, 211<br />

patterns of lactate dehydrogenase isoenzymes 1<br />

and 2 in serum on exercise (SN), 301<br />

role of Mg in etiology of cardiovascular disease<br />

(A), 1055<br />

S-100a0 protein in blood and urine during<br />

open-heart<br />

simultaneous<br />

surgery, 1942<br />

detn. of pentoxifylline and three<br />

metabolites in bioL fluids by hiq. chromatog.<br />

(SN), 298<br />

specific binding of cardiac glycoside drugs and<br />

endogenous digitalis’like substances to<br />

particulate membrane fractions from<br />

placenta, 2093<br />

statis. interpretn. of concns, of Mg, Zn, Ca, K,<br />

cholesterols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

streptokinase binds to lactate dehydrogenase<br />

subunit-M, which shares an epitope with<br />

plasminogen, 69<br />

strong aasocn, of a single nucleotide<br />

substitution in the 3’-untranslated region of<br />

the apolipoprotein-CIhI gene with common<br />

hypertriglyceridemia in Arabs, 256<br />

update on digoxin (5), 1326<br />

Heart disorders<br />

heart disorders and concentrations of directly<br />

measured atriah natriuretic peptide in<br />

plasma, 435<br />

Heart transplant<br />

ohigoclonal banding in serum from hearttransplant<br />

recipients, 431<br />

serum prolactin as a rejection marker in heart<br />

transplantn. (TB), 492<br />

simultaneous deth. of serum neopterin and C-<br />

reactive protein as markers of infection in<br />

heart-transplant recipients (TB), 1258<br />

Hemsgglutination<br />

passive hemagglutinetion assay for HIV<br />

antibody screening (Retrocell HIV#{149}) (A),<br />

1210<br />

Hematocrit<br />

effect of hematocrit and added heparmn on Ca2<br />

in capillary blood from neonates (SN), 486<br />

Hematofluorometers<br />

empirically detd. Pb-poisoning screening cutoff<br />

for the Prototluor-Z hematofluorometer<br />

(SN), 2104<br />

interlab, comparison of control materials for<br />

use with hematofluorometers, 2059<br />

Hematology<br />

artificial intelligence program for<br />

interpretation of raw data from automated<br />

hemotol, instruments (A), 1089<br />

correction factors for extracorporeal pump<br />

hemodihution: evaln, using an in-vitro model<br />

(A), 1158<br />

performance evaln. of Corning 288 and Nova<br />

Stat Profile 1 blood gas systems (A), 1093<br />

Heme<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyria, 2290<br />

empirically detd, Pb-poisoning screening cutoff<br />

for the Protofluor-Z hematofluorometer<br />

(SN), 2104<br />

interaction between pyridine nucleotide<br />

coenaymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

Zn protoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Hemochromatosis<br />

erythrocyte ferritin assay to fmd patients with<br />

homozygous hemochromatosia (A), 1083<br />

Hemodlahysis<br />

See also Dialysis patients<br />

critical appraisal of methods for Al-monitoring<br />

program (A), 1114<br />

improved detn. of Vain bioL fluids by<br />

electratherm, at. absorption spectrom. (SN),<br />

127<br />

interference with mess, of intact parathyrin in<br />

serum from renal dialysis patients (TB),<br />

1543<br />

measuring creatine kinaae MB isoenzyme in a<br />

maintenance hemodialysia popn.:<br />

chemiluminometric immunoassay and<br />

electrophoresis compared (SN), 1965<br />

serum paratbyroid hormone in hemodialysis<br />

patients (A), 1140<br />

Hemoglobin<br />

See also Glycated hemoglobin<br />

apphn. of a silver-binding assay to detn. of<br />

protein in CSF (SN), 860<br />

assay of glucose-6-phosphate dehydrogenase<br />

ecty. in blood on the Hitachi 737, with<br />

simultaneous detn. of Rb (A), 1119<br />

automated detn. of chohinesterase ecty. in<br />

plasma and erythrocytes by flow’injection<br />

anal., and eppln. to identify<br />

sensitive to succinylchaline,<br />

subjects<br />

77<br />

disturbance of the detn. of Hb concn, in<br />

patients with high heukocyte counts (L), 515<br />

effect of hemoglobinemia on bilirubin assays<br />

on Kodak Ektachem 700 and<br />

Bilirubinometer (A), 1157<br />

evain. of dry-chem, analyzer, the Chinistat, for<br />

blood Hb and serum or plasma constituents<br />

(A), 1108<br />

Hb peroxidase acty. for coupled enzymatic<br />

reactions (A), 1122<br />

interaction between pyridine nucheotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-hinked enzymes (SN), 2129<br />

liq.-chromatog. detn, of acetylated Hb, 33<br />

monoclonal antibody to ‘y chain of fetal Hb<br />

used to develop an enzyme immunoassay,<br />

2066<br />

patient-side immunoassay system withs<br />

single-use cartridge for measuring analytes<br />

in blood (5), 1869<br />

reliability of detn, of whole-blood 0 affinity<br />

with blood-gas analyzers and multiwavelength<br />

oximeters, 773<br />

unreliable visual estn, of incidence and amount<br />

of turbidity, hemohysis, and icterus in serum<br />

from hospitalized patients (SN), 837<br />

unusual band on Rb electrophoresis produced<br />

by a monoclonal immunoghobulin in serum<br />

(TB), 1794<br />

unusual band that binds Rb after<br />

ultracentrifn. of hemolyzed plasma<br />

hipoprotein sepn. (TB), 495<br />

for<br />

Hemogloblnopathles<br />

prenatal diagnosis of hemoglobinopathies by<br />

using pohymeraae chain reaction and allelespecific<br />

ohgonucleotide probes (S), 1854<br />

Hemoglobinuria<br />

(Wake Forest University Case Conference):<br />

myoglobinurie, hemoghobinuria, acute renal<br />

failure (CC), 1713<br />

Hemoglobin variants<br />

chromatofocusing and isoelectric focusing in<br />

immobilized pH gradients compared for<br />

characterization of Rb variants, 425<br />

nephelometric method for quantitating HbF<br />

(A), 1199<br />

stability of hemoglobins A, F, 5, and C in dried<br />

neonatal whole-blood samples when<br />

analyzed by cation-exchange RPLC (A),<br />

1152<br />

Hemoproteins<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyria, 2290<br />

Hemorrhagic disease<br />

anal, of supplemented vit. Ki (20) in serum<br />

microeamples by solid-phase extrn. and<br />

narrow-bare HPLC with multichannel uv<br />

detection (5), 1288<br />

Hemorrhagic shock<br />

increases in aspartata aminatransferaae,<br />

creatine kinase in hemorrhagic shock and<br />

encephalopathy syndrome (L), 2253<br />

Heparin<br />

effect of hematocrit end added heparin on Ca2<br />

in capillary blood from neonates (SN), 486<br />

increased concns. of heparmncofactor II in<br />

diabetic patients, and possible effects on<br />

thrombin inhibition assay of antithrombin<br />

111,52<br />

Hepatic disease<br />

See also Liver disease<br />

Hepatitis<br />

calciferin and cathepsin D-hike acid protease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

generalized likelihood ratio concept and<br />

logistic regression anal, for multiple<br />

diagnostic categories, 990<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2383


Hepatitis A<br />

automated enzyme immunoassay for detecting<br />

1gM antibody to hepatitis A virus (A), 1193<br />

rapid diagnostic tasting for simultaneous<br />

detection of acute and remote hepatitis A<br />

infection (A), 1198<br />

Hepatitis B<br />

automated enzyme immunoassay for detecting<br />

1gM antibody to hepatitis B core antigen (A),<br />

1193<br />

detection of antibody to hepatitis B core<br />

antigen using automated microparticlebased<br />

EIA (A), 1193<br />

detection of hepatitis B infection in a randomly<br />

selected pediatric hospital population using<br />

an automated enzyme<br />

1-IBsAg (A), 1152<br />

immunoassay for<br />

rapid automated detection of human 1gM<br />

antibody to hepatitis B core antigen (A),<br />

1206<br />

Hepatitis B surface antigen<br />

automated latex photometric immunoassay for<br />

detection of hepatitis B surface antigen (A),<br />

1206<br />

evaln. of Abbott Commander enzyme<br />

immunoassay system for hepatitis B surface<br />

antigen and B core antibody (A), 1207<br />

evaln. of automated fluorescent immunoassay<br />

for detection of HBsAg (A), 1095<br />

evahn. of enzyme immunoassay kits for<br />

hepatitis B surface antigen, B surface<br />

antibody, and B core antibody (A), 1207<br />

microparticle enzyme immunoassay for<br />

measuring antibodies to hepatitis B surface<br />

antigen, IMx anti-HBs (A), 1193<br />

rapid self-contained immunoassay for hepatitis<br />

B surface antigen (A), 1195<br />

rapid semiquant. teat for hepatitis B surface<br />

antigen using the Icon#{149} Reader’ (A), 1198<br />

screening utility of a rapid, automated<br />

fluorescent enzyme immunoassay for HBsAg<br />

in an S.T.D. clinic (A), 1192<br />

Hepatobiiary disorders<br />

signif. of low serum urea N concns. (SN), 639<br />

Heritable disorders<br />

See also Genetics<br />

automated detn, of cholinesterase acty. in<br />

plasma and erythrocytes by flow-injection<br />

anal,, and appln. to identify subjects<br />

sensitive to succinylcholine, 77<br />

automated procedure for mess, of biotinidase<br />

acty. in serum (SN), 831<br />

biochem. contribution to diagnosis and study<br />

of a new case of D-glyceric acidemia/aciduria<br />

(CR), 2148<br />

construction of a linkage map of the human<br />

genome, and its apphn. to mapping genetic<br />

diseases (S), B33<br />

cystic fibrosis: diagnostic testing<br />

search far the gene (S), B17<br />

and the<br />

detection of Duchenne/Becker muscular<br />

dystrophy carriers by densitometric scanning<br />

(TB), 1256<br />

diagnosis of recessive X-linked ichthyosis:<br />

quantitative HPLC/mass spect. anal. of<br />

plasma for cholesterol sulfate, 1906<br />

diagnostic test for mucopolyssccharidoais. II.<br />

rapid quantn. of ghycosammnoghycan in urine<br />

samples on a paper matrix, 2074<br />

discordant<br />

globulin<br />

RIA results for thyroxin-binding<br />

(TBG): new indicator of variant<br />

TBG molecules with decreased affinity for<br />

thyroxin (TB). 1257<br />

DNA probes for carrier identn, in Duchenne<br />

muscular dystrophy (E), 519<br />

DNA probes used in detecting carriers of<br />

Duchenne muscular dystrophy: selected case<br />

studies (CR), 679<br />

enzymatic detn. of urinary oxalate (SN), 2330<br />

fundamental mechanisms of tumorigenesis in<br />

the nervous system: isoln. and charactern. of<br />

genes assocd. with hered, forms of cancer (5),<br />

B25<br />

genetics of bipolar affective disorder: chin.<br />

implications (S), B28<br />

hered. complete deficiency of lactate<br />

dehydrogenase H-subunit (CR), 687<br />

high-M, (“bihiary”) isoenzyme of elk.<br />

phoaphataae and the diagnosis of liver<br />

dysfunction<br />

homogentisic<br />

in cystic fibrosis, 1888<br />

acid detd. in bioL fluids by<br />

HPLC (SN), 321<br />

HPLC anal, of brain and plasma for octanoic,<br />

decanoic acids, 1945<br />

l-RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

isolation of “cystic fibrosis protein” from<br />

serum, 1901<br />

lang-chain aliphetic fatty acids and phytanic<br />

acid simultaneously measured by dualcolumn<br />

capillary chromatog. (SN), 1989<br />

mapping the hocus of autosomal dominant<br />

polycystic kidney disease: diagnostic appln.<br />

(S),B13<br />

microassay for screening newborns for<br />

galactoeemia with use of a fluorometric<br />

microplate reader (SN), 1962<br />

mohec. genetics of Duchenne and Becker<br />

muscular dystrophy: emphasis on improved<br />

diagnosis (S), B21<br />

mol. genetics and the transformation of chin.<br />

chem. (5), 2165<br />

pyroghutamic acidemia in an adult (CR), 684<br />

screening for deficiency of ai-proteinase<br />

inhibitor (SN), 1971<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd. familial<br />

amyloidotic pohyneuropathy (SN), 1033<br />

somatotropin as mess, by a two-site timeresolved<br />

immunotluorometric assay, 913<br />

sources of imprecision in screening for<br />

congenital hypothyroidism: anal. of 9 y of<br />

performance data, 1701<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

use of DNA probes and complement<br />

phenotyping for diagnosis and carrier<br />

detection in families with steroid 21-<br />

hydroxylase deficiency (A), 1075<br />

use of pohymerase chain reaction far diagnosis<br />

of inherited disorders(S),<br />

use of the polymerase chain<br />

1843<br />

reaction for<br />

simultaneous anal. of two Pst I<br />

polymorphisms linked to cystic fibrosis<br />

(TB), 1260<br />

Herpes simplex virus<br />

chemiluminescent detection of herpes simplex<br />

virus I DNA in blot and in-situ hybridization<br />

assays(S), 1856<br />

“High-performance” chromatography<br />

See Chromatogaphy, liquid<br />

“High-pressure chromatography<br />

See Chromatography, liquid<br />

Hirsutism<br />

measurement of free testosterone and free<br />

androgen index by use of sex-hormonebinding<br />

globulin concns.<br />

(fluoroimmunoassay) in hirsutism (A), 1143<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

Histocompatibihity complex<br />

fi2-microglobulin and immune activation (L),<br />

2158<br />

HIV<br />

See also Acquired immunodeficiency<br />

syndrome<br />

anal. of serum antibodies to HIV using a<br />

multiple synthetic antigen-coated test strip<br />

(A), 1204<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

detection of HIV praviral DNA in peripheral<br />

blood mononuclear cells by polymerase chain<br />

reaction (A), 1076<br />

detection of HIV-1 RNA by polymerase chain<br />

reaction (A), 1076<br />

development of a confirmatory enzyme-linked<br />

immunoeorbent assay for HIV-1 antibodies,<br />

946<br />

ELb. for detection of HTLV-1 antibodies using<br />

a mixture of synthetic peptide and viral<br />

hysate (A), 1204<br />

enhanced luminescence competitive<br />

inimunoassay for anti-HIV (A), 1207<br />

evahn. of leukocyte-associated dipeptidyl<br />

peptidase IV enzyme in normal and<br />

immunodeficient conditions (A), 1153<br />

evahn, of new recombinant ELISA immunoassay<br />

far detection of antibodies to HIV vs DuPont<br />

Western blot (A), 1204<br />

improved test for confirming antibodies to HIV<br />

using six recombinant peptides, including<br />

the intact gag gene-product, p24 (A), 1191<br />

molecular probes used to detect<br />

cytomegalovirus and human<br />

immunodeficiency virus (5), 1581<br />

neopterin as a predictive marker for disease<br />

progression in human immunodeficiency<br />

virus type 1 infection (SN), 1746<br />

ohigochonal immunoglobuhins in HIV infection,<br />

1669<br />

passive hemagglutination assay for HIV<br />

antibody screening (Retroceil HIV) (A),<br />

1210<br />

specific routine detn, of 3’-azido-3’-<br />

deoxythymidine in plasma by<br />

semiautomated hiq. chromatog. (5), 1313<br />

urinary neopterin concns. vs total neoptenns<br />

for chin, utility (SN), 2305<br />

Homocystelne<br />

fully automated fluorescence assay far detg.<br />

total homocysteine in plasma, 1921<br />

rapid detn. of total homocysteine in plasma<br />

(TB), 2002<br />

Homogentisic acid<br />

anal, for homogentisic acid by NMR<br />

spectrometry on diagnosis of alkaptonuria<br />

(L), 1806<br />

homogentisic acid detd. in bioL fluids by<br />

HPLC (SN), 321<br />

Homosexuality<br />

serum Zn in homosexual men (L), 704<br />

Hormones<br />

See also specific hormone of interest<br />

alteration of lymphocyte subsets and endocrine<br />

response during 80 days of competitive swim<br />

training (A), 1136<br />

effect of repeated freezing and thawinjon<br />

vitamins and hormones in serum (1 B), 2145<br />

effects of hemolysis and storage on quanth. of<br />

hormones in blood samples from animals<br />

(A), 1133<br />

evaln, of chemiluminescent immunoassay for<br />

deth. of serum peptide hormones (A), 1206<br />

sample treatment for long-distance transport<br />

of plasma far hormone assay (TB), 331<br />

HPLC<br />

See Chromatography, liquid; or analyte of<br />

interest<br />

Human Immunodeficiency virus<br />

See RN, Acquired immunodeficiency<br />

syndrome<br />

Hurler’s<br />

syndrome<br />

diagnostic test far mucopohysaccharidosis I.<br />

direct method for quantg. excessive urinary<br />

glycosaminoglycan excretion, 374<br />

Hydatidiform mole<br />

algorithm for testing and reporting serum<br />

choriogonsdotropin at chin, signif. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

Hydroxyapatite<br />

tumoral cahcinosis: seasonal biochem. studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

Hydroxybutyrate<br />

kinetic mess, of ketone bodies (L), 1263<br />

multipoint kinetic simultaneous mess, of<br />

combined cancns, of acetoacetate-fihydroxybutyrate<br />

and lactate-pyruvate (SN),<br />

1526<br />

Hydroxyindoleacetic acid<br />

fluorescence poharn. immunoaasay of urinary<br />

hydraxy-3.indoheacetic acid, 356<br />

5-<br />

urinary 5-hydroxyindoleacetic acid by HPLC<br />

with electrochem. detection (L), 507<br />

2-Hydroxy-1-naphthaldehyde<br />

salicyloylhydrazone<br />

fluorometry of Mg2<br />

1-naphthaldehyde<br />

in serum with 2-hydroxysalicyloylhydrazone,<br />

1492<br />

Hydroxyprogesterone<br />

assessment of screening program for congenital<br />

adrenal hyperplasia in Portugal based on<br />

antibody-coated tube RIA for 17a-OH<br />

progesterone (L), 2338<br />

Hydroxyvitamin D<br />

25-hydroxyvitamin D and 1,25-<br />

dihydroxyvitamin D detd. in serum by<br />

“SPE-octadecyl (C18)” coL extraction and<br />

radioassay (TB), 1995<br />

Hyperamylssemla<br />

diagnostic value of measuring pancreatic lipase<br />

and the P3 isoform of pancreatic amylase<br />

isoenzyme in serum of hospitalized<br />

hyperamyhasemic patients, 417<br />

hyperamylasemia and a.amylase isoenzymes in<br />

acute liver congestion due to cardiac<br />

circulatory failure (TB), 1793<br />

Hypercalcenila<br />

grand round at Sahlgren’s Hospital:<br />

hypercalcemia in a patient with mammary<br />

carcinoma; metastases or primary<br />

hyperparathyroidism? (CC), 1019<br />

Hypercholesterolemia<br />

See also Heart disease, Hyperhipidemia<br />

Hyperlipidemia<br />

apolipoprotein E phenotype detd, by agaroae<br />

gel electrofocusing, immunoblotting, 2070<br />

cholesterol measurement in grossly hipemic<br />

specimens (A), 1072<br />

mess. of apohipoprotein B in plasma from<br />

hyperhipidemic subjects treated with<br />

2384 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


cholestyramine or placebo: differential<br />

effects of storage at -70 0C, 380<br />

simultaneous liq.-chromatog. detn. of vit. K1,<br />

vit. E in serum, 2285<br />

Hypermagnesemia<br />

frequency of hypo- and hypermagnesemia for<br />

each chin, service in four teaching hospitals<br />

(A), 1130<br />

Hyperoxaluria<br />

simple liq.-chromatog.<br />

in plasma, 241<br />

method for vit. B6 cmps.<br />

Hyperparathyroidism<br />

assay of “intact” parathyrin in the immediate<br />

and hong-term postoperative follow-up of<br />

patients treated for hyperparathyroidism or<br />

thyroid tumor (L), 340<br />

effects of estrogen on mineral metab, in<br />

poetmenopauaal women as evald. by multiple<br />

assays measuring parathyrin bioacty.,<br />

grand round at Sahlgren’s Hospital:<br />

18<br />

hypercalcemia in a patient with mammary<br />

carcinoma; metaatases or primary<br />

hyperparathyroidism? (CC), 1019<br />

two-site immunochemiluminometric assay of<br />

intact parathyrin with use of a tracer peptide<br />

purified by reversed-phase lig. chromatog.,<br />

215<br />

Hyperphosphatssemia<br />

benign transient hyperphosphatasemia in an<br />

adult with malignant hymphoma (L), 897<br />

Hyperphosphatemic tumoral calcinosis<br />

tumoral calcinosis: seasonal biochem. studies<br />

and chem, studies of eyelid lesion (CR), 183<br />

Hypertension<br />

anal, of urinary metanephrines of patients<br />

treated with antihypertensive a-methyhdopa<br />

(Aldomet) (A), 1138<br />

Ca metab. in hypertension (A), 1054<br />

endogenous digoxin measured by receptor<br />

assay in normotensive and hypertensive<br />

subjects (A), 1135<br />

increased Ca uptake in vascular tissue by<br />

plasma of salt-induced hypertensive Dahh<br />

rats (A), 1138<br />

role of Mg in etiology of cardiovascular disease<br />

(A), 1055<br />

Hyperthyroidism<br />

elk. phosphatase isoenzymes in plasma in<br />

hyperthyroidism, 1427<br />

increased laminin concns. in serum in<br />

hyperthyroidism (TB), 1540<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

Hypertriglyceridemia<br />

strong assocn, of a single nucleotide<br />

substitution in the 3’-untranslated region of<br />

the apolipoprotain-CIlI gene with common<br />

hypertriglyceridemia in Arabs, 256<br />

Hypnotic agents<br />

simult. liq.-chromatog. detn. of some<br />

bronchodilators, anticonvulaants,<br />

chloramphenicoh, and hypnotic agents, with<br />

Chromosorb P columns used for sample<br />

prepn., 1615<br />

Hypocahcemia<br />

critical anal. and chin. aspects of ionized Cain<br />

neonates (R), 2027<br />

Hypomagnesemia<br />

frequency of hypo- and hypermagnesemia for<br />

each cm. service in four teaching hospitals<br />

(A), 1130<br />

Hypoparathyroidism<br />

effects of estrogen on mineral metab. in<br />

postmenopausal women as evald, by multiple<br />

assays measuring parathyrin bioacty., 18<br />

Hypothalamic-pituitary-adrenal<br />

system<br />

immunoradiometry of corticotropin with use of<br />

avidin-biotin sepn., 804<br />

Hypothermia<br />

serum creatine kinaae in primary hypothermia<br />

(L), 2254<br />

Hypothyroidism<br />

neonatal screening far congenital<br />

hypothyroidism with LKB Delfia neonatal<br />

TSH kit (A), 1152<br />

sources of imprecision in screening for<br />

congenital hypothyroidism: anal. of 9 y of<br />

performance data, 1701<br />

Hypoxanthine<br />

increase of hypoxanthine during cardiac<br />

surgery, as measured by an indirect<br />

automated enzymatic assay (L), 898<br />

Hypoxia<br />

effects of in viva and in vitro production of<br />

lactic acid on ionized, protein-bound, and<br />

complex-bound Ca in blood, 935<br />

Ichthyosis<br />

diagnosis of recessive X-hinked ichthyosis:<br />

quantitative HPLC/mass spect. anal. of<br />

plasma for cholesterol sulfate, 1906<br />

IFCC<br />

standn, of immunochem. detn. of<br />

apolipoproteins A-I and B: report on IFCC<br />

meeting on standn. of apohipoprotein A-I and<br />

B measurements (basis for future<br />

consensus), Vienna, Austria, April 18-19,<br />

1989 (SR), 2009<br />

Ig<br />

See Immunoghobulins<br />

Imipramine<br />

fluoxetine inhibition of imipramine<br />

metabolism (A), 1180<br />

Immobilized metal affinity chromatography<br />

purifn., characterization of intact lactoferrin<br />

found in the urine of human milk-fed<br />

preterm infants, 1928<br />

Immune<br />

complexes<br />

reliable mess. of circulating immune complex<br />

depends on stable, accurate ref. material (L),<br />

1555<br />

Immune response<br />

leukotriene B4 is measurable in serum of<br />

smokers and nonsmokers (SN), 459<br />

Immunoassay<br />

See also Immunoinetric assay, specific type of<br />

assay<br />

calibration problems with the I<br />

immunoasaay for cychosporin A (L), 1551<br />

cyclosporine cancns. in blood after liver<br />

transplantn.: correlation of immunoassay<br />

results with chin, events, 564<br />

diajnosis of infertility:<br />

SpermCheck’”-immunoassey for detection<br />

of anti-sperm antibodies (A), 1140<br />

digoxin anal, using Abbott’s digoxin NXT<br />

system (A), 1164<br />

estrediol-17$ detd, in plasma by gas<br />

chromatog.-mass spectrom. with selected ian<br />

monitoring of mixed silyl<br />

ether-perfluoroacyh ester derivs. and use of<br />

various stable-isotope-labeled internal sods.,<br />

532<br />

eveln. of Affinity’” automated immunoassay<br />

system (A), 1188<br />

evaln, of Becton Dickinson Affinity’”<br />

immunoasaay system (A), 1107<br />

evaln. of matrix effects of hyophilized pools on<br />

apolipopratein B immunoassays (A), 1074<br />

evaln, of the TDx and ADx methadone<br />

immunoassays (TB), 1794<br />

immunoaaaay for estrogen receptor does not<br />

detect inactivated receptor (SN), 824<br />

immunoassays for rubella antibodies (IgG and<br />

1gM) in serum using time-resolved<br />

fluorescence (A), 1153<br />

interferences of human anti-mouse antibodies<br />

in mouse monochonal antibody-based<br />

immunoassays (A), 1188<br />

mechanism of false-negative urine cannabinoid<br />

immunoassay screens by Visine’” eyedrops<br />

(SN), 636<br />

murmnemonoclonal antibody adsorbed onto<br />

vinylidene fluoride floccules used to<br />

eliminate antibody interference in<br />

“sandwich”-type immunoassays<br />

new highly sensitive dye-forming<br />

(SN), 1743<br />

system for<br />

immunostaining (A), 1187<br />

performance evain. of thyroid-function panel<br />

for DuPont Vista’” immunoassay system (A),<br />

1145<br />

rapid detn. of ferritin in serum by the<br />

“Stratus” fluoroenzymoimmunometric assay<br />

(TB), 672<br />

role of rapid immunoasaays for urgent detna. of<br />

creetine kinase isoenzyme MB (SN), 1752<br />

sensitivity of CYCLO-Trac SP (specific<br />

monoclonal immunoasssy for cychosporin A)<br />

(L),900<br />

sequential changes in cross reactivity of antidigoxin<br />

antibodies during immunization (A),<br />

1186<br />

shaking polystyrene beads during coating with<br />

antibody: effect on precision profile of<br />

enzyme immunoassay of triiodothyronine<br />

(L), 701<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoasaays<br />

of carcinoembryonic antigen (SN), 146<br />

Immunoblot technique<br />

apolipoprotein E phenotype detd. by agarose<br />

gel electrofocusing, immunoblatting, 2070<br />

IgG heavy-chain subclass typing of myeloma<br />

paraproteins by isoelectric focusing<br />

immunoblot anal., 364<br />

improved immunoblotting technique far Lp(a)<br />

phenotyping (A), 1070<br />

Immunocatalytic assay<br />

immunocat.ahytic assay of pancreatic a-amyhase<br />

in serum and urine with a specific<br />

monochonal antibody (SN), 662<br />

Immunochemiluminometrlc assay<br />

appin. of Magic Lita<br />

immunochemihuminometric method for<br />

measurement of creatine<br />

spots (A), 1123<br />

kinase-MB in blood<br />

chin, and anal. evaln. of different methods for<br />

mess. of creatine kinase isoenzyme MB (SN),<br />

130<br />

development and validation of<br />

immunochemiluininometric assay for whole<br />

molecule and N-terminal parathyroid<br />

hormone (A), 1147<br />

quantn. of hCG and its a-subunit in the<br />

Amerlite system (A), 1205<br />

solid-phase immunochemiluminometric assay<br />

for human choriogonadotropin<br />

two-site immunochemiluminometric<br />

1147 (A),<br />

assay of<br />

intact parathyrin with use of a tracer peptide<br />

purified by reversed-phase hg. chromatog.,<br />

215<br />

Immunochemistry<br />

See also specific analyte of interest<br />

dissocn, of immunocomptexes by ionic shock<br />

for development of immunosenaors: appln. to<br />

mess, of ai-fetoprotein (SN), 1026<br />

Immunoelectrophoresls<br />

See also specific technique of interest<br />

148 cryoimmunoglobulins characterized by<br />

cryocrit, immunoelectrophoresis, and<br />

immunonephehometry (A), 1083<br />

Immunosnzyniometric assay<br />

See also Enzyme immunoassay<br />

APP quantn. compared using a semiautomated<br />

monoclonal<br />

pohyclonal-monochonal<br />

and a<br />

immunoenzymatic<br />

assay (A), 1200<br />

anal, of serum antibodies to HIV using a<br />

multiple synthetic antigen-coated test strip<br />

(A), 1204<br />

automated assay specific for cychoeporine in<br />

whole blood, with use of a Cr02 particle<br />

column (S), 1860<br />

CK-MM interference with an<br />

immunoenzymometric method for quantn. of<br />

CE-MB in serum (L), 901<br />

evsln. of immunoenzymatic assay for CE-MB<br />

using the Icon format (A), 1121<br />

evahn. of new ELISA procedure for detecting IgG<br />

antibodies to Toxoplasma gondii (A), 1203<br />

evaln, of rapid, automated ELISA method for<br />

prolactin (A), 1188<br />

immunoenzymometric assay for antibody<br />

against human acetylcholine receptor using<br />

precoated microtiter plate and receptor<br />

isolated from normal leg muscle (A), 1196<br />

immunometric assay for digaxin adapted to<br />

Roche Cobas Fara centrifugal analyzer (A),<br />

1166<br />

is electrophoresis a ref. method for CE-MB in<br />

comparison with an immunoenzymametric<br />

method? (L), 900<br />

measurement of creetine kinase MB by the<br />

Baxter Stratus fluoromctric analyzer (A),<br />

1123<br />

pancreatic oncofetal antigen and carbohydrate<br />

antigen 19-9 in sera of patients with<br />

pancreatic cancer, 405<br />

rapid diagnostic testing for simultaneous<br />

detection of acute and remote hepatitis A<br />

infection (A), 1198<br />

rapid, quant. immunaassay for creatine kinase-<br />

MB using Tandem Icon#{149} QSR’” technology<br />

(A), 1197<br />

rapid semiquant. test for hepatitis B surface<br />

antigen using the Icon Reader’” (A), 1198<br />

role of rapid immunoassays far urgent detns. of<br />

creatine kinase isoenzyme MB (SN), 1752<br />

simultaneous mess, of total and IgAconjugated<br />

ai-microglobuhin by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

two-site immunoenzymometric assay of 52.kDa<br />

pro-cathepsin D; use in breast diseases, 234<br />

two-site immunaenzymometry of 52-kDa<br />

cathepsin D in cytosols of breast-cancer<br />

tissues, 81<br />

Immunoflxation<br />

ehectrophoretic<br />

electrophoresis<br />

examin. of proteinurie in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

CLINICALCHEMISTRY,Vol. 35, No. 12, 1989 2385


Immunofluorometric assay<br />

aberrant hectin-binding acty. of<br />

immunoglobuhin G in serum in rheumatoid<br />

arthritis, 1638<br />

direct and indirect immunofluorometry of<br />

thyrotropin<br />

immunoassay<br />

(A), 1206<br />

of neonatal hTSH in paper discs<br />

using time-resolved fluorescence (A), 1139<br />

solid-phase immunofluorometric assay for<br />

human serum ferritin (A), 1189<br />

solid-phase time-resolved immunofluorometric<br />

assay for carcinoembryonic antigen (A), 1077<br />

somatotropin as mess, by a two-site timeresolved<br />

immunofluorometric assay, 913<br />

time-resolved immunofluorometric assay for<br />

measuring human thyroglobulin (A), 1205<br />

time-resolved immunofluorometric assay for<br />

thyroxin-binding globulin in serum (A), 1139<br />

time-resolved immunofluorometric assay of<br />

human pancreatic amylaae in serum (A),<br />

1117<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamylase in serum, with use of<br />

two monoclonal antibodies, 1915<br />

time-resolved immunofluorometry of<br />

folhitropin in serum (TB), 181<br />

(A), 1138<br />

ultra-specific time-resolved<br />

immunofluorometric assay of lutropin in<br />

serum (TB), 2251<br />

use of murine monoclonah antibodies<br />

roup.relatad antigens for<br />

to blood-<br />

immunofluorescent detection of blood<br />

groups on human spermatozoa (A), 1208<br />

Immunoglobuhin-enzyme complexes<br />

high incidence of appearance and/or<br />

disapperance of macro CE type in hosp.<br />

population (A), 1123<br />

IgA-CK-BB complex with CE-MB<br />

electrophoretic mobility can lead to<br />

erroneous diagnosis of acute myocard.<br />

infarct. (CR), 2003<br />

macroenzymes: biochem. characterization, din.<br />

signif., and lab. detection (R), 2261<br />

Immunoghobuhins<br />

aberrant lectin-binding acty. of<br />

immunoghobulin G in serum in rheumatoid<br />

arthritis, 1638<br />

appln. of a silver-binding assay to detn. of<br />

protein in CS? (SN), 860<br />

appln. of three turbidimetric immunoglobuhin<br />

assays, IgG, IgA, and 1gM, to the Express 550<br />

analyzer (A), 1095<br />

assays for immunoglobulins on the Cobas Mire<br />

analyzer (A), 1197<br />

automated enzyme immunoassay for detecting<br />

1gM antibody to hepatitis B core antigen (A),<br />

1193<br />

automated enzyme immunoassay for detecting<br />

1gM antibody to hepatitis A virus (A), 1193<br />

automated nephelometric immunoassay of IgE<br />

with novel shell/core particles (A), 1092<br />

Bence Jones immunoglobulins in the urine in<br />

multiple sclerosis (L), 186<br />

biotin-avidin-based solid-phase enzyme-linked<br />

immunosorbent assay for human serum IgE<br />

(A), 1192<br />

chemiluminescent assay for total serum IgE<br />

(A), 1194<br />

circulating antibodies to mouse monoclonal<br />

immunoglobuhins caused false-positive<br />

results in two-site assay for alphafetoprotain<br />

(L), 2339<br />

comparison of 1gM antigen capture assay with<br />

standard EIA and WA methods for detecting<br />

1gM antibodies to Toxoplasma gondii (A),<br />

1201<br />

evaln. of new ELISA procedure for detecting IgG<br />

antibodies to Toxoplasma gondii (A), 1203<br />

evaln, of radial partition immunoassay for<br />

quantn. of IgE (A), 1199<br />

falsely elevated IgG indices in CSF of<br />

plasmapheresed patients (A), 1158<br />

fructosamine and IgA: no correin. in nondiabetics<br />

(L), 1556<br />

lgG heavy-chain subclass typing of myeloma<br />

paraproteins by isoelectric focusing<br />

immunoblot anal., 364<br />

immunoasaays fo, rubella antibodies (IgG and<br />

1gM) in serum using time-resolved<br />

fluorescence (A), 1153<br />

nonenzymic glycation of human<br />

immunoglobuhins does not impair their<br />

immunoreactivity (A), 1154<br />

oligoclonal immunoglobulin bands in HTLV-lassociated<br />

myelopathy (A), 1085<br />

ohigochonal immunoglobulins in HIV infection,<br />

1669<br />

quantn. of x- and A-containing<br />

immunoglobuhins by rate nephehometry:<br />

comparison of two comm. reagent antisera<br />

(A), 1198<br />

serum proteins, immunoglobulin, and<br />

complement (C3 & C4) levels in Down’s<br />

syndrome in Kuwait sample (A), 1081<br />

three methods for demonstration of oligoclonal<br />

bands of IgG in CSF compared (A), 1085<br />

unusual band on Hb electrophoresia produced<br />

by a monoclonal immunoglobuhin in serum<br />

(TB), 1794<br />

WHO/RPSP standardization of Beckman<br />

Synchron CX’”5 and correlation of Igs and<br />

transferrin to Beckman Array’” protein<br />

system (A), 1106<br />

Immunoinhibition<br />

chin, and anal. evahn. of different methods for<br />

mess, of creatine kinase isoenzyme MB (SN),<br />

130<br />

development of theophylhine assay for Abbott<br />

EPx’” system (A), 1170<br />

interference of macro-creatine kinase in detn.<br />

of CK-MB in serum with the Kodak<br />

Ektachem (L), 2155<br />

Immunology<br />

decreased immunoreacty. and binding acty. of<br />

corticosteroid-binding globulin in serum in<br />

septic shock, 1675<br />

Immunometric assay<br />

how sensitive are immunometric assays for<br />

thyrotropin?, 289<br />

more on “hook effects” in immunometric<br />

assays for prostate-specific antigen (L), 1262<br />

(L), 2154<br />

quantn. of choriogonadotropin: differential<br />

cross-reactivities of free hCG 9-subunit with<br />

assays<br />

eight different monoclonal<br />

hCG and (hCG +<br />

antibody-based<br />

fi)“sandwich”-type<br />

(TB). 1791<br />

Stratus automated creatine kinase-MB assay<br />

evald.: identn. and elimn. of falsely increased<br />

results assocd. with a high-M, form of alk.<br />

phosphatase, 2048<br />

Immunonephelometry<br />

chin. apphns. for quant. ic and A light chain<br />

detna. (A), 1084<br />

comparative measurements of apohipoprotein<br />

B by immunonephehometry and radial<br />

immunodiffusion (A), 1069<br />

148 cryoimmunoglobulins characterized by<br />

cryocrit, immunoelectrophoresis, and<br />

immunonephehometry (A), 1083<br />

effect of glycation of how-density hipoprotain on<br />

immunolog. detn. of apolipoprotein B (SN),<br />

2219<br />

hmmunopreclpliation assay<br />

pancreatic amyhase mess, in serum by use of a<br />

monoclonal antibody immunochem.<br />

immobilized to a solid phase, 110<br />

Immunoradiometric assay<br />

assay for human choriogonadotropin using<br />

ligand and anti-ligand system (A), 1093<br />

assay for human foilitropin using higand and<br />

anti-higand system (A), 1190<br />

assay for human hutropin using ligand and antihigand<br />

system (A), 1093<br />

chin, and anal. evaln. of different methods for<br />

mess. of creatine kinsse isoenzyme MB (SN),<br />

130<br />

comparison of ref. standard and standard curve<br />

data-reduction methods for NMI low-end<br />

sensitive TSH IRMA (A), 1187<br />

counting errors: effect on immunoassay<br />

precision, 1362<br />

critical evaln. of an immunoradiometric assay<br />

of sex-hormone binding globulin (TB), 2146<br />

development and vahidn, of a two-site<br />

immunoradiometric assay for atrial<br />

natriuretic factor in unextracted plasma, 953<br />

development of solid-phase FSH IRMA (A).<br />

1201<br />

discordant hCG measurements in a patient<br />

with carcinoma (TB), 1259<br />

evaln. of high sensitivity corticotropin<br />

immunoradiometric assay (A), 1146<br />

highly sensitive assays of autoantibodies to<br />

thyroghobuhin, thyroid peroxidase, 1949<br />

high-sensitivity assay for human thyrotropin<br />

using ligand and anti-ligand system (A), 1093<br />

immunoradiometry of a-y- and -enoIase<br />

(neuron-specific enohase), with use of<br />

monochonal antibodies and magnetizable<br />

polymer particles, 2034<br />

immunoradiometry of carcinoembryonic<br />

antigen with use of avidin-biotin labeling,<br />

573<br />

immunoradiometry of corticotropin with use of<br />

avidin-biotin sepn., 804<br />

influence of matrix on cancns. of somatotropin<br />

mess. in serum with commercial<br />

immunoradiometric assays, 1423<br />

IRMA for serum type III procoilagen peptide<br />

using monochonal antibodies (A), 1188<br />

labeled-antibody assay for free T4 (A), 1148<br />

new immunoradiometric assay for<br />

corticotropin evald. in normal subjects and<br />

patients with Cushing’s syndrome, 596<br />

novel inimunoradiometric assay of<br />

thyroghobulin in serum with monochonal<br />

antibodies selected for lack of crossreactivity<br />

with autoantibodies, 422<br />

pancreatic oncofetal antigen and carbohydrate<br />

antigen 19-9 in sera of patients with<br />

pancreatic cancer, 405<br />

performance, diagnostic apphn. of a two-site<br />

immunoradiometric assay for parathyrin in<br />

serum (SN), 1957<br />

simultaneous mess, of total and IgAconjugated<br />

a1-microghobulin by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

somatotropin as mess, by a two-site timeresolved<br />

immunofluorometric assay, 913<br />

two-site IRMA for detn. of urinary<br />

cytokeratin-18; apphicn. to management of<br />

bladder cancer (A), 1198<br />

Immunosensors<br />

dissocn. of immunocomplexes by ionic shock<br />

for development of immunoeensors: apphn. to<br />

mess, of aj-fetoprotam (SN), 1026<br />

Immunosuppressive drugs<br />

adv. in cyclosporine pharmacol., measurement,<br />

and ther. monitoring (S), 1299<br />

continuing need for qual. assessment of<br />

cyclosporine measurement (S), 1309<br />

distribn. of cyclosporin A metabohites among<br />

plasma and cells in whole blood: effect of<br />

tamp., hematocrit, and metabohite concn,, 59<br />

Immunoturbidiinetry<br />

adaptation of serum apolipoproteins A-I and B<br />

immunoturbidimetric assays on the I-hitachi<br />

737 Autoanahyzer (A), 1069<br />

assays for immunoghobulins on the Cobas Mire<br />

analyzer (A), 1197<br />

evaln, of assays for apolipoprotein A-I and B<br />

on TurhiTimer (A), 1072<br />

evaln, of the Tina-quant immunoturbidimetric<br />

method for C-reactive protein on the Hitachi<br />

705 (A), 1081<br />

four immunochem, methods compared for<br />

mess, C-reactive protein in plasma (SN), 461<br />

immunoturbidimetric detn. of apolipoprotein<br />

A-I and Ban Hitachi analyzers (A), 1067<br />

immunoturbidimetric technique for detn, of<br />

serum 2-microglobulin (A), 1189<br />

immunoturbidimetry of 2-microghobulin in<br />

serum (TB), 1996<br />

immunoturbidimetry of prealbumin<br />

(transthyretin) in a microcentrifugal<br />

analyzer (TB), 178<br />

immunoturbidimetry of serum protens with<br />

the Behring “Turbitimer” (TB), 2144<br />

influence of end-stage renal failure on concns.<br />

of free apohipoprotein A-i in serum, 963<br />

Inborn errors of metabolism<br />

See Heritable disorders<br />

hndoleamines<br />

fluorescence polarn. immunoassay of urinary 5-<br />

hydroxy-3-indoleacetic acid, 355<br />

Indohes<br />

indole compounds do not cause false positives<br />

with the TDx cannabinoid assay (TB), 323<br />

melanin and other indole compds. do not cause<br />

false-positive cannabinoid assay results (L),<br />

1809<br />

Indomethacin<br />

liquid-chromatog. method for indomethacin<br />

and other inflammatory drugs (A), 1164<br />

Infants<br />

See Newborns, Neonates<br />

Infection<br />

alterations in lactate dehydrogenase isoenzyme<br />

patterns after therapy with streptokinase or<br />

streptococcal infection (SN), 1763<br />

appln. of a rapid non-radiaisotopic nucleic acid<br />

anal, system to the detection of sexually<br />

transmitted disease-causing organisms and<br />

asaocd. antimicrobial resistances (5), 1571<br />

comparison of 1gM antigen capture assay with<br />

standard EIA and IFA methods for detecting<br />

2386 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


1gM antibodies to Toxoplasma gondii (A),<br />

1201<br />

delta and conjugated bilirubins as predictors<br />

early liver allograft rejection are unaffected<br />

of<br />

by cytomegalovirus infection (A), 1137<br />

detection of hepatitis B infection in a randomly<br />

selected pediatric hospital population using<br />

an automated enzyme immunoassay far<br />

HBsAg (A), 1152<br />

evaln. of new EUSA procedure for detecting IgG<br />

antibodies to Toxoplasma gondii (A), 1203<br />

implications of probability anaL for<br />

interpreting results of leukocyte esterase and<br />

nitrite test stipe, 1663<br />

neopterin as a predictive marker for disease<br />

progression in human immunodeficiency<br />

virus type 1 infection (SN), 1746<br />

oligoclonal immunoghobulin bands in HTLV-Iassociated<br />

myelopathy (A), 1085<br />

simultaneous detn. of serum neopterin and C-<br />

reactive protein as markers of infection in<br />

heart-transplant recipients (TB), 1258<br />

Infertility<br />

See also Fertility studies<br />

diagnosis of infertilit1r<br />

SpermCheck”-immunoassay far detection<br />

of anti-sperm antibodies (A), 1140<br />

hormonal evaln. of female infertility,<br />

reproductive disorders (CC), 620<br />

lab, assays in infertility diagnosis (A), 1062<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

Inflammation<br />

changes in concanavalin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

leukotriene 84 is measurable in serum of<br />

smokers and nonsmokers (SN), 459<br />

meas. of urinary leukotrienes by reversedphase<br />

hiq. chromatog. and RIA, 388<br />

Information for authors<br />

information for authors (E), 1<br />

Infrared spectroecopy<br />

enzymatic detn. of total cholesterol in<br />

gallstones (SN), 2247<br />

use of GC/IR/MS for high-confidence identifn.<br />

of drugs(S), 1279<br />

Inherited anomalies<br />

See Heritable disorders<br />

$-Inhlbin<br />

RIA of -microeeminoprotein, a prostaticsecreted<br />

protein in sara of men and women,<br />

1497<br />

Instrumentation<br />

See also Discrete analysis, Continuous-flaw<br />

analysis, etc.<br />

chin. chem, analyzer evald. by NCCLS<br />

guidelines for use ins military field lab, unit<br />

(SN), 2223<br />

evaln. of Boehringer Mannheim/Hitachi 717<br />

analyzer (A), 1096<br />

evahn. of Corning 288 analyzer (A), 1131<br />

evaln. of improved Technicon Chem 1 system<br />

(A), 1089<br />

evaln. of performance of DCL reagents on<br />

Hitachi 704 analyzer (A), 1110<br />

evaln, of the Olympus PK31O automated<br />

enzyme immunoassay system (TB), 1995<br />

multicenter evaln. of the Boehringer<br />

MannheimfHitachi 717 analysis system<br />

(TB), 1260<br />

multi-factor designs. II. design for identifying<br />

instrumente with sample-to-sample<br />

carryover and drift (SN), 2118<br />

Olympus AU 5000-alternative reagents (A),<br />

1110<br />

performance of pre-production model of<br />

Technicon’s DPA-1 analyzer for automated<br />

quantn. of IgG, IgA, 1gM, C3, C4, and<br />

apolipoproteina A and B (A), 1112<br />

recent advances in instrumentation for use in<br />

physicians’ offices and public health<br />

screening programs (A), 1232<br />

serum, plasma compared for use in 19 common<br />

chem. tests performed in the Hitachi 737<br />

analyzer (L), 1562<br />

two whole-blood multi-analyte analyzers evald.<br />

(SN), 1532<br />

Insulin<br />

evaln. of RIA kit far detn. of free insulin:<br />

effects of sample handling and storage (A),<br />

1144<br />

improved RIA of C-peptide<br />

muhtiyearstudy, 37<br />

and its appln. in a<br />

simple method for free insulin<br />

1146<br />

Interference<br />

See Analytical error; Variation, source of<br />

by a RIA kit (A),<br />

“Interferographs”<br />

re-evaln. of Reftotron, to characterize influence<br />

of drugs, hemolysate, lipemla, and bilirubin<br />

on results (A), 1160<br />

Interinstrument comparison<br />

accuracy, precision, and chin, reliability of three<br />

capillary blood glucose monitors (A), 1135<br />

interinstrument comparison in p02 between<br />

tonometered whole blood and<br />

perfluorocarbon (A), 1131<br />

Interlaboratory<br />

continuing<br />

performance<br />

need for qual. assessment of<br />

cyclosporine measurement (5), 1309<br />

development and evaln, of quality-assurance<br />

program based on interlab. comparison (A),<br />

1160<br />

interhospital lab. comparison of total and highdensity<br />

lipoprotein cholesterol assays (A),<br />

1075<br />

sources of imprecision in screening for<br />

congenital hypothyroidism: anal. of 9 y of<br />

performance data, 1701<br />

utilization of NatL Ref. System far Chin. Labs.-<br />

recommended methods for six anshytes (A),<br />

1104<br />

Wisconsin cholesterol study-assessment of<br />

lab. performance (A), 1068<br />

Interleukin<br />

enzyme immunoassay measurement of serum<br />

interheukin-2 receptor in heart-transplanted<br />

patients (A), 1155<br />

Intermethod comparison<br />

APP quantn. compared using a semiautomated<br />

monoclonal and a<br />

polyclonal-monoclonal immunoenzymatic<br />

assay (A), 1200<br />

anal. of cocaine metabolites in urine:<br />

comparison of TDx FPIA cocaine metabohite<br />

assay with GC/MS (A), 1186<br />

appraisal of twa rapid automated<br />

“supersensitive” TSH immunoessays (A),<br />

1151<br />

aspects of method comparison study that need<br />

more attention (A), 1110<br />

cardiac isoenzyme (CE-MM isoform) assays for<br />

early detection of acute myocardial<br />

infarction: comparison of immunometric and<br />

electrophoretic systems (A), 1117<br />

chin, comparison of Helena REP vs Kodak<br />

Ektachem creatine kinase MB slide in<br />

patients with suspected acute myocardial<br />

infarction (A), 1125<br />

din. evaln, of four “high-sensitivity” assays for<br />

thyratropin (A), 1145<br />

comparative measurements of apolipoprotein<br />

B by immunonephehometry and radml<br />

immunodiffusion (A), 1069<br />

comparison of agaroee gel electrophoresis<br />

immunoassay (Abbott A-GENT) for<br />

and<br />

measurement of lactate dehydrogenase<br />

isoenzyme-1 (A), 1124<br />

comparison of assay methods for a new<br />

strategy for cyclosporine monitoring (A),<br />

1186<br />

comparison of Centocor CA 19-9, Tandem-R<br />

CA 195, and Truqusnt GI (A), 1078<br />

comparison of cyclosporine immunoassay<br />

methods: examination of rejection and<br />

nephrotoxic episodes in liver transplantation<br />

(A), 1183<br />

comparison of four methods for measurement<br />

of cyclosporin (A), 1186<br />

comparison of HPLC and radioenzymatic assay<br />

for plasma catecholamines (A), 1100<br />

comparison of 1gM antigen capture assay with<br />

standard EIA and IFA methods for detecting<br />

1gM antibodies to Toxoplasma gondii (A),<br />

1201<br />

comparison of hutropin immunoreactivity in<br />

serum by RIA and time-resolved<br />

fluorescence findings in serum from normal<br />

children and those treated with LHRH<br />

analogs (A), 1150<br />

comparison of new Hybritech TSH EIA with<br />

two other high sensitivity TSH assays (A),<br />

1147<br />

comparison of Stratus and Roche methods for<br />

CE-MB detn, (A), 1124<br />

comparison of Technicon Chem-1 HDL<br />

cholesterol method with pptn. and<br />

ultracentrifugation methods (A), 1066<br />

comparison of test results of Hitachi 704 and<br />

American Monitor Perspective analyzers (A),<br />

1110<br />

comparison of tests used to assess fetal<br />

maturity (A), 1069<br />

diagnostic performances of CE-MB assays by<br />

DuPont and by Ciba-Corningcompared (A),<br />

1122<br />

differing results for carbamazepine between<br />

aca and TDx (A), 1182<br />

evaln. of immunochem. methods for detg. how<br />

concns. of albumin in urine (A), 1209<br />

evaln, of six direct l7-estradioh RIA kits and<br />

comparison with an in-house extn. EtA (A),<br />

1150<br />

evaln, of Syva ETS and Abbott AD1 urine drug<br />

screening immunoassay analyzers (A), 1176<br />

evaln. of three serum thyrotropin assays ins<br />

chin. outpatient population without other<br />

serious mess (A), 1147<br />

evaln. of total and direct bilirubin assays on<br />

the Beckman Astra and Synchron CX5 and<br />

Kodak Ektachem systems in comparison<br />

with HPLC bilirubin measurements (A),<br />

1095<br />

evaln. of unsaturated Fe-binding capacity on<br />

the Technicon Chem’l’” (A), 1091<br />

flecainide: comparison of fluorescence<br />

polarization with HPLC (A), 1097<br />

four assays for creatine kinase MB compared<br />

(A), 1124<br />

four nonisotopic immunoassays of free<br />

thyroxin evahd. (SN), 115<br />

four sensitive thyrotropin assays compared (A),<br />

1145<br />

immunochemical vs electrophoretic CE-MB<br />

detns. in early detection of acute myocsrdiah<br />

infarction (A), 1125<br />

mess, of cychosporine concns. in whole blood:<br />

HPLC and RIA with a specific monochonal<br />

antibody and 3H- or issllabeled ligand<br />

compared (SN), 120<br />

method comparison for C-reactive protein<br />

comparing the Array protein system from<br />

Beckman to the Behring BNA (A), 1085<br />

method-dependent correlation of major<br />

thyroxin-binding proteins with serum F?4 in<br />

patients with nonthyroidal illness (A), 1143<br />

performance evaln. of Corning 288 and Nova<br />

Stat Profile 1 blood gas systems (A), 1093<br />

qual. assurance of cyclosporine measurements:<br />

comparison of current methods (A), 1236<br />

relative operating characteristic curves used to<br />

compare drug screening immunoassays for<br />

amphetamine and methamphetamine (A),<br />

1175<br />

renal function assessed by serum creatinine<br />

and creatinine clearance: ghomeruhar<br />

filtration rate estd. by four procedures (SN),<br />

2326<br />

three methods for demonstration of ohigochonal<br />

bands of IG in CSF compared (A), 1085<br />

total bilirubm bias: is accuracy more important<br />

than consistency? (A), 1128<br />

whole-blood cychoeporin A. comparison of<br />

monoclonal antibody RIA with HPLC (A),<br />

1100<br />

International Federation of <strong>Clinical</strong><br />

<strong>Chemistry</strong><br />

See tFCC<br />

Intra-individual variation<br />

intra-individual variability of blood Mg<br />

parameters with time (A), 1114<br />

intra-individual variation of electrophoretic<br />

serum protein fractions (TB), 1544<br />

Intralaboratory performance<br />

sources of imprecision in screening far<br />

congenital hypothyroidism: anaL of 9 y of<br />

performance data, 1701<br />

Inulin<br />

assessment of renal function by inulin<br />

clearance: comparison with creatinine<br />

clearance as detd, enzymatically (SN), 312<br />

Iodine<br />

moderate I deficiency, possible explanation for<br />

inverse relation between cord serum<br />

thyrotropin and birth weight in a normal<br />

Kenyan popn. (L), 710<br />

Ion-selective electrodes<br />

effect of Br on ion-specific electrodes in the<br />

Hitachi 736(A), 1161<br />

effects on ionized Ca by different heparin<br />

preparations measured in ICA 2 analyzer<br />

(A), 1128<br />

enzymatic detn, of K in serum, 817<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns. (CR), 333<br />

new method for detg. bound and ionized Cain<br />

serum (TB), 491<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2387


performance characteristics of Na, K, and Cl in<br />

urine on the Paramax analytical system#{149} (A),<br />

1131<br />

role of new whole-blood anal, techniques in<br />

critical care (A), 1232<br />

simultaneous detn, of urea, glucose, Na, K, Cl,<br />

and total CO2 in undiluted human serum<br />

using an electrode-based automated analyzer<br />

(A), 1091<br />

use of enzyme electrodes in whole-blood<br />

measurements (A), 1233<br />

Ion transport<br />

defective epithelial ion transport in cystic<br />

fibrosis (S), 726<br />

Iron<br />

anal. performance of Kodak Ektachem chin.<br />

chem. slides (Fe) (A), 1101<br />

changes in Fe, Zn, Cu concns. in serum and in<br />

their binding to transport proteins after<br />

cholecystectomy, cardiac surgery (SN), 2243<br />

Fe detn. using CIBA Corning 550 Express<br />

analyzer (A), 1113<br />

investigation of protoporphyrin IX sod.<br />

materials used in acid-extn. methods;<br />

proposed correction for the millimohar<br />

absorptivity of protoporphyrin IX, 1601<br />

nath. ref. system for serum Fe: evaln, and use of<br />

proposed guidelines for detn. of serum Fe<br />

compared with a method in daily service (A),<br />

1113<br />

performance of the KOdak iron and total ironbinding<br />

capacity methods (TB), 2250<br />

pretreatment of sara before coulometric anal.<br />

maximizes recovery for serum Fe and TIBC<br />

(A), 1131<br />

Zn protoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Iron-binding capacity<br />

evaln, of unsaturated Fe-binding capacity on<br />

the Technicon Chemhln (A), 1091<br />

performance of the Kodak iron and total ironbinding<br />

capacity methods (TB), 2250<br />

pretreatment of sara before coulometric anal.<br />

maximizes recovery for serum Fe and TIBC<br />

(A), 1131<br />

Ischemia<br />

free radical ablation for organ preservation (A),<br />

1051<br />

Isoamylase<br />

pancreatic amylase meas. in serum by use of a<br />

monoclonal antibody immunochem.<br />

immobilized toe solid phase, 110<br />

P3 isoamylase accompanying renal<br />

insufficiency (L), 187<br />

ISO-DALT<br />

See Electrophoresis, two-dimensional<br />

Isoelectric focusing<br />

See also Electrophoresis, two-dimensional<br />

anal, of a-amylase isoenzymes by automated<br />

isoehectric focusing (SN), 2116<br />

chromatofocusing and isoelectric focusing in<br />

immobilized pH gradients compared for<br />

characterization of Hb variants, 425<br />

complement C4 allotypes and psoriasis (TB),<br />

2142<br />

creatine kinase isoforms in ischemic heart<br />

disease<br />

detecting<br />

(R), 7<br />

serum acidic range ghycaproteins<br />

using isoehectric focusing on cellulose acetate<br />

mambranea (A), 1083<br />

IgG heavy-chain subclass typing of myelama<br />

paraprateins by isoehectric focusing<br />

immunoblot anal., 364<br />

ohigochonal immunoglobuhins in HIV infection,<br />

1669<br />

Isoenzymes<br />

See also enzyme of interest<br />

agarose gel ehectrophoresis, and a chaotropic<br />

method compared for lactate dehydrogenase<br />

isoenzyme-1 (TB), 2250<br />

alk. phosphatase isoenzyme mystery (L), 707<br />

alk. phoaphatase isoenzymes in plasma in<br />

hyperthyroidism, 1427<br />

elk. phoephatase isoenzymes of liver and bone<br />

origin are incompletely resolved by wheatgerm-lectin<br />

affinity chromatog., 29<br />

alterations in lactate dehydrogenase isoenzyme<br />

patterns after therapy with streptokinase or<br />

streptococcal infection (SN), 1763<br />

a-amylsse detn. with the Reflotron reagent<br />

carrier system: use of whole blood, plasma,<br />

and serum, and effect of isoenzymes (SN),<br />

317<br />

anal, of a-amyhase isoenzymes by automated<br />

isoelectric focusing (SN), 2116<br />

appln. of Magic Lite<br />

immunochemiluminometric method far<br />

measurement of creatine kinase-MB in blood<br />

spots (A), 1123<br />

bihiary alk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-celluhoee:<br />

appln. to detection of hepatobihiary diseases,<br />

1684<br />

cardiac isoenzyme (CK-MM isoform) assays for<br />

early detection of acute myocardial<br />

infarction: comparison of immunometric and<br />

ehectrophoretic systems (A), 1117<br />

changes in isoform patterns and stability of<br />

CK-MB during storage (A), 1120<br />

CE-MM interference with an<br />

immunoenzymometric method for quantn. of<br />

CE-MB in serum (L), 901<br />

CE-unrelated serum component identified in<br />

CK isoenzyme anal, using Helena Rep<br />

system (A), 1117<br />

cliii. and anal. evaln, of different methods for<br />

meas. of creatine kinase isoenzyme MB (SN),<br />

130<br />

cm, comparison of Helena REP vs Kodak<br />

Ektachem creatine kunase MB slide in<br />

patients with suspected acute myocardial<br />

mfarction (A), 1125<br />

comparison of agarose gel electraphoresis and<br />

immunoassay (Abbott A-GENT) for<br />

measurement of lactate dehydrogenase<br />

isoenzyme-1 (A), 1124<br />

comparison of automated vs manual<br />

electrophoresis system for creatine kinase<br />

isoenzymes (A), 1106<br />

comparison of KOdak CE-MB assay with CE<br />

isoenzyme electrophoresis (A), 1123<br />

comparison of Stratus and Roche methods for<br />

CK-MB detn, (A), 1124<br />

concordance of creatine kinase-MB acty. and<br />

mass, 440<br />

conflicting results of hiq.-chromatog. detns. of<br />

alk, phoephatase isoenzymes (L), 2255<br />

creatine kunase and lactate dehydrogenase<br />

isoenzymes in serum and tissues of patients<br />

with stomach adenocarcinoma, 1385<br />

creatine kinase and lactate dehydrogenase<br />

isoenzyme utilization: cut-off values for<br />

fractionation based on total CK activity, and<br />

monitoring of ordering patterns in 334<br />

intensive-care-unit patients (A), 1122<br />

creatine kunase isoforms in ischemic heart<br />

disease (R), 7<br />

creatine kinase MB isoenzyme in<br />

rhabdamyosarcoma (L), 896<br />

detection of serum CE-MB isoforms by RIA<br />

(A), 1121<br />

diagnosis of acute myocardial infarction from<br />

two measurements of creatine kunase<br />

isoenzyme MB with use of nonparametric<br />

probability estn., 444<br />

diagnosis of acute myocardial infarct, when<br />

skel, muscle damage is present: a caveat<br />

regarding use of creatine kinase isoenzymes<br />

(L), 705<br />

diagnostic performances of CK-MB assays by<br />

Du Pont and by Ciba-Corning compared (A),<br />

1122<br />

diagnostic value of measuring pancreatic hipase<br />

and the P3 isoform of pancreatic amylase<br />

isoenzyme in serum of hospitalized<br />

hyperamylasemic patients, 417<br />

ECG evidence of myocardial infarction without<br />

cardiac isoenzymes abnormalities (A), 1116<br />

effect of forced diuresis on urinary excretion of<br />

pancreatic amyhase (A), 112’7<br />

effect of therapeutic coronary reperfusion on<br />

serum aspartate aminotransferase<br />

isoenzymes in patients with acute<br />

myocardial infarction (A), 1116<br />

effects of therapeutic coronary reperfusion on<br />

aspartate aminotransferase isoenzymes in<br />

sara of patients with acute myocardial<br />

infarct,, 909<br />

elevated CE-MB ins patient with pelvic<br />

sarcoma (A), 1124<br />

EMDS test pack CK-MB immunoassay:<br />

immunoinhibition with anti-CE-M antibody<br />

(A), 1115<br />

estn, of brain lesion size based on quantifying<br />

CE-BB in serum (L), 2018<br />

evahn. of a photometric assay far detn. of<br />

human bone elk. phosphatase (A), 1089<br />

evaln. of automated CE-MB mass assay (A),<br />

1107<br />

evaln, of Dade Stratus for detn, of CK-MB (A),<br />

1090<br />

evahn. of immunoenzymatic assay for CE-MB<br />

using the Icon format (A), 1121<br />

evolution of serum CK-MB isoforms after<br />

acute myocardial infarction (A), 1120<br />

four assays for creatine kinase MB compared<br />

(A), 1124<br />

hered. complete deficiency of lactate<br />

dehydrogenase H-subunit (CR), 687<br />

heterogeneity of serum creatine kinase<br />

isoenzyme MM in myocardial infarction:<br />

chin, significance and poet-synthetic<br />

conversion of “abnormal” sub-bands, 206<br />

high-M, (“biliary”) isoenzyme of alk.<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

hypereanylasemia and a-amylase isoenzymes in<br />

acute liver congestion due to cardiac<br />

circulatory failure (TB), 1793<br />

immunoaffinity<br />

from human,<br />

purifn. of creatune kunase-MB<br />

dog, and rabbit heart with use<br />

of monoclonal antibody specific for CE-MB,<br />

985<br />

immunoassay of band 5 (“tartrate-resistant”)<br />

acid phosphatase involving use of antiporcine<br />

uteroferrin antibodies, 86<br />

immunochemical vs electrophoretic CE-MB<br />

detns, in early detection of acute myocardial<br />

infarction (A), 1125<br />

is electraphoresis a ref. method for CK-MB in<br />

comparison with an immunoenzymometric<br />

method? (L), 900<br />

isoenzymes and isoforms of CE: what is the<br />

score? (E), 201<br />

lactate dehydrogenase and its isoenzymes in<br />

serum in multiple myehoma (SN), 1968<br />

lactate dehydrogenase-1 assay using an M-<br />

subunit-specific, immobilized monoclonal<br />

antibody (A), 1121<br />

lactate dehydrogenase isoenzyme compn. of<br />

platelets (SN), 2325<br />

lactate dehydrogenase isoenzyme 1:<br />

development of automated chem, method<br />

(A), 1119<br />

lactate dehydrogenase isoenzyme pattern in<br />

sara in malignant diseases, 396<br />

lactate dehydrogenase isoenzyme patterns in<br />

serum in metastetic liver disease (SN), 871<br />

measurement of creatine kinase MB by the<br />

Baxter Stratus fluorometric analyzer (A),<br />

1123<br />

measurement of lactate dehydrogenase using<br />

purified human placental LD isoenzyme-5<br />

(A), 1116<br />

measuring crestine kinase MB isoenzyme in a<br />

maintenance hemodialysis popn.:<br />

chemiluminometric immunoassay and<br />

ehectrophoresis compared (SN), 1965<br />

methodol. and din, multicenter evaln. of<br />

specific pancreatic a-amylase assay based on<br />

a double monochonal antibody technique (A),<br />

1090<br />

methods compared for detg. total acty. and<br />

isoenzymes of axnylase in serum (SN), 645<br />

more on methods for CK-MB (L), 899<br />

pancreatic isoamyhase: direct assay based on<br />

efficient capture by a monochonal antibody<br />

(A), 1123<br />

partial charectern. of an abnormal lactate<br />

dehydrogenase isoenzyme, LDH-lex, in<br />

serum from a patient with hepatocellular<br />

carcinoma (SN), 844<br />

patterns of lactate dehydrogenase isoenzymes 1<br />

and 2 in serum on exercise (SN), 301<br />

platelet LDH isoenzymes (A), 1134<br />

purified hyophihized lactate dehydragenase<br />

isoenzyme 5 used in a study of measuring<br />

LDH acty. (SN), 1774<br />

rapid purifn. of creatine kunaseMB isaenzyme<br />

on preparative pohyacryhamide slabs, 96<br />

rapid, quant. inimunoassay for creatine kinase-<br />

MB using Tandem Icon QSR technology<br />

(A), 1197<br />

rap!d,specific method for CE-MB using<br />

Tandem Icon OSR CK-MB reagents (A),<br />

1120<br />

reproducibility of creatine kinase isoenzyme<br />

electrophoresis (L), 710<br />

role of rapid immunoassays for urgent detns. of<br />

creatine kinase isoenzyme MB (SN), 1752<br />

S-lOOa,, protein in blood and urine during<br />

open-heart surgery, 1942<br />

scheme for detecting elevated CE-MB in<br />

children (A), 1109<br />

sensitive, rapid assay of subforms of creatine<br />

kinase MB in plasma, 1452<br />

serum creatine kinase isoenzyme BB: poor<br />

index to size of various brain lesions (SN),<br />

651<br />

2388 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


serum P-amyhase detn. using monochonal<br />

antibody (A), 1127<br />

sialidase from different sources compared for<br />

electrophoretically sepg. serum alk.<br />

phosphatase fractions from liver and bone<br />

(SN), 1955<br />

single-vial screening assay for creatine kinase-<br />

MB (A), 1122<br />

staining method for use in ehectrophoretic<br />

detn. of amyhase isoenzymes in serum (SN),<br />

2322<br />

standn. of nomenclature in chin. chem. (L),<br />

1552<br />

statis, intarpretn. of concns. of Mg, Zn, Ca, K,<br />

cholesterols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

Stratus automated creatine kinase-MB assay<br />

evald,: identn, and ehimn. of falsely increased<br />

results assocd. with a high-M, form of alk,<br />

phosphatase, 2048<br />

time-resolved immunofluorometric assay of<br />

human pancreatic amylase in serum (A),<br />

1117<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamylase in serum, with use of<br />

two monoclonal antibodies, 1915<br />

use of creatine kinase MB isoforms for<br />

predicting myocardial reperfusion (A), 1125<br />

variability in serum lactate dehydrogenase<br />

acty. and isoenzyme patterns induced by<br />

streptokinase (A), 1119<br />

variation in decision thresholds for CK and<br />

CK-2 in myocardial infarction (A), 1116<br />

Jaff#{233} reaction<br />

See Creatinine<br />

Ketoconazole<br />

cyclosporine pharmacokinetics with<br />

concomitant<br />

Ketoisocaproic<br />

ketoconazole<br />

acid<br />

therapy (A), 1176<br />

etabn. of a-ketoisocaproic acid in serum and<br />

plasma (TB), 495<br />

Ketone bodies<br />

kinetic mess. of ketone bodies (L), 1263<br />

Kidney disease<br />

See also Renal disease, Renal function<br />

biol, variation of urinary N-acetyh--Dghucosaminidase:<br />

practical and chin,<br />

implications, 560<br />

circadian variations and ref. intervals for same<br />

enzymes in urine of healthy children (SN),<br />

864<br />

electrophoretic examin, of proteinuria in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

high-yield purifn. of the complex-farming<br />

glycoprotein in urine, 577<br />

interference with meas. of intact parathyrin in<br />

serum from renal dialysis patients (TB),<br />

1543<br />

Lp(a) lipoprotein concn, in serum of patients<br />

with heavy protainuria of different origin<br />

(SN), 2121<br />

mapping the locus of autosomal dominant<br />

polycystic kidney disease: diagnostic appln.<br />

(S),B13<br />

i-microghobulun and immune activation (L),<br />

2158<br />

new technique for measuring free thyroxin in<br />

serum: multi-center study (SN), 2137<br />

P3 isoamyhase accompanying renal<br />

insufficiency (L), 187<br />

rhabdomyolysis in a case of free-base cocaine<br />

(“crack”) overdose (CR), 1547<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

urine protein 1: sex-dependent marker of<br />

tubular or glomerular dysfunction (TB),<br />

2141<br />

(Wake Forest University Case Conference):<br />

myoglobinuria, hemoglobinuria, acute renal<br />

failure (CC), 1713<br />

Kinetic analysis<br />

concn. of free thyroxin in serum during<br />

nonthyroidal ihhness-calcn. or mess,? (SN),<br />

159<br />

performance of kinetic BUN assay on<br />

BM/Hitachi 717’ (A), 1098<br />

Kinetic assays<br />

enzymatic detn. of K in serum, 817<br />

kinetic detn, of serum biotinidase using a<br />

unique chromogenic substrata (A), 1151<br />

kinetic study of the ,Jaff#{233} reaction for<br />

creatinine in serum: 2. evaln, of buffered<br />

reagent and comparison of different dataprocessing<br />

options, 360<br />

muhtipoint kinetic simultaneous mess. of<br />

combined concns. of acetoacetate--<br />

hydroxybutyrate and hactate-pyruvate (SN),<br />

1526<br />

nonenzymatic stopped-flow fluorimetry for<br />

direct detn, of uric acid in serum and urine,<br />

230<br />

Kinetic enzyme assay<br />

alk. phosphatase acty. from ostaosarcoma cell<br />

line SaOS-2: iaoenzyme sod, for quantifying<br />

skeletal elk. phosphatase acty. in serum, 223<br />

detn. of acid phosphatase in serum with 2,6-<br />

dichhoro-4-acetylphenyl phosphate substrate<br />

(A), 1117<br />

“Kit” methods<br />

algorithm for testing and reporting serum<br />

choriogonadotropin at chin. sigrnf. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

automated enzyme immunoassay for lutropin<br />

(Abbott IMx analyzer) (SN), 2333<br />

calibration of hi1 immunoassay measuring<br />

cyclosporin A (TB), 181<br />

chin, and anal. evaln. of different methods for<br />

mess. of creatine kinsse isoenzyme MB (SN),<br />

130<br />

Coloscreen VPI test kit evald. for detection of<br />

fecal occult blood, 156<br />

commercially available dissociation-enhanced<br />

hanthanide fluaroimmunoassay kit evald. for<br />

quantifying ferritin in serum (TB), 327<br />

critical evaln, of an immunoradiometric assay<br />

of sex-hormone binding globulin (TB), 2146<br />

cychosporine concns, in blood after liver<br />

trensphantn.: correlation of immunoassay<br />

results with chin, events, 564<br />

detection of poisoning by plant-origin cardiac<br />

glycoside with the Abbott TDx analyzer<br />

(SN), 295<br />

diagnostic performance of a modified freethyroxin<br />

assay in subjects with anomalies in<br />

their binding proteins (TB), 493<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerlex cortisol, Biodata testostarone (SN),<br />

641<br />

enzymatic detn. of urinary oxalate (SN), 2330<br />

enzymatic method for lactate in whole blood<br />

adapted to the Cobss Bio (TB), 324<br />

estrogen and progesterone receptor assays,<br />

the EIA method (Abbott), of low-speed<br />

by<br />

supernates of breast-cancer homogenates<br />

(SN), 2226<br />

evahn. of a particle-enhanced immunoaasay for<br />

quantifying C-reactive protein (TB), 2001<br />

evahn. of biotinyhatad (Blugene’”) vs 32p<br />

labeled cDNA probes of -<br />

ghucocerebrosidsse: rel, sensitivities in<br />

genomic and other systems (SN), 1512<br />

four nonisotopic immunoassays of free<br />

thyroxinevald. (SN), 115<br />

four sensitive thyrotropin assays critically<br />

evald., compared (SN), 1785<br />

high incidence of false-positive albuminuria<br />

results with the Micro-Bumintest’” (TB),<br />

1252<br />

influence of matrix on concns. of somatotropin<br />

mess, in serum with commercial<br />

immunoradiometric assays, 1423<br />

interference of coumarin therapy with the<br />

“Heptest” owing to declining prothrombin<br />

concns. (SN), 483<br />

mess, of cychosporine concns. in whole blood:<br />

HPLC and RIA with a specific monoclonal<br />

antibody and 3H- or ‘25I-habeled higand<br />

compared (SN), 120<br />

mechanism of false-negative urine cannabinoid<br />

immunoassay screens by VisineTMeyedrops<br />

(SN), 636<br />

methods compared for detg. total acty. and<br />

isoenzymes of amyhase in serum (SN), 645<br />

microplate mess, of urinary albumin,<br />

creatinine, 1371<br />

more on “hook effects” in immunametric<br />

assays for prostate-specific antigen (L), 2154<br />

new commercial method for enzymatic detn. of<br />

creetinine in serum and urine evald:<br />

comparison with a kinetic Jaff#{233} method and<br />

isotope diln.-mass spectrometry (SN), 835<br />

new technique for measuring free thyroxin in<br />

serum: multi-center study (SN), 2137<br />

pancreatic amylase in serum for differential<br />

diagnosis of acute pancreatitis, acute<br />

abdominal diseases (TB), 2142<br />

performance, diagnostic apphn. of a two-site<br />

immunoradiometric assay for parathyrin in<br />

serum (SN), 1957<br />

performance of the Recombigen5 HIV-1<br />

antibody latex agglutn. test (TB), 2140<br />

preliminary appraisal of a PR-EIA kit for<br />

quantifying progesterone receptors in breastcancer<br />

tissue (L), 339<br />

quantn. of choriogonadotropin: differential<br />

cross-reactivities of free hCG a-subunit with<br />

eight different monoclonal antibody-based<br />

hCG and (hCG + $) “sandwich”-type assays<br />

(TB), 1791<br />

relative potency of commercial calibrators for<br />

fructosamine, and their effect on mess, of<br />

fructosamine in serum (L), 712<br />

reservations regarding assessment of data<br />

obtained with commercialhy available<br />

cortisol RIA kits (L), 2153<br />

sensitivity of CYCLO-Trac SP (specific<br />

monoclonal immunoassay for cyclosporin A)<br />

(L),900<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoassays<br />

of carcinoembryonic antigen (SN), 146<br />

sources of imprecision in screening for<br />

congenital hypothyroidism:<br />

performance data, 1701<br />

anal, of 9 y of<br />

standn. of a commercial (Boehringer<br />

Mannheim Diagnostics) enzymtc method for<br />

cholesterol, 409<br />

three nonisotopic methods for human<br />

choriogonadotropin evald, (TB), 1545<br />

two kits for CK-MM isoforms evald. for early<br />

recognition of acute myocardial infarction<br />

(TB), 493<br />

Wako UV colorimetric pancreatic hipase assay<br />

with 1,2-dihinoleoylglycerol as substrate<br />

evald. (TB), 1540<br />

Laboratory safety<br />

field evaln. of Paramax Plus anal, system with<br />

Closed Container Sampling’” (A), 1106<br />

Lactate<br />

effects of in vivo and in vitro production of<br />

lactic acid on ionized, protein-bound, and<br />

complex-bound Ca in blood, 935<br />

enzymatic method for lactate in whole blood<br />

adapted to the Cobas Bio (TB), 324<br />

evahn. of the Kodak Ektachem din. chem.<br />

slides for lactate<br />

multipoint kinetic<br />

(A), 1132<br />

simultaneous mesa, of<br />

combined concns. of acetoacetate--<br />

hydroxybutyrate and lactate-pyruvate (SN),<br />

1526<br />

“stat” measurements of L-lactate ip whole<br />

blood and CSF assessed (SN), 1740<br />

test-strip method for lactate in whole blood<br />

(SN), 1992<br />

Lactate dehydrogenase<br />

agarose gel electrophoresis, and a chaotropic<br />

method compared for lactate dehydrogenase<br />

isoenzyme-1 (TB), 2250<br />

alterations in lactate dehydrogenase isoenzyme<br />

patterns after therapy with streptokinase or<br />

streptococcal infection (SN), 1763<br />

autoantibodies to lactate dehydrogenase in<br />

serum identified by use of immobihized<br />

Protein G and immobilized jacahin, a<br />

jackfruit lectin, 2190<br />

comparison of agarose gel electrophoresis and<br />

immunoasaay (Abbott A-GENT) for<br />

measurement of lactate dehydrogenase<br />

isoenzyme-1 (A), 1124<br />

creatine kinase<br />

whole blood,<br />

and lactate dehydrogenase in<br />

plasma, and serum determined<br />

with Abbott’s Vision system (A), 1125<br />

creatine kinase and lactate dehydrogenase<br />

isoenzymes in serum and tissues of patients<br />

with stomach adenocarcinoma, 1385<br />

creatine kinase and lactate dehydrogenase<br />

isoenzyme utilization: cut-off values for<br />

fractionation based on total CE activity, and<br />

monitoring of ordering patterns in 334<br />

intensive-care-unit patients (A), 1122<br />

hered. complete deficiency of lactate<br />

dehydrogenase H-subunit (CR), 687<br />

lactate dehydrogenase acty. of murine natural<br />

killer cells in young and old mice:<br />

implications (A), 1155<br />

lactate dehydrogenase and its isoenzymes in<br />

serum in multiple myeloma (SN), 1968<br />

lactate dehydrogenase-1 assay using an M-<br />

subunit-specific, immobilized monoclonal<br />

antibody (A), 1121<br />

lactate dehydrogenase in serum of patients<br />

performing an exercise test (L), 2016<br />

lactate dehydrogenase isoenzyme compn. of<br />

platelets (SN), 2325<br />

lactate dehydrogenase isoenzyme 1:<br />

development of automated chem. method<br />

(A), 1119<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2389


lactate dehydrogenase isoenzyme pattern in<br />

sera in malignant diseases, 396<br />

lactate dehydrogenase isoenzyme patterns in<br />

serum in metastatic liver disease (SN), 871<br />

measurement of lactate dehydrogenase using<br />

purified human placental LD isoenzyme-5<br />

(A), 1116<br />

partial charactern. of an abnormal lactate<br />

dehydrogenase isoenzyme, LDH-iex, in<br />

serum from a patient with hepatocelluhar<br />

carcinoma (SN), 844<br />

patterns of lactate dehydrogenase isoenzymes 1<br />

and 2 in serum on exercise (SN), 301<br />

platelet LDH isoenzymes (A), 1134<br />

purified lyophihized lactate dehydrogenase<br />

isoenzyme 5 used in a study of measuring<br />

LDH acty. (SN), 1774<br />

streptokinase binds to lactate dehydrogenase<br />

subunit-M, which shares an epitope with<br />

plasminogen, 69<br />

variability in serum lactate dehydrogenase<br />

acty. and isoenzyme patterns induced by<br />

streptokinase (A), 1119<br />

Lactoferrin<br />

purifn., characterization of intact lactoferrin<br />

found in the urine of human milk-fed<br />

preterm infants, 1928<br />

Lactogen<br />

turbidimetric latex immunoasaay of placental<br />

hactogen on microtiter plates, 141<br />

Laminin<br />

increased laminin concns. in serum in<br />

hyperthyroidiam (TB), 1540<br />

Laser<br />

nephelometry<br />

four immunochem. methods compared for<br />

mess. C-reactive protein in plasma (SN), 461<br />

functional, immunohog, concns, of a2-<br />

macroghobuhincompared in plasma of<br />

subjects without a1-protease inhibitor<br />

defidiency (SN), 1535<br />

screening for microalbuminuria in patients<br />

with diabetes: frozen storage of urine<br />

samples decreases their albumin content<br />

(SN), 308<br />

Latex agglutination assay<br />

automated enhanced latex agghutn. assay for<br />

rheumatoid factors in serum (SN), 303<br />

patient-side immunoassay system with a<br />

single-use cartridge for measuring analytas<br />

in blood (S), 1869<br />

performance of the Recombigen5 HP/-i<br />

antibody latex agghutn. test (TB), 2140<br />

quant. detn. of myoglobin by a latex-enhanced<br />

turbidimetric assay (A), 1091<br />

Latex agglutination immunoassay<br />

automated latex photometric immunoassay for<br />

detection of hepatitis B surface antigen (A),<br />

1206<br />

development of automated latex agglutination<br />

immunoassay for procainamide for IL<br />

Monarch’”chem, system (A), 1171<br />

latex-based immunoassay for detn. of<br />

carbamazepine with IL Monarch’” chem,<br />

system (A), 1171<br />

turbidimetric latex immunoasaay of placental<br />

lactogen on microtiter plates, 141<br />

urine protein 1: sex-dependent marker of<br />

tubular or glomerular dysfunction (TB),<br />

2141<br />

Latex agglutination inhibition assay<br />

comparison of two comm. available<br />

immunological occult blood tests and a<br />

guaiac slide test (A), 1162<br />

Latex agglutination inhibition immunoassay<br />

development of latex-based tobramycin<br />

immunoassay for the IL Monarch’” chem.<br />

system (A), 1172<br />

latex agglutination inhibition immunoassay for<br />

gentamicin on the IL Monarch’” chem.<br />

system (A), 1172<br />

latex agglutination inhibition immunoassay for<br />

quinidine on the IL Monarch’” chem. system<br />

(A), 1172<br />

poisoning<br />

empirically detd. Pb-poisoning screening cutoff<br />

for the Protofluor-Z hematofluorometer<br />

(SN), 2104<br />

interhab, comparison of control materials for<br />

use with hematofluorometers, 2059<br />

investigation of protoporphyrmn IX sod.<br />

materials used in acid-extn. methods;<br />

proposed correction for the milhimolar<br />

absorptivity of protoporphyrmn IX, 1601<br />

Lead<br />

Lecithin/sphingomyehin ratio<br />

muhticenter evaln. of TDx teat for assessing<br />

fetal lung maturity, 1005<br />

phosphohipid surface tension: diagnostic utility<br />

of amniotic fluid and its lipid extract, an<br />

anal, of the value of pptn. with cold acetone,<br />

800<br />

usefulness of hecithin/sphingomyelin ratio and<br />

uselessness of phosphatidyhghyceroh deths. in<br />

tracheal aspirates from pretarm infants (L),<br />

706<br />

Lectins<br />

aberrant lectin-binding acty. of<br />

immunoghobulin G in serum in rheumatoid<br />

arthritis, 1638<br />

autoantibodies to lactate dehydrogenase in<br />

serum identified by use of immobilized<br />

Protein G and immobilized jacalin, a<br />

jackfruit hectin, 2190<br />

changes in concanavahin A-reactive<br />

inflammatory disorders, 2207<br />

proteins in<br />

effect of Triton X-100 on pptn. of bihiary<br />

phosphatase by wheat-germ lectin (L), 513<br />

Leukemia<br />

chin, significance of 2-microghobuhin in chronic<br />

lymphocytic leukemia and non-Hodgkins<br />

hymphoma (A), 1079<br />

extn, of intracellular nucheosides and<br />

nucheotides with acetonitrile, 48<br />

hiq,-chromatog. monitoring of cytoeine<br />

arabinoside and its metabolite, uracil<br />

arabinoside, in serum, 1011<br />

molecular genetics of leukemia and hymphoma<br />

(5), B43<br />

Leukocyte esterase<br />

implications of probability anal. for<br />

interpreting results of leukocyte esterase and<br />

nitrite teat stips, 1663<br />

Leukocytes<br />

(acyh)carnitine distribution between plasma,<br />

erythrocytes, and heukocytes in blood (L),<br />

711<br />

fast, stable method for harvesting leukocytes<br />

for measuring intracellular Mg (SN), 1986<br />

Leukotrienes<br />

leukotriene B4 is measurable in serum of<br />

smokers and nonsmokers (SN), 459<br />

mess, of urinary heukotrienes by reversedphase<br />

liq. chromatog. and RIA, 388<br />

Light-chain proteins<br />

chin, apphns. for quant. a and A light chain<br />

detns. (A), 1084<br />

normal range of a/A light-chains<br />

immunoghobuhins in 422 hospital patients<br />

(A), 1086<br />

Likelihood ratios<br />

diagnostic utility of serum total creatine kinsse<br />

and creatine kinase-2 in myocardial<br />

infarction re-evaluated, 1435<br />

generalized likelihood ratio concept and<br />

logistic regression anal, for multiple<br />

diagnostic categories, 990<br />

Lipase<br />

diagnostic value of measuring pancreatic Lipase<br />

and the P3 isoform of pancreatic amyhase<br />

isoenzyme in serum of hospitalized<br />

hyperamyhasemic patients, 417<br />

enzymatic method using 1,2-dighyceride for<br />

pancreatic lipase test in serum (A), 1126<br />

immunohog.-derived pancreatic amyhase,<br />

pancreatic hipase, and total amyhase<br />

compared as predictors of pancreatic<br />

inflammation (TB), 1542<br />

lipase acty. measured in serum by a<br />

continuous-monitoring PH-Stat<br />

technique-update, 1688<br />

measuring carboxypeptidsse A acty. with a<br />

centrif, analyzer anal, and din.<br />

considerations, 251<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

Wako UV cohorimetric pancreatic hipase assay<br />

with 1,2-dilinoleoyhghyceroh as substrate<br />

evald. (TB), 1540<br />

Lipemia<br />

effects of lipemia of Hitachi 737 measurements<br />

(A), 1159<br />

Lipids<br />

CDC/NHLBI<br />

lipid standardization<br />

program-30 years of collaboration (A), 1073<br />

comparison of serum apohipoprotein<br />

measurements and serum lipid parameters<br />

(A), 1067<br />

concns, of lipids, apohipoproteins in patients<br />

with chin, well-controlled insulin-dependent<br />

and non-insulin-dependent diabetes, 813<br />

degree of lipid peroxidation in postmortem<br />

blood of fire victims (A), 1176<br />

HUP-hipid program: apolipoprotein A-I and B<br />

and the apo B/epa A-I ratio (A), 1065<br />

managing lipids by diet, exercise, and drugs in<br />

adult patients (A), 1062<br />

managing of lipids by diet, exercise, and drugs<br />

in pediatric patients (A), 1061<br />

rapid deth. of total lipid profile using only 0.5<br />

mL of plasma (A), 1071<br />

rapid micra-scale proced. for detn. of total lipid<br />

profile, 1486<br />

serum lipid and apohipoprotein changes in<br />

normal pregnancy (A), 1066<br />

simultaneous hiq.-chromatog. detn, of vit. K1,<br />

vit. E in serum, 2285<br />

transport conditions and stability of biochem,<br />

markers in blood (SN), 2313<br />

Lipoprotein receptors<br />

development of a receptor assay for measuring<br />

serum “active” apolipoprotein B-100 concn,<br />

(A), 1066<br />

Lipoproteins<br />

alpha alow-moving HDL subfraction in serum<br />

of a patient with radiation enteritis and<br />

peritoneal carcinosis (CR), 674<br />

changes in structure and function of LDL<br />

following oxidation (A), 1234<br />

comparison of Technicon Chem-1 HDL<br />

cholesterol method with pptn. and<br />

ultracentrifugation methods (A), 1066<br />

composition of very-how-density hipoproteins in<br />

non-insulin-dependent diabetes, 808<br />

cord blood hipoprotein(a) in blacks and whites<br />

(A), 1065<br />

cychospormne does not interfere in total and<br />

high-density hipoprotein cholesterol mess,<br />

with use of enzymatic cholesterol assays<br />

(TB), 2251<br />

differential detn, of HDL-subfractions in cm.<br />

labs. (L), 701<br />

distribn. of thiobarbituric acid-reactive<br />

substances in lipoproteins, proteins in serum,<br />

2054<br />

dual-ppth. method evald, for mess. of<br />

cholesterol in high-density lipoprotein<br />

subfrections HDL2 and HDL3 in plasma, 265<br />

effect of glycation of how-density hipoprotein on<br />

immunolog. detn. of apolipoprotein B (SN),<br />

2219<br />

evaln, of the Kodak Ektachem HDL<br />

cholesterol kit on the Kodak Ektachem 700<br />

analyzer (A), 1069<br />

extrapolation of hipoprotein ref. limits to<br />

apohipoprotain measurements (A), 1070<br />

fasting vs nonfasting hipoprotain measurements<br />

(A), 1066<br />

implications for mess, of pre-fl high-density<br />

hipoprotein (free apo A-I) by ultracentrifn,<br />

(L), 2336<br />

improved immunoblotting technique for Lp(a)<br />

phenotyping (A), 1070<br />

improved methods for sepn. of total MDL and<br />

subclasses (A), 1086<br />

mnterhospital lab. comparison of total and highdensity<br />

hipoprotein cholesterol assays (A),<br />

1075<br />

LDL heterogeneity: relationships between<br />

particle size and coronary disease (A), 1234<br />

hipoprotein(a): genetic marker for<br />

atherosclerosis (A), 1234<br />

hipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

hipoprotein changes in subjects on a modified<br />

fasting regimen (A), 1068<br />

Lp(a) lipoprotein concn, in serum of patients<br />

with heavy proteinuria of different origin<br />

(SN), 2121<br />

Lp(a) phenotype frequency in a normal North<br />

Am. population (A), 1070<br />

meas. of apolipoprotein B in plasma from<br />

hyperlipidemic subjects treated with<br />

chohestyramine or placebo: differential<br />

effects of storage at -70 #{176}C, 380<br />

performance eveln, of Ciba Corning<br />

Diagnostics MDL cholesterol reagent on the<br />

Impact 400E (A), 1094<br />

plasma hipoprotein(a) and the Friedewald<br />

formula (L), 2156<br />

pohyacryhaniide gel ehectropharesis used in a<br />

critical study of ppth. reagents for<br />

quantifying HDL cholesterol (TB), 1254<br />

rapid micro-scale proced. for detn. of total lipid<br />

profile, 1486<br />

regional interlab, standn. of serum cholesterol,<br />

HDL cholesterol, and triglycerides (A), 1065<br />

screening of serum cholesterol and HDL<br />

cholesterol using the EM. Diagnostic<br />

2390 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


Systems EASY ST analyzer (A), 1074<br />

serum lipoproteins and coronarographic<br />

features (L), 1266<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

unusual band that binds Mb after<br />

ultracentrifn. of hemohyzed plasma for<br />

lipopratein sepn. (TB), 495<br />

use of adual-pptn. proced. for mess. highdensity<br />

lipoprotain 3 in normolipidemic<br />

serum, 1390<br />

ApO.Omes<br />

stable liposomes for microcapsule<br />

immunoassay in human sera (A), 1204<br />

,.ithiasls<br />

See Calculous disease<br />

aver disease<br />

See also Liver function, Hepatic disease<br />

elk. phosphatase isoenzymes in plasma in<br />

hyperthyroidism, 1427<br />

biliary alk. phosphatase measured by minicolumn<br />

chromatog. on DEAE-celluhose:<br />

appln. to detection of hepatobihiary diseases,<br />

1684<br />

calciferin and cathepsin D-hike acid protease in<br />

serum in acute, chronic liver injuries in rats,<br />

humans, 2202<br />

cydhosporineconcns. in blood after liver<br />

transphanth.: correlation of immunoassay<br />

results with chin, events, 564<br />

detn, of branched-chain amino acids and<br />

tyrosine in serum in various hepatic diseases,<br />

and its din, usefulness, 1399<br />

functional acty. of protein S detd. with use of<br />

protein C activated by venom activator,<br />

high-M, (“bihiary”) isoenzyme of alk.<br />

1644<br />

phosphatase and the diagnosis of liver<br />

dysfunction in cystic fibrosis, 1888<br />

lactate dehydrogenase isoenzyme patterns in<br />

serum in metastatic liver disease (SN), 871<br />

mess, of glutathione S-transferase B1 in plasma<br />

after birth asphyxim early indication of<br />

hepatocehlular damage, 995<br />

plasma glutathione S-transferase and F protein<br />

are more sensitive than alanine<br />

aminotransferase as markers of<br />

ecetaminophen-induced<br />

ratio of serum aspartate<br />

liver damage,<br />

to alanine<br />

2186<br />

aminotrensferase as a prognostic index in<br />

pediatric liver disease (A). 1151<br />

rhabdomyohysis in a case of free-base cocaine<br />

(“crack”) overdose (CR), 1547<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasie, and assessment of<br />

effects of organ failure, 1631<br />

signif. of how serum urea N concns, (SN), 639<br />

Liver function<br />

See also Liver disease<br />

antipyrine, indocyanine green, and horazepem<br />

deed, in plasma by HPLC (SN), 2124<br />

effect of hypoxia and oxygen free radicals on<br />

liver lysosomes (A), 1137<br />

prognostic value of MEGX liver-function test<br />

in transplant candidates (A), 1135<br />

Lowe’s syndrome<br />

ehectrophoretic examin. of proteinuria in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

Luliberin<br />

comparison of lutropin immunoreactivity in<br />

serum by RIA and time-resolved<br />

fluorescence findings in serum from normal<br />

children and those treated with LHRH<br />

analogs (A), 1150<br />

Luminescence lmmunoassay<br />

development of enhanced luminescence<br />

immunoassay for progesterone (A), 1149<br />

enhanced luminescence immunoassay for<br />

eatradiol (A), 1149<br />

enhanced luminescence immunoassay for free<br />

T3 (A), 1149<br />

immunometric assay for carcinoembryonic<br />

antigen based on enhanced luminescence<br />

(A), 1080<br />

one-step immunometric assay for TSH based<br />

on enhanced luminescence (A), 1149<br />

Lung disease<br />

bronchopulmonary dysphasia-current<br />

concepts (A), 1241<br />

changes of growth-related hormones and<br />

growth factors following pneumonectomy: I.<br />

growth hormone (A), 1150<br />

defective epithehial ion transport in cystic<br />

fibrosis (S), 726<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN), 166<br />

functional, immunohag. concns. of 02-<br />

macroglobulin compared in plasma of<br />

subjects without a1-protease inhibitor<br />

deficiency (SN), 1535<br />

proton NMR studies of plasma to determine<br />

metab. status of patients with adult reap.<br />

distress syndrome (SN), 667<br />

Lupus erythematosus<br />

See also Systemic lupus erythematosus<br />

changes in concanavalin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

Lutropin<br />

assay for human hutropin using higand and antihigand<br />

system (A), 1093<br />

automated enzyme immunoassay for hutropin<br />

(Abbott IMx analyzer) (SN), 2333<br />

comparison of hutropin immunoreactivity in<br />

serum by RIA and time-resolved<br />

fluorescence findings in serum from normal<br />

children and those treated with LHRH<br />

analogs (A), 1150<br />

detn, of FSH, LH, and cortisoh with automated<br />

enzyme immunoassays (A), 1141<br />

development of fully automated immunoassay<br />

for hLH on the Abbott IMx automated<br />

immunoassay system (A), 1203<br />

evaln. of new consumer test for hutropin (A),<br />

1146<br />

predicting ovulation in in-vitro fertilization<br />

program by monitoring lutainizing<br />

hormone/creatinine ratio in random urine<br />

samples (A), 1144<br />

rapid enzyme immunoassay far visual,<br />

semiquant. detn. of hutropin in urine for<br />

ovulation prediction (A), 1148<br />

ultra-specific time-resolved<br />

immunofluorometric assay of lutropin in<br />

serum (TB), 2251<br />

Lyme disease<br />

detecting Lyme disease, 1812<br />

Lymphocytes<br />

alteration of lymphocyte subsets and endocrine<br />

response during 80 days of competitive swim<br />

training (A), 1136<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

evaln, of heukocyte-associated dipeptidyl<br />

peptidase IV enzyme in normal and<br />

immunodeficient conditions (A), 1153<br />

quantn. Mn in lymphocytes to assess Mn<br />

nutrit. status, 1939<br />

Lymphokine-actlvated killer cells<br />

tumor-derived activated cells: prehim. lab, and<br />

din, results<br />

Lymphoma<br />

(5), 1576<br />

molecular<br />

(S),B43<br />

genetics of leukemia and lymphoma<br />

Lysine<br />

does the effective diminution of nonenzymatic<br />

glycation by D-lysine really highlight its<br />

potential use in vivo? (L), 2254<br />

Lysosomes<br />

effect of hypoxia and oxygen free radicals on<br />

liver hysosomes (A), 1137<br />

Macroamylasemia<br />

immobilized anti-salivary amylase antibody<br />

interacts with macroamylases: implications<br />

for use in a pancreatic amylase assay to<br />

distinguish macroamyhasemia from acute<br />

pancreatitia, 1651<br />

Macroenzymes<br />

See Immunoglabulin-enzyme complexes<br />

macroenzymes: biochem, characterization, cm.<br />

signif., and lab, detection (R), 2261<br />

Macroghobuhin<br />

detn, of a2-macroghobulin-trypsin complex<br />

with a new synthetic substrata, 2169<br />

functional, immunohog. concns. of 02-<br />

macroglobulin compared in plasma of<br />

subjects without ai-protease inhibitor<br />

deficiency (SN), 1535<br />

Magnesium<br />

blood Mg parameters in premenstrual<br />

syndrome (A), 1115<br />

detn, of Mg2 in granulocytea, 1404<br />

enzymatic assay of Mg through glucokinase<br />

actn. (SN), 2212<br />

evaln. of single-reagent Mg procedure on the<br />

Hitachi 737 (A), 1128<br />

fast, stable method for harvesting leukocytes<br />

for measuring intracellular Mg (SN), 1986<br />

fluorometry of Mg21’in serum with 2-hydroxy-<br />

1-nephthaldehyde salicyhoyhhydrazone, 1492<br />

frequency of hypo- and hypermagnesemia for<br />

each chin, service in four teaching hospitals<br />

(A), 1130<br />

hypomagnesemia and howelk. phosphatase<br />

acty. in patients’ serum after cardiac surgery<br />

(SN), 664<br />

intra-individual variability of blood Mg<br />

parameters with time (A), 1114<br />

meas, of Mg2 in mononuclear blood cells (L),<br />

1559<br />

modified Mg method in the aca III: ehimn. of<br />

interference by bihirubin (SN), 1031<br />

performance characteristics of a Mg procedure<br />

for the Ohympus AU5000 series of chem.<br />

analyzers (A), 1089<br />

performance<br />

Diagnostic<br />

characteristics of Ciba Corning<br />

single hiq. Mg reagent on the<br />

Express 550 (A), 1094<br />

performance of Beckman Liquid-Stat Mg<br />

reagent (A), 1131<br />

serum Mg as affected by drugs (L), 506<br />

stetis. intarpretn. of concns. of Mg, Zn, Ca, K,<br />

cholestarols, and creatine kinase isoenzymea<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

variation among units for blood cellular Mg<br />

(A), 1115<br />

Malondialdehyde<br />

distribn, of thiobarbituric acid-reactive<br />

substances in hipoprateins, proteins in serum,<br />

2054<br />

plasma malondialdehyde, lipid peroxides, and<br />

the thiobarbituric acid reaction (L), 336<br />

Manganese<br />

quanth. Mn in lymphocytes to assess Mn<br />

nutrit, status, 1939<br />

Marijuana<br />

sample preparation for thin-layer chromatog.<br />

anal. for 11-nor-9-tetrahydrocannabinol-9-<br />

carboxylic acid in urine (SN), 163<br />

Mass spectrometry<br />

automation advances in mass spectrometry<br />

(A), 1240<br />

benzodiazepines identified by capillary gas<br />

chromatog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derive., 1394<br />

diagnosis of recessive X-hinked ichthyosis:<br />

quantitative HPLC/mass spect. anal. of<br />

plasma for cholesterol sulfate, 1906<br />

HPLC/mass spectrom.: state of the art for the<br />

drug anal, lab. (S), 1282<br />

new commercial method for enzymatic<br />

creatinine in serum and urine evald:<br />

detn, of<br />

comparison with a kinetic Jaff#{233} method and<br />

isotope dihn.-mass spectrometry (SN), 835<br />

quant. anal. for org. acids in biol, samples:<br />

batch isolation followed by gas<br />

chromstog.-mass spectrom. anal,, 587<br />

simultaneous quantn. of morphine, codeine,<br />

and 06-monoacetyl morphine by gas<br />

chromatog. mass spectram. (A), 1355<br />

use of GCIIR/MS for high-confidence identifn.<br />

of drugs (S), 1279<br />

Melanin<br />

melanin and other indohe compds. do not cause<br />

false-positive cannabinoid assay results (L),<br />

1809<br />

Mehatonin<br />

salivary melstonin estn. in assessment of<br />

pmneal-gland function (L), 514<br />

Menopause<br />

effects of estrogen on mineral metab. in<br />

postmenopausal women as evald, by multiple<br />

assays measuring parathyrin bioacty., 18<br />

improved method for calcg. Ca fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

relation between plasma cholesterol and total<br />

and ionized Ca concns, in serum from<br />

postmenopausal women (TB), 328<br />

solid-phase enzymoinimunoassay of estrone in<br />

saliva, 569<br />

Menstrual cycle<br />

blood Mg parameters in premenstrual<br />

syndrome (A), 1115<br />

mess, of estrone.3-glucuronide in urine by<br />

rapid, homogeneous time-resolved<br />

fluoroimmunoassay, 555<br />

Mental disorders<br />

free 3-methoxy-4-hydroxyphenylglycol deed, in<br />

plasma by liq. chromatog. with coulometric<br />

detection, 202<br />

Metabolic acidoals<br />

calculated HCO3’ or total C02?, 1697<br />

multipoint kinetic simultaneous mess, of<br />

combined concns, of acetoacetate--<br />

hydroxybutyrata and hactate-pyruvate (SN),<br />

1526<br />

pyroghutamic acidemia in an adult (CR), 684<br />

Metabolic disease<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

Metabolism<br />

biochem, contribution to diagnosis and study<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2391


of a new case of D-ghyceric acidemia/aciduria<br />

(CR), 2148<br />

distribn. of cychosporin A metabohites among<br />

plasma and cells in whole blood: effect of<br />

temp., hematocrit, and metabohite concn,, 59<br />

hered, complete deficiency of lactate<br />

dehydrogenase H-subunit (CR), 687<br />

methylmalonic acid, I. concns, in serum and<br />

urinary excretion in normal subjects after<br />

feeding and during fasting, and after loading<br />

with protein, fat, sugar, isoleucine, valine,<br />

2271<br />

methylmalonic acid. II. relation between<br />

concns, in serum and urinary excretion, and<br />

the correhn, between serum cobalamin and<br />

accumulation of methylmalonic acid, 2277<br />

purifn., characterization of intact Iactoferrin<br />

found in the urine of human milk-fed<br />

preterm infants, 1928<br />

rapid, reliable in viva assays of phosphate<br />

metabohites by NMR, 392<br />

simple hiq.-chromatog, method for vit, B6 cmps.<br />

in plasma, 241<br />

Metadrenaline<br />

modified method of anal, for metadrenaline in<br />

urine (L), 513<br />

Metanephrlnes<br />

anal, of urinary metanephrines of patients<br />

treated with antihypertensive a-methyhdopa<br />

(Ahdomet) (A), 1138<br />

Methadone<br />

development of TD/AD’ fluorescence<br />

polarization immunoassay for detection of<br />

methadone in human urine (A), 1176<br />

evaln, of the TDx and ADx methadone<br />

immunoassays (TB), 1794<br />

methadone and thyroid-function teats (L),<br />

1807<br />

Methainphetamine<br />

amphetamine, methamphetamine quant.<br />

confirmation procedure by GC/MS (A), 1169<br />

development of EMIT drugs of abuse assay for<br />

amphetaxnine/methamphetamine in urine on<br />

the ETS’ system (A), 1180<br />

relative operating characteristic curves used to<br />

compare drug screening immunoassays for<br />

amphetamine and methamphetamine (A),<br />

1175<br />

Methotrexate<br />

measurement of methotrexate on Du Pont aca<br />

discrete chin, analyzer (A), 1169<br />

Methoxyhydroxyphenyhglycol<br />

free 3-methoxy-4-hydroxyphenylglycol deed. in<br />

plasma by hiq. chromatog, with coulometric<br />

detection, 202<br />

Methoxytryptophol<br />

RIA of 5-methoxytryptophol in plasma (SN),<br />

1749<br />

Methylenebiachloroanihine<br />

detn, of 4,4’-methyhenebis(2-chloroaniline) in<br />

urine (L), 506<br />

Methyl ketones<br />

effect of light on reactions between N’-<br />

methylnicotinamide and methyl ketones<br />

(TB), 2000<br />

Methylmalonic acid<br />

methyhmalonic acid. I. concns. in serum and<br />

urinary excretion in normal subjects after<br />

feeding and during fasting, and after loading<br />

with protein, fat, sugar, isoleucine, valine,<br />

2271<br />

methylmalonic acid. II. relation between<br />

concns, in serum and urinary excretion, and<br />

the correln, between serum cobahemin and<br />

accumulation of methylmalonic acid, 2277<br />

solid-phase sample extn, for rapid detn, of<br />

methylmalonic acid in serum, urine by stable<br />

isotope dilution, 260<br />

Methylnicotinamide<br />

effect of light on reactions between N’-<br />

methylnicotinamide and methyl ketones<br />

(TB), 2000<br />

Mexiletine<br />

anal, of mexihetine stereoisomers in serum by<br />

HPLC with a chiral column (A), 1178<br />

Mice<br />

lactate dehydrogenase acty. of murine natural<br />

killer cells in young and old mice:<br />

implications (A), 1155<br />

Microalbuminurla<br />

See Albumin<br />

Microdiffusion<br />

alcohol detection by microdiffusion (L), 1269<br />

Microghobuhin<br />

chin, significance of 2-microglobulin in chronic<br />

hymphocytic leukemia and non-Hodgkins<br />

lymphoma (A), 1079<br />

high-yield purifn. of the complex-forming<br />

glycoprotein in urine. 577<br />

immunoturbidimetric technique for detn, of<br />

serum 2-microglobulin (A), 1189<br />

immunoturbidimetry of $2-microghobulin in<br />

serum (TB), 1996<br />

IMx z-microglobulin, fully automated<br />

micropartiche enzyme immunoassay (A),<br />

1192<br />

z-microghobuhin and immune activation (L),<br />

2158<br />

navel nonisotopic immunoasaay for grkb2-<br />

microghobuhin (A), 1205<br />

simultaneous meas. of total and IgAconjugated<br />

ai-microglobulin by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

Micropartiche capture enzyme inimunoassay<br />

fully automated assay for human folliclestimulating<br />

automated<br />

hormone on the Abbott IMx’<br />

immunoassay system (A), 1142<br />

Microplate assay<br />

direct solid-phase enzymoimmunoassay<br />

testosterone in saliva, 2044<br />

of<br />

fluorometric method for phenyhalanine<br />

microplate assay adapted for<br />

phenylketonuria screening (SN), 2112<br />

fl-Microseminoprotein<br />

RIA of -microseminoprotain, a prostaticsecreted<br />

protein in sara of men and women,<br />

1497<br />

Military medicine<br />

chin, chem, analyzer evald, by NCCLS<br />

guidelines for use in a military field lab. unit<br />

(SN), 2223<br />

Mineral metabolism<br />

effects of estrogen on mineral metab, in<br />

postmenopausal women as evald, by multiple<br />

assays measuring parathyrmn bioacty., 18<br />

Molecular biology<br />

DNA fingerprinting (S), 1832<br />

glossary for molecular biology (S), 1816<br />

Molecular genetics<br />

automated DNA sequencing methods involving<br />

pohymerase chain reaction, 2196<br />

moL genetics and the transformation of chin.<br />

chem, (S), 2165<br />

Molecular<br />

probes<br />

molecular probes used to detect<br />

cytomegahovirus and human<br />

immunodeficiency virus (S), 1581<br />

Monitoring pregnancy<br />

See also Amniotic fluld, Fetal status, etc.<br />

Monitoring therapy<br />

adv, in cychosporine pharmacoL, measurement,<br />

and ther, monitoring (S), 1299<br />

assessment of compliance status in outpatients<br />

(A), 1353<br />

bedside monitoring for neonatal intensive care<br />

patients (A), 1241<br />

continuing need for qual. assessment of<br />

cychosporine measurement (S), 1309<br />

cost-effective assays for use in monitoring<br />

carbamazepine, phenobarbital, and<br />

phenytoin in serum (SN), 1782<br />

cychosporin A mess, in plasma in various<br />

transplant types by HPLC and RIA (A),<br />

1356<br />

cyclosporine concns, in blood after liver<br />

transplantn.: correlation of immunoaasay<br />

results with cm. events, 564<br />

cychosporine measured in plasma from patients<br />

with various transplants:<br />

with a specific monoclonal antibody<br />

compared (SN), 1726<br />

detn. of cychosporine in plasma: specific<br />

HPLC and RIA<br />

RIA<br />

with a monoclonal antibody and hiq.<br />

chromatog. compared, 608<br />

deth, of the allyl hysophosphohipid derivative<br />

ET-18-OCH3, a new antineophastic drug, in<br />

plasma, 821<br />

development of a confirmatory enzyme-linked<br />

immunosorbent assay for HIV-1 antibodies,<br />

946<br />

documentation of cytosine arabinoside toxicity<br />

using drug monitoring (A), 1182<br />

evaln, of Boehringer MannheimfHitachi 717<br />

for routine TDM (A), 1165<br />

evain, of the Ames Seralyzer for therapeutic<br />

drug monitoring of phenobarbitah, phenytoin<br />

(TB), 324<br />

extn, of intracellular nucheosides and<br />

nucheotides with acetonitrile, 48<br />

free 3-methoxy-4-hydroxyphenyhghycoh deed. in<br />

plasma by hiq. chromatog. with coulometric<br />

detection, 202<br />

geriatric ther. drug monitoring: special<br />

considerations (S), 1337<br />

glycated Hb in fractionated erythrocytes, 958<br />

implications of near-patient testing at an<br />

anticonvuhaent clinic (A), 1352<br />

indirect therapeutic drug monitoring by<br />

measuring monoamine oxidase actys. from<br />

platelets (A), 1175<br />

intravascular monitoring: techniques, risks and<br />

problems (A), 1059<br />

issues in methodology and apphns. for ther,<br />

monitoring of antidepressants (S), 1318<br />

lactate dehydrogenase and its isoenzymes in<br />

serum in multiple myeloma (SN), 1968<br />

lactate dehydrogenase isoenzyme pattern in<br />

sara in malignant diseases, 396<br />

hiq.-chromatog. monitoring of cytosine<br />

arabinoside and its metabohite, uracil<br />

arabinoside, in serum, 1011<br />

meas, of cychosporine concns, in whale blood:<br />

HPLC and RIA with a specific monoclonah<br />

antibody and 3H- or unIlabehed ligand<br />

compared (SN), 120<br />

measurement of methotrexate on Du Pont oca<br />

discrete din, analyzer (A), 1169<br />

morphine monitoring for an anaesthesia pain<br />

service (A), 1182<br />

new directions in cychosporine monitoring (A),<br />

1235<br />

orgn. of a chin. pharmacokinetics service (A),<br />

1354<br />

quality assurance study of gentamicin usage<br />

and monitoring in a children’s hospital (A),<br />

1167<br />

relevance of pharmecokinetics to monitoring<br />

new entiarrhythmics (S), 1332<br />

specific routine detn. of 3’-azido-3’-<br />

deoxythymidine in plasma by<br />

semiautomated liq. chromatog. (5), 1313<br />

spectroscapic systems for nan-invasive<br />

measurements (A), 1059<br />

strategies far sample prepn. with use of solidphase<br />

extrn, in TDM of basic drugs (A), 1352<br />

supercritical fluid chromatog. and microbore<br />

liq. chromatog. for drug anal. (S), 1293<br />

ther, drug monitoring in the 19904 (S), 1348<br />

update on CHEMFET sensors for patient<br />

monitoring (A), 1060<br />

update on digoxin (5), 1326<br />

variations in protein binding of drugs in<br />

plasma, serum (SN), 1722<br />

Monoamine oxidase<br />

indirect therapeutic drug monitoring by<br />

measuring monoamine oxidase ectys. from<br />

platelets (A), 1175<br />

Monoclonal antibodies<br />

elk, phosphatase isoenzymes of liver and bone<br />

origin are incompletely resolved by wheatgerm-lectin<br />

affinity chromatog., 29<br />

calibration of 1I immunoassay measuring<br />

cyclosporin A (TB), 181<br />

cyclosporine measured in plasma from patients<br />

with various transplants: HPLC and RIA<br />

with a specific monochonal antibody<br />

compared (SN), 1726<br />

detn. of cychosporine in plasma specific RIA<br />

with a monochonal antibody and liq.<br />

chromatog. compared, 608<br />

development of monochonal antibodies to<br />

human myoglobin and their use in<br />

fluorescence immunoassay (A), 1203<br />

enzyme-linked immunosorbent assay for<br />

chromogranin A, 1934<br />

evahn, of Dade Stratus for detn. of CK-MB (A),<br />

1090<br />

genetically<br />

IgG heavy-chain<br />

engineered<br />

subclass<br />

antibodies(S),<br />

typing of<br />

1849<br />

myehoma<br />

paraproteins by isoehectric focusing<br />

immunoblot anal., 364<br />

immunoaffmity purifn. of creetine kinase-MB<br />

from human, dog, and rabbit heart with use<br />

of monochonal antibody specific for CK-MB,<br />

985<br />

immunocatahytic assay of pancreatic a-amylase<br />

in serum and urine with a specific<br />

monochonal antibody (SN), 662<br />

immunochem, detn. of C4b-bindmg protein in<br />

human plasma (A), 1163<br />

immunohistochem, studies utilizing<br />

monoclonal and pohyclonal antibodies to c-<br />

erbB-2 protein (A), 1079<br />

immunoradiometry of a’- and 7’y-enalase<br />

(neuron-specific enolase), with use of<br />

monoclonal antibodies and magnetizable<br />

polymer particles, 2034<br />

interferences of human anti-mouse antibodies<br />

in mouse monoclonal antibody-based<br />

immunoassays (A), 1188<br />

hipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

mess. of cyclosporine concns, in whole blood:<br />

HPLC and ifiA with a specific monoclonal<br />

antibody and 3H- or unIhabehed higand<br />

compared (SN). 120<br />

2392 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


methodoL and chin. multicentar evaln. of<br />

specific pancreatic a-amyhase assay based on<br />

a double monoclonal antibody technique (A),<br />

1090<br />

monochonal antibodies evald, for use in<br />

screening for conjugates of human serum ahb,<br />

and pyridaxal 5’-P04 (SN), 1756<br />

monoclonal antibody to ‘y chain of fetal Hb<br />

used to develop an enzyme immunoassay,<br />

2066<br />

monochonal chemihuminescent digoxmn assay<br />

(A), 1194<br />

murmnemonochonal antibody adsorbed onto<br />

vinyhidene fluoride floccules used to<br />

eliminate antibody interference in<br />

“sandwich”-type immunoessays (SN), 1743<br />

novel immunoradiometric assay of<br />

thyroghobulin in serum with monochonal<br />

antibodies<br />

reactivity<br />

selected for lack of cross-<br />

with autoantibodies, 422<br />

pancreatic amylase mess, in serum by use of a<br />

monoclonal antibody immunochem,<br />

immobilized to a solid phase, 110<br />

pancreatic isoamylase: direct assay based on<br />

efficient capture by a monochonal antibody<br />

(A), 1123<br />

pancreatic oncofetal antigen and carbohydrate<br />

antigen 19-9 in sara of patients with<br />

pancreatic cancer, 405<br />

prehim. chin. evaln, of an ovarian cancer<br />

marker-CA 215 (A), 1081<br />

quantn. of choriogonadotropin: differential<br />

cross-reactivities of free hCG a-subunit with<br />

eight different monoclonal antibody-based<br />

hCG and (hCG<br />

(TB), 1791<br />

+ ) “sandwich”-type assays<br />

RIA of osteocalcin with pohyclonal and<br />

monochonal antibodies, 1408<br />

solid-phase enzymoimmunoassay for<br />

osteocalcin in serum or plasma, with use of a<br />

monochonal antibody, 2087<br />

solving the problem of antibody interference in<br />

commercial “sandwich”-type immunoassays<br />

of carcinoembryonic antigen (SN), 146<br />

somatotropin as mess, by a two-site timeresolved<br />

immunofluorometric assay, 913<br />

standn, of apohipoprotein B and A-I mess, (R),<br />

1357<br />

Stratus automated creatine kinase-MB assay<br />

evald,: identn, and elimn, of falsely increased<br />

results assocd, with a high-M, form of alk,<br />

phoephataae, 2048<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamylase in serum, with use of<br />

two monochonal antibodies, 1915<br />

two-site immunoenzymometry of 52-kDa<br />

cathepsin D in cytosols of breast-cancer<br />

tissues, 81<br />

use of murine monoclonal antibodies to bloodgroup-related<br />

antigens for<br />

immunofluorescent detection of blood<br />

groups on human spermatozoa (A), 1208<br />

Monochonal gammopathies<br />

follow-up of monochonah gammopathies<br />

asymptomatic HIV-infected subjects<br />

in<br />

(L), 338<br />

hazard of commercial antiserum crossreactivity<br />

in monochonal gammopathy evaln,<br />

(L), 2016<br />

mare on monochonal gammopathies<br />

quantn. of ii- and X-containing<br />

(L), 1268<br />

immunoghobulins by rate nephehometry:<br />

comparison of two comm. reagent antisera<br />

(A), 1198<br />

racial and age-related differences in incidence<br />

of monoclonal gammopathy of uncertain<br />

significance (A), 1154<br />

strategy for diagnosis of monochonal<br />

gammopathies in serum (L), 508<br />

r4onochonah immunoglobulins<br />

monochonal immunoglohuhina: affinity blotting<br />

for low concns. in serum (SN), 478<br />

t4ononuchear cells<br />

detection of HIV proviral DNA in peripheral<br />

blood mononuclear cells by polymerase chain<br />

reaction (A), 1076<br />

meas. of Mg2 in mononuclear blood cells (L),<br />

1559<br />

Morphine<br />

morphine monitoring for an anaesthesia pain<br />

service (A), 1182<br />

rapid thin-layer chromatog, semiquantification<br />

of morphine in urine via dabsylation:<br />

comparison with EMIT and thin-layer<br />

- chromatog.-iodophatinate methods (TB), 329<br />

simultaneous quantn. of morphine, codeine,<br />

and 06-manoacetyl morphine by gas<br />

chromatog,<br />

ts1ucin<br />

mass spectrom. (A), 1355<br />

IMx” BCM, automated microparticle enzyme<br />

immunoassay for breast cancer mucin (A),<br />

1078<br />

Mucopohysaccharides<br />

diagnostic test for mucopohysaccharidosis I.<br />

direct method for quantg. excessive<br />

glycosaminoghycan excretion, 374<br />

urinary<br />

Mucopohysaccharidosis<br />

diagnostic test for mucopolysaccharidosis. II.<br />

rapid quanta. of glycosaminoghycan in urine<br />

samples on a paper matrix, 2074<br />

dimethylmethyhene blue-based spectrophotom.<br />

of glycosaminoghycans in untreated urine:<br />

rapid screening for mucopohysaccharidoses,<br />

1472<br />

Multihayer film analysis<br />

anal. performance of Kodak Ektachem chin.<br />

chem, slides (Fe) (A), 1101<br />

assessment of renal function by mum<br />

clearance: comparison with creatinine<br />

clearance ss deed, enzymaticahly (SN), 312<br />

chin. important interference of sulfasalazine in<br />

measurement of conjugated bihirubin by<br />

Ektachem slide method (A), 1158<br />

comparison of Kodak CK-MB assay with CK<br />

isoenzyme electrophoresis (A), 1123<br />

development of Kodak Ektachem thin-film<br />

assay for serum cholinestarase (A), 1120<br />

differences between values for plasma and<br />

serum in tests performed in the Ektachem<br />

700 XR analyzer, and evaln, of “plasma<br />

separator tubes (PST)” (SN), 151<br />

dry-chem. multilayer immunoassay for total<br />

thyroxin (A), 1180<br />

estn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

evahn, of assay of misc. body fluids by Kodak<br />

Ektachem 700(A), 1100<br />

evahn, of dry-chem, analyzer, the Chinistat, for<br />

blood Hb and serum or plasma constituents<br />

(A), 1108<br />

evaln, of Kodak slides for CSF protein assays<br />

(A), 1090<br />

evahn, of the Kodak Ektachem chin. chem,<br />

slides for lactate (A), 1132<br />

evahn, of the Kodak Ektachem HDL<br />

cholesterol kit on the Kodak Ektachem 700<br />

analyzer (A), 1069<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns, (CR), 333<br />

feline and canine ref. ranges for the Kodak<br />

Ektachem 700 analyzer (A), 1134<br />

Indocyanine Green interference in the Kodak<br />

Ektachem detn, of total bilirubin (L), 899<br />

interference of macro-creatine kinase in detn,<br />

of CK-MB in serum with the Kodak<br />

Ektachem (L), 2155<br />

measurement of alk. phosphatase acty. by<br />

Kodak Ektachem 700 XR analyzer compared<br />

with other routine anal. methods (TB), 328<br />

modifn, of Kodak Ektachem<br />

creatinine to substantially<br />

slide for<br />

reduce<br />

interference from lidocaine metabohita (A),<br />

1098<br />

multilayer fluorescence immunoassay<br />

technique (S), 1865<br />

performance of Kodak Ektachem DT6O<br />

analyzer in dispersed hosp. settings (A), 1101<br />

performance of the Kodak iron and total ironbinding<br />

capacity methods (TB), 2250<br />

thin-film enzyme immunoassay for<br />

measurement of serum or phssma T4 (A),<br />

1200<br />

thin-film immunochem, messurement of<br />

digoxin in human serum (A), 1200<br />

Multiple myeloma<br />

lactate dehydrogenase and its isoenzymes in<br />

serum in multiple myehoma (SN), 1968<br />

Multiple sclerosis<br />

Bence Jones immunoglobulins in the urine in<br />

multiple sclerosis (L), 186<br />

Bence Jones proteins in urine of patients with<br />

multiple sclerosis (L), 1550<br />

cystatin C quantn. in CSF (TB), 179<br />

more on ohigoclonal bands and diagnosis of<br />

multiple sclerosis (L), 337<br />

Multivariate discrimination<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

Muscular dystrophy<br />

apphn. of Magic Lite<br />

immunochemihuminometric method for<br />

measurement of creatine kinase-MB in blood<br />

spots (A), 1123<br />

carrier detection and characterization of gene<br />

deletions in Duchenne and Becker muscular<br />

dystrophy utilizing dystrophin cDNA probes<br />

(A), 1075<br />

detection of Duchenne/Becker muscular<br />

dystrophy carriers by densitometric scanning<br />

(TB), 1256<br />

mohec, genetics of Duchenne and Becker<br />

muscular dystrophy: emphasis on improved<br />

diagnosis (S), B21<br />

Mycotoxicosis<br />

tissue damage assessment in T2 mycotoxicosis<br />

(A), 1135<br />

Mycotoxins<br />

time-resolved fluoroimmunoassay of aflatoxins<br />

(SN), 2308<br />

Myelin<br />

modulated adhesion: proposal for role of<br />

myelin-as8ocd. glycoprotein in myelin<br />

wrapping(S),<br />

Myehln-associated<br />

717<br />

ghycoprotehn<br />

modulated adhesion: proposal for role of<br />

myehin-assocd. glycoprotein in myehin<br />

wrapping (5), 717<br />

Myehoma<br />

IgG heavy-chain subclass typing of myehoma<br />

paraprateins by isoelectric focusing<br />

immunoblot anal., 364<br />

simultaneous mess, of total and IgAconjugated<br />

oi-microglobuhin by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

Myelopathy<br />

oligoclonal immunaghobulin bands in HTLV-Iassociated<br />

myelopathy (A), 1085<br />

Myocardiah Infarction<br />

See also Heart disease<br />

cardiac iaoenzyme (CK-MM isoform) assays for<br />

early detection of acute myocardial<br />

infarction: comparison of immunometric and<br />

ehectrophoretic systems (A), 1117<br />

changes in creatine kinase ecty. in acute<br />

myocardial infarction, 414<br />

characteristics of creatine kinase-MB and MB<br />

isoforms in serum after reperfusion in acute<br />

myocard. infarct, 2179<br />

cm. and anal, evain. of different methods for<br />

mess, of creatine kinase iaoenzyme MB (SN),<br />

130<br />

cm. comparison of Helena REP vs Kodak<br />

Ektachem creatine kinase MB slide in<br />

patients with suspected acute myocardial<br />

infarction (A), 1125<br />

creatine kinase isoforms in ischemic heart<br />

disease(R),7<br />

diagnosis of acute myocardial infarction from<br />

two measurements of creatine kinase<br />

isoenzyme MB with use of nonparametric<br />

probability estn,, 444<br />

diagnosis of acute myocardial infarct, when<br />

skeL muscle damage is present: a caveat<br />

regarding use of creatine kinase isoenzymes<br />

(L), 705<br />

diagnostic utility of serum total creatine kinase<br />

and creatine kinase-2 in myocardial<br />

infarction re-evaluated, 1435<br />

ECG evidence of myocardial infarction without<br />

cardiac isoenzymes abnormalities (A), 1116<br />

effect of therapeutic coronary reperfusian on<br />

serum aspartata aminotransferase<br />

isoenzymes in patients with acute<br />

myocardial infarction (A), 1116<br />

effects of therapeutic coronary reperfusion on<br />

aspartate aminotransferase isoenzymes in<br />

sara of patients with acute myocardial<br />

infarct,, 909<br />

evolution of serum CK-MB isofarms after<br />

acute myocardial infarction (A), 1120<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

heterogeneity of serum creatine kinase<br />

isoenzyme MM in myacardial infarction:<br />

chin. significance and post-synthetic<br />

conversion of “abnormal” sub-bands, 206<br />

high alanine aminotransferase activities in<br />

phasma, hearts in patients with acute<br />

myocardial infarction, 279<br />

IgA-CK-BB complex with CK-MB<br />

electrophoretic mobility can lead to<br />

erroneous diagnosis of acute myocard.<br />

infarct, (CR), 2003<br />

immunochemical vs ehectrophoretic CK-MB<br />

detns. in early detection of acute myocardial<br />

infarction (A), 1125<br />

measurements of apolipoprotein A-I and B in<br />

normal individuals and in survivors of<br />

myocardial infarction (A), 1073<br />

rate of release of CK isoforms into serum of<br />

patients with myocardiahinfarction treated<br />

with thrombohysis (L), 1264<br />

reducing misdiagnosis of myocardial infarct.<br />

(L), 1801<br />

role of CK subforms in thrombolytic therapy:<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2393


early diagnosis and assessment of efficacy<br />

(A), 1050<br />

role of rapid immunoasaays for urgent detns, of<br />

creatine kinase isoenzyme MB (SN), 1752<br />

sensitive, rapid assay of subforms of creatine<br />

kinase MB in plasma, 1452<br />

two kits for CK-MM isoforms evald, for early<br />

recognition of acute myocardial infarction<br />

(TB), 493<br />

use of creatine kinase MB isoforms for<br />

predicting myocardial reperfusion (A), 1125<br />

variation in decision thresholds for CK and<br />

CK-2 in myocardial infarction (A), 1116<br />

Myocardial Ischemia<br />

myocardial response to ischemia and<br />

reperfusion: effects of preconditioning on<br />

myocardial metabolism and infarction (A),<br />

1049<br />

patterns of lactate dehydrogenase isoenzymes 1<br />

and 2 in serum on exercise (SN), 301<br />

Myoghobln<br />

automated nephehometricimmunoassa)r of<br />

myoghobin with novel shell/core particles<br />

(A), 1092<br />

development of monochonal antibodies to<br />

human myoglobin and their use in<br />

fluorescence immunoassay (A), 1203<br />

interaction between pyridine nucheotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

isoln. and charactern. of myoglobin and its two<br />

major isoforms from sheep heart, 778<br />

quant. detn. of myoghobin by a latex-enhanced<br />

turbidimetric assay (A), 1091<br />

Myoglobinuria<br />

(Wake Forest University Case Conference):<br />

myoglobinuria, hemoghobinurie, acute renal<br />

failure (CC), 1713<br />

Natal chemistry<br />

See Pediatric chemistry, Newborns, Pregnancy<br />

National Committee for <strong>Clinical</strong> Laboratory<br />

Standards<br />

See NCCLS<br />

NCCLS<br />

chin, chem, analyzer evald. by NCCLS<br />

guidelines for use ins military field lab, unit<br />

(SN), 2223<br />

NCCLS evaln. protocols EP-5 (precision), EP-<br />

6 (linearity), and EP-lO (preliminary<br />

evalustion) tested with an unsuitable Ce<br />

method (AAS) (A). 1099<br />

NCCLS publications, 715, 2141<br />

Neonates<br />

See also Newborns<br />

cocaine and pregnancy: chin, and toxicol.<br />

implications for the neonate (5), 1276<br />

critical anal. and chin, aspects of ionized Cain<br />

neonates (R), 2027<br />

diagnostic test for mucopolysaccharidosis I.<br />

direct method for quantg. excessive<br />

glycosaminoghycan excretion, 374<br />

urinary<br />

diagnostic test for mucopohysaccharidosis. LI.<br />

rapid quantn. of glycosaminoghycan in urine<br />

samples on a paper matrix, 2074<br />

effect of hematocrit and added heparmn on Ca2<br />

in capillary blood from neonates (SN), 486<br />

enzyme-linked immunosorbent assay of<br />

apolipoprotein B in blood spatted onto filter<br />

paper, suitable for neonatal screening, 1000<br />

125IRLA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

hipoprotain(a) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

moderate I deficiency, possible explanation for<br />

inverse relation between cord serum<br />

thyrotropin and birth weight in a normal<br />

Kenyan popn. (L), 710<br />

purifn., characterization of intact lactoferrin<br />

found in the urine of human milk-fed<br />

pretarm infants, 1928<br />

quant. anal. for org. acids in biol, samples:<br />

batch isolation followed by gas<br />

chromatog.-mass spectrom. anal., 587<br />

screening for deficiency of aj-proteinase<br />

inhibitor (SN), 1971<br />

sources of imprecision in screening for<br />

congenital hypothyroidism: anal, of 9 y of<br />

performance data, 1701<br />

three direct spectrophotometric methods for<br />

detn. of total biirubin in neonatal and adult<br />

serum, adapted to the Technicon RA-1000<br />

analyzer (SN), 1980<br />

total digoxin-like immunoreactive factor(s),<br />

total biirubin concn., and birth wt, in<br />

neonates (L), 192<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

usefulness of lecithin/sphingomyehin ratio and<br />

uselessness of phosphatmdyhghyceroh detns. in<br />

tracheal aspirates from preterm infants (L),<br />

706<br />

Neopterin<br />

concns. of neopterin in serum<br />

renal allografts (L), 2157<br />

of recipients of<br />

generalized likelihood ratio concept and<br />

logistic regression anal, for multiple<br />

diagnostic categories, 990<br />

neopterin as a predictive marker for disease<br />

progression in human immunodeficiency<br />

virus type 1 infection (SN), 1746<br />

neopterin mess, in serum, tissue culture<br />

supernates by competitive enzyme-linked<br />

immunosorbant assay, 1467<br />

simultaneous detn. of serum neoptarin and C-<br />

reactive protein as markers of infection in<br />

heart-transplant recipients (TB), 1258<br />

urinary neopterin concns, vs total neopterins<br />

for chin. utility (SN), 2305<br />

Nephelometric Immunoassay<br />

automated nephehometric immunoassay of IgE<br />

with novel shell/core particles (A), 1092<br />

automated nephehometric immunoassay of<br />

myoghobin with novel shell/core particles<br />

(A), 1092<br />

Nephelonietry<br />

See also Rate nephelometry<br />

designing a reliable calibrator for<br />

nephehometric epa A-I and B assays (A),<br />

1073<br />

microalbuminuria in rats and humans (A),<br />

1137<br />

nephelometric detn. of C-reactive protein (A),<br />

1197<br />

nephehometricmethod for quantitating HbF<br />

(A), 1199<br />

nephehometric prealbumin assay on the BA-<br />

1000 (A), 1203<br />

rheumatoid factors deed, by fluorescence<br />

immunoassay: comparison with qual. and<br />

quant. methods (SN), 464<br />

Nephropathy<br />

albuminuria and progression of diabetic<br />

nephropathy (A), 1237<br />

effect of exercise training on glycemic control,<br />

kidney function, and renal ultrastructure in<br />

obese (diabetic) Zucker rats (A), 1135<br />

Nervous system disorders<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd. familial<br />

amyloidotic pohyneuropathy (SN), 1033<br />

Netilmicin<br />

fluorescence poharn. immunoassay of<br />

gentamicin or netilmicin<br />

filter paper (SN), 867<br />

in blood spotted on<br />

Neural development<br />

cell and substrate adhesion molecules<br />

embryonic and neural development<br />

in<br />

(S), 738<br />

Neural tube defects<br />

chemiluminescent enzyme immunoassay of a-<br />

fetoprotain with adamantyh dioxetane<br />

phenyl phosphate as substrate (SN), 2319<br />

evahn, of Abbott IMx immunoaaaay analyzer<br />

for maternal serum ahpha-fetoprotain<br />

screening of open neural tube defect and<br />

Down syndrome (A), 1195<br />

prospective study of Abbott AFP-EIA as an aid<br />

in detection of fetal neural tube defect (A),<br />

1192<br />

Neuramlnic acid<br />

See also Sialic acid<br />

methods for detg. “reference changes” from<br />

serial measurements: plasma lipid-bound<br />

sialic acid, 972<br />

Neuraminldase<br />

See Siehidase<br />

Neurobhsstoma<br />

chin. signif. of genetic rearrangements in<br />

neuroblastomas (S), B38<br />

Neurological disease<br />

HPLC anal, for serotonin and tryptamine<br />

excreted in urine after oral loading with L-<br />

tryptophan, 43<br />

Neutrophil elastase<br />

screening far deficiency of ai-proteinase<br />

inhibitor (SN), 1971<br />

Newborns<br />

See also Neonates, Pediatric chemistry<br />

anal. of supplemented vit, K1 (20) in serum<br />

microsamples by solid-phase extrn, and<br />

narrow-bore HPLC with multichannel uv<br />

detection (S), 1288<br />

antipyrine interferes with chem. detn. of Br- in<br />

simultaneous estn, of total body H20 and<br />

extracelluhar H20, 1367<br />

apphn. of Magic Lita<br />

immunochemihuminometric method for<br />

measurement of creatine kinsse-MB in blood<br />

spots (A), 1123<br />

bedside monitoring for neonatal intensive care<br />

patients (A), 1241<br />

bronchopulmanary dysphasia-current<br />

concepts (A), 1241<br />

chin. lab, team assessment of nutritional status<br />

of low-birth-wt, infants-I (A), 1237<br />

chin. lab. team assessment of nutritional status<br />

of how-birth-wt. infants-IL (A), 1238<br />

cord blood hipoprotain(s) in blacks and whites<br />

(A), 1065<br />

detn. of bihirubin in neonatal serum with<br />

Abbott A-Gent neonatal bilirubin reagent<br />

(A), 1151<br />

digoxin-hike immunoreactivity in neonates and<br />

infants minimized by centrifugal<br />

ultrafiltration and FPIA (A), 1163<br />

fluorescence poharn. immunoassay of<br />

gentamicin or netilmicin in blood spotted on<br />

filter paper (SN), 867<br />

immunoassay of neonstal hTSH in paper discs<br />

using time-resolved fluorescence (A), 1139<br />

lab, assessments of nutritional status of lowbirth-wt,<br />

infants (A), 1238<br />

microsssay for screening newborns for<br />

galactosemia with use of a fhuorometric<br />

microphate reader (SN), 1962<br />

neonatal phenyhalanine screening using the<br />

Encore centrifugal analyzer (A), 1153<br />

neonatal screening for congenital<br />

hypothyroidism with LKB Delfia<br />

TSH kit (A), 1152<br />

neonatal<br />

NMR in viva: experience in a neonatal ICU<br />

(A), 1058<br />

nutritional needs and assessment in very-law<br />

birthweight infants (A), 1060<br />

role of the lab. in management of the growing<br />

very-low-birth.wt. infant (A), 1238<br />

simultaneous hiq.-chromatog. detn. of vit. K1,<br />

vit, E in serum, 2285<br />

spectrophotometric stat detn. of HbCO in<br />

microsamphes (A), 1163<br />

stability of hemaghobins A, F, 5, and C in dried<br />

neonatal whole-blood samples when<br />

analyzed by cation-exchange HPLC (A),<br />

1152<br />

Niacin<br />

effect of light on reactions between N’-<br />

methyhnicotinamide and methyl ketones<br />

(TB), 2000<br />

Nicotine<br />

caffeine interference eliminated in HPLC detn,<br />

of urinary nicotine and cotinine, 1456<br />

Nicotinic acetylchohlne receptors<br />

genes encoding neuronal nicotinic<br />

acetylchohine receptors (5), 731<br />

Nitrogen<br />

comparison of sample preparation techniques<br />

for measurement of total N in stool and food<br />

samples by chemihuminescence (A), 1114<br />

Nomenclature<br />

glossary for molecular biology(S), 1816<br />

Nonesterified fatty acids<br />

See Fatty acids<br />

Nonthyroldah illness<br />

concn, of free thyroxin in serum during<br />

nonthyroidal ihlnesa-cahcn. or mess,? (SN),<br />

159<br />

direct and indirect techniques for free thyroxin<br />

compared in nonthyroidal illness I. effect of<br />

free fatty acids, 102<br />

four nonisotopic immunoassays of free<br />

thyroxin evald, (SN), 115<br />

Norepinephrlne<br />

reversed-phase HPLC sepn. of plasma<br />

norepinephrine,<br />

with 3-electrode<br />

epmnephrine,<br />

coulometric<br />

and dopamine,<br />

detection (SN),<br />

1975<br />

Normal values<br />

See Reference interval<br />

Nuclear magnetic resonance<br />

anal, for homogentisic acid by NMR<br />

spectrometry on diagnosis of alkaptonuria<br />

(L), 1806<br />

NMR in vivo: experience in a neonatal LCU<br />

(A), 1058<br />

proton NMR studies of plasma to determine<br />

metab. status of patients with adult reap.<br />

distress syndrome (SN), 667<br />

rapid, reliable in vivo assays of phosphate<br />

metabohites by NMR, 392<br />

Nucleic acids<br />

appin. of a rapid non-radioisotopic nucleic acid<br />

anal. system to the detection of sexually<br />

transmitted disease-causing organisms and<br />

assocd. antimicrobial resistances (5), 1571<br />

use and applns. of nucleic acid probes in the<br />

chin. lab. (S), 1819<br />

2394 CLINICAL CHEMISTRY,Vol.35, No. 12, 1989


Nucheosides<br />

extn. of intracellular nucleosides and<br />

nucheotides with acetonitrile, 48<br />

Nucleotides<br />

extn. of intracellular nucheosides and<br />

nucheotides with acetonitrile, 48<br />

Nutritional status<br />

amino acid anal, for nutritional assessment by<br />

Pica-Tag HPLC: precision studies, ref.<br />

ranges, and correlations with ion-exchange<br />

method (A), 1113<br />

assessment of protein calorie malnutrition<br />

using serum prealbumin (A), 1112<br />

chin, lab, team assessment of nutritional status<br />

of how-birth-wt, infants-I (A), 1237<br />

chin, lab. team assessment of nutritional status<br />

of how-birth-wt. infants-IL (A), 1238<br />

concns. of carotenoids, retinal, and tocopheroh<br />

in phssma after a meal (SN), 310<br />

lab. assessments of nutritional status of howbirth-wt.<br />

nutritional<br />

infants (A), 1238<br />

needs and assessment in very-how<br />

birthweight infants (A), 1060<br />

quantn. Mn in lymphocytes to assess Mn<br />

nutrit. status, 1939<br />

serum prealbumin hevela in normal individuals<br />

of various age; and in patients with AIDS (A),<br />

1115<br />

short- and hong-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

solid-phase sample extn. for rapid detn. of<br />

methylnialonic acid in serum, urine by stable<br />

isotope dilution, 260<br />

usefulness of date on albumin and prealbumin<br />

concns, in detg. effectiveness of nutrit., 271<br />

Znprotoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Oak Ridge Conference<br />

introduction(S), 1815<br />

Occult blood<br />

cm. effective screening of asymptomatic<br />

patients for fecal occult blood loss requires<br />

lab. assistance (L), 2337<br />

Cohoscreen VPI test kit evald. for detection of<br />

fecal occult blood, 156<br />

comparison of two comm. available<br />

immunological occult blood tests and a<br />

guaiac slide test (A), 1162<br />

“Fecatwin Sensitive” test for fecal occult blood<br />

not intended for use without testing positives<br />

with the FECA-RIA assay (L), 1555<br />

Octanoic acid<br />

HPLC anal, of brain and plasma for octanoic,<br />

decanoic acids, 1945<br />

Oligoclonal bands<br />

ohigoclonal banding detected by urinary<br />

protein ehectrophoresis and immunofixation<br />

in two patients with AIDS and proteinuria<br />

(CR), 1795<br />

oligochonal banding in serum from hearttransplant<br />

recipients, 431<br />

oligochonal immunoghobulin bands in HTLV-Iassociated<br />

myelopathy (A), 1085<br />

sensitive and specific procedure for detecting<br />

ohigoclonal banding in CSF by agarose gel<br />

ehectrophoresis (A), 1082<br />

(TB), 1997<br />

three methods for demonstration of ohigochonal<br />

bends of LgG in CSF compared (A), 1085<br />

Oncogenes<br />

proto-oncogene abnormalities in human cancer<br />

(A), 1057<br />

Opiates<br />

evain. of TLC technique for detection of<br />

opiates in urine (A), 1173<br />

Organic acidopathies<br />

quant. anal, for org. acids in bioL samples:<br />

batch isolation followed by gas<br />

chromatog.-masa<br />

Organic acids<br />

spectrom. anal., 587<br />

biochem. contribution to diagnosis and study<br />

of a new case of D-glyceric acidemia/aciduria<br />

(CR), 2148<br />

calculated HCO3- or total C02?, 1697<br />

glyoxal: an artefact from metronidazole and<br />

ghyoxyhic acid in urinary org. acid anal. (TB),<br />

673<br />

organic acids and drug interference in<br />

measurement of CO2 concn, by Kodak<br />

Ektachem 700(A), 1156<br />

quant. anal. for org. acids in bioL samples:<br />

batch isolation followed by gas<br />

chromatog.-masa spectrom. anal., 587<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

Organ transplants<br />

comparison of cyclosporine assays in pediatric<br />

patients<br />

1168<br />

receiving organ transplants (A),<br />

comparison of cychosporine immunoassay<br />

methods: examination of rejection and<br />

nephrotoxic episodes in liver transplantation<br />

(A), 1183<br />

delta and conjugated bilirubins as predictors of<br />

early liver allograft rejection are unaffected<br />

by cytomegalovirus infection (A), 1137<br />

detn, of cychosporine<br />

with a monoclonal<br />

in plasma: specific<br />

antibody and hiq.<br />

RLA<br />

chromatog. compared, 608<br />

digoxin-hike immunoreactive substances in<br />

post-liver transplantation patients with<br />

positive fluid balance (A), 1144<br />

distribn, of cychosporin A metabolites among<br />

plasma and cells in whole blood: effect of<br />

temp., hematocrit, and metabohite concn,, 59<br />

enzyme immunoassay measurement of serum<br />

interleukin-2 receptor in heart-transplanted<br />

patients (A), 1155<br />

heart disorders and concentrations of directly<br />

measured atrial natriuretic peptide in<br />

plasma, 435<br />

impact of meal timing on bioavailabihity of<br />

cychosporine in CsA-treated renal allograft<br />

recipients post-transphantetion (A), 1179<br />

mess, of cyclosporine concns. in whole blood:<br />

HPLC and RIA with a specific monoclonal<br />

antibody and 3H- or ‘251-habehedhigand<br />

compared (SN), 120<br />

nonsehective measurements of cychosporin A in<br />

transplant patient specimens by RIA with a<br />

monochonal antibody and I’tracer (A),<br />

1164<br />

prognostic value of MEGX liver-function test<br />

in transplant candidates (A), 1135<br />

Ornithine decarboxylase<br />

more on ornithine decarboxyhase (L), 897<br />

Osteoarthritis<br />

activities of dipeptidyl peptidsse LI and<br />

dipeptidyl peptidase LVin synovial fluid<br />

from patients with rheumatoid and<br />

osteoarthritis, 1016<br />

Osteocalcin<br />

effects of estrogen on mineral metab, in<br />

poatmenopausal women as evald, by multiple<br />

assays measuring parathyrin bioacty., 18<br />

osteocalcin: biol. variations and ref. limits (A),<br />

1126<br />

RIA of osteocalcin with polychonal and<br />

monochonal antibodies, 1408<br />

simultaneous “sandwich” enzyme<br />

immunoassay for measuring human<br />

osteocalcin using antibodies against<br />

synthetic peptides (A), 1208<br />

solid-phase enzymoimmunoaasay for<br />

osteocalcin in serum or plasma, with use of a<br />

monochonal antibody, 2087<br />

Osteochasts<br />

immunoassay of band 5 (“tartrate-resistent”)<br />

acid phosphatase involving use of antiporcine<br />

uteroferrin antibodies, 86<br />

Osteoporosis<br />

effects of estrogen on mineral metab. in<br />

postmenopausah women as evald, by multiple<br />

assays measuring parathyrin bioacty., 18<br />

improved method for cahcg. Ca fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

osteoporosis 1989 (A), 1053<br />

solid-phase enzymoimmunoessay for<br />

osteocalcin in serum or plasma, with use of a<br />

monochonal antibody, 2087<br />

Ovulation<br />

evahn. of new consumer test for lutropin (A),<br />

1146<br />

hormonal evaln, of female infertility,<br />

reproductive disorders (CC), 620<br />

predicting ovulation in in-vitro fertilization<br />

program by monitoring huteinizing<br />

hormone/creatinine ratio in random urine<br />

samples (A), 1144<br />

rapid enzyme immunoassay for visual,<br />

semiquant. deth. of lutropin in urine for<br />

ovulation prediction (A), 1148<br />

solid-phase enzymoimmunoassay of estrone in<br />

saliva, 569<br />

Oxalate<br />

effect of citrate on urinary excretion of Ca and<br />

oxalate: relevance to Ca oxahate<br />

nephrohithissis, 23<br />

enzymatic detn, of urinary oxalate (SN), 2330<br />

enzymatic method for oxalata automated with<br />

the Cobas Fara centrif, analyzer (SN), 2094<br />

improved urinary oxalate method for a centrif.<br />

analyzer (L), 1806<br />

oxalata is overestd. in elk. urines collected<br />

during administration of HCO3 with no<br />

specimen pH adjustment (SN), 2107<br />

Oxpentifylline<br />

simultaneous detn, of pentoxifylline and three<br />

metabohites in bioh, fluids by liq. chromatog.<br />

(SN), 298<br />

Oxygen<br />

reliability of detn, of whole-blood 02 affinity<br />

with blood-gas analyzers and multiwavelength<br />

oximeters, 773<br />

Oxygen free radicals<br />

effect of hypoxia and oxygen free radicals on<br />

liver lysosomes (A), 1137<br />

free radical ablation for organ preservation (A),<br />

1051<br />

02-derived free radicals in postischemic tissue<br />

injury (A), 1050<br />

Pancreatic disease<br />

detn. of a2-macroghobulin-trypsin complex<br />

with a new synthetic substrate, 2169<br />

fecah chymotrypsin: suitable test for diagnosing<br />

pancreatic insufficiency (A), 1090<br />

immunocatalytic assay of pancreatic a-amyhase<br />

in serum and urine with a specific<br />

monochonal antibody (SN), 662<br />

immunohog.-derived pancreatic amyiase,<br />

pancreatic lipase, and total amyhase<br />

compared as predictors of pancreatic<br />

inflammation (TB), 1542<br />

mechanism of action of pancreatic and salivary<br />

a-amyhase on 4,6-ethyhidene-a-4-<br />

nitrophenyhmaltoheptaoside substrate (L),<br />

188<br />

staining method for use in ehectropharetic<br />

detn, of amyhase isoenzymes in serum (SN),<br />

2322<br />

time-resolved immunofluarometric assay of<br />

pancreatic isoamyhase in serum, with use of<br />

two monochonal antibodies, 1915<br />

Pancreatic oncofetal antigen<br />

pancreatic oncofetal antigen and carbohydrate<br />

antigen 19-9 in sera of patients with<br />

pancreatic cancer, 405<br />

Pancreatitis<br />

diagnostic value of measuring pancreatic hipase<br />

and the P3 isoform of pancreatic amyhase<br />

isoenzyme in serum of hospitalized<br />

hyperamyhasemic patients, 417<br />

hyperamyhaaemia and a-amylase isoenzymes in<br />

acute liver congestion due to cardiac<br />

circulatory failure (TB), 1793<br />

immobilized anti-salivary amyhase antibody<br />

interacts with macroamylases: implications<br />

for use in a pancreatic amylase assay to<br />

distinguish mecroamylasemia from acute<br />

pancreatitis, 1651<br />

hipase acty. measured in serum by a<br />

continuous-monitoring PH-Stat<br />

technique-update, 1688<br />

measuring carboxypeptidase A acty. with a<br />

centrif, analyzer: anal, and chin,<br />

considerations, 251<br />

methods compared for detg. total arty. and<br />

isoenzymes of amylase in serum (SN), 645<br />

pancreatic amyhase in serum for differential<br />

diagnosis of acute pancrestitis, acute<br />

abdominal diseases (TB), 2142<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamylsse in serum, with use of<br />

two monochonal antibodies, 1915<br />

Pai’aproteins<br />

hgC heavy-chain subclass typing of myehoma<br />

paraproteins by isoehectric focusing<br />

immunoblot anal,, 364<br />

strategy for diagnosis of monochonal<br />

gammopathies<br />

Parathyrin<br />

in serum (L), 508<br />

essay of “intact” parathyrin in the immediate<br />

and hong-term postoperative follow-up of<br />

patients treated for hyperparathyroidism or<br />

thyroid tumor (L), 340<br />

din, utility of intact and total immunoreactive<br />

parathyroid hormone immunoassays (A),<br />

1148<br />

development and validation of<br />

immunochemihuminometric assay for whole<br />

molecule and N-terminal parathyroid<br />

hormone (A), 1147<br />

diagnostic efficacy of Magic Lite intact<br />

parathyrin assay (A), 1187<br />

effects of estrogen on mineral metab. in<br />

postmenopausal women as evald, by multiple<br />

assays measuring parathyrin bioacty., 18<br />

interference with mess, of intact parathyrin in<br />

serum from renal dialysis patients (TB),<br />

1543<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2395


performance, diagnostic appln. of a twa-site<br />

immunoradiometric assay for parathyrin in<br />

serum (SN), 1957<br />

serum parathyroid hormone in hemodialysis<br />

patients (A), 1140<br />

twa-site immunochemiluminometric assay of<br />

intact parathyrin with use of a tracer peptide<br />

purified by reversed-phase hg. chromatog.,<br />

215<br />

use of affinity chromatog. in developing<br />

chemihuminescent-labeled antibodies for a<br />

parathyrin immunametric assay (A), 1210<br />

Particle-enhanced immunoassay<br />

evaln, of a particle-enhanced immunoassay for<br />

quantifying C-reactive protein (TB), 2001<br />

Pauclalbuminuria<br />

See Albumin<br />

Pco,<br />

See Blood gases<br />

Pediatric chemistry<br />

See also Fetal status, Heritable disorders,<br />

Neonates, Newborns<br />

anal, of supplemented vit, K1 (20) in serum<br />

microsamphes by solid-phase extrn, and<br />

narrow-bore HPLC with multichannel uv<br />

detection (S), 1288<br />

appln. of a silver-binding assay to detn. of<br />

protein in CSF (SN), 860<br />

circadian variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

comparison of cychosporine assays in pediatric<br />

patients receiving organ transplants (A),<br />

1168<br />

comparison of hutropin immunoreactivity in<br />

serum by RIA and time-resolved<br />

fluorescence fmdings in serum from normal<br />

children and those treated with LHRH<br />

analogs (A), 1150<br />

cychosporine measured in plasma from patients<br />

with various transplants: HPLC and RLA<br />

with a specific monochonal antibody<br />

compared (SN), 1726<br />

detn, of trans-phylloquinone in children’s<br />

serum (SN), 874<br />

diagnostic test for mucopolysaccharidosis I.<br />

direct method for quantg. excessive urinary<br />

glycosaminoghycan excretion, 374<br />

fluorescence polarn. immunoassay of<br />

gentamicin or netilmicin in blood spotted on<br />

filter paper (SN), 867<br />

HPLC anal. of brain and plasma far octanoic,<br />

decanoic acids, 1945<br />

1251.RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

managing of lipids by diet, exercise, and drugs<br />

in pediatric patients (A), 1061<br />

nonenzymatic stopped-flow fluorimetry for<br />

direct detn, of uric acid in serum and urine,<br />

230<br />

optimized microturbidimetric assay for<br />

fibrinogen, 211<br />

ratio of serum aspartate to alanine<br />

aminotransferase as a prognostic index in<br />

pediatric liver disease (A), 1151<br />

scheme for detecting elevated CK-MB in<br />

children (A), 1109<br />

serum phylloquinone concns. in a normal popn.<br />

of children as compared with ref. interval in<br />

adults (TB), 671<br />

transient increase of sweat electrolyte cancna,<br />

associated with environmental deprivation<br />

(A), 1153<br />

Zn protoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Pelvic inflammatory disease<br />

concns. of tumor-associated trypsin inhibitor<br />

and C-reactive protein in serum in acute<br />

pelvic inflammatory disease (SN), 869<br />

Penicilhinase<br />

prostatic inhibin-like peptide in urine of<br />

prostatic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

Pentoxlfyhhine<br />

simultaneous detn. of pentoxifylline and three<br />

metabohites in bioL fluids by hiq. chromatog.<br />

(SN), 298<br />

Pepsinogen<br />

pepsin and pepsinogen group I levels in human<br />

gastroduodenal biopsies (A), 1126<br />

Peptide hormones<br />

automation and interpretation of quantn. of<br />

antibodies to therapeutic proteins,<br />

illustrated with somatotrapin, 1623<br />

chemilumineacent assay of alk. phosphatase<br />

applied in an ultrasensitive enzyme<br />

immunoassay of thyrotropin. 1441<br />

hormonal evaln, of female infertility,<br />

reproductive disorders (CC), 620<br />

immunoradiometry of corticotropin with use of<br />

avidin-biotin sepn., 804<br />

improved RLA of atrial natriuretic peptide in<br />

plasma, 1431<br />

influence of matrix on concns, of somatotropin<br />

mess. in serum with commercial<br />

immunoradiometric assays, 1423<br />

new immunoradiometric assay for<br />

corticotropin evald, in normal subjects and<br />

patients with Cushing’s syndrome, 596<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neophssia, and assessment of<br />

effects of organ failure, 1631<br />

units for peptide hormones (L), 189<br />

Peptldes<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd, familial<br />

amyloidotic pohyneuropathy (SN), 1033<br />

simultaneous “sandwich” enzyme<br />

immunoassay for measuring human<br />

osteocaicin using antibodies against<br />

synthetic peptides (A), 1208<br />

Peritoneal carcinosis<br />

alpha slow-moving HDL subfraction in serum<br />

of a patient with radiation enteritis and<br />

peritoneal carcinosis (CR), 674<br />

Peroxidase<br />

acetaminophen as substrate for peroxidase (A),<br />

1122<br />

Hb peroxidaae acty. for coupled enzymatic<br />

reactions (A), 1122<br />

Peroxides<br />

plasma malondialdehyde, lipid peroxides, and<br />

the thiobarbituric acid reaction (L), 336<br />

Peroxisomal defects<br />

hong-chain aliphatic fatty acids and phytanic<br />

acid simultaneously measured by dualcolumn<br />

capillary chromatog. (SN), 1989<br />

pH<br />

development and evaln, of device for<br />

measuring body fluids (A), 1129<br />

hipase acty. measured in serum by a<br />

continuous-monitoring PH-Stat<br />

technique-update, 1688<br />

variations in protein binding<br />

plasma, serum (SN), 1722<br />

of drugs in<br />

Pharmacokinetics<br />

adv. in cychosporine pharmacol., measurement,<br />

and ther. monitoring<br />

antipyrine, indocyanine<br />

(5), 1299<br />

green, and horazepam<br />

detd. in plasma by HPLC (SN), 2124<br />

arginine pharmacokinetics assessed with an<br />

enzymatic assay adapted to a centrif.<br />

analyzer (SN), 1024<br />

cyclosporine metabolism impeded/blocked by<br />

co-administration of phenobarbital (A), 1160<br />

cyclosporine pharmacokinetics with<br />

concomitant ketoconazohe therapy (A), 1176<br />

detn. of physostigmine in plasma and CSF by<br />

liq. chromatog. with ehectrochem, detection<br />

(SN), 292<br />

deth. of serum deaipramine and 2-<br />

hydroxydesipramine for pharmacokinetic<br />

apphna. by HPLC with uv detection (SN),<br />

2134<br />

orgn. of a chin, pharmacokinetics service (A),<br />

1354<br />

pharmacokinetics and biotransformation of<br />

cychosporine metebohita,M-17 (A), 1164<br />

quantn. of Sr in plasma and urine with<br />

flamehess at. absorp. spectrom., 1911<br />

relevance of pharmacokinetics to monitoring<br />

new antiarrhythmics (S), 1332<br />

simultaneous detn, of pentoxifylhine and three<br />

metabolites<br />

(SN), 298<br />

Pharmacology<br />

adv. in cychosporine pharmacol.,<br />

in bioL fluids by hiq. chromatog,<br />

measurement,<br />

and ther. monitoring(S), 1299<br />

Phencycidine<br />

frequency of low-level PCP in urine specimens<br />

for drug screening (A), 1182<br />

Phenehzlne<br />

indirect therapeutic drug monitoring by<br />

measurine monoamine oxidase actys. from<br />

platelets rA), 1175<br />

Phenobarbital<br />

See also Barbiturates<br />

cychosporine metabolism impeded/blocked by<br />

co-administration of phenobarbital (A), 1160<br />

dry-chem. multilayer immunoassay tests for<br />

phenytoin and phenobarbital (A), 1196<br />

mess. of carbamazepine, phenobarbital,<br />

EMIT<br />

and theophylhline in the “Monarch” centrif,<br />

analyzer (L), 895<br />

evaln, of the Ames Seralyzer for therapeutic<br />

drug monitoring of phenobarbitah, phenytoin<br />

(TB), 324<br />

monoclonal turbidimetric<br />

phenobarbital<br />

assay for<br />

on the RA-1000’” system (A),<br />

1172<br />

Phenoxynaphthahenesulfonic<br />

acid<br />

multilayer fluorescence immunoassay<br />

technique (S), 1865<br />

Phenylalanine<br />

fluorometric method for phenylalanine<br />

microplate assay adapted for<br />

phenyhketonuria screening (SN), 2112<br />

HPLC mess, of phenylalanine by direct<br />

injection of plasma onto an internal-surface<br />

reversed-phase silica support, 975<br />

neonatal phenylalanine screening using the<br />

Encore centrifugal analyzer (A), 1153<br />

proton NMR studies of plasma to determine<br />

metab. status of patients with adult reap.<br />

distress syndrome (SN), 667<br />

Phenylketonuria<br />

fluorometric method for phenyhahanine<br />

microplate assay adapted for<br />

phenylketonuria screening (SN), 2112<br />

HPLC mess, of phenyhalanine by direct<br />

injection of plasma onto an internal-surface<br />

reversed-phase silica support, 975<br />

Phenytoin<br />

dry-chem. multihayer immunoassay tests for<br />

phenytoin and phenobarbital (A), 1196<br />

effect of serum albumin on displacement of<br />

phenytoin by ceftriaxone and nafcillin (A),<br />

1176<br />

evaln, of the Ames Seralyzer for therapeutic<br />

drug monitoring of phenobarbital, phenytoin<br />

(TB), 324<br />

four fluorescence polarization immunoassays<br />

for therapeutic drug monitoring evald,, 138<br />

TDM assays by fluorescence polarization on<br />

Cobas Fara II’”: detn, of serum N-<br />

acetylprocainamide, theophylhine,and<br />

phenytoin (A), 1178<br />

Phosphate<br />

See Phosphorus<br />

Phosphatidylglycerol<br />

evahn. of PG-Numeric’” test for semiautomated<br />

anal. of phosphatidyhghyceroh in<br />

amniotic<br />

multicenter<br />

fluid (A), 1072<br />

evahn. of TDx test for assessing<br />

fetal hung maturity, 1005<br />

usefulness of hecithin/sphingomyehin<br />

uselessness of phosphatidylghycerol<br />

ratio and<br />

detns. in<br />

tracheal aspirates from preterm infants (L),<br />

706<br />

Phosphatldylserlne<br />

ELISA method to measure antibodies to<br />

cardiohipin and phosphatidylserine (A), 1207<br />

Phospholipids<br />

improved staining of thin-layer chromatograms<br />

of amniotic fluid phosphohipids (TB), 1539<br />

phosphohipidsurface tension: diagnostic utility<br />

of amniotic fluid and its lipid extract, an<br />

anal, of the value of pptn. with cold acetone,<br />

800<br />

Phosphorus<br />

new single-vial reagent for detn. of P with<br />

autoblanking capability (A), 1129<br />

rapid, reliable in viva essays of phosphate<br />

metabohites by NMR, 392<br />

tumoral calcinosis: seasonal biochem. studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

Phylloquinone<br />

detn. of trans-phyiloquinone in children’s<br />

serum (SN), 874<br />

serum phylloquinone concns. in a normal popn.<br />

of children as compared with ref. interval in<br />

adults (TB), 671<br />

Physician’s office testing<br />

evaln. of a dry reagent digoxin immunometric<br />

assay on a physician’s office analyzer (A),<br />

1109<br />

evahn, of Mihes Chinistat compact “dry-chem.”<br />

analyzer for physician’s office and satellite<br />

lab, testing (A), 1106<br />

performance of Reflotron amyhase and<br />

bihirubin test methods in two physicians<br />

office labs. (A), 1093<br />

photometric microtiter strip technique for<br />

doctor’s office lab (A), 1209<br />

physician office evaln, of Chininiate’” digoxin<br />

and theaphyhline systems (A), 1099<br />

recent advances in instrumentation for use in<br />

physicians’ offices and public health<br />

screening programs (A), 1232<br />

two-center evaln, of physician’s office chem.<br />

analyzer (Clinistat) for cholesterol anal. (A),<br />

1102<br />

2396 CLINICAL CHEMISTRY, Vol.35, No. 12, 1989


Physostigmine<br />

detn, of physostigmine in plasma and CSF by<br />

hiq. chromatog. with ehectrochem. detection<br />

(SN), 292<br />

Phytanic acid<br />

lang-chain aliphatic fatty acids and phytanic<br />

acid simultaneously measured by dualcolumn<br />

capillary chromatog. (SN), 1989<br />

phytanic acid, pristanic acid, and very-hongchain<br />

fatty acid methyl esters mess.<br />

simultaneously by capillary gas chromatog.<br />

(L), 703<br />

Pigmented nodular adrenal dysplasia<br />

decreased dehydroepiandrosterone sulfate in<br />

pigmented nodular adrenal dysphasia (SN),<br />

2216<br />

Pineal function<br />

salivary melatonin estn, in assessment of<br />

pineal-gland function (L), 514<br />

Pituitary<br />

new immunoradiometric assay for<br />

corticotrapin evald. in normal subjects and<br />

patients with Cushing’s syndrome, 596<br />

Phasmapheresis<br />

falsely elevated IgG indices in CSF of<br />

plssmapheresed patients (A), 1158<br />

Phasminogen<br />

streptokinase binds to lactate dehydrogenase<br />

subunit-M, which shares an epitope with<br />

plasminogen, 69<br />

Plasmlnogen activator<br />

impact of immediate acidification of blood on<br />

measurement of plasma tissue phssminogen<br />

activator (tPA) arty. in surgical patients<br />

(TB), 1999<br />

Plasminogen activator inhibitor<br />

standn, of methods for mess. phasminogen<br />

activator inhibitor acty. in plasma, 787<br />

Platelets<br />

indirect therapeutic drug monitoring by<br />

measuring monoamine oxidase actys. from<br />

platelets (A), 1175<br />

lactate dehydrogenase isoenzyme compn. of<br />

platelets (SN), 2325<br />

platelet-derived ATP may contribute to<br />

measured concn. of inorg. pyrophosphate in<br />

serum (TB), 326<br />

platelet LDH isoenzymes (A), 1134<br />

Platinum<br />

DNA binding differences of active and inactive<br />

platinum anticancer drugs shown by agarose<br />

electrophoresis of restriction endonuclease<br />

fragments of drug-treated DNA (A), 1077<br />

Pleural effusions<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN), 166<br />

P02<br />

See Blood gases<br />

Pohyamine oxidase<br />

polyamines assayed by HPLC with<br />

electrochem, detection after post-column<br />

reaction with immobilized pohyamine<br />

oxidsse, 1694<br />

Polyamines<br />

pohyaminea assayed by HPLC with<br />

electrochem. detection after post-column<br />

reaction with immobilized polyamine<br />

oxidsse, 1694<br />

Pohyamino acids<br />

surface characterization of polystyrene (A),<br />

1190<br />

Polychromatic analysis<br />

urine eppln. for Abbott Spe.trum and VP<br />

using Abbott liq. amylase reagent (A), 1102<br />

Polycystic kidney disease<br />

mapping the locus of autosomal dominant<br />

polycystic kidney disease: diagnostic appln.<br />

(S),B13<br />

Pohycystic ovarian disease<br />

steroid profile for urine: ref. values, 2281<br />

Polymerase chain reaction<br />

applicn. of polymerase chain reaction (PCR) to<br />

detection of human retroviruses (A), 1058<br />

automated DNA sequencing methods involving<br />

polymerase chain reaction, 2196<br />

detection of HIV proviral DNA in peripheral<br />

blood mononuclear cells by pohymerase chain<br />

reaction (A), 1076<br />

detection of HIV-1 RNA by pohymerase chain<br />

reaction (A), 1076<br />

evaln. of parameters that influence pohymerase<br />

chain reaction (A), 1076<br />

prenatal diagnosis of hemoghobinopathies by<br />

using pohymerase chain reaction and allelespecific<br />

ohigonucleotide probes (S), 1854<br />

use of pohymerase chain reaction for diagnosis<br />

of inherited disorders (5), 1843<br />

Porphobilinogen<br />

liq.-chromatog, assay of urinary<br />

porphobilinogen (SN), 471<br />

sensitive method of screening for urinary<br />

porphobilinogen (SN), 2311<br />

Porphyria<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyrmns, 2290<br />

hiq.-chromatog, assay of urinary<br />

porphobihinogen (SN), 471<br />

sensitive method of screening for urinary<br />

porphobihinagen (SN), 2311<br />

Porphyrinogens<br />

quantn. of urinary porphyrins by hiq.<br />

chromatog. after oxidn, of porphyrinogens,<br />

1619<br />

Porphyrins<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyrins, 2290<br />

investigation of protoporphyrin IX std.<br />

materials used in acid-extn. methods;<br />

proposed correction for the millimohar<br />

absorptivity of protoporphyrin IX, 1601<br />

loss of porphyrmns from sohn, during anal.:<br />

effect of sample pH and matrix on porphyrin<br />

quanth. in urine by HPLC (SN), 1508<br />

quantn. of urinary porphyrmns by hiq.<br />

chromatog. after oxidn. of porphyrmnogens,<br />

1619<br />

resolution of issues in HPLC anal. of urinary<br />

porphyrmns (A), 1157<br />

thin-layer chromatog. of free porphyrms for<br />

diagnosis of porphyria (SN), 1043<br />

Potassium<br />

See also Electrolytes<br />

development of human serum ref. materials to<br />

unify Na, K results in serum to their natl,<br />

ref. systems (A), 1130<br />

enzymatic detn, of K in serum, 817<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns, (CR), 333<br />

performance of Technicon calorimetric K<br />

method on the RA-100’ system (A), 1130<br />

statis. interpretn. of concns. of Mg, Zn, Ca, K,<br />

choheaterols, and creatine kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

Potentiometry<br />

See also Ehectrochemicah detection, Ionselective<br />

electrodes<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns. (CR), 333<br />

influence of aspirin on in vitro direct<br />

potentiometry of Cl- in serum (TB), 2146<br />

Power curves<br />

between-run component of variation in<br />

internal qual. control, 1416<br />

Prevastatin<br />

specific RIA for measuring pravastatin in<br />

human serum (A), 1189<br />

Prealbuniin<br />

See also Tranathyretin<br />

assessment of protein calorie malnutrition<br />

using serum prealbumin (A), 1112<br />

direct, indirect techniques for free thyroxin<br />

compared in patients with nonthyroidal<br />

illness. II. effect of prealbumin, albumin,<br />

thyroxin-binding globulin, 1655<br />

immunoturbidimetry of prealbumin<br />

(transthyretin) in a microcentrifugal<br />

analyzer (TB), 178<br />

liq. chromatog. assay for free and<br />

transthyretin-bound retinol-binding protein<br />

in serum, 582<br />

nephelometric prealbumin assay on the RA-<br />

1000 (A), 1203<br />

serum prealbumin hevels in normal individuals<br />

of various age; and in patients with AIDS (A),<br />

1115<br />

usefulness of date on albumin and prealbumin<br />

concns, in detg. effectiveness of nutrit., 271<br />

Pregnancy<br />

algorithm for testing and reporting serum<br />

choriogonadotropin at cm, signif. decision<br />

levels with use of “pregnancy test” reagents,<br />

545<br />

choriogonadotropin discriminatory zone and<br />

ultrasonography (L), 2019<br />

cocaine and pregnancy: chin, and toxicol,<br />

implications far the neonate (5), 1276<br />

comparison of intact and beta-subunit hCG<br />

levels in maternal serum with normal and<br />

aborting pregnancy (A), 1136<br />

confusion about the discriminatory zone and<br />

choriogonadotropin stds. (L), 2336<br />

correln, of HbAic, glycated serum proteins and<br />

albumin, and fructosamine with 24-h glucose<br />

profile of insulin-dependent pregnant<br />

diabetics, 922<br />

hiq.-chromatog. detn, of acetyhated Hb, 33<br />

longitudinal study of thyroid function in<br />

pregnancy, 275<br />

low-normal concna, of free thyroxin in serum in<br />

hate pregnancy physiol. fact, not tech.<br />

artefact, 1891<br />

new technique for measuring free thyroxin in<br />

serum: multi-center study (SN), 2137<br />

oral glucose tolerance test does not provide a<br />

uniform stimulus to pancreatic islets in<br />

pregnancy, 1482<br />

RLA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neophasia, and assessment of<br />

effects of organ failure, 1631<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

salivary progesterone excellently reflects free<br />

and total progesterone in plasma during<br />

pregnancy (SN), 168<br />

serum lipid and apolipoprotein changes in<br />

normal pregnancy (A), 1066<br />

standn. of methods for mess. phasminogen<br />

activator inhibitor acty. in plasma, 787<br />

“stat” measurements of L-lactate in whole<br />

blood and CSF assessed (SN), 1740<br />

three methods compared for estg. testosterone<br />

and estradiol not bound to sex-hormonebinding<br />

globulin (SN), 632<br />

urinary excretion of some proteins and<br />

enzymes during normal pregnancy (SN),<br />

1978<br />

variables involved in evaluating maternal<br />

serum alpha-fetoprotein: albumin, total<br />

protein and fructosamine (A), 1159<br />

Prenatal diagnosis<br />

See also Amniotic fluid, Fetal status, Heritable<br />

disorders<br />

chemihuminescent enzyme immunoessay of a-<br />

fetoprotein with adamantyh dioxetane<br />

phenyl phosphate as substrate (SN), 2319<br />

prenatal diagnosis of hemoghobinopathiea by<br />

using pohymerase chain reaction and allelespecific<br />

oligonucheotide probes (S), 1854<br />

use of pohymerase chain reaction for diagnosis<br />

of inherited disorders (5), 1843<br />

use of the polymerase chain reaction for<br />

simultaneous anal, of two Pst I<br />

polymorphisms linked to cystic fibrosis<br />

(TB), 1260<br />

Pristanic acid<br />

phytanic acid, pristanic acid, and very-longchain<br />

fatty acid methyl esters mess.<br />

simultaneously by capillary gas chromatog.<br />

(L), 703<br />

Probes<br />

enzymatic amplification of RNA purified from<br />

crude cell hysata by reversible target capture<br />

(5), 1878<br />

prenatal diagnosis of hemoghobinopathies by<br />

using polymerase chain reaction and allelespecific<br />

ohigonucheotide probes (S), 1854<br />

quant. assays based on use of rephicatabhe<br />

hybridization probes (S), 1826<br />

quantn. of residual DNA in biol. products (5),<br />

1859<br />

use and appins. of nucleic acid probes in the<br />

chin, lab, (S), 1819<br />

Procainamide<br />

development of automated latex agglutination<br />

immunoassay for procainamide for IL<br />

Monarch’” chem. system (A), 1171<br />

four fluorescence polarization immunoassays<br />

for therapeutic drug monitoring evald., 138<br />

Pro-cathepsin<br />

two-site immunoenzymometric assay of 52-kDe<br />

pro-cathepsin D; use in breast diseases, 234<br />

Procollagen<br />

IRMA for serum type III procohlagen peptide<br />

using monochonal antibodies (A), 1188<br />

Proficiency testing<br />

See also Interleboratory performance<br />

effectiveness of proposed CDC/HCFA criteria<br />

to assess intralab. performance through<br />

proficiency testing programs (A), 1088<br />

external assessment of lab, cholesterol<br />

measurements using patients specimens (A),<br />

1069<br />

proficiency testing in a med.-needs context (0),<br />

347<br />

proficiency tasting on drugs of abuse: one<br />

year’s experience in Spain (SN), 879<br />

use of patient samples to evaluate accuracy of<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2397


theophyhhmne proficiency tasting performance<br />

evalns, (A), 1184<br />

Progesterone<br />

development of enhanced luminescence<br />

immunoassay for progesterone (A), 1149<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerlex cortisol, Biodata testosterone (SN),<br />

641<br />

estrogen and progesterone receptor assays, by<br />

the EIA method (Abbott), of how-speed<br />

supernates of breast-cancer homogenates<br />

(SN), 2226<br />

preliminary appraisal of a PR-EIA kit for<br />

quantifying progesterone receptors in breastcancer<br />

tissue (L), 339<br />

quantn. of progesterone in human serum using<br />

the Amerhita system (A), 1205<br />

relative importance of estrogen<br />

progesterone receptor assays<br />

and<br />

as prognostic<br />

indicators in primary breast cancer shortterm<br />

study, 238<br />

salivary progesterone excellently reflects free<br />

and total progesterone in plasma during<br />

pregnancy (SN), 168<br />

Progesterone receptors<br />

effect of ether or ketamine anesthesia on rat<br />

uterine estrogen, progesterone receptors<br />

(SN), 143<br />

measurement of estrogen and progesterone<br />

receptors in breast tumors using steroidbinding<br />

assays and monoclonal enzyme<br />

immunoassays (A), 1138<br />

Progestin receptors<br />

influence of O.C.T. embedding compd. on<br />

detns. of estrogen and progestin receptors in<br />

breast cancer (SN), 2317<br />

Proinsulin<br />

improved RIA of C-peptide and its appln. in a<br />

multiyear study, 37<br />

Prolactin<br />

evaln. of rapid, automated ELISA method for<br />

prohactin (A), 1188<br />

rapid automated detn. of total prolactin on the<br />

Stratus analyzer (A), 1095<br />

serum prohactmn as a rejection marker in heart<br />

transplantn. (TB), 492<br />

Prostate<br />

evaln, of kinetic method for prostatic acid<br />

phosphatase with use of self-indicating<br />

substrate, 2,6-dichhoro-4-nitrophenyl<br />

phosphate, 939<br />

PAP and PSA as markers of proatatic<br />

carcinoma (A), 1191<br />

RIA of fl-microseminoprotein, a prostaticsecreted<br />

protein in sera of men and women,<br />

1497<br />

Prostate-specific antigen<br />

anal, sensitivity of prostate-specific antigen<br />

Tandem-E enzyme immunometric assay<br />

(A), 1078<br />

measuring decision values for prostate-specific<br />

antigen in serum (A), 1077<br />

more on “hook effects” in immunometric<br />

assays for prostate-specific antigen (L), 1262<br />

(L), 2154<br />

PAP and PSA as markers of prostatic<br />

carcinoma (A), 1191<br />

prostate-specific antigen and the female<br />

prostate (L), 507<br />

Prostatic acid phoaphatase<br />

See Acid phosphatase<br />

Prostatic inhibin-like peptide<br />

prostatic inhibin-hike peptide in urine of<br />

prostatic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

Proteinase inhibitor<br />

functional, immunalog. concns. of a2-<br />

macroghobulin compared in plasma of<br />

subjects without ai-protaase inhibitor<br />

deficiency (SN), 1535<br />

screening for deficiency of a1-proteinase<br />

inhibitor (SN), 1971<br />

Protein<br />

C<br />

functional acty. of protein S detd. with use of<br />

protein C activated by venom activator, 1644<br />

simultaneous “sandwich” enzyme<br />

immunoassay for protein C using monochonal<br />

antibodies (A), 1208<br />

Protein G<br />

autoantibodies to lactate dehydrogenase in<br />

serum identified by use of immobilized<br />

Protein G and immobilized jacalin, a<br />

jackfruit hectin, 2190<br />

Proteins<br />

accuracy of total protein and albumin system<br />

specific values for SMA, SMAc-3, RA-1000,<br />

Assist, and Demand compared with the ref.<br />

method for T. protein and a comparative<br />

method for albumin (A), 1104<br />

apphn. of a silver-binding assay to detn. of<br />

protein in CSF (SN), 860<br />

bichromatics for total protein detn, (A), 1159<br />

Biotrol urine proteins reagent using pyrogalhoh<br />

red-Mo complex (A), 1082<br />

changes in Fe, Zn, Cu concns. in serum and in<br />

their binding to transport proteins after<br />

chohecystectomy, cardiac surgery (SN), 2243<br />

din. applns. of high-resolution 2-D<br />

ehectrophoresis of proteins: comparative<br />

anal, by 2DE of proteins in high-resolution<br />

agarose electrophoresis bands and current<br />

med. indications for 2DE anal, of serum<br />

proteins (A), 1083<br />

computerized quant. anal, of Coomassie-Bhuestained<br />

serum proteins sepd. by twodimensional<br />

ehectrophoresis, 2297<br />

detn. of protein concn, in human breast milk<br />

using Coomassie Brilliant Blue on the<br />

Fara centrifugal analyzer (A), 1082<br />

Cobas<br />

distribn, of thiobarbituric acid-reactive<br />

substances in hipoprateins,proteins in serum,<br />

2054<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerhex-M progesterone,<br />

Amerlex cortisoh, Biadata testosterone (SN),<br />

641<br />

effect of thyroid hormone-binding proteins and<br />

fatty acids on modified analog assays of FT4<br />

and FT3 in serum (L), 708<br />

estn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

evaln. and performance characteristics of<br />

Paramax anal. system for detg. spinal fluid<br />

and urine protein with liq. Coomassie<br />

user-defined chem. (A), 1112<br />

Blue<br />

evahn. of Kodak slides for CSF protein assays<br />

(A), 1090<br />

evahn. of liquid immunology control using the<br />

Beckman Array (A), 1154<br />

evaln, of Paragon high-resolution<br />

electrophoresis system (A), h085<br />

functional acty. of protein S deed. with use of<br />

protein C activated by venom activator, 1644<br />

immunohistochem, studies utilizing<br />

monoclonal and pohyclonal antibodies to c-<br />

erbB-2 protein (A), 1079<br />

immunoturbidimetry of serum protens with<br />

the Behring “Turbitimer” (TB), 2144<br />

interference of plasma expanders in detn. of<br />

total protein (TB), 2143<br />

intra-individual variation of electrophoretic<br />

serum protein fractions (TB), 1544<br />

isolation of “cystic fibrosis protein” from<br />

serum, 1901<br />

isoln. and charactern. of myoglobin and its two<br />

major isoforms from sheep heart, 778<br />

micro-method for total protein in CSF, using<br />

benzethonium chloride in microtiter plate<br />

wells (SN), 1731<br />

performance characteristics of CSF protein on<br />

Paramax (A), 1084<br />

performance characteristics of urine protein on<br />

Paramax (A), 1084<br />

purifn., characterization of intact lactoferrin<br />

found in the urine of human milk-fed<br />

preterm infants, 1928<br />

S-100a0 protein in blood and urine during<br />

open-heart surgery, 1942<br />

sepn., identn, of urinary proteins and stonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate-polyacrylamide gel electrophoresis<br />

(SN), 658<br />

serum proteins, immunoghobulin, and<br />

complement (C3& C4)levels in Down’s<br />

syndrome in Kuwait sample (A), 1081<br />

simple procedure for evaluating thyroxinbinding<br />

proteins abnormalities in euthyroid<br />

hyperthyroxinemia and hypothyroxinemia<br />

(A), 1150<br />

total protein deed, in breast milk by use of<br />

Coomassie Brffliant Blue and centrif, anal.<br />

(SN), 2127<br />

urinary excretion of some proteins and<br />

enzymes during normal pregnancy (SN),<br />

1978<br />

urine protein 1: sex-dependent marker of<br />

tubular or glomerular dysfunction (TB),<br />

2141<br />

(Wake Forest University Case Conference):<br />

myoghobmnurie, hemoglobinuria, acute renal<br />

failure (CC), 1713<br />

Proteinuria<br />

electrophoretic examin. of proteinuria in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

improved pyrogallol red-Mo method for detg.<br />

total urinary protein (SN), 2233<br />

Lp(s) lipoprotein concn, in serum of patients<br />

with heavy proteinuria of different origin<br />

(SN), 2121<br />

ohigochonal banding detected by urinary<br />

protein electrophoresis and immunofixation<br />

in two patients with AIDS and proteinuria<br />

(CR), 1795<br />

proteinuria (R), 755<br />

Prothrombln<br />

correction of instrument- and reagent-based<br />

differences in detn, of the mt. normalized<br />

ratio for monitoring anticoagulant therapy<br />

(SN), 840<br />

interference of coumarmn therapy with the<br />

“Heptest” owing to declining prothrombin<br />

concns. (SN), 483<br />

new chromogenic substrate for detn. of<br />

prothrombin time with the Reflotron5 (A),<br />

1161<br />

Protoporphyrin<br />

effect of ingestion of hemoproteins on fecal<br />

excretion of hemes and porphyrins, 2290<br />

empirically deed. Pb-poisoning screening cutoff<br />

for the Protofluor-Z hematofluorometar<br />

(SN), 2104<br />

interhab. comparison of control materials for<br />

use with hematofluorometers, 2059<br />

investigation of protoporphyrin IX sod.<br />

materials used in ecid-exth. methods;<br />

proposed correction for the milhimohar<br />

absorptivity of protoporphyrin IX, 1601<br />

Zn protoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Psoriasls<br />

complement C4 allotypes and psoriasis (TB),<br />

2142<br />

Psychotropic drugs<br />

See also Anticonvulsant drugs, Tricychic<br />

antidepressants, etc.<br />

Pulmonary disease<br />

See Lung disease<br />

Purines<br />

depressed activities of purine enzymes in<br />

lymphocytes of patients infected with HIV,<br />

1478<br />

Pyridine nucheotide cosnzymes<br />

interaction between pyridine nucleotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

Pyridoxal phosphate<br />

intercorrehations between direct and total<br />

phasma pyridoxah 5’ phosphate and social<br />

and therapeutic drug use, and health status<br />

(A), 1136<br />

monochonal antibodies evald, for use in<br />

screening for conjugates of human serum alb.<br />

and pyridoxah 5’-P04 (SN), 1756<br />

simple hq.-chrometog. method for vit. B6 cmps.<br />

in plasma, 241<br />

Pyroglutamic acidemla<br />

pyroglutamic acidemia in an adult (CR), 684<br />

Pyrophosphate<br />

platelet-derived ATP may contribute to<br />

measured concn. of inarg. pyrophosphate in<br />

serum (TB), 326<br />

Pyruvate<br />

multipoint kinetic simultaneous mess. of<br />

combined concns, of acetoacetate-$hydroxybutyrate<br />

and hactate-pyruvate (SN),<br />

1526<br />

pyruvate mess. in whole blood with the Cobas<br />

Bia analyzer (TB), 325<br />

Pyruvate kinase<br />

enzymatic detn. of K in serum, 817<br />

Quality control<br />

allowable limit of error in cm. chem. qual.<br />

control (SN), 630<br />

apphn. of Quality Management System<br />

microcomputer quah.-cantroh program in the<br />

RIA/endocrine lab. (A), 1086<br />

between-run component of variation in<br />

internal qual. control, 1416<br />

choosing quah.-control systems to detect max.<br />

chin. allowable anal. errors, 284<br />

continuing need for qual. assessment of<br />

cyclosporine measurement (S), 1309<br />

counting errors: effect on immunoassay<br />

precision, 1362<br />

development and evaln. of quality-assurance<br />

program based on interlab. comparison (A),<br />

1160<br />

differences between alk. phosphatase activities<br />

in serum and lyophihized controls in AMP<br />

buffer explained (L). 510<br />

2398 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


evaln. of a new linearity material (A), 1096<br />

improved RIA of C-peptide and its appin. in a<br />

muhtiyear study, 37<br />

individual home glucose meters evaluated by<br />

routine chin, lab, methods (A), 1142<br />

new mt. tamp. scale of 1990 (ITS-90) (SR), 503<br />

qual. control of glucose monitors outside the<br />

chin, lab.: use of commercial nonhuman<br />

erythrocyte prepns. supplemented with<br />

glucose (L), 509<br />

quality assurance study of gentamicin usage<br />

and monitoring in a children’s hospital (A),<br />

1167<br />

quality-control program for evaluating and<br />

monitoring multiple-site reflectance glucose<br />

analyses (A), 1160<br />

quality-management approach to preventing<br />

lab, testing mistakes (A), 1087<br />

serum-based quality control fluids and<br />

calibrators: lyophilization vs vacuum-drying?<br />

(A), 1101<br />

whole-blood quality-control material for<br />

Reflotron assays of cholesterol (TB), 1255<br />

Quinidine<br />

four fluorescence polarization immunoessays<br />

for therapeutic drug monitoring evald,, 138<br />

latex agglutination inhibition immunoassay for<br />

quinidine on the IL Monarch chem. system<br />

(A), 1172<br />

Rabbits<br />

normal biochem. and hematol, values in New<br />

Zealand White rabbits (SN), 1777<br />

Race-related differences<br />

cord blood hipoprotein(a) in blacks and whites<br />

(A), 1065<br />

racial and age-related differences in incidence<br />

of monochonal gammopathy of uncertain<br />

significance (A), 1154<br />

racial and other differences of maternal serum<br />

a-fetoprotein in a large obstetrical<br />

population (A), 1136<br />

Radial immunodiffusion<br />

comparative measurements of apolipoprotein<br />

B by immunonephehometry and radial<br />

immunodiffusion (A), 1069<br />

enzyme-linked immunosorbent assay of<br />

apohipoprotein<br />

paper, suitable<br />

B in blood spotted onto filter<br />

for neonatal screening, 1000<br />

four immunochem, methods compared for<br />

mess, C-reactive protein in plasma (SN), 461<br />

high concns. of Zna2-ghycoprotain and lack of<br />

a2HS-ghycoprotein in ejaculates, 1649<br />

hipoprotein(a) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

liq. chromatog. assay for free and<br />

transthyretin-bound retinoh-binding protein<br />

in serum, 582<br />

mess, of apohipoprotein B in plasma from<br />

hyperlipidemic subjects treated with<br />

cholestyramine or placebo: differential<br />

effects of storage at -70 #{176}C, 380<br />

rate immunonephehometry, radial<br />

immunodiffusion compared for<br />

apolipoproteins Al and B assay (SN), 2236<br />

Radial partition immunoassay<br />

Baxter Stratus evaluated as anal. system (A),<br />

1111<br />

evaln, of Baxter Dade Stratus as a stat method.<br />

for human choriogonadotropin, digoxin, and<br />

digitoxin (A), 1111<br />

evaln, of radial partition immunoassay for<br />

quantn. of IgE (A), 1199<br />

rapid automated detection of human 1gM<br />

antibody to hepatitis B core antigen (A),<br />

1206<br />

rapid automated detn. of total prohactin on the<br />

Stratus analyzer (A), 1095<br />

Radiation enteritis<br />

alpha slow-moving HDL subfraction in serum<br />

of a patient with radiation entaritis and<br />

peritoneal carcinosis (CR), 674<br />

Radioassay<br />

25-hydroxyvitamin D and 1,25-<br />

dihydroxyvitamin D deed, in serum by<br />

“SPE-octadecyl (C18)” cal, extraction and<br />

radioassay (TB), 1995<br />

Radioenzymatic assay<br />

rapid detn, of total homocystemne in plasma<br />

(TB), 2002<br />

Radioimmunoassay<br />

assessment of screening program for congenital<br />

adrenal hyperplasia in Portugal based on<br />

antibody-coated tube RIA for 17a-OH<br />

progesterone (L), 2338<br />

automated enzyme immunoassay for hutropin<br />

(Abbott IMx analyzer) (SN), 2333<br />

binding of labeled thyroxin analog to serum<br />

proteins evald. after RIA of free thyroxin<br />

(SN), 475<br />

chin, utility of intact and total immunoreactive<br />

parathyroid hormone immunoassays (A),<br />

1148<br />

comparison of Centocor CA 19-9, Tandem-R<br />

CA 195, and Truquant GI (A), 1078<br />

comparison of free testosterone by analog RIA<br />

and ultrafiltration (A), 1148<br />

concn. of free thyroxmn in serum during<br />

nonthyroidal ihhness-calcn. or meas.? (SN),<br />

159<br />

counting errors: effect on immunoassay<br />

precision, 1362<br />

cyclosporin A mess, in plasma in various<br />

transplant types by HPLC and RIA (A),<br />

1356<br />

cychosporine concns. in blood after liver<br />

transplantn.: correlation of immunoassay<br />

results with chin, events, 564<br />

cyclosporine measured in plasma from patients<br />

with various transplants: HPLC and RIA<br />

with a specific monoclonal antibody<br />

compared (SN), 1726<br />

decreased immunoreacty, and binding acty. of<br />

corticosteroid-bmnding globulin in serum in<br />

septic shock, 1675<br />

detection of serum CK-MB isoforms by RIA<br />

(A), 1121<br />

detn. of cychosporine in plasma: specific<br />

with a monochonal antibody and hiq.<br />

RIA<br />

chromatog. compared, 608<br />

direct and indirect techniques for free thyroxin<br />

compared in nonthyroidal illness I. effect of<br />

free fatty acids, 102<br />

direct detn. of free thyroxin in undiluted serum<br />

by equilibrium diahysis/RIA (L), 510<br />

direct, indirect techniques for free thyroxin<br />

compared in patients with nonthyroidal<br />

illness. II. effect of prealbumin, albumin,<br />

thyroxin-binding globulin, 1655<br />

discordant RIA results for thyroxin-binding<br />

giobuhin (TBG): new indicator of variant<br />

TBG molecules with decreased affinity for<br />

thyroxin (TB), 1257<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerhex-M progesterone,<br />

Amerhex cortisoh, Biodata testosterone (SN),<br />

641<br />

enzyme-linked immunosorbent assay for free<br />

thyroxmn in serum (SN), 1770<br />

estimation of true values in RIAs, 1680<br />

evaln, of an RIA of urinary cortisol without<br />

extrn. (SN), 125<br />

evahn. of Corning magnetic particle RIA for<br />

free T3 (A), 1207<br />

evaln. of RIA kit for detn. of free insulin:<br />

effects of sample handling and storage (A),<br />

1144<br />

evahn, of six direct 17fl-estradiol RIA kits and<br />

comparison with an in-house extn, RIA (A),<br />

1150<br />

exposure to environmental tobacco smoke<br />

measured by cotinine ‘251-RIA (SN), 1036<br />

five cannabinoid immunosssay systems<br />

compared at the screening threshold of 100<br />

ig/L (SN), 2241<br />

heart disorders and concentrations of directly<br />

measured atrial natriuretic peptide in<br />

plasma, 435<br />

improved RIA of atrial natriuretic peptide in<br />

plasma, 1431<br />

improved RIA of C-peptide and its apphn. in a<br />

multiyear study, 37<br />

influence of matrix on concns, of somatotropin<br />

mess, in serum with commercial<br />

immunoradiometric assays, 1423<br />

investigation of sex-hormone-binding globulin<br />

interference in direct RIAs for testosterone<br />

and estradiol, 979<br />

‘251-RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

heukotriene B4 is measurable in serum of<br />

smokers and nonsmokers (SN), 459<br />

low-dose monitoring of haloperidol (A), 1179<br />

mess, of cychospormne concns, in whole blood:<br />

HPLC and RIA with a specific monochonal<br />

antibody and 3H- or mnIlabehed higand<br />

compared (SN), 120<br />

mess, of urinary heukotrienes by reversedphase<br />

hiq. chromatog. and RIA, 388<br />

measurement of benzodiazepines in urine by<br />

double-antibody RIA (A), 1175<br />

neopterin mess, in serum, tissue culture<br />

supernates by competitive enzyme-linked<br />

immunosorbant assay, 1467<br />

new immunoradiometric assay for<br />

corticotropin evald. in normal subjects and<br />

patients with Cushing’s syndrome, 596<br />

nonselective measurements of cyclospormn A in<br />

transplant patient specimens by RIA with a<br />

monoclonal antibody and I-tracer (A),<br />

1164<br />

19-O-carboxymethyh ether derivative of<br />

testosterone: its immunogenicity and<br />

radiohigand for RIA of testosterone (A), 1200<br />

one-step estradiol RIA with use of pre-reacted<br />

double-antibody system (A), 1198<br />

prostatic inhibin-hike peptide in urine of<br />

prostatic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

reservations regarding assessment of data<br />

obtained with commercially available<br />

cortisol RIA kits (L), 2153<br />

RIA for measurement of natural and Rh<br />

erythropoietin in patient sera (A), 1191<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

RIA of 5-methozytryptophol in plasma (SN).<br />

1749<br />

RIA of -microseminoprotein, a prostaticsecreted<br />

protein in sera of men and women,<br />

1497<br />

RIA of osteocalcin with polychonal and<br />

monochonal antibodies, 1408<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

sensitive radiobmnding assay for measuring<br />

autoantibodies to thyroperoxidsse in human<br />

serum (A), 1208<br />

simple method for free insulin by a RIA kit (A),<br />

1146<br />

solid-phase enzymoimmunoassay for<br />

osteocalcin in serum or plasma, with use of a<br />

monoclonal antibody, 2087<br />

specific RIA for measuring new thromboxane<br />

antagonist, SQ 30,741, in plasma (A), 1189<br />

specific RIA for measuring pravastatin in<br />

human serum (A), 1189<br />

specific RIA for measuring SQ 31,765 in human<br />

serum (A), 1189<br />

turbidimetric latex immunoassay of placental<br />

lactogen on microtiter plates, 141<br />

1988 version of two-step immunoextn. assay for<br />

PT4: chin, performance (A), 1144<br />

whole-blood cychosporin A: comparison of<br />

monoclonal antibody RIA with HPLC (A),<br />

1100<br />

Radioreceptor assay<br />

digoxin drug-drug interactions investigated<br />

with a human myocardial Na’iK-ATPsse<br />

radioreceptor assay (A), 1168<br />

radioreceptor assay for endogenous digitalishike<br />

substances using microsomal fractions<br />

from human placenta (A), 1140<br />

receptor assay for cyclosporine acty. in whole<br />

blood (A), 1167<br />

Random-access analysis<br />

adaptation of drugs of abuse testing to<br />

Synchron CX4 and CX5 chin, analyzers<br />

(A), 1178<br />

adaptation of six DGKC enzymes and<br />

chohinestarase to Synchron CX5 at 30#{176}C<br />

and 37#{176}C (A), 1126<br />

adaptation of Syva assays for drugs of abuse on<br />

the Olympus Reply lab. analyzer (A), 1174<br />

adaption of Syva EMIT TDM assays to the 550<br />

Express (A), 1170<br />

automated detn. of urinary NaF, K, C1, P1,<br />

urea, and creatinine without sample dun.<br />

with the “RAT-XT” (SN), 481<br />

cardiac enzyme measurement with Eur.<br />

reagents using Ciba Corning 550 Expresstm<br />

(A), 1118<br />

din. evahn, of Beckman Synchron CX5 chem.<br />

analyzer (A), 1103<br />

dry-chem. multihayer element for thyroid<br />

hormone uptake assay (A), 1195<br />

dry-chem. muhtihayer immunoassay for total<br />

thyroxin (A), 1180<br />

dry-chem. multilayer immunoassay test for<br />

theophylline (A), 1196<br />

dry-chem. multilayer immunoassay tests for<br />

phenytoin and phenobarbital (A), 1196<br />

enzymatic detn, of K in serum, 817<br />

evaln, and performance characteristics of<br />

Paramax anal. system for detg. spinal fluid<br />

and urine protein with hiq. Coomassie Blue<br />

user-defined chem, (A), 1112<br />

evaln, of Affinitytm automated immunosssay<br />

system (A), 1188<br />

evahn, of Baxter Paramax analyzer (A), 1111<br />

CLINICAL CHEMISTRY,Vol. 35, No. 12, 1989 2399


evaln. of Beckman Synchron CX5 analyzer (A),<br />

1108<br />

evaln. of Biotrol bicarbonate reagent on Abbott<br />

Spectrum (A), 1091<br />

evain. of carryover on Synchron CX#{174}4 and<br />

CX5 (A), 1109<br />

evain. of Syva EMIT’ d.a.u. appins. on 550<br />

Express (A), 1170<br />

evahn. of TDM available on the DuPont<br />

Dimension (A), 1096<br />

evahn. of user-defined reagents on Beckman<br />

Synchron CX’ and CX5 din, systems (A),<br />

1097<br />

measurement of serum digoxin using CEDIAW<br />

reagents and the RA-1000 (A), 1183<br />

modified enzymatic approach to measure blood<br />

urea N on the Technicon RA-1000’ (A), 1104<br />

modified IFCC reagents for ALT and AST<br />

testing on Ciba Corning 550 Express (A),<br />

1118<br />

monoclonal turbidimetric assay for<br />

phenobarbitah on the RA.l000” system (A),<br />

1172<br />

nephehometric prealbumin assay on the RA-<br />

1000 (A), 1203<br />

performance characteristics of automated<br />

random-access analyzer Cobas Mira#{174} for<br />

measurement of drugs of abuse (A), 1097<br />

performance of CEDIAtm Digoxin R assay on<br />

Technicon RA1000tm chem. analyzer (A),<br />

1171<br />

performance of Technicon Chem-1#{176}1 analyzer<br />

for quant. measurement of 10 anahytes in<br />

urine (A), 1130<br />

performance of theophylline, gentamicin,<br />

tobramycin, phenytoin, and digoxin reagents<br />

on the Beckman Synchron CX’4 (A), 1181<br />

random-access technol.: evaln. of Technicon<br />

AXONtm system (A), 1105<br />

random-access technol.: evahn. of Technicon<br />

DAX’” system (A), 1104<br />

rapid self-contained immunoassay for human<br />

thyrotropin (A), 1195<br />

Synchron CXTM 4/5 system meets cholesterol<br />

accuracy goals of nath. cholesterol education<br />

program (A). 1071<br />

Technicon tobramycin and gentamicin: secondgeneration,<br />

improved methods on the RA-<br />

1000 system (A), 1172<br />

three direct spectrophotometric methods for<br />

detn. of total bihirubin in neonatal and adult<br />

serum, adapted to the Technicon RA-1000<br />

analyzer (SN), 1980<br />

urine Ca anal, using Beckman Synchron CX’3<br />

and Synchron CX5 chin, systems (A), 1132<br />

Rate immunonephelometry<br />

rate immunonephehometry, radial<br />

immunodiffusion compared for<br />

apolipoproteins Al and B assay (SN), 2236<br />

Rate nephelometry<br />

quantn. of z- and A-containing<br />

immunoglobuhins by rate nephehometry:<br />

comparison of two comm. reagent antisera<br />

(A), 1198<br />

Rats<br />

changes in concanavalin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

changes of growth-related<br />

growth factors following<br />

hormones and<br />

pneumonectomy: I.<br />

growth hormone (A), 1150<br />

genes encoding neuronah nicotinic<br />

acetyhchohine<br />

hiq. chromatog.<br />

receptors (S), 731<br />

assay for free and<br />

transthyretin-bound retinal-binding protein<br />

in serum, 582<br />

Receiver-operating characteristic curves<br />

See also Statistics<br />

diagnostic utility of serum total creatine kinase<br />

and creatine kinase-2 in myocardial<br />

infarction re-evaluated, 1435<br />

diagnostic value of measuring pancreatic lipase<br />

and the P3 isoform of pancreatic amylsse<br />

isoenzyme in serum of hospitalized<br />

hyperamylasemic patients, 417<br />

erythrocyte sedimentation rate and C-reactive<br />

protein compared in the elderly (SN), 466<br />

measuring carboxypeptidase A acty. with a<br />

centrif. analyzer: anal, and chin.<br />

considerations, 251<br />

relative operating characteristic curves used to<br />

compare drug screening immunosssays for<br />

amphetamine and methamphetamine (A),<br />

1175<br />

role of rapid immunoasssys for urgent detns. of<br />

creatine kinase isoenzyme MB (SN), 1752<br />

strategic use of individual and combined<br />

enzyme indicators for acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

Receptors<br />

effect of ether or ketamine anesthesia on rat<br />

uterine estrogen, progesterone receptors<br />

(SN), 143<br />

estrogen and progesterone receptor assays, by<br />

the EIA method (Abbott), of how-speed<br />

supernates of breast-cancer homogenates<br />

(SN), 2226<br />

genes encoding neuronal nicotinic<br />

acetyhchohine receptors (5), 731<br />

immunoenzymometric assay for antibody<br />

against human acetyhchohine receptor using<br />

precoated microtiter plate and receptor<br />

isolated from normal leg muscle (A), 1196<br />

preliminary appraisal of a PR-EIA kit for<br />

quantifying progesterone receptors in breastcancer<br />

tissue (L), 339<br />

relative importance of estrogen and<br />

progesterone receptor assays as prognostic<br />

indicators in primary breast cancer: shortterm<br />

study, 238<br />

specific binding of cardiac glycoside drugs and<br />

endogenous digitalis-hike substances to<br />

particulate membrane fractions from<br />

placenta, 2093<br />

Recombinant DNA<br />

anal, of serum antibodies to HIV using a<br />

multiple synthetic antigen-coated test strip<br />

(A), 1204<br />

antigens produced by recombinant DNA<br />

technol. (S), 1838<br />

evahn. of new recombinant ELISA immunoassay<br />

for detection of antibodies to HIV vs DuPont<br />

Western blot (A), 1204<br />

improved test for confirming antibodies to HIV<br />

using six recombinant peptides, including<br />

the intact gag gene-product, p24 (A), 1191<br />

measurement of antibodies to soluble CD4 by<br />

ELISA using recombinant CD4 (A), 1191<br />

performance of CEDIA’” T4 MAb and T-uptake<br />

assays on Technicon RA-1000’M (A), 1191<br />

recombinant DNA technol. in diagnosis of<br />

genetic disorders (5), B4<br />

update on cystic fibrosis: a molecular approach<br />

(A), 1057<br />

Recombinant RNA<br />

qusnt. assays based on use of rephicatable<br />

hybridization probes (5), 1826<br />

“Redox” reactions<br />

measurement of human ceruhoplasmin by its<br />

oxidase arty. using 4,4’-<br />

bis(dimethyhamino)diphenyhamine (A), 1082<br />

Reference interval<br />

automated enhanced latex agghutn. assay for<br />

rheumatoid factors in serum (SN), 303<br />

circadian variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

chin. chem. ref-intervals for healthy elderly<br />

(A), 1061<br />

cobalamin-bmnding capacity of haptocorrin and<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

detn. of Mg2 in granulocytes, 1404<br />

detn, of trans-phyhhoquinone in children’s<br />

serum (SN), 874<br />

diagnostic test for mucopohysaccharidosis. II.<br />

rapid quantn. of glycosaminoglycan in urine<br />

samples on a paper matrix, 2074<br />

effects of various serum proteins on quantn. of<br />

fructosamine (SN), 134<br />

enzyme-linked immunosorbent assay for<br />

chromogranin A, 1934<br />

estr.. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

immunoradiometry of corticotropin with use of<br />

avidin-biotin sepn., 804<br />

improved detn. of Va in biol, fluids by<br />

ehectrotherm. at. absorption spectrom. (SN),<br />

127<br />

improved method for calcg. Ca fractions in<br />

plasma: ref. values, effect of menopause, 14<br />

improved pyrogallol red-Mo method for detg.<br />

total urinary protein (SN), 2233<br />

‘251-RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

lactate dehydrogenase isoenzyme compn. of<br />

platelets (SN), 2325<br />

hiq.-chromatog. assay of urinary<br />

porphobihinogen (SN), 471<br />

measuring carboxypeptidaae A acty. with a<br />

centrif, analyzer: anal. and chin.<br />

considerations, 251<br />

measuring tissue factor (Factor III) acty. in<br />

plasma, 1897<br />

methods compared for detg. total acty. and<br />

isoenzymes of aznyhase in serum (SN), 645<br />

normal biochem. and hematol, values in New<br />

Zealand White rabbits (SN), 1777<br />

prepn. of fecal samples for assay of volatile<br />

fatty acids by gas-liq. chromatog. and<br />

HPLC, 74<br />

prostatic inhibin-hike peptide in urine of<br />

prostatic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

quantn. of urinary porphyrins by hiq.<br />

chromatog. after oxidn. of porphyrinogens,<br />

1619<br />

ref. intervals for hTSH by two automated<br />

ultrasensitive assays: London Diagnostics<br />

LumsTag’” and Abbott’s IMxtm (A), 1143<br />

ref. intervals for two bone-derived enzyme<br />

activities in serum: bone isoenzyme of elk.<br />

phosphatase and tartrate-resistant acid<br />

phosphatsse (TB), 180<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplssia, and assessment of<br />

effects of organ failure, 1631<br />

RIA of fl-microseminoprotein, a prostaticsecreted<br />

protein in sera of men and women,<br />

1497<br />

RIA of osteocalcin with polychonal and<br />

monochonal antibodies, 1408<br />

self-consistent set of ref. values for 23 chin.<br />

chem. anahytes, 448<br />

serum phylloquinone concns, in a normal popn.<br />

of children as compared with ref. interval in<br />

adults (TB), 671<br />

simple hiq.-chromatog. method for vit, B6 cmps.<br />

in plasma, 241<br />

solid-phase enzymoimmunoassay of estrone in<br />

saliva, 569<br />

somat.otropin as mess. by a two-site timeresolved<br />

immunofluorometric assay, 913<br />

staining method for use in ehectrophoretic<br />

detn. of amyisse isoenzymes in serum (SN),<br />

2322<br />

standn. of methods for mess, plasmmnogen<br />

activator inhibitor acty. in plasma, 787<br />

time-resolved immunofluorometric assay of<br />

pancreatic isoamyhase in serum, with use of<br />

two monoclonal antibodies, 1915<br />

two-site immunochemihuminometric assay of<br />

intact parathyrmn with use of a tracer peptide<br />

purified by reversed-phase 1mg.chromatog.,<br />

215<br />

Reference materials<br />

CAP-CDC cholesterol ref. materials study (A),<br />

1073<br />

CDC/NHLBI lipid standardization<br />

program-30 years of collaboration (A), 1073<br />

development of human serum ref. materials to<br />

unify Na, K results in serum to their nath.<br />

ref. systems (A), 1130<br />

immunoaffinity purifn. of creatine kinaae-MB<br />

from human, dog, and rabbit heart with use<br />

of monoclonal antibody specific for CR-MB,<br />

985<br />

new SRM: trace elements, 2023<br />

reliable mess, of circulating immune complex<br />

depends on stable, accurate ref. material (L),<br />

1555<br />

standn, of apohipoprotein B and A-I mess. (R),<br />

1357<br />

whole-blood quality-control material for<br />

Reflotron’ assays of cholesterol (TB), 1255<br />

Reference methods<br />

candidate Ref. Method for measurement of<br />

apolipoprotain B-100: evaln, of a<br />

monochonal-antibody-based enzyme-linked<br />

immunosorbent assay (A), 1073<br />

estimation of true values in RIAs, 1680<br />

evaln, of the IFCC Ref. Method for alanine<br />

aminotransferase: spurious blank ALT acty.<br />

due to contamination of D-alanine with L-<br />

ahanine; recommendations for a correction<br />

(SN), 153<br />

standn. of apohipoprotein B and A-I mess, (R),<br />

1357<br />

Reference values<br />

appln. of a silver-binding assay to detn, of<br />

protein in CSF (SN), 860<br />

biol. variation of urinary N-acetyh-fl-Dglucosaminidase:<br />

practical and chin.<br />

implications, 560<br />

determining “ref. changes” for serial<br />

measurements of plasma lipid-bound siahic<br />

acid (A), 1080<br />

dimethylmethyhene blue-based spectrophotom.<br />

of glycosaminoglycans in untreated urine:<br />

rapid screening for mucopohysaccharidoses,<br />

1472<br />

direct detn. of 4 sulfates and 7 glucuronides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” liq. chromatog., 794<br />

extrapolation of hipoprotein ref. limits to<br />

apohipoprotein measurements (A), 1070<br />

2400 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


feline and canine ref. ranges for the Kodak<br />

Ektachem 700 analyzer (A), 1134<br />

normal range of ic/Alight-chains<br />

immunoglobulins in 422 hospital patients<br />

(A), 1086<br />

ref. range of glycated Hb in nondiabetic<br />

persons possessing Hb S by affinity<br />

chromatog. (A), 1162<br />

ref. values for creetine, creatinine, and<br />

carnitine are lower in vegetarians (L), 1802<br />

self-consistent set of ref. values for 23 chin,<br />

chem. analytes, 448<br />

solid-phase enzymoimmunoassay for<br />

osteocalcin in serum or plasma, with use of a<br />

monochonal antibody, 2087<br />

steroid profile for urine: ref. values, 2281<br />

Reflectance photometry<br />

accuracy, preclsion of anal, for total cholesterol<br />

as measured with the Reflotron cholesterol<br />

method (SN), 1734<br />

cs-ansylase deth. with the Reflotron’ reagent<br />

carrier system: use of whole blood, plasma,<br />

and serum, and effect of isoenzymes (SN),<br />

317<br />

aqueous-based glucose control sohns. for use<br />

with glucose reagent-stripe and meters (L),<br />

2017<br />

characterization<br />

in mess, of<br />

of sulfasalazine’s<br />

conj. bihirubinwith<br />

interference<br />

the Ektachem<br />

slide (SN), 1760<br />

chin, lab. evaln, of Clinimate’” digoxin,<br />

theophylline, phenytoin, phenobarbital, and<br />

carbamazepine systems (A), 1103<br />

comparison testing of hot-to-hot variance in<br />

Reflotron dry reagent strip method<br />

cholesterol measurement (A), 1098<br />

of<br />

dry-strip immunometric assay for digoxin on<br />

the Ames’” seralyzer’ (A), 1168<br />

eatn. of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

immunoassay system for panel testing enzyme<br />

(S), 1874<br />

immunometric total thyroxin assay for use with<br />

dry reagent strips and a reflectance<br />

photometer (A), 1140<br />

new chromogenic substrate for detn. of<br />

prothrombin time with the Reflotron’ (A),<br />

1161<br />

performance of Reflotron amyhase and<br />

bihirubintest methods in two physicians<br />

office labs. (A), 1093<br />

physician office evaln, of Chinimate’ digoxin<br />

and theophyhline systems (A), 1099<br />

quality-control program for evaluating and<br />

monitoring multiple-site reflectance glucose<br />

analyses (A), 1160<br />

re-evain. of Reflotron, to characterize influence<br />

of drugs, hemohysate, hipemia, and bihirubin<br />

on results (A), 1160<br />

Reflotron amyhase: evahn. of new dry-chem. test<br />

for the Refiotron (A), 1096<br />

test-strip method for lactate in whole blood<br />

(SN), 1992<br />

Renal disease<br />

See also Kidney disease<br />

microplate mess, of urinary albumin,<br />

creatinine, 1371<br />

proteinuria (R), 755<br />

sepn., identn. of urinary proteins and stonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate-pohyacryhamide gel ehectrophoresis<br />

(SN), 658<br />

Renal failure<br />

elimination of total digoxin from a patient in<br />

chronic renal failure post-Fab fragment<br />

(Digibind) therapy (A), 1179<br />

enzyme immunoassay of Hb A1,,:anal.<br />

characteristics and chin, performance in<br />

diabetes mellitus, with and without uremia,<br />

93<br />

influence of end-stage renal failure on concns.<br />

of free apolipoprotein A-i in serum, 963<br />

(Wake Forest University Case Conference):<br />

myoghobinuria, hemaghobmnuria, acute renal<br />

failure (CC), 1713<br />

Renal function<br />

adenosine and dopamine simultaneously deed.<br />

in urine by reversed.phase HPLC, with online<br />

mess. of uv absorbance and ehectrochem,<br />

detection, 64<br />

assessment of renal function by inuhin<br />

clearance: comparison with creatinine<br />

clearance as deed. enzymatically (SN), 312<br />

RIA of -microseminoprotein, a prostaticsecreted<br />

protein in sera of men and women,<br />

1497<br />

simultaneous mess, of total and IgAconjugated<br />

a1-microglobuhmn by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

Renal transplant<br />

concns. of neopterin in serum of recipients of<br />

renal eilografts (L), 2157<br />

two-site immunochemiluminometric assay of<br />

intact parathyrmn with use of a tracer peptide<br />

purified by reversed-phase 1mg.chromatog.,<br />

215<br />

Rephicatable hybridization probes<br />

quant. assays based on use of rephicatabhe<br />

hybridization probes (S), 1826<br />

Resistive-pulse counting<br />

amniotic fluid hamellar bodies characterized by<br />

resistive-pulse counting: relation to measures<br />

of fetal lung maturity, 612<br />

Respiratory acidosis<br />

calculated HCO3- or total C02?, 1697<br />

Respiratory disorders<br />

See Lung disease<br />

Respiratory distress syndrome<br />

See Amniotic fluid, Fetal status<br />

Restriction fragment length polymorphisms<br />

construction of a linkage map of the human<br />

genome, and its apphn. to mapping genetic<br />

diseases(s), B33<br />

cystic fibrosis: diagnostic testing and the<br />

search for the gene (S), B17<br />

genetics of bipolar affective disorder: chin,<br />

implications (5), B28<br />

mapping the hocus of autosomal dominant<br />

pohycystic kidney disease: diagnostic appln.<br />

(S),B13<br />

use of the pohymerase chain reaction for<br />

simultaneous anal. of two Pst I<br />

polymorphisms linked to cystic fibrosis<br />

(TB), 1260<br />

Reticuloendothehiosis<br />

immunoassay of band 5 (“tartrate-resistant”)<br />

acid phosphatase involving use of antiporcine<br />

uteroferrin antibodies, 86<br />

Retinol<br />

concns. of carotenoids, retinol, and tocopheroh<br />

in plasma after a meal (SN), 310<br />

hiq. chromatog. assay for free and<br />

transthyretmn-bound retmnol-binding protein<br />

in serum, 582<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

Retinol-binding<br />

hiq. chromatog.<br />

protein<br />

assay for free and<br />

transthyretin-bound retinol-binding protein<br />

in serum, 582<br />

Retinopathy<br />

transferrin in urine of non-insulin-dependent<br />

diabetics: marker for early complications?,<br />

1672<br />

Retroviruses<br />

apphicn. of pohymerase chain reaction (PCR) to<br />

detection of human retroviruses (A), 1058<br />

Reversible target capture<br />

enzymatic amplification of RNA purified from<br />

crude cell lysate by reversible target capture<br />

(S), 1878<br />

quant. assays based on use of rephicateble<br />

hybridization probes (S), 1826<br />

Rhabdomyohysis<br />

rhabdomyohysis in a case of free-base cocaine<br />

(“crack”) overdose (CR), 1547<br />

Rhabdomyosarcoma<br />

creatine kinaae MB isoenzyme in<br />

rhebdomyosarcoma (L), 896<br />

Rheumatic diseases<br />

expression of the major human<br />

ribonucheoprotein (RNP) autoantigens in E.<br />

coli and their use in an EIA far screening<br />

sere from patients with autoimmune diseases<br />

(5), 1861<br />

Rheumatoid arthritis<br />

aberrant lectin-binding acty. of<br />

immunoghobulin G in serum in rheumatoid<br />

arthritis, 1638<br />

activities of dipeptidyl peptidase II and<br />

dipeptidyl peptidase IV in synovial fluid<br />

from patients with rheumatoid and<br />

osteoarthritis, 1016<br />

changes in concanavahin A-reactive proteins in<br />

inflammatory disorders, 2207<br />

Rheumatoid factor<br />

automated enhanced latex agghutn. assay for<br />

rheumatoid factors in serum (SN), 303<br />

rheumatoid factors deed. by fluorescence<br />

immunosssay: comparison with qual. and<br />

quant. methods (SN), 464<br />

Ritodrine<br />

false-positive urine amphetamine screen with<br />

ritodrine (TB), 1542<br />

RNA<br />

detection of HIV-1 RNA by polymerase chain<br />

reaction (A), 1076<br />

enzymatic amplification of RNA purified from<br />

crude cell lysate by reversible target capture<br />

(S), 1878<br />

Robotics<br />

fully automated robotics lab, in Kochi Med.<br />

School, Japan (A), 1052<br />

state of the art in chin, lab, robotics (A), 1051<br />

use of robotics in method development (A),<br />

1052<br />

Rocket immunoelectrophoresis<br />

See Immunoehectrophoresis<br />

Rubella<br />

enzyme immunoassay for quantn. of IgG<br />

antibody to rubella virus in serum (A), 1092<br />

immunoassays for rubella antibodies (IgG and<br />

1gM) in serum using time-resolved<br />

fluorescence (A), 1153<br />

Sahicylate<br />

enzymatic salicylate and aceteminophen anal.<br />

on Monarch 2000 (A), 1185<br />

enzymic assay of salicylate adapted to the<br />

Monarch centrifugal analyzer (TB), 326<br />

influence of aspirin on in vitro direct<br />

potentiometry of C1 in serum (TB), 2146<br />

Saliva<br />

direct solid-phase enzymoimmunoassay of<br />

testosterone in saliva, 2044<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerlex cortisol. Biodata testosterone (SN),<br />

641<br />

hered. complete<br />

dehydrogenase<br />

deficiency of lactate<br />

H-subunit (CR), 687<br />

mechanism of action of pancreatic and salivary<br />

a-amyhase on 4,6-ethyhidene-a-4-<br />

nitrophenyhmaltoheptaoside substrate (L),<br />

188<br />

salivary progesterone excellently reflects free<br />

and total progesterone in plasma during<br />

pregnancy (SN), 168<br />

solid-phase enzymoimmunoassay of estrone in<br />

saliva, 569<br />

Sample collection<br />

concns. of carotenoids, retinal, and tocopherol<br />

in plasma after a meal (SN), 310<br />

liquid chromatog./electrochem.: in vivo detns.<br />

with microdialysis sampling probes (A), 1240<br />

Sample<br />

handling<br />

albuterol: transdermal absorption and<br />

fingerprick blood-sample contamination<br />

from nebulizers (TB), 889<br />

analyte stability in closed containers after 6<br />

days’ storage (A), 1158<br />

differences between capillary and venous<br />

blood-alcohol concns. as a function of time<br />

after drinking, with emphasis on sampling<br />

variations in left vs right arm, 400<br />

distribn. of cyclospormn A metahohites among<br />

plasma and cells in whole blood: effect of<br />

temp., hematocrit, and metabohite concn., 59<br />

effectiveness of NaF as a preservative of blood<br />

glucose (SN), 315<br />

effect of hematocrit end added heparmn on Ca2<br />

in capillary blood from neonates (SN), 486<br />

effect of repeated freezing and thawing on<br />

vitamins and hormones in serum (TB), 2145<br />

electrothermal at. absorp. spectrom. detn. of<br />

Al: serum matrix effects eliminated (SN),<br />

1517<br />

estimation of true values in RIAs, 1680<br />

evaln, of RIA kit for detn. of free insulin:<br />

effects of sample handling and storage (A),<br />

1144<br />

factors affecting a cyanogen bromide-based<br />

assay of thiamin, 2173<br />

fast, stable method for harvesting leukocytes<br />

for measuring intracellular Mg (SN), 1986<br />

field evaln, of Paramax’ Plus anal. system<br />

Closed Container Sampling’” (A), 1106<br />

with<br />

impact of immediate acidification of blood on<br />

measurement of plasma tissue plssmmnogen<br />

activator (tPA) acty. in surgical patients<br />

(TB), 1999<br />

influence of OCT. embedding compd. on<br />

detns. of estrogen and progestin receptors in<br />

breast cancer (SN), 2317<br />

loss of porphyrmns from soln. during anal.:<br />

effect of sample pH and matrix on porphyrin<br />

quantn. in urine by HPLC (SN), 1508<br />

meas. of apohipoprotein H in plasma from<br />

hyperhipidemic subjects treated with<br />

chohestyramine or placebo: differential<br />

effects of storage at -70 #{176}C, 380<br />

mechanisms responsible for increasing<br />

immunoreactivity of apohipoprotein A-I with<br />

storage: role of oxidn., 2082<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2401


Monoject Amber Samphettafree of bihirubin<br />

photohysis (TB), 889<br />

sample treatment for hong-distance transport<br />

of plasma for hormone assay (TB), 331<br />

screening for microalbuminuria in patients<br />

with diabetes: frozen storage of urine<br />

samples decreases their albumin content<br />

(SN), 308<br />

SDS improves recovery of free tryptophan in<br />

plasma samples deproteinized with<br />

Centrifree Micropartition Devices (A), 1161<br />

sepn., identn, of urinary proteins and stonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate-polyacryhamide gel electrophoresis<br />

(SN), 658<br />

Serum Separator Tube problems in Hitachi<br />

736/737 analyzers (L), 1554<br />

stability of red cell fohate after hemolysls with<br />

ascorbic acid soln. (A), 1160<br />

stability of sex-hormone-binding globulin in<br />

serum, plasma (TB), 1253<br />

stabilizer effect on cancn. of serum prostatic<br />

acid phosphatase (A), 1118<br />

stabn. of a’ketoisocaproic acid in serum and<br />

plasma (TB), 495<br />

standn. of apohipoprotemn B and A-I mess. (R),<br />

1357<br />

“stat” measurements of L-lactate in whole<br />

blood and CSF assessed (SN), 1740<br />

storage conditions and saliva thiocyanate<br />

cancn. (TB), 496<br />

storage temp. and concns, of digoxmn-hike<br />

immunoreactive factor(s) in plasma (L), 895<br />

study of lyophihization effect on enzymatic<br />

methods for cholesterol (A). 1066<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

unreliable visual estn, of incidence and amount<br />

of turbidity, hemohysis, and icterus in serum<br />

from hospitalized patients (SN), 837<br />

updated evaln. of Becton Dickinson Serum<br />

Separator Tube (A), 1159<br />

use of a duah-ppth. proced. for meas. highdensity<br />

lipoprotein 3 in normolipidemic<br />

serum, 1390<br />

Sample preparation<br />

differences between values for plasma and<br />

serum in tests performed in the Ektachem<br />

700 XR analyzer, and evaln. of “plasma<br />

separator tubes (PST)” (SN), 151<br />

liq.-chromatog. assay of urinary<br />

porphobihinogen (SN), 471<br />

micro-quantity tissue digestion for metal<br />

measurements by use of a microwave aciddigestion<br />

bomb (SN), 488<br />

sample preparation for thin-layer chromatog,<br />

anal, for 11-nor-9-tetrehydrocannabmnol-9-<br />

carboxyhic acid in urine (SN), 163<br />

Sample treatment<br />

evaln. of hipochear’” nonionic polymer system<br />

for removal of interfering hipemia (A), 1103<br />

pretreatment of sera before coulometric anal.<br />

maximizes recovery for serum Fe and TIBC<br />

(A), 1131<br />

San IMego Conference<br />

Third San Diego Conference on Nucleic Acid<br />

Probes, October, 1988, practical aspects of<br />

molecular probes (S), 1571<br />

Sarcoma<br />

ehevated CK-MB in a patient with pelvic<br />

sarcoma (A), 1124<br />

Screening<br />

accuracy, precision of anal, for total cholesterol<br />

as measured with the Reflotron cholesterol<br />

method (SN), 1734<br />

adulterants intended to cause false negatives in<br />

urine screens for marijuana or cocaine use<br />

(A), 1175<br />

apphn. of Magic Lite<br />

immunochemiluminometric method for<br />

measurement of creatine kinase-MB in blood<br />

spots (A), 1123<br />

assessment of screening program for congenital<br />

adrenal hyperphasia in Portugal based on<br />

antibody-coated tube RIA for 17a-OH<br />

progesterone (L), 2338<br />

automated procedure for mess, of biotinidase<br />

acty. in serum (SN), 831<br />

chin, effective screening of ssymptomatic<br />

patients for fecal occult blood loss requires<br />

lab, assistance (L), 2337<br />

calorimetric screening method for<br />

microalbuminuria: intra-individual<br />

variability for untimed day specimens (L),<br />

2019<br />

Cohoscreen VPI test kit evald. for detection of<br />

fecal occult blood, 156<br />

cost-effective EMIT method for qual. d.a.u.<br />

performed on Cobas Mire (A), 1168<br />

diabetes mehhitus: diagnosis and screening (A),<br />

1236<br />

diagnostic test for mucopohysaccharidosis I.<br />

direct method for quantg. excessive urinary<br />

glycosaminoglycan excretion, 374<br />

diagnostic test for mucopolysaccharidosis. II.<br />

rapid quantn. of ghycosaminaghycan in urine<br />

samples on a paper matrix, 2074<br />

dimethylmethyhene blue-based spectrophotom.<br />

of ghycossminoghycans in untreated urine:<br />

rapid screening for mucopohysaccharidoses,<br />

1472<br />

ehectrophoresis gel model for Ca oxalate<br />

crystallization (A), 1130<br />

EMrr convenient two-reagent system for drug<br />

of abuse testing on most common chem,<br />

analyzers (A), 1167<br />

empirically deed. Pb-poisoning screening cutoff<br />

for the Protofluor-Z hematofluorometer<br />

(SN), 2104<br />

enzyme-linked immunosorbent assay of<br />

apohipoprotein B in blood spotted onto filter<br />

paper, suitable for neonatal screening, 1000<br />

evaln. of Abbott IMx immunoassay analyzer<br />

for maternal serum alpha-fetoprotein<br />

screening of open neural tube defect and<br />

Down syndrome (A), 1195<br />

evaln. of Abbott TD,, for drugs of abuse<br />

testing in afield environment (A), 1179<br />

evaln, of combined cocaine/opiate screening<br />

procedure on Abbott labs. TDx (A), 1165<br />

evaln, of screening method bias for five drugs<br />

of abuse classes (A), 1102<br />

evaln. of Syva ETS and Abbott AD,, urine drug<br />

screening immunoassay analyzers (A), 1176<br />

evaln. of urine temp. measurement methods to<br />

screen urine specimens for drug tasting (A),<br />

1181<br />

expression of the major human<br />

ribonucheoprotein (RNP) autoantigens in E.<br />

coli and their use in an EIA for screening<br />

sera from patients with autoiinmune diseases<br />

(S), 1861<br />

false-positive urine amphetamine screen with<br />

ritodrine (TB), 1542<br />

five cannabinoid immunoassay systems<br />

compared at the screening threshold of 100<br />

,g/L (SN), 2241<br />

fluorometric method for phenylalanine<br />

microplate assay adapted for<br />

phenylketonuria screenin (SN), 2112<br />

frequency of law-level PCP in urine specimens<br />

for drug screening (A), 1182<br />

functional acty. of protein S deed, with use of<br />

protein C activated by venom activator, 1644<br />

glycated Hb in fractionated erythrocytes, 958<br />

high-volume Syva EMrr drug testing on<br />

multiple Epos analyzers interfaced to a<br />

central computer system<br />

implications of probability<br />

(A), 1166<br />

anal. for<br />

interpreting results of leukocyte esterase and<br />

nitrite test stips, 1663<br />

interlab, comparison of control materials for<br />

use with hematof1uorometers, 2059<br />

investigation of protoporphyrmn IX std.<br />

materials used in acid-extn, methods;<br />

proposed correction for the milhimohar<br />

absorptivity of protoporphyrin IX, 1601<br />

125I.RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

hipoprotein(e) quantified by an enzyme-linked<br />

immunosorbent assay with monochonal<br />

antibodies, 1380<br />

maternal serum estriol in acreenin& for Dawn’s<br />

syndrome: significance of high SD for the<br />

population (A), 1193<br />

mechanism of false-negative urine cannabinoid<br />

screens by Visine’” eyedrops<br />

immunoassay<br />

(SN), 636<br />

(A), 1163<br />

microassey for screening newborns for<br />

galactosemia with use of a fluorometric<br />

microplate reader (SN), 1962<br />

monochonal antibodies evald. for use in<br />

screening for conjugates of human serum alb.<br />

and pyridoxal 5’-P04 (SN), 1756<br />

neonatal phenylalanmne screening using the<br />

Encore centrifugal analyzer (A), 1153<br />

neonatal screening for congenital<br />

hypothyroidism with LKB Delfia neonatal<br />

TSH kit (A), 1152<br />

passive hemagglutination assay for HIV<br />

antibody screening (Retrocell HIV) (A),<br />

1210<br />

racial and other differences<br />

of maternal serum<br />

a-fetoprotein in a large obstetrical<br />

population (A), 1136<br />

recent advances in instrumentation for use in<br />

physicians’ offices and public health<br />

screening programs (A), 1232<br />

screening for deficiency of ai-proteinase<br />

inhibitor (SN), 1971<br />

screening for microalbuminuria a rapid,<br />

how-cost calorimetric assay (SN), 456<br />

screening of serum cholesterol and HDL<br />

cholesterol using the EM. Diagnostic<br />

Systems EASY ST analyzer (A), 1074<br />

screening utility of a rapid, automated<br />

fluorescent enzyme immunoassay for HBsAg<br />

in an S.T.D. clinic (A), 1192<br />

self-consistent set of ref. values for 23 chin.<br />

chem, anahytes, 448<br />

sensitive method of screening for urinary<br />

porphobihinogen (SN), 2311<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd. familial<br />

amyloidotic pohyneurapathy (SN), 1033<br />

single-vial screening assay for creatine kinase-<br />

MB (A), 1122<br />

sources of imprecision in screening for<br />

congenital hypothyroidism: anal, of 9 y of<br />

performance data, 1701<br />

stability of hemoghobins A, F, 5, and C in dried<br />

neonatal whole-blood samples when<br />

analyzed by cation-exchange HPLC (A),<br />

1152<br />

thin-layer chromatog. of free porphyrins for<br />

diagnosis of porphyria (SN), 1043<br />

time-resolved fluoroimmunoassay of aflatoxins<br />

(SN), 2308<br />

urine screening for cocaine use with ELISA and<br />

confirmation with GC/MS (A), 1171<br />

use of Sentry’” drugcontrol in evaluating<br />

performance of TDx drugs of abuse<br />

screening near NIDA cutoff concns. (A), 1103<br />

Selenium<br />

at, absorption spectrom. detn, of Se in blood<br />

components, 537<br />

Seminal fluid<br />

high concns, of Zna2.glycoprotein and lack of<br />

a2HS-glycoprotemn in ejaculates, 1649<br />

Seminal plasma<br />

prostatic inhibin-like peptide in urine of<br />

prostetic cancer patients, mess, by enzymelinked<br />

immunosorbent assay, 1376<br />

RIA of -microseminoprotein, a prostaticsecreted<br />

protein in sara of men and women,<br />

1497<br />

tumor markers in seminal plasma end amniotic<br />

fluid (A), 1079<br />

Septic shock<br />

decreased immunoreacty. and binding acty. of<br />

corticostaroid-binding globulin in serum in<br />

septic shock, 1675<br />

Serotonin<br />

HPLC anal, for serotonin and tryptamine<br />

excreted in urine after oral loading with I..<br />

tryptophan, 43<br />

Sex- and age-related effects<br />

automated detn, of chohinesterase acty. in<br />

plasma and erythrocytes by flow-injection<br />

anal., and apphn. to identify subjects<br />

sensitive to succinyhchohine, 77<br />

biol, variation of urinary N-acetyl-fl-Dglucosaminidase:<br />

practical and chin,<br />

implications, 560<br />

cobalamin-binding capacity of haptocorrin<br />

end<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

critical anal, and chin, aspects of ionized Cain<br />

neonates (R), 2027<br />

diagnostic test for mucopolysaccharidosis. II.<br />

rapid quantn. of glycosaminoglycan in urine<br />

samples on a paper matrix, 2074<br />

dimethyimethylene blue-based spectrophotom.<br />

of glycosaminoglycans in untreated urine:<br />

rapid screening for mucopolysaccharidoses,<br />

1472<br />

effect of hemetocrit and added heparmn on Ce2<br />

in capillary blood from neonates (SN), 486<br />

effects of age and sex on the interpretation of<br />

chem, test results (A), 1155<br />

enzyme-linked immunosorbent assay of<br />

apohipoprotein B in blood spotted onto filter<br />

paper, suitable for neonatal screening, 1000<br />

estn, of ref. intervals for total protein in CSF<br />

(SN), 1766<br />

geriatric ther, drug monitoring: special<br />

considerations (S), 1337<br />

influence of blood pressure, heart rate, age, and<br />

sex on concns, of atrial natriuretic<br />

cyclic GMP (SN), 1519<br />

factor and<br />

2402 CLINICALCHEMISTRY,Vol.35, No. 12, 1989


I-RIA for androstenedione in serum and in<br />

blood-spot-samples from neonates, 1706<br />

osteocalcin: bioL variations and ref. limits (A),<br />

1126<br />

quant. anal. for org. acids in biol, samples:<br />

batch isolation followed by gas<br />

chromatog.-mass spectrom. anal,, 587<br />

quantn. of urinary porphyrmns by liq.<br />

chromatog. after oxidn, of porphyrinogens,<br />

1619<br />

racial and age-related differences in incidence<br />

of monoclonal gammopathy of uncertain<br />

significance (A), 1154<br />

relation between plasma cholesterol and total<br />

and ionized Ca cancns. in serum from<br />

poetmenopausal women (TB), 328<br />

RIA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

steroid profile for urine: ref. values, 2281<br />

Sex-hormone binding globulin<br />

critical evaln. of an immunaradiometric assay<br />

of sex-hormone binding globulin (TB), 2146<br />

investigation of sex-hormone-binding globulin<br />

interference in direct RIAs for testosterone<br />

and estradioh, 979<br />

lIlA of testosterone not bound to sex-steroidbinding<br />

protein in plasma, 1609<br />

stability of sex-hormone-binding globulin in<br />

serum, plasma (TB), 1253<br />

three methods compared far estg. testosterone<br />

and estradiol not bound to sex-hormonebinding<br />

globulin (SN), 632<br />

Sexually transmitted disease-causing<br />

organisms<br />

apphn. of a rapid non-radioisotopic nucleic acid<br />

anal, system to the detection of sexually<br />

transmitted disease-causing organisms and<br />

assocd. antimicrobial resistances (S), 1571<br />

Slalic<br />

acid<br />

See also Neuraminic acid<br />

determining “ref. changes” for serial<br />

measurements lipid-bound of plasma sialic<br />

acid (A), 1080<br />

measurement of sialic acid in squamous cell<br />

carcinoma patients (anal canal and cervix)<br />

by an automated Cobas-Mira procedure (A),<br />

1079<br />

methods for detg. “reference changes” from<br />

serial measurements: plasma lipid-bound<br />

sialic acid, 972<br />

use of CEA, CA 15-3, and sialic acid in<br />

evaluating chin, course of breast cancer<br />

patients (A), 1080<br />

Slahidase<br />

apolipoprotein E phenotype deed. by agarose<br />

gel electrofocuamg, immunoblotting, 2070<br />

siahidase from different sources compared far<br />

electrophoretically sepg. serum alk,<br />

phosphatase fractions from liver and bone<br />

(SN), 1955<br />

Skin disorders<br />

changes in serum acute-phase proteins in<br />

patients with dermatologic diseases (A), 1084<br />

collagen-linked fluorescence in skin biopsy<br />

specimens from young insulin-dependent<br />

diabetic patients (A), 1137<br />

Smoking<br />

caffeine interference eliminated in HPLC detn.<br />

of urinary nicotine and cotinine, 1456<br />

exposure to environmental tobacco smoke<br />

measured by cotinine imI.RIA (SN), 1036<br />

heukotriene B4 is measurable in serum of<br />

smokers and nonsmokers (SN), 459<br />

Sodium<br />

antiarrhythmic drugs and the cardiac Na<br />

channel: current models(S), 748<br />

development of human serum ref. materials to<br />

unify Na, K results in serum to their nath,<br />

ref. systems (A), 1130<br />

factitiously high Na activities in the<br />

Ektachem 400 owing to interferences by high<br />

gamma-globulin concns, (CR), 333<br />

Solid-phase extraction<br />

strategies for samphe prepn. with use of solid.<br />

phase extrn, in TDM of basic drugs (A), 1352<br />

Somatotropin<br />

automation and interpretation of quantn. of<br />

antibodies to therapeutic proteins,<br />

illustrated with somatotropin, 1623<br />

influence of matrix on cancns. of somatotrapin<br />

mess, in serum with commercial<br />

immunoradiometric assays, 1423<br />

somatotropin as mess, bye two-site timeresolved<br />

immunofluorometric assay, 913<br />

Somatrem<br />

automation and interpretation of quantn. of<br />

antibodies to therapeutic proteins,<br />

illustrated with somatotropin, 1623<br />

Specific gravity<br />

See Relative density<br />

Specimen handling<br />

See Sample handling<br />

Spectrofluorometry<br />

See Fluorometry<br />

Spectrophotofluorometry<br />

See Fluorometry<br />

Spectrophotometry<br />

See also Atomic absorption<br />

spectrophotometry, Calorimetry<br />

automated detn. of chohinesterase acty. in<br />

plasma and erythrocytes by flow-injection<br />

anal., and apphn. to identify subjects<br />

sensitive to succinylcholine, 77<br />

dimethylmethyhene blue-based spectrophotom.<br />

of glycosaminoghycans in untreated urine:<br />

rapid screening for mucopohysaccharidoses,<br />

1472<br />

hiq.-chromatog. assay of urinary<br />

porphobihinogen (SN), 471<br />

modified Mg method in the ace III: elimn, of<br />

interference by bilirubin (SN), 1031<br />

modifn, and automation of whole-blood CN<br />

assay (A), 1177<br />

nonmercurimetric spectrophotometric assay<br />

for Chin blood serum (A), 1129<br />

apectrophotometric stat detn. of HbCO in<br />

microsamples (A), 1163<br />

three direct spectrophotometric methods for<br />

detn, of total bilirubin in neonatal and adult<br />

serum, adapted to the Technicon RA-1000<br />

analyzer (SN), 1980<br />

Spectroscopy<br />

rapid detn, of uroporphyrmn and<br />

coproporphyrins in urine using secondderivative<br />

spectroscopy (A), 1132<br />

reagentless detn, of glucose and other<br />

constituents in blood by ATR-FT-IRspectroscopy<br />

(5), 1854<br />

spectroscopic systems for non-invasive<br />

measurements (A), 1059<br />

Spermatozoa<br />

use of murine monoclonal antibodies to bloodroup-rehated<br />

antigens for<br />

immunofluorescent detection of blood<br />

groups on human spermatozoa (A), 1208<br />

Sports medicine<br />

drug testing in sports-the 1988 Olympics and<br />

beyond (A), 1056<br />

test-strip method for lactate in whole blood<br />

(SN), 1992<br />

5100 protein<br />

5- lOOa,,protein in blood and urine during<br />

open-heart surgery, 1942<br />

Standardization<br />

CDC/NHLBI lipid standardization<br />

program-30 years of collaboration (A), 1073<br />

cholesterol standardization for 13 years by<br />

CDC and Japanese cholesterol levels (A),<br />

1065<br />

designing a reliable calibrator for<br />

nephehometric apo A-I and B assays (A),<br />

1073<br />

effect of lyophihn. on results of five enzymic<br />

methods far cholesterol (SN), 1523<br />

evahn, of Beckman cholesterol reagents by a<br />

natL cholesterol ref. method lab. (A), 1068<br />

improved accuracy of cholesterol values<br />

obtained by Synchron AS calibrator setpoint<br />

modn, as evidenced in patient<br />

correlation to Abell-Kendall ref. method (A),<br />

1071<br />

influence of matrix on cancns, of somatotropin<br />

mess, in serum with commercial<br />

immunoradiometric assays, 1423<br />

investigation of protoporphyrin IX std,<br />

materials<br />

proposed<br />

used in acid-extn. methods;<br />

correction for the mihllmolar<br />

absorptivity of protoporphyrin IX, 1601<br />

new int. temp. scale of 1990 (ITS-90) (SR), 503<br />

regional interhsb, standn, of serum cholesterol,<br />

HDL cholesterol, and triglycerides (A), 1065<br />

standn, of immunochem, detn. of<br />

epohipoproteins A-I and B: report on IFCC<br />

meeting on standn, of apohipoprotein A-I and<br />

B measurements (basis for future<br />

consensus), Vienna, Austria, April 18-19,<br />

1989 (SR), 2009<br />

successful detn, of triglycerides with the CDC<br />

standardization program (A), 1074<br />

system to standardize ALT cutoff actys. (A),<br />

1118<br />

WHO/RPSP standardization of Beckman<br />

Synchron CX’”5 and correlation of Igs and<br />

transferrin to Beckman Array’” protein<br />

system (A), 1106<br />

Statistics<br />

allowable limit of error in chin. chem, qual.<br />

control (SN), 630<br />

aspects of method comparison study that need<br />

more attention (A), 1110<br />

between-run component of variation in<br />

internal quah, control, 1416<br />

counting errors: effect on immunoassay<br />

precision, 1362<br />

CV at the detection limit (L), 901<br />

detn, of the lower limit of detection (L), 2152<br />

diagnosis of acute myocardial infarction from<br />

two measurements of creatine kinase<br />

isoenzyme MB with use of nonparametric<br />

probability estn., 444<br />

generalized likelihood ratio concept and<br />

logistic regression anal. for multiple<br />

diagnostic categories, 990<br />

methods comparison-Deming regression vs<br />

linear least squares regression (A), 1086<br />

methods for detg. “reference changes” from<br />

serial measurements: plasma lipid-bound<br />

sialic acid, 972<br />

sampling distribn, of skewness and kurtosis<br />

(TB), 330<br />

standard deviation errors in spreadsheet<br />

statistics (A), 1087<br />

t-test data anal. using a Lotus 1-2-3’”<br />

spreadsheet template (A), 1087<br />

Steroid hormones<br />

estradiol-17 deed. in plasma by gas<br />

chromatog.-mass spectrom. with selected ion<br />

monitoring of mixed silyh<br />

ether-perfluoroacyl ester derivs, and use of<br />

various stable-isotope-labeled internal sIde.,<br />

532<br />

Steroid receptors<br />

See also specific steroid of interest<br />

comparison of CA-15 and steroid receptors in<br />

cancerous and adjacent noncancerous tissue<br />

of the breast (A), 1080<br />

Steroids<br />

See also specific steroid of interest<br />

chin, steroid profiles by GCIMS (A), 1142<br />

decreased dehydroepiandrosterone sulfate in<br />

pigmented nodular adrenal dysphasia (SN),<br />

2216<br />

direct detn, of 4 sulfates and 7 glucuronides of<br />

l7-oxysteroids in urine by fluorescence<br />

“high-performance” liq. chrometog., 794<br />

direct solid-phase enzymoimmunoassay of<br />

testosterone in saliva, 2044<br />

effect of salivary proteins on binding curves of<br />

three RIA kits: Amerlex-M progesterone,<br />

Amerhex cortisol, Biodata testosterone (SN),<br />

641<br />

estimation of true values in RIAs, 1680<br />

investigation of sex-hormone-binding globulin<br />

interference in direct RIAs for testosterone<br />

and estradiol, 979<br />

solid-phase enzyme immunoassay of serum<br />

DHEA-S (A), 1197<br />

steroid profile for urine: ref. values, 2281<br />

three methods compared for estg. testosterone<br />

and estradiol not bound to sex-hormonebinding<br />

globulin (SN), 632<br />

Streptokinase<br />

alterations in lactate dehydrogenase isoenzyme<br />

patterns after therapy with streptokinase or<br />

streptococcal infection (SN), 1763<br />

creatine kinase isoforms in ischemic heart<br />

disease (R), 7<br />

streptokinese binds to lactate dehydrogenase<br />

subunit-M, which shares an epitope with<br />

plasminogen, 69<br />

Strontium<br />

quantn. of Sr in plasma and urine with<br />

flamehess at, absorp. spectrom., 1911<br />

Suhfasalaxlne<br />

characterization of sulfasahazine’sinterference<br />

in mess. of conj. bihirubin with the Ektachem<br />

slide (SN), 1760<br />

chin. important interference of sulfasalazine in<br />

measurement of conjugated bihirubin by<br />

Ektachem slide method (A), 1158<br />

simplified, rapid test for acetylator<br />

phenotyping by use of the peak height ratio<br />

of two urinary caffeine metabohites (SN), 848<br />

Superoxide dismutase<br />

automated methods for chin. assay of<br />

superoxide dismutase and glutathione<br />

peroxidase in human plasma and<br />

erythrocytes using a Cobas Bio centrifugal<br />

analyser (A), 1126<br />

improved superoxide dismutase assay for chin,<br />

use (L), 1265<br />

short- and long-term variability of indices<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2403


elated to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

Surgery<br />

changes in Fe, Zn, Cu concns, in serum and in<br />

their binding to transport proteins after<br />

chohecystectomy, cardiac surgery (SN), 2243<br />

impact of immediate acidification of blood on<br />

measurement of plasma tissue plasminogen<br />

activator (tPA) acty. in surgical patients<br />

(TB), 1999<br />

mess, of autoimmune response against collagen<br />

types I, III, and IV by enzyme-linked<br />

immunosorhent assay, and appln. in<br />

infective endocarditis, 246<br />

Sweat<br />

defective epithehial ion transport in cystic<br />

fibrosis (S), 726<br />

transient increase of sweat electrolyte concns,<br />

associated with environmental deprivation<br />

(A), 1153<br />

Symposia<br />

Nath, Aced, of Chin, Biochem, Annual<br />

Symposium: “Membrane Function and<br />

Dysfunction in Health and Disease”<br />

(introduction) (S), 717<br />

Synoviah fluid<br />

activities of dipeptidyl peptidase II and<br />

dipeptidyl peptidase IV in synovial fluid<br />

from patients with rheumatoid and<br />

osteoarthritis, 1016<br />

Target cycling<br />

molecular probes used to detect<br />

cytomegalovirus and human<br />

immunodeficiency virus (S), 1581<br />

Tears<br />

tumoral calcinosis: seasonal biochem. studies<br />

and chem. studies of eyelid lesion (CR), 183<br />

Temperature<br />

new mt. temp. scale of 1990 (ITS-90) (SR), 503<br />

reliability of temp. correction algorithms for<br />

assessing blood gas parameters at


moderate I deficiency, possible explanation for<br />

inverse relation between card serum<br />

thyrotropmn and birth weight in a normal<br />

Kenyan popn. (L), 710<br />

neonatal screening for congenital<br />

hypothyroidism with LKB Dehfia neonatal<br />

TSH kit (A), 1152<br />

one-step immunometric assay for TSH based<br />

on enhanced luminescence (A), 1149<br />

rapid self-contained immunoassay for human<br />

thyrotropin (A), 1195<br />

ref. intervals far hTSH by two automated<br />

ultrasensitive assays: London Diagnostics<br />

LumaTag’” and Abbott’s IMx’” (A), 1143<br />

sensitive TSH in “weilness programs”:<br />

participant outcomes following abnormal<br />

results (A), 1148<br />

simplified strategy for tasting thyroid function<br />

(SN), 828<br />

ultrasensitive bioassay of thyrotropin (TB),<br />

1252<br />

Thyroim<br />

binding of labeled thyroxin analog to serum<br />

proteins evald. after RIA of free thyroxin<br />

(SN), 475<br />

concn. of free thyroxin in serum during<br />

nonthyraidal illness-calcn. or meas,? (SN),<br />

159<br />

dependence of thyroxin/thyroxin-binding<br />

globulin (TBG) ratio and free thyroxin index<br />

on TBG concns,, 541<br />

diagnostic performance of a modified freethyroxin<br />

assay in subjects with anomalies in<br />

their binding proteins (TB), 493<br />

direct and indirect techniques for free thyroxin<br />

compared in nonthyroidal illness I. effect of<br />

free fatty acids, 102<br />

direct detn. of free thyroxin in undiluted serum<br />

by equilibrium dialysis/RLA (L), 510<br />

direct, indirect techniques for free thyroxin<br />

compared in patients with nonthyroidal<br />

illness. II. effect of prealbumin, albumin,<br />

thyroxin-binding globulin, 1655<br />

discordant RIA results for thyroxin-binding<br />

globulin (TBG): new indicator of variant<br />

TBG molecules with decreased affinity far<br />

thyroxin (TB), 1257<br />

do nonesterified fatty acids displace thyroxin<br />

from its plasma binding sites in severe<br />

nonthyroidal illnesses? (A), 931<br />

dry-chem. multilayer immunoassay for total<br />

thyroxin (A), 1180<br />

effect of albumin on results for free-thyroxin<br />

index as estd.<br />

(L),706<br />

by total T4,PF3 uptake ratio<br />

effect of thyroid hormone-binding proteins and<br />

fatty acids on modified analog assays of Fl’4<br />

and FL’3in serum (L), 708<br />

enzyme-linked immunosorbent assay for free<br />

thyroxin in serum (SN), 1770<br />

evain. of Abbott IMx’” essays for thyrozin and<br />

thyroxin uptake (A), 1105<br />

evaln. of Amerhite’” FT4 method in patients<br />

with FDH and nonthyroidal illness (A), 1142<br />

fluorometric enzyme immunoassey far<br />

measurement of free T4 using Magnisep’”<br />

Cr02 particles (A), 1202<br />

fluorometric enzyme immunoassay for<br />

measurement of total thyroxin using a<br />

reagent delivery module’” (RDM) (A), 1140<br />

four nanisotopic immunoaasays of free<br />

thyroxin evald, (SN), 115<br />

immunometric total thyroxin assay for use with<br />

dry reagent strips and a reflectance<br />

photometer (A), 1140<br />

labeled-antibody assay for free T4 (A), 1148<br />

longitudinal study of thyroid function in<br />

pregnancy, 275<br />

how-normal concns, of free thyroxin in serum in<br />

late pregnancy: physiol. fact, not tech.<br />

artefact, 1891<br />

measurement of thyrotropin and T4 by new<br />

luminescence immunoassay LIA-MAT (A),<br />

1209<br />

method-dependent correlation of major<br />

thyroxin-binding proteins with serum FT4 in<br />

patients with nonthyroidal illness (A), 1143<br />

modified EMI’I’ thyroxmn assay for use on<br />

Cobas Mira and Cobas Bia analyzers (A),<br />

1141<br />

multilayer fluorescence immunoassay<br />

technique (5), 1865<br />

new technique for measuring free thyrozin in<br />

serum: multi-center study (SN), 2137<br />

one-step enzyme immunoassay for free<br />

thyroxin: results with dysalbuminemic sara<br />

and one serum containing autoantibodies to<br />

thyroxin (TB), 888<br />

performance of CEDIA’” T4 MAb and T-uptake<br />

assays on Technicon RA-1000’” (A), 1191<br />

performance of CEDIA’”<br />

enzyme immunoassay<br />

T4 MAb homogeneous<br />

on the Olympus AU-<br />

5000 chin, analyzer (A), 1141<br />

performance of Microgenics CEDIA’” thyroxin<br />

and T-uptake assays on the Ciba-Corning<br />

550 Express’” analyzer (A), 1141<br />

simple procedure for evaluating thyroxinbinding<br />

proteins abnormalities in euthyroid<br />

hyperthyroxinemia and hypothyroxinemia<br />

(A), 1150<br />

simplified strategy for testing thyroid function<br />

(SN), 828<br />

thermal mactn. of L-thyroxin, 90<br />

thin-film enzyme immunoassay for<br />

measurement of serum or plasma T4 (A),<br />

1200<br />

1988 version of two-step immunoextn. assay for<br />

FL’4: chin. performance (A), 1144<br />

Thyroxin-binding globulin<br />

dependence of thyroxmn/thyroxin-binding<br />

globulin (TBG) ratio and free thyroxmn index<br />

on TBG concns,, 541<br />

direct, indirect techniques for free thyroxin<br />

compared in patients with nonthyroidal<br />

illness. LI.effect of prealbumin, albumin,<br />

thyroxin-binding globulin, 1655<br />

discordant RIA results for thyroxin-binding<br />

giobulmn (TBG): new indicator of variant<br />

TBG molecules with decreased affinity for<br />

thyroxin (TB), 1257<br />

longitudinal study of thyroid function in<br />

pregnancy, 275<br />

how-normal concns, of free thyroxin in serum in<br />

hate pregnancy: physiol. fact, not tech.<br />

artefact, 1891<br />

time-resolved fhuoroimmunoassay for<br />

measuring thyroxin-binding globulin (A),<br />

1205<br />

time.resohved immunofluorometric assay for<br />

thyroxin-binding globulin in serum (A), 1139<br />

Thyroxin index<br />

dependence of thyroxmn/thyroxin-binding<br />

globulin (TBG) ratio and free thyroxin index<br />

on TBG concns., 541<br />

Tissue analysis<br />

at, absorption spectrom. detn. of Se in blood<br />

components, 537<br />

choice of substrate concn. in the search far<br />

abnormal enzyme acty. in tissues (L), 1267<br />

computerized quant. anal. of Coomassie-Bluestained<br />

serum proteins sepd. by twodimensional<br />

electrophoresis, 2297<br />

concns, of Se, Zn, Cu, Fe, Mg, K in blood and<br />

heart tissue in coronary heart disease (SN),<br />

851<br />

creatine kinase and lactate dehydrogenase<br />

isoenzymes in serum and tissues of patients<br />

with stomach adenocarcinoma, 1385<br />

HPLC mess, of chlorophenoxy herbicides,<br />

bromoxynih, and ioxynil, in biol. specimens<br />

to aid diagnosis of acute poisoning(S), 1342<br />

improved superoxide dismutase assay for chin,<br />

use (L), 1265<br />

measuring carbozypeptidase A acty. with a<br />

centrif, analyzer: anal, and chin,<br />

considerations, 251<br />

micro-quantity tissue digestion for metal<br />

measurements by use of a microwave aciddigestion<br />

bomb (SN), 488<br />

rapid, reliable in viva assays of phosphate<br />

metabohites by NMR, 392<br />

RIA of circulating chromogranin A: in vitro<br />

stability, exploration of neuroendocrine<br />

character of neoplasia, and assessment of<br />

effects of organ failure, 1631<br />

two-sita immunoenzymometry of 52-kDa<br />

cathepsin D in cytoaols of breast-cancer<br />

tissues, 81<br />

‘I’issue culture<br />

neopterin mess, in serum, tissue culture<br />

supernates by competitive enzyme-linked<br />

immunosorbant assay, 1467<br />

Tissue factor<br />

measuring tissue factor (Factor III) acty. in<br />

plasma, 1897<br />

Tobramycmn<br />

development of latex-based tobramycin<br />

immunoassay for the IL Monarchiu chem.<br />

system (A), 1172<br />

Syva EMI’I convenience pack assays for<br />

carbamazepine and tobramycin on the Cobss<br />

Mire analyzer (A), 1173<br />

TDM assays by fluorescence polarization on<br />

Cobas Fare II’” analyzer; detn. of serum<br />

amikacin, gentamicin, and tobramycin (A),<br />

1178<br />

Technicon tobramycmn and gentamicin: secondgeneration,<br />

improved methods on the RA-<br />

1000 system (A), 1172<br />

Tocopheroh<br />

concn, of tocopherol isomers in dietary oila (A),<br />

1114<br />

concna, of carotenoids, retinol, and tocopherol<br />

in plasma after a meal (SN), 310<br />

simultaneous hiq.-chromatog. detn. of vit, K,,<br />

vit. E in serum, 2285<br />

transport conditions and stability of biochem.<br />

markers in blood (SN), 2313<br />

Total body water<br />

antipyrine interferes with chem, detn. of Br in<br />

simultaneous estn. of total body H20 and<br />

extracehhular H20, 1367<br />

Toxicology<br />

alk. phosphatase of possible renal origin<br />

identified in plasma after colchicine overdose<br />

(L), 702<br />

automated detn. of chohinesterase acty. in<br />

plasma and erythrocytes by flow-injection<br />

anal,, end appln. to identify subjects<br />

sensitive to succinyhchohine, 77<br />

benzodiazepines identified by capillary gas<br />

chrometog.-mass spectrom., with specific ion<br />

screening used to detect benzophenone<br />

derivs., 1394<br />

brodifacoum (super warfarmn) poisoning: lab,<br />

methods for assessment of vit, K antagonism<br />

(A), 1162<br />

cocaine and pregnancy: din, and toxicol.<br />

implications for the neonate (S), 1276<br />

cychosporine concns. in blood after liver<br />

transplantn.: correlation of immunoassay<br />

results with chin, events, 564<br />

detection of poisoning by plant-origin cardiac<br />

ghycoeide with the Abbott TDx analyzer<br />

(SN), 295<br />

documentation of cytosine arabinoaide toxicity<br />

using drug monitoring (A), 1182<br />

does the effective diminution of nonenzymatic<br />

glycation by D-lysine really highlight its<br />

potential use in viva? (L), 2254<br />

emetine identified in urine by I-IPLC, with<br />

fluorescence and ultraviolet/diode array<br />

detection, in a patient with cardiomyopathy<br />

(CR), 499<br />

HPLC mess, of chhorophenoxy herbicides,<br />

bromoxynil, and ioxynil, in biol, specimens<br />

to aid diagnosis of acute poisoning(S), 1342<br />

interhab. comparison of control materials for<br />

use with hemetofluorometars, 2059<br />

new approach to etiohogic diagnosis in<br />

environmental chem. poisoning (A), 1055<br />

nitromethane interferes in assay for creatinine<br />

by Jaff#{233} reaction (SN), h772<br />

plasma glutathiane S.transferase and F protein<br />

are more sensitive than alanine<br />

aminotransferese as markers of<br />

acetaminophen-induced liver damage, 2186<br />

rapid detn. of toxic CN- concns, in blood, 617<br />

supercriticah fluid chromatog. and microbore<br />

hiq. chromatog. for drug anal. (5), 1293<br />

system for toxicol. screening by capillary gas<br />

chromatog. with use of a drug retention<br />

index based on Ni-containing ref. cmpds.,<br />

601<br />

ther, drug monitoring and toxicol.: issues,<br />

perspectives for the ‘804 and ‘90s: a<br />

symposium held in Chicago, IL, October 6-8,<br />

1988(5), 1273<br />

time-resolved fhuoroimmunoassay of afhatoxins<br />

(SN), 2308<br />

vahproate therapy depresses GSH-PX and<br />

SOD enzyme acty.: possible mechanism for<br />

VPA-induced idiosyncratic drug toxicity (A),<br />

1173<br />

versatihe, efficient system far extracting<br />

from urine for gas chromatog./mass<br />

drugs<br />

spectrom. anal. (SN), 2100<br />

Trace elements<br />

See also specific element of interest<br />

at, absorption spectrom. detn. of Se in blood<br />

components, 537<br />

bladder catheters and Zn contamination of<br />

urine (TB), 888<br />

changes in Fe, Zn, Cu concns. in serum and in<br />

their binding to transport proteins after<br />

cholecystectomy, cardiac surgery (SN), 2243<br />

concns. of Se, Zn, Cu, Fe, Mg, K in blood and<br />

heart tissue in coronary heart disease (SN),<br />

electrothermal at: absorp. spectrom. detn, of<br />

Al: serum matrix effects eliminated (SN),<br />

1517<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2405


evaln. of urine metals control using at.<br />

absorption spectrophotom. (A), 1177<br />

improved detn, of Va in hioh, fluids by<br />

ehectrotherm. at. absorption spectram. (SN),<br />

127<br />

interactions of Cu with some analytas in serum<br />

(L),335<br />

isotope diln, GC-MS of metals at trace levels in<br />

biol. samples (A), 1113<br />

micro-quantity tissue digestion for metal<br />

measurements by use of a microwave aciddigestion<br />

bomb (SN), 488<br />

quantn. Mn in lymphocytes to assess Mn<br />

nutrit. status, 1939<br />

sensitive, direct cohorimetry of Cu in serum,<br />

552<br />

serum Zn in homosexual men (L), 704<br />

short- and long-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

Transcobahamin<br />

cobalammn-binding capacity of haptocorrin and<br />

transcobalamin: age-correlated ref. intervals<br />

and values from patients, 1447<br />

Transcortin<br />

decreased immunorescty. and binding acty. of<br />

corticosteroid-binding globulin in serum in<br />

septic shock, 1675<br />

Transferrin<br />

measurement of carbohydrate-deficient<br />

transfemin, biochem. marker for alcohol<br />

disease (A), 1109<br />

short- and long-term variability of indices<br />

related to nutritional status, I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

transfemmn in urine of non-insulin-dependent<br />

diabetics: marker for early complications?,<br />

1672<br />

WHO/RPSP standardization of Beckman<br />

Synchron CX’”5 and correlation of Igs and<br />

transfemmn to Beckman Array’” protein<br />

system (A), 1106<br />

Transketolase<br />

effect of substrata concn. on erythrocyte<br />

transketohase assay (L), 1557<br />

interaction between pyridmne nucleotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-linked enzymes (SN), 2129<br />

Transthyretin<br />

See also Preahbumin<br />

hiq. chromatog. assay for free and<br />

transthyretin-bound retinal-binding protein<br />

in serum, 582<br />

simplified screening of populations at risk for<br />

transthyretin Met30-assocd. familial<br />

amyhoidotic polyneuropathy (SN), 1033<br />

Triacylglycorols<br />

See Triglycerides<br />

Tricyclic antidepressants<br />

See also Antidepressants<br />

automated detn. of drugs in serum by columnswitching<br />

HPLC. IV. sepn. of tricychic and<br />

tetracychic antidepressants and their<br />

metabohites (SN), 453<br />

detn, of serum desipramine and 2-<br />

hydroxydesipramine for pharmacokinetic<br />

apphns. by HPLC with uv detection (SN),<br />

2134<br />

evaln, of serum acetaminophen and tricychic<br />

antidepressants assays on the Abbott ADZ’”<br />

drug detection system (A), 1102<br />

Triglycerides<br />

concns. of lipids, apohipoproteins in patients<br />

with chin, well-controlled insulin-dependent<br />

and non-insulin-dependent diabetes, 813<br />

development of liq. triglycerides-GPO reagent<br />

utilizing response-surface co-optimization<br />

(A), 1071<br />

free glycerol correction for accurate detn, of<br />

plasma trichycerides in lab. animals (A), 1134<br />

glycerol-blanked triglyceride measurement on<br />

the Hitachi 705 chem. analyzer (A), 1072<br />

Lp(a) hipoprotein concn. in serum of patients<br />

with heavy proteinuria of different origin<br />

(SN), 2121<br />

rapid micro-scale proced. for detn. of total lipid<br />

profile, 1486<br />

regional interhab, standn. of serum cholesterol,<br />

HDL cholesterol, and triglycerides (A), 1065<br />

single-channel glycerol-blanked triglyceride<br />

method adapted to the Cohas Fare (A), 1067<br />

successful detn, of triglycerides with the CDC<br />

standardization program (A), 1074<br />

Triiodothyrouine<br />

CEDIA’” total T3. a rapid homogeneous enzyme<br />

immunoassay for serum total T3 (A), 1095<br />

effect of thyroid hormone-binding proteins and<br />

fatty acids on modified analog<br />

and FT3 in serum (L), 708<br />

assays of FT4<br />

enhanced luminescence immunoassay for free<br />

‘l’3(A), 1149<br />

evaln. of Abbott LMx T3 assay (A), 1202<br />

evaln. of Corning magnetic particle RIA for<br />

free T3 (A), 1207<br />

evaln. of total T3 on Abbott IMx automated<br />

immunoassay systems (A), 1099<br />

fluorometric enzyme immunoassay for,<br />

measurement<br />

Cr02 particles<br />

of total I3<br />

(A), 1202<br />

using Magnisep’”<br />

longitudinal study of thyroid function in<br />

pregnancy, 275<br />

shaking polystyrene beads during coating with<br />

antibody: effect on precision profile of<br />

enzyme immunoassay of triiodothyronine<br />

(L), 701<br />

Trypsin<br />

detn. of a2-macroghobulin-trypsin complex<br />

with a new synthetic substrate, 2169<br />

Trypsinogen<br />

strategic use of individual and combined<br />

enzyme indicators far acute pancreatitis<br />

analyzed by receiver-operator<br />

characteristics, 967<br />

Tryptamine<br />

HPLC anal, for serotonin and tryptamine<br />

excreted in urine after oral loading with L-<br />

tryptophan, 43<br />

Tryptophan<br />

HPLC detn, of L-tryptophan in serum and<br />

urine (A), 1115<br />

SDS improves recovery of free tryptophan in<br />

plasma samples deproteinized with<br />

Centrifree Micropartition Devices (A), 1161<br />

Tumor-associated trypsin inhibitor<br />

concns. of tumor-associated trypsin inhibitor<br />

and C-reactive protein in serum in acute<br />

pelvic inflammatory disease (SN), 869<br />

Tumor-derived activated cells<br />

tumor-derived activated cells: prehim. lab, and<br />

chin, results (S), 1576<br />

Tumor markers<br />

CA195, marker far cohorectal cancer (A), 1077<br />

chin, significance of 2-microglobuhin in chronic<br />

lymphocytic leukemia and non-Hodgkins<br />

lymphoma (A), 1079<br />

comparison of CA-15 and steroid receptors in<br />

cancerous and adjacent noncancerous tissue<br />

of the breast (A), 1080<br />

comparison of Centocor CA 19-9, Tandem-R<br />

CA 195, and Truquant GI (A), 1078<br />

fibronectin is unsuitable as a tumor marker in<br />

pleural effusions (SN), 166<br />

immunohistochem. studies utilizing<br />

monochonal and polychonal antibodies to c-<br />

erbB-2 protein<br />

immunoradiometry<br />

(A), 1079<br />

of ay- and yy-enolase<br />

(neuron-specific enohase), with use of<br />

monoclonal antibodies and magnetizable<br />

polymer particles, 2034<br />

incidence of elevation of tumor markers CA-<br />

549, CA-15.3, and CEA in sera of breast<br />

cancer patients (A), 1078<br />

lactate dehydrogenase isoenzyme pattern in<br />

sara in malignant diseases, 396<br />

measurement of sialic acid in squamous cell<br />

carcinoma patients (anal canal and cervix)<br />

by an automated Cobas-Mira procedure (A),<br />

1079<br />

partial charactern. of an abnormal lactate<br />

dehydrogenase isoenzyme, LDH-lex, in<br />

serum from a patient with hepatocellular<br />

carcinoma (SN), 844<br />

prehim. chin. evaln. of an ovarian cancer<br />

marker-CA 215 (A), 1081<br />

prostatic inhibin-like peptide in urine of<br />

prostatic cancer patients, mess. by enzymelinked<br />

immunoaorbent assay, 1376<br />

tumor markers in seminal<br />

fluid (A), 1079<br />

two-site immunoenzymometry of 52-kfle<br />

cathepsin D in cytosols of breast-cancer<br />

tissues, 81<br />

plasma and amniotic<br />

Turbidimetric immunoassay<br />

sensitive turbidimetric immunoassay for detn.<br />

of C-reactive protein in serum (A), 1082<br />

Turbidlmetrlc inhibition imniunoassay<br />

performance of theophylline, gentemicin,<br />

tobramycin, phenytoin, and digoxin reagents<br />

on the Beckman Synchron CX’”4 (A), 1181<br />

Turbidimetry<br />

See also Rate turbidimetry<br />

appln. of three turbidimetric immunoglobuhin<br />

assays, IgG, IgA, and 1gM, to the Express 550<br />

analyzer (A), 1095<br />

diagnostic value of measuring pancreatic hipase<br />

and the P3 isoform of pancreatic amyhase<br />

isoenzyme in serum of hospitalized<br />

hyperamylasemic patients, 417<br />

monochonal turbidimetric assay for<br />

phenobarbital on the RA-1000’” system (A),<br />

1172<br />

optimized microturbidimetric assay for<br />

fibrinoen, 211<br />

patient-side immunoassay system a<br />

single-use cartridge for measuring analytes<br />

in blood (5), 1869<br />

performance characteristics of CSF protein on<br />

Paramax’ (A), 1084<br />

performance characteristics of urine protein on<br />

Paramaz<br />

rapid assays<br />

(A), 1084<br />

for microalbuminuria on two<br />

analyzers (A), 1196<br />

turbidimetric latex immunoassay of placental<br />

lactogen on microtiter plates, 141<br />

Two-dimensional centrifugatlon<br />

See Centrifugation, two-dimensional<br />

Two-dimensional electrophoresis<br />

See Electropharesis, two-dimensional<br />

Tyramine<br />

detn. of tyramine in plasma by ion-pair extn,<br />

and reversed-phase liquid chromatog. with<br />

ehectrochem, detection (A), 1152<br />

Tyrosine<br />

detn, of branched-chain amino acids and<br />

tyrosine in serum in various hepatic diseases,<br />

and its chin, usefulness, 1399<br />

Ultracentrifugation<br />

distribn, of thiobarbituric acid-reactive<br />

substances in hipoproteins, proteins in serum,<br />

2054<br />

implications for mess, of pre-$ high-density<br />

lipoprotein (free apo A-I) by ultracentrifn,<br />

(L), 2336<br />

rapid micro-scale proced. for detn, of total lipid<br />

profile, 1486<br />

unusual band that binds Hb after<br />

ultracentrifn, of hemolyzed plasma for<br />

hipoprotein sepn. (TB), 495<br />

use of a dual-pptn. proced. for mess. highdensity<br />

hipoprotem 3 in normohipidemic<br />

serum, 1390<br />

Ultrafiltration<br />

comparison<br />

and ultrafiltration<br />

of free testosterone<br />

(A), 1148<br />

by analog RIA<br />

kinetic behavior of digoxin-like<br />

immunoreactive substances during<br />

ultrafiltration studies (A), 1157<br />

Uhtrasonography<br />

choriogonadotropin discriminatory zone and<br />

ultrasonogrephy (L), 2019<br />

Uradil arablnoside<br />

hiq.-chromatog. monitoring of cytosine<br />

arabinoside and its metabolite, uradil<br />

arabinoside, in serum, 1011<br />

Urate<br />

detergent enhances interference of urate in<br />

detns, of fructosamine (L), 1803<br />

Urea<br />

automated detn. of urinary Na, K, Cl, P1,<br />

urea, and creatinine without sample diln,<br />

with the “RAT-XT” (SN), 481<br />

enzymic urea assay- new calorimetric method<br />

based on 14203 mess, (SN), 654<br />

evain, of Nova-12 urea electrode (A), 1100<br />

simultaneous detn. of urea, glucose, Na, K, Cl,<br />

and total CO2 in undiluted human serum<br />

using an electrode-based automated analyzer<br />

(A), 1091<br />

Urea nitrogen<br />

evaln, of Nova 12: whole-blood and serum<br />

electrolyte, glucose, and BUN analyzer (A),<br />

1128<br />

modified enzymatic approach to measure blood<br />

urea N on the Technicon RA-1000 (A), 1104<br />

performance of kinetic BUN assay on<br />

BM/Hitachi 717’” (A), 1098<br />

signif. of how serum urea N concns. (SN), 639<br />

Uremia<br />

improved detn. of Vain biol, fluids by<br />

ehectrotherm, at, absorption spectrom. (SN),<br />

127<br />

Uric acid<br />

nonenzymatic stopped-flow fluorimetry for<br />

direct detn, of uric acid in serum and urine,<br />

230<br />

Urine<br />

See also specific anahyte of interest<br />

adaptation of drugs of abuse testing to<br />

Synchron CX#{149}4 and CX’5 chin. analyzers<br />

(A), 1178<br />

adenosine and dopamine simultaneously detd,<br />

in urine by reversed-phase HPLC, with on-<br />

2406 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989


line mess, of uv absorbance and ehectrochem,<br />

detection, 64<br />

adulterants intended to cause false negatives in<br />

urine screens for marijuana or cocaine use<br />

(A), 1175<br />

anal, of urinary metanephrines of patients<br />

treated with antihypertensive a-methyldopa<br />

(Aldomet) (A), 1138<br />

automated detn. of urinary Nat, K, C1, P,<br />

urea, and creatinine without sample diln,<br />

with the “RAT-XT” (SN), 481<br />

Bence Jones immunoghobulins in the urine in<br />

multiple sclerosis (L), 186<br />

Bence Jones proteins in urine of patients with<br />

multiple sclerosis (L), 1550<br />

biochem. contribution to diagnosis and study<br />

of a new case of D-ghyceric acidemia/aciduria<br />

(CR), 2148<br />

biol. variation of urinary N-acetyh-9-D.<br />

glucosaminidase: practical and chin.<br />

implications, 560<br />

Biotrol urine proteins reagent using pyrogallol<br />

red-Mo complex (A), 1082<br />

bladder catheters and Zn contamination of<br />

urine (TB), 888<br />

circadian variations and ref. intervals for some<br />

enzymes in urine of healthy children (SN),<br />

864<br />

chin. applns. for quant. aand Xlight chain<br />

detns. (A), 1084<br />

cocaine and pregnancy: chin, and toxicol.<br />

implications for the neonate (S), 1276<br />

cohorimetric screening method for<br />

microalbuminuriL intra-individuah<br />

variability for untimed day specimens (L),<br />

2019<br />

comparison of Abbott Tl)x FPIA for<br />

cannabinoids with GC/MS (A), 1185<br />

comparison of intact and beta subunit hCG<br />

levels in paired serum and urine samples (A),<br />

1143<br />

contamination of urine samples by test-strip<br />

measurements? (TB), 2144<br />

detection limit of the Tl)x fluorescence<br />

polarization immunoassay<br />

benzoyhecgonine in urine<br />

extended for<br />

(SN), 2110<br />

detection of dimethyl sulfoxide in urine using a<br />

modified Toxilab’ procedure (A), 1165<br />

detn. of cocaine<br />

ester in urine,<br />

metabolite, ecgonine methyl<br />

by gas chromatog. with N-<br />

selective detector (A), 1168<br />

detn. of 4,4’-methylenebis(2-chloroanihine) in<br />

urine (L), 506<br />

development of EMrr’ drugs of abuse assay for<br />

amphetamine/methamphetemine<br />

the ETS’” system (A), 1180<br />

in urine on<br />

development of’fl)./4&i) fluorescence<br />

polarization immunoassay far detection<br />

methadone in human urine (A), 1176<br />

of<br />

diagnostic test for mucopohysaccharidoeis I.<br />

direct method for quantg. excessive urinary<br />

glycosaminoghycan excretion, 374<br />

diagnostic test for mucopohysaccharidoais, II.<br />

rapid quantn. of glycosaminoghycan in urine<br />

samples on a paper matrix, 2074<br />

dimethyimethyhene blue-based spectrophotom.<br />

of glycosaminoglycens in untreated urine:<br />

rapid screening for mucopohysaccharidoses,<br />

1472<br />

direct detn. of 4 sulfates and 7 glucuronides of<br />

17-oxysteroids in urine by fluorescence<br />

“high-performance” hiq. chromatog,, 794<br />

effect of citrate on urinary excretion of Ca and<br />

oxalate: relevance to Ca oxalate<br />

nephrohithiasis, 23<br />

effect of forced diuresis on urinary excretion of<br />

pancreatic amyhase (A), 1127<br />

electrophoretic examin, of proteinurie in<br />

Lowe’s syndrome and other causes of renal<br />

tubular Fanconi syndrome (SN), 2231<br />

EMIl’ convenient two-reagent system for drug<br />

of abuse testing on most common chem.<br />

analyzers (A), 1167<br />

EMil’ ethanoh assays for use on Cobas Mire<br />

and Cobas Bio analyzers (A), 1166<br />

enzymatic assay of Mg through glucokinase<br />

ectn, (SN), 2212<br />

enzymatic detn, of urinary oxalate (SN), 2330<br />

enzymatic method far oxalete automated with<br />

the Cobas Fara centrif, analyzer (SN), 2094<br />

evaln. and performance characteristics of<br />

Paramax anal, system for detg. spinal fluid<br />

and urine protein with hiq. Coomassie Blue<br />

user-def’med chem, (A), 1112<br />

evaln. of Abbott MTD,,’” drug anal. system (A),<br />

1185<br />

evaln. of Abbott TDa#{149} for drugs of abuse<br />

testing in a field environment (A), 1179<br />

evaln, of an RIA of urinary cortisol without<br />

extrn, (SN), 125<br />

evein. of Boehringer Mannheim/Hitechi 717<br />

for routine drug of abuse testing (A), 1165<br />

evaln. of immunochem, methods for detg. how<br />

concns. of albumin in urine (A), 1209<br />

evaln. of TLC technique for detection of<br />

opiates in urine (A), 1173<br />

evaln, of urine metals control using at,<br />

absorption spectrophotom. (A), 1177<br />

evaln. of urine temp. measurement methods to<br />

screen urine specimens for drug testing (A),<br />

1181<br />

excretion of urinary enzymes after<br />

extracorporeal shock-wave hithotripsy (TB),<br />

2000<br />

false-positive urine amphetamine screen with<br />

ritodrine (TB), 1542<br />

five cannabinoid immunoassay systems<br />

compared at the screening threshold of 100<br />

ig/L (SN), 2241<br />

frequency of how-level PCP in urine specimens<br />

for drug screening (A), 1182<br />

glyoxal: an artefact from metronidazole and<br />

glyoxyhic acid in urinary org. acid anal. (TB),<br />

673<br />

high-volume Syve EMIT drug testing on<br />

multiple Epos analyzers interfaced to a<br />

central computer system (A), 1166<br />

high-yield purifn. of the complex-forming<br />

glycoprotein in urine, 577<br />

homogentisic acid deW, in bioh, fluids by<br />

HPLC (SN), 321<br />

HPLC anal. for serotonin and tryptamine<br />

excreted in urine after oral loading with L-<br />

tryptophan, 43<br />

HPLC detn, of L-tryptophan in serum and<br />

urine (A), 1115<br />

HPLC mess, of chlorophenoxy herbicides,<br />

bromoxynil, and ioxynil, in bioL specimens<br />

to aid diagnosis of acute poisoning(S), 1342<br />

identn, of some typical a-blockers (bisoprolol,<br />

betaxohol) and propafenone in bioL<br />

specimens: applicn. to doping anal. (A), 1183<br />

immunocatahytic assay of pancreatic a-amylase<br />

in serum and urine with a specific<br />

monochonal antibody (SN), 662<br />

implications of probability anal, for<br />

interpreting results of heukocyte esterase and<br />

nitrite test stips, 1663<br />

improved detn, of Vain biol, fluids by<br />

electrotherm, at, absorption spectrom. (SN),<br />

127<br />

improved pyrogallol red-Mo method for detg.<br />

improved urinary oxalate method for a centrif,<br />

total urinary protein (SN), 2233<br />

analyzer (L), 1806<br />

IMi’ 2-microglobulin, fully automated<br />

microparticle enzyme immunoassay (A),<br />

1192<br />

interference of common household chemicals in<br />

immunoassays for drugs of abuse (SN), 648<br />

intra-individual biol, variation in the N-acetyh-<br />

-glucosaminidase/creatininium ratio for<br />

first morning<br />

hiq.-chromatog.<br />

urine (TB), 1256<br />

assay of urinary<br />

porphobihinogen (SN), 471<br />

loss of porphyrins from soln, during anal,:<br />

effect of sample pH and matrix on porphyrin<br />

quantn. in urine by HPLC (SN), 1508<br />

mess, of estrone-3-ghucuronide in urine by<br />

rapid, homogeneous time-resolved<br />

fluoroimmunoassey, 555<br />

mess, of urinary heukotrienes by reversed.<br />

phase liq. chromatog, and RIA, 388<br />

measurement of benzodiazepines in urine by<br />

double-antibody RIA (A), 1175<br />

mechanism of false-negative urine cannabinoid<br />

immunoassay screens by Visine’” eyedrops<br />

(SN), 636<br />

(A), 1163<br />

methylmalonic acid, I. concns, in serum and<br />

urinary excretion in normal subjects after<br />

feeding and during fasting, and after loading<br />

with protein, fat, sugar, isoheucine, valine,<br />

2271<br />

methyimalonic acid, H. relation between<br />

concns. in serum and urinary excretion, and<br />

the correln. between serum cobalamin and<br />

accumulation of methylmalonic acid, 2277<br />

microalbuminuria in diabetes mellitus: more on<br />

urine storage and accuracy of calorimetry<br />

(L), 1560<br />

microplate mess, of urinary albumin,<br />

creatinine, 1371<br />

modified method of anal, for metadrenaline in<br />

urine (L), 513<br />

new commercial method for enzymatic detn, of<br />

creatinine in serum and urine evald:<br />

comparison with a kinetic Jeff#{233} method and<br />

isotope diln.-msss apectrametry (SN), 835<br />

nonenzymatic stopped-flow fluorimetry for<br />

direct detn, of uric acid in serum and urine,<br />

230<br />

nonprotein components of urine interfere with<br />

calorimetry of urinary albumin with<br />

bromphenol blue (L), 336<br />

oligoclonal banding detected by urinary<br />

protein electrophoresis and immunoflxation<br />

in two patients with AIDS and proteinuria<br />

(CR), 1795<br />

axalate is overestri, in alk. urmnes collected<br />

during administration of HC032 with no<br />

specimen pH adjustment (SN), 2107<br />

pancreatic amylsse mess, in serum by use of a<br />

monochonal antibody immunochem,<br />

immobilized to asolid phase, 110<br />

performance characteristics of Na, K, and Cl in<br />

urine on the Paramax analytical system (A),<br />

1131<br />

performance characteristics of urine protein on<br />

Paramax’ (A), 1084<br />

performance of Beckman Liquid-Stat’ Mg<br />

reagent (A), 1131<br />

performance<br />

for quant.<br />

of Technicon Chem-1’” analyzer<br />

measurement of 10 analytes in<br />

urine (A), 1130<br />

predicting<br />

program<br />

ovulation in in-vitro fertilization<br />

by monitoring huteinizing<br />

hormone/crestinine ratio in random urine<br />

samples (A), 1144<br />

prostatic inhibin-hike peptide in urine of<br />

prostatic cancer patients, mess, by enzyme.<br />

linked immunosorbent assay, 1376<br />

proteinuria (K), 755<br />

purifn., characterization of intact lactoferrin<br />

found in the urine of human milk-fed<br />

preterm infants, 1928<br />

quant. anal, for org. acids in biol, samples:<br />

batch isolation followed by gas<br />

chromatog.-mass spectrom. anal., 587<br />

quant. measurement of urinary cystine by<br />

nitroprusside reaction (A), 1152<br />

quantn. of Sr in plasma and urine with<br />

flamehess at, absorp. spectrom., 1911<br />

quantn. of urinary porphyrins by hiq.<br />

chromatog. after oxidn, of porphyrmnogens,<br />

1619<br />

rapid assays for microalbuminuria on two<br />

analyzers (A), 1196<br />

rapid detn, of uroporphyrmn and<br />

coproporphyrins in urine using secondderivative<br />

spectroecapy (A), 1132<br />

rapid enzyme<br />

semiquant.<br />

immunoassay for visual,<br />

detn, of lutropin in urine for<br />

ovulation prediction (A), 1148<br />

rapid thin-layer chromatog. semiquantificatian<br />

of morphine in urine via dabsylation:<br />

comparison with EMIT and thin-layer<br />

chromatog,-iodoplatinate methods (TB), 329<br />

reflectometric evahn, of Quantimetrix urine<br />

dipstick controls (A), 1108<br />

renal function assessed by serum creatinine<br />

and creatinine clearance: glomerular<br />

filtration rate estal, by four procedures (SN),<br />

2326<br />

resolution of issues in HPLC anal. of urinary<br />

porphyrins (A), 1157<br />

response of allergic and normal persons to<br />

sulfiting agents in wine: detn, of urinary<br />

thiosulfate excretion (TB), 1792<br />

5-bOa,, protein in blood and urine during<br />

open-heart surgery, 1942<br />

screening for microahbuminuria in patients<br />

with diabetes: frozen storage of urine<br />

samples decreases their albumin content<br />

(SN), 308<br />

sensitive method of screening for urinary<br />

porphobihinogen (SN), 2311<br />

sepn., identn, of urinary proteins and stonematrix<br />

proteins by mini-slab Na dodecyl<br />

sulfate-polyacryhamide<br />

(SN), 658<br />

gel ehectrophoresis<br />

simple hiq.-cbromatog. method for vit. Be cmpe.<br />

in plasma, 241<br />

simplified, rapid test for acetylator<br />

phenotyping by use of the peak height ratio<br />

of two urinary caffeine metabohites (SN), 848<br />

simultaneous detn, of pentoxifyhhine and three<br />

metabohites in bioh, fluids by hiq. chromatog.<br />

(SN), 298<br />

simultaneous mess. of total and IgAconjugated<br />

a1-microglobuhin by combined<br />

immunoenzyme/immunoradiometric assay,<br />

766<br />

CLINICALCHEMISTRY, Vol. 35, No. 12, 1989 2407


solid-phase sample extn, for rapid detn. of<br />

methylmalonic acid in serum, urine by stable<br />

isotope dilution, 260<br />

status of drugs-of-abuse blind tasting in urine:<br />

an AACC study (SR), 891<br />

steroid profile for urine: ref. values, 2281<br />

thin-layer chromatog. of free porphyrins for<br />

diagnosis of porphyria (SN), 1043<br />

transferrin in urine of non-insulin-dependent<br />

diabetics: marker for early complications?,<br />

1672<br />

two-site IRMA for detn, of urinary<br />

cytokeratin-18; apphicn. to management of<br />

bladder cancer (A), 1198<br />

underestn, of urinary glucose by an automated<br />

dipstick analyzer based on glucose oxidase<br />

with has indicator chromogen (L), 1804<br />

urinary excretion of some proteins and<br />

enzymes during normal pregnancy (SN),<br />

1978<br />

urinary 5-hydroxyindoleacetic acid by HPLC<br />

with electrochem, detection (L), 507<br />

urinary neopterin concns. vs total neopterins<br />

for chin. utility (SN), 2305<br />

urinary org. acid excretion by premature<br />

babies, 1460<br />

urine apphn, for Abbott Spectrum and VP<br />

using Abbott liq. amylase reagent (A), 1102<br />

urine Ca anaL using Beckman Synchron CX3<br />

and Synchron CX5 chin, systems (A), 1132<br />

urine free cortisol in depressed patients<br />

assayed by HPLC (A), 1138<br />

urine protein 1: sex-dependent marker of<br />

tubular or glomerular dysfunction (TB),<br />

2141<br />

urine screening for cocaine use with ELISA and<br />

confirmation with GC/MS (A), 1171<br />

Urokinase<br />

effects of therapeutic coronary reperfusion on<br />

aspartate aminotransferase isoenzymes in<br />

sera of patients with acute myocardial<br />

infarct,, 909<br />

Urohithiasia<br />

See Calculous disease<br />

Uroporphyrin<br />

rapid detn. of uroporphyrmn and<br />

coproporphyrins in urine using secondderivative<br />

spectroscopy (A), 1132<br />

Uteroferrin<br />

immunoassay of band 5 (“tartrate-resistant”)<br />

acid phosphatase involving use of antiporcine<br />

utaroferrin antibodies, 86<br />

Vahproic acid<br />

automated fluoroimmunoassay of theophylline<br />

and valproic acid by (how-injection anal, with<br />

use of HPLC (SN), 489<br />

serum valproic acid detn, on Cobas Bio’FP<br />

centrifugal analyzer (A), 1178<br />

valproate therapy depresses GSH-PX and<br />

SOD enzyme acty.: possible mechanism for<br />

VPA-induced idiosyncratic drug toxicity (A),<br />

1173<br />

Vanadium<br />

improved detn. of Va in bioL fluids by<br />

electrotherm, at. absorption spectrom. (SN),<br />

127<br />

Vancomycin<br />

chin, performance of the EMIT vancomycin<br />

assay (SN), 1504<br />

detection of CDP in sera from patients on<br />

vancomycin (A), 1166<br />

development of applicn. protocols for EMfi’<br />

vancomycin assay on the Syva#{149} Autolab’”<br />

instrument system and for Cobss Mire<br />

analyzer (A), 1167<br />

measurement of vancomycin on the Du Pont<br />

aca discrete din, analyzer (A), 1169<br />

Van Slyke Society<br />

Van Slyke Society, 2259<br />

Variation, source of<br />

See also Analytical error<br />

accuracy, precision of anal, for total cholesterol<br />

as measured with the Reflotron cholesterol<br />

method (SN), 1734<br />

adulterants intended to cause false negatives in<br />

urine screens for marijuana or cocaine use<br />

(A), 1175<br />

analyte stability in closed containers after 6<br />

days’ storage (A), 1158<br />

binding of labeled thyroxin analog to serum<br />

proteins evald, after<br />

(SN), 475<br />

RIA of free thyroxin<br />

bioh, variability of 26 chin, chem. anahytes in the<br />

elderly, 783<br />

biol. variation of urinary N.acetyh.-D.<br />

glucosaminidase: practical and chin.<br />

implications, 560<br />

calibrator design considerations for Du Pont<br />

Vista’” immunoassey system (A), 1202<br />

changes in isoform patterns and stability of<br />

CK-MB during storage (A), 1120<br />

contamination of urine samples by test-strip<br />

measurements? (TB), 2144<br />

correction of instrument- and reagent-based<br />

differences in detn, of the mt. normalized<br />

ratio for monitoring anticoagulant therapy<br />

(SN), 840<br />

critical anal. and chin.aspects of ionized Ca in<br />

neonates (H), 2027<br />

cychosporine measured in plasma from patients<br />

with various transplants: HPLC and RIA<br />

with a specific monoclonal antibody<br />

compared (SN), 1726<br />

cychosporine metabolism impeded/blocked by<br />

co-administration of phenobarbital (A), 1160<br />

cyclosporine pharmacokinetics with<br />

concomitant ketoconazohe therapy (A), 1176<br />

differences between capillary and venous<br />

blood-alcohol concns, as a function of time<br />

after drinking, with emphasis on sampling<br />

variations in heft vs right arm, 400<br />

digoxin drug-drug interactions investigated<br />

with a human myocardial Na/K-ATPase<br />

redioreceptor assay (A), 1168<br />

digoxin immune Feb (Digibind) markedly<br />

affects results of immunoassays for digaxin<br />

(A), 1165<br />

effect of Bc on ian-specific electrodes in the<br />

Hitachi 736 (A), 1161<br />

effect of gel separator tubes on specimens for<br />

therapeutic drug anal. (A), 1182<br />

effect of hemoglobinemia on bilirubin assays<br />

on Kodak Ektachem 700 and<br />

Bilirubinometer (A), 1157<br />

effect of lyophiln. on results of five enzymic<br />

methods for cholesterol (SN), 1523<br />

effect of serum albumin on displacement of<br />

phenytoin by ceftriaxone and nafcillin (A),<br />

1176<br />

effects of glucose on spectrophotometric detn,<br />

of blood D-xyhose (A), 1156<br />

effects of hemohysis and storage on quantn. of<br />

hormones<br />

(A), 1133<br />

in blood samples from animals<br />

effects of hipemia of Hitachi 737 measurements<br />

(A), 1159<br />

effects of various serum proteins on quantn. of<br />

fructosamine (SN), 134<br />

effects on ionized Ca by different heparin<br />

preparations measured in ICA 2 analyzer<br />

(A), 1128<br />

evaln, of Amerhite’” F’I’4 method in patients<br />

with FDH and nonthyroidal illness (A), 1142<br />

evain, of matrix effects of lyophilized pools on<br />

apohipoprotein B immunoaasays<br />

evahn, of parameters that influence<br />

(A), 1074<br />

polymeraae<br />

chain reaction (A), 1076<br />

eveln. of RIA kit for detn, of free insulin:<br />

effects of sample handling and storage (A),<br />

1144<br />

evaln, of the IFCC Ref. Method for alanine<br />

aminotransferase: spurious blank ALT acty.<br />

due to contamination of D-alanine with L-<br />

alsnine; recommendations for a correction<br />

(SN), 153<br />

factors affecting a cyanogen bromide-based<br />

assay of thiamin, 2173<br />

fasting vs nonfasting lipoprotain measurements<br />

(A), 1066<br />

five cannabinoid immunoassay systems<br />

compared at the screening threshold of 100<br />

pg/L (SN), 2241<br />

fluoxetine inhibition of imipramine<br />

metabolism (A), 1180<br />

improvement in Synchron CX#{149}-3 electrolyte<br />

performance by use of an enzymatic cleaner<br />

(A), 1097<br />

influence of matrix on concns, of somatotropin<br />

mess, in serum with commercial<br />

immunoradiometric assays, 1423<br />

interaction between pyridmne nucheotide<br />

coenzymes and heme proteins: possible<br />

source of error in assay of activities of<br />

coenzyme-hinked enzymes (SN), 2129<br />

interference by intravenous fluorescein with<br />

lab, tests (A), 1159<br />

int’rinstrument differences in P02<br />

measurement on four recent blood gas<br />

analyzers (A), 1133<br />

intra-individual biol, variation<br />

fl-glucosaminidase/creatininium<br />

in the N-acetyh-<br />

ratio for<br />

first morning urine (TB), 1256<br />

hpoprotein changes in subjects on a modified<br />

fasting regimen (A), 1068<br />

nonenzymic glycation of immunoghobulins does<br />

not impair their immunoreactivity (SN),<br />

1039<br />

organic acids and drug interference in<br />

measurement of CO2 concn, by Kodak<br />

Ektachem 700(A), 1156<br />

patterns of lactate dehydrogenase isoenzymes 1<br />

and 2 in serum on exercise<br />

plasma conjugated androgens<br />

(SN), 301<br />

as digitalis-hike<br />

factors ins dialysis-dependent male (A),<br />

1150<br />

sequential<br />

digoxin<br />

changes in cross reactivity of anti-<br />

antibodies during immunization (A),<br />

1186<br />

short- and long-term variability of indices<br />

related to nutritional status. I: Ca, Cu, Fe,<br />

Mg, and Zn, 369<br />

Stratus automated creatine kinase-MB assay<br />

evald,: identn, and ehimn, of falsely increased<br />

results assocd. with a high-M, form of alk.<br />

phosphatase, 2048<br />

thermal inactn. of L-thyroxin, 90<br />

thyroid-function tests in subjects with<br />

alterations in thyroxin-binding proteins (A),<br />

1139<br />

transport conditions and stability of biochem,<br />

markers in blood (SN), 2313<br />

variability in serum lactate dehydrogenase<br />

acty. and isoenzyme patterns induced by<br />

streptokinase (A), 1119<br />

variables involved in evaluating maternal<br />

serum alpha-fetoprotein: albumin, total<br />

protein and fructosamine (A), 1159<br />

variation among units for blood cellular Mg<br />

(A), 1115<br />

Veterinary chemistry<br />

detection of dimethyl sulfoxide in urine using a<br />

modified Toxihab procedure (A), 1165<br />

detection of poisoning by plant-origin cardiac<br />

glycoside with the Abbott TDx analyzer<br />

(SN), 295<br />

effect of ether or ketamine anesthesia on rat<br />

uterine estrogen, progesterone receptors<br />

(SN), 143<br />

effect of exercise training on glycemic control,<br />

kidney function, and renal ultrastructure in<br />

obese (diabetic) Zucker rats (A), 1135<br />

effects of hemolysis and storage on quantn. of<br />

hormones in blood samples from animals<br />

(A), 1133<br />

feline and canine ref. ranges for the Kodak<br />

Ektachem 700 analyzer (A), 1134<br />

free glycerol correction for accurate detn. of<br />

plasma triclycerides in lab. animals (A), 1134<br />

increased Ca uptake in vascular tissue by<br />

plasma of salt-induced hypertensive DahI<br />

rats (A), 1138<br />

Magiwel’” enzyme immunasssay<br />

heartworm (Dirofilaria immitis)<br />

for dog<br />

infections<br />

(A), 1137<br />

time-resolved fluoroimmunoassay of aflatoxins<br />

(SN), 2308<br />

tissue damage assessment in T2 mycotoxicosis<br />

(A), 1135<br />

Viruses<br />

applicn. of polymerase chain reaction (PCR) to<br />

detection of human retroviruses (A), 1058<br />

delta and conjugated bihirubins as predictors of<br />

early liver allograft rejection are unaffected<br />

by cytomegahavirus infection (A), 1137<br />

detection of HIV proviral DNA in peripheral<br />

blood mononuclear cells by pohymerasechain<br />

reaction (A), 1076<br />

detection of HIV-1 RNA by polymerase chain<br />

reaction (A), 1076<br />

enzyme immunoassay for quantn. of IgG<br />

antibody to rubella virus in serum (A), 1092<br />

evaln. of automated fluorescent immunoassay<br />

for detection of HBsAg (A), 1095<br />

neopterin as a predictive marker for disease<br />

progression in human immunodeficiency<br />

virus type 1 infection (SN), 1746<br />

oligoclonal immunoglobulin bands in HTLV-Iassociated<br />

myelopathy (A), 1085<br />

quant. ELA for detn. of tumor necrosis factoralpha<br />

(A), 1187<br />

Vitamin A<br />

liq. chromatog. essay for free and<br />

transthyretin-bound retinol-binding protein<br />

in serum, 582<br />

Vitamin B<br />

simple hiq.-chromathg. method for vit, Be cmps.<br />

in plasma, 241<br />

Vitamin B12<br />

chemilumescence receptor assay for vit, B12<br />

(A), 1194<br />

cobalamin-binding capacity of haptocorrin and<br />

transcobalamin: age-correlated ref. intervals<br />

2408 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989


and values from patients, 1447<br />

high prevalence of atrophic gastritis in the<br />

elderly implications for health-associated<br />

ref. limits for cobahamin in serum (L), 1557<br />

methylmalonic acid, I. cancns. in serum and<br />

urinary excretion in normal subjects after<br />

feeding and<br />

with protein,<br />

during fasting,<br />

fat, sugar,<br />

and after loading<br />

isoleucine, valine,<br />

2271<br />

methyhmalonic acid. H. relation between<br />

concns. in serum and urinary excretion, and<br />

the correhn, between serum cobahamin and<br />

accumulation of methylmalonic acid, 2277<br />

solid-phase sample extn. for rapid detn, of<br />

methylmahonic acid in serum, urine by stable<br />

isotope dilution, 260<br />

Vitamin D<br />

tumoral calcinosis: seasonal biochem. studies<br />

and chem, studies of eyelid lesion (CR), 183<br />

Vitamin E<br />

simultaneous liq,-chromatog. detn, of vit. K1,<br />

vit. E in serum, 2285<br />

Vitamin K<br />

anal, of supplemented vit, K1 (20) in serum<br />

microsamples by sohid-phaseextrn, and<br />

narrow-bore HPLC with multichannel uv<br />

detection (S), 1288<br />

brodifacoum (super warfarmn) poisonin lab,<br />

methods for assessment of vit, K antagonism<br />

(A), 1162<br />

detn. of trans-phylhoquinone in children’s<br />

serum (SN), 874<br />

serum phyhloquinone concns, in a normal popn.<br />

of children as compared with ref. interval in<br />

adults (TB), 671<br />

simultaneous hiq.-chromatog. detn, of vit. K1,<br />

vit. E in serum, 2285<br />

Vitamins<br />

effect of repeated freezing and thawing on<br />

vitamins and hormones in serum (TB), 2145<br />

quantn. of biotin in serum by competition with<br />

solid-phase biotin for binding to<br />

peroxidase-avidin conjugate (SN), 1721<br />

Vitreous fluid<br />

evaln. of vitreous fluid as a specimen far drug<br />

abuse testing (A), 1181<br />

Voltammetry<br />

rapid detn. of Cl- in serum using a cyclic<br />

voltammetric method (A), 1133<br />

Waaler-Rose assay<br />

automated enhanced latex agglutn. assay for<br />

rheumatoid factors in serum (SN), 303<br />

Xylose<br />

effects of glucose on spectrophotometric detn.<br />

of blood D-xyloae (A), 1156<br />

Zinc<br />

bladder catheters and Zn contamination<br />

urine (TB), 888<br />

of<br />

changes in Fe, Zn, Cu concns, in serum and in<br />

their binding to transport proteins after<br />

cholecystectomy, cardiac surgery (SN), 2243<br />

serum Zn in homosexual men (L), 704<br />

statis. interpretn. of condos,<br />

cholesterohs, and creatine<br />

of Mg, Zn, Ce, K,<br />

kinase isoenzymes<br />

in men at different stages of ischemic heart<br />

disease (SN), 833<br />

Znprotoporphyrin/heme ratio: primary test for<br />

Fe deficiency in a pediatric population (A),<br />

1114<br />

Zonal ultracentrifugatlon<br />

dual-pptn. method evald, for meas, of<br />

cholesterol<br />

subfractions<br />

in high-density hipoprotein<br />

HDL2 and HDL3 in plasma, 265<br />

Cumulative indexes for volumes 1-18, 19-26, and 27-31 are available. Write to the Business Office, AACC.<br />

CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2409


January: pages 1-200<br />

February: pages 201-346<br />

March: pages 347-518<br />

April: pages 519-716<br />

May: pages 717-908<br />

June: pages 909-1272<br />

July: pages 1273-1 570<br />

August: pages 1571 -1814<br />

September: pages 1815-2026<br />

October: pages 2027-2164<br />

November: pages 2165-2260<br />

December: pages 2261 -2409<br />

Beckman Supplement Issue:<br />

pages B1-B54

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!